<SEC-DOCUMENT>0001683168-20-003974.txt : 20201116
<SEC-HEADER>0001683168-20-003974.hdr.sgml : 20201116
<ACCEPTANCE-DATETIME>20201116172039
ACCESSION NUMBER:		0001683168-20-003974
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		93
CONFORMED PERIOD OF REPORT:	20200831
FILED AS OF DATE:		20201116
DATE AS OF CHANGE:		20201116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIMULATIONS PLUS INC
		CENTRAL INDEX KEY:			0001023459
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		IRS NUMBER:				954595609
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32046
		FILM NUMBER:		201318438

	BUSINESS ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
		BUSINESS PHONE:		661-723-7723

	MAIL ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>simulations_i10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:simu="http://simulations.com/20200831">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_simu_simulations.com_20200831 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20190901_20200831 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001023459 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DDocumentFiscalYearFocus_2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wOC0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_073_SO_C%2D%2D\Users\Fran\Dropbox (GlobalOne)\GlobalOne Team Folder\edgar\Simulations 10%2DK 08%2D31%2D20\simulations 10k tagged.xdxs -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityCentralIndexKey">0001023459</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:DocumentFiscalYearFocus">2020</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:CurrentFiscalYearEndDate">--08-31</ix:nonNumeric>
    <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2020-08-31" id="xdx2ixbrl0154" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2019-08-31" id="xdx2ixbrl0155" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2017-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0315" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0329" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0331" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0332" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0343" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0344" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0345" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0349" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0351" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0364" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0372" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0379" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0380" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0419" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0421" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0435" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0449" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0458" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0463" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains" contextRef="From2019-09-012020-08-31_us-gaap_CommercialPaperMember" id="xdx2ixbrl1255" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains" contextRef="From2019-09-01to2020-08-31" id="xdx2ixbrl1263" unitRef="USD" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" id="xdx2ixbrl1539" unitRef="Shares" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" id="xdx2ixbrl1541" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" id="xdx2ixbrl1579" unitRef="Shares" xs:nil="true"></ix:nonFraction>
    <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" id="xdx2ixbrl1581" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="simu-20200831.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2019-09-01to2020-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_OtherIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-02-28_us-gaap_RoyaltyAgreementsMember_custom_EnslienMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-09-012012-02-28_us-gaap_RoyaltyAgreementsMember_custom_EnslienMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-09-01</xbrli:startDate>
        <xbrli:endDate>2012-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-05-15_custom_TermAndNonassertionAgrMember_custom_TSRLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:TermAndNonassertionAgrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-05-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-09-012014-05-15_custom_TermAndNonassertionAgrMember_custom_TSRLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:TermAndNonassertionAgrMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-09-01</xbrli:startDate>
        <xbrli:endDate>2014-05-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-02_custom_CertainDevelopedTechnologiesMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainDevelopedTechnologiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-09-012017-06-02_custom_CertainDevelopedTechnologiesMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainDevelopedTechnologiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-09-01</xbrli:startDate>
        <xbrli:endDate>2017-06-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_CertainIntellectualPropertyRightsMember_custom_EntelosHoldingCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainIntellectualPropertyRightsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosHoldingCoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012018-09-30_custom_CertainIntellectualPropertyRightsMember_custom_EntelosHoldingCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainIntellectualPropertyRightsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosHoldingCoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-02_custom_CertainDevelopedTechnologiesMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainDevelopedTechnologiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-04-02_custom_CertainDevelopedTechnologiesMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainDevelopedTechnologiesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-04-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_IntellectualPropertyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:SoftwareLicensesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:SoftwareLicensesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:SoftwareLicensesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:SoftwareLicensesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_ConsultingServicesMember_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:ConsultingServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_ConsultingServicesMember_us-gaap_TransferredOverTimeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:ConsultingServicesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_CommercialPaperMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_CommercialPaperMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_HoldbackLiabilityLixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:HoldbackLiabilityLixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_HoldbackLiabilityLixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:HoldbackLiabilityLixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_EarnoutLiabilityLixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:EarnoutLiabilityLixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_EarnoutLiabilityLixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:EarnoutLiabilityLixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_EarnoutLiabilityDilisymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:EarnoutLiabilityDilisymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_EarnoutLiabilityDilisymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:EarnoutLiabilityDilisymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_custom_WellsFargoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">simu:WellsFargoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-03-31_custom_WellsFargoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">simu:WellsFargoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_WellsFargoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">simu:WellsFargoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_RecordDate20181Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20181Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_RecordDate20182Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20182Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_RecordDate20183Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20183Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_RecordDate20184Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20184Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_RecordDate20191Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20191Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_RecordDate20192Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20192Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_RecordDate20193Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20193Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_RecordDate20194Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20194Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_RecordDate20201Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20201Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_RecordDate20202Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20202Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_RecordDate20203Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20203Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_RecordDate20204Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20204Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_Equity2017IncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">simu:Equity2017IncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price5Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price6Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_SalesMember_custom_InternationalSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:InternationalSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_SalesMember_custom_InternationalSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:InternationalSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_InternationalSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:InternationalSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer2Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer2Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer3Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer3Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer4Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer4Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_AccountsReceivableMember_custom_ACustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:ACustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_AccountsReceivableMember_custom_BCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:BCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_AccountsReceivableMember_custom_ACustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:ACustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_CognigenMember137486375">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_DILIsymMember137486390">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_LixoftMember137486390">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_CognigenMember137486437">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_DILIsymMember137486453">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_LixoftMember137486453">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_srt_ConsolidationEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_us-gaap_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_CognigenMember137486562">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_DILIsymMember137486578">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_CognigenMember137486625">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_custom_DILIsymMember137486640">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_srt_ConsolidationEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-31_us-gaap_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_CognigenMember137486718">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_DILIsymMember137486734">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_custom_CognigenMember137486781">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_custom_DILIsymMember137486796">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_srt_ConsolidationEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_us-gaap_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_EuropeMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_AsiaMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_EuropeMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_AsiaMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_EuropeMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_AsiaMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_EuropeMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_AsiaMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_EuropeMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_AsiaMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_EuropeMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_AsiaMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_EuropeMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_AsiaMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_EuropeMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_AsiaMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_LixoftMember137487265">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_EuropeMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_AsiaMember_custom_SimulationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_EuropeMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_AsiaMember_custom_CognigenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_EuropeMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_AsiaMember_custom_DILIsymMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_EuropeMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_AsiaMember_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_LixoftMember137487406">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_EuropeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-012018-08-31_srt_AsiaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:FormerShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:FormerShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012018-09-30_custom_DILIsymMember_custom_DilisymEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DilisymEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012018-09-30_custom_DILIsymMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_DILIsymMember_custom_DilisymEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DilisymEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012019-08-31_custom_DILIsymMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_DILIsymMember_custom_DilisymEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DilisymEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_DILIsymMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-08-31_custom_LixoftMember_custom_FormerShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:FormerShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-08-31_custom_LixoftMember_custom_FormerShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:FormerShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-02_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012020-04-02_custom_LixoftMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2020-04-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-012019-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-01</xbrli:startDate>
        <xbrli:endDate>2019-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-12-012020-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-12-01</xbrli:startDate>
        <xbrli:endDate>2020-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-012020-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-01</xbrli:startDate>
        <xbrli:endDate>2020-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-012020-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-01</xbrli:startDate>
        <xbrli:endDate>2020-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-012018-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-01</xbrli:startDate>
        <xbrli:endDate>2018-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-012019-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-01</xbrli:startDate>
        <xbrli:endDate>2019-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-012019-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-01</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-06-012019-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001023459</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-06-01</xbrli:startDate>
        <xbrli:endDate>2019-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><a href="#a_007">Table of Contents</a></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION<br />
Washington, DC 20549<br />
<br />
FORM <span id="xdx_906_edei--DocumentType_c20190901__20200831_zCCwKAHqOWG6"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Wingdings"><span id="xdx_90A_edei--DocumentAnnualReport_c20190901__20200831_zGti1LKKxZM4"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">x</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the fiscal year
ended <span id="xdx_903_edei--DocumentPeriodEndDate_c20190901__20200831_zkrsIxKeylK7"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 31, 2020</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Wingdings"><span id="xdx_90D_edei--DocumentTransitionReport_c20190901__20200831_znnhPJGzlSk9"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">o</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the transition
period from _________ to _________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission file number: <span id="xdx_90D_edei--EntityFileNumber_c20190901__20200831_zYcqRoMCULZ8"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityFileNumber">001-32046</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_001.jpg" alt="" style="height: 51pt; width: 236.25pt" />&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20190901__20200831_zQFbgMGbt9Ik"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityRegistrantName">Simulations Plus, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 50%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20190901__20200831_z1jTzXnORld"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">California</ix:nonNumeric></span></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of incorporation
        or organization)</p></td>
    <td style="width: 50%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20190901__20200831_zrhlUo26oGuc"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityTaxIdentificationNumber">95-4595609</ix:nonNumeric></span></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer Identification No.)</p></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">&#160;</td>
    <td style="text-align: center; font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20190901__20200831_zhVuL2SIpu2f"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20190901__20200831_zCutppLSaZke"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityAddressAddressLine1"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityAddressAddressLine1">42505 Tenth Street West</ix:nonNumeric></ix:nonNumeric></span></span></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityAddressCityOrTown_c20190901__20200831_zjCkv2t5vas1"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityAddressCityOrTown">Lancaster</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20190901__20200831_zA3eh25dqJZ"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20190901__20200831_zZBhOTmd4Flj"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityAddressPostalZipCode">93534-7059</ix:nonNumeric></span></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices
        including zip code)</p></td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--CityAreaCode_c20190901__20200831_zfFktufvYE33"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:CityAreaCode">(661)</ix:nonNumeric></span> <span id="xdx_906_edei--LocalPhoneNumber_c20190901__20200831_zywThJurh194"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:LocalPhoneNumber">723-7723</ix:nonNumeric></span></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
        area code)</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES REGISTERED PURSUANT TO SECTION
12(b) OF THE ACT:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 34%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline">Title of Each Class</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--Security12bTitle_c20190901__20200831_z9Fq3xlTOtwf" title="Title of 12(b) Security"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></b></p></td>
    <td style="width: 33%; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Trading Symbol(s)<br />
</span><b><span id="xdx_90E_edei--TradingSymbol_c20190901__20200831_zPnH7ys749lg"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:TradingSymbol">SLP</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline">Name of Each Exchange on Which Registered</span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--SecurityExchangeName_c20190901__20200831_z6k1AcZyYHZ2"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span> Stock Market LLC</b></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES REGISTERED PURSUANT TO SECTION
12(G) OF THE ACT: NONE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. &#160;&#160; <span id="xdx_905_edei--EntityWellKnownSeasonedIssuer_c20190901__20200831_zRDc7B7ZbWUb"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityWellKnownSeasonedIssuer">Yes</ix:nonNumeric></span>&#160;</span><span style="font-family: Wingdings">x</span><span style="font-family: Times New Roman, Times, Serif">&#160;No&#160;</span><span style="font-family: Wingdings">o</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. &#160;&#160;
Yes&#160;</span><span style="font-family: Wingdings">o</span><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_905_edei--EntityVoluntaryFilers_c20190901__20200831_zvvJ0geuEDM2"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>&#160;</span><span style="font-family: Wingdings">x</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filings requirements for the past 90 days.&#160;&#160;<span id="xdx_90C_edei--EntityCurrentReportingStatus_c20190901__20200831_zd0Ty93UihAb"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span>&#160;&#160;&#160;&#160;</span><span style="font-family: Wingdings">x</span><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;No&#160;&#160;&#160;</span><span style="font-family: Wingdings">o</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit such files). &#160;&#160;<span id="xdx_90A_edei--EntityInteractiveDataCurrent_c20190901__20200831_zQKTHu4Ivkyc"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>&#160;&#160;&#160;&#160;</span><span style="font-family: Wingdings">x</span><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;No&#160;&#160;&#160;</span><span style="font-family: Wingdings">o</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth
company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting
company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 1%; text-align: justify; font-size: 10pt">&#160;</td>
    <td style="width: 48%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Large accelerated Filer&#160;&#160;</span><span style="font: 10pt Wingdings">o</span></td>
    <td style="width: 51%; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Accelerated Filer&#160;&#160;</span><span style="font: 10pt Wingdings">o</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--EntityFilerCategory_c20190901__20200831_z4gLnmtne909"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" name="dei:EntityFilerCategory">Non-accelerated Filer</ix:nonNumeric></span>&#160;&#160;</span><span style="font: 10pt Wingdings">x</span></td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Smaller reporting company&#160;</span><span style="font: 10pt Wingdings"><span id="xdx_903_edei--EntitySmallBusiness_c20190901__20200831_zaIYM2hgkf3i"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">x</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">Emerging growth company&#160;&#160;</span><span style="font: 10pt Wingdings"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20190901__20200831_zBImfgpbdRqa"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">o</ix:nonNumeric></span></span></td>
    <td style="text-align: justify; font-size: 10pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family: Wingdings">o</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. &#160;</span><span style="font-family: Wingdings">o </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes&#160;</span><span style="font-family: Wingdings">o</span><span style="font-family: Times New Roman, Times, Serif">&#160;<span id="xdx_90A_edei--EntityShellCompany_c20190901__20200831_zq2T0my34cL6"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span>&#160;</span><span style="font-family: Wingdings">x</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate market value of the registrant&#8217;s
common stock held by non-affiliates of the registrant as of February 29, 2020, based upon the closing price of the common stock
as reported by The Nasdaq Capital Market on such date, was approximately $<span id="xdx_901_edei--EntityPublicFloat_iI_c20200229_z6CfyH4DZmRa"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2020-02-29" format="ixt:numdotdecimal" decimals="0" unitRef="USD">412,688,004</ix:nonFraction></span>. This calculation does not reflect a determination
that persons are affiliates for any other purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of November 16, 2020, <span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_c20201116_zmjVrV081vak"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2020-11-16" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,931,709</ix:nonFraction> s</span></span><span style="font-family: Times New Roman, Times, Serif">hares
of the registrant&#8217;s common stock were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DOCUMENTS INCORPORATED BY REFERENCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain portions of the registrant&#8217;s
definitive proxy statement to be delivered to its shareholders in connection with the registrant&#8217;s 2020 Annual Meeting of
Shareholders are incorporated by reference into Part III of this Form 10-K. Such definitive proxy statement will be filed with
the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this annual report on Form 10-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Simulations Plus, Inc.<br />
FORM 10-K<br />
For the Fiscal Year Ended August 31, 2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a_007"></span>Table of Contents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 90%">&#160;</td>
    <td style="width: 10%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><b>Page</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif"><b><a href="#a_008">PART I</a></b></span></span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_009">ITEM 1 &#8211; BUSINESS</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_010">ITEM 1A &#8211; RISK FACTORS</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">13</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_011">ITEM 1B &#8211; UNRESOLVED STAFF COMMENTS</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">28</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_012">ITEM 2 &#8211; PROPERTIES</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">28</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_013">ITEM 3 &#8211; LEGAL PROCEEDINGS</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">29</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_014">ITEM 4 &#8211; MINE SAFETY DISCLOSURES</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">29</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><a href="#a_015">PART II</a></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_016">ITEM 5 &#8211; MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></td>
    <td style="text-align: right">30</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_017">ITEM 6 &#8211; SELECTED FINANCIAL DATA</a></span></td>
    <td style="text-align: right">32</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_018">ITEM 7 &#8211; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="text-align: right">33</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_019">ITEM 7A &#8211; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></td>
    <td style="text-align: right">47</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_020">ITEM 8 &#8211; FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">47</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_021">ITEM 9 &#8211; CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">47</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_022">ITEM 9A &#8211; CONTROLS AND PROCEDURES</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">47</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_023">ITEM 9B &#8211; OTHER INFORMATION</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">48</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><a href="#a_024">PART III</a></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_025">ITEM 10 &#8211; DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_026">ITEM 11 &#8211; EXECUTIVE COMPENSATION</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_027">ITEM 12 &#8211; SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_028">ITEM 13 &#8211; CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_029">ITEM 14 &#8211; PRINCIPAL ACCOUNTING FEES AND SERVICES</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">49</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><a href="#a_030">PART IV</a></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_031">ITEM 15 &#8211; EXHIBITS, FINANCIAL STATEMENT SCHEDULES</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">50</span></td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_032">SIGNATURES</a></span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">52</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SPECIAL NOTE REGARDING FORWARD-LOOKING
STATEMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Annual Report on Form 10-K contains
forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, concerning our business,
operations, and financial performance and condition, as well as our plans, objectives, and expectations for our business operations
and financial performance and condition. Any statements contained herein that are not statements of historical facts may be deemed
to be forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;aim,&#8221;
&#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221;
&#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221;
&#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;positioned,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221;
&#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and other similar expressions that are predictions of or indicate
future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements
include, but are not limited to, statements about:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">the continued growth in demand for our software products and consulting services in the pharmaceutical drug development industry;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">our sales, marketing, and distribution prospects;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">the continuing productivity and effectiveness of our commercial infrastructure and worldwide salesforce;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">our financial performance;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">our expectations regarding the worldwide market for modeling and simulation services;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">the continued competitive positioning of our software products and services;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">our expectations regarding the potential market size and the continuing expansion of modeling and simulation usage in the drug development sector;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 91%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">the scope of protection we are able to maintain for intellectual
        property rights covering our software products;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">the modeling and simulation software and services market;</span></td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">the continued expectations of growth
    for pharmaceutical drug development research and development expenditures;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">our ability to grow our consulting staff to meet demand and retain scientific employees to perform consulting services for our customers;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">the continuing support of the use of modeling and simulation by regulatory authorities like the U.S. Food
and Drug Administration (FDA);</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">the implementation of our business model and strategic plans for our business and technology;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">our expectations regarding the effects of the COVID-19 pandemic on our business and our clients&#8217;; and</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top; width: 91%"><span style="font: 10pt Times New Roman, Times, Serif">developments and projections relating to our competitors and our industry.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These forward-looking statements are based
on management&#8217;s current expectations, estimates, forecasts, and projections about our business and the industry in which
we operate and management&#8217;s beliefs and assumptions and are not guarantees of future performance or development and involve
known and unknown risks, uncertainties, and other factors that are in some cases beyond our control. As a result, any or all of
our forward-looking statements in this Annual Report on Form 10-K may turn out to be inaccurate. Factors that may cause actual
results to differ materially from current expectations include, among other things, those listed under &#8220;Risk Factors&#8221;
and elsewhere in this Annual Report on Form 10-K. Investors are urged to consider these factors carefully in evaluating the forward-looking
statements. These forward-looking statements speak only as of the date of this Annual Report on Form 10-K. Except as required by
law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes
available in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="a_008"></span>PART I</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_009"></span>ITEM 1 &#8211;BUSINESS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As used in this report, each of the terms
&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; and &#8220;Simulations Plus&#8221; refers to Simulations
Plus, Inc. and its wholly owned subsidiaries Cognigen Corporation, of Buffalo, New York; DILIsym Services, Inc. of Research Triangle
Park, North Carolina; and Lixoft of Paris, France, unless otherwise stated or the context otherwise requires.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>OVERVIEW</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulations Plus, Inc., incorporated
in 1996, is a premier developer of modeling and simulation software for drug discovery and development, including the prediction
of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. We also provide consulting
services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support
of product approval. Our software and consulting services are provided to major pharmaceutical, biotechnology, agrochemical, cosmetics,
and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research.
SLP is headquartered in Southern California, with offices in Buffalo, NY, Research Triangle Park, NC, and Paris, France. The Company&#8217;s
common stock trades on the Nasdaq Capital Market under the symbol &#8220;SLP&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a global leader focused on improving
the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical and biotechnology agents by
providing a wide range of early discovery, preclinical, and clinical consulting services and software. Our innovations in integrating
new and existing science in medicinal and computational chemistry, pharmaceutical science, biology, physiology, and machine learning
into our software have enabled us to be a leading software provider for physiologically based pharmacokinetics (PBPK) modeling
and simulation, pharmacometric modeling and simulation, prediction of molecular properties from structure, and prediction of the
propensity of drugs to induce liver injury or to treat nonalcoholic fatty liver disease. Our scientific consulting staff draw upon
extensive experience across multiple therapeutic areas and a full range of modeling and simulation techniques to assist our clients
across the full spectrum of drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generate revenue by delivering relevant,
cost-effective software and creative and insightful consulting services. Pharmaceutical and biotechnology companies use our software
programs and scientific consulting services to guide early drug discovery (molecule design screening and lead optimization), preclinical,
and clinical development programs, including using our software products and services to enhance their understanding of the properties
of potential new medicines and to use emerging data to improve formulations, select and justify dosing regimens, support the generics
industry, optimize clinical trial designs, and simulate outcomes in special populations, such as in elderly and pediatric patients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulations Plus acquired Cognigen Corporation
(Cognigen) as a wholly owned subsidiary in September 2014. Cognigen was originally incorporated in 1992. Through the integration
of Cognigen into Simulations Plus, Simulations Plus became a leading provider of population modeling and simulation contract research
services for the pharmaceutical and biotechnology industries. Our clinical-pharmacology-based consulting services include pharmacokinetic
and pharmacodynamic modeling, clinical trial simulations, data programming, and technical writing services in support of regulatory
submissions. We have also developed software for harnessing cloud-based computing in support of modeling and simulation activities
and secure data archiving, and we provide consulting services to improve interdisciplinary collaborations and research and development
productivity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulation Plus acquired DILIsym Services,
Inc. (DILIsym) as a wholly owned subsidiary in June 2017. The acquisition of DILIsym positioned the Company as the leading provider
of Drug Induced Liver Injury (DILI) modeling and simulation software and related scientific consulting services. In addition to
the DILIsym&#174; software for analysis of potential drug-induced liver injury, DILIsym Services, Inc. also has developed a simulation
program for analyzing nonalcoholic fatty liver disease (NAFLD) called NAFLDsym&#8482;. Both the DILIsym and NAFLDsym software programs
require outputs from physiologically based pharmacokinetics (PBPK) software as inputs. Outputs generated by the GastroPlus&#8482;
PBPK software that are required by DILIsym software can be automatically mapped to DILIsym applications; thus, the integration
of these technologies provides a seamless capability for analyzing the potential for drug-induced liver injury for new drug compounds
and for investigating the potential for new therapeutic agents to treat NAFLD. Since the acquisition, DILIsym has applied its mechanistic
modeling resources in other disease areas including idiopathic pulmonary fibrosis (IPF).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulations Plus acquired Lixoft as a
wholly owned subsidiary on April 1, 2020. Lixoft brings to Simulations Plus its powerful software products, Monolix, Simulx and
PKanalix, which can take modeling projects from data exploration to clinical trial simulations. In addition, Lixoft provides training
and focused consulting services which can accelerate pharmacometric studies. Lixoft&#8217;s technologies were developed as a result
of a research program led by the French national research institute for digital science and technology (Inria), on nonlinear mixed
effect models for advanced population analysis, pharmacometrics, pre-clinical, and clinical trial modeling and simulation. Lixoft
continues to work with Inria.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PRODUCTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently offer eleven software products
for pharmaceutical research and development: five simulation programs that provide time-dependent results based on solving large
sets of differential equations: GastroPlus&#174;; DDDPlus&#8482;; MembranePlus&#8482;; DILIsym&#174;; and NAFLDsym&#8482;; three
programs that are based on predicting and analyzing static (not time-dependent) properties of chemicals: ADMET Predictor&#174;;
MedChem Designer&#8482;; and MedChem Studio&#8482; (the combination of ADMET Predictor, MedChem Designer, and MedChem Studio is
called our ADMET Design Suite&#8482;); a program which is designed for rapid clinical trial data analysis and regulatory submissions
called PKPlus&#8482;; a program called KIWI&#8482; from our Cognigen division that provides an integrated platform for data analysis
and reporting through our proprietary secure cloud; and in April 2020 with the acquisition of Lixoft, we added the Monolix Suite&#8482;
of products &#8211; a modeling and simulation solution that allows nonparametric analyses, population PKPD analyses, and modeling
and clinical trial simulation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">GastroPlus&#174;</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
flagship product, originally introduced in 1998, and currently our largest single source of software revenue, is GastroPlus. GastroPlus
mechanistically simulates the absorption, pharmacokinetics, pharmacodynamics, and drug-drug interactions of compounds administered
to humans and animals and is currently one of the most widely used commercial software of its type by industry, the U.S. Food and
Drug Administration (FDA), the U.S. National Institutes of Health (NIH), and other government agencies in the U.S. and around the
world.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
goal with GastroPlus is to integrate the most advanced science into user-friendly software to enable researchers and regulators
to perform sophisticated analyses of complex compound behaviors in humans and laboratory animals. GastroPlus is one of the most
widely used program in the world for physiologically based biopharmaceutics (PBBM)/PBPK modeling with a user base including early
pharmaceutical research and development, biopharmaceuticals, food, cosmetics, and general toxicology. We work to release updated
versions of the program on an ongoing basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2019, we released Version 9.7 of
GastroPlus. This version added several important new capabilities, including improvements to population simulations, dissolution,
absorption, PBPK models, and drug-drug interactions, among others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The ability to add lysosomal trapping effect to PBPK tissues</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">New mechanistic pregnancy PBPK model (with fetus compartment)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Additional solubility inputs for different drug forms (crystalline, amorphous)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">New standard compound models (substrates/inhibitors/inducers) in the DDI Module</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Expanded fed state conditions based on meal type</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">New ability to allow different tissue model types (perfusion- or permeability-limited) between parent and metabolites or victim perpetrator in metabolite tracking/DDI simulations</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">PK/PD model additions to PKPlus Module</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Updates to the dermal absorption (TCAT) model through our Cosmetics Europe project</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">New effect of immune response with intramuscular injection models</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Updated default populations for extensive, intermediate, and poor metabolizers based on specific genotypes</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><i>In
vitro</i> transdermal model: as part of the Research Collaboration Agreement (RCA) awarded by the FDA in September 2018 to improve
the TCAT model in GastroPlus, we developed a novel simulation tool to analyze data from <i>in vitro</i> skin penetration studies
to better inform <i>in vivo</i> predictions within GastroPlus.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of the widespread use of GastroPlus,
we have been able to enter into both funded and unfunded collaborations with industry and government agencies to drive advances
to modeling and simulation science. In all, Simulations Plus owns the intellectual property developed within the GastroPlus program,
and updates are integrated into future versions and made available to clients:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ocular absorption model: in September 2014,
we entered into an RCA with the FDA to enhance the Ocular Compartmental Absorption and Transit (OCAT&#8482;) model within the Additional
Dosage Routes Module of GastroPlus. The objective of this agreement was to provide a tool for generic drug companies and the FDA
to assess the likely bioequivalence of generic drug formulations dosed to the eye. After a successful second year, the RCA was
extended for two additional years in September 2016, with primary tasks completed in September 2018. Additional functionality was
further requested by the FDA, and a new funded contract was awarded for the 2018-19 period. In May 2020, we were awarded yet another
grant from the FDA to support interspecies translation for ocular drug delivery in GastroPlus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-acting injectable (LAI) product models:
in September 2015, we were awarded an RCA by the FDA to expand the capabilities of GastroPlus to simulate the dosing of long-acting
injectable microspheres for both small and large molecules (biologics). Under this agreement, we developed simulation models to
deal with the very slow dissolution/decomposition of microsphere carrier materials that gradually release active drugs over periods
as long as weeks or months. After a successful second year, the RCA was renewed for the third year in September 2017 and was completed
in September 2018. In September 2019, we entered a new funded collaboration with a clinical-stage biotechnology company to develop
an intra-articular (IA) delivery model, using much of the technology developed through the LAI collaboration with the FDA. This
collaboration enhances the GastroPlus PBBM/PBPK model for drug dosing into joints through IA injection products and incorporates
mechanistic models for different species and population groups that assist in efficient evaluation of IA injection strategies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transdermal absorption model: in July 2018
we entered a research collaboration with a large European consortium to further develop and validate the mechanistic Transdermal
Compartmental Absorption and Transit (TCAT&#8482;) model in GastroPlus. This project contributed substantially to improvements
in the program, specifically directed toward the predictions of local exposure within the skin layer following topical administration
of various chemicals. In September 2018, we were awarded another funded RCA by the FDA to integrate drug product quality attributes
into the mechanistic TCAT&#8482; model in GastroPlus. This grant award focuses on the incorporation of drug product quality attributes
into PBPK models developed for dermatological topical dosage forms and transdermal delivery systems.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Virtual bioequivalence trials: in October
2019, we entered a new funded collaboration with a large pharmaceutical company to develop the Virtual Bioequivalence (BE) Trial
Simulator&#8482; in GastroPlus. This collaboration will enhance the GastroPlus PBBM/PBPK platform to evaluate population and formulation
variability on the BE of different products. We intend to improve virtual BE trial simulation methodologies and efficiently address
regulatory concerns as model results are reviewed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Oral absorption &#8211; Advanced Compartmental
Absorption and Transit (ACAT&#8482;) model: in November 2019, we entered a new funded collaboration with a large pharmaceutical
company to modify the mechanistic ACAT&#8482; model in GastroPlus to support gastrointestinal disease research. This collaboration
will enhance and advance understanding of local drug disposition in gut tissue and improve the accuracy of drug concentration predictions
to assist with the development of new therapies for gastrointestinal diseases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unfunded research collaborations: in addition
to the active funded efforts with the FDA and industry described above, we also have two unfunded RCAs with the FDA: one with the
Office of Generic Drugs (OGD) that began in 2014, and one announced in July 2019 with the Center for Veterinary Medicine (CVM).
With OGD, the objective is directed toward the FDA&#8217;s evaluation of mechanistic IVIVCs (<i>in vitro-in vivo</i> correlations)
to determine whether a mechanistic absorption modeling (MAM) can relate laboratory (<i>in vitro</i>) dissolution experiment results
to the behavior of dosage forms in humans and animals (<i>in vivo</i>) better than traditional empirical methods. With CVM, the
objective is to use GastroPlus, with <i>in vitro </i>and <i>in vivo</i> data, to investigate how bioequivalence (BE) of non-systemically
absorbed products can be evaluated in canines without the need for clinical endpoint trials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2020, through a joint proposal
with the St. Louis College of Pharmacy at University of Health Sciences and Pharmacy in St. Louis, we were awarded a new funded
cooperative agreement from the FDA to establish novel <i>in vitro/in silico</i> models for the oral cavity route of administration
in GastroPlus to accelerate pharmaceutical research and regulatory assessment of innovative and generic drug products delivered
intraorally.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">DDDPlus&#8482; </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DDDPlus mechanistically simulates <i>in
vitro</i> (laboratory) experiments that measure the rate of dissolution of a drug as well as, if desired, the additives (excipients)
in a particular dosage form (e.g., powder, tablet, capsule, or injectable solids) under a variety of experimental conditions. This
unique software program is used by formulation scientists in industry and the FDA to: (1) understand the physical mechanisms affecting
the disintegration and dissolution rates of various formulations, (2) reduce the number of cut-and-try attempts to design new drug
formulations, (3) design <i>in vitro</i> dissolution experiments to better mimic <i>in vivo</i> (animal and human) conditions,
and (4) justify product specifications. Version 6.0 of DDDPlus was released in January 2019 and offered a series of new capabilities,
including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify">&#160;</td>
    <td style="width: 24px; text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">simulation of the <i>in vitro</i> dissolution of long-acting injectable dosage forms (funded by an FDA grant supporting GastroPlus development)</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">simulation of the <i>in vitro</i> dissolution of controlled release bead formulations</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">new simulation of artificial stomach-duodenum (ASD) experiments</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ability to fit models from precipitation experiments</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">new dissolution apparatus models</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">improved output reporting</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">MembranePlus&#8482;</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Like DDDPlus, MembranePlus mechanistically
simulates laboratory experiments, but in this case, the experiments are for measuring permeability or clearance of drug-like molecules
through various membranes, including several different standard cell cultures (Caco-2, MDCK), as well as hepatocytes. The value
of such simulations derives from the fact that when the same molecules are measured in different laboratories using (supposedly)
the same experimental conditions, the results are often significantly different. These differences are caused by a complex interplay
of factors in how the experiment was set up and run. MembranePlus simulates these experiments with their specific experimental
details, and this enables scientists to better interpret how results from specific experimental protocols can be used to predict
permeability or clearance mechanisms in human and animals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>In vitro</i> transdermal model: as part
of the RCA awarded by the FDA in September 2018 to improve the TCAT model in GastroPlus, we developed a novel simulation tool to
analyze data from <i>in vitro</i> skin penetration studies to better inform <i>in vivo</i> predictions within GastroPlus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PKPlus&#8482;</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The standalone PKPlus program, originally
based on the internal PKPlus Module in GastroPlus that has been available since 2000, provides the full level of functionality
needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to fully satisfy regulatory
agency requirements for noncompartmental analysis (NCA) and provides limited support for compartmental PK modeling.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PKPlus version 2.5 was released in July
2019. This version incorporated a wide variety of requested features from current users, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 20px">&#160;</td>
    <td style="width: 20px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Import CDISC SEND packages with PC domain as source data</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 20px">&#160;</td>
    <td style="width: 20px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Improved command-line functionality</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 20px">&#160;</td>
    <td style="width: 20px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">64-bit system optimization for improved performance</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 20px">&#160;</td>
    <td style="width: 20px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Streamlined auto-reports</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 20px">&#160;</td>
    <td style="width: 20px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Additional workflow refinements</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Automated PK/TK data analysis: in November
2019, we entered a new funded collaboration with a large pharmaceutical company to enhance PKPlus. Following a rigorous evaluation
of multiple commercial offerings, our partner selected PKPlus as the pharmacokinetics/toxicokinetic (PK/TK) modeling program to
support the internal data platform that connects their global teams. Our objectives for this project are to design the next-generation
engine that automates the import and mapping of data, selection of calculation templates, and generation of reports within a streamlined,
validated system.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">ADMET Predictor&#174;</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ADMET (Absorption, Distribution, Metabolism,
Excretion, and Toxicity) Predictor is a top-ranked, chemistry-based computer program that takes molecular structures (i.e., drawings
of molecules represented in various formats) as inputs and uses machine learning technology to predict approximately 175 different
properties for them at an average rate of over 200,000 compounds per hour on a modern laptop computer. This capability allows chemists
to generate estimates for a large number of important molecular properties without the need to synthesize and test the molecules,
as well as to generate estimates of unknown properties for molecules that have been synthesized, but for which only a limited number
of experimental properties have been measured. Thus, a chemist can assess the likely success of a large number of existing molecules
in a company&#8217;s chemical library, as well as molecules that have never been made, by providing only their molecular structures,
either by drawing them using a tool such as our MedChem Designer software, or by automatically generating large numbers of molecules
using various computer algorithms, including those embedded in our MedChem Studio&#8482; Module.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The optional ADMET Modeler&#8482; Module
in ADMET Predictor enables scientists to use their own experimental data to quickly create proprietary high-quality predictive
models using the same powerful artificial intelligence (AI) engine we use to build our top-ranked property predictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Version 9.5 of ADMET Predictor was released
in April 2019, adding:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Novel approaches to calculate uncertainty estimates on all regression models </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">New machine learning models for important metabolism and transporter endpoints </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">New machine learning models for AMES mutagenicity, a primary toxicity endpoint required during risk assessment </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">New Structure Sensitivity Analysis visualization tool to easily map atom-level contributions to model predictions </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Improved rat-specific models to more accurately inform HTPK Simulation predictions </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Improved Pipeline Pilot and KNIME components to extend deployment options and enterprise support for ADMET Predictor </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Updates to output displays in MedChem Designer&#8482; </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have made significant investments in
two key areas with recent versions: improving integration of our top-ranked ADMET Predictor and GastroPlus models to leverage our
novel &#8216;Discovery PBPK&#8217; approaches for chemists and safety researchers, and further enhancing our best-in-class machine
learning engine to assist with drug discovery. Recent publications from pharmaceutical and chemical companies describing how they
have leveraged our &#8216;Discovery PBPK&#8217; methods to guide lead optimization and risk assessment illustrate how our unique
offerings provide substantial value in these spaces.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Drug discovery workflows: in December 2019,
we entered into a new collaboration agreement with Bayer AG to advance our ADMET Predictor machine learning software for use within
integrated drug discovery workflows by developing improved structure and tautomer handling capabilities that will support data
integrity across the different discovery platforms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">High-throughput pharmacokinetic (HTPK)
simulations: in April 2020, we entered into a new collaboration agreement with a large pharmaceutical company to develop enhanced
capabilities in our existing HTPK Simulation Module which will incorporate PBPK modeling into the partner&#8217;s discovery platform
to support compound screening activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">MedChem Designer&#8482;</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">MedChem Designer was initially a molecule-drawing
program, or &#8220;sketcher&#8221;, but now has capabilities far exceeding those of other molecule-drawing programs because of
its integration with ADMET Predictor. We provide MedChem Designer for free because we believe that in the long run it will help
to increase demand for ADMET Predictor. Over 34,000 copies of MedChem Designer have been downloaded by scientists around the world
to date. Our free version includes a small set of ADMET Predictor&#8217;s best-in-class property predictions, allowing the chemist
to modify molecular structures and then see a few key properties very quickly. When used with a license for ADMET Predictor, MedChem
Designer becomes a <i>de novo</i> molecule design tool. With it, a researcher can draw one or more molecular structures, then click
on the ADMET Predictor icon and have approximately 175 properties for each structure calculated in seconds, including our proprietary
ADMET Risk&#8482; index which provides a single number that instantly compares the effects of different structural changes in many
dimensions. Researchers can also click on an icon to generate the likely metabolites of a molecule and then predict all the properties
of those metabolites from ADMET Predictor, including each of their ADMET Risk scores.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">KIWI&#8482;</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Drug development programs rely increasingly
on modeling and simulation analyses to support decision-making and submissions to regulatory agencies. To ensure high-quality reliable
analyses, organizations must not only apply high-quality science, but must also be able to support the science with validated and
reproducible results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">KIWI is a cloud-based web application that
provides scientists with a secure, validated, enterprise-scale environment wherein they can efficiently organize, process, maintain,
and communicate the volume of data and results generated over the duration of a drug development program. KIWI enables global teams
to collaborate on model-based decision-making and has been proven to support and encourage interdisciplinary discussions about
the model development process and the interpretation of results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to providing a structured workflow
for model-based analyses, key features of the application include powerful visualization tools to support exploratory analyses,
a data repository to facilitate management and organization of data and documents, and a Model Wizard module to streamline coding
and model development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New versions of KIWI are released on a
regular basis. KIWI Version 2 was released in December 2017, KIWI 3 was released in August 2018, and KIWI 4 was released in June
2019. In fiscal year 2020, we have:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">further improved the visualization tools,</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">introduced <span style="background-color: white">kiwiConnect, an R-based API to improve interaction and interconnectivity between R and KIWI, and</span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">completed a major update to the Oracle database infrastructure, including new hardware, additional storage, and increased bandwidth. </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">DILIsym</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The DILIsym software is a quantitative
systems pharmacology (QSP) program that has been in development since 2011. QSP software models are based on the fundamental understanding
of complex biological pathways, disease processes, and drug mechanisms of action, integrating information from experiments and
forming hypotheses for the next experimental model. DILIsym deals with the propensity for some drug molecules to induce temporary
or permanent changes in biological functions within liver cells (hepatocytes) that can result in damage to the liver (i.e., drug-induced
liver injury or DILI).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Version 8A of the DILIsym software was
released in January of 2019. This version is delivered as a secure executable file that incorporates new proprietary code enabling
tighter integration with our GastroPlus PBPK software. A number of important new capabilities were added, including new exemplar
compounds, new biomarkers, and new mechanisms of DILI. DILIsym version X is expected to be released in late Fall of 2020. DILIsym
X will be a completely refactored, much faster, and more user-friendly software tool.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">NAFLDsym</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where DILIsym is used to investigate the
likelihood that a known drug molecule would cause injury to the liver, NAFLDsym is concerned with a liver that is already diseased
(NAFLD/NASH) by excess fat, fibrosis, and inflammation, and investigates the likelihood that various molecules might provide therapeutic
benefits to treat or cure the disease. DILIsym can be considered a &#8220;shrink wrap&#8221; software product, usable across many
companies and drug development projects. NAFLDsym, on the other hand, requires modification for each of a number of different mechanisms
of action that potential new drug compounds could use to treat the disease, and so is a customized tool used in consulting projects
for each new client project. NAFLDsym version 2A was released in the summer of 2019 for licensing and consulting use. The software
now includes the three most important components of NAFLD/NASH: steatosis, inflammation, and fibrosis, along with a host of other
important updates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">RENAsym</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RENAsym will be focused on investigating
and predicting drug-induced kidney injury, or acute kidney injury (AKI). RENAsym will be another &#8220;shrink wrap&#8221; software
product, usable across many companies and drug development projects. The software will utilize predictions of drug exposure in
the kidney from PBPK platforms such as GastroPlus, along with <i>in vitro</i> data related to certain kidney injury mechanisms,
to make predictions. The first expected release of RENAsym will be available in summer of 2021. The initial development is being
funded via an NIH small business grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">IPFsym</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IPFsym is a software tool that will investigate the likelihood
that various molecules might provide beneficial therapeutic benefits to treat or cure idiopathic pulmonary fibrosis (IPF). IPFsym,
like NAFLDsym, requires modification for each of a number of different mechanisms of action that potential new drug compounds could
use to treat the disease, and so is a customized tool used in consulting projects for each new client project. IPFsym is targeted
for release for licensing and consulting use in late 2020. The software will include the most important mechanisms of IPF and will
be closely coupled with GastroPlus for drug concentration predictions within the lungs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Monolix Suite</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Monolix Suite is a unique solution
for modeling and simulation for pharmaceutical companies, biotechs, and hospitals. It supports nonparametric analyses, population
PKPD analyses and modeling, and clinical trial simulation. The extended MonolixSuite contains three main products: Monolix, Simulx,
and PKanalix. These products are interconnected and interoperable, i.e., the user can go from one application to another one without
changing anything in terms of data set or of biological models.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The products are used by many pharmaceutical
companies across the globe at each step of drug development, from preclinical to first-in-human, clinical, and post approval.
These products are well established in the research and drug development communities and have been accepted by most regulatory
agencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Lixoft's technologies come from an eight-year
research program in modeling and biostatistics led by Inria and sponsored by the pharmaceutical industry. The extended MonolixSuite
was developed in view of the increasing importance of pharmacometrics experts in drug development, taking a modeling project from
the first data exploration up to clinical trial simulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Monolix</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Monolix (Nonlinear mixed-effects models
or &#8220;MOd&#232;les NOn LIn&#233;aires &#224; effets miXtes&#8221; in French) is a platform of reference for model-based&#160;drug
development. It combines the most advanced algorithms with unique ease of use.&#160;Pharmacometricians of preclinical and clinical
groups can rely on Monolix for population&#160;analysis and to model PK/PD and other complex biochemical and physiological processes.&#160;Monolix
is an easy, fast, and powerful tool for parameter estimation in nonlinear mixed-effects&#160;models, model diagnosis and assessment,
and advanced graphical representation.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Simulx</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulx&#160;is a powerful and flexible
simulator for clinical trial pharmacometrics that runs on top of the Lixoft simulation engine. It allows simulation of any type
of model output (continuous, event, categorical&#8230;). It directly connects with Monolix for seamless modeling and simulation,
or can be used as a standalone application to simulate a new model. Potential applications include comparison of different trial
designs, extrapolation to different populations, non-adherence to treatment, optimal dosing, and dose individualization after
therapeutic drug monitoring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Simulx</span></i> is currently available
via the comprehensive R package mlxR. Starting with the 2020 version, it will have a user interface to easily define groups of
simulations as well as simulation outcomes to compare.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PKanalix</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PKanalix performs analysis on PK data sets.
Several analyses are performed including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">noncompartmental analysis (NCA),</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">compartmental analysis (CA) consisting&#160;in finding parameters of a model representing the PK as the dynamics in compartments for each individual. Notice that this compartmental analysis does not include population analysis that could be performed in Monolix.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">PKanalix provides
a clear user interface with a simple workflow to perform NCA and CA analysis in an efficient way.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Consulting Services</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our scientists and engineers have extensive
expertise in drug absorption via various dosing routes (oral, intravenous, subcutaneous, intramuscular, ocular, nasal/pulmonary,
and dermal), pharmacokinetics, pharmacodynamics, drug-drug interactions and others related to the drug development process. They
have attended over 200 scientific meetings worldwide in the past four years, often speaking and presenting. We conduct contracted
consulting studies for large customers (including many of the top twenty global pharmaceutical companies) who have particularly
complex problems and who recognize our expertise in solving them, as well as for smaller customers who prefer to have studies
run by our scientists rather than to license our software and train someone to use it. The demand for our consulting services
has been steadily increasing, and we have expanded our consulting teams to meet the increased workload.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have a reputation for high-quality
analyses and regulatory reporting of data collected during preclinical experiments as well as clinical trials of new and existing
pharmaceutical products, typically working on 80-100 drug projects per year. Traditionally, model-based analysis of clinical trial
data was different from the modeling analysis offered by GastroPlus or our quantitative systems toxicology/pharmacology software
(DILIsym and NAFLDsym); the former relied more on statistical and semi-mechanistic models, whereas the latter is based on very
detailed mechanistic models. Statistical models rely on direct observation and mathematical equations that are used to fit data
collected across multiple studies along with describing the variability within and between patients. Mechanistic models are based
on a detailed understanding of the human body and the chemistry of the drug and involve deep mathematical and scientific representation
of the phenomena involved in drug dissolution/precipitation, absorption, distribution, metabolism, and elimination. Collectively,
the models support safety and efficacy decisions, first-in-human estimations, formulation optimization, and drug-drug interaction
assessments. Beginning in 2014, the FDA and other regulatory agencies began to emphasize the need to encourage mechanistic PBPK
modeling and simulation in clinical pharmacology, with final guidance documents completed in 2018, and we have seen the benefit
of having our clinical pharmacology teams across all three divisions working together to achieve this goal. To date, there have
been approximately 40 approved drug products on the market today whose submissions were informed by results from GastroPlus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PRODUCT DEVELOPMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Development of our software is focused
on expanding product lines, designing enhancements to our core technologies, and integrating existing and new products into our
principal software architecture and platform technologies. We intend to continue to offer regular updates to our products and to
continue to look for opportunities to expand our existing suite of products and services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To date, we have developed products internally,
sometimes also licensing or acquiring products, or portions of products, from third parties. These arrangements at times have required
that we pay royalties to third parties. We intend to continue to license or otherwise acquire technology or products from third
parties when it makes business sense to do so.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>MARKETING AND DISTRIBUTION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We distribute our products and offer our
services throughout the world.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We market our pharmaceutical software
and consulting services through attendance and presentations at scientific meetings, exhibits at trade shows, seminars at pharmaceutical
companies and government agencies, our website, and various communication channels to our database of prospects and customers.
At various scientific meetings around the world each year there are numerous presentations and posters reporting research that
was performed using our software. Many of these presentations are from industry and FDA scientists; some are from our staff. Numerous
peer-reviewed scientific journal articles are published, and conference presentations delivered, each year using our software,
mostly by our customers, further supporting its use in a wide range of preclinical and clinical studies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our sales and marketing efforts are handled
primarily internally by sales and marketing staff and with our scientific team and several senior management staff assisting our
marketing and sales staff with trade shows, seminars, and customer trainings both online and on-site. We also have independent
distributors in Japan, China, India, and Korea who sell and market our products with support from our scientists and engineers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide support to the GastroPlus User
Group in Japan, which was organized by Japanese researchers in 2009. In early 2013, a group of scientists in Europe and North America
organized another GastroPlus User Group following the example set in Japan. Over 1,000 members have joined this group to date.
We support this group through coordination of online meetings each month and managing the user group website for exchange of information
among members. These user groups provide us valuable feedback with respect to desired new features and suggested interface changes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>PRODUCTION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our pharmaceutical software products are
designed and developed by our development teams managed out of offices in California, North Carolina (Research Triangle Park),
New York (Buffalo), and Paris, France. We also employ people who are able to work remotely using collaboration software. Our products
and services are delivered electronically.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COMPETITION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our pharmaceutical software and services
business, we compete against a number of established companies that provide screening, testing, and research services, and products
that are not based on simulation software. There are also software companies whose products do not compete directly with, but are
sometimes closely related to, ours. Our competitors in this field include some companies with financial, personnel, research, and
marketing resources that are larger than ours. Our flagship product, GastroPlus, is a leading commercial PBPK modeling platform
and has one significant competitor; others could be developed over time, but with the high barrier to entry, it would be difficult
to validate new software to levels required to support regulatory submissions. Our PKPlus software product competes with one major
and a few minor software programs. MedChem Studio, MedChem Designer, and ADMET Predictor/ADMET Modeler operate in a more competitive
environment. Several other companies presently offer simulation or modeling software, or simulation-software-based services, to
the pharmaceutical industry. Lixoft&#8217;s Monolix Suite competes with a few established software products offered within the
pharmaceutical software industry. We believe DILIsym and NAFLDsym enjoy a unique market position, with no significant competition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Major pharmaceutical companies conduct
drug discovery and development efforts through their internal development staffs and through outsourcing. Smaller companies generally
need to outsource a greater percentage of this effort. Thus, we compete not only with other software suppliers and scientific consulting
service providers, but also with the in-house development and scientific consulting teams at some of the larger pharmaceutical
companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although competitive products exist, both
new licenses and license renewals for our software products have continued to grow. We believe that we enjoy a dominant market
share in this segment. We believe our GastroPlus, ADMET Predictor/ADMET Modeler, MedChem Studio, MedChem Designer, DDDPlus, MembranePlus,
PKPlus, KIWI, DILIsym, NAFLDsym and Monolix Suite software offerings are each unique in their combination of capabilities and
remain a focus of our marketing strategy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on our technical knowledge and expertise,
the Company is strategically placed to offer modeling and simulation consulting services to companies. Our clients seek out our
services for multiple reasons: (1) to acquire scientific, therapeutic-area-related modeling expertise that they do not have in-house,
(2) to address a need for modeling and simulation efforts beyond the capacity of in-house resources, (3) to fulfill their modeling
requirements more efficiently than they could do in-house, and (4) to utilize our software when they do not have the in-house expertise
to do so. We apply our software and assist companies in such areas as: <span style="background-color: white">physiologically based
pharmacokinetic&#160;modeling (PBPK), pharmacokinetic/pharmacodynamic (PK/PD) data analysis; and quantitative systems pharmacology/toxicology
(QSP/T). We compete against numerous service providers, ranging from departments within large contract research organizations (CROs)
to independent consulting organizations of various sizes as well as individual consultants</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe the key factors in our ability
to successfully compete in this field are our ability to: (1) continue to invest in research and development, and develop and support
industry-leading simulation and modeling software and related products and services, (2) develop and maintain a proprietary database
of results of physical experiments that serve as a basis for simulated studies and empirical models, (3) continue to attract and
retain a highly skilled scientific and engineering team, (4) aggressively promote our products and services to our global market,
and (5) develop and maintain relationships with research and development departments of pharmaceutical companies, universities,
and government agencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, we actively seek strategic
acquisitions to expand both our pharmaceutical software and services business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>TRAINING AND TECHNICAL SUPPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Customer training and technical support
are important factors in customer satisfaction for our pharmaceutical products, and we believe we are an industry leader in providing
strong customer training and technical support in our business areas. We provide in-house seminars at customers&#8217; and potential
customers&#8217; sites, as well at selected universities to train students who will soon be industry scientists. These seminars
often serve as initial training in the event the potential customer decides to license or evaluate our software. Technical support
is provided after the sale of any software in the form of on-site training (at the customer&#8217;s expense), web meetings and
telephone, fax, and e-mail assistance to the customer&#8217;s users during the customer&#8217;s license period.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide free telephone, e-mail, and
web-based support for all of our pharmaceutical software products worldwide from our offices in the United States. Technical support
for pharmaceutical software is provided by our life sciences teams and our inside sales and support staff. Technical support for
pharmaceutical software products is generally minimal, averaging a few person-hours per product sale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>RESEARCH AND DEVELOPMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development (R&amp;D) activities
include both enhancement of existing products and development of new products. Development of new products and adding functionality
to existing products are capitalized in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification
(ASC) 985-20, &#8220;Costs of Software to Be Sold Leased, or Marketed&#8221;. R&amp;D expenditures, which primarily relate to both
capitalized and expensed salaries, R&amp;D supplies, laboratory testing, and R&amp;D consulting, were approximately $5,328,000
during fiscal year 2020, of which $2,353,000 was capitalized. R&amp;D expenditures were approximately $4,268,000 during fiscal
year 2019, of which $1,768,000 was capitalized. R&amp;D expenditures during fiscal year 2018 were approximately $3,936,000 of which
$2,145,000 was capitalized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>CUSTOMERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our customers include large, medium-sized,
and smaller biotech and&#160;pharmaceutical&#160;companies, universities, and regulatory agencies and other&#160;government organizations.
We concentrate on serving the needs of our customers in drug discovery,&#160;development, clinical trials, and post-patent generic
formulation development. Our current customer base is highly fragmented; in 2020 three of our customers were each 9%, 7% and 7%
of our revenues. With those exceptions, no other customers made up more than 9% of our revenues in the last 3 years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>SEASONALITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have traditionally experienced seasonal
revenue weakness during our fiscal fourth quarter (June-August) due to summer vacations and reduced activities at our customers&#8217;
sites. Our net sales figures for any quarter are not necessarily indicative of sales for any future period; our pharmaceutical
software is typically licensed on an annual basis which means renewal revenues are usually recognized in the same quarter year
after year. In recent years as we have grown revenues, we have seen a bit of flattening from quarter to quarter and we have reported
seasonally higher revenue in our second and third quarters. This is due to pharmaceutical industry buying patterns as well as our
revenue recognition policies for software, consulting service slowdowns due to vacations, and lower customer and employee conference
attendance in those periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ENVIRONMENTAL MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
believe we are in compliance in all material respects with all applicable environmental laws. Presently, we do not anticipate
that such compliance will have a material effect on capital expenditures, earnings, or competitive position with respect to any
of our operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>HUMAN CAPITAL RESOURCES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, Simulations Plus
and its subsidiaries Cognigen Corporation, DILIsym, and Lixoft, employed a total of 137 persons, including 129 full-time employees
and 8 part-time employees, consisting of 95 in scientific, technical, and research and development, 8 in marketing and sales, and
34 in administration and accounting. Currently 73 employees hold PhDs. (including PharmDs) in their respective science or engineering
disciplines, and 26 employees hold one or more Master&#8217;s degrees. Most of the senior management team and all of the members
of our Board of Directors hold graduate degrees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that our future success will
depend, in part, on our ability to continue to attract, hire, and retain qualified personnel. We continue to seek additions to
our science and technical staff, although the competition for such personnel in the pharmaceutical industry is intense. None of
our employees is represented by a labor union, and we have never experienced a work stoppage. We believe that our relations with
our employees are good.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>INTELLECTUAL PROPERTY AND OTHER PROPRIETARY
RIGHTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We primarily protect our intellectual property
through copyrights and trade secrets. Our intellectual property consists primarily of source code for computer programs and data
files for various applications of those programs in the pharmaceutical software businesses. The expertise of our staff is a considerable
asset closely related to intellectual property, and attracting and retaining highly qualified scientists and engineers is essential
to our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>EFFECT OF GOVERNMENT REGULATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company believes that its operations
are substantially in compliance with all applicable laws and regulations, and that it holds all necessary permits to operate its
business in each jurisdiction in which its facilities are located. Laws and government regulations are subject to change and interpretation.
Our pharmaceutical software products are tools used in research and development and are neither approved nor approvable by the
FDA or other government agencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COMPANY WEBSITE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain a corporate Internet website
at: www.simulations-plus.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The contents of this website are not incorporated
in or otherwise to be regarded as part of this Annual Report. We file reports with the SEC which are available on our website free
of charge. These reports include annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, &#8220;Section
16&#8221; filings on Form 3, Form 4, and Form 5, and other related filings, each of which is provided on our website as soon as
reasonably practical after we electronically file such materials with or furnish them to the SEC. In addition, the SEC maintains
a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file
electronically with the SEC, including the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_010"></span>ITEM 1A &#8211; RISK FACTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>You should carefully consider the risks
described below before investing in our publicly traded securities. The risks described below are not the only ones facing us.
Our business is also subject to the risks that affect many other companies, such as competition, technological obsolescence, labor
relations, general economic conditions, geopolitical changes, and international operations. We operate in a rapidly changing environment
that involves a number of risks, some of which are beyond our control. Additional risks not currently known to us or that we currently
believe are immaterial also may impair our business operations and our liquidity. The risks described below could cause our actual
results to differ materially from those contained in the forward-looking statements we have made in this Annual Report on Form
10-K, the information incorporated herein by reference, and those forward-looking statements we may make from time to time. We
note these factors for investors as permitted by the Private Securities Litigation Reform Act of 1995. You should understand that
it is not possible to predict or identify all such factors. Consequently, you should not consider the following to be a complete
discussion of all potential risks or uncertainties.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Risks Related to Our Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business is subject to risks
arising from epidemic diseases, such as the recent outbreak of the COVID-19 illness.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to risks related to public
health crises such as the global pandemic associated with COVID-19. In December 2019, a novel strain of coronavirus, SARS-CoV-2,
was reported to have surfaced in Wuhan, China. Since then, SARS-CoV-2, and the resulting disease COVID-19, has spread to most countries,
and all 50 states within the United States. COVID-19 poses the risk that we or our employees, contractors, suppliers, and other
partners may be prevented from conducting business activities for an indefinite period of time, including due to shutdowns that
may be requested or mandated by governmental authorities. The governors of California (where our headquarters is located) and over
forty other states, as well as mayors of many cities, ordered their residents to cease traveling to nonessential jobs and to curtail
all unnecessary travel, and to stay in their homes as much as possible. If the current economic conditions worsen or last for an
extended period of time, we may be forced to significantly scale back our business and growth plans, which could have a material
adverse effect on our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have undertaken several measures in
an effort to mitigate the spread of COVID-19, including adjusting our business practices to combat the effects by restricting employee
travel, closing our offices in compliance with local guidelines and, when reopened, implementing social distancing at our office
locations and additional sanitary measures. There have been no reductions in the workforce as a result of COVID-19. During the
last half of fiscal year 2020, software renewal revenue and services revenues generated primarily from contracts signed prior to
the effects of the pandemic have not been materially impacted. Revenue from new software licenses and new service contracts has
been negatively impacted with our clients&#8217; increased focus on opportunities to address COVID-19 mitigation efforts and shift
away from other therapeutic areas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While the COVID-19 pandemic has not materially
adversely affected our business operations as of the date of this annual report, the continued spread of COVID-19 and the measures
taken by the governments of countries affected could disrupt the supply chain and adversely impact our business, financial condition,
or results of operations. The COVID-19 outbreak and mitigation measures may also have an adverse impact on global economic conditions,
which could have an adverse effect on our business and financial condition. The extent to which the COVID-19 outbreak further impacts
our results will depend on future developments that are highly uncertain and cannot be predicted, including new information that
may emerge concerning the severity of the virus and the actions to contain its impact. In addition, a recession or market correction
resulting from the spread of COVID-19 could materially affect our business and the value of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain Risks Related to Our Marketplace
and Environment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our ability to sustain or increase
revenues will depend upon our success in entering new markets, continuing to increase our customer base, and in deriving additional
revenues from our existing customers.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our products are currently used primarily
by modeling and simulation specialists in pharmaceutical, biotechnology, agrotechnology, cosmetics, and government research organizations.
One component of our overall business strategy is to derive more revenues from our existing customers by expanding their use of
our products and services. Such strategy would have our customers utilize our scientific informatics platforms and our tools and
components to leverage vast amounts of information stored in both corporate databases and public data sources in order to make
informed scientific and business decisions during the research and development process. In addition, we seek to expand into new
markets, and new areas within our existing markets, by acquiring businesses in these markets, attracting and retaining personnel
knowledgeable in these markets, identifying the needs of these markets, and developing marketing programs to address these needs.
If successfully implemented, these strategies would increase the usage of our software and services by pharmacologists or pharmacometricians
operating within our existing pharmaceutical, biotechnology, and chemical customers, as well as by new customers in other industries.
However, if our strategies are not successfully implemented, our products and services may not achieve market acceptance or penetration
in targeted new departments within our existing customers or in new industries. As a result, we may incur additional costs and
expend additional resources without being able to sustain or increase revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Consolidation within the pharmaceutical
and biotechnology industries may continue to lead to fewer potential customers for our products and services</i>.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant portion of our customer base
consists of pharmaceutical and biotechnology companies. Consolidation within the pharmaceutical and biotechnology industries may
result in fewer customers for our products and services. Although the industry consolidation that has taken place over the past
20 years has not prevented our business from growing to date, if one of the parties to a consolidation uses the products or services
of our competitors, we may lose existing customers as a result of such consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Increasing competition and increasing
costs within the pharmaceutical and biotechnology industries may affect the demand for our products and services, which may affect
our results of operations and financial condition</i>.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our pharmaceutical and biotechnology customers'
demand for our products is impacted by continued demand for their products and by our customers' research and development costs.
Demand for our customers' products could decline, and prices charged by our customers for their products may decline, as a result
of increasing competition, including competition from companies manufacturing generic drugs. In addition, our customers' expenses
could continue to increase as a result of increasing costs of complying with government regulations and other factors. A decrease
in demand for our customers' products, pricing pressures associated with the sales of these products, and additional costs associated
with product development, could cause our customers to reduce research and development expenditures. Although our products increase
productivity and reduce costs in many areas, because our products and services depend on such research and development expenditures,
our revenues may be significantly reduced.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Health care reform and restrictions
on reimbursement may affect the pharmaceutical, biotechnology, and industrial chemical companies that purchase or license our products
or services, which may affect our results of operations and financial condition</i>.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The continuing efforts of government and
third-party payers in the markets we serve to contain or reduce the cost of health care may reduce the profitability of pharmaceutical,
biotechnology, and industrial chemical companies, causing them to reduce research and development expenditures. Because some of
our products and services depend on such research and development expenditures, our revenues may be significantly reduced. We cannot
predict what actions federal, state, or private payers for health care goods and services may take in response to any health care
reform proposals or legislation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We face strong competition in the
life science market for modeling and simulation software and for cheminformatics products.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for our modeling and simulation
software products for the life science market is intensely competitive. We currently face competition from other scientific software
providers, larger technology and solutions companies, in-house development by our customers and academic and government institutions,
and the open-source community. Some of our competitors and potential competitors have longer operating histories in certain segments
of our industry than we do and could have greater financial, technical, marketing, research and development, and other resources.
Many of our competitors offer products and services directed at more specific markets than those we target, enabling these competitors
to focus a greater proportion of their efforts and resources on these markets. Some offerings that compete with our products are
developed and made available at lower cost by government organizations and academic institutions, and these entities may be able
to devote substantial resources to product development and also offer their products to users for little or no charge. We could
also face competition from open-source software initiatives, in which developers provide software and intellectual property free
over the Internet. In addition, some of our customers spend significant internal resources in order to develop their own software.
Moreover, we intend to leverage our scientific informatics platform in order to enable our customers to more effectively utilize
the vast amounts of information stored in both their databases and public data sources in order to make informed scientific and
business decisions during the research and development process. This strategy could lead to competition from much larger companies
that provide general data storage and management software. There can be no assurance that our current or potential competitors
will not develop products, services, or technologies that are comparable to, superior to, or render obsolete, the products, services,
and technologies we offer. There can be no assurance that our competitors will not adapt more quickly than we to technological
advances and customer demands, thereby increasing such competitors' market share relative to ours. Any material decrease in demand
for our technologies or services may have a material adverse effect on our business, financial condition, and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to pricing pressures
in some of the markets we serve.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for modeling and simulation
products for the life science industry is intensely competitive. Although the average price of our software licenses has increased
slightly or remained relatively constant for fiscal years 2018, 2019, and 2020, we may experience a decline in the future. In response
to increased competition and general adverse economic conditions in this market, we may be required to modify our pricing practices.
Changes in our pricing model could adversely affect our revenues and earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our operations may be interrupted
by the occurrence of a natural disaster or other catastrophic event at our primary facilities.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our research and development operations
and administrative functions are primarily conducted at our facilities in Lancaster, California, Buffalo, New York, Paris, France
and Research Triangle Park, North Carolina. Although we have contingency plans in effect for natural disasters or other catastrophic
events, the occurrence of such events could still disrupt our operations. For example, our Lancaster, California facility is located
in a state that is particularly susceptible to earthquakes. Any natural disaster or catastrophic event in our facilities or the
areas in which they are located could have a significant negative impact on our operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Our insurance coverage may not be sufficient to avoid
material impact on our financial position or results of operations resulting from claims or liabilities against us, and we may
not be able to obtain insurance coverage in the future.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain insurance coverage for protection
against many risks of liability. The extent of our insurance coverage is under continuous review and is modified as we deem it
necessary. Despite this insurance, it is possible that claims or liabilities against us may have a material adverse impact on our
financial position or results of operations. In addition, we may not be able to obtain any insurance coverage, or adequate insurance
coverage, when our existing insurance coverage expires. For example, we do not carry earthquake insurance for our facilities in
Lancaster, California, because we do not believe the costs of such insurance are reasonable in relation to the potential risk for
our part of California.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Changes in government regulation
or in practices relating to the pharmaceutical or biotechnology industries, including potential health care reform, could decrease
the need for the services we provide.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Governmental agencies throughout the world,
but particularly in the U.S., strictly regulate the drug development process. Our business involves helping pharmaceutical and
biotechnology companies, among others, navigate the regulatory drug approval process. Accordingly, many regulations, and often
new regulations, are expected to result in higher regulatory standards and often additional revenues for companies that service
these industries. However, some changes in regulations, such as a relaxation in regulatory requirements or the introduction of
streamlined or expedited drug approval procedures, or an increase in regulatory requirements that we have difficulty satisfying
or that make our services less competitive, could eliminate or substantially reduce the demand for our services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Any negative commentaries made by any regulatory agencies
or any failure by us to comply with applicable regulations and related guidance could harm our reputation and operating results,
and compliance with new regulations and guidance may result in additional costs.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any negative commentaries made by any regulatory
agencies or any failure on our part to comply with applicable regulations could result in the termination of ongoing research or
the disqualification of data for submission to regulatory authorities. This could harm our reputation, our prospects for future
work, and our operating results. If our operations are found to violate any applicable law or other governmental regulations, we
might be subject to civil and criminal penalties, damages, and fines. Any action against us for violation of these laws, even if
we successfully defend against it, could cause us to incur significant legal expenses, divert our management's attention from the
operation of our business, and damage our reputation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Many of our contracts are fixed-price
and may be delayed or terminated or reduced in scope for reasons beyond our control, or we may underprice or overrun cost estimates
with these contracts, potentially resulting in financial losses.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Many of our contracts provide for services
on a fixed-price or fee-for-service with a cap basis and, accordingly, we bear the financial risk if we initially underprice our
contracts or otherwise overrun our cost estimates. In addition, these contracts may be terminated or reduced in scope either immediately
or upon notice. Cancellations may occur for a variety of reasons, and often at the discretion of the client. The loss, reduction
in scope, or delay of a large contract or the loss or delay of multiple contracts could materially adversely affect our business,
although our contracts frequently entitle us to receive the costs of winding down the terminated projects, as well as all fees
earned by us up to the time of termination. Some contracts also entitle us to a predetermined termination fee and irrevocably committed
costs/expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We could experience a breach of the
confidentiality of the information we hold or of the security of our computer systems.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate large and complex computer systems
that contain significant amounts of client data. As a routine element of our business, we collect, analyze, and retain substantial
amounts of data pertaining to the clinical study data analysis we conduct for our clients. Unauthorized third parties could attempt
to gain entry to such computer systems for the purpose of stealing data or disrupting the systems. We believe that we have taken
appropriate measures to protect them from intrusion, and we continue to improve and enhance our systems in this regard, but in
the event that our efforts are unsuccessful, we could suffer significant harm. Our contracts with our clients typically contain
provisions that require us to keep confidential the information generated from these studies. In the event the confidentiality
of such information was compromised, we could suffer significant harm.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Impairment of goodwill or intangible
assets may adversely impact future results of operations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have intangible assets, including goodwill,
capitalized computer software development costs, intellectual property, and other intangible assets, on our balance sheet due to
our acquisitions of businesses. The initial identification and valuation of these intangible assets and the determination of the
estimated useful lives at the time of acquisition involve use of management judgments and estimates. These estimates are based
on, among other factors, input from accredited valuation consultants, reviews of projected future income cash flows, and statutory
regulations. The use of alternative estimates and assumptions might have increased or decreased the estimated fair value of our
goodwill and intangible assets that could potentially result in a different impact to our results of operations. If the future
growth and operating results of our business are not as strong as anticipated and/or our market capitalization declines, this could
impact the assumptions used in calculating the fair value of goodwill or intangibles. To the extent goodwill or intangibles are
impaired, their carrying value will be written down to its implied fair value and a charge will be made to our income from continuing
operations. Such an impairment charge could materially and adversely affect our operating results. As of August 31, 2020 and August
31, 2019, the carrying amount of goodwill and intangibles was $37,914,808 and $23,653,183, respectively, on our consolidated balance
sheet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain Risks Related to Our Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Software defects or malfunctions
in our products could hurt our reputation among our customers, result in delayed or lost revenue, and expose us to liability.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business and the level of customer
acceptance of our products depend upon the continuous, effective, and reliable operation of our software and related tools and
functions. To the extent that defects cause our software to malfunction and our customers' use of our products is interrupted,
our reputation could suffer and our revenue could decline or be delayed while such defects are remedied. We may also be subject
to liability for the defects and malfunctions of third-party technology partners and others with whom our products and services
are integrated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Delays in the release of new or enhanced
products or services or undetected errors in our products or services may result in increased cost to us, delayed market acceptance
of our products, and delayed or lost revenue.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To achieve market acceptance, new or enhanced
products or services can require long development and testing periods, which may result in delays in scheduled introduction. Any
delays in the release schedule for new or enhanced products or services may delay market acceptance of these products or services
and may result in delays in new customer orders for these new or enhanced products or services or the loss of customer orders.
In addition, new or enhanced products or services may contain a number of undetected errors or &#8220;bugs&#8221; when they are
first released. Although we extensively test each new or enhanced software product or service before it is released to the market,
there can be no assurance that significant errors will not be found in existing or future releases. As a result, in the months
following the introduction of certain releases, we may need to devote significant resources to correct these errors. There can
be no assurance, however, that all of these errors can be corrected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to risks associated
with the operation of a global business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We derive a significant portion of our
total revenue from our operations in international markets. During the years ended August 31, 2020, 2019 and 2018, 29%, 34% and
39% respectively, of our total revenue was derived from our international operations. Our global business may be affected by local
economic conditions, including inflation, recession, and currency exchange rate fluctuations. In addition, political and economic
changes, including international conflicts and terrorist acts, throughout the world may interfere with our or our customers' activities
in particular locations and result in a material adverse effect on our business, financial condition, and operating results. Potential
trade restrictions, exchange controls, adverse tax consequences, and legal restrictions may affect the repatriation of funds into
the U.S. Also, we could be subject to unexpected changes in regulatory requirements, the difficulties of compliance with a wide
variety of foreign laws and regulations, potentially negative consequences from changes in or interpretations of U.S. and foreign
tax laws, import and export licensing requirements, and longer accounts receivable cycles in certain foreign countries. These risks,
individually or in the aggregate, could have an adverse effect on our results of operations and financial condition. For example,
we are subject to compliance with the U.S. Foreign Corrupt Practices Act and similar anti-bribery laws, which generally prohibit
companies and their intermediaries from making improper payments to foreign government officials for the purpose of obtaining or
retaining business. While our employees, distributors, and agents are required to comply with these laws, we cannot be sure that
our internal policies and procedures will always protect us from violations of these laws despite our commitment to legal compliance
and corporate ethics. The occurrence or allegation of these types of risks may adversely affect our business, performance, prospects,
value, financial condition, and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The drug discovery and development
services industry is highly competitive.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our clinical pharmacology division often
competes for business not only with other clinical research organization (CROs), but also with internal discovery and development
departments within our larger clients, who may have greater resources than ours. We also compete with universities and teaching
hospitals for outsourced services. We compete based on a variety of factors, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px; text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">reputation for on-time quality performance;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">reputation for regulatory compliance;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">expertise and experience in multiple specialized areas;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">scope and breadth of service and product offerings across the drug discovery and development spectrum;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">ability to provide flexible and customized solutions to support our clients' drug discovery and development needs;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">price/value;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">technological expertise and efficient drug development processes;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">financial stability;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">accessibility of client data through secure portals; and</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">ability to acquire, process, analyze, and report data in an accurate manner.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we do not compete successfully, our
business could suffer. Increased competition might lead to price and other concessions that might adversely affect our operating
results. The drug discovery and development services industry has continued to see a trend towards consolidation, particularly
among biotechnology companies, who are targets for each other and for larger pharmaceutical companies. If this trend continues,
it is likely to produce more competition among the larger companies and CROs generally, with respect to both clients and acquisition
candidates. In addition, while there are substantial barriers to entry for large, global competitors with broad-based services,
small, specialized entities considering entering the CRO industry will continue to find lower barriers to entry, and private equity
firms may determine that there are opportunities to acquire and consolidate these companies, thus further increasing possible competition.
More generally, our competitors or others might develop technologies, services, or products that are more effective or commercially
attractive than our current or future technologies, services, or products, or that render our technologies, services, or products
less competitive or obsolete. If competitors introduce superior technologies, services, or products and we cannot make enhancements
to ours to remain competitive, our competitive position, and in turn our business, revenue, and financial condition, would be materially
and adversely affected. In the aggregate, these competitive pressures may affect the attractiveness of our technologies, services,
or products and could adversely affect our financial results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Potential changes in U.S. and international
tax law.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tax proposals to reform corporate tax law
are constantly being considered. Proposals include both increasing and reducing the corporate statutory tax rate, broadening the
corporate tax base through the elimination or reduction of deductions, exclusions, and credits, implementing a territorial regime
of taxation, limiting the ability of U.S. corporations to deduct interest expense associated with offshore earnings, modifying
the foreign tax credit rules, and reducing the ability to defer U.S. tax on offshore earnings. These or other changes in the U.S.
tax laws could increase our effective tax rate, which would affect our profitability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Contract research services create a risk of liability.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a CRO, we face a range of potential liabilities which may
include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Errors or omissions in reporting of study detail in preclinical studies that may lead to inaccurate reports, which may undermine the usefulness of a study or data from the study, or which may potentially advance studies absent the necessary support or inhibit studies from proceeding to the next level of testing; and</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Risks associated with our possible failure to properly care for our clients' property, such as research models, records, work in progress, or other archived materials.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Contractual risk transfer indemnifications
generally do not protect us against liability arising from certain of our own actions, such as negligence or misconduct. We could
be materially and adversely affected if we are required to pay damages or bear the costs of defending any claim that is outside
any contractual indemnification provision, or if a party does not fulfill its indemnification obligations, or the damage is beyond
the scope or level of insurance coverage. We also often contractually indemnify our clients (subject to a limitation of liability),
similar to the way they indemnify us, and we may be materially adversely affected if we have to fulfill our indemnity obligations.
Furthermore, there can be no assurance that we nor a party required to indemnify us will be able to maintain such insurance coverage
(either at all or on terms acceptable to us).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Upgrading our software could result
in implementation issues and business disruptions.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We update our software on a regular basis
and in the process of refactoring our software programs. In doing so, we face the possibility that existing users will find the
software unacceptable, or new users may not be as interested as they have been in the past versions. Translation errors might introduce
new software bugs that will not be caught.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The drug discovery and development
industry has a history of patent and other intellectual property litigation, and we might be involved in costly intellectual property
lawsuits.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The drug discovery and development industry
has a history of patent and other intellectual property litigation and these lawsuits will likely continue. Accordingly, we face
potential patent infringement suits by companies that have patents for similar products and methods used in business or other suits
alleging infringement of their intellectual property rights. Legal proceedings relating to intellectual property could be expensive,
take significant time, and divert management's attention from other business concerns, whether we win or lose. If we do not prevail
in an infringement lawsuit brought against us, we might have to pay substantial damages, including treble damages, and we could
be required to stop the infringing activity or obtain a license to use technology on unfavorable terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to successfully
develop and market new services and products.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may seek to develop and market new services
and products that complement or expand our existing business or service offerings. We cannot guarantee that we will be able to
identify new technologies of interest to our customers. Even if we are able to identify new technologies of interest, we may not
be able to negotiate license agreements on acceptable terms, or at all. If we are unable to develop new services and products and/or
create demand for those newly developed services and products, our future business, results of operations, financial condition,
and cash flows could be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Ability to incur debt could adversely affect our business
and growth prospects.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 31, 2020 we established a line
of credit with a bank in the amount of $3,500,000 and, to date, we have not accessed the line. Prior to the establishment of the
line we have not had any borrowed debt and have no need to do so to fund normal operations in the foreseeable future. Should circumstances
require us to incur additional debt and a lender could not be found to provide that debt, this could have a significant adverse
effect on our business, including making it more difficult for us to obtain financing on favorable terms, limiting our ability
to capitalize on significant business opportunities, and making us more vulnerable to rising interest rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We depend on key personnel and may
not be able to retain these employees or recruit additional qualified personnel, which could harm our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our success depends to a significant extent
on the continued services of our senior management and other members of management. We have employment agreements with our CEO
and division presidents that range from one to three years. If our CEO, our division presidents, or other members of senior management
do not continue in their present positions, our business may suffer. Because of the specialized scientific nature of our business,
we are highly dependent upon attracting and retaining qualified scientific and technical and managerial personnel. While we have
a strong record of employee retention, there is still significant competition for qualified personnel in the software, pharmaceutical,
and biotechnology fields. Therefore, we may not be able to attract and retain the qualified personnel necessary for the development
of our business. The loss of the services of existing personnel, as well as the failure to recruit additional key scientific, technical,
and managerial personnel in a timely manner, could harm our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are not successful in selecting
and integrating the businesses and technologies we acquire, or in managing our current and future divestitures, our business may
suffer.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Over the years, we have expanded our business
through acquisitions. We continue to search to acquire businesses and technologies and form strategic alliances. However, businesses
and technologies may not be available on terms and conditions we find acceptable. We risk spending time and money investigating
and negotiating with potential acquisition or alliance partners, but not completing transactions. Even if completed, acquisitions
and alliances involve numerous risks which may include: difficulties in achieving business and continuing financial success; difficulties
and expenses incurred in assimilating and integrating operations, services, products, technologies, or pre-existing relationships
with our customers, distributors, and suppliers; challenges with developing and operating new businesses, including those which
are materially different from our existing businesses and which may require the development or acquisition of new internal capabilities
and expertise; challenges of maintaining staffing at the acquired entities, including loss of key employees; potential losses resulting
from undiscovered liabilities of acquired companies that are not covered by the indemnification we may obtain from the seller(s);
the presence or absence of adequate internal controls and/or significant fraud in the financial systems of acquired companies;
diversion of management's attention from other business concerns; acquisitions could be dilutive to earnings, or in the event of
acquisitions made through the issuance of our common stock to the shareholders of the acquired company, dilutive to the percentage
of ownership of our existing shareholders; new technologies and products may be developed which cause businesses or assets we acquire
to become less valuable; and risks that disagreements or disputes with prior owners of an acquired business, technology, service,
or product may result in litigation expenses and distribution of our management's attention. In the event that an acquired business
or technology or an alliance does not meet our expectations, our results of operations may be adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some of the same risks exist when we decide
to sell a business, site, or product line. In addition, divestitures could involve additional risks, including the following: difficulties
in the separation of operations, services, products, and personnel; and the need to agree to retain or assume certain current or
future liabilities in order to complete the divestiture. We evaluate the performance and strategic fit of our businesses. These
and any divestitures may result in significant write-offs, including those related to goodwill and other intangible assets, which
could have an adverse effect on our results of operations and financial condition. In addition, we may encounter difficulty in
finding buyers or alternative exit strategies at acceptable prices and terms and in a timely manner. We may not be successful in
managing these or any other significant risks that we encounter in divesting a business, site, or product line, and as a result,
we may not achieve some or all of the expected benefits of the divestitures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our quarterly and annual operating
results fluctuate and may continue to fluctuate in the future, and if we fail to meet the expectations of analysts or investors,
our stock price and the value of your investment could decline substantially</i></b><i>.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that operating results for any
particular quarter are not necessarily a meaningful indication of future results. Nonetheless, fluctuations in our quarterly operating
results could negatively affect the market price of our common stock. Our results of operations in any quarter or annual period
have varied in the past and may vary from quarter to quarter or year to year and are influenced by such factors as:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes in the general global economy;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the number and scope of ongoing client engagements; the commencement, postponement, delay, progress, completion, or cancellation of client contracts in the quarter;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes in customer budget cycles;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the number and scope of ongoing client engagements;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the commencement, postponement, delay, progress, completion, or cancellation of client contracts in the quarter;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes in the mix of our products and services;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">competitive pricing pressures;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the extent of cost overruns;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">buying patterns of our clients;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">budget cycles of our clients;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the effect of potential acquisitions and consequent integration;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the timing of new product releases by us or our competitors;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">general economic factors, including factors relating to disruptions in the world credit and equity markets and the related impact on our customers&#8217; access to capital;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes in tax laws, rules, regulations, and tax rates in the locations in which we operate;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the timing and charges associated with completed acquisitions and other events;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the financial performance of our investments; and</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">exchange rate fluctuations.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We derive a significant percentage
of our revenues from a concentrated group of customers and the loss of more than one of our major customers could materially and
adversely affect our business, results of operations or financial condition.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Three customers accounted for 9%, 7% and
7% (a dealer account in Japan representing various customers) of net sales for fiscal year 2020. Three customers accounted for
8%, 8% and 7% (a dealer account in Japan representing various customers) of net sales for fiscal year 2019. Four customers accounted
for 9% (a dealer account in Japan representing various customers), 7%, 6% and 5% of net sales for fiscal year 2018. The loss of
any of our major customers could have a material adverse effect on our results of operations and financial condition. We may not
be able to maintain our customer relationships, and our customers may delay payment under, or fail to renew, their agreements with
us, which could adversely affect our business, results of operations, or financial condition. Any reduction in the amount of revenues
that we derive from these customers, without an offsetting increase in new sales to other customers, could have a material adverse
effect on our operating results. A significant change in the liquidity or financial position of our customers could also have a
material adverse effect on the collectability of our accounts receivable, our liquidity, and our future operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We conduct business outside the US,
which exposes us to foreign currency exchange rate risk, and could have a negative impact on our financial results.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate on a global basis. In the three
years ended August 31, 2020, 2019 and 2018, we had sales of $4,961,000, $4,148,000, and $3,574,000, respectively, denominated in
foreign currency in certain Asian markets. In 2020 we expanded our operations in Europe with the addition of Lixoft in Paris, France.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we continue to increase our international
operations, our sales and expenditures in foreign currencies are expected to become more material and subject to greater foreign
currency exchange rate fluctuations. Also, our foreign distributors typically sell our products in local currency, which impacts
the price to foreign consumers. One of our subsidiaries operates with their local currency as their functional currency. Future
foreign currency exchange rate fluctuations and global credit markets may cause changes in the US dollar value of our purchases
or sales and materially affect our sales, profit margins, and results of operations, when converted to US dollars. Changes in the
value of the US dollar relative to other currencies could result in material foreign currency exchange rate fluctuations and, as
a result, our net earnings could be materially adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we continue to expand international
operations and increase purchases and sales in foreign currencies, we may utilize derivative instruments, as needed, to hedge our
foreign currency exchange rate risk. Our hedging strategies will depend on our forecasts of sales, expenses, and cash flows, which
are inherently subject to inaccuracies. Foreign currency exchange rate hedges, transactions, re-measurements, or translations could
materially impact our consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A significant portion of our operating
expenses is relatively fixed and planned expenditures are based in part on expectations regarding future revenues.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accordingly, unexpected revenue shortfalls
may decrease our gross margins and could cause significant changes in our operating results from year to year. As a result, in
future quarters, our operating results could fall below the expectations of securities analysts or investors, in which event our
stock price would likely decrease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our customers cancel their contracts
or terminate or delay their clinical trials, we may lose or delay revenues and our business may be harmed.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain of our customer contracts are subject
to cancellation by our customers at any time with limited notice. Customers engaged in clinical trials may terminate or delay a
clinical trial for various reasons, including the failure of the tested product to satisfy safety or efficacy requirements, unexpected
or undesired clinical results, decisions to deemphasize a particular product or forgo a particular clinical trial, decisions to
downsize clinical development programs, insufficient patient enrollment or investigator recruitment, and production problems resulting
in shortages of required clinical supplies. Any termination or delay in the clinical trials would likely result in a consequential
delay or termination in those customers&#8217; service contracts. We have experienced terminations and delays of our customer service
contracts in the past (although no such past terminations have had a significant impact on our results of operations) and we expect
to experience additional terminations and delays in the future. The termination of single-study arrangements could result in decreased
revenues and the delay of our customers&#8217; clinical trials could result in delayed professional services revenues, which could
materially harm our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our security is breached, our
business could be disrupted, our operating results could be harmed, and customers could be deterred from using our products and
services.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business relies on the secure electronic
transmission, storage, and hosting of sensitive information, including clinical data, financial information, and other sensitive
information relating to our customers, company, and workforce. As a result, we face some risk of a deliberate or unintentional
incident involving unauthorized access to our computer systems (including, among other methods, cyber- attacks or social engineering)
that could result in misappropriation or loss of assets or sensitive information, data corruption, or other disruption of business
operations. In light of this risk, we have devoted significant resources to protecting and maintaining the confidentiality of our
information, including implementing security and privacy programs and controls, training our workforce, and implementing new technology.
We have no guarantee that these programs and controls will be adequate to prevent all possible security threats. We believe that
any compromise of our electronic systems, including the unauthorized access, use, or disclosure of sensitive information, or a
significant disruption of our computing assets and networks, would adversely affect our reputation and our ability to fulfill contractual
obligations, and would require us to devote significant financial and other resources to mitigate such problems, and could increase
our future cyber security costs. Moreover, unauthorized access, use, or disclosure of such sensitive information could result in
contractual or other liability. In addition, any real or perceived compromise of our security or disclosure of sensitive information
may result in lost revenues by deterring customers from using or purchasing our products and services in the future or prompting
them to use competing service providers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Any failure by us to properly protect
customer data we possess or are deemed to possess, in connection with the conduct of clinical trials, could subject us to significant
liability.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our customers use our solutions to collect,
manage, and report information in connection with the conduct of clinical trials. This information may be considered our customers&#8217;
proprietary information. Since we receive and process our customers&#8217; data from customers utilizing our hosted solutions,
there is a risk that we could be liable if there were a breach of any obligation to a protected person under contract, standard
of practice, or regulatory requirement. If we fail to properly protect our customers&#8217; data that is in our possession or deemed
to be in our possession, we could be subjected to significant liability and our reputation would be harmed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely upon a single internal hosting
facility and Amazon Web Services to deliver our solutions to our customers and any disruption of or interference with our hosting
systems, operations, or use of the Amazon Web Services could harm our business and results of operations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all of the computer hardware
necessary to deliver our CRO and KIWI solutions is located at our internal hosting facility in Buffalo, New York. In addition to
our dedicated hosting facility, we utilize third-party cloud computing services from Amazon Web Services (&#34;AWS&#34;) to help
us efficiently scale our cloud-based solutions and provide training. Because we cannot easily switch our AWS-serviced operations
to another cloud provider, any disruption of or interference with our use of AWS would impact our operations, and our business
would be adversely impacted. Our systems and operations or those of AWS could suffer damage or interruption from human error, fire,
flood, power loss, telecommunications failure, break-ins, terrorist attacks, acts of war, and similar events. The occurrence of
a natural disaster, an act of terrorism or other unanticipated problems at our or AWS' hosting facilities could result in lengthy
interruptions in our service. Although we and AWS maintain backup facilities and disaster recovery services in the event of a system
failure, these may be insufficient or fail. Any system failure, including network, software, or hardware failure, that causes an
interruption in our Buffalo data center or our use of AWS,or that causes a decrease in responsiveness of our cloud-based solutions,
could damage our reputation and cause us to lose customers, which could harm our business and results of operations. Our business
may be harmed if our customers and potential customers believe our service is unreliable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Defects or errors in our software
applications could harm our reputation, result in significant cost to us and impair our ability to market our solutions.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our software applications are inherently
complex and may contain defects or errors, some of which may be material. Errors may result from our own technology or from the
interface of our cloud-based solutions with legacy systems and data, which we did not develop. The risk of errors is particularly
significant when a new product is first introduced or when new versions or enhancements of existing products are released. The
likelihood of errors is increased when we do more frequent releases of new products and enhancements of existing products. We have,
from time to time, found defects in our solutions. Although these past defects have not resulted in any litigation against us to
date, we have invested significant capital, technical, managerial, and other resources to investigate and correct these past defects
and we have needed to divert these resources from other development efforts. In addition, material performance problems or defects
in our solutions may arise in the future. Material defects in our cloud-based solutions could result in a reduction in sales, delay
in market acceptance of our solutions, or credits or refunds to our customers. In addition, such defects may lead to the loss of
existing customers and difficulty in attracting new customers, diversion of development resources, or harm to our reputation. Correction
of defects or errors could prove to be impossible or impractical. The costs incurred in correcting any defects or errors or in
responding to resulting claims or liability may be substantial and could adversely affect our operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are not able to reliably meet
our data storage and management requirements, or if we experience any failure or interruption in the delivery of our services over
the Internet, customer satisfaction and our reputation could be harmed and customer contracts may be terminated.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of our current business model,
we deliver our software over the Internet and store and manage hundreds of terabytes of data for our customers, resulting in substantial
information technology infrastructure and ongoing technological challenges, which we expect to continue to increase over time.
If we do not reliably meet these data storage and management requirements, or if we experience any failure or interruption in the
delivery of our services over the Internet, customer satisfaction and our reputation could be harmed, leading to reduced revenues
and increased expenses. Our hosting services are subject to service-level agreements and, in the event that we fail to meet guaranteed
service or performance levels, we could be subject to customer credits or termination of these customer contracts. If the cost
of meeting these data storage and management requirements increases, our results of operations could be harmed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Some of our software solutions and
services utilize open source software, and any failure to comply with the terms of one or more of these open source licenses could
adversely affect our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Some of our software solutions utilize
software covered by open-source licenses. Open-source software is typically freely accessible, usable and modifiable, and is used
by our development team in an effort to reduce development costs and speed up the development process. Certain open-source software
licenses require a user who intends to distribute the open-source software as a component of the user's software to disclose publicly
part or all of the source code to the user's software. In addition, certain open-source software licenses require the user of such
software to make any derivative works of the open-source code available to others on unfavorable terms or at no cost. This can
subject previously proprietary software to open-source license terms. While we monitor the use of all open-source software in our
products, processes, and technology and try to ensure that no open-source software is used in such a way as to require us to disclose
or make available the source code to the related product or solution, such use could inadvertently occur. This could harm our intellectual
property position and have a material adverse effect on our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be unable to adequately enforce
or defend our ownership and use of our intellectual property and other proprietary rights</i></b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our success is heavily dependent upon our
intellectual property and other proprietary rights. We rely upon a combination of trademark, trade secret, copyright, patent, and
unfair competition laws, as well as license and access agreements and other contractual provisions, to protect our intellectual
property and other proprietary rights. In addition, we attempt to protect our intellectual property and proprietary information
by requiring certain of our employees and consultants to enter into confidentiality, noncompetition, and assignment-of-inventions
agreements. The steps we take to protect these rights may not be adequate to prevent misappropriation of our technology by third
parties, or may not be adequate under the laws of some foreign countries, which may not protect our intellectual property rights
to the same extent as do the laws of the United States. Our attempts to protect our intellectual property may be challenged by
others or invalidated through administrative process or litigation, and agreement terms that address noncompetition are difficult
to enforce in many jurisdictions and may not be enforceable in any particular case. In addition, there remains the possibility
that others will &#8220;reverse engineer&#8221; our products in order to introduce competing products, or that others will develop
competing technology independently. If we resort to legal proceedings to enforce our intellectual property rights or to determine
the validity and scope of the intellectual property or other proprietary rights of others, the proceedings could be burdensome
and expensive, even if we were to prevail. The failure to adequately protect our intellectual property and other proprietary rights
may have a material adverse effect on our business, results of operations or financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Current and future litigation against
us, which may arise in the ordinary course of our business, could be costly and time-consuming to defend.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to claims that arise in
the ordinary course of business, such as claims brought by our customers in connection with commercial disputes and employment
claims made by our current or former employees. Third parties may in the future assert intellectual property rights to technologies
that are important to our business and demand back royalties or demand that we license their technology. Litigation may result
in substantial costs and may divert management&#8217;s attention and resources, which may seriously harm our business, overall
financial condition, and operating results. Insurance may not cover such claims, may not be sufficient for one or more such claims,
and may not continue to be available on terms acceptable to us. A claim brought against us that is uninsured or underinsured could
result in unanticipated costs, negatively affecting our business, results of operations, and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We could incur substantial costs
resulting from product liability claims relating to our products or services or our customers&#8217; use of our products or services.
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any failure or errors in a customer&#8217;s
clinical trial caused or allegedly caused by our products or services could result in a claim for substantial damages against us
by our customers or the clinical trial participants, regardless of our responsibility for the failure. Although we are generally
entitled to indemnification under our customer contracts against claims brought against us by third parties arising out of our
customers&#8217; use of our products, we might find ourselves entangled in lawsuits against us that, even if unsuccessful, may
divert our resources and energy and adversely affect our business. Further, in the event we seek indemnification from a customer,
a court may not enforce our indemnification right if the customer challenges it or the customer may not be able to fund any amounts
for indemnification owed to us. In addition, our existing insurance coverage may not continue to be available on reasonable terms
or may not be available in amounts sufficient to cover one or more large claims, or the insurer may disclaim coverage as to any
future claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business depends on the clinical
trial market, and a downturn in this market could cause our revenues to decrease.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business depends on clinical trials
conducted or sponsored by pharmaceutical, biotechnology, and medical device companies, CROs, and other entities. Our revenues may
decline as a result of conditions affecting these industries, including general economic downturns, increased consolidation, decreased
competition, or fewer products under development. Other developments that may affect these industries and harm our operating results
include product liability claims, changes in government regulation, changes in governmental price controls or third-party reimbursement
practices, and changes in medical practices. Disruptions in the world credit and equity markets may also result in a global downturn
in spending on research and development and clinical trials and may impact our customers&#8217; access to capital and their ability
to pay for our solutions. Any decrease in research and development expenditures or in the size, scope, or frequency of clinical
trials could materially adversely affect our business, results of operations, or financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As a public company, we are obligated
to maintain proper and effective internal control over financial reporting. As our business expands both organically and through
acquisitions, we may be unable to effectively adapt our current systems to our changing business needs and may fail to develop
and maintain an effective system of disclosure controls and internal control over financial reporting which could impair our ability
to produce timely and accurate financial statements or comply with applicable laws and regulations.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a public company, we are subject to
the reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), the Sarbanes-Oxley
Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the
&#8220;Dodd-Frank Act&#8221;), and other applicable securities rules and regulations. Compliance with these rules and regulations
will increase our legal and financial compliance costs, make some activities more difficult, time consuming, or costly, and increase
demand on our systems and resources. The Exchange Act requires, among other things, that we file annual, quarterly, and current
reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain
effective disclosure controls and procedures and internal control over financial reporting. As a company, we continually review
and evaluate the adequacy of our disclosure controls and procedures and internal controls over financial reporting for deficiencies
and improvements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we expand our operations through acquisitions
and organic growth, our current systems for disclosure controls and procedures and internal control over financial reporting may
be inadequate to meet our growing and changing business. Accordingly, we may require significant resources and management oversight
to maintain and, if necessary, improve our disclosure controls and procedures and internal control over financial reporting. As
a result, management&#8217;s attention may be diverted from other business concerns, which could adversely affect our business
and operating results. In addition, we may need to hire more employees in the future or engage outside consultants with respect
to developing and maintaining our disclosure controls and internal control over financial reporting, which would increase our costs
and expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, as a public company, we are
required, pursuant to Section&#160;404 of the Sarbanes-Oxley Act to furnish a report by management on, among other things, the
effectiveness of our internal control over financial reporting. Effective internal control over financial reporting is necessary
for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent
fraud.&#160; As a result of the growth of our business both organically and through acquisitions, we may fail to implement required
new or improved controls, or experience difficulties in their implementation, which may cause us to not meet our reporting obligations.
If we or our independent registered public accounting firm were to identify a material weakness, if we are unable to assert that
our internal control over financial reporting is effective, we could lose investor confidence in the accuracy and completeness
of our financial reports, which could cause the price of our common stock to decline, and we may be subject to investigation by
the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As a public company, we may incur
significant administrative workload and expenses in connection with new and changing compliance requirements</i></b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a public company with common stock listed
on The Nasdaq Capital Market, we must comply with various laws, regulations and requirements. New laws and regulations, as well
as changes to existing laws and regulations affecting public companies, including the provisions of the Sarbanes-Oxley Act, the
Dodd-Frank Act, and rules adopted by the SEC and by The Nasdaq Capital Market, may result in increased general and administrative
expenses and a diversion of management's time and attention as we respond to new requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Certain
Risks Related to Ownership of Our Common Stock</b></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have been paying quarterly dividends
on our common stock, and although there has been a consistent track record of paying these dividends, the Board of Directors may
suspend the dividend, and, consequently, your ability to achieve a return on your investment will depend on appreciation in the
price of our common stock.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Should the Board of Directors suspend the
dividend and decide to use those funds to invest more into the business, you may not receive any dividends on your investment in
our common stock for the foreseeable future and the success of an investment in shares of our common stock will depend upon any
future appreciation in its value. Shares of our common stock may depreciate in value or may not appreciate in value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The price of our common stock may
fluctuate significantly, and investors could lose all or part of their investments. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares of our common stock were sold in
our initial public offering (&#34;IPO&#34;) in 1996 at a price of $1.25 per share (on a post-split basis), and our common stock
has subsequently traded as high as $73.58 and as low as $0.38 from our IPO through August 31, 2020. However, an active, liquid,
and orderly market for our common stock on The Nasdaq Capital Market or otherwise may not be sustained, which could depress the
trading price of our common stock. The trading price of our common stock may be subject to wide fluctuations in response to various
factors, some of which are beyond our control, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 10%">&#160;</td>
    <td style="width: 5%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="width: 85%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">our quarterly or annual earnings or those of other companies in our industry;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">announcements by us or our competitors of significant contracts or acquisitions;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">changes in accounting standards, policies, guidance, interpretations, or principles;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">general economic and stock market conditions, including disruptions in the world credit and equity markets;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the failure of securities analysts to cover our common stock or changes in financial estimates by analysts;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">future sales of our common stock; and</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the other factors described in these &#8220;Risk Factors.&#8221;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In recent years, the stock market in general,
and the market for technology-related companies in particular, has experienced wide price and volume fluctuations. This volatility
has had a significant impact on the market price of securities issued by many companies, including companies in our industry. The
price of our common stock could fluctuate based upon factors that have little to do with our performance, and these fluctuations
could materially reduce our stock price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the past, some companies, including
companies in our industry, have had volatile market prices for their securities and have had securities class action suits filed
against them. The filing of a lawsuit against us, regardless of the outcome, could have a material adverse effect on our business,
financial condition, and results of operations, as it could result in substantial legal costs and a diversion of our management&#8217;s
attention and resources.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The price of our common stock may
be volatile, and our stockholders may not be able to resell shares of our common stock at or above the price they paid.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading price of our common stock is
volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. Factors
that could cause volatility in the market price of our common stock include, but are not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">achievement of expected software product and consulting service sales and profitability, including the effects of seasonality on our results of operations, as well as adjustments to our sales forecasts;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">the ongoing&#160;COVID-19&#160;pandemic, see &#8220;&#8212;Certain Risks Related to our Business&#8212;Our business is subject to risks arising from epidemic diseases, such as the recent outbreak of the COVID-19 illness.&#8221;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">announcements of new products by us or our competitors;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">announcements or developments in any intellectual property infringement actions in which we may become involved;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">our operating results;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">results from, or any delays in, clinical trial programs of our clients and their need for our services;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">changes or developments in laws or regulations applicable to our products;</span></td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td>&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">consolidation within the pharmaceutical and biotechnology industries
        leading to fewer potential customers for our products and services;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">delays in the release of new or enhanced products or services or undetected errors in our products or services may result in increased cost to us, delayed market acceptance of our products, and delayed or lost revenue;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">adverse actions taken by regulatory agencies with respect to our clinical trials, manufacturing supply chain, or sales and marketing activities;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">the success of our efforts to acquire or develop additional products;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">announcements concerning our competitors or the pharmaceutical industry in general;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">actual or anticipated fluctuations in our operating results;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">FDA or other U.S. or foreign regulatory actions affecting us or our industry or other healthcare reform measures in the United States;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">changes in financial estimates or recommendations by securities analysts;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">trading volume of our common stock;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">sales of our common stock by us, our executive officers and directors, or our stockholders in the future;</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">general economic and market conditions and overall fluctuations in the United States equity markets, including as a result of volatility related to the recent coronavirus outbreak and related health concerns; and</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: top; width: 1%">&#160;</td>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">the loss of any of our key scientific or management personnel.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Broad market fluctuations may adversely
affect the trading price or liquidity of our common stock. In the past, when the market price of a stock has been volatile, holders
of that stock have sometimes instituted securities class action litigation against the issuer. If any of our stockholders were
to bring such a lawsuit against us, we could incur substantial costs defending the lawsuit and the attention of our management
would be diverted from the operation of our business, which could seriously harm our financial position. Any adverse determination
in litigation could also subject us to significant liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If securities or industry
analysts issue an adverse or misleading opinion regarding our stock, or our inclusion in the S&amp;P 600 discontinues, our
stock price and trading volume could decline.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
trading market for our common stock is influenced by the research and reports that industry or securities analysts publish about
us or our business as well as the stock indices that our common stock is included in. If any of the analysts who cover us issue
an adverse or misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if our
operating results fail to meet the expectations of analysts, our stock price would likely decline. If one or more of these analysts
cease coverage of us or fail to publish reports on us regularly, or if the S&amp;P 600 removes us from its index, we could lose
visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>We may raise capital through the issuance of our common
stock, convertible debt or equity linked securities which could result in dilution to our stockholders or negatively impact the
price of our common stock. </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020 we issued 2,090,909 shares
of our common stock in a follow-on public offering. We may choose to raise additional capital due to market conditions or strategic
considerations. To the extent that additional capital is raised through the sale of equity, convertible debt or other equity linked
securities, the issuance of these securities could result in dilution to our stockholders or result in downward pressure on the
price of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_011"></span>ITEM 1B &#8211; UNRESOLVED STAFF COMMENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_012"></span>ITEM 2 &#8211; PROPERTIES&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We lease approximately 13,500 square feet
of office space in Lancaster, California. The original lease had a five-year term with two, three-year options to extend. The initial
five-year term expired in February 2011, and we extended the lease to February 2, 2014. In June 2013, the lease was amended to
extend the term to February 2, 2017. The amended lease also provides for an annual base rent increase of 3% per year and two, two-year
options to extend. In May 2016 the Company exercised two, two-year options extending the term of the lease through February 2,
2021 at a fixed rate of $25,000 per month. The new extension agreement gives the Company the right, upon 90 days&#8217; prior notice,
to terminate the lease in the last two years of the term upon payment of a recapture payment equal to the 3% base payment increase
that would have been due under the original agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Buffalo subsidiary leases approximately
12,623 square feet of space in Buffalo, New York. The initial five-year term expired in October 2018 and was renewed for a three-year
option to extending it to November 2021. The new base rent is $16,147 per month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DILIsym leases approximately 2,700 square
feet of space in Research Triangle Park, North Carolina. The initial three-year term was due to expire October 2020. An amendment
to the initial lease became effective April 1, 2020. This amendment added 686 square feet and extended the term of the lease to
September 30, 2023. The new base rent is approximately $7,500 per month with an annual 3% adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In Paris, France Lixoft leases approximately
2,300 square feet of office space, which as of April 1, 2020, had minimum payments equaling approximately $288,000. The lease is
for a 9-year term, with an option to terminate every 3 years, and expires in November of 2024. The rent is $16,555 per quarter
and can be adjusted each December based on a consumer price index.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rent expense, including common area maintenance
fees for the fiscal years ended August 31, 2020, 2019 and 2018 was $644,000, $584,000, and $567,000, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company believes its existing facilities
and equipment are in good operating condition and are suitable for the conduct of its business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_013"></span>ITEM 3 &#8211; LEGAL PROCEEDINGS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may become subject to litigation, claims,
investigations, and audits arising from time to time in the ordinary course of our business. At this time, however, we are not
a party to any legal proceedings and are not aware of pending legal proceedings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_014"></span>ITEM 4 &#8211; MINE SAFETY DISCLOSURES.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="a_015"></span>PART II</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_016"></span>ITEM 5 &#8211; MARKET FOR REGISTRANT&#8217;S COMMON EQUITY,
RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s common stock, par value
$0.001 per share, trades on the Nasdaq Capital Market under the symbol &#8220;SLP.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Price Range of Common Stock </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows high and low
sales prices for the Company&#8217;s common stock for each quarter during the past two fiscal years:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">FY19:</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 65%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Quarter ended November 30, 2018</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">21.25</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">18.04</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Quarter ended February 28, 2019</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">21.66</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17.18</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Quarter ended May 31, 2019</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27.33</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">19.74</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Quarter ended August 31, 2019</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">41.95</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">24.08</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">FY20:</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Quarter ended November 30, 2019</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">38.32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">31.53</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Quarter ended February 29, 2020</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">40.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27.71</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Quarter ended May 31, 2020</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">52.73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">26.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Quarter ended August 31, 2020</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">73.58</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">46.77</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
of <span>November 16, 2020, there were 46</span> shareholders of record.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dividends</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We paid a total of approximately $4.3 million
in cash dividends during fiscal year 2020, and $4.2 million in fiscal year 2019 as set forth in the table below. We expect to pay
quarterly dividends of $0.06 per share of common stock each quarter, subject to declaration by our Board of Directors. However,
there can be no assurances that our Board of Directors will continue the dividend distributions for any specified number of quarters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fiscal Year</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Record Date</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Distribution <br />
Date</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b># of Shares<br />
Outstanding on<br />
Record Date</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Dividend per<br />
Share</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total <br />
Amount</b></span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 15%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2019</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">11/01/2018</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 17%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">11/08/2018</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 17%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">17,417,875</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="width: 12%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,045,073</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1/25/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2/01/2019</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">17,481,450</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,048,887</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4/24/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">5/01/2019</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">17,515,228</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,050,914</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">7/25/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8/01/2019</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">17,536,454</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,052,181</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10/25/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">11/01/2019</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">17,606,314</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,056,379</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1/27/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2/03/2020</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">17,645,639</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,058,740</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4/24/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">5/01/2020</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">17,769,134</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,066,148</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">7/27/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8/03/2020</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">17,820,057</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,069,203</span></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Shareholder Return Performance Graph</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph compares the cumulative
total stockholder return on our common stock of a $100 investment from August 31, 2016 through August 31, 2020 assuming reinvestment
of dividends, with a similar investment in the Russell 3000 index (the &#8220;Russell 3000&#8221;) and with the companies listed
in the Nasdaq Composite - Total Returns (&#8220;IXIC&#8221;), and the S&amp;P600 Health Care Equipment &amp; Services Industry
Group Index (SP600-3510). The historical information set forth below is not necessarily indicative of future performance. This
performance graph shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended or incorporated by reference into any of our filings under the Securities Act of 1933, as amended, of the Exchange Act,
except as shall be expressly set forth by specific reference in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_002.jpg" alt="" style="height: 261.75pt; width: 453.75pt" />&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Repurchases</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is currently no share repurchase
program pending, and the Company has made no repurchases of its securities since fiscal year 2011.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_017"></span>ITEM 6 &#8211; SELECTED FINANCIAL DATA</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables set forth the selected
consolidated financial data for each of the fiscal years in the five-year period ended August 31, 2020. We derived the selected
consolidated financial data from our audited consolidated financial statements, which should be read in conjunction with Item 7,
Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II of this Annual Report on
Form 10-K and our consolidated financial statements and the related notes included elsewhere in this report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td colspan="17" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Year ended August 31,</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">Statements of operations data</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>&#160;</b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b>2020[c][d]</b></p></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; text-align: center"><b>2019</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; text-align: center"><b>2018[b]</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; text-align: center"><b>2017[a]</b></td><td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1pt; text-align: center"><b>&#160;</b></td><td style="border-bottom: Black 1pt solid; text-align: center"><b>2016</b></td><td style="padding-bottom: 1pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 35%; font-weight: bold; text-align: left">Net Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">41,589,084</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">33,970,440</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">29,666,524</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">24,137,913</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,972,079</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Cost of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,649,230</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,025,704</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,994,228</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,307,800</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,601,513</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,939,854</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">24,944,736</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">21,672,296</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">17,830,113</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">15,370,566</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">SG&amp;A expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,360,053</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,796,027</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,583,852</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,198,184</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,693,691</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">R&amp;D</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,974,623</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,499,980</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,790,656</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,367,645</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,445,069</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">19,334,676</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,296,007</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,374,508</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,565,829</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,138,760</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1pt">Income from operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,605,178</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,648,729</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,297,788</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,264,284</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,231,806</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(218,129</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(92,253</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(158,846</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(24,017</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,586</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,387,049</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,556,476</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,138,942</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,240,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,236,392</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Provision for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,054,989</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,973,147</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,204,130</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,452,670</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,286,256</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Net Income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,332,060</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,583,329</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,934,812</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,787,597</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,950,136</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: justify">Earnings per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.34</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.29</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.48</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.50</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.33</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.29</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Weighted-average common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Basic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,819,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,492,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,328,707</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,239,490</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,028,566</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,538,373</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,057,431</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,860,392</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,515,917</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,209,506</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Dividend per common share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.24</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.20</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Dividends</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,250,470</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,197,055</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,161,740</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,448,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,413,274</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other comprehensive Income (Loss), net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Foreign currency translation adjustments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">58,467</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of August 31,</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Balance sheet data at year end</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">&#160;</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2020</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2017</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2016</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 35%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">49,207,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">11,435,499</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">9,400,701</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,215,718</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,030,284</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net working capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">123,586,788</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">16,381,665</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,996,901</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,625,437</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10,574,712</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">168,421,517</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">45,196,697</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">43,279,016</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">38,512,468</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">27,814,317</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Total liabilities associated with business and intangible acquisitions</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,063,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,761,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,890,940</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,985,516</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,385,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,515,093</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11,356,391</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,707,581</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,081,723</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total shareholders&#8217; equity</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">156,035,945</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,681,604</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">31,922,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">25,804,887</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,732,594</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Notes to Five-Year Summary</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[a] Effective June 1, 2017, we acquired
DILIsym Services, Inc. and incurred approximately $620,000 of acquisition related costs in FY2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[b] In FY2018 we posted a $1.5 million
deferred tax benefit due to the effect of new tax rates enacted under the Tax Cuts and Jobs Act of 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[c] Effective April, 2020, we acquired
Lixoft and incurred approximately $1,416,000 of acquisition-related costs in FY2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[d] In August 2020 the company issued 2,090,909
of shares in a follow-on public offering, priced at $55.00 per share. Net proceeds from this offering after underwriting discounts
and commissions and other offering expenses were $107.7 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_018"></span>ITEM 7 &#8211; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion and analysis should
be read in conjunction with the Financial Statements and related notes included in this Annual Report on Form 10-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Management Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Fiscal year 2020 highlights:</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We acquired Lixoft of Paris, adding the Monolix Suite to our product offerings</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We completed a follow-on public offering in August 2020; net proceeds from the offering were $107.7 million</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Entered into several funded collaborations to enhance Gastro Plus to include an intra-articular delivery model, a virtual bioequivalence trial simulator; and expansion of Mechanistic Oral Absorption (ACAT)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Entered a funded collaboration with large pharmaceutical company to enhance PKPlus</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Entered a collaboration agreement with Bayer AG to advance ADMET predictor, improving structure and tautomer handling capabilities supporting data integrity across their discovery platforms</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Entered into an agreement with a large pharmaceutical company for
    a new component, a QSP (Quantitative Systems Pharmacology) model focused on treating heart failure, such as can occur after
    myocardial infarction</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Entered a collaboration agreement to advance ADMET Predictor software for use within integrated drug discover workflows, by enhancing the HTPK Simulation Model that incorporates PBPK modeling into the partner&#8217;s discovery platform to support compound screening activities</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Received notice of an FDA funded agreement to develop physiologically based pharmacokinetics/pharmacodynamics (PBPK/PD) approaches to support inter species translation for ocular drug delivery in GastroPlus</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We released Version 4.3 of our KIWI&#8482; Pharmacometric Communication and Collaboration Platform</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Continued quarterly payment of dividend of 6 cents per share</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Fiscal Year 2020 Financial Summary:</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Consolidated net revenues increased by $7.62&#160;million, or 22.4%, to $42 million in fiscal year 2020 from $34 million in fiscal year 2019</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Consolidated gross margin increased $6.0 million or 24.0%, to $30.9 million in fiscal year 2020 from $24.9 million in fiscal year 2019</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net income from operations increased $956,000, or 9.0%, to $11.6
million in fiscal year 2020 from $10.6 million in fiscal year 2019. Fiscal year 2020 includes one-time acquisition costs of $1.4
million related to Lixoft</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Net income increased by $749,000, or 8.7%, to $9.33 million in fiscal year 2020 from $8.58 million in fiscal year 2019</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Diluted earnings per share increased by $0.02 or 4.2% to $0.50 in 2020 from $0.48 in 2019</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">Strategy Going Forward:</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 24px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Continue to pursue funded and unfunded collaborations in support of improving our products and services</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Continue our aggressive marketing and sales campaign, including numerous scientific conferences and meetings</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Continue to expand our use of social media and advertising</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Continue to expand our sales staff, both in-house and in the field</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Continue to recruit scientific and other resources to support our product and scientific consulting services</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Seek accretive acquisitions that complement our existing offerings and expand our markets</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Expand infrastructure to support corporate growth</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fiscal year 2020 was yet another record
year for the Company. We saw increased growth in the midst of a COVID-19 economic environment. We believe the continued growth
of our pharmaceutical software and services business is the result of steadily increasing adoption and awareness of the value of
simulation and modeling software tools across the pharmaceutical industry, the continuing push by regulatory agencies for increased
use of modeling and simulation, and the expertise we offer as consultants to assist companies involved in the research and development
of new medicines. We have received a continuing series of study contracts with pharmaceutical companies ranging from several of
the largest in the world to a number of medium-sized and smaller companies in the U.S., Europe, and Japan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020 we completed a follow-on
public offering that will enable an expedited approach to potential acquisitions, continue our research and development activities,
and invest in staffing and infrastructure to meet the needs of a wider customer base and the growth of the business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have any stock repurchase programs
currently in place or pending; however, our Board of Directors may consider such programs from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Results of Operations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">FY20 COMPARED WITH FY19</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following sets forth selected items
from our statements of operations (in thousands) and the percentages that such items bear to net sales for the fiscal years ended
August 31, 2020 (FY20) and August 31, 2019 (FY19) (Because of rounding, numbers may not foot.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal year ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>8/31/20</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>8/31/19</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: justify">Net revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">41,589</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">100.00%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">33,970</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">100.00%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Cost of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">10,649</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">25.6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,025</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26.6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">30,940</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">74.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">24,945</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">73.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Selling, general and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16,360</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39.3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,796</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34.6</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,975</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7.2</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">19,335</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">46.5</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,296</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42.1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Income from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,605</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27.9</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,649</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.4</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(218</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.5</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(92</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.3</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Net income before taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,387</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">27.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,556</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.2</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">(Provision) for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,055</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4.9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,973</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5.8</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,332</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">22.4%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,583</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">25.4%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Net Revenues</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated net revenues increased
by 22.4% or $7.6 million to $41.59 million in FY20 from $33.97 million in FY19. Our Lancaster, California division increased
revenues by $2.4 million or 12.1%, to $22.0 million in FY20 from $19.6 million in FY19. $1.78 million was an increase from
revenues generated by our Buffalo subsidiary (Cognigen), an increase of 19.1%. DILIsym Services, Inc. (DILIsym) increased
revenues by $1.88 million or 37.2%. $1.58 million of revenue was generated by our French subsidiary (Lixoft), which was
acquired April 1, 2020. FY20 software and software-related revenues increased $3.1 million or 16.8% while consulting revenues
increased by $4.5 million or 29.1% compared to FY19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Cost of Revenues</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated cost of revenues increased
by $1.6 million or 18.0% to $10.6 million in FY20 from $9.0 million in FY19. Labor-related cost incurred increased by $1.6 million,
mainly in support of increased consulting revenues. Cost of revenues for direct contract-related cost increased by $274,000, offset
by a decrease of approximately $217,000 of royalty expenses as well as $212,000 in training-related expenses in FY2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant portion of cost of revenues
for pharmaceutical software products is the systematic amortization of capitalized software development costs, which is an independent
fixed cost rather than a variable cost related to revenues. This amortization cost of $2.36 million in FY20 increased by approximately
$103,000 as compared to FY19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues as a percentage of revenue
remained fairly consistent at 25.6% in FY20 as compared to 26.6% in FY19, a decrease of 1.0% year over year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Gross Margin</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated gross margin increased $6.0
million or 24.0%, to $30.9 million in FY20 from $24.9 million in FY19. $2.7 million of this increase is from the California division,
which showed an 86.7% gross margin. The Buffalo Division gross margin increased $959,000 or 19% with margins of 53.3%. DILIsym
of North Carolina recorded a $997,000 increase, a 67.3% margin, versus a 72.7% margin in FY19. Lixoft recorded a margin of $1.3
million or 83.1%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall gross margin has increased to 74.4%
in FY20 as compared to 73.4% in FY19 an increase of 1.0% year over year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Selling, General and Administrative
Expenses</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Selling, general, and administrative (SG&amp;A)
expenses increased $4.56 million, or 38.7% to $16.4 million in FY20 from $11.80 million in FY19. As a percent of revenues, SG&amp;A
was 39.3% for FY20, compared to 34.7% in FY19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The major increases in SG&amp;A expense
were:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 2%">&#160;</td>
    <td style="width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="width: 96%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">During the year the Company incurred approximately $1,416,000 of costs associated with the acquisition of Lixoft.&#160;&#160;These fees included legal and accounting, due diligence, and M&amp;A related consulting. </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Commission expenses were up $226,000, this increase is related to increased sales in Asia as well as domestic sales</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Contract labor increased $152,000 for other temporary labor and consulting costs related to various corporate initiatives</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">G&amp;A salaries and wages increased by $1.49 million; this increase is a combination of increased headcount both from acquisitions and salaries in support of corporate growth </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Insurance expense increased $259,000; $136,000 was health-related medical costs from increased headcount and rate increases</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Payroll tax expense increased $478,000, the effect of higher employee count and salary expense </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Director compensation increase by $394,000, based on an increase in the number of paid directors and compensation increases</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">401k expense increased $52,000 due to increased staffing </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The major decreases in SG&amp;A expense
were:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 2%">&#160;</td>
    <td style="width: 2%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="width: 96%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Trade show and travel related costs decreased by $145,000 mainly due to lower attendance and less travel costs due to COVID-19</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Recruiting fees decreased by $86,000</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Research and Development</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incurred approximately $5,328,000 of
research and development costs during FY20. Of this amount, $2,353,000 was capitalized and $2,975,000 was expensed. We incurred
approximately $4,268,000 of research and development costs during FY19. Of this amount, $1,768,000 was capitalized and $2,500,000
was expensed. The increase of $1,060,000, or 24.8%, in total research and development expenditures from FY19 to FY20 was mainly
from increased costs in the Lancaster and DILIsym divisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><i><span style="text-decoration: underline">Provision for Income Taxes</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The provision for income taxes was $2.05
million for FY20 compared to $1.97 million for FY19. Our effective tax rate decreased slightly to 18.0% in FY20 from 18.7% in FY19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
effective rate differs from anticipated combined statutory rates of approximately 25.7% due to R&amp;D credits, foreign tax related
items (tax credits and foreign deemed intangible income deductions), and the tax effect of stock compensation related items for
stock compensation and disqualifying dispositions. In the last part of FY20, as occurred also in FY19, as a result of an increase
in stock prices, a number of employees exercised and sold incentive stock options granted to them under their corporate incentive
plans, creating corporate tax deductions that lowered the effective tax rate.</span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><i><span style="text-decoration: underline">Net Income </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net income increased by $749,000 or 8.7%,
to $9.3 million in FY20 from $8.6 million in FY19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">FY19 COMPARED WITH FY18</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following sets forth selected items
from our statements of operations (in thousands) and the percentages that such items bear to net sales for the fiscal years ended
August 31, 2019 (FY19) and August 31, 2018 (FY18) (Because of rounding, numbers may not foot.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal year ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>8/31/19</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>8/31/18</b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: justify">Net revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">33,970</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">100.00%</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">29,667</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">100.00%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Cost of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">9,025</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26.6</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,994</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">26.9</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">24,945</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">73.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">21,672</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">73.1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Selling, general and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,796</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34.6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,584</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32.3</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7.4</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,791</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6.0</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">14,296</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42.1</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,375</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">38.3</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Income from operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,649</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,298</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34.7</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(92</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.3</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(159</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.5</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Net income before taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,556</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,139</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34.2</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">(Provision) for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,973</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5.8</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,204</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(4.1</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,583</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">25.4%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,935</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">30.1%</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Net Revenues</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated net revenues increased by
14.5% or $4.3 million to $33.97 million in FY19 from 29.67 million in FY18. Our Lancaster, California division increased revenues
by $2.03 million or 11.6%, to $19.6 million in FY19 from $17.6 million in FY18. $1.46 million of this increase was from revenues
generated by our Buffalo subsidiary (Cognigen), an increase of 18.6%. DILIsym Services, Inc. (DILIsym) increased revenues by $807,000
or 19%. FY19 software and software-related revenues increased $1.8 million or 11.0% while consulting revenues increased by $2.5
million or 19.0% compared to FY18.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Cost of Revenues</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated cost of revenues increased
by $1.03 million or 12.9% to $9.0 million in FY19 from $8.0 million in FY18. Labor-related cost incurred by our Lancaster and Buffalo
divisions increased by $190,000 and $1.06 million, respectively mainly in support of increased consulting revenues. This was offset
by a $380,000 decrease in cost of revenues for direct contract expenses paid for testing at DILIsym. We saw a decrease of approximately
$52,000 in training-related expenses in FY2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant portion of cost of revenues
for pharmaceutical software products is the systematic amortization of capitalized software development costs, which is an independent
fixed cost rather than a variable cost related to revenues. This amortization cost of $1.33 million in FY19 increased by approximately
$31,000 in FY19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of revenues as a percentage of revenue
remained fairly consistent at 26.6% in FY19 as compared to 26.9% in FY18, a decrease of 0.3% year over year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Gross Margin</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated gross margin increased $3.27
million or 15.1%, to $24.94 million in FY19 from $21.67 million in FY18. $1.8 million of this increase is from the California division,
which showed an 83.3% gross margin. The Buffalo Division gross margin increased $325,000 or 7% with a margin of 53.2%. DILIsym
of North Carolina recorded a $1.14 million increase, a 72.7% margin, versus a 59.6% margin in FY18.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall gross margin has remained fairly
consistent at 73.4% in FY19 as compared to 73.1% in FY18, an increase of 0.3% year-over-year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Selling, General and Administrative
Expenses</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Selling, general, and administrative (SG&amp;A)
expenses increased $2.22 million, or 23.1% to $11.80 million in FY19 from $9.58 million in FY18. As a percent of revenues, SG&amp;A
was 34.6% for FY19, compared to 32.3% in FY18.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The major increases in SG&amp;A expense
were:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Commission expenses were up $122,000, mainly related to increased sales through representatives in Asia</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounting and audit fees increased by $73,000, associated with costs of consolidated audits and other compliance-related expenses</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Contract labor increased $172,000 due to increased director fees and consulting related to various corporate initiatives</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">G&amp;A salaries and wages increased by $939,000; this increase is a combination of increased headcount and salaries in support of corporate growth </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Insurance expense increased $218,000; $174,000 was health-related medical costs from increased headcount and rate increases </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Payroll tax expense increased $116,000, the effect of higher salary expense </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">401k expense increased $78,000 due to the increased staffing </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Recruiting and hiring costs increased $214,000 mainly due to recruiting fees of scientific personnel &#160;</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Software licenses costs increased $87,000 mainly due to sales volume related license fee increases </span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The major decreases in SG&amp;A expense
were:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 24px"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Symbol">&#183;</span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Trade-show-related costs decreased by $52,000 mainly due to lower attendance costs</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Research and Development</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We incurred approximately $4,268,000 of
research and development costs during FY19. Of this amount, $1,768,000 was capitalized and $2,500,000 was expensed. We incurred
approximately $3,936,000 of research and development costs during FY18. Of this amount, $2,145,000 was capitalized and $1,791,000
was expensed. The increase of $332,000, or 8.4%, in total research and development expenditures from FY18 to FY19 was mainly from
$316,000 of costs incurred by DILIsym Services Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><i><span style="text-decoration: underline">Provision for Income Taxes</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The provision for income taxes was $1.97
million for FY19, compared to $1.20 million for FY18. Our effective tax rate increased to 18.7% in FY19 from 11.9% in FY18.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This increase results mainly from a second
quarter 2018 assessment of deferred taxes based on the new tax rates enacted under the Tax Cuts and Jobs Act of 2017 (the &#8220;2017
Tax Act&#8221;). Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification Topic 740, Income
Taxes (&#8220;ASC 740&#8221;) requires that the company recognize the effects of changes in tax laws or tax rates in the financial
statements for the period in which such changes were enacted. Among other things, changes in tax laws or tax rates can affect the
amount of taxes payable for the current period, as well as the amount and timing of deferred tax liabilities and deferred tax assets.
Based on the assessment, the Company posted a one-time tax benefit in the amount of $1,500,000 in the second fiscal quarter of
2018, the result of estimating future deferred liabilities at the lower tax rates under the newly enacted tax laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effective rate differs from anticipated
combined statutory rates of approximately 25.4% due to R&amp;D credits and the tax effect of disqualifying dispositions. In the
last part of FY19, as a result of increase in stock prices, a number of employees exercised and sold incentive stock options granted
to them under their corporate incentive plans, creating corporate tax deductions that lowered the effective rate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><i><span style="text-decoration: underline">Net Income </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net income decreased by $351,000 or 3.9%,
to $8.6 million in FY19 from $8.93 million in FY18. The decrease in income was substantially effected by the deferred tax benefit
of $1.5 million discussed above in the note on Provision for Income Taxes, which reduced taxes in FY18.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">SEASONALITY</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our sales exhibit some seasonal fluctuations,
with the fourth fiscal quarter (June-August) generally having the lowest sales due to summer vacations and reduced activities at
our customers&#8217; sites. This unaudited quarterly sales information has been prepared on the same basis as the annual information
presented elsewhere in this Annual Report on Form 10-K and, in the opinion of management, reflects all adjustments (consisting
of normal recurring entries) necessary for a fair presentation of the information presented. Net sales for any quarter are not
necessarily indicative of sales for any future period; however, because our pharmaceutical software is licensed on an annual basis,
renewals are usually within the same quarter year after year. (Numbers may not foot because of rounding.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="21" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Net Sales (in thousands of dollars)</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font: 10pt Times New Roman, Times, Serif"><b>FY</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>First Quarter</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Second Quarter</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Third Quarter</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fourth Quarter</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total</b></span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 20%"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,401</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">$</td>
    <td style="width: 13%; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>
                                              <p style="margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif">10,350</span></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">$</td>
    <td style="width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">12,298</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">$</td>
    <td style="width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,540</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">41,589</span></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2019</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,536</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,472</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,937</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,026</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">33,971</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2018</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,069</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">7,357</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,553</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,688</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">29,667</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2017</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,418</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,706</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,748</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,265</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">24,138</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2016</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,839</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,164</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">6,011</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,958</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">19,972</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2015</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,086</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">4,574</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5,942</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,712</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">18,314</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2014</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,641</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,081</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,741</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,998</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">11,461</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2013</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,290</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,118</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3,095</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,568</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">10,071</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2012</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,248</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,789</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,772</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,640</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">9,449</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td><span style="font: 10pt Times New Roman, Times, Serif">2011</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,050</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,622</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">2,640</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>$</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,427</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">8,739</span></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">LIQUIDITY AND CAPITAL RESOURCES</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our principal sources of capital have been
cash flows from our operations. We have achieved continuous positive operating cash flow over the last eleven fiscal years. In
August 2020, the company closed an underwritten public offering of 2,090,909 shares of its common stock to the public at $55.00
per share, which included the full exercise of the underwriters&#8217; option to purchase 272,727 additional shares of common stock.
The aggregate gross proceeds to the company from this offering were approximately $115 million, before deducting underwriting discounts
and commissions; net proceeds were approximately $107.7 million. The company intends to use the net proceeds from the offering
for strategic mergers and acquisitions (although the company has no present commitments or agreements to enter into any such mergers
or acquisitions), working capital requirements, and other general corporate purposes, including investing in enhanced information
and accounting systems, and personnel in support of corporate growth. As of August 31, 2020, the Company had $49.2 million in cash
and cash equivalents and $66.8 million in short-term investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that our existing capital and
anticipated funds from operations will be sufficient to meet our anticipated cash needs for working capital and capital expenditures
for the foreseeable future. Thereafter, if cash generated from operations is insufficient to satisfy our capital requirements,
we may draw from our revolving line of credit with the bank, or we may have to sell additional equity or debt securities or obtain
expanded credit facilities. In the event such financing is needed in the future, there can be no assurance that such financing
will be available to us, or, if available, that it will be in amounts and on terms acceptable to us. If cash flows from operations
became insufficient to continue operations at the current level, and if no additional financing was obtained, then management would
restructure the Company in a way to preserve its pharmaceutical business while maintaining expenses within operating cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not aware of any trends or demands,
commitments, events or uncertainties that are reasonably likely to result in a decrease in liquidity of our assets. The trend over
the last ten years has been increasing cash deposits from our operating cash flows, and we expect that trend to continue for the
foreseeable future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 31, 2020, the Company entered into a Stock Purchase
and Contribution Agreement (the &#8220;Agreement&#8221;) with Lixoft, a French soci&#233;t&#233; par actions simplifi&#233;e
(&#8220;Lixoft&#8221;). On April 1, 2020, the Company consummated the acquisition of all outstanding equity interests of Lixoft
pursuant to the terms of the Agreement, with Lixoft becoming a wholly owned subsidiary of the Company. Under the terms of the Agreement,
the Company will pay the former shareholders of Lixoft total consideration of up to $16,500,000, consisting of two-thirds cash
and one-third newly issued, unregistered shares of the Company&#8217;s common stock. In addition, the Company paid $3,456,029 of
excess working capital based on the March 31, 2020 financial statements of Lixoft. As part of the total consideration, the agreement
calls for earnout payments up to an additional $5,500,000, two-thirds cash and one-third newly issued, unregistered shares of the
Company&#8217;s common stock based on a revenue growth formula each year for the two years subsequent to April 1, 2020. The former
shareholders can earn up to $2,000,000 the first year and $3,500,000 in year two. See Note 14 for a further description of the
Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 1, 2017 we signed a stock acquisition
agreement with DILIsym Services, Inc. of Research Triangle Circle, North Carolina, and on June 1, 2017 consummated the acquisition
of all the outstanding capital stock of DILIsym Services, Inc. pursuant to a Stock Purchase Agreement. DILIsym became a wholly-owned
subsidiary of Simulations Plus. Under the terms of the Agreement, the Company: (1) paid to the DILIsym Shareholders Five Million
Dollars, $4,515,982 payable at the closing of the Acquisition subject to certain adjustments and holdbacks. As part of the consideration
there were certain earnout provisions in the agreement, subject to those provisions the company paid $5,000,000 in payments over
the 3 years ended August 31, 2020 based on earnings of DILIsym before income taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will continue to seek opportunities
for strategic acquisitions. If one or more such acquisitions is identified, a substantial portion of our cash reserves may be required
to complete it; however, we intend to maintain sufficient cash reserves after any acquisition to provide reasonable assurance that
outside financing will not be necessary to continue operations. If we identify an attractive acquisition that would require more
cash to complete than we are willing or able to use from our cash reserves, we will consider financing options to complete the
acquisition, including obtaining loans and issuing additional securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quarterly dividend payments made in FY19
and FY20 are listed in the following table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Fiscal Year</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Record Date</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Distribution <br />
Date</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b># of Shares<br />
Outstanding on<br />
Record Date</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Dividend per<br />
Share</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Total <br />
Amount</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 13%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2019</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">11/01/2018</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 17%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">11/08/2018</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="width: 17%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">17,417,875</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="width: 13%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,045,073</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1/25/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2/01/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">17,481,450</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,048,887</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4/24/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">5/01/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">17,515,228</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,050,914</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">7/25/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8/01/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">17,536,454</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,052,181</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2020</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">10/25/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">11/01/2019</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">17,606,314</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,056,379</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">1/27/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">2/03/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">17,645,639</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,058,740</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">4/24/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">5/01/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">17,769,134</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,066,148</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">7/27/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">8/03/2020</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">17,820,057</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">0.06</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">$</span></td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">1,069,203</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board of directors has indicated its
intention to pay $0.06 quarterly dividends; however, there can be no assurances that our Board of Directors will continue the dividend
distributions as the decision is made on a quarterly basis based on current financial conditions and strategic plans. In October
2020, our Board of Directors declared a dividend distribution of $0.06 per share. The dividend was paid in November 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">KNOWN TRENDS OR UNCERTAINTIES</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we have not seen any significant
reduction in revenues to date, we have seen some consolidation in the pharmaceutical industry during economic downturns. These
consolidations have not had a negative effect on our total sales to that industry; however, should consolidations and downsizing
in the industry continue to occur, those events could adversely impact our revenues and earnings going forward.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed in the risk section of this
10-K, the world has been affected due to the COVID-19 pandemic. Though there has not been a substantial impact on sales revenues,
until the pandemic has passed, there remains uncertainty as to the effect on our business in both the short and long-term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the need for improved productivity
in the research and development activities directed toward developing new medicines will continue to result in increasing adoption
of simulation and modeling tools such as those we produce. New product developments in the pharmaceutical business segments could
result in increased revenues and earnings if they are accepted by our markets; however, there can be no assurances that new products
will result in significant improvements to revenues or earnings. For competitive reasons, we do not disclose all of our new product
development activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our continued quest for acquisitions could
result in a significant change to revenues and earnings if one or more such acquisitions are completed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The potential for growth in new markets
(e.g., healthcare) is uncertain. We will continue to explore these opportunities until such time as we either generate sales or
determine that resources would be more efficiently used elsewhere.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">INFLATION</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not been affected materially by
inflation during the periods presented, and no material effect is expected in the near future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">OFF-BALANCE SHEET ARRANGEMENTS</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, we did not have
any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance
or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or
other contractually narrow or limited purposes. As such, we are not materially exposed to any financing, liquidity, market, or
credit risk that could arise if we had engaged in such relationships.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have relationships or transactions
with persons or entities that derive benefits from their non-independent relationship with us or our related parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">CONTRACTUAL OBLIGATIONS</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table provides aggregate information regarding
our contractual obligations as of August&#160;31, 2020 (in thousands).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Payments due by period</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Contractual obligations:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1 year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2&#8211;3<br /> years</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">4&#8211;5<br /> years</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">More&#160;than<br /> 5 years</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="18">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 35%; text-align: left">Operating lease obligations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">961</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">486</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">389</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">86</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Contracts Payable</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,064</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,064</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,025</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,486</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,453</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">86</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">RECENTLY ISSUED OR NEWLY ADOPTED
ACCOUNTING STANDARDS</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding Accounting Standards Codification
Topic 606 (ASC Topic 606), Revenue from Contracts with Customers. The standard provides principles for recognizing revenue for
the transfer of promised goods or services to customers with the consideration to which the entity expects to be entitled in exchange
for those goods or services. The standard also provides guidance on the recognition of incremental costs related to obtaining customer
contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing the modified retrospective method. This approach was
applied to contracts that were in process as of September 1, 2018, and the corresponding incremental costs of obtaining those contracts,
which resulted in a cumulative effect adjustment of $493,279 to the opening balance of retained earnings at the date of adoption.
The adoption of this ASU primarily impacts the timing of our revenue recognition for certain sales contracts, the capitalization
and amortization of incremental costs of obtaining a contract, and related disclosures. The reported results for fiscal year 2019
reflect the application of ASC Topic 606.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,
Leases (Topic 842), which supersedes existing guidance on accounting for leases in &#34;Leases (Topic 840)&#34; and generally
requires all leases to be recognized in the consolidated balance sheet. ASU 2016-02 is effective for annual and interim reporting
periods beginning after December 15, 2018. The Company adopted this ASU on September 1, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In April 2016, the FASB issued ASU 2016-10,
Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board's new revenue standard, ASU 2014-09,
Revenue from Contracts with Customers. The standard was adopted concurrently with the adoption of ASU 2014-09 which is effective
for annual and interim periods beginning after December 15, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline">SIGNIFICANT ACCOUNTING POLICIES</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Estimates</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial statements and accompanying
notes are prepared in accordance with GAAP. Preparing financial statements requires management to make estimates and assumptions
that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by
management&#8217;s application of accounting policies. Actual results could differ from those estimates. Significant accounting
policies for us include revenue recognition, accounting for capitalized software development costs, valuation of stock options,
and accounting for income taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Revenue Recognition</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted Topic 606 effective
September&#160;1, 2018 using the modified retrospective method applying this guidance to all open contracts at the date of initial
application, which resulted in an adjustment to retained earnings for the cumulative effect of applying this guidance. The most
significant impact of Topic 606 on revenue to the Company relates to the timing of revenue recognition for one of its payment contracts.
Under 606 the revenues under the contract are being recognized as time is expended and costs are being expensed as incurred. Under
ASC 605 revenues were recognized as invoiced and certain costs were capitalized as development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines revenue recognition
through the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the contract, or contracts, with a customer</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Determination of the transaction price</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Recognition of revenue when, or as, the Company satisfies a performance obligation</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for a contract when
it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract
has commercial substance and collectability of consideration is probable. Contracts generally have fixed pricing terms and are
not subject to variable pricing. The Company considers the nature and significance of each specific performance obligation under
a contract when allocating the proceeds under each contract. Accounting for contracts includes significant judgement in the estimation
of estimated hours/cost to be incurred on consulting contracts, and the <i>di minimis</i> nature of the post-sales costs associated
with software sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Cash and Cash Equivalents</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of the statements of cash
flows, we consider all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Accounts Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We analyze the age of customer balances,
historical bad-debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability
of the Company&#8217;s trade accounts receivable balances. If we determine that the financial conditions of any of our customers
deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts receivable
are written off when all collection attempts have failed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Capitalized Computer Software Development
Costs</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Software development costs are capitalized
in accordance with FASB ASC 985-20, &#8220;Costs of Software to Be Sold Leased, or Marketed&#8221;. Capitalization of software
development costs begins upon the establishment of technological feasibility and is discontinued when the product is available
for sale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The establishment of technological feasibility
and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management
with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues,
estimated economic life, and changes in software and hardware technologies. Capitalized computer software development costs are
comprised primarily of salaries and direct payroll-related costs and the purchase or licensing of existing software to be used
in the Company&#8217;s software products. Total capitalized computer software development costs were $2,353,000, $1,768,000 and
$2,145,000 for the fiscal years ending August 31, 2020, 2019 and 2018, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization of capitalized computer software
development costs is calculated on a product-by-product basis on the straight-line method over the estimated economic life of the
products not to exceed five years. Amortization of software development costs amounted to $1,225,544, $1,331,753 and $1,300,434
for the fiscal years ending August 31, 2020, 2019 and 2018, respectively. We expect future amortization expense to vary due to
increases in capitalized computer software development costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We test capitalized computer software development
costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Property and Equipment</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are recorded at
cost, less accumulated depreciation and amortization. Depreciation and amortization are provided using the straight-line method
over the estimated useful lives as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment</span></td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 47%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5 years</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Computer equipment</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">3 to 7 years</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">5 to 7 years</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Shorter of life of asset or lease</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maintenance and minor replacements are
charged to expense as incurred. Gains and losses on disposals are included in the results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Intangible Assets and Goodwill</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company performs valuations of assets
acquired and liabilities assumed on each acquisition accounted for as a business combination and recognizes the assets acquired
and liabilities assumed at their acquisition date fair value. Acquired intangible assets include customer relationships, software,
trade name, and noncompete agreements. The Company determines the appropriate useful life by performing an analysis of expected
cash flows based on historical experience of the acquired businesses. Intangible assets are amortized over their estimated useful
lives using the straight-line method, which approximates the pattern in which the majority of the economic benefits are expected
to be consumed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of the cost
of an acquired entity over the fair value of the acquired net assets. Goodwill is not amortized, instead it is tested for impairment
annually or when events or circumstances change that would indicate that goodwill might be impaired. Events or circumstances that
could trigger an impairment review include, but are not limited to, a significant adverse change in legal factors or in the business
climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes
in the manner of the Company's use of the acquired assets or the strategy for the Company's overall business, significant negative
industry or economic trends or significant under-performance relative to expected historical or projected future results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is tested for impairment at the
reporting unit level, which is one level below or the same as an operating segment. As of August 31, 2020, the Company determined
that it has&#160;four&#160;reporting units, Simulations Plus, Cognigen Corporation, DILIsym Services, Inc. and Lixoft. When testing
goodwill for impairment, the Company first performs a qualitative assessment to determine whether it is necessary to perform step
one of a two-step annual goodwill impairment test for each reporting unit. The Company is required to perform step one only if
it concludes that it is more likely than not that a reporting unit's fair value is less than its carrying value. Should this be
the case, the first step of the two-step process is to identify whether a potential impairment exists by comparing the estimated
fair values of the Company's reporting units with their respective book values, including goodwill. If the estimated fair value
of the reporting unit exceeds book value, goodwill is considered not to be impaired, and no additional steps are necessary. If,
however, the fair value of the reporting unit is less than book value, then the second step is performed to determine if goodwill
is impaired and to measure the amount of impairment loss, if any. The amount of the impairment loss is the excess of the carrying
amount of the goodwill over its implied fair value. The estimate of implied fair value of goodwill is primarily based on an estimate
of the discounted cash flows expected to result from that reporting unit, but may require valuations of certain internally generated
and unrecognized intangible assets such as the Company's software, technology, patents and trademarks. If the carrying amount of
goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to the excess.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, the entire balance
of goodwill was attributed to three of the Company's reporting units Cognigen, DILIsym and Lixoft. Intangible assets subject to
amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of these assets may
not be recoverable. The Company recognized any impairment charges during FY20, FY19 and FY18.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reconciliation of Goodwill for FY20, FY19
and FY18:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 39%; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance, August 31, 2017</b></span></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 11%; font-weight: bold; text-align: right">4,789,248</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 11%; font-weight: bold; text-align: right">5,597,950</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 11%; font-weight: bold; text-align: right">&#8211;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 11%; font-weight: bold; text-align: right">10,387,198</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Addition</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Impairments</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance, August 31, 2018</b></span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,789,248</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">5,597,950</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">10,387,198</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Addition</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Impairments</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance, August 31, 2019</b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">4,789,248</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">5,597,950</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">10,387,198</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Addition</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">2,533,987</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">2,533,987</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Impairments</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b>Balance, August 31, 2020</b></span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">4,789,248</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">5,597,950</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,533,987</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">12,921,185</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Other Intangible Assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes other intangible
assets as of August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization<br /> Period</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Acquisition<br /> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br /> Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net book <br /> value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 33%; text-align: left">Customer relationships-Cognigen</td><td style="width: 2%">&#160;</td>
    <td style="width: 20%; text-align: left">Straight line 8 years</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">825,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">275,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Cognigen</td><td>&#160;</td>
    <td>None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Covenants not to compete-Cognigen</td><td>&#160;</td>
    <td style="text-align: left">Straight line 5 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Covenants not to compete-DILIsym</td><td>&#160;</td>
    <td style="text-align: left">Straight line 4 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Trade Name-DILIsym</td><td>&#160;</td>
    <td>None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">860,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">860,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships-DILIsym</td><td>&#160;</td>
    <td style="text-align: left">Straight line 10 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">617,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,282,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Customer relationships-Lixoft</td><td>&#160;</td>
    <td style="text-align: left">Straight line 14 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,474,108</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Lixoft</td><td>&#160;</td>
    <td>None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,550,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Covenants not to compete-Lixoft</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">Straight line 3 years</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">60,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">8,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">51,667</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">8,650,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,641,725</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">7,008,275</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for FY20, FY19, and
FY18 was $431,725, $357,500, and $357,500, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Business Acquisitions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounted for the acquisition
of Cognigen, DILIsym Services Inc., and Lixoft using the purchase method of accounting where the assets acquired and liabilities
assumed are recognized based on their respective estimated fair values. The excess of the purchase price over the estimated fair
values of the net assets acquired is recorded as goodwill. Determining the fair value of certain acquired assets and liabilities
is subjective in nature and often involves the use of significant estimates and assumptions, including, but not limited to, the
selection of appropriate valuation methodology, projected revenue, expenses, and cash flows, weighted average cost of capital,
discount rates and estimates of terminal values. Business acquisitions are included in the Company's consolidated financial statements
as of the date of the acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Fair Value of Financial Instruments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities recorded at fair
value in the Condensed Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure
their fair value. The categories, as defined by the standard are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 15%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Level&#160;Input:</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 84%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Input Definition:</b></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level I</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level II</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level III</span></td>
    <td>&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unobservable inputs that reflect management&#8217;s
        best estimate of what market participants would use in pricing the asset or liability at the measurement date.</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For certain of our financial instruments,
including accounts receivable, accounts payable, contract payable, accrued payroll, and other expenses, and accrued bonus to officer,
the amounts approximate fair value due to their short maturities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Research and Development Costs</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs are charged
to expense as incurred until technological feasibility has been established. These costs include salaries, laboratory experiment,
and purchased software that was developed by other companies and incorporated into, or used in the development of, our final products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Income Taxes</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes in
accordance with ASC 740-10, <i>&#8220;Income Taxes&#8221;</i> which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements or tax returns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Stock-Based Compensation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock options
using the modified prospective method in accordance with FASB ASC 718-10, <i>&#8220;Compensation-Stock Compensation&#8221;</i>.
Under this method, compensation costs include estimated grant date fair value of the awards amortized over the options&#8217; vesting
period. Stock-based compensation was $1,286,625, $865,848 and $562,079 for the fiscal years ended August 31, 2020, 2019 and 2018,
respectively, and is included in the statements of operations as Consulting, Salaries, and Research and Development expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_019"></span>ITEM 7A &#8211; QUANTITATIVE AND QUALITATIVE
DISCLOSURES ABOUT MARKET RISK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, and August 31, 2019,
we had cash and cash equivalents of $49.21 million and $11.44 million, respectively. We hold held-to-maturity short-term investments
that are exposed to market risk related to changes in interest rates, which could affect the value of our assets and liabilities.
We do not hold any trading and or available-for-sale securities. Some of our cash and cash equivalents are held in money market
accounts; however, they are not exposed to market-rate risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the years ended August 31, 2020, 2019,
and 2018 we sold $4.96 million, $4.15 million and $3.57 million, respectively, of software licenses through representatives in
certain Asian markets in local currencies. As a result, our financial position, results of operations, and cash flows can be affected
by fluctuations in foreign currency exchange rates, particularly fluctuations in the yen and RMB exchange rates. These transactions
give rise to receivables that are denominated in currencies other than the entity&#8217;s functional currency. The value of these
receivables is subject to changes because the receivables may become worth more or less due to changes in currency exchange rates.
The majority of our software license agreements are denominated in U.S. dollars. We record foreign gains and losses as they are
realized. We mitigate our risk from foreign currency fluctuations by adjusting prices in our foreign markets on a periodic basis.
We base these changes on market conditions while working closely with our representatives. Our Paris, France, division sells mainly
in U.S. Dollars and Euros and uses the Euro as a functional currency. As such, we are subject to currency translation and exchange
rate changes. We do not hedge currencies or enter into derivative contracts.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_020"></span>ITEM 8 - FINANCIAL STATEMENTS AND SUPPLEMENTARY
DATA</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See the financial statements included elsewhere
in this report beginning at page F-1, which are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_021"></span>ITEM 9 &#8211; CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_022"></span>ITEM 9A. CONTROLS AND PROCEDURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Evaluation of Disclosure Controls and
Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Chief Executive Officer and our Chief
Financial Officer, after evaluating our &#8220;disclosure controls and procedures&#8221; (as defined in Securities Exchange Act
of 1934 (the &#8220;Exchange Act&#8221;) Rules 13a-15(e) and 15d-15(e) as of the end of the period covered by this Annual Report
on Form 10-K (the &#8220;Evaluation Date&#8221;), have concluded that as of the Evaluation Date, our disclosure controls and procedures
are effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is
recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and
forms, and to ensure that information required to be disclosed by us in such reports is accumulated and communicated to our management,
including our Chief Executive Officer and Chief Financial Officer, where appropriate, to allow timely decisions regarding required
disclosure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Management Report on Internal Control
over Financial Reporting</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management is responsible for establishing
and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act) to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of consolidated financial
statements for external purposes in accordance with U.S. GAAP. Management assessed our internal control over financial reporting
as of August&#160;31, 2020, the end of our fiscal year. Management based its assessment on criteria established in Internal Control&#8212;Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Management&#8217;s assessment
included evaluation of elements such as the design and operating effectiveness of key financial reporting controls, process documentation,
accounting policies, and our overall control environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on this assessment, management has
concluded that our internal control over financial reporting was effective as of the end of the fiscal year to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external
reporting purposes in accordance with U.S. GAAP. We reviewed the results of management&#8217;s assessment with the Audit Committee
of our Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Inherent Limitations on Effectiveness
of Controls</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management, including the CEO and CFO,
does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect
all errors and all fraud. A control system, no matter how well-designed and operated, can provide only reasonable, not absolute,
assurance that the control system&#8217;s objectives will be met. The design of a control system must reflect the fact that there
are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent
limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or
fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of
controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any
design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness
of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions
or deterioration in the degree of compliance with policies or procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changes in Internal Control over Financial
Reporting</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No change in the Company&#8217;s internal
controls over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act) occurred during the Company&#8217;s
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over
financial reporting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Attestation Report of the Registered
Public Accounting Firm</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This annual report does not include an attestation report of
our independent registered public accounting firm as the Company is a non-accelerated filer and is thus not required to provide
such a report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_023"></span>ITEM 9B - OTHER INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="a_024"></span>PART III</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_025"></span>ITEM 10 &#8211; DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE
GOVERNANCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Information required by Item 10 is incorporated
by reference from the sections entitled &#8220;Board Matters and Corporate Governance,&#8221; &#8220;Election of Directors,&#8221;
&#8220;Executive Compensation and Other Information,&#8221; and &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221;
in our definitive proxy statement on Schedule 14A to be distributed in connection with our 2020 Annual Shareholders&#8217; Meeting
(the &#8220;Proxy Statement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There have been no material changes to
the procedures by which security holders may recommend nominees to our board of directors since we last described such procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has a Corporate Code of Ethics
which is posted on our website: www.simulations-plus.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_026"></span>ITEM 11 &#8211; EXECUTIVE COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information required by Item 11 is
incorporated by reference from the sections entitled &#8220;Executive Compensation and Other Information&#8221; and &#8220;Board
Matters and Corporate Governance&#8221; in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_027"></span>ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information required by Item 12 is
incorporated by reference from the sections entitled &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221;
and &#8220;Executive Compensation and Other Information&#8221; in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_028"></span>ITEM 13 &#8211; CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS,
AND DIRECTOR INDEPENDENCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information required by Item 13 is
incorporated by reference from the subsection entitled &#8220;Certain Relationships and Related Transactions; Transactions with
Related Persons&#8221; and the section entitled &#8220;Board Matters and Corporate Governance&#8221; in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="a_029"></span>ITEM 14 &#8211; PRINCIPAL ACCOUNTING FEES AND SERVICES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information required by Item 14 is
incorporated by reference from the section of the proposal entitled &#8220;Ratification of Selection of Independent Registered
Public Accounting Firm&#8221; in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="a_030"></span>PART IV</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="a_031"></span>ITEM 15 &#8211; EXHIBITS, FINANCIAL
STATEMENT SCHEDULES </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
Statements. The consolidated financial statements are included in this Annual Report on Form 10-K beginning on page F-1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
Statement Schedules. All financial statement schedules have been omitted since the information is either not applicable or required
or was included in the financial statements or notes included in this Annual Report on Form 10-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;List
of Exhibits required by Item 601 of Regulation S-K. See part (b) below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.
The following exhibits are filed or furnished with this report. Those exhibits marked with a (&#8224;) refer to management contracts
or compensatory plans or arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">EXHIBIT NUMBER</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 89%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">DESCRIPTION</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">2.1 (4)&#94;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000101968714004363/simulations_8ka-ex0201.htm"><span style="font: 10pt Times New Roman, Times, Serif">Agreement and Plan of Merger, dated July 23, 2014, by and among the Company, Cognigen Corporation and the other parties thereto.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">2.2 (12)&#94;</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1023459/000168316820001066/simulations_ex0201.htm"><span style="font-family: Times New Roman, Times, Serif">Share Purchase and Contribution Agreement, dated March 31, 2020</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">3.1 (2)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000101968710004248/simulations_10k-ex0301.htm"><span style="font: 10pt Times New Roman, Times, Serif">Articles of Incorporation of the Company.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">3.2 (2)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000101968710004248/simulations_10k-ex0302.htm"><span style="font: 10pt Times New Roman, Times, Serif">Amended and Restated Bylaws of the Company.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">4.1 (1)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Form of Common Stock Certificate.</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">4.2 (1)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Share Exchange Agreement.</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">4.3(13)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1023459/000168316820001119/simulations_ex0401.htm"><span style="font-family: Times New Roman, Times, Serif">Revolving Line of Credit Note, dated as of March 31, 2020, by and between the Company, as borrower, and Wells Fargo Bank, National Association, as lender.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">4.4(13)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1023459/000168316820001119/simulations_ex0402.htm"><span style="font-family: Times New Roman, Times, Serif">Credit Agreement, dated as of March 31, 2020, by and between the Company, as borrower, and Wells Fargo Bank, National Association, as lender.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.1 (1) (&#8224;)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s 1996 Stock Option Plan and forms of agreements relating thereto. </span><span style="font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.2 (3) (&#8224;)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000101968714001314/slp_10q-ex1003.htm"><span style="font: 10pt Times New Roman, Times, Serif">The Company&#8217;s 2007 Stock Option Plan, as amended. </span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.3 (10)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000168316816000633/simulations_10k-ex1004d.htm"><span style="font: 10pt Times New Roman, Times, Serif">Second Amendment to Lease by and between the Company and Crest Development LLC, dated as of May 1, 2016.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.4 (5) (&#8224;)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000101968716007157/simulations_8k-ex1001.htm"><span style="font: 10pt Times New Roman, Times, Serif">Employment Agreement by and between the Company and Walter S. Woltosz, dated as of August 8, 2016.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.5 (6)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000101968716007142/simulations_8k-ex1001.htm"><span style="font: 10pt Times New Roman, Times, Serif">Form of Indemnification Agreement.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.6 (8)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000168316816001031/simulations_def14a.htm"><span style="font: 10pt Times New Roman, Times, Serif">2017 Equity Incentive Plan.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.7 (7)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000168316817001747/simulations_10q-ex1013.htm"><span style="font: 10pt Times New Roman, Times, Serif">Stock Purchase Agreement by and among Simulation Plus, Inc., DILIsym Services, Inc., The Shareholders&#8217; Representative and The Shareholders of DILIsym Services, Inc., dated as of May 1, 2017. </span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.8 (9)(&#8224;)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000168316817002317/simulations_ex1003.htm"><span style="font: 10pt Times New Roman, Times, Serif">Employment Agreement by and between the Company and Walter S. Woltosz, dated as of September 1, 2017.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.9 (9) (&#8224;)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000168316817002317/simulations_ex1002.htm"><span style="font: 10pt Times New Roman, Times, Serif">Employment Agreement by and between the Company and John DiBella, dated as of September 1, 2017.</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.10 (9) (&#8224;)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000168316817002317/simulations_ex1001.htm"><span style="font: 10pt Times New Roman, Times, Serif">Employment Agreement by and between the Company and Thaddeus H Grasela Jr., dated as of September 2, 2017. </span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.11 (11) (&#8224;)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000168316818001918/simulations_10q-ex1010.htm"><span style="font: 10pt Times New Roman, Times, Serif">Employment Agreement by and between the Company and Shawn O&#8217;Connor dated June 26, 2018</span></a></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">10.12 (14) (&#8224;)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1023459/000168316818001918/simulations_10q-ex1010.htm"><span style="font: 10pt Times New Roman, Times, Serif">Employment Agreement by and between the Company and Shawn O&#8217;Connor dated September 3, 2020</span></a></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif">21.1 *</span></td>
    <td style="vertical-align: bottom; width: 1%">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify; width: 89%"><span style="font: 10pt Times New Roman, Times, Serif"><a href="simulations_ex2101.htm">List of Subsidiaries.</a></span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">23.1 *</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="simulations_ex2301.htm">Consent of Independent Registered Public Accounting Firm.</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">31.1 *</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="simulations_ex3101.htm">Section 302 &#8211; Certification of the Principal Executive Officer.</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">31.2 *</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="simulations_ex3102.htm">Section 302 &#8211; Certification of the Principal Financial Officer.</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">32.1 *</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="simulations_ex3201.htm">Section 906 &#8211; Certification of the Chief Executive Office and Chief Financial Officer.</a></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">101.INS **</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Instance Document.</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">101.SCH **</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Schema Document.</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">101.CAL **</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">101.DEF **</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
<tr>
    <td style="vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">101.LAB **</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">101.PRE **</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;__________________________</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 10%"><span style="font: 10pt Times New Roman, Times, Serif">&#94;</span></td>
    <td style="width: 90%"><span style="font: 10pt Times New Roman, Times, Serif">Schedules and exhibits omitted pursuant to Item 601(b)(2) of Registration S-K. The registrant agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">*</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Filed herewith.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">** </span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">The XBRL related information in Exhibit 101 shall not be deemed filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(&#8224;)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Refers to management contracts or compensatory plans or arrangements</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(1)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to the Company&#8217;s Registration Statement on Form SB-2 (Registration No. 333-6680) filed on March 25, 1997. </span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(2)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 10-K for the fiscal year ended August 31, 2010.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(3)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 10-Q filed April 9, 2014.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(4)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 8-K/A filed November 18, 2014.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(5) </span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 8-K filed August 11, 2016.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(6)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 8-K filed August 10, 2016.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(7)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 10-Q filed July 10, 2017.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(8)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to Appendix A to the Company&#8217;s Schedule 14A filed December 29. 2016.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(9)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 8-K filed September 6, 2017.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(10)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 10-K for the fiscal year ended August 31, 2016.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(11)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 10-Q filed July 10, 2018.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(12)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 8-K filed April 2, 2020.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(13)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 8-K filed April 3, 2020.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">(14)</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Incorporated by reference to an exhibit to the Company&#8217;s Form 8-K filed September 9, 2020.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
Statement Schedule.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See Item 15(a)(2) above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_032"></span>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of Section
13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">November 16, 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif"><b>SIMULATIONS PLUS, INC.</b></span></td></tr>
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
<tr>
    <td style="vertical-align: top; width: 53%">&#160;</td>
    <td style="width: 1%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;By:</span></td>
    <td style="vertical-align: top; width: 46%"><span style="font: 10pt Times New Roman, Times, Serif">/s/ John R. Kneisel</span></td></tr>
<tr>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td>
    <td style="border-top: black 1pt solid; vertical-align: top"><span style="font: 10pt Times New Roman, Times, Serif">John R. Kneisel<br />
Chief Financial Officer</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">Signature</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Title</span></td></tr>
<tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 40%; text-align: center">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 50%; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Shawn O&#8217;Connor</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer (Principal executive officer)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Shawn O&#8217;Connor</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">November 16, 2020</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Walter S. Woltosz</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Chairman of the Board of Directors</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Walter S. Woltosz</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">November 16, 2020</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Dr. Lisa LaVange</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Director</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Dr. Lisa LaVange</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">November 16, 2020</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Dr. Daniel Weiner</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Director</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Dr. Daniel Weiner</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">November 16, 2020</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Dr. David L. Ralph</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Director</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Dr. David L. Ralph</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">November 16, 2020</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Dr. John K. Paglia</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Director</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Dr. John K. Paglia</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">November 16, 2020</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">/s/ John R. Kneisel</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer (Principal financial</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">John R. Kneisel</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">officer and principal accounting officer)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">November 16, 2020</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>SIMULATIONS PLUS, INC. &amp; SUBSIDIARY
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>August 31, 2020, 2019 and 2018</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 90%; text-align: justify">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 10%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Page</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><a href="#a_001">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></b></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">F-2</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>FINANCIAL STATEMENTS</b></span></td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_002">Consolidated Balance Sheets</a></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">F-3</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#IS">Consolidated Statements of Operations and Comprehensive Income</a></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">F-4</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_004">Consolidated Statements of Shareholders&#8217; Equity</a></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">F-5</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_005">Consolidated Statements of Cash Flows</a></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">F-6</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><a href="#a_006">Notes to Consolidated Financial Statements</a></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">F-7 &#8211; F-31</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 56; Options: NewSection -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_001"></span>REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Board of Directors and<br />
Stockholders of Simulations Plus, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying consolidated
balance sheets of Simulations Plus, Inc. and subsidiaries (the Company) as of August 31, 2020 and 2019, and the related consolidated
statements of operations and comprehensive income, shareholders&#8217; equity, and cash flows for each of the years in the three-year
period ended August 31, 2020, and the related notes (collectively referred to as the financial statements). In our opinion, the
consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company
as of August 31, 2020 and 2019, and the consolidated results of its operations and its cash flows for each of the years in the
three-year period ended August 31, 2020, in conformity with accounting principles generally accepted in the United States of America.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for Opinion</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws
and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with
the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether
the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have,
nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required
to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the
effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures
to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe
that our audits provide a reasonable basis for our opinion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Rose, Snyder &amp; Jacobs LLP</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rose, Snyder &amp; Jacobs LLP</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&#8217;s auditor since 2004.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Encino, California</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 16, 2020</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>SIMULATIONS PLUS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><span id="a_002"></span>CONSOLIDATED BALANCE SHEETS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>As of August 31,</b></p>


















































































<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="border-bottom: Black 1.5pt solid; width: 100%">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_302_111_zfJ9jbttg9Pb" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49D_20200831_zDSLXzkpkwtb" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20190831_z4FvZWo1FSUk" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--AssetsCurrentAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_pp0p0_maACzcXE_zudlZHBvtAHf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; width: 66%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,207,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,435,499</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_i01I_pp0p0_maACzcXE_zK8D4jkdcNr1" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable, net of allowance for doubtful accounts of $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_c20200831_pp0p0" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_c20190831_pp0p0" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,421,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,026,558</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_i01I_pp0p0_maACzcXE_zlvbIzYOqPu8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Revenues in excess of billings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,093,343</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,233,659</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--PrepaidTaxes_i01I_pp0p0_maACzcXE_zCocG6UgXQ53" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">969,688</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidTaxes" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">765,110</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_pp0p0_maACzcXE_zNixAiEW6WJ6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,595,447</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">704,316</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--ShortTermInvestments_i01I_pp0p0_d0_maACzcXE_zlBQ6ecDRUmh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Short-term investments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,803,595</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AssetsCurrent_iTI_pp0p0_mtACzcXE_maAzmMi_zJalwx0i3108" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 20pt; text-align: left">Total current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">129,091,357</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,165,142</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--AssetsNoncurrentAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Long-term assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--CapitalizedComputerSoftwareNet_i01I_pp0p0_maAzmMi_zuZRc8CnunL3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Capitalized computer software development costs, net of accumulated amortization of $<span id="xdx_909_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_c20200831_pp0p0" title="Accumulated amortization of computer software development costs"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,581,599</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--CapitalizedComputerSoftwareAccumulatedAmortization_c20190831_pp0p0" title="Accumulated amortization of computer software development costs"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,356,055</ix:nonFraction></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareNet" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,087,378</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareNet" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,959,736</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentNet_i01I_pp0p0_maAzmMi_zbuLZuWGzxo" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net (note 4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">437,787</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">341,145</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_pp0p0_d0_maAzmMi_ziwMLoSBfpb8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Operating lease right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">926,600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_pp0p0_maAzmMi_zBvTz6eXCch5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Intellectual property, net of accumulated amortization of $<span id="xdx_900_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Accumulated amortization on intangible assets"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,087,031</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Accumulated amortization on intangible assets"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,948,750</ix:nonFraction></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,897,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,026,249</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsNet_i01I_pp0p0_maAzmMi_zrnnWcLuGX93" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Other intangible assets net of accumulated amortization of $<span title="Accumulated amortization on intangible assets"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zAiB1MYNo8Rf"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,641,725</ix:nonFraction></span></span> and $<span title="Accumulated amortization on intangible assets"><span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zldKhPKZhYAd"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,210,000</ix:nonFraction></span></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,008,275</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,280,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--Goodwill_i01I_pp0p0_maAzmMi_z9w898r5ahmj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,921,185</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,387,198</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OtherAssetsNoncurrent_i01I_pp0p0_maAzmMi_z5bDKFdf6BP6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,965</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,227</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--Assets_iTI_pp0p0_mtAzmMi_z1pjMYm7sIg3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">168,421,517</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,196,697</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: center">LIABILITIES AND SHAREHOLDERS' EQUITY</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--AccountsPayableCurrent_i02I_pp0p0_maLCzof8_ze6b67Keyf25" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">349,939</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">204,075</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--EmployeeRelatedLiabilitiesCurrent_i02I_pp0p0_maLCzof8_zD8Y8wQhIiyg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accrued payroll and other expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,250,692</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,639,038</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_ecustom--ContractsPayableCurrent_i02I_pp0p0_maLCzof8_zKdIaF2pSvGe" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Current portion - Contracts payable (note 6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="simu:ContractsPayableCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="simu:ContractsPayableCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--BillingsInExcessOfCost_i02I_pp0p0_maLCzof8_znxydThQyHhg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Billings in excess of revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BillingsInExcessOfCost" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,991</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BillingsInExcessOfCost" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">798,549</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_pp0p0_d0_maLCzof8_zsoF9g70sHpa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating Lease Liability, current portion</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">463,465</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--ContractWithCustomerLiabilityCurrent_i02I_pp0p0_maLCzof8_z8QBkwenlXF8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Deferred revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">299,482</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">380,787</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--LiabilitiesCurrent_i02TI_pp0p0_mtLCzof8_maLzsNl_maLzxJS_z687Xg5xXLvh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,504,569</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,783,477</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--LiabilitiesNoncurrentAbstract_i01B" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Long-term liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i02I_maLzxJS_zKtFmUF8GYu6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Deferred income taxes, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,353,858</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilitiesNet" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,731,616</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_pp0p0_d0_maLzsNl_maLzxJS_zHMTL48zyyd9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Operating Lease Liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">463,312</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_ecustom--ContractsPayableNoncurrent_i02I_pp0p0_d0_maLzsNl_maLzxJS_zpqJGasw78O5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Payments due under Contracts payable (note 6)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="simu:ContractsPayableNoncurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,063,833</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="simu:ContractsPayableNoncurrent" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--Liabilities_i01TI_pp0p0_maLASEzxX2_mtLzxJS_zCn5eKJxzpV9" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left">Total liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,385,572</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,515,093</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--CommitmentsAndContingencies_iI_pp0p0_dn_zS0PXV0vKC08" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Commitments and Contingencies (note 7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0154">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0155">&#8211;</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--StockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shareholders' equity (note 8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--PreferredStockValue_i01I_pp0p0_d0_maSEzJE8_zDZ0CsxtBDLg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Preferred stock, $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20200831_zIJ40rzcsPQh" title="Preferred stock par value"><span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20190831_zgiGy5TCkXhj" title="Preferred stock par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20200831_zpoNIADertBi" title="Preferred stock, shares authorized"><span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20190831_zM3Iv5V3CFYb" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_do_c20200831_zR5h5e0vpn6c" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_do_c20190831_z5fWEsBhZNXg" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20190831_zB3kCY7JmB71" title="Preferred stock, shares outstanding"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20200831_ziBchu3Xtogi" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2020-08-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2019-08-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2019-08-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2020-08-31" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2020-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--CommonStockValue_i01I_pp0p0_maSEzJE8_zWDIYyluZZD5" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Common stock, $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20200831_zN3UuuR5g3R8" title="Common stock par value"><span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20190831_zu2Gh2TXCLnf" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20200831_zcPYDHDu934k" title="Common stock shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20190831_zbvz5v037W4c" title="Common stock shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20200831_zCSdz3eeRgN1" title="Common stock shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20200831_z2UuH8L5MVIk" title="Common stock shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,923,277</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20190831_z2Bk8Rt3Kcw5" title="Common stock shares outstanding"><span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_c20190831_z3eq0hxcTIA8" title="Common stock shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,591,834</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,926</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,595</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AdditionalPaidInCapital_i01I_pp0p0_maSEzJE8_zX0yu9lhAmzc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Additional paid-in capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,531,427</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,319,474</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i01I_pp0p0_d0_maSEzJE8_ztNZsi3V40ma" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accumulated Other Comprehensive Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,467</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--RetainedEarningsAccumulatedDeficit_i01I_pp0p0_maSEzJE8_zRW5P0uKD8i" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Retained earnings</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,436,125</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,354,535</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--StockholdersEquity_i01TI_pp0p0_mtSEzJE8_maLASEzxX2_z2XKLc43GHqk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total shareholders' equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,035,945</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">37,681,604</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_pp0p0_mtLASEzxX2_zFFjudP2zHMd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and shareholders' equity</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">168,421,517</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,196,697</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<!-- Field: Page; Sequence: 58 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>SIMULATIONS PLUS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><span id="IS"></span>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>For the years ended August 31,</b></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="border-bottom: Black 1.5pt solid; width: 100%">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_113_zL91RhByhK3d" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20190901__20200831_zhqazkjMWI14" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20180901__20190831_z1cobeTjnyHi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20170901__20180831_zqqVu3F9cab5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--Revenues_maGPz3yN_zY7IOo6DdUR2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; font-weight: bold">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,589,084</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,970,440</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,666,524</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CostOfRevenue_msGPz3yN_zt0KWR8Jnk68" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1pt">Cost of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,649,230</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,025,704</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,994,228</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--GrossProfit_iT_pp0p0_mtGPz3yN_maOILzvdO_zCZxaU86JiA6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross margin</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,939,854</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">24,944,736</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,672,296</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Operating expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_pp0p0_maOEznAD_zjJeYv10Upsk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Selling, general, and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,360,053</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,796,027</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,583,852</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ResearchAndDevelopmentExpense_i01_pp0p0_maOEznAD_zqzOZe6Lo8cb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Research and development</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,974,623</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,499,980</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,790,656</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingExpenses_i01T_pp0p0_mtOEznAD_msOILzvdO_zahGSYMJIjhd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total operating expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,334,676</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,296,007</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,374,508</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingIncomeLoss_i01T_pp0p0_mtOILzvdO_maILFCOzmEN_zRFiWHMMISOl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Income from operations</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,605,178</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,648,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,297,788</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--OtherIncomeAndExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--InterestIncomeOperating_i01_pp0p0_maNIEzCwh_zxfyD9Qvu0X4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Interest income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOperating" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,468</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOperating" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,522</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOperating" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,122</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_ecustom--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability_i01N_pp0p0_di_msNIEzCwh_zycUtYulNXhi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Change in value of contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,500</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">109,078</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">153,034</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_i01_pp0p0_maNIEzCwh_zei26Jznh57" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">(Loss) income on currency exchange</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">45,097</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">16,697</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">32,934</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_mtNIEzCwh_maILFCOzmEN_zW4zvcmd6xs5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total other income (expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">218,129</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">92,253</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">158,846</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_i01T_pp0p0_mtILFCOzmEN_maNILzyyf_z0fonk9Onbb2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Income before provision for income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,387,049</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,556,476</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,138,942</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_i01N_pp0p0_di_msNILzyyf_zxeNLCfl1RU" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Provision for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,054,989</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,973,147</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,204,130</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_401_eus-gaap--NetIncomeLoss_i01T_pp0p0_mtNILzyyf_maCINOTzB1d_zcJmZZNQJld2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Income</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,332,060</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,583,329</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,934,812</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Earnings per share</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--EarningsPerShareBasic_i01_pii" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Basic</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.52</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.49</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.52</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EarningsPerShareDiluted_i01_pii" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Diluted</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.48</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.50</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Weighted-average common shares outstanding</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pii" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt">Basic</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,819,064</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,492,258</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,328,707</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pii" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Diluted</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,538,373</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,057,431</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,860,392</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ComprehensiveIncomeNetOfTaxAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Other Comprehensive Income, net of tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_i01_pp0p0_d0_maCINOTzB1d_zx9UNAnPoy27" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Foreign currency translation adjustments</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">58,467</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ComprehensiveIncomeNetOfTax_i01_pp0p0_d0_zG1crTlpB0X5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Comprehensive Income </td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,390,527</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 26.3pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>SIMULATIONS PLUS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><span id="a_004"></span>CONSOLIDATED
STATEMENTS OF SHAREHOLDERS' EQUITY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>For the years ended August 31, 2020, 2019 and 2018</b></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="border-bottom: Black 1.5pt solid; width: 100%">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<table cellpadding="0" cellspacing="0" id="xdx_306_114_ze73kO7z1w25" summary="xdx: Statement - STATEMENTS OF SHAREHOLDERS&apos; EQUITY" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z2ikXBLHoU79" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zvyVMFlIREX3" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_ztqnIzUffZVj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zD1w6sJCN9jl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td id="xdx_4B2_zs7QIQR7djli" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Additional</td><td>&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">Accumulated Other</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">Paid-In</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="padding-bottom: 1pt; text-align: center">Comprehensive</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">Retained</td><td style="padding-bottom: 1pt">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Capital</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Earnings</td><td style="padding-bottom: 1pt">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Total</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: 400; font-style: normal">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="3">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr id="xdx_435_c20170901__20180831_eus-gaap--StockholdersEquity_iS_zZreMz2dYbl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; font-weight: bold; padding-bottom: 1pt">Balance, August 31, 2017</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iS_c20170901__20180831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ6bcW2yzibi" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; width: 9%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2017-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,277,604</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2017-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,278</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2017-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,109,141</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0315">&#8211;</span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2017-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,688,468</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; width: 9%">$<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2017-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,804,887</ix:nonFraction></td>
    <td style="width: 1%">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_d0_zDDxKmEhq3e8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20170901__20180831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcTfHHnEB0e4" title="Exercise of stock options, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">130,006</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635,452</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635,583</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_zLBBstt1ta59" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Stock-based Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0329">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">562,078</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0331">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0332">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">562,078</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_d0_zRQ0ebE9DjD9" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Shares issued to Directors for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20170901__20180831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zD4QvOFtOial" title="Shares issued to Directors for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,835</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">146,997</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">147,005</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DividendsCash_iN_pp0p0_di_zSm2NpMT1TT" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Declaration of Dividend</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0343">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0344">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0345">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,161,740</ix:nonFraction></td><td style="text-align: left">)</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,161,740</ix:nonFraction></td>
    <td>)</td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0349">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0351">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,934,812</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,934,812</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_43F_c20180901__20190831_eus-gaap--StockholdersEquity_iS_d0_zG10bY3lEhK7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance, August 31, 2018</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_c20180901__20190831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEihzGkq5xSg" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2018-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,416,445</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,417</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,453,668</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,461,540</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">$<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,922,625</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_403_ecustom--CumulativeEffectOfChangesRelatedToAdoptionOfAsc606_zDjGcco6CEVi" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -5pt; padding-left: 5pt; font-weight: bold; text-align: left">Cumulative Effect of Changes related to adoption of ASC 606</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0363">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0364">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0365">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">493,279</ix:nonFraction></td><td style="text-align: left">)</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">(<ix:nonFraction name="simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">493,279</ix:nonFraction></td>
    <td>)</td></tr>
<tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zcmTOYANhDx4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20180901__20190831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEvAc6ROsrce" title="Exercise of stock options, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">166,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">787,979</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0371">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0372">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">788,147</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_zmOGKaZhbzD" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stock-based Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">865,848</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0379">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0380">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">865,848</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_d0_z8XiGOcIwTH4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Shares issued to Directors for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20180901__20190831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4b9e2r6gD32" title="Shares issued to Directors for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,686</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,979</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">211,989</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--DividendsCash_iN_pp0p0_di_zcPOXWlXdun6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Declaration of Dividend</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0391">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0392">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0393">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,197,055</ix:nonFraction></td><td style="text-align: left">)</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,197,055</ix:nonFraction></td>
    <td>)</td></tr>
<tr id="xdx_401_eus-gaap--NetIncomeLoss_zNDNwk9vF9l8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0397">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0398">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,583,329</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,583,329</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_432_c20190901__20200831_eus-gaap--StockholdersEquity_iS_d0_zsW2U1TM57el" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Balance, August 31, 2019</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_c20190901__20200831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBntrcXjq3nj" title="Beginning balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2019-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,591,834</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,595</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,319,474</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,354,535</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">$<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,681,604</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zCU5VzEgvqH" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20190901__20200831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXQ5qJTxpCNd" title="Exercise of stock options, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">121,647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">629,626</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0414">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">629,747</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_409_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_zmvfFNx6mJC5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stock-based Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0419">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,286,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0421">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,286,625</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zsTXUT98GI8f" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Shares issued to Directors for services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20190901__20200831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zb2EbS7iqO9c" title="Shares issued to Directors for services, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,205</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289,893</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0427">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0428">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">289,900</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_407_eus-gaap--DividendsCash_iN_pp0p0_di_zEongCaiUtA1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Declaration of Dividend</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0433">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0434">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0435">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,250,470</ix:nonFraction></td><td style="text-align: left">)</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsCash" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,250,470</ix:nonFraction></td>
    <td>)</td></tr>
<tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_zwYPRdNOlUE5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold">Shares issued - Lixoft</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20190901__20200831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9FHUpik6Ps1" title="Shares issued - Lixoft, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">111,682</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">112</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,260,562</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0441">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0442">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,260,674</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_ze2o6iQgQGHe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Common stock issued for cash, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190901__20200831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQpkMFuT1Zsj" title="Common stock issued for cash, net, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,090,909</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,091</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,745,247</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0449">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0450">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,747,338</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_z3wduG5tk9Id" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -5pt; padding-left: 5pt; font-weight: bold; text-align: left">Foreign Currency Translation Adjustments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#8211;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,467</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0458">&#8211;</span></td><td style="text-align: left">&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right"><ix:nonFraction name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,467</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_403_eus-gaap--NetIncomeLoss_zAJaYk8DcYT8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0461">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0462">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0463">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,332,060</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,332,060</ix:nonFraction></td>
    <td>&#160;</td></tr>
<tr id="xdx_43F_c20190901__20200831_eus-gaap--StockholdersEquity_iE_zmjCYcm758Oj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_c20190901__20200831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgFTK6hWxbw5" title="Ending balance, shares" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,923,277</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,926</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">128,531,427</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">58,467</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,436,125</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">$<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">156,035,945</ix:nonFraction></td>
    <td>&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>SIMULATIONS PLUS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><span id="a_005"></span>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>For the years ended August 31, 2020, 2019 and 2018</b></p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="border-bottom: Black 1.5pt solid; width: 100%">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_303_zbp8Fo6Oihp4" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20190901__20200831_zLtqwhe4Tmcj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49D_20180901__20190831_zwFQtr0zNjLg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20170901__20180831_zfqZmOGsB9bl" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zycDHpkqDUCj" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Cash flows from operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--NetIncomeLoss_i01_maCzEoM_z1bTGgs2gBN5" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left">Net income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,332,060</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,583,329</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,934,812</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zBEmBXgz6zt1" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Adjustments to reconcile net income to net cash provided by operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DepreciationAndAmortization_i01_maCzEoM_zXa5m8Ep8hkh" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,961,930</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,750,245</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,721,304</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_i01_maCzEoM_zU8sl8HOEqY9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Change in value of contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">202,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109,060</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,752</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--ShareBasedCompensation_i01_maCzEoM_zQQXDuQtY2je" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,576,525</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,077,837</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">709,083</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--IncreaseDecreaseInDeferredIncomeTaxes_i01N_di_msCzEoM_zkcYQ8xvH7w" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Deferred income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">377,759</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">299,096</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,731,821</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_iB_zip7FDjRnuSf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">(Increase) decrease in</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzEoM_zFhkIm0w9sm7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,017,792</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">487,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,465,803</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_eus-gaap--IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_i01N_di_msCzEoM_z5VjHiFjRBgk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Revenues in excess of billings</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">140,316</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,248,063</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">504,514</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_408_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msCzEoM_zKyX2w9EJaqd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Prepaid income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,380</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">452,517</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">149,850</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i01N_di_msCzEoM_zVHLBBeOTmM2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">398,213</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,877</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">153,682</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_iB_zwmrly62APe8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Increase (decrease) in</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maCzEoM_zsINrxOGjDzc" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,584</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">147,529</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,713</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--IncreaseDecreaseInEmployeeRelatedLiabilities_i01_maCzEoM_z88Zxc5wShQ3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accrued payroll and other expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,030</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">486,862</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168,883</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--IncreaseDecreaseInBillingInExcessOfCostOfEarnings_i01_maCzEoM_zxlPI1Df20t7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Billings in excess of revenues</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">657,558</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">413,946</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,645</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccruedIncomeTaxesPayable_i01_d0_maCzEoM_zjeZbXJGJwF2" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Accrued income taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2019-09-01to2020-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--IncreaseDecreaseInDeferredRevenue_i01_maCzEoM_zpofEVrrOUk8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Deferred revenue</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">81,305</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,747</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,966</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_mtCzEoM_maCzn0A_zPGqqeFhUZLe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Net cash provided by operating activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,911,938</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,638,420</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,287,188</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z4pyYiyhhI3k" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Cash flows used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCz5wh_zbl0LbFgFcfd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Purchases of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">231,380</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">137,745</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">183,291</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di0_msCz5wh_zpc3yTF1TkVd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Purchases of intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2019-09-01to2020-08-31" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--PaymentsToAcquireShortTermInvestments_i01N_di0_msCz5wh_zshqkdovMPhj" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Purchase of short-term investments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,248,924</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireShortTermInvestments" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--PaymentsToAcquireInterestInSubsidiariesAndAffiliates_i01N_di0_msCz5wh_zZ3vftpTl6Dl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Cash used to acquire subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,471,352</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--CashAcquiredFromAcquisition_i01_d0_maCz5wh_zVEuWlfxu6Wa" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Cash received in acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,799,134</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAcquiredFromAcquisition" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--PaymentsToDevelopSoftware_i01N_di_msCz5wh_zdTVFsih2IQ5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Capitalized computer software development costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToDevelopSoftware" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,353,188</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToDevelopSoftware" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,767,996</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToDevelopSoftware" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,145,429</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtCz5wh_maCzn0A_zZ4Vcr94Cfne" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net cash used in investing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">75,505,710</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,955,741</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,328,720</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zGWOuM5yIERd" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Cash flows provided by (used in) financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--PaymentsOfDividends_i01N_di_msCzPPj_zXYhA8wTmIa5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Payment of dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,250,470</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,197,055</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividends" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,161,740</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40B_ecustom--PaymentsOnContractsPayable_i01N_di_msCzPPj_z5rdkQoAjSqb" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Payments on contracts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="simu:PaymentsOnContractsPayable" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="simu:PaymentsOnContractsPayable" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,238,973</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="simu:PaymentsOnContractsPayable" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,328</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--ProceedsFromStockOptionsExercised_i01_maCzPPj_z6a4uSU0805j" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left">Proceeds from the exercise of stock options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">629,747</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">788,147</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">635,583</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i01_d0_maCzPPj_zeFVT0OrSY45" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Proceeds from follow-on public offering, net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,747,338</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtCzPPj_maCzn0A_zS8B9R9YBWrf" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,365,587</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,647,881</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,773,485</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--CashAndCashEquivalentsPeriodIncreaseDecrease_iT_mtCzn0A_zmHZME9zmtEi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Net increase in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,771,815</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,034,798</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,184,983</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iS_z77CG0ID1SLh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Cash and cash equivalents, beginning of year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,435,499</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,400,701</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2017-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,215,718</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iE_zme7VU1QSHb5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents, end of period</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">49,207,314</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,435,499</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,400,701</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--SupplementalCashFlowInformationAbstract_iB_znVEAfmtxzCd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left">Supplemental disclosures of cash flow information</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--IncomeTaxesPaid_i01_z506IsBVTMf2" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Income taxes paid</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,352,770</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,673,475</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,712,988</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zSOjGo4Lqc1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non-Cash Investing and Financing Activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--StockIssuedForAcquisitionOfLixoft_i01_d0_z3qZbHc5iTa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Stock issued for acquisition of Lixoft</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:StockIssuedForAcquisitionOfLixoft" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,260,674</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:StockIssuedForAcquisitionOfLixoft" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:StockIssuedForAcquisitionOfLixoft" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--LiabilitiesAssumed1_i01_d0_zZDD3oRNMink" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Creation of contract liabilities for acquisition of subsidiaries</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAssumed1" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,528,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAssumed1" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAssumed1" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_ecustom--RightOfUseAssetsCapitalized_i01_d0_zrtXw4RSZ2Rd" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Right of use assets capitalized</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:RightOfUseAssetsCapitalized" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,498,542</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:RightOfUseAssetsCapitalized" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:RightOfUseAssetsCapitalized" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part
of these consolidated financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Simulations Plus, Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a_006"></span>Notes to Financial Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Year Ended August 31, 2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_809_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zTK5N3T9EHLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - <span id="xdx_821_zFrbVCeK9iF9">ORGANIZATION AND LINES OF BUSINESS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Organization</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulations Plus, Inc. (&#8220;Simulations
Plus&#8221;, &#8220;Lancaster&#8221;) was incorporated on July 17, 1996. In September 2014, Simulations Plus acquired all of the
outstanding equity interests of Cognigen Corporation (&#8220;Cognigen&#8221;, &#8220;Buffalo&#8221;) and Cognigen became a wholly
owned subsidiary of Simulations Plus, Inc. In June 2017, Simulations Plus acquired DILIsym Services, Inc. (DILIsym) as a wholly
owned subsidiary. In April 2020, Simulations Plus, Inc. acquired Lixoft, a French soci&#233;t&#233; par actions simplifi&#233;e
(&#8220;Lixoft&#8221;, &#8220;Paris&#8221;) as a wholly-owned subsidiary pursuant to a stock purchase and contribution agreement.
(Collectively, &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Lines of Business</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company designs and develops pharmaceutical
simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education
of pharmacy and medical students, and it provides consulting services to the pharmaceutical and chemical industries. Recently,
the Company has begun to explore developing software applications for defense and for health care outside of the pharmaceutical
industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zspAg91dKTGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 - <span id="xdx_82C_zk26ltINtj87">SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zLeqCyNdEKae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Principles of Consolidation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the accounts of Simulations Plus, Inc. and, as of September 2, 2014, its wholly owned subsidiary, Cognigen Corporation, as of June
1, 2017, the accounts of DILIsym Services, Inc., and as of April 1, 2020, Lixoft accounts. All significant intercompany accounts
and transactions are eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_84A_eus-gaap--UseOfEstimates_z01cKeDwoRV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Use of Estimates</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial statements and accompanying
notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial
statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue,
and expenses. These estimates and assumptions are affected by management&#8217;s application of accounting policies. Actual results
could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized
computer software development costs, valuation of stock options, and accounting for income taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zyPHw0BDcvE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Reclassifications</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain numbers in the prior year have
been reclassified to conform to the current year's presentation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_z3lyisFPeqe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Revenue Recognition</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In May 2014, the
Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding
Accounting Standards Codification Topic 606 (ASC Topic 606), <i>Revenue from Contracts with Customers</i>. The standard provides
principles for recognizing revenue for the transfer of promised goods or services to customers with the consideration to which
the entity expects to be entitled in exchange for those goods or services. The standard also provides guidance on the recognition
of incremental costs related to obtaining customer contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing
the modified retrospective method. This approach was applied to contracts that were in process as of September 1, 2018, and the
corresponding incremental costs of obtaining those contracts, which resulted in a cumulative effect adjustment of $493,279 to the
opening balance of retained earnings at the date of adoption. The adoption of this ASU primarily impacts the timing of our revenue
recognition for certain sales contracts, the capitalization and amortization of incremental costs of obtaining a contract, and
related disclosures. The reported results for fiscal years 2020 and 2019 reflect the application of ASC Topic 606, while the reported
results for fiscal year 2018 are not adjusted and continue to be reported under ASC Topic 605.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_237_zvIzLckrKIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zZTcEGMFGgv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zMJllEYQQDS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 62 -->
    <div id="xdx_230_zIxJiWDNFcn3" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23F_z7jzKHkKPP4a" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td id="xdx_23C_zxFkQAjOl07d" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_236_zQ7S2XHiNTn7" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_zYBfDr1ADZR3" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zuqfvNt4DQq6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines revenue recognition
through the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td>
    <td style="width: 95%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the contract, or contracts, with a customer</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Determination of the transaction price</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Recognition of revenue when, or as, the Company satisfies a performance obligation</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Deferred Commissions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales commissions earned by our sales force
and our commissioned sales representatives are considered incremental and recoverable costs of obtaining a contract with a customer.
Sales commissions for new contracts are deferred and then amortized on a straight-line basis over a period of benefit. We determined
the period of benefit by taking into consideration our customer contracts, our technology and other factors. Sales commissions
for renewal contracts are deferred and then amortized on a straight-line basis over the related contractual renewal period. Amortization
expense is included in sales and marketing expenses on the condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We apply the practical expedient in ASC
Topic 606 to expense costs as incurred for sales commissions when the period of benefit would have been one year or less. Most
of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with
them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Practical Expedients and Exemptions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has elected the following additional
practical expedients in applying Topic 606:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Commission Expense</i></b>: We apply the practical expedient in ASC Topic 606 to expense costs as incurred for sales commissions when the period of benefit is one year or less. Most of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with them<i>.</i></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: bottom">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Transaction Price Allocated to Future
        Performance Obligations</i></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 606 requires that the Company disclose
        the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of August
        31, 2020. ASC 606 provides certain practical expedients that limit the requirement to disclose the aggregate amount of transaction
        price allocated to unsatisfied performance obligations.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applied the practical expedient
        to not disclose the amount of transaction price allocated to unsatisfied performance obligations when the performance obligation
        is part of a contract that has an original expected duration of one year or less.</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z42PwMyYxHjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Cash and Cash Equivalents </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of the statements of cash
flows, the Company considers all highly liquid investments purchased with original maturities of three months or less to be cash
equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_84E_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zBcFHT8No2Ja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Accounts Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We analyze the age of customer balances,
historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability
of the Company&#8217;s trade accounts receivable balances. If we determine that the financial conditions of any of our customers
have deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts
receivable are written off when all collection attempts have failed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23F_zaWoF0xu6Dag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_235_zXYWMQORHtMa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_z04rytqr77p9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 63 -->
    <div id="xdx_232_zf0E14kZf8Eh" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_231_zw90rxtMrk9a" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td id="xdx_23C_z3Et9AWPyvl4" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_238_z94H8YeiF2v3" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zE420lpqqESg" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_z1LrtrUdLym3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:InvestmentPolicyTextBlock"><p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_z91iV48QM9Hj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Investments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may invest excess cash balances in short-term
and long-term marketable debt securities. Investments may consist of certificates of deposit, money market accounts, government-sponsored
enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities
in accordance with FASB ASC 320, Investments &#8211; Debt and Equity Securities. This statement requires debt securities to be
classified into three categories:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Held-to-maturity&#8212;Debt securities
that the entity has the positive intent and ability to hold to maturity are reported at amortized cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trading Securities&#8212;Debt securities
that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains
and losses included in earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Available-for-Sale&#8212;Debt securities
not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or
losses excluded from earnings and reported as a separate component of shareholders&#8217; equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company classifies its investments
in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. During the
years ended August 31, 2020, all of the Company&#8217;s investments were classified as held-to-maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Held-to-maturity investments are measured
and recorded at amortized cost on the Company&#8217;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt
securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities
are realized until they are sold or a decline in fair value is determined to be other-than-temporary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"><p id="xdx_847_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zs3HpkzXLr74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Capitalized Computer Software Development
Costs</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Software development costs are capitalized
in accordance with ASC 985-20, <i>&#8220;Costs of Software to Be Sold, Leased, or Marketed&#8221;</i>. Capitalization of software
development costs begins upon the establishment of technological feasibility and is discontinued when the product is available
for sale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The establishment of technological feasibility
and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management
with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues,
estimated economic life, and changes in software and hardware technologies. Capitalized computer software development costs are
comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in the Company's
software products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization of capitalized computer software
development costs is provided on a product-by-product basis on the straight-line method over the estimated economic life of the
products not to exceed five years. Amortization of software development costs amounted to $<span id="xdx_908_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20190901__20200831_pp0p0" title="Amortization of software development"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAmortization1" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,225,544</ix:nonFraction></span>, $<span id="xdx_901_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20180901__20190831_pp0p0" title="Amortization of software development"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAmortization1" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,331,753</ix:nonFraction></span>, and $<span id="xdx_90F_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20170901__20180831_pp0p0" title="Amortization of software development"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareAmortization1" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,300,434</ix:nonFraction></span>
for the years ended August 31, 2020, 2019, and 2018, respectively. We expect future amortization expense to vary due to increases
in capitalized computer software development costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We test capitalized computer software development
costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zuOp5O4a3s8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Property and Equipment</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are recorded at
cost, or fair market value for property and equipment acquired in business combinations, less accumulated depreciation and amortization.
Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="simu:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_89E_ecustom--PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z57BwBKBd17j" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zId55k5a3xZf" style="display: none">Property and Equipment estimated useful lives</span></td>
    <td>&#160;</td>
    <td id="xdx_49F_20190901__20200831_zRnKl9OntJp7" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment</span></td>
    <td style="width: 4%">&#160;</td>
    <td title="Estimated useful lives" style="width: 47%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zSJ94LMI3jW2"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_EquipmentMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">5 years</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Computer equipment</span></td>
    <td>&#160;</td>
    <td title="Estimated useful lives" style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zxYSFSHDCa2i"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_ComputerEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">3 to 7 years</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</span></td>
    <td>&#160;</td>
    <td title="Estimated useful lives" style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdwfRk2MRXo4"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_FurnitureAndFixturesMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">5 to 7 years</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</span></td>
    <td>&#160;</td>
    <td title="Estimated useful lives" style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zZ7hPNG6YRb3"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_LeaseholdImprovementsMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">Shorter of life of asset or lease</ix:nonNumeric></span></span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8A5_zoCoFxYwtNn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maintenance and minor replacements are
charged to expense as incurred. Gains and losses on disposals are included in the results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_239_zgyhqmDhpdL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zNGdrWi1HkEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zJtwS77gUzvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 64 -->
    <div id="xdx_230_zxeUAoKuJNEd" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_231_z1jOLWKMxWLh" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td id="xdx_234_zmnICRnfANB6" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_235_zlu1GyZ53f06" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zpz9euL1f06a" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zZCgoUPi8VK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zrcvmE3qmnM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0"><span style="text-decoration: underline">Leases</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU No.
2016-02&#8212;Leases, to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities
on the balance sheet and disclosing key information about leasing arrangements. A lessee should recognize in the statement of financial
position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying
asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessor
have not significantly changed from previous U.S. GAAP. This ASU was effective for annual periods, including interim periods within
those annual periods, beginning after December 15, 2018. We adopted this ASU on September 1, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We lease various production, administrative
and sales offices under operating leases. We evaluate our contracts to determine if an arrangement is a lease at inception and
classify it as a finance or operating lease. Currently, all our leases are classified as operating leases. Leased assets and corresponding
liabilities are recognized based on the present value of the lease payments over the lease term. Our lease terms may include options
to extend when it is reasonably certain that we will exercise that option. Costs associated with operating leases are recognized
on a straight-line basis within operating expenses over the term of the lease. With the adoption of ASC 842 on September 1, 2019,
we recognized all leases with terms greater than 12 months in duration on our consolidated balance sheets as right-of-use assets
and lease liabilities. We adopted the standard using the prospective approach and did not retrospectively apply to prior periods.
Right-of-use assets are recorded in long-term assets on our consolidated balance sheets. Current and non-current lease liabilities
are recorded as operating lease liabilities within current liabilities and long-term liabilities, respectively, on our consolidated
balance sheets. As part of the adoption of this standard we recorded the following assets and liabilities as of September 1, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zTtNDqhLnfG7" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BE_zSqDmV3ka2a7" style="display: none">Schedule of Operating assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20190902__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zL2WufTMtCs5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zoaaRhyOZZb9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Right of use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">902,553</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_zcy5QdVlyte6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease Liabilities, Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">537,017</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zbdJMiR7Eh55" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Lease Liabilities, Long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">365,536</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zNbhSBZ9dUbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have made certain assumptions and judgments
when applying ASC 842, the most significant of which are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We elected the package of practical expedients available for transition that allow us to not reassess whether expired or existing contracts contain leases under the new definition of a lease, lease classification for expired or existing leases and whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We did not elect to use hindsight when considering judgments and estimates such as assessments of lessee options&#160;&#160; to extend or terminate a lease or purchase the underlying asset.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">The determination of the discount rate used in a lease is our estimated incremental borrowing rate that is based on what we would expect to pay to borrow over a similar term an amount equal to the lease payments.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Supplemental balance sheet information
related to operating leases was as follows as of August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:LeaseCostTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zKoM6hMVYr81" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BC_zf5nJv1vY6T" style="display: none">Schedule of lease cost</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20200831_ztCF8vNQALEg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Right of use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">926,600</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease Liabilities, Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">463,465</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Lease Liabilities, Long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">463,312</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseCost_pp0p0_c20190901__20200831_zQBxhB4OiEd4" title="Operating lease costs" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseCost" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">600,717</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted Average remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200831_zi078OFyofUa" title="Weighted average remaining lease term"><ix:nonNumeric contextRef="AsOf2020-08-31" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">2.27</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Weighted Average Discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pii_dp_c20200831_zvOvrb8miQZ1" title="Weighted average discount rate"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.25</ix:nonFraction></span>%</td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_z7z82ziGig1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_232_zxYIGyXN9ONb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_z4PnPrqOPkF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zl1VA9QzTdqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 65 -->
    <div id="xdx_239_zxTlyWnDQC69" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_239_zR1oiGNUTYwe" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td id="xdx_23F_z0w8mrpLRlm8" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zdP00YCh7xa4" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_238_zQMkodiq2ULb" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_z7eTXGc2SgR5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock"><p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z8aP6yZfFgAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Intangible Assets and Goodwill </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company performs valuations of assets
acquired and liabilities assumed on each acquisition accounted for as a business combination and recognizes the assets acquired
and liabilities assumed at their acquisition date fair value. Acquired intangible assets include customer relationships, software,
trade name, and non-compete agreements. The Company determines the appropriate useful life by performing an analysis of expected
cash flows based on historical experience of the acquired businesses. Intangible assets are amortized over their estimated useful
lives using the straight-line method, which approximates the pattern in which the majority of the economic benefits are expected
to be consumed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of the cost
of an acquired entity over the fair value of the acquired net assets. Goodwill is not amortized, instead it is tested for impairment
annually or when events or circumstances change that would indicate that goodwill might be impaired. Events or circumstances that
could trigger an impairment review include, but are not limited to, a significant adverse change in legal factors or in the business
climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes
in the manner of the Company's use of the acquired assets or the strategy for the Company's overall business, significant negative
industry or economic trends or significant under-performance relative to expected historical or projected future results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is tested for impairment at the
reporting unit level, which is one level below or the same as an operating segment. As of August 31, 2020, the Company determined
that it has four reporting units, Simulations Plus, Cognigen Corporation, DILIsym Services, Inc. and Lixoft. When testing
goodwill for impairment, the Company first performs a qualitative assessment to determine whether it is necessary to perform step
one of a two-step annual goodwill impairment test for each reporting unit. The Company is required to perform step one only if
it concludes that it is more likely than not that a reporting unit's fair value is less than its carrying value. Should this be
the case, the first step of the two-step process is to identify whether a potential impairment exists by comparing the estimated
fair values of the Company's reporting units with their respective book values, including goodwill. If the estimated fair value
of the reporting unit exceeds book value, goodwill is considered not to be impaired, and no additional steps are necessary. If,
however, the fair value of the reporting unit is less than book value, then the second step is performed to determine if goodwill
is impaired and to measure the amount of impairment loss, if any. The amount of the impairment loss is the excess of the carrying
amount of the goodwill over its implied fair value. The estimate of implied fair value of goodwill is primarily based on an estimate
of the discounted cash flows expected to result from that reporting unit, but may require valuations of certain internally generated
and unrecognized intangible assets such as the Company's software, technology, patents and trademarks. If the carrying amount of
goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to the excess.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, the entire balance
of goodwill was attributed to three of the Company's reporting units, Cognigen Corporation, DILIsym Services and Lixoft. Intangible
assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of
these assets may not be recoverable. The Company has <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zPQSY2jLPcrl" title="Impairment of long-lived assets"><span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zTalRBgg96G3" title="Impairment of long-lived assets"><span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z23eeCj7Ky32" title="Impairment of long-lived assets"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2019-09-012020-08-31_us-gaap_GoodwillMember" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2018-09-012019-08-31_us-gaap_GoodwillMember" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" contextRef="From2017-09-012018-08-31_us-gaap_GoodwillMember" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>t recognized any impairment charges during the periods ended August 31,
2020, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reconciliation of Goodwill for the period
ended August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfGoodwillTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfGoodwillTextBlock_z4HAeKRfXG9a" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BF_zuAQoWfd73Qe" style="display: none">Schedule of reconciliation of goodwill</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-weight: bold">Balance, August 31, 2017</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zoR0fNA1RpMj" title="Goodwill, beginning balance" style="width: 11%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2017-08-31_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,789,248</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zSoxwTUSYCRj" title="Goodwill, beginning balance" style="width: 11%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2017-08-31_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,597,950</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iS_pp0p0_d0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zCFcLsBeuOa4" title="Goodwill, beginning balance" style="width: 11%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2017-08-31_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20170831_zvEwCAhEXfJi" title="Goodwill, beginning balance" style="width: 11%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2017-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,387,198</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zvsgqGbcSyG9" title="Addition" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2017-09-012018-08-31_custom_CognigenMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zhhwZkbMyTLd" title="Addition" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2017-09-012018-08-31_custom_DILIsymMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHg46XMJXXJe" title="Addition" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2017-09-012018-08-31_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831_zHaTc6ijB0Be" title="Addition" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Impairments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zkbUasYxCbG1" title="Impairments" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2017-09-012018-08-31_custom_CognigenMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zuasCTew16Ag" title="Impairments" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2017-09-012018-08-31_custom_DILIsymMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zzQNnyC5Xr92" title="Impairments" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2017-09-012018-08-31_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831_zkKJBVSQO7md" title="Impairments" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance, August 31, 2018</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zMUXOD9rtnRg" title="Goodwill, beginning balance" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2018-08-31_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,789,248</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zeXXADTv1cvf" title="Goodwill, beginning balance" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2018-08-31_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,597,950</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Goodwill_iS_pp0p0_d0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zR6QbZfcc7Ed" title="Goodwill, beginning balance" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2018-08-31_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20180831_zyYx0cSdkeBd" title="Goodwill, beginning balance" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,387,198</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zLgbuxdmazBk" title="Addition" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2018-09-012019-08-31_custom_CognigenMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zgEZVCjCjow5" title="Addition" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2018-09-012019-08-31_custom_DILIsymMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zE5XV05nhK1c" title="Addition" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2018-09-012019-08-31_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831_zqBiLpeMMal9" title="Addition" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Impairments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zCj29W7ZobBb" title="Impairments" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2018-09-012019-08-31_custom_CognigenMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zXdfBHzScdga" title="Impairments" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2018-09-012019-08-31_custom_DILIsymMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcnZUfhUVYac" title="Impairments" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2018-09-012019-08-31_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831_zIhzqb75zgAa" title="Impairments" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balance, August 31, 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zSBcD1rOk8mj" title="Goodwill, beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,789,248</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zxCJv7IZot2d" title="Goodwill, beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,597,950</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_d0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFpsM4tMcXBf" title="Goodwill, beginning balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831_zq5CD50hQSz1" title="Goodwill, beginning balance" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,387,198</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zAA9MZ82Firl" title="Addition" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2019-09-012020-08-31_custom_CognigenMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zUaRbbH9IZ8j" title="Addition" style="text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2019-09-012020-08-31_custom_DILIsymMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_pp0p0" title="Addition" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2019-09-012020-08-31_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,533,987</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831_pp0p0" title="Addition" style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,533,987</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Impairments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zpDb6srRyPR6" title="Impairments" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2019-09-012020-08-31_custom_CognigenMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zImENgHoNJp8" title="Impairments" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2019-09-012020-08-31_custom_DILIsymMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zrnP0MMN3oHf" title="Impairments" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2019-09-012020-08-31_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831_zOVAChUZbsPb" title="Impairments" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:GoodwillImpairmentLoss" contextRef="From2019-09-01to2020-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z8WvpIiRt9X3" title="Goodwill, ending balance" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,789,248</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zQfPUAISziy7" title="Goodwill, ending balance" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,597,950</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zGIfo8AZhXH7" title="Goodwill, ending balance" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,533,987</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iE_pp0p0_c20200831_zB26qGUiDAe9" title="Goodwill, ending balance" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,921,185</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zHmLQSCUzkp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_232_zj3VLHbzbwa5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23B_zQ8LRw6t6VY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 66 -->
    <div id="xdx_230_zzVNWrobFwz1" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zjXBFgk4jCuh" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td id="xdx_23F_zcuNE0JCFvpg" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23F_zUzkI6o2OzB4" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_233_zqw8EKLSLcX5" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zAskP2sdKmel" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zbMRhXdE1U3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Other Intangible Assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes other intangible
assets as of August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zcdMv2SMnMX6" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_z8PKBG7mUBPe" style="display: none">Schedule of other intangible assets</span></td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization<br /> Period</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Acquisition<br /> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br /> Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net book <br /> value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 30%; text-align: left">Customer relationships-Cognigen</td><td style="width: 2%">&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period" style="width: 23%; text-align: left"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember" name="simu:AmortizationPeriodIntangibleAssets">Straight line 8 years</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" title="Acquisition value" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,100,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" title="Accumulated amortization" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">825,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" title="Net book value" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">275,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Cognigen</td><td>&#160;</td>
    <td id="xdx_98E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember" name="simu:AmortizationPeriodIntangibleAssets">None</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" title="Acquisition value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z9H50fVKZ7h4" title="Accumulated amortization" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" title="Net book value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Covenants not to compete-Cognigen</td><td>&#160;</td>
    <td id="xdx_980_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period" style="text-align: left"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember" name="simu:AmortizationPeriodIntangibleAssets">Straight line 5 years</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" title="Acquisition value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" title="Accumulated amortization" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zWM81nzb5Q4f" title="Net book value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Covenants not to compete-DILIsym</td><td>&#160;</td>
    <td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period" style="text-align: left"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember" name="simu:AmortizationPeriodIntangibleAssets">Straight line 4 years</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" title="Acquisition value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">65,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" title="Net book value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Trade Name-DILIsym</td><td>&#160;</td>
    <td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember" name="simu:AmortizationPeriodIntangibleAssets">None</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" title="Acquisition value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">860,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zK8OpZ196sib" title="Accumulated amortization" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" title="Net book value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">860,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships-DILIsym</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period" style="text-align: left"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember" name="simu:AmortizationPeriodIntangibleAssets">Straight line 10 years</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" title="Acquisition value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,900,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">617,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" title="Net book value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,282,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Customer relationships-Lixoft</td><td>&#160;</td>
    <td id="xdx_982_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcuIzsZApaQ7" title="Amortization period" style="text-align: left"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember" name="simu:AmortizationPeriodIntangibleAssets">Straight line 14 years</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxDMpotqsKGh" title="Acquisition value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,550,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zwghqLFIKLF2" title="Accumulated amortization" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,892</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_ztnFFsowEzg1" title="Net book value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,474,108</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Lixoft</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHqRhmhyaYL8" title="Amortization period"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember" name="simu:AmortizationPeriodIntangibleAssets">None</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zZXtOxMG2TF1" title="Acquisition value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,550,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zTvrtuBVMjP4" title="Accumulated amortization" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zAqcvFAQ80Y7" title="Net book value" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,550,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Covenants not to compete-Lixoft</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxkBBuWqUWr1" title="Amortization period" style="text-align: left; padding-bottom: 1pt"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember" name="simu:AmortizationPeriodIntangibleAssets">Straight line 3 years</ix:nonNumeric></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z7pFB0M4R3C5" title="Acquisition value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">60,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z0gE94uETOqf" title="Accumulated amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,333</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zexyHyyHGowf" title="Net book value" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,667</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" title="Acquisition value" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,650,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" title="Accumulated amortization" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,641,725</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" title="Net book value" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,008,275</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AC_zG1JJ03xFfx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for the year ended
August 31, 2020, 2019 and 2018 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3ZFxKJwWMbb" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-09-012020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">431,725</ix:nonFraction></span>, $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3bmRuno6Ook" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2018-09-012019-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,500</ix:nonFraction></span>, and $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVABDRip64Ae" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2017-09-012018-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,500</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Future amortization for the next five years is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zxQnkrdiyGO6" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span id="xdx_8B9_z234vGfYtfFf" style="display: none">Schedule of future amortization</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ending</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>August 31,</b></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 35%; text-align: center">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zRWulqymKJsl" title="2021" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">545,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zCSW1w5HslL6" title="2022" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">530,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_znfvw1zNOtAf" title="2023" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">384,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zT0va5RT4hTj" title="2024" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">372,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyakFlEwBm42" title="2025" style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">372,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_zjzYJ5dEGP21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock"><p id="xdx_84C_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zOecTBEg1Jo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Business Acquisitions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounted for the acquisition
of Cognigen, DILIsym Services, Inc. and Lixoft using the purchase method of accounting where the assets acquired and liabilities
assumed are recognized based on their respective estimated fair values. The excess of the purchase price over the estimated fair
values of the net assets acquired is recorded as goodwill. Determining the fair value of certain acquired assets and liabilities
is subjective in nature and often involves the use of significant estimates and assumptions, including, but not limited to, the
selection of appropriate valuation methodology, projected revenue, expenses and cash flows, weighted average cost of capital, discount
rates, estimates of advertiser and publisher turnover rates and estimates of terminal values. Business acquisitions are included
in the Company's consolidated financial statements as of the date of the acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zSLqoAyvl6U2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Fair Value of Financial Instruments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities recorded at fair
value in the Consolidated Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure
their fair value. The categories, as defined by the standard are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_238_zmYZbIvQyQK5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zLJbO1lZAX7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_z78OPbKvqxj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 67 -->
    <div id="xdx_23B_zVCWgxfXTaF7" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_238_zzO51oVBxry4" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td id="xdx_231_zQ04UEhVI0i1" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23E_zY930el0Cj68" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_231_zwbZLyVmb0nd" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zjle1DBi6PPc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Level&#160;Input:</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 89%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Input Definition:</b></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level I</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level II</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level III</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unobservable inputs that reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For certain of our financial instruments,
including accounts receivable, accounts payable, accrued payroll and other expenses, and accrued bonuses to officers the carrying
amounts approximate fair value due to their short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes fair value
measurements at August 31, 2020 and August 31, 2019 for assets and liabilities measured at fair value on a recurring basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zYyIrAvXvjG5" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B3_zmHSUlmxpb69" style="display: none">Summarizes fair value measurements</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zHYQ0Goe3Hb5" title="Fair value assets" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,207,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zZ6wlmbkx7L" title="Fair value assets" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_ziuNLvNKmt38" title="Fair value assets" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z4nxg8L59Dx5" title="Fair value assets" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,207,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAa6u8BjB1X2" title="Fair value assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,803,595</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAWqU7EJeqUj" title="Fair value assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zWtPp8qtylG9" title="Fair value assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zMPsbjxizirf" title="Fair value assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,803,595</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Acquisition-related contingent consideration obligations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zByirdDWDExh" title="Fair value liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zvasR6GY54w7" title="Fair value liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zlBoNlObcO7b" title="Fair value liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,730,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zf1qb4fCDcwg" title="Fair value liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,730,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zFigkOPxI4Xe" title="Fair value assets" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,435,499</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z3O9eET3mUIc" title="Fair value assets" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zgzKEnI30r7g" title="Fair value assets" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zNqQAJFxum1h" title="Fair value assets" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,435,499</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zRwKH7oQn7c9" title="Fair value assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCgK0YlFXF79" title="Fair value assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_z18hJNKcgH31" title="Fair value assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCSurT1FLxF7" title="Fair value assets" style="text-align: right"><ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Acquisition-related contingent consideration obligations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zGm1wLfpJDr4" title="Fair value liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zPbSMnDQbZX4" title="Fair value liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zilckSxYLB4c" title="Fair value liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zIYMvbu92SJa" title="Fair value liabilities" style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_zaLRR8e5v6tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020 and 2019, the Company
has a liability for contingent consideration related to its acquisition of Lixoft and DILIsym Services, Inc. The fair value measurement
of the contingent consideration obligations is determined using Level 3 inputs. The fair value of contingent consideration obligations
is based on a discounted cash flow model using a probability-weighted income approach. These fair value measurements represent
Level 3 measurements as they are based on significant inputs not observable in the market. Significant judgment is employed in
determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes
in assumptions could have a material impact on the amount of contingent consideration expense the Company records in any given
period. Changes in the value of the contingent consideration obligations are recorded in the Company&#8217;s Consolidated Statement
of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a reconciliation of contingent
consideration value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="simu:ReconciliationOfContingentConsiderationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfContingentConsiderationTableTextBlock_zsdXNYIcBFB" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zPTdvf5hZ8Tc" style="display: none">Reconciliation of contingent consideration value</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; font-weight: bold">Value at August 31, 2019</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iS_pp0p0_c20190831_znoY4GgeeSva" title="Contingent consideration, beginning balance" style="width: 11%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAssetCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchase price contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--PurchasePriceContingentConsiderationAdditions_c20190901__20200831_pp0p0" title="Purchase price contingent consideration" style="text-align: right"><ix:nonFraction name="simu:PurchasePriceContingentConsiderationAdditions" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,528,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Contingent consideration payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ContingentConsiderationPayments_iN_pp0p0_di_c20190901__20200831_zoY0KuUfKOgj" title="Contingent consideration payments" style="text-align: right">(<ix:nonFraction name="simu:ContingentConsiderationPayments" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in value of contingent consideration</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c20190901__20200831_pp0p0" title="Change in value of contingent consideration" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">202,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Value at August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iE_pp0p0_c20200831_zxjqMrPZPwba" title="Contingent consideration, ending balance" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAssetCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,730,500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A0_zfMjwN14OCPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_238_zn6lo7YgYo4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zwb6Y5LjCdY2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zw9NKriiV1c3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 68 -->
    <div id="xdx_234_zeW4oEo43PBd" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_237_znH4DYe8wLYb" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td id="xdx_238_zESEA6HtqiMi" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_zrlJPMVZVcH8" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23A_zcUdDOlJLHBc" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zkax13IGZbri" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zmjCyVBPBIwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Advertising</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expenses advertising costs
as incurred. Advertising costs for the years ended August 31, 2020, 2019 and 2018 were approximately $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20190901__20200831_pp0p0" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,944</ix:nonFraction></span>, $<span id="xdx_908_eus-gaap--AdvertisingExpense_c20180901__20190831_pp0p0" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,213</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--AdvertisingExpense_c20170901__20180831_pp0p0" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,848</ix:nonFraction></span>,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy"><p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zWe1iL9IrDuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Research and Development Costs</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs are charged
to expense as incurred until technological feasibility has been established. These costs include salaries, laboratory experiment,
and purchased software which was developed by other companies and incorporated into, or used in the development of, our final products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zUIPGgh40rS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Income Taxes</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes in
accordance with ASC 740-10, <i>&#8220;Income Taxes&#8221;</i> which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements or tax returns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"><p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z8GNJWW9O9J9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Intellectual property</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 28, 2012, we bought out the
royalty agreement with Enslein Research. The cost of $<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsGross_c20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Intangible asset acquisition value"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2012-02-28_us-gaap_RoyaltyAgreementsMember_custom_EnslienMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></span> is being amortized over <span id="xdx_900_ecustom--AmortizationPeriodIntangibleAssets_c20110901__20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember" title="Amortization period"><ix:nonNumeric contextRef="From2011-09-012012-02-28_us-gaap_RoyaltyAgreementsMember_custom_EnslienMember" name="simu:AmortizationPeriodIntangibleAssets">10 years under the straight-line method</ix:nonNumeric></span>. Amortization
expense for each of the fiscal years ended August 31, 2020 and 2019 was $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zhbLmTWT8ICe" title="Amortization of intangible assets"><span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_z7TtErqFcd5f" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,500</ix:nonFraction></ix:nonFraction></span></span>. Accumulated amortization as of August 31, 2020
and 2019 was $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,750</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">56,250</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 15, 2014, we entered into a termination
and non-assertion agreement with TSRL, Inc., pursuant to which the parties agreed to terminate an exclusive software licensing
agreement entered into between the parties in 1997. As a result, the Company obtained a perpetual right to use certain source code
and data, and TSRL relinquished any rights and claims to any GastroPlus products and to any claims to royalties or other payments
under that 1997 agreement. We agreed to pay TSRL total consideration of $<span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsGross_c20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Intangible asset acquisition value"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2014-05-15_custom_TermAndNonassertionAgrMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,000,000</ix:nonFraction></span>, which is being amortized over <span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20130901__20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember" title="Amortization period"><ix:nonNumeric contextRef="From2013-09-012014-05-15_custom_TermAndNonassertionAgrMember_custom_TSRLMember" name="simu:AmortizationPeriodIntangibleAssets">10 years under
the straight-line method</ix:nonNumeric></span>. Amortization for the year ended August 31, 2020, and 2019 was $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zwHu0ELID6e4" title="Amortization of intangible assets"><span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zEYLoca8Ywo7" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">600,000</ix:nonFraction></ix:nonFraction></span></span>. Accumulated amortization as of
August 31, 2020 and 2019 was $<span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,775,000</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,175,000</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2017, as part of the acquisition
of DILIsym Services, Inc. the Company acquired certain developed technologies associated with the drug induced liver disease (DILI).
These technologies were valued at $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsGross_c20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Intangible asset acquisition value"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2017-06-02_custom_CertainDevelopedTechnologiesMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,850,000</ix:nonFraction></span> and are being amortized over <span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20160901__20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember" title="Amortization period"><ix:nonNumeric contextRef="From2016-09-012017-06-02_custom_CertainDevelopedTechnologiesMember_custom_DILIsymMember" name="simu:AmortizationPeriodIntangibleAssets">9 years under the straight-line method</ix:nonNumeric></span>. Amortization
expense for the fiscal years ended August 31, 2020 and 2019 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,667</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,667</ix:nonFraction></span>, respectively, and is included in cost of
revenues. Total accumulated amortization as of August 31, 2020 and 2019 was $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,029,167</ix:nonFraction></span> and $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">712,500</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2018, we purchased certain
intellectual property rights of Entelos Holding Company, a Delaware Corporation. The cost of $<span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember_pp0p0" title="Intangible asset acquisition value"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2018-09-30_custom_CertainIntellectualPropertyRightsMember_custom_EntelosHoldingCoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">50,000</ix:nonFraction></span> is being amortized over <span id="xdx_907_ecustom--AmortizationPeriodIntangibleAssets_c20180901__20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember" title="Amortization period"><ix:nonNumeric contextRef="From2018-09-012018-09-30_custom_CertainIntellectualPropertyRightsMember_custom_EntelosHoldingCoMember" name="simu:AmortizationPeriodIntangibleAssets">10
years under the straight-line method</ix:nonNumeric></span>. Amortization expense for the year ended August 31, 2020 and 2019 was $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zOs5YJaHO26e" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span>. Accumulated
amortization as of August 31, 2020 and 2019 was $<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zW3aUM43FTwl" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2020, as part of the acquisition
of Lixoft, the Company acquired certain developed technologies associated with the Lixoft scientific software. These technologies
were valued at $<span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zpMxPfJZDHJ8" title="Intangible asset acquisition value"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2020-04-02_custom_CertainDevelopedTechnologiesMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,010,000</ix:nonFraction></span> and are being amortized over <span id="xdx_90E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zXXpglxEVPh6" title="Amortization period"><ix:nonNumeric contextRef="From2019-09-012020-04-02_custom_CertainDevelopedTechnologiesMember_custom_LixoftMember" name="simu:AmortizationPeriodIntangibleAssets">16 years under the straight-line method</ix:nonNumeric></span>. Amortization expense for the fiscal
years ended August 31, 2020 was $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zhQXw7zg7SEg" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">208,594</ix:nonFraction></span> and is included in cost of revenues. Total accumulated amortization as of August 31, 2020
was $<span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zviBsbOkc0i2" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">208,594</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23C_zWNSXEYibyFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_231_zC5CRcyE14P" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zMbYzCp90kvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 69 -->
    <div id="xdx_23E_zDLcAvjIHnqi" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_238_zv2n7qWrjOo" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td id="xdx_235_zwfxgXDH6LK7" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23C_z6O89FUJNl53" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_z36DwFOsePQ" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_zyRJ49pIUic5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total amortization expense for intellectual
property agreements for the years ended August 31, 2020, 2019 and 2018 was $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,138,280</ix:nonFraction></span>, $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">929,167</ix:nonFraction></span>, and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2017-09-012018-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">924,167</ix:nonFraction></span>. Accumulated amortization
as of August 31, 2020 and 2019 was $<span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zwvNPyR8Newi" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,087,031</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyv8Lja8rOle" title="Accumulated amortization of intellectual property"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,948,750</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future amortization for the next five years
is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="simu:ScheduleOfAmortizationExpensesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAmortizationExpensesTableTextBlock_zOT6nlAoXPva" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zQOnpBhAbNVj" style="display: none">Schedule of future amortization expenses</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zW7YXI5yZCLi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zX8dAQzarkKd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIMember_zsIOn20qZid7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_z1Tbr52GkpBk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_z4DTQrCGhw8g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zYZYZ4o7tgSi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ending <br /> August 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">TSRL</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Enslein</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILI-Acquired<br /> Developed<br /> Technologies</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft-Acquired<br /> Developed<br /> Technologies</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Entelos</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 16%; text-align: center">2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">600,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,667</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,625</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,429,792</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,750</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,667</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,426,042</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_d0_z5Oqy1grb2Yl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,667</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,422,292</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_d0_zBybeV9Z08F8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">425,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,667</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,247,292</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_d0_zGkQdQVNENzi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">316,667</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">500,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">822,292</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A6_zHZaIfKMDUP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zebAV6RoGKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Earnings per Share</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reports earnings per share
in accordance with FASB ACS 260-10. Basic earnings per share is computed by dividing income available to common shareholders by
the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per
share except that the denominator is increased to include the number of additional common shares that would have been outstanding
if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted
earnings per share for the years ended August 31, 2020, 2019 and 2018 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwPNl37oEuQh" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BE_zbpYZd26dcYg" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20200831_z42pDCeajb91" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20180901__20190831_zgQ42h8vLxn6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20170901__20180831_zpLAOwGeQ94d" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Numerator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left; padding-bottom: 2.5pt">Net income attributable to common shareholders</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,332,060</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,583,329</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,934,812</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pii_zWGOoVnDS8j7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Weighted-average number of common shares outstanding during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,819,064</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,492,258</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,328,707</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pii_zl1t74brxaL1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dilutive effect of stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">719,309</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">565,173</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">531,685</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pii_zuS8ByLCnD6g" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Common stock and common stock equivalents used for diluted earnings per share</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,538,373</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">18,057,431</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,860,392</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_8AF_zTKM3q9U7om3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zYvIuhl0p9Rd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Stock-Based Compensation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock options
using the modified prospective method in accordance with FASB ASC 718-10, <i>&#8220;Compensation-Stock Compensation&#8221;</i>.
Under this method, compensation costs include estimated grant date fair value of the awards amortized over the options&#8217; vesting
period. Stock-based compensation was $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,286,625</ix:nonFraction></span>, $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">865,848</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">562,078</ix:nonFraction></span> for the fiscal years ended August 31, 2020, 2019 and 2018,
respectively, and is included in the statements of operations as Consulting, Salaries, and Research and Development expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zt0zasQu6cZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Impairment of Long-lived Assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for the impairment
and disposition of long-lived assets in accordance with ASC 350, <i>&#8220;Intangibles &#8211; Goodwill and Other</i>&#8221; and
ASC 360, <i>&#8220;Property and Equipment&#8221;</i>. Long-lived assets to be held and used are reviewed for events or changes
in circumstances that indicate that their carrying value may not be recoverable. We measure recoverability by comparing the carrying
amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may
not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an
impairment charge to the extent of the difference between the fair value and the asset's carrying amount. <span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20190901__20200831_z1hibgz7fx1" title="Impairment losses"><span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20180901__20190831_zdzaE5YyJ5h4" title="Impairment losses"><span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20170901__20180831_zTk5MITYte01" title="Impairment losses"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2019-09-01to2020-08-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2018-09-012019-08-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" contextRef="From2017-09-012018-08-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span> impairment losses
were recorded during the years ended August 31, 2020, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_231_zL2KhpAA1WTl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zPyyQdfZd4Kj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zaMYrq04HTo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 70 -->
    <div id="xdx_23B_zpsqlhGGeV9b" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_z8a2OtdQX0fk" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td id="xdx_234_zBVGnSJvDXDc" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_zEuHrS06zOVb" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23F_zc3zCjIPSAU9" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zFo9O8FHfiy4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zHjSKuHffNZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Recently Issued Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding Accounting Standards Codification
Topic 606 (ASC Topic 606), Revenue from Contracts with Customers. The standard provides principles for recognizing revenue for
the transfer of promised goods or services to customers with the consideration to which the entity expects to be entitled in exchange
for those goods or services. The standard also provides guidance on the recognition of incremental costs related to obtaining customer
contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing the modified retrospective method. This approach was
applied to contracts that were in process as of September 1, 2018, and the corresponding incremental costs of obtaining those contracts,
which resulted in a cumulative effect adjustment of $493,279 to the opening balance of retained earnings at the date of adoption.
The adoption of this ASU primarily impacts the timing of our revenue recognition for certain sales contracts, the capitalization
and amortization of incremental costs of obtaining a contract, and related disclosures. The reported results for fiscal year 2019
reflect the application of ASC Topic 606.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,
Leases (Topic 842), which supersedes existing guidance on accounting for leases in &#34;Leases (Topic 840)&#34; and generally
requires all leases to be recognized in the consolidated balance sheet. ASU 2016-02 is effective for annual and interim reporting
periods beginning after December 15, 2018. The Company adopted this ASU on September 1, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In April 2016, the FASB issued ASU 2016-10,
Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board's new revenue standard, ASU 2014-09,
Revenue from Contracts with Customers. The standard was adopted concurrently with the adoption of ASU 2014-09 which is effective
for annual and interim periods beginning after December 15, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerTextBlock"><p id="xdx_807_eus-gaap--RevenueFromContractWithCustomerTextBlock_zKzR0jkn9nw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 &#8211; <span id="xdx_828_zIsxOFXa1L85">REVENUE RECOGNITION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted Topic 606 effective
September&#160;1, 2018 using the modified retrospective method applying this guidance to all open contracts at the date of initial
application, which resulted in an adjustment to retained earnings for the cumulative effect of applying this guidance. The most
significant impact of Topic 606 on revenue to the Company relates to the timing of revenue recognition for one of its payment contracts.
Under 606 the revenues under the contract are being recognized as time is expended and costs are being expensed as incurred. Under
ASC 605 revenues were recognized as invoiced and certain costs were capitalized as development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines revenue recognition
through the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td>
    <td style="width: 95%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the contract, or contracts, with a customer</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Determination of the transaction price</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Recognition of revenue when, or as, the Company satisfies a performance obligation</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Components of revenue</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a description of principal
activities from which the Company generates revenue. As part of the accounting for these arrangements, the Company must develop
assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the
contract. Stand-alone selling prices are determined based on the prices at which the Company separately sells its services or goods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_237_z3XMONCVUdce" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zm23hLu9d8N3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zd4rPOF7JX7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 71 -->
    <div id="xdx_23F_zLPnk4kHqpF8" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23D_zQMYhLBuM2vb" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td id="xdx_239_z32dB0yE5NWc" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_zi9rQCh3l3xe" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_231_z2DmfNaSFRIk" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_239_zMR4YWFlrcle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Components</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 48%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Typical payment terms</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Software Revenues:</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Software revenues are generated primarily from sales of software
        licenses at the time the software is unlocked and the term commences. The license period typically is one year or less. Along with
        the license a <i>di minimis</i> amount of customer support is provided to assist the customer with the software. Should the customer
        need more than a di minimis amount of support they can choose to enter into a separate contract for additional training. Most software
        is installed on our customers&#8217; servers and the Company has no control of the software once the sale is made.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For certain software arrangements the Company hosts the licenses
        on servers maintained by the Company, revenue for those arrangements are accounted as <i>Software as a Service</i> over the life
        of the contract. These arrangements are a small portion of software revenues of the Company.</p></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Payments are generally due upon invoicing on a net 30 basis unless other payment terms are negotiated with the customer based on customer history. Typical industry standards apply.</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><i>Consulting Contracts:</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Consulting services provided to our customers are generally recognized over time as the contracts are performed and the services are rendered. The company measures its consulting revenue based on time expended compared to total estimated hours to complete a project. The Company believes the methods chosen for its contract revenue best depicts the transfer of benefits to the customer under the contracts.</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Payment terms vary, depending on the size of the contract, credit history and history with the client and deliverables within the contract.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Consortium Member Based Services:</i></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 48%">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">The performance obligation is recognized on a time elapsed basis, by month, for which the services are provided, as the Company transfers control evenly over the contractual period.</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Payment is due at the beginning of the period, generally on a net 30 or 60 basis.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Remaining performance obligations
that do not fall under the expedients require the Company to perform various&#160;consulting and software development
services and consortium memberships of approximately $<span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_c20200831_pp0p0" title="Remaining performance obligations"><ix:nonFraction name="us-gaap:RevenueRemainingPerformanceObligation" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,303,461</ix:nonFraction></span>.
It is anticipated these revenues will be recognized within the next year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Contract liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended August 31, 2020 the
Company recognized $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20190901__20200831_pp0p0" title="Revenues included in contract liabilities"><ix:nonFraction name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,146,000</ix:nonFraction></span> of revenue that was included in contract liabilities as of August 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:exclude><p id="xdx_239_z8ixlhnbmRre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_zfJdeltOHE6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_230_zNF7HN3x3Muk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_232_zcevnops4g0d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 72 -->
    <div id="xdx_23D_z9joDJ0HtJcb" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23B_z1JNfThHf12" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td id="xdx_234_zp8oF5qexOAh" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zZ3CjRXje223" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_233_zTO8QNjV3rUa" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zIBZoXPT2YKe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b>&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disaggregation of Revenues</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:DisaggregationOfRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zagC0y6wzAVc" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Disaggregation)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10pt"><span id="xdx_8B3_zQo710fJ5tV3" style="display: none">Schedule of disaggregation of revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Disaggregation of Revenues:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended <br /> August 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended <br /> August 31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Software licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; text-align: left; text-indent: 10pt">Point in time</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,668,195</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,425,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: 10pt">Over time</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredOverTimeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">919,344</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredOverTimeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,053,562</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">Consulting services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Over time</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_ConsultingServicesMember_us-gaap_TransferredOverTimeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">20,001,545</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_ConsultingServicesMember_us-gaap_TransferredOverTimeMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,491,525</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20190901__20200831_pp0p0" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,589,084</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20180901__20190831_pp0p0" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,970,440</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AF_zIORA1xti5Ld" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Contracts in Progress</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contracts in progress are included in the accompanying balance
sheets under the following captions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zCdLLMp8FQm3" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zqfCiXdLAFU2" style="display: none">Schedule of contract in progress</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_49D_20200831_zjzGgHGToG3b" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_49C_20190831_zJaf8b3ahOO7" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_iI_pp0p0_maROBOUztWJ_zYD86VrOVm5b" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Revenues in excess of billings</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,093,343</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,233,659</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--BillingsInExcessOfCost_iNI_pp0p0_di_msROBOUztWJ_z2FWgTLFLdwc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Billings in excess of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:BillingsInExcessOfCost" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,991</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:BillingsInExcessOfCost" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">798,549</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--RevenuesOverBillingsOnUncompletedContracts_iTI_pp0p0_mtROBOUztWJ_zcQQ5a2vCZgb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 2.5pt">Revenues over billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:RevenuesOverBillingsOnUncompletedContracts" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,952,352</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:RevenuesOverBillingsOnUncompletedContracts" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,435,110</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost, estimated earnings, and billings
on uncompleted contracts are summarized as follows as of August 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_401_ecustom--RevenuesEarnedToDateOnUncompletedContracts_iI_z1MJMCb5jmk6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Revenues earned to date on uncompleted contracts</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="simu:RevenuesEarnedToDateOnUncompletedContracts" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">20,235,573</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="simu:RevenuesEarnedToDateOnUncompletedContracts" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,254,928</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--BillingsToDateOnUncompletedContracts_iNI_di_zfUIObO0Xka1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Billings to date on uncompleted contracts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="simu:BillingsToDateOnUncompletedContracts" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,283,221</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="simu:BillingsToDateOnUncompletedContracts" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,819,818</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 2.5pt">Revenues over billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,952,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,435,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zyxtl2K24A2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Balance increases and decreases in these
accounts are due to the timing of amounts billed, payments received, and revenue recognized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zhY0Pl7JLjBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 &#8211; <span id="xdx_82B_zzpnZEgZzN14">PROPERTY AND EQUIPMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment at August 31, 2020
and 2019 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2XcKW4fbxvg" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B7_zb3ozx5Y0Mv8" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify">Equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" title="Property and equipment, gross" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-08-31_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">864,560</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" title="Property and equipment, gross" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-08-31_us-gaap_EquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">741,486</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Computer equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-08-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">547,738</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-08-31_us-gaap_ComputerEquipmentMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">411,632</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-08-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">160,991</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-08-31_us-gaap_FurnitureAndFixturesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">160,990</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and equipment, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-08-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">114,005</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" title="Property and equipment, gross" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-08-31_us-gaap_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">110,165</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200831_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,687,294</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20190831_pp0p0" title="Property and equipment, gross" style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,424,273</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20200831_pp0p0" title="Less accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,249,507</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20190831_pp0p0" title="Less accumulated depreciation and amortization" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,083,128</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_c20200831_pp0p0" title="Net Book Value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">437,787</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_c20190831_pp0p0" title="Net Book Value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">341,145</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense was $<span id="xdx_90D_eus-gaap--Depreciation_c20190901__20200831_pp0p0" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,379</ix:nonFraction></span>, $<span id="xdx_906_eus-gaap--Depreciation_c20180901__20190831_pp0p0" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">131,827</ix:nonFraction></span>,
and $<span id="xdx_908_eus-gaap--Depreciation_c20170901__20180831_pp0p0" title="Depreciation"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">139,202</ix:nonFraction></span> for the years ended August 31, 2020, 2019, and 2018, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_239_zaSjdMF4769e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zKYYKEeHdqpj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zhwzmOgScJ18" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 73 -->
    <div id="xdx_232_zaPrlpdneVba" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_zhOS1DoKjrHl" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td id="xdx_231_zqkM4AWTgh1l" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_235_zP2VtASSVB4a" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_z5ADTi6rDEz3" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zZEXRlJORwVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"><p id="xdx_802_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zgEeqAb9qf26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 &#8211; <span id="xdx_82B_zMsmAeLKNikj">INVESTMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company invests a portion of its
excess cash balances in short-term debt securities. Investments at August 31, 2020 consisted of corporate bonds with
maturities remaining of less than 12 months. The Company may also invest excess cash balances in certificates of deposits,
money market accounts, government-sponsored enterprise securities, corporate bonds and/or commercial paper. The Company
accounts for its investments in accordance with FASB ASC 320, Investments &#8211; Debt and Equity Securities. At August 31,
2020, all investments were classified as held-to-maturity securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables summarize the Company&#8217;s short-term
investments as of August 31, 2020. The Company had <span id="xdx_90B_eus-gaap--ShortTermInvestments_iI_do_c20190831_z32ektnUzkUg" title="Short-term investments"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2019-08-31" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> short-term investments for the year ended August 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FY 2020 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:InvestmentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--InvestmentTableTextBlock_zkCOSS5CwoJj" summary="xdx: Disclosure - INVESTMENTS (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8B6_zWYafKIsrk3d" style="display: none">Schedule of short term investment</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Gross</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Unrealized</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Gains</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Gross</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Unrealized</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Losses</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Commercial notes (due within one year)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortTermInvestments_iI_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_z5z0YeKmXdRk" title="Short term investment, amortized cost" style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2020-08-31_us-gaap_CommercialPaperMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,803,595</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" title="Gross unrealized gains" style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1255">&#8211;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_zIqg0YqQOL95" title="Gross unrealized loss" style="border-bottom: Black 1pt solid; width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" contextRef="From2019-09-012020-08-31_us-gaap_CommercialPaperMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">60,977</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" title="Short term investment, fair value" style="border-bottom: Black 1pt solid; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-08-31_us-gaap_CommercialPaperMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,742,618</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortTermInvestments_iI_c20200831_zl8P0WCnCdH2" title="Short term investment, amortized cost" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,803,595</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831_pp0p0" title="Gross unrealized gains" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1263">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831_zbSgKAap4zDc" title="Gross unrealized loss" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">60,977</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_c20200831_pp0p0" title="Short term investment, fair value" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">66,742,618</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:OtherLiabilitiesDisclosureTextBlock"><p id="xdx_80E_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zR2Xve9UfJva" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 6 - <span id="xdx_827_zUFGZpqzmAEh">CONTRACTS PAYABLE</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">DILIsym Acquisition Liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2017, the Company acquired DILIsym
Services, Inc. The agreement provided for a working capital adjustment, an eighteen-month $1,000,000 holdback provision against
certain representations and warrantees, and an Earn-out agreement of up to an additional $5,000,000 in Earn-out payments based
on earnings over the three years following acquisition. The Earn-out liability has been recorded at an estimated fair value. Payments
under the Earn-out liability will be due starting in FY 2019. In September 2018, $1,556,644 was paid out under the first earn-out
payment, a second earn-out payment was made in August 2019 in the amount of $1,682,329. The final payment of $1,761,028 was paid
in August 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"><span style="text-decoration: underline">Lixoft Acquisition Liabilities</span>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">On April 1, 2020, the Company
acquired Lixoft. The agreement provided for a twenty-four month $2,000,000 holdback provision against certain representations and
warrantees, comprised of $1,333,333 of cash and the release from an escrow shares of stock valued at $666,337 issued at the date
of the Agreement. In addition, based on a revenue growth formula for the two years subsequent to April 1, 2020, the agreement calls
for earn-out payments up to $5,500,000 (two thirds cash and one-third newly issued, unregistered shares of the Company&#8217;s
common stock). The former shareholders can earn up to $2,000,000 the first year and $3,500,000 in year two.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020 and 2019 the following
liabilities have been recorded:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:OtherLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--OtherLiabilitiesTableTextBlock_zmP989z4S3jh" summary="xdx: Disclosure - CONTRACTS PAYABLE (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B3_zIUlL5BCIDJ1" style="display: none">Schedule of Liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify">Holdback Liability - Lixoft</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zdDXDKhB3mZh" title="Total contract with customer" style="width: 11%; text-align: right"><ix:nonFraction name="simu:ContractsPayable" contextRef="AsOf2020-08-31_custom_HoldbackLiabilityLixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,333,333</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zYCijRiOKDae" title="Total contract with customer" style="width: 11%; text-align: right"><ix:nonFraction name="simu:ContractsPayable" contextRef="AsOf2019-08-31_custom_HoldbackLiabilityLixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Earn-out Liability - Lixoft</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zcPF0mZJV035" title="Total contract with customer" style="text-align: right"><ix:nonFraction name="simu:ContractsPayable" contextRef="AsOf2020-08-31_custom_EarnoutLiabilityLixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,730,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zbVdJZcSIkt" title="Total contract with customer" style="text-align: right"><ix:nonFraction name="simu:ContractsPayable" contextRef="AsOf2019-08-31_custom_EarnoutLiabilityLixoftMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Earn-out Liability - Dilisym</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zr63wDRbjKu7" title="Total contract with customer" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="simu:ContractsPayable" contextRef="AsOf2020-08-31_custom_EarnoutLiabilityDilisymMember" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zBzDvLHfQomf" title="Total contract with customer" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="simu:ContractsPayable" contextRef="AsOf2019-08-31_custom_EarnoutLiabilityDilisymMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Sub Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ContractWithCustomerLiability_c20200831_pp0p0" title="Total contract with customer" style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiability" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,063,833</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ContractWithCustomerLiability_c20190831_pp0p0" title="Total contract with customer" style="text-align: right"><ix:nonFraction name="us-gaap:ContractWithCustomerLiability" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Current Portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ContractsPayableCurrent_iI_pp0p0_c20200831_zqRAm4D7al37" title="Less: Current Portion" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="simu:ContractsPayableCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,000,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ContractsPayableCurrent_iI_pp0p0_c20190831_zno9uBoiCO5k" title="Less: Current Portion" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="simu:ContractsPayableCurrent" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,761,028</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Long-Term</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--ContractsPayableNoncurrent_iI_pp0p0_c20200831_zPVMD6c1oMi4" title="Long-Term" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:ContractsPayableNoncurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,063,833</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--ContractsPayableNoncurrent_iI_pp0p0_d0_c20190831_zuUCoc68wCn4" title="Long-Term" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="simu:ContractsPayableNoncurrent" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_234_zozy6PaPktZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_238_zQsT507QSTcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_zT2Lkwh0AzS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 74 -->
    <div id="xdx_238_z00NWMdxPFv7" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zG8RzpsvK8aa" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td id="xdx_236_zP1HSnXpSAf" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23D_zFy0ee2n3ZL" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zRitWffnJOrg" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_z5FuqcJIhYZ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_ziW0IEDTohJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 - <span id="xdx_820_z05mb5RXPU4">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Leases</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We lease approximately 13,500 square feet
of space in Lancaster, California. The original lease had a five-year term with two, three-year options to extend. The initial
five-year term expired in February 2011, and we extended the lease to February 2, 2014. In June 2013, the lease was amended to
extend the term to February 2, 2017. The amended lease also provides for an annual base rent increase of 3% per year and two, two-year
options to extend. In May 2016 the Company exercised the two, two-year options extending the term of the lease through February
2, 2021 at a fixed rate of $25,000 per month. The new extension agreement allowed the Company with 90 days&#8217; notice to opt
out of the remaining lease in the last two years of the term upon payment of a recapture payment equal to the 3% base payment increase
that would have been due under the original agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Buffalo subsidiary leases approximately
12,623 square feet of space in Buffalo, New York. The initial five-year term expired in October 2018; and was renewed for a three-year
option to extending it to November 2021. The new base rent is $16,147 per month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DILIsym leases approximately 2,700 square
feet of space in Research Triangle Park, North Carolina. The initial three-year term was due to expire October 2020. An amendment
to the initial lease became effective April 1, 2020. This amendment added 686 square feet and extended the term of the lease to
September 30, 2023. The new base rent is approximately $7,500 per month with an annual 3% adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In Paris, France Lixoft leases approximately
2,300 square feet of office space, which as of April 1, 2020, had minimum payments equaling $288,000. The lease is for a 9-year
term, with an option to terminate every 3 years, and expires in November of 2024. The rent is $16,555 per quarter and can be adjusted
each December based on a consumer price index.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rent expense, including common area maintenance
fees for the years ended August 31, 2020, 2019 and 2018 was $<span id="xdx_90A_eus-gaap--OperatingLeaseExpense_c20190901__20200831_pp0p0" title="Rent expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">644,000</ix:nonFraction></span>, $<span id="xdx_901_eus-gaap--OperatingLeaseExpense_c20180901__20190831_pp0p0" title="Rent expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">584,000</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20170901__20180831_pp0p0" title="Rent expense"><ix:nonFraction name="us-gaap:OperatingLeaseExpense" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">567,000</ix:nonFraction></span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future minimum lease payments under non-cancelable
operating leases with remaining terms of one year or more at August 31, 2020 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zwFpebZzQH0i" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zU4P7VpsUZgk" style="display: none">Future minimum lease payments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20200831_zCQu7tjBUsOj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ending August 31,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0_maOLFMPzcU7_z9LUrgXv9M8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 33%; text-align: center">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">486,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0_maOLFMPzcU7_zNQr2PI4G4z3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">217,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0_maOLFMPzcU7_zKwWOoiB0PSk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">172,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0_maOLFMPzcU7_z1Q0If2dy0cb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">75,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_pp0p0_maOLFMPzcU7_zsICFrla2TX8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0_mtOLFMPzcU7_zq3lZfs7ArKf" style="vertical-align: bottom; background-color: White">
    <td style="visibility: hidden; text-align: center; padding-bottom: 2.5pt">Future minimum lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">961,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"><span style="text-decoration: underline">Line of Credit</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 31, 2020, Simulations Plus,
Inc. entered into a Credit Agreement with Wells Fargo Bank, N.A. The Credit Agreement, has provided Simulations Plus, Inc.
with a credit facility of $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20200331__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_pp0p0" title="Line of credit maximum amount"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2020-03-31_custom_WellsFargoMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,500,000</ix:nonFraction></span>
through <span id="xdx_90E_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20190901__20200331__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_zce35qmoJiLh" title="Line of credit expiration date"><ix:nonNumeric contextRef="From2019-09-012020-03-31_custom_WellsFargoMember" format="ixt:datemonthdayyearen" name="us-gaap:LineOfCreditFacilityExpirationDate1">April
15, 2022</ix:nonNumeric></span>. As of August 31, 2020, there were no amounts drawn against the line of credit. Interest accrues daily at the
bank&#8217;s base rate. The base rate is the rate equal to the highest of (i) the Prime Rate in effect, (ii) 1.5% above Daily
One Month LIBOR, and (iii) the Federal Funds Rate plus 1.5%. The rate at August 31, 2020 was 3.25%. Under the terms of the
agreement the borrower is to maintain a <span title="Line of credit amount outstanding">zero <span id="xdx_90A_eus-gaap--LineOfCredit_iI_pp0p0_do_c20200831__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_zzzcvRAi7gX" title="Line of credit amount outstanding" style="display: none"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2020-08-31_custom_WellsFargoMember" format="ixt-sec:numwordsen" decimals="0" scale="0" unitRef="USD">No</ix:nonFraction></span></span>
balance under this line of credit for a period of thirty consecutive days during each 12-month period commencing March 31,
2020. The Credit Agreement is collateralized by the assets of Simulations Plus Lancaster Division and is subject to certain
financial covenants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Employment Agreements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business the Company
has entered into employment agreements with certain of its key management personnel that may require compensation payments upon
termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_231_z4TucSBD4qf6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zfoFLZTfYy3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zjIgnc6c7Ur8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 75 -->
    <div id="xdx_23A_zIOSKVJrPRlj" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_236_z7GrK5KyONE6" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td id="xdx_23B_zmIDsPaqxnod" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_zsdbCwu1sEH7" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_233_zJ8B2SfLuLTl" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zvBx1No3rQKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">License Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had a royalty agreement with
Dassault Syst&#232;mes Americas Corp. for access to their Metabolite Database for developing our Metabolite Module within ADMET
Predictor&#8482;. The module was renamed the Metabolism Module when we released ADMET Predictor version 6 on April 19, 2012. Under
this agreement, we pay a royalty of 25% of revenue derived from the sale of the Metabolism/Metabolite module. This agreement was
recently renegotiated, and the Company does not bear any royalty obligations towards Dassault Syst&#232;mes Americas Corp. effective
as of June 30, 2019. In addition, the license agreement terminated on September 5, 2020. Under this agreement for the years ended
August 31, 2020, 2019 and 2018 we incurred royalty expense (benefit) of $<span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20190901__20200831_zgSI0OgHz4a4" title="Royalties expense">(<ix:nonFraction name="simu:RoyaltyExpenses" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">26,055</ix:nonFraction>)</span>, $<span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20180901__20190831_zIrj4rKBx96j" title="Royalties expense"><ix:nonFraction name="simu:RoyaltyExpenses" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">195,828</ix:nonFraction></span> and $<span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20170901__20180831_zFDxrye0Ex84" title="Royalties expense"><ix:nonFraction name="simu:RoyaltyExpenses" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">175,740</ix:nonFraction></span>, respectively. The Company
is in the process of replacing the database.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Litigation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not a party to any legal proceedings
and are not aware of any pending legal proceedings of any kind.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zsQqEUnKsSkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 - <span id="xdx_821_z7BjDRZPCPwe">SHAREHOLDERS' EQUITY</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Dividend </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s Board of Directors
declared cash dividends during fiscal year 2020, 2019 and 2018. The details of dividend paid are in the following tables:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfDividendsPayableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDividendsPayableTextBlock_zYXn5OwzWm9f" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zwwsUCr2hev7" style="display: none">Schedule of dividends declared and paid</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="15" style="font-weight: bold; text-align: center">FY2018</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br /> Outstanding on<br /> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br /> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_908_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" title="Record Date"><ix:nonNumeric contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">11/13/2017</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_983_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" title="Distribution Date" style="width: 26%; text-align: center"><ix:nonNumeric contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">11/20/2017</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" title="Number of Shares Outstanding on Record Date" style="width: 11%; text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,284,792</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" title="Dividend per Share" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pp0p0" title="Total Amount" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,037,088</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_909_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" title="Record Date"><ix:nonNumeric contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">1/26/2018</ix:nonNumeric></span></td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" title="Distribution Date" style="text-align: center"><ix:nonNumeric contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">2/02/2018</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" title="Number of Shares Outstanding on Record Date" style="text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,317,752</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" title="Dividend per Share" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pp0p0" title="Total Amount" style="text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,039,065</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" title="Record Date"><ix:nonNumeric contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">4/25/2018</ix:nonNumeric></span></td><td>&#160;</td>
    <td id="xdx_981_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" title="Distribution Date" style="text-align: center"><ix:nonNumeric contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">5/02/2018</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" title="Number of Shares Outstanding on Record Date" style="text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,354,005</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" title="Dividend per Share" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pp0p0" title="Total Amount" style="text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,041,240</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" title="Record Date"><ix:nonNumeric contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">7/26/2018</ix:nonNumeric></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" title="Distribution Date" style="text-align: center; padding-bottom: 1pt"><ix:nonNumeric contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">8/02/2018</ix:nonNumeric></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" title="Number of Shares Outstanding on Record Date" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,405,775</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" title="Dividend per Share" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pp0p0" title="Total Amount" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,044,347</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--Dividends_c20170901__20180831_pp0p0" title="Total Amount" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,161,740</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FY2019</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br /> Outstanding on<br /> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br /> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" title="Record Date"><ix:nonNumeric contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">11/01/2018</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" title="Distribution Date" style="width: 26%; text-align: center"><ix:nonNumeric contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">11/08/2018</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" title="Number of Shares Outstanding on Record Date" style="width: 11%; text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,417,875</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" title="Dividend per Share" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pp0p0" title="Total Amount" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,045,073</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" title="Record Date"><ix:nonNumeric contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">1/25/2019</ix:nonNumeric></span></td><td>&#160;</td>
    <td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" title="Distribution Date" style="text-align: center"><ix:nonNumeric contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">2/01/2019</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" title="Number of Shares Outstanding on Record Date" style="text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,481,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" title="Dividend per Share" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pp0p0" title="Total Amount" style="text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,048,887</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" title="Record Date"><ix:nonNumeric contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">4/24/2019</ix:nonNumeric></span></td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" title="Distribution Date" style="text-align: center"><ix:nonNumeric contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">5/01/2019</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" title="Number of Shares Outstanding on Record Date" style="text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,515,228</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" title="Dividend per Share" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pp0p0" title="Total Amount" style="text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,050,914</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" title="Record Date"><ix:nonNumeric contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">7/25/2019</ix:nonNumeric></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" title="Distribution Date" style="text-align: center; padding-bottom: 1pt"><ix:nonNumeric contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">8/01/2019</ix:nonNumeric></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" title="Number of Shares Outstanding on Record Date" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,536,454</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" title="Dividend per Share" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pp0p0" title="Total Amount" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,052,181</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--Dividends_c20180901__20190831_pp0p0" title="Total Amount" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,197,055</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_237_zsM0MyFoIlNg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zo2Gble6F55h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_230_zmtvDs9Dv3Dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 76 -->
    <div id="xdx_23C_zqAvUW5C0svd" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23D_z109wiZDAaKb" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td id="xdx_23D_zHoktMK5ujY" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_230_zupylJWQiUq5" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zjNGb7YHU4Bd" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zEm6KlIuFuuc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FY2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br /> Outstanding on<br /> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br /> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_904_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" title="Record Date"><ix:nonNumeric contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">10/25/2019</ix:nonNumeric></span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_98C_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" title="Distribution Date" style="width: 26%; text-align: center"><ix:nonNumeric contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">11/01/2019</ix:nonNumeric></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" title="Number of Shares Outstanding on Record Date" style="width: 11%; text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,606,314</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" title="Dividend per Share" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pp0p0" title="Total Amount" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,056,379</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" title="Record Date"><ix:nonNumeric contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">1/27/2020</ix:nonNumeric></span></td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" title="Distribution Date" style="text-align: center"><ix:nonNumeric contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">2/03/2020</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" title="Number of Shares Outstanding on Record Date" style="text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,645,639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" title="Dividend per Share" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pp0p0" title="Total Amount" style="text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,058,740</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" title="Record Date"><ix:nonNumeric contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">4/24/2020</ix:nonNumeric></span></td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" title="Distribution Date" style="text-align: center"><ix:nonNumeric contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">5/01/2020</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" title="Number of Shares Outstanding on Record Date" style="text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,769,134</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" title="Dividend per Share" style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pp0p0" title="Total Amount" style="text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,066,148</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" title="Record Date"><ix:nonNumeric contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateOfRecordDayMonthAndYear">7/27/2020</ix:nonNumeric></span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" title="Distribution Date" style="text-align: center; padding-bottom: 1pt"><ix:nonNumeric contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member" format="ixt:datemonthdayyear" name="us-gaap:DividendsPayableDateDeclaredDayMonthAndYear">8/03/2020</ix:nonNumeric></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" title="Number of Shares Outstanding on Record Date" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,820,057</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" title="Dividend per Share" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:CommonStockDividendsPerShareDeclared" contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.06</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pp0p0" title="Total Amount" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,069,203</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--Dividends_c20190901__20200831_pp0p0" title="Total Amount" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Dividends" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,250,470</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zolEj0uCF6w8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although dividend distributions are currently
expected to continue on a quarterly basis, the Company&#8217;s Board of Directors reserves the right to discontinue the dividend
distribution any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Stock Option Plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 23, 2007, the Board of Directors
adopted, and the shareholders approved, the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had
been reserved for issuance. On February 25, 2014 the shareholders approved an additional 1,000,000 shares increasing the total
number of shares that may be granted under the Option Plan to 2,000,000. This plan terminated in February 2017 by its term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 23, 2016 the Board of Directors
adopted, and on February 23, 2017 the shareholders approved, the 2017 Equity Incentive Plan under which a total of <span id="xdx_90F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pii_c20200831__us-gaap--PlanNameAxis__custom--Equity2017IncentivePlanMember_zmp3voatPznc" title="Common stock reserved for issuance under the plan"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2020-08-31_custom_Equity2017IncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares
of common stock has been reserved for issuance. This plan will terminate in <span title="Equity plan termination date">December 2026</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, employees and directors
hold stock options to purchase 1,223,661 shares of common stock at exercise prices ranging from $6.75 to $61.84 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information
about stock options:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zSr229JwgMK" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"><span id="xdx_8B7_zAN0GhH22zpg" style="display: none">Schedule of stock option activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY18</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br /> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br /> Exercise Price <br /> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br /> Remaining<br /> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2017</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEmJKLz0jDak" title="Option outstanding, beginning balance" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2017-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,249,126</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqZvx2UgdR4f" title="Outstanding" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2017-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.51</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--OutstandingRemainingContractualLife_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zl3sQ6c8ZNv4" title="Outstanding, beginning of period" style="width: 11%; text-align: right"><ix:nonNumeric contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="simu:OutstandingRemainingContractualLife">7.74</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZeGbhUIA3Ie" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">22.36</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfdHMQEFvLOf" title="Exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">130,006</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.97</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1CCY01E1Ei7" title="Canceled/Forfeited" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,144</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Canceled/Forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z74F6X7O9K5h" title="Expired" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Expired" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.06</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2018</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaIyp400GGif" title="Options Outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,134,976</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpYo4tgysgU9" title="Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.44</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAJq5Md5lLd1" title="Outstanding, end of period" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonNumeric contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">7.31</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8uNDYErUvQe" title="Vested and Exercisable, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">483,696</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPmTRz5nZlv7" title="Vested and Exercisable, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.79</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDGEoaKkCZae" title="Vested and Exercisable" style="text-align: right"><ix:nonNumeric contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">6.48</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zze8rqGw8XUb" title="Vested and Expected to Vest, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,069,807</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJgbTPCiBn38" title="Vested and Expected to Vest, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.35</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z25uFgz35HD1" title="Vested and Expected to Vest" style="text-align: right"><ix:nonNumeric contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">7.26</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:exclude><p id="xdx_238_zueVKxHZY2M3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_233_zYVYALQBkt6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zLorsKegdQF" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 77 -->
    <div id="xdx_234_zLLTngQcDHV7" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_znGl9oBAcOE2" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td id="xdx_23B_z9SBEo2nQRF" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_z0JWtZo9KBPe" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zCR4Yw7HeOeg" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zNQC2lkjWWR2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY19</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br /> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br /> Exercise Price <br /> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br /> Remaining<br /> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5tiSbVHNHQ1" title="Option outstanding, beginning balance" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,134,976</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuNgDguDPFJe" title="Outstanding" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.44</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--OutstandingRemainingContractualLife_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zD4mZtpPQaA5" title="Outstanding, beginning of period" style="width: 11%; text-align: right"><ix:nonNumeric contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="simu:OutstandingRemainingContractualLife">7.31</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">263,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">22.78</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0tul9S7E3z1" title="Exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">166,703</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">7.15</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXwRjy9aqy1i" title="Canceled/Forfeited" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">68,514</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Canceled/Forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1539">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1541">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyUPwLwkZob1" title="Awards Outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,163,259</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWmBv4a6At8j" title="Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.63</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zK0zy9D79jIl" title="Outstanding, end of period" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonNumeric contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">7.13</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znG6VYz2SlH5" title="Vested and Exercisable, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">515,394</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfXkUtlWsXEe" title="Vested and Exercisable, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.57</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDfas0zUwvOj" title="Vested and Exercisable" style="text-align: right"><ix:nonNumeric contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">6.09</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zczJzIX8cWB3" title="Vested and Expected to Vest, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,101,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zoOfywrKUdhd" title="Vested and Expected to Vest, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.39</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqPPJ0FIpf0f" title="Vested and Expected to Vest" style="text-align: right"><ix:nonNumeric contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">7.07</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY20</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br /> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br /> Exercise Price <br /> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br /> Remaining<br /> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfwOBZP38bxa" title="Option outstanding, beginning balance" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,163,259</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zmjiDHvEm9nh" title="Outstanding" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.63</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--OutstandingRemainingContractualLife_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXj9Bfgi1CYh" title="Outstanding, beginning of period" style="width: 11%; text-align: right"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="simu:OutstandingRemainingContractualLife">7.13</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">223,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">39.23</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zItDmrTb6cn5" title="Exercised" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">121,647</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.29</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfnRZ3cit0Og" title="Canceled/Forfeited" style="text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,951</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Canceled/Forfeited" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.19</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1579">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Expired" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1581">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrsDghe0G1o2" title="Awards Outstanding, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,223,661</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuwytd9hDha9" title="Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.76</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zRiA6Cw8x8ab" title="Outstanding, end of period" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">6.79</ix:nonNumeric></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqA24fEGqDMa" title="Vested and Exercisable, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">596,311</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0hy42e5eOR2" title="Vested and Exercisable, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.69</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z97XlNuraP17" title="Vested and Exercisable" style="text-align: right"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">5.59</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfCoaGynvyS4" title="Vested and Expected to Vest, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,194,239</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpvw61my3nP5" title="Vested and Expected to Vest, end of period" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvoPhIIhYss9" title="Vested and Expected to Vest" style="text-align: right"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">6.77</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A4_zrmavE32Mks9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Intrinsic Value of options outstanding and options exercisable</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_zZvHpp2Iyuo" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BC_zw3Qq8hTf1wl" style="display: none">Intrinsic Value of options outstanding and options exercisable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value<br /> of Options<br /> Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic<br /> Value of <br /> Options<br /> Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic <br /> Value of<br /> Options<br /> Exercised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">FY18</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Outstanding" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,064,884</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Exercisable" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,315,086</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Exercised" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,495,313</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>FY19</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,312,742</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Exercisable" style="text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,194,724</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,224,454</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>FY20</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,272,966</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Exercisable" style="text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,150,912</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Intrinsic Value of Options Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,085,753</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A3_zCGlJu08KFZ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted-average remaining contractual
life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified SO, was <span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zBhm4J4yox96" title="Weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="simu:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">6.79</ix:nonNumeric></span> years at August 31, 2020.
The total fair value of non-vested stock options as of August 31, 2020 was $<span id="xdx_90C_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pp0p0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNVGLtYjHq27" title="Fair value of non-vested options"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,122,054</ix:nonFraction></span> and is amortizable over a weighted average
period of <span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEHuW7CinWU1" title="Fair value amortization period"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">3.39</ix:nonNumeric></span> years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_232_z61LCc0spRFf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23F_zIv0sPkjXAtk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_237_zTepi6T4Lohb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_232_z0pfx5mN6Ho1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 78 -->
    <div id="xdx_234_zIYIaGwlgsU3" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23C_zhU9kMAY2DP" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td id="xdx_23B_zda0cJA8tuN" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zADyacSENsve" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23B_ziZXQEfL53K1" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zqVyGuq5SBph" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"><span style="background-color: white">The
fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model. The Black-Scholes
option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions
and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including
the expected stock price volatility. Because our stock options have characteristics significantly different from those of traded
options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's
opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">The following table summarizes
the fair value of the options, including both ISOs and NQSOs, granted during the current fiscal year 2020 and fiscal year 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_znYDjjsdi7f3" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zqwPDquoB8v" style="display: none">Schedule of fair value of options</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20190901__20200831_zvzmEAwEbUs8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20180901__20190831_zsycPpqRHxNh" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">FY 2020</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">FY 2019</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_403_ecustom--FairValueOptionsGranted_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Estimated fair value of awards granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="simu:FairValueOptionsGranted" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,997,120</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="simu:FairValueOptionsGranted" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,928,820</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_dp_z0I9GPJv0zMd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unvested Forfeiture Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="simu:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="simu:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.20</ix:nonFraction>%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_i_pii" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average grant price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">39.23</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">22.78</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--WeightedAverageMarketPrice_i_pii" style="vertical-align: bottom; background-color: White">
    <td>Weighted average market price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="simu:WeightedAverageMarketPrice" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">39.23</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="simu:WeightedAverageMarketPrice" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">22.69</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_zd4EBYOt8dfh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">33.56</ix:nonFraction>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">31.61</ix:nonFraction>%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_zKQYAbPzJk37" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.39</ix:nonFraction>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.59</ix:nonFraction>%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_znRMoWL42Moa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.65</ix:nonFraction>%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.10</ix:nonFraction>%</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20190901__20200831_zcTIMfsoCyM5" title="Weighted average expected life"><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.67</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20180901__20190831_zYfunD3yDYn4" title="Weighted average expected life"><ix:nonNumeric contextRef="From2018-09-012019-08-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">6.64</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A8_zjnEgW8tDcdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise prices for the options outstanding
at August 31, 2020 ranged from $6.75 to $61.84, and the information relating to these options is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zwYNb1ixCUm9" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left"><span id="xdx_8B6_zU4aeSWAm19l" style="display: none">Schedule of options by exercise price range</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quantity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted <br /> Average<br /> Remaining<br /> Contractual<br /> Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br /> Average<br /> Exercise<br /> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quantity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br /> Average<br /> Remaining<br /> Contractual <br /> Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br /> Average<br /> Exercise<br /> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" title="Exercise price low" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.75</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" title="Exercise price high" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" title="Awards outstanding" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">177,730</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zYAgfXhLp8Ee" title="Awards outstanding weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">4.0</ix:nonNumeric></span> years</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" title="Awards outstanding weighted average exercise price" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.85</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" title="Awards exercisable" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">177,730</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zLHJiQHfJld" title="Awards exercisable weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">4.0</ix:nonNumeric></span> years</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" title="Awards exercisable weighted average exercise price" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.85</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" title="Exercise price low" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.01</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" title="Exercise price high" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" title="Awards outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">547,901</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zUXqLed3JHo1" title="Awards outstanding weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">6.0</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" title="Awards outstanding weighted average exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.98</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" title="Awards exercisable" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350,721</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zKjm2Zf3Jfo3" title="Awards exercisable weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">6.0</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" title="Awards exercisable weighted average exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.97</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" title="Exercise price low" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.01</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" title="Exercise price high" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">24.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" title="Awards outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">230,280</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_ztnBAqKE8ai2" title="Awards outstanding weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.8</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" title="Awards outstanding weighted average exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">20.70</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" title="Awards exercisable" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">50,560</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_zTqdaOALFxM7" title="Awards exercisable weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">7.2</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" title="Awards exercisable weighted average exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">21.18</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" title="Exercise price low" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">24.01</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" title="Exercise price high" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">38.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" title="Awards outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">204,950</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zlKX79epvqOa" title="Awards outstanding weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">9.1</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" title="Awards outstanding weighted average exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">33.45</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" title="Awards exercisable" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zA6ylx0XQ703" title="Awards exercisable weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">8.9</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" title="Awards exercisable weighted average exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">34.23</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" title="Exercise price low" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">38.01</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" title="Exercise price high" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" title="Awards outstanding" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">19,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zJU0o2pDpEO5" title="Awards outstanding weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price5Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">9.6</ix:nonNumeric></span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" title="Awards outstanding weighted average exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">38.64</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zpz92DykdhW" title="Awards exercisable" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zniP2siXJeXk" title="Awards exercisable weighted average exercise price" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member" format="ixt:zerodash" decimals="INF" unitRef="USDPShares">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" title="Exercise price low" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.01</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" title="Exercise price high" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">61.84</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" title="Awards outstanding" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">43,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zTkUdVyurq8h" title="Awards outstanding weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price6Member" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">9.9</ix:nonNumeric></span> years</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" title="Awards outstanding weighted average exercise price" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">61.84</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zT7mHUedCxAa" title="Awards exercisable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member" format="ixt:zerodash" decimals="INF" unitRef="Shares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zGi5unlxX5Eg" title="Awards exercisable weighted average exercise price" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member" format="ixt:zerodash" decimals="INF" unitRef="USDPShares">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Awards outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,223,661</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z56sDULWgo2g" title="Awards outstanding weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">6.8</ix:nonNumeric></span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Awards outstanding weighted average exercise price" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">17.76</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Awards exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">596,311</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDOY9JpQkOe8" title="Awards exercisable weighted average remaining contractual life"><ix:nonNumeric contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">5.6</ix:nonNumeric></span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" title="Awards exercisable weighted average exercise price" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2020-08-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.69</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_zkS872X5dTVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Follow-on Public Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020, the company closed an
underwritten public offering of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190901__20200831_zRppK3jiVJt" title="Shares issued under public offering"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,090,909</ix:nonFraction></span>
shares of its common stock to the public at $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20200831_zFv4QnpxOAS2" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">55.00</ix:nonFraction></span>
per share, which included the full exercise of the underwriters&#8217; option to purchase 272,727 additional shares of common
stock. The aggregate gross proceeds to the company from this offering were approximately $<span title="Proceeds from public offering">115</span>
million, before deducting underwriting discounts and commissions; net proceeds were approximately $<span title="Proceeds from public offering">107.7</span>
million <span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_dm_c20190901__20200831_zkqECWzRjuUf" title="Proceeds from public offering" style="display: none"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">107,747,338</ix:nonFraction></span>. The offering was made pursuant to the Company&#8217;s automatic shelf registration statement on Form S-3 filed with
the Securities and Exchange Commission on July 9, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_233_zW7veMPwy2De" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_239_z7Hzdq1Kh8O9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z0u7DzTek5Df" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 79 -->
    <div id="xdx_23B_zh2txYtl1Nb9" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_238_zNqCdwUQvKW2" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td id="xdx_23F_zOqD6zEZKQ5c" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23F_zHE6HCJSwJv4" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zmQcWk72hbi7" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23D_zfzeUbyIseG1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zqXIMdHYeqik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 - <span id="xdx_821_zW29q5bloEtc">INCOME TAXES </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We utilize FASB ASC 740-10, <i>&#8220;Income
Taxes&#8221;</i> which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences
of events that have been included in the financial statements or tax returns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of the income tax provision
for fiscal year 2020, 2019 and 2018 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zMFfFcQt1xmg" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax provision)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span id="xdx_8B7_zagOldVKEnd2" style="display: none">Components of the income tax provision</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20190901__20200831_zsYtLRMf3OBk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20180901__20190831_zeGGgwkwikue" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20170901__20180831_zVeZB6h85yt3" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zgXzb3eafgh1" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; padding-left: 10pt">Federal</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,097,725</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,794,596</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,370,955</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zrEF9BuHWLX7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">477,744</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">426,364</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">460,619</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zPmxairo0Us4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">39,038</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,285</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentForeignTaxExpenseBenefit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">104,377</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01T_pp0p0_mtCITEBzgOr_maITEBzYIH_zYSUWo71p3u6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Total current tax expense (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,614,507</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,272,245</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,935,951</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zPDAa5MwzY3a" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">427,644</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,730</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,698,201</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zhjqJZaXPJ6k" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">131,874</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">158,368</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,620</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i01NT_pp0p0_di_mtDITATzwIq_maITEBzYIH_znxE5mdhb7E9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Total deferred federal and state</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">559,518</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">299,098</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndTaxCredits" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,731,821</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_i01T_pp0p0_mtITEBzYIH_zVNPzpxQZ4df" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,054,989</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,973,147</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,204,130</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_zQSaklA9ztf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A reconciliation of the expected income
tax (benefit) computed using the federal statutory income tax rate to the Company's effective income tax rate is as follows for
fiscal year 2020, 2019 and 2018:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zwqw6tDO2oE6" summary="xdx: Disclosure - INCOME TAXES (Details - Reconciliation)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_zeHlw3e1gyG1" style="display: none">Effective income tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20200831_zFPXY8wYHiw" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20180901__20190831_zyR2udabmake" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20170901__20180831_zrqvTJHUFK8b" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_ziFhmue5SCxk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; text-align: justify">Income tax computed at federal statutory tax rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21.0</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">25.4</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zDRpPq6iHdq4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">State taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_dp_zIis2XbHznzg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Meals &amp; entertainment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_dp_zrqJXLlMHj01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">1.2</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">2.6</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.5</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_zAcMWigEiG6l" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Other permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.3</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.7</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.2</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pii_dpi_znSDn1apBFKl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Research and development credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.7</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.3</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.6</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pii_dp0_z827QgPMm06a" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Foreign tax related differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">1.4</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_pii_dp0_zF2T52Vq8bWl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Research &amp; credit adjustments to expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.3</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" contextRef="From2017-09-012018-08-31" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_iN_pii_dpi0_z3szFnvHwqD6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Domestic production activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" contextRef="From2019-09-01to2020-08-31" format="ixt:zerodash" decimals="INF" scale="-2" sign="-" unitRef="Pure">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="INF" scale="-2" sign="-" unitRef="Pure">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.8</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp0_zb9Ev8H2igD5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Change in deferred income taxes due to statutory rate changes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2019-09-01to2020-08-31" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2018-09-012019-08-31" format="ixt:zerodash" decimals="INF" scale="-2" unitRef="Pure">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">14.8</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zcBS6RXu5rO7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Change in prior year estimated taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">1.8</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.9</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Pure">0.0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zpRtCO6unFB3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18.0</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18.7</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.9</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr>
</table>


</ix:nonNumeric><p id="xdx_8A9_zwONgyhDMZgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23D_z1nzIjvIDut8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zKA0FbvvDWt1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zmvVke4qom9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 80 -->
    <div id="xdx_23F_z55hArTzHlNf" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23F_zICO6DFy3SD" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td id="xdx_232_zJGiWL8EeFmd" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_236_zt08EUKfY60f" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zhE8VLlicH77" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zfB6YXj6sgJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant components of the Company's
deferred tax assets and liabilities for income taxes for the fiscal years ended August 31, 2020 and 2019 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zCZXffuI3e0f" summary="xdx: Disclosure - INCOME TAXES (Details - Deferred taxes)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span id="xdx_8B0_zIMmSciWJ2ml" style="display: none">Components of the Company deferred tax assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20200831_zTX8Mol7GUm7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20190831_zVTY58QvbX8f" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_i01I_pp0p0_maDTAGz4SD_zU0Uta00rk6g" style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; text-align: left; padding-left: 10pt">Accrued payroll and other expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">402,355</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">236,455</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_pp0p0_maDTAGz4SD_zZOAjNd9Pare" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,862</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">55,038</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsEquityMethodInvestments_i01I_pp0p0_maDTAGz4SD_zvFnqPWEw25l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Capitalized merger costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsEquityMethodInvestments" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">742,056</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsEquityMethodInvestments" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">361,103</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_i01I_pp0p0_maDTAGz4SD_z60sjSZnITR3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,301</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsStateTaxes_i01I_pp0p0_maDTAGz4SD_zrJrwnpRb7D8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsStateTaxes" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">100,326</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsStateTaxes" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">89,537</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_d0_maDTAGz4SD_zaWJXuWwKFK9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Allowance for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,450</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_i01I_pp0p0_maDTAGz4SD_zLl3hW3ixf18" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">State tax deferred</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,417</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">146,815</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGz4SD_maDTANzteO_z0LDpi0OTbMk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,398,143</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">898,249</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di0_msDTANzteO_zBSFWqsm3dxk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2020-08-31" format="ixt:zerodash" decimals="0" scale="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2019-08-31" format="ixt:zerodash" decimals="0" scale="0" sign="-" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzteO_maDTALNzZow_zEciOfMQmQ2h" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Deferred tax asset</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,398,143</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">898,249</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di_maDITLzYzc_zAUCDGKx7tF5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">81,910</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,991</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesOther_i01NI_pp0p0_di_maDITLzYzc_z5MOCRbkd2a5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">State tax deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">19,468</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesOther" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,471</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_pp0p0_di_maDITLzYzc_ztqmljXTTbAc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,876,274</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,217,234</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_i01NI_pp0p0_di_maDITLzYzc_zkggYemUV7H5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Capitalized computer software development costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,774,349</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,334,169</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di_mtDITLzYzc_msDTALNzZow_zwTcyyi37Vye" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,752,001</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,629,865</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_i01NTI_pp0p0_di_mtDTALNzZow_zs9zP256ZpUe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net deferred tax liabilities</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,353,858</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" contextRef="AsOf2019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,731,616</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A1_z2yUitcNsUd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We follow guidance issued by the FASB with
regard to our accounting for uncertainty in income taxes recognized in the financial statements. Such guidance prescribes a recognition
threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than
not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume
that the tax position will be examined by taxing authorities. Our policy is to include interest and penalties related to income
tax expense. Interest and penalties totaled $<span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20190901__20200831_pp0p0" title="Interest and penalties"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">332</ix:nonFraction></span>, $<span id="xdx_907_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20180901__20190831_pp0p0" title="Interest and penalties"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,531</ix:nonFraction></span>, and $-<span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20170901__20180831_pp0p0" title="Interest and penalties"><ix:nonFraction name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">0</ix:nonFraction></span>- for fiscal years 2020, 2019, and 2018, respectively. We file
income tax returns with the IRS and various state jurisdictions and India. Our federal income tax returns for fiscal year 2016
thru 2019 are open for audit, and our state tax returns for fiscal year 2015 through 2019 remain open for audit. In addition, our
California tax return for the fiscal year 2007 and fiscal year 2008 remains open with regard to R&amp;D tax credits as a result
of a previous audit for which we received a letter from the California Franchise Tax Board stating that an audit will not be conducted
for those years at this time; however it may be subject to future audit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our review of prior year tax positions
using the criteria and provisions presented in guidance issued by FASB did not result in a material impact on our financial position
or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_80B_eus-gaap--ConcentrationRiskDisclosureTextBlock_zLyfrtLhpVGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10 &#8211; <span id="xdx_82B_z3ByhgWpmBe3">CONCENTRATIONS AND UNCERTAINTIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially
subject the Company to concentration of credit risk consist principally of cash, cash equivalents and trade accounts receivable.
The Company holds cash and cash equivalents at banks located in California, with balances that often exceed FDIC insured limits.
Historically, the Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit
risk on cash and cash equivalents. However, considering the current banking environment, the Company is investigating alternative
ways to minimize its exposure to such risks. While the Company may be exposed to credit losses due to the nonperformance of its
counterparties, the Company does not expect the settlement of these transactions to have a material effect on its results of operations,
cash flows or financial condition. The Company maintains cash at financial institutions that may, at times, exceed federally insured
limits. At August 31, 2020, the Company had cash and cash equivalents exceeding insured limits by $<span id="xdx_903_eus-gaap--CashUninsuredAmount_c20200831_pp0p0" title="Cash and cash equivalents exceeding insured limits"><ix:nonFraction name="us-gaap:CashUninsuredAmount" contextRef="AsOf2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,790,000</ix:nonFraction></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_239_zsI7rDwJsx4c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zKTwRITQoiG6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 81 -->
    <div id="xdx_23F_zAMCkmP2k5e5" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_231_zP9DlUdPYir2" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td id="xdx_23D_zxeTSROtnne4" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_235_zVAYGy9sFqng" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_zWzoeYBliPUj" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zGc1qkvdIBp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue concentration shows that international
sales accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_ztMkU0azh3F1" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-09-012020-08-31_us-gaap_SalesMember_custom_InternationalSalesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29</ix:nonFraction></span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_zFijk4CsFE8" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2018-09-012019-08-31_us-gaap_SalesMember_custom_InternationalSalesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction></span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_zUnsrper1evb" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_InternationalSalesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">39</ix:nonFraction></span>% of net sales for fiscal years 2020, 2019 and 2018, respectively. Three customers accounted
for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zjUMSmrDTvca" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zAbmMpN7R8hf" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>% (a dealer account in Japan representing various customers), and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_zfubQZlpyaFc" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>% of net sales for fiscal year 2020. Three customers
accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zedJITtibWqf" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zP6et4e5nok7" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% (a dealer account in Japan representing various customers), and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_z1yx07xGTmd1" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>% of net sales for fiscal year 2019. Four
customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zBXeKPfsfSJg" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer1Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>% (a dealer account in Japan representing various customers), <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zSStXQj3gXX9" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer2Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7</ix:nonFraction></span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_zY9vq8sXyxJl" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer3Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6</ix:nonFraction></span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer4Member_zzIffaJSpaHf" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer4Member" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% of net sales for fiscal year
2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FY20 accounts receivable concentrations
show that two customers comprised <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ACustomerMember_zbmzWSy1zkJg" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-09-012020-08-31_us-gaap_AccountsReceivableMember_custom_ACustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--BCustomerMember_zf4UkKL5y218" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2019-09-012020-08-31_us-gaap_AccountsReceivableMember_custom_BCustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% of accounts receivable as of August 31, 2020, respectively. FY19 accounts receivable
concentrations show that one customer comprised <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ACustomerMember_zuzPRWeNKvNl" title="Net sales concentration percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2018-09-012019-08-31_us-gaap_AccountsReceivableMember_custom_ACustomerMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% of accounts receivable as of August 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate in the computer software industry,
which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop
new products and find new distribution channels for new and existing products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The majority of our customers are in the
pharmaceutical industry. During economic downturns, we have seen consolidations in the pharmaceutical industry. Although we have
not seen any significant reduction in total revenues to date, our growth rate could be affected by consolidation and downsizing
in the pharmaceutical industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80D_eus-gaap--SegmentReportingDisclosureTextBlock_zGBLN5PDfWCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 11 &#8211; <span id="xdx_825_zCN6KCYbWm0f">SEGMENT AND GEOGRAPHIC REPORTING</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for segments and geographic
revenues in accordance with guidance issued by the FASB. Our reportable segments are strategic business units that offer different
products and services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Results for each segment and consolidated
results are as follows years ended August 31, 2020, 2019 and 2018 (in thousands, because of rounding, numbers may not foot):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_znlQ7VnPMeuh" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_zNsYceOS2LWd" style="display: none">Schedule of consolidated results from reportable segments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2020</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zIPywJ9pGXG6" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,961</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zv5nt7qgAwVl" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,105</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zpSrOIEUz3u3" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,948</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z6YM73V6Tbi4" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,575</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z45ynvxMb8E4" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41,589</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zJ2MUtMlxgHb" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-09-012020-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zoj7oGP9L2Fg" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,770</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcuWRU2Zh0Ld" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,744</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zeOykSYmylh1" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">717</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zrqzGSMYVjS5" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,605</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zoGXa3yNB2kk" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">162,807</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zin2MELpq9Me" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-08-31_custom_CognigenMember137486437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,654</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zRkJH5towc67" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-08-31_custom_DILIsymMember137486453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,084</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z1jzyh0rhdOb" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-08-31_custom_LixoftMember137486453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,972</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20200831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zT7pazXMHsre" title="Total assets" style="text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-08-31_srt_ConsolidationEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">40,095</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zh4OWXVwA3g5" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2020-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168,422</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_d0_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3ajge7nSrk2" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31_custom_SimulationsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zkwSfZBdeeNd" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31_custom_CognigenMember137486437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,789</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNhiendOEiug" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31_custom_DILIsymMember137486453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zHwKetURkVg9" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31_custom_LixoftMember137486453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,534</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zDvZcR44EVs4" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,921</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLu0FkKhDyKk" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-09-012020-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">111</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zDVXBHkGYpee" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxQZg4WltYoi" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">31</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zfQWcGWgrRm5" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zwR5az5tFyg1" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">231</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zs0LFsjXIq02" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2020-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,028</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdmmXcyK1fG4" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2020-08-31_custom_CognigenMember137486437" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcHgswTtk81b" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2020-08-31_custom_DILIsymMember137486453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">124</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zIAbtTkh5Gvj" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2020-08-31_custom_LixoftMember137486453" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">160</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zAYhe7mp9Dld" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2020-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,353</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3efLMHOP3q6" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-09-012020-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,713</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zrwFSKywakDf" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">349</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0G2yjTh1Bx1" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">600</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zxs5NEQo86f6" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zab7kr5cEef6" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,962</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_239_zIY573PxCwHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_236_zpZv4DwDJITi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23C_zAF9iwJZugkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 82 -->
    <div id="xdx_238_zkxpnyl9c8t9" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_238_z5G1QVVmtIG8" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td id="xdx_234_zgWnGo5DnAs" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_zG6ax0kmqnLa" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_236_zPiZYgBFhv44" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zsRGzL79OKQk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2019</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zn3r6NCB494a" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,585</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zyOyqLDUPZTl" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,321</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zASPvToUczt7" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,065</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z2ciSn1N3Ey" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,970</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zjpV8RYaPKla" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2018-09-012019-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,752</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zqO7zlgLC8xi" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,481</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4AGL3fHx2F7" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,416</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_znd8uMPtLDe" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,648</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zKuiVv1veg41" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,535</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zzv2ZI8pODkb" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-08-31_custom_CognigenMember137486625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,196</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXvzQfUGkEq1" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-08-31_custom_DILIsymMember137486640" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,168</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zHIsFlb4Ilfa" title="Total assets" style="text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-08-31_srt_ConsolidationEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,702</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zC4oN1WXivla" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2019-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45,197</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iI_pn3n3_d0_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zP4POxkXCxPg" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31_custom_SimulationsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjHihHBK6ith" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31_custom_CognigenMember137486625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,789</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z8G1gG6qqTEk" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31_custom_DILIsymMember137486640" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z50Xh3ea9PAj" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2019-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,387</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zvV317UUkjy1" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2018-09-012019-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">39</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zu8XsvhmZmNk" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4NfvL1JSBIi" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zYGnIy2MeXI8" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">138</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zxuIiWePb92c" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2019-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,482</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zZ4EMeHrhzC3" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2019-08-31_custom_CognigenMember137486625" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zUFbJrqSbbRk" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2019-08-31_custom_DILIsymMember137486640" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">172</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z0LbRipTKsja" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2019-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,768</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zOi20rlPfhTk" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2018-09-012019-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zti5NmFeyJh8" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">364</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zKwS3AL9OWI3" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">580</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zBGgubPSupkd" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,750</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2018</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVLlVPi5RII9" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,553</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z5RrY4VpIBHl" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,857</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z1h25TrgiGue" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,257</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zEQ7SQCSoWa2" title="Net Revenues" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,667</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zpvlM3Ozyxx" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2017-09-012018-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,533</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zFhh4FyUWyCl" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,902</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxJuOS4E3Sm4" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">863</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z583A7bMubaa" title="Income (loss) from operations before income taxes" style="text-align: right"><ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,298</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4ZEwN3Zfo8k" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2018-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zUdaU5qVjEOk" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2018-08-31_custom_CognigenMember137486781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,733</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zHgkXH2iB4bh" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2018-08-31_custom_DILIsymMember137486796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,248</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20180831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zCoMpkmy4Az" title="Total assets" style="text-align: right">(<ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2018-08-31_srt_ConsolidationEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">17,702</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zae8v4WmW4U1" title="Total assets" style="text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2018-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,279</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_d0_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_znG7MJKgt4a6" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2018-08-31_custom_SimulationsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMIRR1kmb7hd" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2018-08-31_custom_CognigenMember137486781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,789</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNMbfUjJs1pk" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2018-08-31_custom_DILIsymMember137486796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zd2YKBKNnRP9" title="Goodwill" style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2018-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,387</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPptWlUTBGsl" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2017-09-012018-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zHWWQiN2ku3a" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">100</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zkxv0kpkgiSg" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zqrxySbGToQk" title="Capital expenditures" style="text-align: right"><ix:nonFraction name="us-gaap:PaymentsToAcquireProductiveAssets" contextRef="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">183</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zMtcehUmqHy4" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2018-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,365</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zQdvaXgc19D" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2018-08-31_custom_CognigenMember137486781" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z26ZBHMN1p29" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2018-08-31_custom_DILIsymMember137486796" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">155</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zfaX3D0GeKf7" title="Capitalized software costs" style="text-align: right"><ix:nonFraction name="us-gaap:CapitalizedComputerSoftwareGross" contextRef="AsOf2018-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,145</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_ztfkJjILVJH7" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2017-09-012018-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,748</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z3SemHzU5HNi" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">401</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zA2y1TrPxW2a" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">572</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zP7EnCmLNme6" title="Depreciation and Amortization" style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,721</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A5_zuCGSe30iLF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company allocates revenues
to geographic areas based on the locations of its customers. Geographical revenues for the years ended August 31, 2020, 2019 and
2018 were as follows (in thousands, because of rounding, numbers may not foot):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_pn3n3_zJrhz4QAColl" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zuA8uMzIV7U7" style="display: none">Schedule of geographical revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2020</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRRtk1mciEr5" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,124</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4yCkIHGEr2k" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_EuropeMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,024</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLGa3wTTIbpl" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_AsiaMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,812</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zipCPTlqCSLi" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,961</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zS6zaOvq9Tcb" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,105</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z4QH0lWQs0El" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_EuropeMember_custom_CognigenMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zlMUXIoHGoxe" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_AsiaMember_custom_CognigenMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdhdygJzQwla" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,105</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrOzjHoFpMSe" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,057</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zPs7H6lgkPu4" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_EuropeMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">646</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zvYEwyOsevOl" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_AsiaMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">246</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z5KLxPhrEwd5" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,948</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z07XcB5cktcg" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,388</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsqjK87yRc17" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_EuropeMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zZYnEzVzGvY8" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_AsiaMember_custom_LixoftMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsh10MIbss47" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,575</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_z5yqrScQSQwh" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29,674</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember_zOnois1EIm8f" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,827</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember_zvdDrRbbwXk8" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012020-08-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,088</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><p id="xdx_98C_eus-gaap--Revenues_pp0p0_c20190901__20200831_z9njnkBHIQ5j" style="font: 13.33px Times New Roman, Times, Serif; color: rgb(0, 0, 0)"><span style="display: none; font-style: normal; font-weight: normal; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(238, 238, 238)"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,589,084</ix:nonFraction></span></p>41,589</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23E_zGPhkchUUkq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_239_zrNRKViqAHwl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zLT2E7YcxyYe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 83 -->
    <div id="xdx_238_ziDby3KEBw94" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_239_zAQYKldEc02b" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td id="xdx_231_zp5dCfzvdsA7" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_230_z9wqzKRk8tvj" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_zYDzkaCtdmEl" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_zxVGoZXBs48g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2019</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZmTkeGk2Sug" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,381</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRzm5JMPj6w8" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_EuropeMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,144</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRWStue2Okei" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_AsiaMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,060</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zniiji62O83c" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,585</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMO6Lxx5Agj3" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,321</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z6eeplQ50xha" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_EuropeMember_custom_CognigenMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zwpsWdlPCULf" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_AsiaMember_custom_CognigenMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zfbqIsA7K6B3" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,321</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zTOZ1VBc7xs5" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,875</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4Y0OFo1EBe8" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_EuropeMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">685</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zzJWHoPnH7xb" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_AsiaMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">505</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z03s9YIMGVMd" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,065</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zaluMlhDbgu9" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zQWBY2eDLcr" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_EuropeMember_custom_LixoftMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zoy1dgU5u9f3" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_AsiaMember_custom_LixoftMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBUWGxGn6cUl" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_LixoftMember137487265" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zQXAMrG0aDz1" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,577</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember_zGxG2JGrcUf" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,829</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember_zVfuqcc6xwlf" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,565</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><p id="xdx_98E_eus-gaap--Revenues_pp0p0_c20180901__20190831_zAtGEVnm2Cn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">33,970,440</ix:nonFraction></p>33,971</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2018</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zeII7hrIMrz" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,856</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZcI0NCLxXm6" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_EuropeMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,964</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVSdlLepy8Cf" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_AsiaMember_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,733</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPAJQsH37C26" title="Revenues" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_SimulationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,553</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zpfDKcC42Y2c" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,857</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zBnbPWJRwNGe" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_EuropeMember_custom_CognigenMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjcsa3iwsG1b" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_AsiaMember_custom_CognigenMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zPEVeQfhi0a4" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,857</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrsSyW0gwLf2" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,163</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zi7bAEWFFde6" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_EuropeMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">312</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0lqB9ZFUBHk" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_AsiaMember_custom_DILIsymMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">782</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXAU3PLhCyF3" title="Revenues" style="text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,257</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zNN1YKP0Xto7" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zf4xV1WRj6Q9" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_EuropeMember_custom_LixoftMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBfl4xDvSVO2" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_AsiaMember_custom_LixoftMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zup81ldnN3Ai" title="Revenues" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_LixoftMember137487406" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8211;</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zlyiQa1LsN3a" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,876</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember_zISCw3o0FG29" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_EuropeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,276</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember_z6v6aRogU6Kf" title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31_srt_AsiaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,515</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td title="Revenues" style="border-bottom: Black 2.5pt double; text-align: right"><p id="xdx_982_eus-gaap--Revenues_pp0p0_c20170901__20180831_zFqi7WVzFyZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">29,666,524</ix:nonFraction></p>29,667</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*Lixoft was acquired on April 1, 2020.</p>

</ix:nonNumeric><p id="xdx_8A0_zaVCBMc7nXag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zQf2fkS2ccJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 12 &#8211; <span id="xdx_82A_zfh1wubEino9">RELATED PARTY TRANSACTIONS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2017 the Company acquired
DILIsym Service, Inc. As part of that agreement the Company paid $<span id="xdx_90C_eus-gaap--PaymentsToAcquireBusinessesGross_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_pp0p0" title="Payment for acquisition"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="From2019-09-012020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,704,000</ix:nonFraction></span>
to former shareholders of DILIsym Services, Inc. who are currently employees of the Consolidated Company. In addition, as
part of the acquisition agreement the Company owes approximately $<span id="xdx_90E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_pp0p0" title="Acquisition liabilities owed"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" contextRef="AsOf2020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,260,000</ix:nonFraction></span>
of acquisition liabilities at August 31, 2018 to the former shareholders who are still employees of the Consolidated Company.
One of the former shareholders of DILIsym is currently a director of Simulations Plus, under the agreement he received
approximately $29,000 and could receive up to approximately $30,000 in future earn-out payments. In September 2018,
subsequent to year end under terms of the agreement the Company made payments in the amount of approximately $<span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20180930__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_zgZrlgDYJ7e1" title="Earn-out payments made"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2018-09-012018-09-30_custom_DILIsymMember_custom_DilisymEmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">587,000</ix:nonFraction></span>
and $<span id="xdx_90D_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20180930__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zGvNMQVWpKE6" title="Earn-out payments made"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2018-09-012018-09-30_custom_DILIsymMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,000</ix:nonFraction></span>,
respectively to the employees and the current director. In fiscal year 2019, under terms of the agreement the Company made
payments in the amount of approximately $<span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_zLxMStytowK6" title="Earn-out payments made"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2018-09-012019-08-31_custom_DILIsymMember_custom_DilisymEmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,599,534</ix:nonFraction></span>
and $<span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zpwUxQOGPmw6" title="Earn-out payments made"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2018-09-012019-08-31_custom_DILIsymMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,312</ix:nonFraction></span>,
respectively to the employees and the current director. In August 2020 the Company made final payments under the agreement in
the amount of approximately $<span title="Repayment to related party"><span id="xdx_905_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_ztoVbqRjFDVi"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2019-09-012020-08-31_custom_DILIsymMember_custom_DilisymEmployeesMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">664,506</ix:nonFraction></span></span>
and $<span title="Repayment to related party"><span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zilDiZKOz6R2"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2019-09-012020-08-31_custom_DILIsymMember_srt_DirectorMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,346</ix:nonFraction></span></span>,
respectively to the employees and the current director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2020 the Company acquired Lixoft
of Paris. As part of that agreement the Company paid $<span id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesGross_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_zVhLCsW09u9d" title="Payment for acquisition"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="From2019-09-012020-08-31_custom_LixoftMember_custom_FormerShareholdersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,720,615</ix:nonFraction></span> and issued stock with a value of $<span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_zDSKqEjMsHgl" title="Business acquisition, shares issued"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2019-09-012020-08-31_custom_LixoftMember_custom_FormerShareholdersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,602,081</ix:nonFraction></span> to former shareholders
of Lixoft who are currently employees of the Consolidated Company. In addition, as part of the acquisition agreement the Company
owes approximately $<span id="xdx_908_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_z8Xy5RvS6Ar7" title="Acquisition liabilities owed"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" contextRef="AsOf2020-08-31_custom_LixoftMember_custom_FormerShareholdersMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">947,220</ix:nonFraction></span> of acquisition liabilities at August 31, 2020 to the former shareholders who are still employees of
the Consolidated Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_23B_zjePC0xjGlb6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23D_zp5aTUAyniY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23A_zCgvs6QRnjl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 84 -->
    <div id="xdx_23B_zXg1uwuwq5pj" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23A_zGD3mfYaTNyi" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td id="xdx_23B_zmKYnHXbWuKc" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zdmwLzEcpHEi" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_234_z6flE7ML0Ukc" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_238_z2t4VsVp6SHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock"><p id="xdx_808_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zBpmqGCv9Otf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 13 - <span id="xdx_827_zsWglPwrgAde">EMPLOYEE BENEFIT PLAN</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain a 401(k) Plan for eligible
employees. We make matching contributions equal to 100% of the employee&#8217;s elective deferral, not to exceed 4% of the total
employee compensation. We can also elect to make a profit-sharing contribution. We contributed $<span id="xdx_909_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20190901__20200831_pp0p0" title="Contribution by employer in benefit plan"><ix:nonFraction name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">456,484</ix:nonFraction></span>, $<span id="xdx_901_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20180901__20190831_pp0p0" title="Contribution by employer in benefit plan"><ix:nonFraction name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">404,684</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20170901__20180831_pp0p0" title="Contribution by employer in benefit plan"><ix:nonFraction name="us-gaap:DefinedBenefitPlanContributionsByEmployer" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">326,762</ix:nonFraction></span>
for fiscal years 2020, 2019 and 2018, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock"><p id="xdx_806_eus-gaap--MergersAcquisitionsAndDispositionsDisclosuresTextBlock_zBUOoc3ZhE2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 14 - <span id="xdx_828_zSp288Gg3s91">ACQUISITION/MERGER WITH SUBSIDIARIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 31, 2020, the Company entered
into a Stock Purchase and Contribution Agreement (the &#8220;Agreement&#8221;) with Lixoft, a French soci&#233;t&#233; par
actions simplifi&#233;e (&#8220;Lixoft&#8221;). On April 1, 2020, the Company consummated the acquisition of all outstanding
equity interests of Lixoft pursuant to the terms of the Agreement, with Lixoft becoming a wholly owned subsidiary of the Company.
We believe the combination of Simulations Plus and Lixoft provides substantial future potential based on the complementary strengths
of each of the companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the Agreement, as described
below, the Company will pay the former shareholders of Lixoft total consideration of up to $16,500,000, consisting of two-thirds
cash and one-third newly issued, unregistered shares of the Company&#8217;s common stock. In addition, the Company will pay $3,456,029
of excess working capital based on the March 31, 2020 financial statements of Lixoft.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2020, the Company paid the
former shareholders of Lixoft a total of $10,789,362, comprised of cash in the amount of $9,460,129 and the issuance of 111,682
shares of the Company&#8217;s common stock valued at $3,662,337, net of adjustments and a holdback for representations and warranties
(under the terms of the Agreement a price of approximately $32.15 dollars per share was used based upon the volume-weighted average
closing price of the Company&#8217;s shares of common stock for the 30-consecutive-trading-day period ending two trading days prior
to April 1, 2020). 9,669 shares are held in an escrow for offset for representations and warrantees. Within three business days
following the two-year anniversary of March 31, 2020 (the date of the Agreement) and subject to any offsets for representations
and warrantees, the Company will pay the former shareholders of Lixoft a total of $2,000,000, comprised of $1,333,333 of cash and
the release from an escrow shares of stock valued at $666,337 issued at the date of the Agreement. The Agreement provides for a
two-year market standoff period in which the newly issued shares may not be sold by the recipients thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the agreement calls for earn-out
payments up to an additional $5,500,000, two-thirds cash and one-third newly issued, unregistered shares of the Company&#8217;s
common stock based on a revenue growth formula each year for the two years subsequent to April 1, 2020. The former shareholders
can earn up to $2,000,000 the first year and $3,500,000 in year two. The Earn-out liability has been recorded at fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the acquisition method of accounting,
the total purchase price reflects Lixoft&#8217;s tangible and intangible assets and liabilities based on their estimated fair values
at the date of the completion of the acquisition (April 1, 2020). The following table summarizes the preliminary allocation of
the purchase price for Lixoft:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zcIywZDxNYK8" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B3_z2hFyIoMwDi1" style="display: none">Allocation of purchase price</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zJfdS7uAEkF9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 85%; text-align: justify">Assets acquired, Including cash of $3,799,134 and accounts receivable of $629,481</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" contextRef="AsOf2020-04-02_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,006,892</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Developed Technologies Acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" contextRef="AsOf2020-04-02_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,010,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Estimated value of Intangibles assets acquired (Customer Lists, trade name etc.)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" contextRef="AsOf2020-04-02_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,160,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Estimated Goodwill acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2020-04-02_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,533,987</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iNI_pp0p0_di_zTcmmmyhxeZ3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Liabilities Assumed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" contextRef="AsOf2020-04-02_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,117,519</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total Consideration</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20190901__20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFPT57Vz6TIi" title="Total Consideration" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2019-09-012020-04-02_custom_LixoftMember" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">18,593,360</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8A8_zpz8cR8BoPpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill has been provided in the transaction
based on estimates of future earnings of this subsidiary including anticipated synergies associated with the positioning of the
combined company as a leader in model-based drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:exclude><p id="xdx_230_zKYaYUo1RRzc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_23E_ziVvBgbMHgPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<ix:exclude><p id="xdx_234_zBGNE8kpBtrj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 85 -->
    <div id="xdx_239_zl7ZJsj8esnh" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_232_zYBM9l6zYaBl" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td id="xdx_236_zLqk9foXS61l" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_235_zIO0R5W5H7gj" style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zWYYU8f08Lnl" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_z6QJBSDp7eM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Consolidated supplemental Pro Forma
information</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following unaudited consolidated supplemental
pro forma information assumes that the acquisition of Lixoft took place on September 1, 2017 for the income statement years periods
ended August 31, 2020. These amounts have been calculated after applying the Company&#8217;s accounting policies and adjusting
the results of Lixoft to reflect the same expenses in the years ended August 31, 2019 and 2018. The adjustments include costs of
acquisition, and amortization of intangibles and other technologies acquired during the merger, assuming the fair-value adjustments
applied on September 1, 2017, together with consequential tax effects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zrpcNHjAFaUl" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BD_zg37rGxisVDc" style="display: none">Schedule of statement of income</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20190901__20200831_zShnKeJjCig4" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20180901__20190831_zOEIReq5nt8l" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20170901__20180831_zSWTor0Jq3Ej" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2020*</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2019</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2018</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaRevenue_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; text-align: justify; padding-bottom: 2.5pt">Net Sales</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,970</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,918</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaRevenue" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">31,891</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net Income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2019-09-01to2020-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,630</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2018-09-012019-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,250</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" contextRef="From2017-09-012018-08-31" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,132</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*Balances include five months actual results
for Lixoft.</p>

</ix:nonNumeric><p id="xdx_8AE_zRxGKAQVYcCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:QuarterlyFinancialInformationTextBlock"><p id="xdx_803_eus-gaap--QuarterlyFinancialInformationTextBlock_zZnUM75nCet9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 15 -&#160;<span id="xdx_828_zlyAOAtdiz7k">UNAUDITED QUARTERLY FINANCIAL
DATA</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents selected unaudited quarterly financial
data for each full quarterly period of the years ended August 31, 2020 and 2019 (in thousands except for per share data), because
of rounding, numbers may not foot:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zM85Pbncz5Lg" summary="xdx: Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zhI0IIPb7xy7" style="display: none">Quarterly Financial Information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20191130_zyJOyUoVg2k7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20191201__20200229_zS1UKxhr0GXc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20200301__20200531_zZ51MpVxUJVk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20200601__20200831_zsZ4o5vBzVP9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">First</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Second</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Third</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fourth</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year&#160;ended&#160;August 31, 2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--Revenues_pn3n3_zGDaTK6Dgxma" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-09-012019-11-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,401</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-12-012020-02-29" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,350</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-03-012020-05-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,298</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2020-06-012020-08-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,540</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--GrossProfit_pn3n3_zEhW7MN3AE0l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-09-012019-11-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,758</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-12-012020-02-29" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,683</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-03-012020-05-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,633</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2020-06-012020-08-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,865</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_z8Wj5evhf9S" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-09-012019-11-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,058</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-12-012020-02-29" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,150</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-03-012020-05-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,936</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2020-06-012020-08-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,188</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--EarningsPerShareBasic_pip0_zRUg9Klbn2" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share, Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-09-012019-11-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-12-012020-02-29" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-03-012020-05-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.17</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2020-06-012020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_pip0_zIrzKctB0ENc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Earnings per share, Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-09-012019-11-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.11</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-12-012020-02-29" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-03-012020-05-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2020-06-012020-08-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.11</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20180901__20181130_zQoWUsEefpAh" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20181201__20190228_zX0gUe46UYEj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20190301__20190531_znowrDpL7UR9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20190601__20190831_zr2jb1KzBpQ1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">First</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Second</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Third</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fourth</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year&#160;ended&#160;August 31, 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_pn3n3_z3YmL6UNkGY9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-09-012018-11-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,536</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2018-12-012019-02-28" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,472</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-03-012019-05-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,937</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2019-06-012019-08-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,026</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--GrossProfit_pn3n3_zKPBv6FKcH72" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2018-09-012018-11-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,336</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2018-12-012019-02-28" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,264</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-03-012019-05-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,613</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2019-06-012019-08-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,735</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_zAIBuNFd6kv5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-09-012018-11-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,536</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2018-12-012019-02-28" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,099</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-03-012019-05-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,889</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2019-06-012019-08-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,059</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_pip0_zswufykBp244" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share, Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2018-09-012018-11-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.09</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2018-12-012019-02-28" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-03-012019-05-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2019-06-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--EarningsPerShareDiluted_pip0_zcjpIT9x7tv4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Earnings per share, Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2018-09-012018-11-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.09</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2018-12-012019-02-28" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.12</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-03-012019-05-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2019-06-012019-08-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.11</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
</table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2019-09-01to2020-08-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zyuYjK4GCOOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 16 - <span id="xdx_827_zHUcNWpgjPt7">SUBSEQUENT EVENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Dividend Declared</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 9, 2020, our Board of Directors
declared a quarterly cash dividend of $0.06 per share to our shareholders. The dividend in the amount of $1,195,461 was distributed
on Monday, November 2, 2020, for shareholders of record as of Monday, October 26, 2020.</p>

</ix:nonNumeric><p id="xdx_81E_zfnNQ0fxeBqc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 86; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p>




































































</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>simulations_ex2101.htm
<DESCRIPTION>LIST OF SUBSIDIARIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIST OF SUBSIDIARIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cognigen Corporation, a Delaware corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DILIsym Services, Inc., a Delaware corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lixoft, a French soci&eacute;t&eacute; par actions simplifi&eacute;e
<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>simulations_ex2301.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the incorporation by
reference in the Registration Statements of Simulations Plus, Inc. on Form S-8 (Nos. 333-142882, 333-197681, and 333-219446)
on Form S-3 (File No. 333-239770) of our report dated November 16, 2020 with respect to the consolidated financial statements
of Simulations Plus, Inc. as of August 31, 2020 and 2019 and for each of the three years in the period ended August 31, 2020,
included in this Annual Report on Form 10-K of Simulations Plus, Inc. for the fiscal year ended August 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>&nbsp;&nbsp;&nbsp;/s/ Rose, Snyder &amp; Jacobs LLP&nbsp;&nbsp;&nbsp;&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rose, Snyder &amp; Jacobs LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Encino, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">November 16, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>simulations_ex3101.htm
<DESCRIPTION>RULE 13A-14(A) CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RULE 13a-14(a) CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIMULATIONS PLUS, INC.<BR>
a California corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CERTIFICATION OF CHIEF EXECUTIVE OFFICER
(Principal Executive Officer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Shawn O&rsquo;Connor, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this Annual Report on Form 10-K of Simulations Plus, Inc., a California corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or
persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated: November 16, 2020</FONT></TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By:&nbsp;&nbsp; <U>/s/ Shawn O&rsquo;Connor&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shawn
        O&rsquo;Connor</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief
        Executive Officer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Principal
        Executive Officer)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>simulations_ex3102.htm
<DESCRIPTION>RULE 13A-14(A) CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RULE 13a-14(a) CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIMULATIONS PLUS, INC.<BR>
a California corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CERTIFICATION OF CHIEF FINANCIAL OFFICER
(Principal Financial Officer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, John R. Kneisel, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this Annual Report on Form 10-K of Simulations Plus, Inc., a California corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or
persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated: November 16, 2020</FONT></TD>
    <TD STYLE="width: 50%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By:&nbsp;&nbsp; <U>/s/ John R. Kneisel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;John
        R. Kneisel</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief
        Financial Officer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Principal
        Financial Officer)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>simulations_ex3201.htm
<DESCRIPTION>CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATIONS PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002<BR>
(18 U.S.C. SECTION 1350)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Annual Report of
Simulations Plus, Inc., a California corporation (the &ldquo;Company&rdquo;), on Form 10-K for the year ended August 31, 2020,
as filed with the Securities and Exchange Commission (the &ldquo;Report&rdquo;), Shawn O&rsquo;Connor, Chief Executive Officer
of the Company, and John R. Kneisel, Chief Financial Officer of the Company, do each hereby certify, pursuant to 18 U.S.C. &sect;
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company for the period covered by the Report.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>/s/&nbsp; Shawn O&rsquo;Connor</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shawn O&rsquo;Connor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">November 16, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>/s/&nbsp;&nbsp;John R. Kneisel </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">John R. Kneisel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">November 16, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(A signed original of this written statement
required by Section 906 has been provided to Simulations Plus, Inc. and will be retained by Simulations Plus, Inc. and furnished
to the Securities and Exchange Commission or its staff upon request.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ 3L# 2(  A$! Q$!_\0
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M4T'FE)XH 6BFYHW<]: '44TMCN*4&@!:**,T %%&110 449HS0 44A84F_-
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MLA.=C9)4]>QP?PKK-H(Q@4;1Z"@#@K?1-6U;1]6O=4A:WU>5(8K56=24%O\
M,C C@%I3(WT*YZ4\V&N7'AW4KE;0V^LZW.J.&8?Z)%C8"2/[J GCNU=UM7T%
M&U?04 <7'IFKZ?K$4L=I:-97%F;*:.U9OW9128G(;J."G']X9Z51;PMJD?@G
M3(/M>H7-Q!':>9IL[QF)MK)N1L*"0 #W[?A7H6U?04;1Z"@#@[&P:SO-0^UV
M&O&27499D:UN9%B9&;(.%<#Z\5O:UX=.KW,4PN($V+MQ):)-^1;I6]M'H*7
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-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &: L4# 2(  A$! Q$!_\0
M'  !  (" P$               0&!0<! @,(_\0 6Q   0,#  8#"P@'!00'
M!P0# 0 " P0%$082$Q0A,0=!42)35&%C<9&2DZ+1,C,T9'*!L>$5(R12<Z'!
M"!9"1;(W1%6")S5B=+/"TA<V0X.4XO$E)CC#*(33_\0 & $! 0$! 0
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MUS2-7&"21CB@W[HWI#;=(Z#>[34MFB!U7#&'-/81U*%2:7VZJTLJ-'HMMO\
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M1$!V1@<23RYK(Z>:%TVF MXJ:J6GW-[GMU&@ZV<<\^96IHU6@#D."#372?\
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M*L5-XJ[EMBW&\'.SQGEQ///\E0:<_P#^1<W\'_\ I"NNB&A4FCMPEJ7WRXW
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M_P!YE_HKS>[<RZVBLH)'NC94Q.B+FC)&1C*QVA.C4.BEC;;:>HDJ&-D=)KO
M!R?$$&?/):_T[T'N&D4U3/3:055+#)&&[J2=EP'7@]:V >(6L[ET5[:JJ74&
MD=SHZ6H>7OIP<MX\\8(08WH%O9EIZ^QOI8(C1G7VD(QKY.#K=IX<^Q6/IJ/_
M $=W+[4?^L++:$Z'6W1&AD@MVT?)*099I<%SC]W(>)8;2[HX;I+<IZB>^W""
M"4#-*PYC&!V9QU(,ET5D#H\L?\#_ ,Q5H,\0F$)D8)2,AFL-8CS*G:%:"C12
ML=-'>*ZLA,1B;3S']6S)!R!GQ?S5=MMKJ-(.F*KONSEBM]L&P:YX(VKPTMX9
MZLDE!M=$1 1$0$1$!$1 1$0$1$!$1 0HA08+2#YZ+[*)I!\]%]E$&4MGT&'[
M*DJ-;/H,/V5)0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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MCR47_,Q_!_J@E#DB#DB B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M!34TDTE/!''),[7D<QN"\]I4C"Y1<3QG,NXX"(B B(@(B("(B B(@(B("(B
MB(@(B("%$*#!:0?/1?91-(/GHOLH@REL^@P_94E1K9]!A^RI* B(@(B("(B
MB(@(B("(B"GZ7M8:\;G'<(;VZ$MI9Z;@V0CCJ.XZI ."=8=?!>.DUEO-3#-4
M,DI9I7,@C;'LW9CQ(USRTYQQ(SRY *ZXYKE!1#05[K?+9W4LNU?<=YWD#]5L
MS-M2[/;U8YKO34-8;?;K0^EF9)2UPFDG</U9C:\O!#NLG(&.>2>Q7?53"#D\
ME!FCVMQ UWLQ%G+3CK4X\E%_S,?P?ZH I.'TBH]HN=T\O4>T4D<D01MT\O4>
MT3=/+U'M%)1!&W3R]1[1-T\O4>T4E$$;=/+U'M$W3R]1[12401MT\O4>T3=/
M+U'M%)1!&W3R]1[1-T\O4>T4E$$;=/+U'M$W3R]1[12401MT\O4>T3=/+U'M
M%)1!&W3R]1[1-T\O4>T4E"@C;IY>H]HFZ>7J/:*3E<:R9$?=/+U'M$W3R]1[
M12-8)E!'W3R]1[1-T\O4>T4C*93(C[IY>H]HFZ>7J/:*1K+JZ1K!EY#1VDX0
M>.Z>7J/:)NGEZCVB\*F]6RF^D7"DC^U*T?U6)JM.]&J;.TO%*<?N$O\ ](*T
MIM5U>&F7,UTQSEG=T\O4>T3=/+U'M%3:GI4T9A^;GJ*@^3@</]6%#?TI02<*
M&R7*HSR[C'X96L:)>GY9<3?M]5]W3ZQ4>T7&Z^7J/75!.FVE%4?V#1"HP>3I
M2X#\ /YKH+ATD59[BTVVC;U.>X$_ZS^";I7'.8C[PFWI\HE=;K44=JI'5-PK
MY8(&D N=)UGJ7H]]*RD%4^X.;3%H<)73 -P>O*TOTAV;3"6CAK+])'501G&I
M3\1'GK( 'I68T*Z-#76^&JTFDJ0,9AI6R8U6^/LSV#"VG1+5-N*ZKG;BSB_7
M55JQ2LMWT^T=MN6MN-362C_!3'6_GP'\UAQI-I3>^&CMEJH8CRFJY#CS\<#\
M5?;1HQ9[3@T%!!&X?X]76=Z3Q67U!G(66TLT>"C/U_CO4N5>*K'T:S9H9I3=
MAG2'2.2.-W.&F)Q_0?BLM;NC+1ZC(?)!+4R\]>9^>/FY?R5V+<KLN:M*NS&(
MG$>W!U%FB.,\6/I;5!2QAE,7PL'^&-VJ/Y+WW3R]1[1247GS,\9:Q&$;=/+U
M'M$W3R]1[12401MT\O4>T3=/+U'M%)1!&W3R]1[1-T\O4>T4E$$;=/+U'M$W
M3R]1[12401MT\O4>T3=/+U'M%)1!&W3R]1[1-T\O4>T4E$$;=/+U'M$W3R]1
M[12401MT\O4>T3=/+U'M%)1!&W3R]1[1-T\O4>T4E$$;=/+U'M$W3R]1[122
MH#[Q;V/<U];3M<TX(+QD%![;IY>H]HFZ>7J/:+FEK*>K#G4LT<K6G!+'9PI"
M"-NGEZCVB;IY>H]HI*((VZ>7J/:)NGEZCVBDH@\XHMFW&N]_C><E>AY(A08+
M2#YZ+[*)I!\]%]E$&4MGT&'[*DJ-;/H,/V5)0$1$!$1 1$0$1$!$1 1$08.Z
MWBIAN8H;;2;U4,8V:9I<&ZL9..&3Q=P/B[5Z7>\/M@,LU%.ZC:6B2=KF]QK'
M'+.3C(RL5IA2/K:ED$-KF?6/C(I:^*41[%PX]TX$. !P<8(/8N]UIKG45M'3
M5%%-5VV%K))#"^-NWE'+6#G##01G'6?$.(2Y-(V,G.::4T0J12.J<C5$F=7&
M.>-;AGM2/2)CYH3NTS:*><T\542W5<\9'+F 2" ?BL6^S7!U++:MVQ3/K][W
MG:-P(S+M2W&=;6SPY8\:[4UFN&ZT%JDI]2"DJ]N:K:-+7L:\N: ,ZP=Q .1C
M@>)X(+B>2B_YF/X/]5*/)09H]K<0-=[,19RTXZT$X<D444G#Y^H]HN=T\O4>
MT0244;=/+U'M$W3R]1[1!)11MT\O4>T4>L$%)'M*FMDB9Q.7RXSA!D45=LEX
MMEX@,M)7SCNRS5D?J.)\0/:I\[J6G&:BX.B'_;G _%75G.,)K1S9-%6:C2&P
M4^=K?HN'[M2'?@L74:>:+P?YS/)_#UG?T6E-B[5RIGLXF[1'.87I%K&?I.L#
M#B$W><]6HT#\2%Y#I J*C_J[1^]S@\G%Y _DTK2-#O3\N'.\6^K::+5@T@TS
MJOHFCD\8/(S2GAZ<(UO2/5?(924K3^]("1_,J[K5'BJB/O!MXGE$MIHM8MT=
MZ0*GZ3I)3P-/5%G(]#1^*]/[@7NH'[?I=72 \PW6_JY3841SN1]LFTJGE3+8
M\DT<8[N1C?.0% JKY:J7Z1<J*+'[\[1_54IG17;W?3+I<JCSO 4J'HNT9C^5
M#/)]N<_TPFI8CG5/VC_TUKG2.[+5.G6C5/G7O%,['>R7_@"M?W/I:F9I'&ZA
MA#[1&2U[7##I1^\.SQ!77^XVC5)"^1EMB=J-+NZ.MRX]:U755&B4]Q%S=1U%
M+!"2)Z(O:W+QR'#M[!S7IT?=<SFF9X,KNVQ&)B%\/2G2R\**SW*H/5JL !_%
M<C3C2:JX4&AU6 >3IBX ^Z/Q66L&D=CJK/#4R5\5L:1C8353&%N/%G"[5.F>
MB=-G:Z34_#]VHUOP6.O;CPV^\R[U:_.O],-^D^D6KX1VBAHP>1>X'_S%/T5T
MB58_77BBI,][:/\ TKO4]*&A<&<W^9^.]A[OZ+%5/3-HA%G95-WG_AQ$?ZB%
MU%=SY;<1]OZYU:?.J>[)?W'TEJ/IVF5:WM;"' ?Z@N[>BRDD.M77BZ5+NO,@
M _JJS)TW6=_T&UW^<]6L6-_ E19.F"X2YW/1:YD=1DJ"/P8/Q76OI/EP[0:M
MGSX]U]I^C'1N(@OIIICUF28\5EJ;0G1JGQL[-1G'?&:_XY6HW])FF4^=VL#8
M1U&6=Q49^F/2-.[N#;Z9IZR[./YG\%Q.WJ\5?Y6-E'*&^J:SVVE^C6ZCA_AP
M-;^ 4ML;&?):UH\0POGG]*=(-1\YI;0TS>L,9D_^&?Q74P:23C]MZ0:]H/,0
M1D?^9JXFQ,\ZOVZVD1Y?I]%8\:\9:FGA!+YHFX_>> OG=U@IZC_K'3#2"H/_
M &=49]+RN6Z):(.X5=9?:KMUIV#XJ;O'6>R[;Z=VXJ[3.UT-Z;17*IHXJ69F
M8JDU#2TN'-CQ_A/9G@>/6NMCTYM%U=4R-K:*"C8_4ADDJ6!TN.;M7J'9GGS6
MA+EHC8FW-[Z&*5M UHU(Y)BZ1[NO)&,#S+WLFBNCL,\HNU*ZI@YQ&.H=&[S.
MYCAQ_DMIT6G5SB>S*-(^+&8?2D=YMDA 9<:-Q/+$S3G^:]VUU([Y-5 ?-(%\
M\/T8T$=G%NKVY[*W_P"U>+M%=# W$4-UCSSQ6C_T++=X]^SO;>\=WT@*B%V,
M31G/8X+T:YKODN!\Q7S0=&=&P[,53>(QU8K!D>ZO)VC=KQB*\WIGCWD'_P J
MN[=,]C;QUCN^G47S%^A6QD;#26]L Y9G7&Y72/C!I?=F$\\S.^*;K[_B3>(]
MN\/IY%\PEND[#^ITXN36CD'2//\ YEV%5IG&,QZ:U!)_>)_KE-TJZ_B?X;Q3
M_LQ_7TXB^9A=M/68#-+P0.6LW_[5V&D/2(S)_O/22>(L'_\ S3<ZNO[_ (;S
M1Y_]/I==7O8P9>X-&<9)QQ7S6-*^D1F!^F:*3'60!_Y5"OVE&F]?:Y8+G/02
M4IPYV':N".((.1QR D:'7)O-#ZADD9&W+WM:,@9)QQ79?(3[YI=/);Q52M=J
M8?")WX#GCD3QXN',*V1Z==(8[D.MW#AQ=_\ <NIT&YRA(TNWSR^D47S@[3CI
M$+21);!YG#_U*-+IKTC$?2*0#L;J_%3<;IO=OJ^F$) YE?+S]+^D-_!U1%C^
M)_\ <HTFD&G,GRS [SO/_J5W"[[)OEKJ^IGSPL&72QM\[@HLMWM\1_65U*W'
M;*WXKY<==M,''+H*-WG/_P!R]8[OI:"/_P!/MSCX\_\ J4W&[[+O=KJ^DY-)
M[/'SKXB?^R"[/H"B2:96AG*65Y_[,96@HKQIJ#B.T6TD>1)_\RGPZ0=(K.$-
MIHN'[M.?BFY7/;N;W;GDW.[36D.=C25<G9ABZ_WKK9/HUBK)/&01_P"5:DCT
MFZ4P,QVR/'_9@=\5[#2/I8(R+8W'\%W_ *E-SKZQW7>:&U#>M(I1^HL89_$=
M_P#A:ZJWN?5SNDU1)M':X'(.R<A1!?>EP\K9%G[!_P#4J%656D\5\K6U%/%3
MRZP=5,@&=5QYN&2>[PK1H=54XS"5Z533&7T)T7N#J2OP0?UC1P\Q5W51T%M]
MF;H[33Z/OE92SM#SB4DEW7K$]><Y5EW3R]1[1>28Q,P]%,ZT9A)11MT\O4>T
M3=/+U'M%%244;=/+U'M$W3R]1[1!)0KSBBV;<:[W^-YR5Z'D@P6D'ST7V432
M#YZ+[*(,I;/H,/V5)4:V?08?LJ2@(B("(B B(@(B("(B B(@X(R5RBX<<-)"
M#E%@J6\U%9=9(J6C<^@AD?!+.2 1(W'(9SJ\QRYX76/2)CYX3NTS:*>8T\55
MENJYXR.7, D$ _%!GSR47_,Q_!_JI1Y*+_F8_@_U02AR1!R1 1$0%K+ISV#+
M102SR.BDC>\PO9\H/P,8[?,MFK#Z1:.VZ_BF_2<.UW=Q='@XU2>97=N8BJ)J
MY.+D3-,Q#Y6I9])ZZ[,IXJ&GDJW,Q%&]X;C6X$MR\#/'GU+/MZ.^D'CKV*D<
M3_B=4LX>B1;W@T#L4%7!51TSS/ _7C<YY.J5:L+VUZ?--6;48>:C1LTXN2^:
M:?0#I C :VRVL#MDDC?^+BLK2:)=)<?".AL$ '[T,#L^Z5] X3"RJTZY5XL2
MTC1Z8Y-'QV3I<9@Q5UJAP,8B9&T?R8N_]WNEV3+G7^E83U!XX>AJW;A,+C>9
M],=G6RCK+1_]T^E=QP[2B-H/6).7NH[0CI0D&K)I>-4\\2N_]*WAA$WF8Y4Q
MV791UEHL]'72'+PFTO> .6)WK@]%VF\G&32^<GJQ/)\5O4KA-ZKZ1V<S9CK+
M18Z)=+7#,FF-6'>*>3XKS/0Q?7DB32>H(=\K,K^/\UOA%=[N>W9-WIZSW:"J
M.@^LC@D?+?II&M:26Y/' RM;-T1#X))'RS"7/<1O</D]CCVG^2^QB,\UY[M#
MWJ/U0MK6G33G7C/X9W-%UO#.'S]HGT-T=ZL\-?)))"9!\W*22/O&%8H>@^VL
MQF:(GQQD_B5N-C0T8  '8%RLITV[GA+O=:,<6J8NAJVQXU9XA_\ ZX/XE38>
MBBAB(U:TM'_9@:/ZK92*;[>]2[I:Z* WHTI,]U<JH]F&@+NWHTMW^*MK">K!
M:/Z*^(IO=[U+NUKHHPZ-+1@:U37D]NNS_P!*]6]&]E XR5A\\@^"NB*;U=]4
MKN]KTJ>.CRQ Y+*DCL,J]&]']@;SIY3YY7?%6Q%)TB[/S2;O:],*NW0/1]O^
MYN/GE<?ZKT&A5@:W&XM/G<?BK(AY*;>YZI[KL+?IAJW2'0"JGN;WVAE+#28&
MJUSR"#CCU%3-$]!#23S/OD5-.PMPQK27<>WD.Q;%PA"TG3+LT:DSP94Z);BO
M783^Z5B_X93^A/[IV+_AE/Z%G$6.UK]4]VVRH],,'_=.Q?\ #*?T)_=*Q?\
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M;ZNGF?$Z8.D=&YH:"!QU7DCB>"#(;]3_ +Y]4_!-^I_WSZI^"E#DB"+OU/\
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MLI9*6ECFB?/'%*][\:@>\-& .)/=>(<%&GL#JJ\0ULL%OAV,AF:Z&/\ 62O
M(;KNP#@9R1QR0.Q>E\MUTN5KI:?7HMLV2*65YU@TN8]KL-'$X..LY0+[?9*&
MXT-)2PLF=)+&VH<XD;)CW:HY?XB<X'8"K"W..*K%ST8;7.$PGGAJ9*B*HFU)
MW:A+,9U1U<!P5FC&JP =7CR@[(B((UP^CC[;?Q"DJ-</HX^VW\0I* B(@QVD
M-P=:[+5UK(C*86:VKG'7C)\0YGQ!0;34U[K/).)J.Z2$N="^F?J->">1/(:O
M+KX#MX++W'>11R&AV1J ,M$N=4\>(X<N&>*PECME71MKZP14L%96ZCC3,)$4
M9 ZR.;CDY('4$'G27RHGT;I;C/+;J%\A(D=42'9M()&&\LYQVA<_I^=NC%/7
M&E N%2-6*G).JYW'CVZN 7>9<V:W7BUVJ"D8ZWR.C<[))> X$D\^H@GL*\J7
M1.%EOCCEFD;4L$Q:Z![HV,VARX!H/R1R'B""7+>96:'NO CCVHHMYV>3JYU<
MXSV*(^^S"CII(JFVU<E54-IHWP..SC<02=<Y/4.7 \0IEHMM?:[9%103T\C8
M:=C(W2A[B9!SR<_)QR Y*/\ H6JEJ:ZLJHJ":>J9'$8' F+582<NR,EV3V<@
M$$[1ZYR7 UL=0V(5%'.:>0Q'+7' <".S@X<%F%B-&[2+333-.RVL\IFD$+-1
MC3@ !HZ@  %ET!$1!&H.4_\ &=^*DJ-0<I_XSOQ4E 7#ERN'(*Q9;K5W.\5&
MK/2,@A>^&2A)_7,U20'GS\.&,8/-=Q?:B&YW>&NI604U%3-J6.$FLY["7@D]
M0^3P'C^Y=76JNK[Y355PBI(F4,I?%/"#M)@6D:O'Y+>ZXCCDA<5-DK:VZ7.6
MJ=2BDKJ3='-:7%[6C6P>6,]UR\2#RCTE='9:JXNEM\XB8UV[4\NL^(N. 'NS
MU9XG Y%9"U7.HDNU1;:[=S41PLJ&O@)U2UQ(P0>(.0?.%%H[+6MJ6558:.26
M&C-''&T$,>"027Y^R. SS/-<VRQ3T-5+5P,M\%1*6,,44)$3(FDDX P2\Y/$
M^+AP0=Z^XW.DNU#3 4DT=5([#&M<'MC:,DYSCL'+F0HNC^D<]SKX82RG>R5C
MWR,BUM>E<T@:LN>L\1U<BLF;5))>*VNFF[J2 4\&ISB;Q+CYR<>@+&631B6C
MKJ&HDW2-U+&YCI:=I#ZDD8S(3Z>9X]:"VCDB 8'!$!1:GZ92>=W^E2E%J?IE
M)YW?Z4$I$1 5:TJNLU"^DI(*B"C?5E[6UE1\B(@ @8Y9.>&>P\U95AKZRNEB
M9#14U'54\OZN:.HY:IZ^P@=F./!!&T@NEPM-KIZF.E@G>7L;.[:D,8"X ZO#
M+CQX<O&NMPONSO3[;%4T%.Z(,+WU;\:Y=R:T9!)QQSXPH]5H]5C1:FLU%- =
MGJZTDVL/DO#L- SPSPQU#"YN%AK:J2XECZ2-MSA9%4Y!)86@MUF=O ]>.2#V
M??=I?):&&IH(-B]L;MY?W<SB <,;D'@"./')/B65NCZJ* RTLM-&R,%TCIV%
MP  SPP1CK6!JM&:A[;A2P2PMHJ]\;Y7/!VK"T-!U>HY#1@GD>U9*YVZLN=G=
M0U$\+1++JR.C:X9AULZO$\RW@3RXE!C':072.S6FN?00XJY8VRN,A:&->\-;
MAO,G!!Z@.*MZP6DMNK+C2T]/0FF9'%-',3*2/D.#@!@<N&%FH7/+&[4-$F!K
M!IR,^)!W1$0>-;]#G_AN_!=X?FF?9"Z5OT.?^&[\%WA^:9]D(.Z(B#PK93!2
MRRM8Z1T;'/#&\W8&<!8#1BXUUTHIJQM505+)AKQ,B<?U#M4?JW$ \N9//B>"
ML-5M# \0E@E+3J%X):#U9'!5JBM5P?<*F[31T=)<'0.@:R/NFO.MP>\\SR&!
MU H/>FO4T$UUAN@A_8(XY3)!G5<'@X;@\=;N>7C"@QZ3SMLKIZZ"GIZHUAI&
MM=)AC3SUG$]0&2?,O>W:.R[BZFNA8\F45+IX)G"224'.L[@.&<8'5@=B\X]%
MI*>G?L:DR5++@:Z(SN<]N>(P<\<X)XH,[;*HU%O,YJ:6ISDMDI3EA [.)_%8
M?1^^SW6T.K&U=J+M@V4QL>?U!(S^L.3@#CU#DI-HME?0SU$IEI<UDSYYVACC
MJNU6M:&\1P[G)SSSU+S?;+G-<8KC-)0LJJ>%T408UQ:_6+2=<G!QW/ #EG/'
MD@D:-766Y25S)'4\T<#VM94TQ)CER,G'/B#P."5G%AK-;)Z>Y5UPJW0B>J#&
MF. '5 :" 23S=QY]@ ZEF4!$1!&@^FU7_)^"DE1H/IM5_P GX*24&"T@^>B^
MRB:0?/1?91!E+9]!A^RI*C6SZ##]E24!0!MM^J-CL_\ #G7SV*>L/=ZJ2BHK
MQ4PXVD,.T;K<LAI(R@G8J_J_O)BK^K^\JG:]*)F05M562&KHZ6FCF>^.#9/9
M([FS5<>/#!RLU<M(:2WRU,<[92Z!L3CC5 <9'$- )(ZP>> @R6*OZO[R?MGU
M?WEC/T\W?HJ+<ZH5;X]JZ/,>8V:Q;D]UW7$'Y.5TDTB@WAT+8J@1F5].RI[G
M9F5H.6CCGJ(SC&0@RV*OZO[R8J_J_O*M:&W:MN%3&VLGVK3;X)R-5H[MQ=D\
M!X@O:]W:JH+I2LCJ8W-EJ&1F!T!:W4/,[7.,C!([>6$&?&^#EN_O+G]L^K^\
MJK'?ZV.CMUUG?$ZAKI2T0!F'1M()8=;/$\./#K\2C5^D]PM=LMURJ=C-%<6E
ML<+6%NR>YI<P%V>(X8*"Y_MGU?WD_;/J_O+%6^LK8+_^C:^:.HVE-O$<C(]3
M&'8<TC)X<00?.L\@C?MGU?WD_;/J_O*2B"-^V?5_>3]L^K^\I*((IWS'^[^\
MH_[5OX^9U]GX\8RLD>2B_P"9C^#_ %0 :S'^[^\N?VSZO[RDCDB"-^V?5_>7
M'[9]7]Y2E4]*+E/3W>&GDKA;*34;(RI=&7,DDUL:CG9 :.7,C.4%BQ5_5_>3
M]L^K^\L/>Z^X4EWL[(#3[E4U AE)!+R2UQX=0'<CMY]77!EOE<(I+FQ\6X1U
MVZ&#4[HMVFS+M;///'&.2"S8J_J_O)^V?5_>51I=)YW5M'MJFEUJBL=2R4 ;
MB6 9<&N/'/-HYC'=++Z55]QMT5)-1&G$)J(HYC("7$/D:W#0.'7G.>KD@R^*
MOZO[R?MGU?WEB+]65]OJ*26*HA=#-4Q0"G,?=.#CAQUL\P,GER"L#>001_VS
MZO[R?MGU?WE)1!C:[>MCW>QQK-Y9[0I/[9]7]Y+C]''VV_B%)01OVSZO[R?M
MGU?WE)1!%_;/J_O)BK^K^\O'2&IJ:.S5510Q&:IC9EC TNSQXG XG R<=>%B
MK#4S5%GJ7V^YP7*8/=JNF!88W$Y+7CB1@G@,#A@(,WBK^K^\F*OZO[RPMFK+
MA<]&J6K?5T]-.=<S2F++<-)' $\.2C_IZL?HK1U#&1_I2L8=D"#J<,DR$<]7
M5&M]X'6@L6*OZO[R8J_J_O*'::JIJ[!253A&:J:G9)@DM:7EN?'@9\ZKW]X+
MC3Z,5%;6/@;+#6NIYIF1G4CC#]4O#2<G'G06W]L^K^\N?VSZO[RQ>B-SDNU!
M+4/ECGB$SFPSQC5$K!CNL9X<<K.H(W[9]7]Y<?MGU?WE*1!C:/>L3:FP^<=G
M.>:D_MGU?WDH.4_\5WXJ2@C?MGU?WEQ^V?5_>4I=7]2"/^V?5_>3%7]7]Y5J
MSW.>JTADCK*X4]0UTC!;GQENM&"=5[7$]T>1R,\,A3:*YUPTCN=+<74S*6"G
M9/%LP<M:7/'=$\SAH/BS]Z#,8J_J_O)BK^K^\JI%I/5Q17RMJXV"EIX&5%+%
M\EVJ[6#=8\N. ?%E9K1^N=4[2.:O945#&ASHQ Z(L!ZP'<2.!&?$@R.*OZO[
MR?MGU?WE7:&_[Y=96OK8Z:!E4ZE9$8G':%I(.9.0)(.!S7K9[U55^DDL.(Q;
M'4[I:<ZO=OU7ANMGL/''BP4&=_;/J_O+G]L^K^\I#>2Y01OVSZO[RC3[UO5/
MG8:V78QG')9)1:GZ92>=W^E S6?5_>7/[9]7]Y2401OVSZO[RZXJ^RF]Y2U6
M-,:^HI&4\>\/HJ&8/$]:V,NV.!PXCY.>/$\."#.XJ_J_O)^V?5_>6!T@N=PH
M['2UM!-13-UH]K-@D/:YS1E@!QQR>.>'C32F\U=%-%#;MF7,?$ZI<]I(:Q[P
MP-'C.2?,/&@SW[9]7]Y/VSZO[RP#[K4LT@J*>KK!24S)8V0A].=64%H)&T/#
M.>"R]X?+#1OG96-I8X6.?(YT8?D 9ZSP02,5?U?WD_;/J_O*KRW6^4]DL]9-
MNS75$T3:@.80[5D>  &\@<$9.>I7+([4$;]L^K^\G[9]7]Y2400*LU>Z3:VP
MU=0YQG/)=XM\V;<;OC YY7M7?0Y_X;OP7>'YIGV0@\?VSZO[R?MGU?WE)1!%
M.^'P?WD JQX/[R[UKY(Z:5\#-I*UI+&9QK'' *M:*5\U:RJ>;BRHJW-#Y:.5
MAB=3/U1W.#DAOW=9*"Q?MGU?WDQ5_5O>6$L57=+A2W".IJ*>*JIZMT.TBC+F
M@  XP3QY\UXVRX7"IL]35RUC&P[PYD$S:8N)C:=7.J#UN!QXD%AQ6?5_>3%7
M]7]Y8S1FX5%SLQGF?'M=I)&V1C<9 <0"6]1QC(*A1U=T_3592-KHI8::FUY9
M-W^0]Q[D  \>Y!./&$%@_;!X/[RY_;/J_O+$:+7.HKJFY0S3,GCIY&MCDV9B
M><M!.LP\1QY'AE6!!&_;/J_O)^V?5_>4E$$.CU]ZJ=KJZ_<YU>7)3"HT'TVJ
M_P"3\%)*#!:0?/1?91-(/GHOLH@REL^@P_94E1K9]!A^RI* L76T8N$5THW/
MU!/&(R[&<9:1G"RB@!LKJZH,4H8.YSENMU(,96:+0U+96[PYK9J$44H#1W>K
M\A_G&7>E<QV"I$E9/-<(YJBICCC>'TP,6JS/#4SQ!SQX\^L#@,OLZKPEOLOS
M39U7A+?9?F@KHT.;N4-)O4>P9)M>%. ^-VOK?J79_5CJQW7!2*716"FN,U1%
MNVI+*^;+J5IE#GY)_6<]7))QC/C6:V=5X2WV7YILZKPEOLOS08VPZ/MM$S7L
MJ'2ZM+'2X+<<&%QS[RYN=FJ;DYT%57AUO=*V4PB$"3N2'!NOG&,@'Y.?&LCL
MZKPEOLOS39U7A+?9?F@PM/HQJ"FIYJLRVZED=)!!L\.:3G <[/= :QQP'5G.
M%X2Z'MJZ2"CN%<^:CI6.93-;'J/C)& YSLG6(' < /$58=G5>$M]E^:;.J\)
M;[+\T$*V6F:"X.KJ^K%55[(0-<R+9M:S.3W.3Q)YG/4. 67479U7A+?9?FFS
MJO"6^R_-!*11=G5>$M]E^:;.J\);[+\T$I%%V=5X2WV7YILZKPEOLOS02CR4
M7_,Q_!_JABJO"6^R_-1]G4;^!MVZVSY[/JSYT&2')%%$55CZ2WV7YILZKPEO
MLOS02E@[];KA<)'4T-7%';JB,QSM=#K/:,8RPYQD^,'"R6SJO"6^R_-='MJ&
MXUJI@R<<8OS08ZYV.HJ7VT4E7#3PT#FOC8^ R$D-+>)UQPP>S[UY'1IQ>Z)U
M9FWNJ=[=3[+!VFMK$!V?DZW'&/O69V=5X2WV7YILZKPEOLOS00)[145==%/6
MUK7QP/,D$4<.H _! <XEQUB 3CD/$O*[V6MN-MIJ0W&,&-T<DDKZ?)D>QP<#
M@.  R.(64V=5X2WV7YILZKPEOLOS08E]EKW7AEP=<*=[V1B-C)*4D1\.Z+/U
M@P7>//#@K !@*+LZKPEOLOS39U7A+?9?F@E(HNSJO"6^R_--G5>$M]E^:#FX
M?1Q]MOXA25C:UE0(>[J&D:[>&SQUCQJ1LZKPEOLOS02D479U7A+?9?FFSJO"
M6^R_-!S<8ZB6CD;1S-AGQECG,UVY!S@CL/+[UBK9::J!M75RU$'Z5JVLVCQ$
M3$W5&  W6R>9XZWP64,=5CZ2WV7YKK&RH<,MJF$9QPC!XC[T%?&BU9^@X;6;
MG 8(Y-=PW4XD;DG4<-IRR>HCEA9.IL,-=!'^DA%+4LC=&V6)KH@T'J UCV#K
MZE/V=5X2WV7YILZKPEOLOS00;19Y;511TM+5@PQ0-BC:^/(#QS>>.3GAPRL;
M#HM4L@U)+C$Y[*PUT3A3$ 2$G(<-<ZS>Z/#@1PXJP;.J\);[+\TV=5X2WV7Y
MH(UEM7Z.=5RR3"6HJYMM*YK-1NMJAO!N3C@!UD^-9-1=G5>$M]E^:;.J\);[
M+\T$I%%V=5X2WV7YILZKPEOLOS0<T'*?^,[\5)6-HXZ@B;5J&C$C@?U><GTJ
M1LZKPEOLOS02EPYN1PX%1MG5>$M]E^:;.J\);[+\T&(%GK:FYPR72KBFIJ.;
M;4HCBU'N=JD9><XX9(P ,_R0Z/S37>LJJRJIYJ:KA%-)3[N6YC!<0-;7Y]UQ
M../B64+*C::N],UL9QL^./2N^SJO"6^R_-!A':'T!DN!:9&1UD#8"T.)+ ,\
M023QXCJX87M!8ZQM;OLUR#ZS59$7L@#6F-IR1JDGBX\SGS +*[.J\);[+\TV
M=5X2WV7YH,+/HN)W2025>M;7U6]NI]EW1?G6QKY^3K<<8SXU[4>C%#17B*OI
M&F/9P&!L0<XM'= YY^+&%E-G5>$M]E^:;.J\);[+\T$H# PBB[.J\);[+\TV
M=5X2WV7YH)2BU/TRD\[O]*;.J\);[+\U'G94"JIPZH:7$NP=GRX>=!DD479U
M7A+?9?FFSJO"6^R_-!*6*N\-SD=";74P1#.K*V:+7!:>9&"#D>CBI>SJO"6^
MR_-=7LJ&-+G53 T<23'@#^:##U>C+W:/4]HHJQL,$6"Y\D.T<XAP=D8< .([
M/0NUTT5I+G \U6J*R5T;I9X@YNN6D?X=;L&.?!9=L=5X2WV7YKG9U7A+?9?F
M@QURLL]>#335K1;2]CC"(>[PT@ANOGED#JSXUWN%GEN-N-'65ADC=,'R$1@:
MT8=K"/ ZL8&>M3MG5>$M]E^:;.J\);[+\T$#2&TU-UAAA@JXJ>-DK)B'0&0E
MS'!P_P 0X< LM"US8VB1S7/P-8M& 3YLE>&SJO"6^R_--G5>$M]E^:"4BB[.
MJ\);[+\TV=5X2WV7YH/2M^AS_P -WX+O#\TS[(4.KCJ!2S%U0TMU#D;/'5YU
MWBCJ=FW%2W&!_P##_-!,11=G5>$M]E^:;.J\);[+\T'K5,?)"]L4ACD((:\
M$M/;@K#6ZTUIK3<;G40/KVQ.IXME$6L:PNSDC)))P,\0.SM64,55X2WV7YKJ
M&U'$-JF$C@?U8X?S08FCL5;!2W2%URC)KG/?KQTY88WN &1EYY8X+("VR4UM
MI:2V5#*;=PUK2^+:-<T#&",@^/@1R4C9U7A+?9?FFSJO"6^R_-!!M5GEM\A>
MVL+]K*^>H!B $CW  $?N@8'#CXRN:.T24=/7;O5XJZJ9TYG='G#B> +<\0
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M*BLD--22Q&:=\\P&VJ3(=H\@8SGJ\P08:QFHK-#Z%\YN5=*"X.V%0(Y),.<
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?&UD[X_TE-K)WQ_I*#):0?/1?918S6<[Y3B?.40?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>simu-20200831.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOauDaaPty552yYkxvmR6fdk6LykriJsoeyVxnK3moaQB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:simu="http://simulations.com/20200831" elementFormDefault="qualified" targetNamespace="http://simulations.com/20200831">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://simulations.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/StatementsOfShareholdersEquity" id="StatementsOfShareholdersEquity">
	  <link:definition>00000005 - Statement - STATEMENTS OF SHAREHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/OrganizationAndLinesOfBusiness" id="OrganizationAndLinesOfBusiness">
	  <link:definition>00000007 - Disclosure - ORGANIZATION AND LINES OF BUSINESS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/RevenueRecognition" id="RevenueRecognition">
	  <link:definition>00000009 - Disclosure - REVENUE RECOGNITION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000010 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/Investments" id="Investments">
	  <link:definition>00000011 - Disclosure - INVESTMENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ContractsPayable" id="ContractsPayable">
	  <link:definition>00000012 - Disclosure - CONTRACTS PAYABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ShareholdersEquity" id="ShareholdersEquity">
	  <link:definition>00000014 - Disclosure - SHAREHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000015 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ConcentrationsAndUncertainties" id="ConcentrationsAndUncertainties">
	  <link:definition>00000016 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SegmentAndGeographicReporting" id="SegmentAndGeographicReporting">
	  <link:definition>00000017 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000018 - Disclosure - RELATED PARTY TRANSACTIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/EmployeeBenefitPlan" id="EmployeeBenefitPlan">
	  <link:definition>00000019 - Disclosure - EMPLOYEE BENEFIT PLAN</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiaries" id="AcquisitionmergerWithSubsidiaries">
	  <link:definition>00000020 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/UnauditedQuarterlyFinancialData" id="UnauditedQuarterlyFinancialData">
	  <link:definition>00000021 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000022 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/RevenueRecognitionTables" id="RevenueRecognitionTables">
	  <link:definition>00000025 - Disclosure - REVENUE RECOGNITION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000026 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/InvestmentsTables" id="InvestmentsTables">
	  <link:definition>00000027 - Disclosure - INVESTMENTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ContractsPayableTables" id="ContractsPayableTables">
	  <link:definition>00000028 - Disclosure - CONTRACTS PAYABLE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ShareholdersEquityTables" id="ShareholdersEquityTables">
	  <link:definition>00000030 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000031 - Disclosure - INCOME TAXES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SegmentAndGeographicReportingTables" id="SegmentAndGeographicReportingTables">
	  <link:definition>00000032 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables" id="AcquisitionmergerWithSubsidiariesTables">
	  <link:definition>00000033 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/UnauditedQuarterlyFinancialDataTables" id="UnauditedQuarterlyFinancialDataTables">
	  <link:definition>00000034 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" id="SummaryOfSignificantAccountingPoliciesDetails-UsefulLives">
	  <link:definition>00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" id="SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities">
	  <link:definition>00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" id="SummaryOfSignificantAccountingPoliciesDetails-LeaseCost">
	  <link:definition>00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill" id="SummaryOfSignificantAccountingPoliciesDetails-Goodwill">
	  <link:definition>00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" id="SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets">
	  <link:definition>00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" id="SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule">
	  <link:definition>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" id="SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements">
	  <link:definition>00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" id="SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration">
	  <link:definition>00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" id="SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses">
	  <link:definition>00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" id="SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare">
	  <link:definition>00000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/RevenueRecognitionDetails-Disaggregation" id="RevenueRecognitionDetails-Disaggregation">
	  <link:definition>00000046 - Disclosure - REVENUE RECOGNITION (Details - Disaggregation)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess" id="RevenueRecognitionDetails-ContractsInProgess">
	  <link:definition>00000047 - Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/RevenueRecognitionDetailsNarrative" id="RevenueRecognitionDetailsNarrative">
	  <link:definition>00000048 - Disclosure - REVENUE RECOGNITION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/PropertyAndEquipmentDetails" id="PropertyAndEquipmentDetails">
	  <link:definition>00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000050 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/InvestmentsDetails" id="InvestmentsDetails">
	  <link:definition>00000051 - Disclosure - INVESTMENTS (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/InvestmentsDetailsNarrative" id="InvestmentsDetailsNarrative">
	  <link:definition>00000052 - Disclosure - INVESTMENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ContractsPayableDetails" id="ContractsPayableDetails">
	  <link:definition>00000053 - Disclosure - CONTRACTS PAYABLE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/CommitmentsAndContingenciesDetails" id="CommitmentsAndContingenciesDetails">
	  <link:definition>00000054 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ShareholdersEquityDetails-Dividends" id="ShareholdersEquityDetails-Dividends">
	  <link:definition>00000056 - Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ShareholdersEquityDetails-OptionActivity" id="ShareholdersEquityDetails-OptionActivity">
	  <link:definition>00000057 - Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue" id="ShareholdersEquityDetails-IntrinsicValue">
	  <link:definition>00000058 - Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions" id="ShareholdersEquityDetails-FairValueOfOptions">
	  <link:definition>00000059 - Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable" id="ShareholdersEquityDetails-OptionsOutstandingAndExercisable">
	  <link:definition>00000060 - Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ShareholdersEquityDetailsNarrative" id="ShareholdersEquityDetailsNarrative">
	  <link:definition>00000061 - Disclosure - SHAREHOLDERS' EQUITY (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision" id="IncomeTaxesDetails-IncomeTaxProvision">
	  <link:definition>00000062 - Disclosure - INCOME TAXES (Details - Income tax provision)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/IncomeTaxesDetails-Reconciliation" id="IncomeTaxesDetails-Reconciliation">
	  <link:definition>00000063 - Disclosure - INCOME TAXES (Details - Reconciliation)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes" id="IncomeTaxesDetails-DeferredTaxes">
	  <link:definition>00000064 - Disclosure - INCOME TAXES (Details - Deferred taxes)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000065 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative" id="ConcentrationsAndUncertaintiesDetailsNarrative">
	  <link:definition>00000066 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting" id="SegmentAndGeographicReportingDetails-SegmentReporting">
	  <link:definition>00000067 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic" id="SegmentAndGeographicReportingDetails-Geographic">
	  <link:definition>00000068 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative" id="EmployeeBenefitPlanDetailsNarrative">
	  <link:definition>00000070 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" id="AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation">
	  <link:definition>00000071 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" id="AcquisitionmergerWithSubsidiariesDetails-ProformaInformation">
	  <link:definition>00000072 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails" id="UnaudtedQuarterlyFinancialDataDetails">
	  <link:definition>00000073 - Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="simu-20200831_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="simu-20200831_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="simu-20200831_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="simu-20200831_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="simu_CognigenMember" name="CognigenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_DILIsymMember" name="DILIsymMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_LixoftMember" name="LixoftMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_AquisitionRelatedContingentConsiderationObligationsMember" name="AquisitionRelatedContingentConsiderationObligationsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_EnslienMember" name="EnslienMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_TermAndNonassertionAgrMember" name="TermAndNonassertionAgrMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_TSRLMember" name="TSRLMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_CertainDevelopedTechnologiesMember" name="CertainDevelopedTechnologiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_CertainIntellectualPropertyRightsMember" name="CertainIntellectualPropertyRightsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_EntelosHoldingCoMember" name="EntelosHoldingCoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_EntelosMember" name="EntelosMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_DILIMember" name="DILIMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_SoftwareLicensesMember" name="SoftwareLicensesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ConsultingServicesMember" name="ConsultingServicesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_HoldbackLiabilityLixoftMember" name="HoldbackLiabilityLixoftMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_EarnoutLiabilityLixoftMember" name="EarnoutLiabilityLixoftMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_EarnoutLiabilityDilisymMember" name="EarnoutLiabilityDilisymMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_WellsFargoMember" name="WellsFargoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20181Member" name="RecordDate20181Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20182Member" name="RecordDate20182Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20183Member" name="RecordDate20183Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20184Member" name="RecordDate20184Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20191Member" name="RecordDate20191Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20192Member" name="RecordDate20192Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20193Member" name="RecordDate20193Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20194Member" name="RecordDate20194Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20201Member" name="RecordDate20201Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20202Member" name="RecordDate20202Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20203Member" name="RecordDate20203Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RecordDate20204Member" name="RecordDate20204Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Equity2017IncentivePlanMember" name="Equity2017IncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Price1Member" name="Price1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Price2Member" name="Price2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Price3Member" name="Price3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Price4Member" name="Price4Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Price5Member" name="Price5Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Price6Member" name="Price6Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_InternationalSalesMember" name="InternationalSalesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Customer1Member" name="Customer1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Customer2Member" name="Customer2Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Customer3Member" name="Customer3Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_Customer4Member" name="Customer4Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ACustomerMember" name="ACustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_BCustomerMember" name="BCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_SimulationsMember" name="SimulationsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_NorthAndSouthAmericaMember" name="NorthAndSouthAmericaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_FormerShareholdersMember" name="FormerShareholdersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_DilisymEmployeesMember" name="DilisymEmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ContractsPayableCurrent" name="ContractsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ContractsPayableNoncurrent" name="ContractsPayableNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" name="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" name="CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_PaymentsOnContractsPayable" name="PaymentsOnContractsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_StockIssuedForAcquisitionOfLixoft" name="StockIssuedForAcquisitionOfLixoft" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RightOfUseAssetsCapitalized" name="RightOfUseAssetsCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" name="PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ReconciliationOfContingentConsiderationTableTextBlock" name="ReconciliationOfContingentConsiderationTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ScheduleOfAmortizationExpensesTableTextBlock" name="ScheduleOfAmortizationExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="simu_AmortizationPeriodIntangibleAssets" name="AmortizationPeriodIntangibleAssets" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="simu_PurchasePriceContingentConsiderationAdditions" name="PurchasePriceContingentConsiderationAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ContingentConsiderationPayments" name="ContingentConsiderationPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RevenuesOverBillingsOnUncompletedContracts" name="RevenuesOverBillingsOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RevenuesEarnedToDateOnUncompletedContracts" name="RevenuesEarnedToDateOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_BillingsToDateOnUncompletedContracts" name="BillingsToDateOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ContractsPayable" name="ContractsPayable" nillable="true" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_RoyaltyExpenses" name="RoyaltyExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" name="WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="simu_OutstandingRemainingContractualLife" name="OutstandingRemainingContractualLife" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="simu_FairValueOptionsGranted" name="FairValueOptionsGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="simu_WeightedAverageMarketPrice" name="WeightedAverageMarketPrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="simu_EquityPlanTerminationDate" name="EquityPlanTerminationDate" nillable="true" xbrli:periodType="duration" type="xbrli:dateItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>simu-20200831_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://simulations.com/role/Cover" xlink:href="simu-20200831.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedBalanceSheets" xlink:href="simu-20200831.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="simu-20200831.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedStatementsOfOperations" xlink:href="simu-20200831.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/StatementsOfShareholdersEquity" xlink:href="simu-20200831.xsd#StatementsOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="simu-20200831.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/OrganizationAndLinesOfBusiness" xlink:href="simu-20200831.xsd#OrganizationAndLinesOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognition" xlink:href="simu-20200831.xsd#RevenueRecognition" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipment" xlink:href="simu-20200831.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/Investments" xlink:href="simu-20200831.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayable" xlink:href="simu-20200831.xsd#ContractsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingencies" xlink:href="simu-20200831.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquity" xlink:href="simu-20200831.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxes" xlink:href="simu-20200831.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConcentrationsAndUncertainties" xlink:href="simu-20200831.xsd#ConcentrationsAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReporting" xlink:href="simu-20200831.xsd#SegmentAndGeographicReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RelatedPartyTransactions" xlink:href="simu-20200831.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/EmployeeBenefitPlan" xlink:href="simu-20200831.xsd#EmployeeBenefitPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiaries" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiaries" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnauditedQuarterlyFinancialData" xlink:href="simu-20200831.xsd#UnauditedQuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SubsequentEvents" xlink:href="simu-20200831.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionTables" xlink:href="simu-20200831.xsd#RevenueRecognitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentTables" xlink:href="simu-20200831.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsTables" xlink:href="simu-20200831.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayableTables" xlink:href="simu-20200831.xsd#ContractsPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesTables" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityTables" xlink:href="simu-20200831.xsd#ShareholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesTables" xlink:href="simu-20200831.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingTables" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnauditedQuarterlyFinancialDataTables" xlink:href="simu-20200831.xsd#UnauditedQuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetails-Disaggregation" xlink:href="simu-20200831.xsd#RevenueRecognitionDetails-Disaggregation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess" xlink:href="simu-20200831.xsd#RevenueRecognitionDetails-ContractsInProgess" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetailsNarrative" xlink:href="simu-20200831.xsd#RevenueRecognitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentDetails" xlink:href="simu-20200831.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="simu-20200831.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsDetails" xlink:href="simu-20200831.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsDetailsNarrative" xlink:href="simu-20200831.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayableDetails" xlink:href="simu-20200831.xsd#ContractsPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesDetails" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-Dividends" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-Dividends" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-OptionActivity" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-IntrinsicValue" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-FairValueOfOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetailsNarrative" xlink:href="simu-20200831.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-IncomeTaxProvision" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-Reconciliation" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-Reconciliation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-DeferredTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetailsNarrative" xlink:href="simu-20200831.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative" xlink:href="simu-20200831.xsd#ConcentrationsAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingDetails-SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingDetails-Geographic" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="simu-20200831.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative" xlink:href="simu-20200831.xsd#EmployeeBenefitPlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails" xlink:href="simu-20200831.xsd#UnaudtedQuarterlyFinancialDataDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableCurrent" xlink:label="loc_simuContractsPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_simuContractsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BillingsInExcessOfCost" xlink:label="loc_us-gaapBillingsInExcessOfCost" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapBillingsInExcessOfCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableNoncurrent" xlink:label="loc_simuContractsPayableNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_simuContractsPayableNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOperating" xlink:label="loc_us-gaapInterestIncomeOperating" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeOperating" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" xlink:label="loc_simuBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_simuBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/StatementsOfShareholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF SHAREHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:label="loc_us-gaapIncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings" xlink:label="loc_us-gaapIncreaseDecreaseInBillingInExcessOfCostOfEarnings" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInBillingInExcessOfCostOfEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToDevelopSoftware" xlink:label="loc_us-gaapPaymentsToDevelopSoftware" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToDevelopSoftware" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaapPaymentsOfDividends" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividends" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_PaymentsOnContractsPayable" xlink:label="loc_simuPaymentsOnContractsPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_simuPaymentsOnContractsPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/OrganizationAndLinesOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND LINES OF BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognition" xlink:title="00000009 - Disclosure - REVENUE RECOGNITION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/Investments" xlink:title="00000011 - Disclosure - INVESTMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayable" xlink:title="00000012 - Disclosure - CONTRACTS PAYABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquity" xlink:title="00000014 - Disclosure - SHAREHOLDERS&apos; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConcentrationsAndUncertainties" xlink:title="00000016 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReporting" xlink:title="00000017 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/RelatedPartyTransactions" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/EmployeeBenefitPlan" xlink:title="00000019 - Disclosure - EMPLOYEE BENEFIT PLAN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiaries" xlink:title="00000020 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/UnauditedQuarterlyFinancialData" xlink:title="00000021 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionTables" xlink:title="00000025 - Disclosure - REVENUE RECOGNITION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentTables" xlink:title="00000026 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsTables" xlink:title="00000027 - Disclosure - INVESTMENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayableTables" xlink:title="00000028 - Disclosure - CONTRACTS PAYABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesTables" xlink:title="00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityTables" xlink:title="00000030 - Disclosure - SHAREHOLDERS&apos; EQUITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesTables" xlink:title="00000031 - Disclosure - INCOME TAXES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingTables" xlink:title="00000032 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables" xlink:title="00000033 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/UnauditedQuarterlyFinancialDataTables" xlink:title="00000034 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:title="00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:title="00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:title="00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:title="00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:title="00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:title="00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:title="00000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetails-Disaggregation" xlink:title="00000046 - Disclosure - REVENUE RECOGNITION (Details - Disaggregation)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess" xlink:title="00000047 - Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)">
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RevenuesOverBillingsOnUncompletedContracts" xlink:label="loc_simuRevenuesOverBillingsOnUncompletedContracts" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_simuRevenuesOverBillingsOnUncompletedContracts" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BillingsInExcessOfCost" xlink:label="loc_us-gaapBillingsInExcessOfCost" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_simuRevenuesOverBillingsOnUncompletedContracts" xlink:to="loc_us-gaapBillingsInExcessOfCost" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetailsNarrative" xlink:title="00000048 - Disclosure - REVENUE RECOGNITION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentDetails" xlink:title="00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000050 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsDetails" xlink:title="00000051 - Disclosure - INVESTMENTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsDetailsNarrative" xlink:title="00000052 - Disclosure - INVESTMENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayableDetails" xlink:title="00000053 - Disclosure - CONTRACTS PAYABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000054 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-Dividends" xlink:title="00000056 - Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-OptionActivity" xlink:title="00000057 - Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue" xlink:title="00000058 - Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions" xlink:title="00000059 - Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:title="00000060 - Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000061 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision" xlink:title="00000062 - Disclosure - INCOME TAXES (Details - Income tax provision)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-Reconciliation" xlink:title="00000063 - Disclosure - INCOME TAXES (Details - Reconciliation)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes" xlink:title="00000064 - Disclosure - INCOME TAXES (Details - Deferred taxes)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:label="loc_us-gaapDeferredTaxAssetsEquityMethodInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes" xlink:label="loc_us-gaapDeferredTaxAssetsStateTaxes" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsStateTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseOther" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative" xlink:title="00000066 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting" xlink:title="00000067 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic" xlink:title="00000068 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative" xlink:title="00000070 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:title="00000071 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:title="00000072 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails" xlink:title="00000073 - Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>simu-20200831_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://simulations.com/role/Cover" xlink:href="simu-20200831.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedBalanceSheets" xlink:href="simu-20200831.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="simu-20200831.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedStatementsOfOperations" xlink:href="simu-20200831.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/StatementsOfShareholdersEquity" xlink:href="simu-20200831.xsd#StatementsOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="simu-20200831.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/OrganizationAndLinesOfBusiness" xlink:href="simu-20200831.xsd#OrganizationAndLinesOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognition" xlink:href="simu-20200831.xsd#RevenueRecognition" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipment" xlink:href="simu-20200831.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/Investments" xlink:href="simu-20200831.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayable" xlink:href="simu-20200831.xsd#ContractsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingencies" xlink:href="simu-20200831.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquity" xlink:href="simu-20200831.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxes" xlink:href="simu-20200831.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConcentrationsAndUncertainties" xlink:href="simu-20200831.xsd#ConcentrationsAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReporting" xlink:href="simu-20200831.xsd#SegmentAndGeographicReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RelatedPartyTransactions" xlink:href="simu-20200831.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/EmployeeBenefitPlan" xlink:href="simu-20200831.xsd#EmployeeBenefitPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiaries" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiaries" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnauditedQuarterlyFinancialData" xlink:href="simu-20200831.xsd#UnauditedQuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SubsequentEvents" xlink:href="simu-20200831.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionTables" xlink:href="simu-20200831.xsd#RevenueRecognitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentTables" xlink:href="simu-20200831.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsTables" xlink:href="simu-20200831.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayableTables" xlink:href="simu-20200831.xsd#ContractsPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesTables" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityTables" xlink:href="simu-20200831.xsd#ShareholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesTables" xlink:href="simu-20200831.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingTables" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnauditedQuarterlyFinancialDataTables" xlink:href="simu-20200831.xsd#UnauditedQuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetails-Disaggregation" xlink:href="simu-20200831.xsd#RevenueRecognitionDetails-Disaggregation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess" xlink:href="simu-20200831.xsd#RevenueRecognitionDetails-ContractsInProgess" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetailsNarrative" xlink:href="simu-20200831.xsd#RevenueRecognitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentDetails" xlink:href="simu-20200831.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="simu-20200831.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsDetails" xlink:href="simu-20200831.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsDetailsNarrative" xlink:href="simu-20200831.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayableDetails" xlink:href="simu-20200831.xsd#ContractsPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesDetails" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-Dividends" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-Dividends" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-OptionActivity" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-IntrinsicValue" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-FairValueOfOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetailsNarrative" xlink:href="simu-20200831.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-IncomeTaxProvision" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-Reconciliation" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-Reconciliation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-DeferredTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetailsNarrative" xlink:href="simu-20200831.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative" xlink:href="simu-20200831.xsd#ConcentrationsAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingDetails-SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingDetails-Geographic" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="simu-20200831.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative" xlink:href="simu-20200831.xsd#EmployeeBenefitPlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails" xlink:href="simu-20200831.xsd#UnaudtedQuarterlyFinancialDataDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_70" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/StatementsOfShareholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF SHAREHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaapDividendsCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCash_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" xlink:label="loc_simuCumulativeEffectOfChangesRelatedToAdoptionOfAsc606_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_simuCumulativeEffectOfChangesRelatedToAdoptionOfAsc606_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_60" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/OrganizationAndLinesOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND LINES OF BUSINESS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognition" xlink:title="00000009 - Disclosure - REVENUE RECOGNITION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - PROPERTY AND EQUIPMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/Investments" xlink:title="00000011 - Disclosure - INVESTMENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayable" xlink:title="00000012 - Disclosure - CONTRACTS PAYABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquity" xlink:title="00000014 - Disclosure - SHAREHOLDERS&apos; EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ConcentrationsAndUncertainties" xlink:title="00000016 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReporting" xlink:title="00000017 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/RelatedPartyTransactions" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/EmployeeBenefitPlan" xlink:title="00000019 - Disclosure - EMPLOYEE BENEFIT PLAN" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiaries" xlink:title="00000020 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/UnauditedQuarterlyFinancialData" xlink:title="00000021 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionTables" xlink:title="00000025 - Disclosure - REVENUE RECOGNITION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentTables" xlink:title="00000026 - Disclosure - PROPERTY AND EQUIPMENT (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsTables" xlink:title="00000027 - Disclosure - INVESTMENTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayableTables" xlink:title="00000028 - Disclosure - CONTRACTS PAYABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesTables" xlink:title="00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityTables" xlink:title="00000030 - Disclosure - SHAREHOLDERS&apos; EQUITY (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesTables" xlink:title="00000031 - Disclosure - INCOME TAXES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingTables" xlink:title="00000032 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables" xlink:title="00000033 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/UnauditedQuarterlyFinancialDataTables" xlink:title="00000034 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:title="00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:title="00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_20" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:title="00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:title="00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="loc_simuCognigenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuCognigenMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuDILIsymMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuLixoftMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapGoodwill_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss_290" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="loc_simuCognigenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuCognigenMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuDILIsymMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuLixoftMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_AmortizationPeriodIntangibleAssets" xlink:label="loc_simuAmortizationPeriodIntangibleAssets_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_simuAmortizationPeriodIntangibleAssets_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_200" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_20" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:title="00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="loc_us-gaapCashAndCashEquivalentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapCashAndCashEquivalentsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="loc_us-gaapShortTermInvestmentsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapShortTermInvestmentsMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_AquisitionRelatedContingentConsiderationObligationsMember" xlink:label="loc_simuAquisitionRelatedContingentConsiderationObligationsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_simuAquisitionRelatedContingentConsiderationObligationsMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure_250" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:title="00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_TSRLMember" xlink:label="loc_simuTSRLMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuTSRLMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EnslienMember" xlink:label="loc_simuEnslienMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEnslienMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIMember" xlink:label="loc_simuDILIMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuDILIMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuLixoftMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EntelosMember" xlink:label="loc_simuEntelosMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEntelosMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:title="00000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember" xlink:label="loc_us-gaapGoodwillMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapGoodwillMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember" xlink:label="loc_us-gaapRoyaltyAgreementsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapRoyaltyAgreementsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_TermAndNonassertionAgrMember" xlink:label="loc_simuTermAndNonassertionAgrMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_simuTermAndNonassertionAgrMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CertainDevelopedTechnologiesMember" xlink:label="loc_simuCertainDevelopedTechnologiesMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_simuCertainDevelopedTechnologiesMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CertainIntellectualPropertyRightsMember" xlink:label="loc_simuCertainIntellectualPropertyRightsMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_simuCertainIntellectualPropertyRightsMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EnslienMember" xlink:label="loc_simuEnslienMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEnslienMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_TSRLMember" xlink:label="loc_simuTSRLMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuTSRLMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuDILIsymMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EntelosHoldingCoMember" xlink:label="loc_simuEntelosHoldingCoMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEntelosHoldingCoMember_270" xlink:type="arc" order="272" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EntelosMember" xlink:label="loc_simuEntelosMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEntelosMember_290" xlink:type="arc" order="292" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuLixoftMember_330" xlink:type="arc" order="332" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAmortization1_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAmortization1_460" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse_460" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_460" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAdvertisingExpense_460" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_460" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_AmortizationPeriodIntangibleAssets" xlink:label="loc_simuAmortizationPeriodIntangibleAssets_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_simuAmortizationPeriodIntangibleAssets_460" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_460" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensation_460" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill_460" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetails-Disaggregation" xlink:title="00000046 - Disclosure - REVENUE RECOGNITION (Details - Disaggregation)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SoftwareLicensesMember" xlink:label="loc_simuSoftwareLicensesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_simuSoftwareLicensesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ConsultingServicesMember" xlink:label="loc_simuConsultingServicesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_simuConsultingServicesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="loc_us-gaapTransferredAtPointInTimeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredAtPointInTimeMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaapTransferredOverTimeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredOverTimeMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenues_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess" xlink:title="00000047 - Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetailsNarrative" xlink:title="00000048 - Disclosure - REVENUE RECOGNITION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentDetails" xlink:title="00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000050 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsDetails" xlink:title="00000051 - Disclosure - INVESTMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:label="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_us-gaapInvestmentTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaapCommercialPaperMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_us-gaapCommercialPaperMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapShortTermInvestments_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsDetailsNarrative" xlink:title="00000052 - Disclosure - INVESTMENTS (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayableDetails" xlink:title="00000053 - Disclosure - CONTRACTS PAYABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_HoldbackLiabilityLixoftMember" xlink:label="loc_simuHoldbackLiabilityLixoftMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="loc_simuHoldbackLiabilityLixoftMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EarnoutLiabilityLixoftMember" xlink:label="loc_simuEarnoutLiabilityLixoftMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="loc_simuEarnoutLiabilityLixoftMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EarnoutLiabilityDilisymMember" xlink:label="loc_simuEarnoutLiabilityDilisymMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="loc_simuEarnoutLiabilityDilisymMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayable" xlink:label="loc_simuContractsPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_simuContractsPayable_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaapContractWithCustomerLiability_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_us-gaapContractWithCustomerLiability_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableCurrent" xlink:label="loc_simuContractsPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_simuContractsPayableCurrent_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableNoncurrent" xlink:label="loc_simuContractsPayableNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_simuContractsPayableNoncurrent_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000054 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:label="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_WellsFargoMember" xlink:label="loc_simuWellsFargoMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_simuWellsFargoMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLineOfCredit_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RoyaltyExpenses" xlink:label="loc_simuRoyaltyExpenses_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_simuRoyaltyExpenses_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-Dividends" xlink:title="00000056 - Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableLineItems" xlink:label="loc_us-gaapDividendsPayableLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableTable" xlink:label="loc_us-gaapDividendsPayableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapDividendsPayableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsAxis" xlink:label="loc_us-gaapDividendsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDividendsPayableTable" xlink:to="loc_us-gaapDividendsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsDomain" xlink:label="loc_us-gaapDividendsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDividendsAxis" xlink:to="loc_us-gaapDividendsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsDomain" xlink:label="loc_us-gaapDividendsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDividendsAxis" xlink:to="loc_us-gaapDividendsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20181Member" xlink:label="loc_simuRecordDate20181Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20181Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20182Member" xlink:label="loc_simuRecordDate20182Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20182Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20183Member" xlink:label="loc_simuRecordDate20183Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20183Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20184Member" xlink:label="loc_simuRecordDate20184Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20184Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20191Member" xlink:label="loc_simuRecordDate20191Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20191Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20192Member" xlink:label="loc_simuRecordDate20192Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20192Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20193Member" xlink:label="loc_simuRecordDate20193Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20193Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20194Member" xlink:label="loc_simuRecordDate20194Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20194Member_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20201Member" xlink:label="loc_simuRecordDate20201Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20201Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20202Member" xlink:label="loc_simuRecordDate20202Member_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20202Member_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20203Member" xlink:label="loc_simuRecordDate20203Member_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20203Member_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20204Member" xlink:label="loc_simuRecordDate20204Member_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20204Member_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:label="loc_us-gaapDividendsPayableDateOfRecordDayMonthAndYear_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapDividendsPayableDateOfRecordDayMonthAndYear_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:label="loc_us-gaapDividendsPayableDateDeclaredDayMonthAndYear_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapDividendsPayableDateDeclaredDayMonthAndYear_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" xlink:label="loc_simuWeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_simuWeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaapCommonStockDividendsPerShareDeclared_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapCommonStockDividendsPerShareDeclared_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaapDividends_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapDividends_160" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-OptionActivity" xlink:title="00000057 - Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_OutstandingRemainingContractualLife" xlink:label="loc_simuOutstandingRemainingContractualLife_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_simuOutstandingRemainingContractualLife_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_80" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue" xlink:title="00000058 - Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions" xlink:title="00000059 - Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:title="00000060 - Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price1Member" xlink:label="loc_simuPrice1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice1Member_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price2Member" xlink:label="loc_simuPrice2Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice2Member_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price3Member" xlink:label="loc_simuPrice3Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice3Member_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price4Member" xlink:label="loc_simuPrice4Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice4Member_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price5Member" xlink:label="loc_simuPrice5Member_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice5Member_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price6Member" xlink:label="loc_simuPrice6Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice6Member_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_150" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000061 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Equity2017IncentivePlanMember" xlink:label="loc_simuEquity2017IncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_simuEquity2017IncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_simuSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_simuSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering_60" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision" xlink:title="00000062 - Disclosure - INCOME TAXES (Details - Income tax provision)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-Reconciliation" xlink:title="00000063 - Disclosure - INCOME TAXES (Details - Reconciliation)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes" xlink:title="00000064 - Disclosure - INCOME TAXES (Details - Deferred taxes)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative" xlink:title="00000066 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaapSalesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_InternationalSalesMember" xlink:label="loc_simuInternationalSalesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuInternationalSalesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer1Member" xlink:label="loc_simuCustomer1Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuCustomer1Member_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer2Member" xlink:label="loc_simuCustomer2Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuCustomer2Member_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer3Member" xlink:label="loc_simuCustomer3Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuCustomer3Member_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer4Member" xlink:label="loc_simuCustomer4Member_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuCustomer4Member_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ACustomerMember" xlink:label="loc_simuACustomerMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuACustomerMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_BCustomerMember" xlink:label="loc_simuBCustomerMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuBCustomerMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapCashUninsuredAmount_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_180" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting" xlink:title="00000067 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SimulationsMember" xlink:label="loc_simuSimulationsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuSimulationsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="loc_simuCognigenMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuCognigenMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuDILIsymMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuLixoftMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaapOperatingSegmentsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_us-gaapOperatingSegmentsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srtConsolidationItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_srtConsolidationItemsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srtConsolidationItemsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtConsolidationItemsAxis" xlink:to="loc_srtConsolidationItemsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srtConsolidationItemsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtConsolidationItemsAxis" xlink:to="loc_srtConsolidationItemsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember" xlink:label="loc_srtConsolidationEliminationsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtConsolidationItemsDomain" xlink:to="loc_srtConsolidationEliminationsMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapRevenues_300" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss_300" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapAssets_300" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapGoodwill_300" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets_300" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross_300" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_300" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic" xlink:title="00000068 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_NorthAndSouthAmericaMember" xlink:label="loc_simuNorthAndSouthAmericaMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_simuNorthAndSouthAmericaMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaMember" xlink:label="loc_srtAsiaMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SimulationsMember" xlink:label="loc_simuSimulationsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuSimulationsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="loc_simuCognigenMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuCognigenMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuDILIsymMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuLixoftMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues_610" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuDILIsymMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuLixoftMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_srtCounterpartyNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_FormerShareholdersMember" xlink:label="loc_simuFormerShareholdersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuFormerShareholdersMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DilisymEmployeesMember" xlink:label="loc_simuDilisymEmployeesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuDilisymEmployeesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_srtDirectorMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_110" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative" xlink:title="00000070 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:title="00000071 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuLixoftMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:title="00000072 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails" xlink:title="00000073 - Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>simu-20200831_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="us-gaap_IntellectualPropertyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntellectualPropertyMember" xlink:to="us-gaap_IntellectualPropertyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntellectualPropertyMember_lbl" xml:lang="en-US">Intellectual Property [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="us-gaap_OtherIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIntangibleAssetsMember" xlink:to="us-gaap_OtherIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIntangibleAssetsMember_lbl" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember" xlink:label="us-gaap_GoodwillMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillMember" xlink:to="us-gaap_GoodwillMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillMember_lbl" xml:lang="en-US">Goodwill [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="simu_CognigenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_CognigenMember" xlink:to="simu_CognigenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_CognigenMember_lbl" xml:lang="en-US">Cognigen [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="simu_DILIsymMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_DILIsymMember" xlink:to="simu_DILIsymMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_DILIsymMember_lbl" xml:lang="en-US">D I L Isym [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="simu_LixoftMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_LixoftMember" xlink:to="simu_LixoftMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_LixoftMember_lbl" xml:lang="en-US">Lixoft [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="us-gaap_TradeNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeNamesMember" xlink:to="us-gaap_TradeNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeNamesMember_lbl" xml:lang="en-US">Trade Names [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="us-gaap_CashAndCashEquivalentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xml:lang="en-US">Short-term Investments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_AquisitionRelatedContingentConsiderationObligationsMember" xlink:label="simu_AquisitionRelatedContingentConsiderationObligationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_AquisitionRelatedContingentConsiderationObligationsMember" xlink:to="simu_AquisitionRelatedContingentConsiderationObligationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_AquisitionRelatedContingentConsiderationObligationsMember_lbl" xml:lang="en-US">Aquisition Related Contingent Consideration Obligations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember" xlink:label="us-gaap_RoyaltyAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyAgreementsMember" xlink:to="us-gaap_RoyaltyAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyAgreementsMember_lbl" xml:lang="en-US">Royalty Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CounterpartyNameAxis_lbl" xml:lang="en-US">Counterparty Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EnslienMember" xlink:label="simu_EnslienMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_EnslienMember" xlink:to="simu_EnslienMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_EnslienMember_lbl" xml:lang="en-US">Enslien [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_TermAndNonassertionAgrMember" xlink:label="simu_TermAndNonassertionAgrMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_TermAndNonassertionAgrMember" xlink:to="simu_TermAndNonassertionAgrMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_TermAndNonassertionAgrMember_lbl" xml:lang="en-US">Term And Nonassertion Agr [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_TSRLMember" xlink:label="simu_TSRLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_TSRLMember" xlink:to="simu_TSRLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_TSRLMember_lbl" xml:lang="en-US">T S R L [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CertainDevelopedTechnologiesMember" xlink:label="simu_CertainDevelopedTechnologiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_CertainDevelopedTechnologiesMember" xlink:to="simu_CertainDevelopedTechnologiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_CertainDevelopedTechnologiesMember_lbl" xml:lang="en-US">Certain Developed Technologies [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CertainIntellectualPropertyRightsMember" xlink:label="simu_CertainIntellectualPropertyRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_CertainIntellectualPropertyRightsMember" xlink:to="simu_CertainIntellectualPropertyRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_CertainIntellectualPropertyRightsMember_lbl" xml:lang="en-US">Certain Intellectual Property Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EntelosHoldingCoMember" xlink:label="simu_EntelosHoldingCoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_EntelosHoldingCoMember" xlink:to="simu_EntelosHoldingCoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_EntelosHoldingCoMember_lbl" xml:lang="en-US">FY 2016 3rd Qtr [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EntelosMember" xlink:label="simu_EntelosMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_EntelosMember" xlink:to="simu_EntelosMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_EntelosMember_lbl" xml:lang="en-US">Entelos [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIMember" xlink:label="simu_DILIMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_DILIMember" xlink:to="simu_DILIMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_DILIMember_lbl" xml:lang="en-US">D I L I [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SoftwareLicensesMember" xlink:label="simu_SoftwareLicensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_SoftwareLicensesMember" xlink:to="simu_SoftwareLicensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_SoftwareLicensesMember_lbl" xml:lang="en-US">Software Licenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TimingOfTransferOfGoodOrServiceAxis_lbl" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="us-gaap_TransferredAtPointInTimeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredAtPointInTimeMember" xlink:to="us-gaap_TransferredAtPointInTimeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransferredAtPointInTimeMember_lbl" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember" xlink:label="us-gaap_TransferredOverTimeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransferredOverTimeMember" xlink:to="us-gaap_TransferredOverTimeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransferredOverTimeMember_lbl" xml:lang="en-US">Transferred over Time [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ConsultingServicesMember" xlink:label="simu_ConsultingServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ConsultingServicesMember" xlink:to="simu_ConsultingServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ConsultingServicesMember_lbl" xml:lang="en-US">Consulting Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommercialPaperMember_lbl" xml:lang="en-US">Commercial Paper [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_lbl" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_HoldbackLiabilityLixoftMember" xlink:label="simu_HoldbackLiabilityLixoftMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_HoldbackLiabilityLixoftMember" xlink:to="simu_HoldbackLiabilityLixoftMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_HoldbackLiabilityLixoftMember_lbl" xml:lang="en-US">Holdback Liability Lixoft [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EarnoutLiabilityLixoftMember" xlink:label="simu_EarnoutLiabilityLixoftMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_EarnoutLiabilityLixoftMember" xlink:to="simu_EarnoutLiabilityLixoftMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_EarnoutLiabilityLixoftMember_lbl" xml:lang="en-US">Earnout Liability Lixoft [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EarnoutLiabilityDilisymMember" xlink:label="simu_EarnoutLiabilityDilisymMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_EarnoutLiabilityDilisymMember" xlink:to="simu_EarnoutLiabilityDilisymMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_EarnoutLiabilityDilisymMember_lbl" xml:lang="en-US">Earnout Liability Dilisym [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US">Lender Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_WellsFargoMember" xlink:label="simu_WellsFargoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_WellsFargoMember" xlink:to="simu_WellsFargoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_WellsFargoMember_lbl" xml:lang="en-US">Wells Fargo [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsAxis" xlink:label="us-gaap_DividendsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsAxis" xlink:to="us-gaap_DividendsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsAxis_lbl" xml:lang="en-US">Dividends [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20181Member" xlink:label="simu_RecordDate20181Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20181Member" xlink:to="simu_RecordDate20181Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20181Member_lbl" xml:lang="en-US">Record Date 20181 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20182Member" xlink:label="simu_RecordDate20182Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20182Member" xlink:to="simu_RecordDate20182Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20182Member_lbl" xml:lang="en-US">Record Date 20182 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20183Member" xlink:label="simu_RecordDate20183Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20183Member" xlink:to="simu_RecordDate20183Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20183Member_lbl" xml:lang="en-US">Record Date 20183 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20184Member" xlink:label="simu_RecordDate20184Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20184Member" xlink:to="simu_RecordDate20184Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20184Member_lbl" xml:lang="en-US">Record Date 20184 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20191Member" xlink:label="simu_RecordDate20191Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20191Member" xlink:to="simu_RecordDate20191Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20191Member_lbl" xml:lang="en-US">Record Date 20191 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20192Member" xlink:label="simu_RecordDate20192Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20192Member" xlink:to="simu_RecordDate20192Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20192Member_lbl" xml:lang="en-US">Record Date 20192 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20193Member" xlink:label="simu_RecordDate20193Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20193Member" xlink:to="simu_RecordDate20193Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20193Member_lbl" xml:lang="en-US">Record Date 20193 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20194Member" xlink:label="simu_RecordDate20194Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20194Member" xlink:to="simu_RecordDate20194Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20194Member_lbl" xml:lang="en-US">Record Date 20194 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20201Member" xlink:label="simu_RecordDate20201Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20201Member" xlink:to="simu_RecordDate20201Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20201Member_lbl" xml:lang="en-US">Record Date 20201 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20202Member" xlink:label="simu_RecordDate20202Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20202Member" xlink:to="simu_RecordDate20202Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20202Member_lbl" xml:lang="en-US">Record Date 20202 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20203Member" xlink:label="simu_RecordDate20203Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20203Member" xlink:to="simu_RecordDate20203Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20203Member_lbl" xml:lang="en-US">Record Date 20203 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20204Member" xlink:label="simu_RecordDate20204Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RecordDate20204Member" xlink:to="simu_RecordDate20204Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RecordDate20204Member_lbl" xml:lang="en-US">Record Date 20204 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Equity2017IncentivePlanMember" xlink:label="simu_Equity2017IncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Equity2017IncentivePlanMember" xlink:to="simu_Equity2017IncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Equity2017IncentivePlanMember_lbl" xml:lang="en-US">Numerator</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price1Member" xlink:label="simu_Price1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Price1Member" xlink:to="simu_Price1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Price1Member_lbl" xml:lang="en-US">$1.00 to $1.50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price2Member" xlink:label="simu_Price2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Price2Member" xlink:to="simu_Price2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Price2Member_lbl" xml:lang="en-US">$7.51 to $9.00 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price3Member" xlink:label="simu_Price3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Price3Member" xlink:to="simu_Price3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Price3Member_lbl" xml:lang="en-US">$3.01 to $4.50 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price4Member" xlink:label="simu_Price4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Price4Member" xlink:to="simu_Price4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Price4Member_lbl" xml:lang="en-US">$4.51 to $6.00 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price5Member" xlink:label="simu_Price5Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Price5Member" xlink:to="simu_Price5Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Price5Member_lbl" xml:lang="en-US">Price 5 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price6Member" xlink:label="simu_Price6Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Price6Member" xlink:to="simu_Price6Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Price6Member_lbl" xml:lang="en-US">Price 6 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="us-gaap_SalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesMember" xlink:to="us-gaap_SalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesMember_lbl" xml:lang="en-US">Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_InternationalSalesMember" xlink:label="simu_InternationalSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_InternationalSalesMember" xlink:to="simu_InternationalSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_InternationalSalesMember_lbl" xml:lang="en-US">International Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer1Member" xlink:label="simu_Customer1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Customer1Member" xlink:to="simu_Customer1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Customer1Member_lbl" xml:lang="en-US">Customer 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer2Member" xlink:label="simu_Customer2Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Customer2Member" xlink:to="simu_Customer2Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Customer2Member_lbl" xml:lang="en-US">Customer 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer3Member" xlink:label="simu_Customer3Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Customer3Member" xlink:to="simu_Customer3Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Customer3Member_lbl" xml:lang="en-US">Customer 3 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer4Member" xlink:label="simu_Customer4Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Customer4Member" xlink:to="simu_Customer4Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_Customer4Member_lbl" xml:lang="en-US">Denominator</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ACustomerMember" xlink:label="simu_ACustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ACustomerMember" xlink:to="simu_ACustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ACustomerMember_lbl" xml:lang="en-US">A Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_BCustomerMember" xlink:label="simu_BCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_BCustomerMember" xlink:to="simu_BCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_BCustomerMember_lbl" xml:lang="en-US">B Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SimulationsMember" xlink:label="simu_SimulationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_SimulationsMember" xlink:to="simu_SimulationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_SimulationsMember_lbl" xml:lang="en-US">Simulations Plus, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xml:lang="en-US">Operating Segments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidationItemsAxis_lbl" xml:lang="en-US">Consolidation Items [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember" xlink:label="srt_ConsolidationEliminationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationEliminationsMember" xlink:to="srt_ConsolidationEliminationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidationEliminationsMember_lbl" xml:lang="en-US">Consolidation, Eliminations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_NorthAndSouthAmericaMember" xlink:label="simu_NorthAndSouthAmericaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_NorthAndSouthAmericaMember" xlink:to="simu_NorthAndSouthAmericaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_NorthAndSouthAmericaMember_lbl" xml:lang="en-US">North And South America [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EuropeMember_lbl" xml:lang="en-US">Europe [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaMember" xlink:label="srt_AsiaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_AsiaMember_lbl" xml:lang="en-US">Asia [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_FormerShareholdersMember" xlink:label="simu_FormerShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_FormerShareholdersMember" xlink:to="simu_FormerShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="simu_FormerShareholdersMember_lbl" xml:lang="en-US">Numerator</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DilisymEmployeesMember" xlink:label="simu_DilisymEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_DilisymEmployeesMember" xlink:to="simu_DilisymEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_DilisymEmployeesMember_lbl" xml:lang="en-US">Dilisym Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $50,000 and $0</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:to="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_lbl" xml:lang="en-US">Revenues in excess of billings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidTaxes_lbl" xml:lang="en-US">Prepaid income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Long-term assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="us-gaap_CapitalizedComputerSoftwareNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareNet" xlink:to="us-gaap_CapitalizedComputerSoftwareNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareNet_lbl" xml:lang="en-US">Capitalized computer software development costs, net of accumulated amortization of $13,581,599 and $12,356,055</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net (note 4)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right of use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intellectual property, net of accumulated amortization of $5,087,031 and $3,948,750</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Other intangible assets net of accumulated amortization of $1,641,725 and $1,210,000</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll and other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableCurrent" xlink:label="simu_ContractsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContractsPayableCurrent" xlink:to="simu_ContractsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ContractsPayableCurrent_lbl" xml:lang="en-US">Current portion - Contracts payable (note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BillingsInExcessOfCost" xlink:label="us-gaap_BillingsInExcessOfCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BillingsInExcessOfCost" xlink:to="us-gaap_BillingsInExcessOfCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BillingsInExcessOfCost_lbl" xml:lang="en-US">Billings in excess of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating Lease Liability, current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred income taxes, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating Lease Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableNoncurrent" xlink:label="simu_ContractsPayableNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContractsPayableNoncurrent" xlink:to="simu_ContractsPayableNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ContractsPayableNoncurrent_lbl" xml:lang="en-US">Payments due under Contracts payable (note 6)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders' equity (note 8)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 par value 50,000,000 shares authorized 19,923,277 and 17,591,834 shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total shareholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization of computer software development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization on intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross margin</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general, and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOperating" xlink:label="us-gaap_InterestIncomeOperating" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOperating" xlink:to="us-gaap_InterestIncomeOperating_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOperating_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" xlink:label="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" xlink:to="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability_lbl" xml:lang="en-US">Change in value of contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">(Loss) income on currency exchange</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Income before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xml:lang="en-US">Other Comprehensive Income, net of tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency translation adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_lbl" xml:lang="en-US">Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Shares issued to Directors for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Shares issued to Directors for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCash" xlink:label="us-gaap_DividendsCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsCash_lbl" xml:lang="en-US">Declaration of Dividend</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" xlink:label="simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" xlink:to="simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606_lbl" xml:lang="en-US">Cumulative Effect of Changes related to adoption of ASC 606</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Shares issued - Lixoft</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Shares issued - Lixoft, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Common stock issued for cash, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Common stock issued for cash, net, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_lbl" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xml:lang="en-US">Change in value of contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xml:lang="en-US">Deferred income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_lbl" xml:lang="en-US">Increase (decrease) in</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:label="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:to="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_lbl" xml:lang="en-US">Revenues in excess of billings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Accrued payroll and other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings" xlink:label="us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings" xlink:to="us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings_lbl" xml:lang="en-US">Billings in excess of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_lbl" xml:lang="en-US">Accrued income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchases of intellectual property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_lbl" xml:lang="en-US">Purchase of short-term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_lbl" xml:lang="en-US">Cash used to acquire subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US">Cash received in acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToDevelopSoftware" xlink:label="us-gaap_PaymentsToDevelopSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToDevelopSoftware" xlink:to="us-gaap_PaymentsToDevelopSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToDevelopSoftware_lbl" xml:lang="en-US">Capitalized computer software development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows provided by (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividends_lbl" xml:lang="en-US">Payment of dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_PaymentsOnContractsPayable" xlink:label="simu_PaymentsOnContractsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_PaymentsOnContractsPayable" xlink:to="simu_PaymentsOnContractsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="simu_PaymentsOnContractsPayable_lbl" xml:lang="en-US">Payments on contracts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from the exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from follow-on public offering, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-Cash Investing and Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_StockIssuedForAcquisitionOfLixoft" xlink:label="simu_StockIssuedForAcquisitionOfLixoft" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_StockIssuedForAcquisitionOfLixoft" xlink:to="simu_StockIssuedForAcquisitionOfLixoft_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_StockIssuedForAcquisitionOfLixoft_lbl" xml:lang="en-US">Stock issued for acquisition of Lixoft</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="us-gaap_LiabilitiesAssumed1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAssumed1" xlink:to="us-gaap_LiabilitiesAssumed1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAssumed1_lbl" xml:lang="en-US">Creation of contract liabilities for acquisition of subsidiaries</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RightOfUseAssetsCapitalized" xlink:label="simu_RightOfUseAssetsCapitalized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RightOfUseAssetsCapitalized" xlink:to="simu_RightOfUseAssetsCapitalized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RightOfUseAssetsCapitalized_lbl" xml:lang="en-US">Right of use assets capitalized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">ORGANIZATION AND LINES OF BUSINESS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">REVENUE RECOGNITION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">INVESTMENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">CONTRACTS PAYABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHAREHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">CONCENTRATIONS AND UNCERTAINTIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND GEOGRAPHIC REPORTING</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTY TRANSACTIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US">EMPLOYEE BENEFIT PLAN</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Business Combinations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xml:lang="en-US">ACQUISITION/MERGER WITH SUBSIDIARIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:to="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationDisclosureAbstract_lbl" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_QuarterlyFinancialInformationTextBlock_lbl" xml:lang="en-US">UNAUDITED QUARTERLY FINANCIAL DATA</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl" xml:lang="en-US">Capitalized Computer Software Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Other Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:label="us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:to="us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_lbl" xml:lang="en-US">Business Acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Intellectual property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_lbl" xml:lang="en-US">Property and Equipment estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:to="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Operating assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of reconciliation of goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of future amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">Summarizes fair value measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ReconciliationOfContingentConsiderationTableTextBlock" xlink:label="simu_ReconciliationOfContingentConsiderationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ReconciliationOfContingentConsiderationTableTextBlock" xlink:to="simu_ReconciliationOfContingentConsiderationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ReconciliationOfContingentConsiderationTableTextBlock_lbl" xml:lang="en-US">Reconciliation of contingent consideration value</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ScheduleOfAmortizationExpensesTableTextBlock" xlink:label="simu_ScheduleOfAmortizationExpensesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ScheduleOfAmortizationExpensesTableTextBlock" xlink:to="simu_ScheduleOfAmortizationExpensesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ScheduleOfAmortizationExpensesTableTextBlock_lbl" xml:lang="en-US">Schedule of future amortization expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of disaggregation of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:label="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:to="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_lbl" xml:lang="en-US">Schedule of contract in progress</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTableTextBlock" xlink:label="us-gaap_InvestmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTableTextBlock" xlink:to="us-gaap_InvestmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTableTextBlock_lbl" xml:lang="en-US">Schedule of short term investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock" xlink:label="us-gaap_OtherLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesTableTextBlock" xlink:to="us-gaap_OtherLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Future minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:label="us-gaap_ScheduleOfDividendsPayableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:to="us-gaap_ScheduleOfDividendsPayableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDividendsPayableTextBlock_lbl" xml:lang="en-US">Schedule of dividends declared and paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of stock option activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_lbl" xml:lang="en-US">Intrinsic Value of options outstanding and options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl" xml:lang="en-US">Schedule of fair value of options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Schedule of options by exercise price range</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Components of the income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Effective income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Components of the Company deferred tax assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of consolidated results from reportable segments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_lbl" xml:lang="en-US">Schedule of geographical revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Allocation of purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">Schedule of statement of income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Quarterly Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Property, Plant and Equipment, Estimated Useful Lives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Right of use assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Lease Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Lease Liabilities, Long-term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Acquired Indefinite-lived Intangible Assets [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Goodwill, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US">Addition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Impairments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_3_lbl" xml:lang="en-US">Goodwill, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_AmortizationPeriodIntangibleAssets" xlink:label="simu_AmortizationPeriodIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_AmortizationPeriodIntangibleAssets" xlink:to="simu_AmortizationPeriodIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_AmortizationPeriodIntangibleAssets_lbl" xml:lang="en-US">Amortization period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Acquisition value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Net book value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_lbl" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Fair value assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US">Fair value liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_lbl" xml:lang="en-US">Contingent consideration, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_PurchasePriceContingentConsiderationAdditions" xlink:label="simu_PurchasePriceContingentConsiderationAdditions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_PurchasePriceContingentConsiderationAdditions" xlink:to="simu_PurchasePriceContingentConsiderationAdditions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_PurchasePriceContingentConsiderationAdditions_lbl" xml:lang="en-US">Purchase price contingent consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContingentConsiderationPayments" xlink:label="simu_ContingentConsiderationPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContingentConsiderationPayments" xlink:to="simu_ContingentConsiderationPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="simu_ContingentConsiderationPayments_lbl" xml:lang="en-US">Contingent consideration payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_2_lbl" xml:lang="en-US">Contingent consideration, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xml:lang="en-US">Numerator</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net income attributable to common shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:label="us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_lbl" xml:lang="en-US">Denominator</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted-average number of common shares outstanding during the year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Dilutive effect of stock options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Common stock and common stock equivalents used for diluted earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:label="us-gaap_CapitalizedComputerSoftwareAmortization1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="us-gaap_CapitalizedComputerSoftwareAmortization1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareAmortization1_lbl" xml:lang="en-US">Amortization of software development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xml:lang="en-US">Impairment of long-lived assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xml:lang="en-US">Intangible asset acquisition value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3_lbl" xml:lang="en-US">Accumulated amortization of intellectual property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Impairment losses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BillingsInExcessOfCost" xlink:to="us-gaap_BillingsInExcessOfCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BillingsInExcessOfCost_2_lbl" xml:lang="en-US">Billings in excess of revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RevenuesOverBillingsOnUncompletedContracts" xlink:label="simu_RevenuesOverBillingsOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RevenuesOverBillingsOnUncompletedContracts" xlink:to="simu_RevenuesOverBillingsOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="simu_RevenuesOverBillingsOnUncompletedContracts_lbl" xml:lang="en-US">Revenues over billings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RevenuesEarnedToDateOnUncompletedContracts" xlink:label="simu_RevenuesEarnedToDateOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RevenuesEarnedToDateOnUncompletedContracts" xlink:to="simu_RevenuesEarnedToDateOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RevenuesEarnedToDateOnUncompletedContracts_lbl" xml:lang="en-US">Revenues earned to date on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_BillingsToDateOnUncompletedContracts" xlink:label="simu_BillingsToDateOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_BillingsToDateOnUncompletedContracts" xlink:to="simu_BillingsToDateOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="simu_BillingsToDateOnUncompletedContracts_lbl" xml:lang="en-US">Billings to date on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xml:lang="en-US">Remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Revenues included in contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Net Book Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_lbl" xml:lang="en-US">Investment Income [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:label="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_lbl" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShortTermInvestments_2_lbl" xml:lang="en-US">Short term investment, amortized cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains_lbl" xml:lang="en-US">Gross unrealized gains</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_lbl" xml:lang="en-US">Gross unrealized loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="us-gaap_InvestmentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Short term investment, fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable_lbl" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems_lbl" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayable" xlink:label="simu_ContractsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContractsPayable" xlink:to="simu_ContractsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ContractsPayable_lbl" xml:lang="en-US">Total contract with customer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xml:lang="en-US">Total contract with customer</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContractsPayableCurrent" xlink:to="simu_ContractsPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="simu_ContractsPayableCurrent_2_lbl" xml:lang="en-US">Less: Current Portion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContractsPayableNoncurrent" xlink:to="simu_ContractsPayableNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="simu_ContractsPayableNoncurrent_2_lbl" xml:lang="en-US">Long-Term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Future minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:label="us-gaap_SummaryOfInvestmentHoldingsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:to="us-gaap_SummaryOfInvestmentHoldingsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SummaryOfInvestmentHoldingsLineItems_lbl" xml:lang="en-US">Summary of Investment Holdings [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of credit maximum amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Line of credit expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Line of credit amount outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RoyaltyExpenses" xlink:label="simu_RoyaltyExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RoyaltyExpenses" xlink:to="simu_RoyaltyExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RoyaltyExpenses_lbl" xml:lang="en-US">Royalties expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableTable" xlink:label="us-gaap_DividendsPayableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableTable" xlink:to="us-gaap_DividendsPayableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableTable_lbl" xml:lang="en-US">Dividends Payable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableLineItems" xlink:label="us-gaap_DividendsPayableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableLineItems" xlink:to="us-gaap_DividendsPayableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableLineItems_lbl" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:label="us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:to="us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableDateOfRecordDayMonthAndYear_lbl" xml:lang="en-US">Record Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:label="us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:to="us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableDateDeclaredDayMonthAndYear_lbl" xml:lang="en-US">Distribution Date</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" xlink:label="simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" xlink:to="simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_lbl" xml:lang="en-US">Number of Shares Outstanding on Record Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Dividend per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="us-gaap_Dividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Dividends" xlink:to="us-gaap_Dividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Dividends_lbl" xml:lang="en-US">Total Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Option outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_OutstandingRemainingContractualLife" xlink:label="simu_OutstandingRemainingContractualLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_OutstandingRemainingContractualLife" xlink:to="simu_OutstandingRemainingContractualLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_OutstandingRemainingContractualLife_lbl" xml:lang="en-US">Outstanding, beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Canceled/Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Canceled/Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Awards Outstanding, ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Outstanding, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Vested and Exercisable, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Vested and Exercisable, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Vested and Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Vested and Expected to Vest, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Vested and Expected to Vest, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Vested and Expected to Vest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Intrinsic Value of Options Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Intrinsic Value of Options Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Intrinsic Value of Options Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_FairValueOptionsGranted" xlink:label="simu_FairValueOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_FairValueOptionsGranted" xlink:to="simu_FairValueOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_FairValueOptionsGranted_lbl" xml:lang="en-US">Estimated fair value of awards granted</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:label="simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:to="simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_lbl" xml:lang="en-US">Unvested Forfeiture Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted average grant price</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_WeightedAverageMarketPrice" xlink:label="simu_WeightedAverageMarketPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_WeightedAverageMarketPrice" xlink:to="simu_WeightedAverageMarketPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_WeightedAverageMarketPrice_lbl" xml:lang="en-US">Weighted average market price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Weighted average volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted average risk-free rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Weighted average dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Weighted average expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Exercise price low</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xml:lang="en-US">Exercise price high</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Awards outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Awards outstanding weighted average remaining contractual life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Awards outstanding weighted average exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Awards exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Awards exercisable weighted average remaining contractual life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Awards exercisable weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock reserved for issuance under the plan</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted average remaining contractual life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Fair value of non-vested options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Fair value amortization period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Shares issued under public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_2_lbl" xml:lang="en-US">Proceeds from public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total current tax expense (benefit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xml:lang="en-US">Total deferred federal and state</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income tax computed at federal statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">State taxes, net of federal benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_lbl" xml:lang="en-US">Meals &amp; entertainment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_lbl" xml:lang="en-US">Other permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xml:lang="en-US">Research and development credit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Foreign tax related differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xml:lang="en-US">Research &amp; credit adjustments to expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_lbl" xml:lang="en-US">Domestic production activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xml:lang="en-US">Change in deferred income taxes due to statutory rate changes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US">Change in prior year estimated taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_lbl" xml:lang="en-US">Accrued payroll and other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:label="us-gaap_DeferredTaxAssetsEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:to="us-gaap_DeferredTaxAssetsEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsEquityMethodInvestments_lbl" xml:lang="en-US">Capitalized merger costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intellectual property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes" xlink:label="us-gaap_DeferredTaxAssetsStateTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsStateTaxes" xlink:to="us-gaap_DeferredTaxAssetsStateTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsStateTaxes_lbl" xml:lang="en-US">State taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_lbl" xml:lang="en-US">State tax deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">State tax deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_lbl" xml:lang="en-US">Intellectual property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_lbl" xml:lang="en-US">Capitalized computer software development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashUninsuredAmount_lbl" xml:lang="en-US">Cash and cash equivalents exceeding insured limits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Net sales concentration percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Net Revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Income (loss) from operations before income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireProductiveAssets_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="us-gaap_CapitalizedComputerSoftwareGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedComputerSoftwareGross" xlink:to="us-gaap_CapitalizedComputerSoftwareGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedComputerSoftwareGross_lbl" xml:lang="en-US">Capitalized software costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_lbl" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_lbl" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US">Payment for acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_lbl" xml:lang="en-US">Acquisition liabilities owed</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_lbl" xml:lang="en-US">Earn-out payments made</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US">Business acquisition, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanContributionsByEmployer_lbl" xml:lang="en-US">Contribution by employer in benefit plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_lbl" xml:lang="en-US">Assets acquired, Including cash of $3,799,134 and accounts receivable of $629,481</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xml:lang="en-US">Developed Technologies Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xml:lang="en-US">Estimated value of Intangibles assets acquired (Customer Lists, trade name etc.)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Goodwill_4_lbl" xml:lang="en-US">Estimated Goodwill acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_2_lbl" xml:lang="en-US">Liabilities Assumed</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Total Consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Net Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Earnings per share, Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Earnings per share, Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" xlink:to="simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606_doc" xml:lang="en-US">Cumulative Effect of Changes related to adoption of ASC 606</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_PaymentsOnContractsPayable" xlink:to="simu_PaymentsOnContractsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_PaymentsOnContractsPayable_doc" xml:lang="en-US">Payment on contracts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_StockIssuedForAcquisitionOfLixoft" xlink:to="simu_StockIssuedForAcquisitionOfLixoft_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_StockIssuedForAcquisitionOfLixoft_doc" xml:lang="en-US">Stock issued for acquisition of Lixoft</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RightOfUseAssetsCapitalized" xlink:to="simu_RightOfUseAssetsCapitalized_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_RightOfUseAssetsCapitalized_doc" xml:lang="en-US">Right of use assets capitalized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" xlink:to="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability_doc" xml:lang="en-US">Change in value of contingent consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:to="simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_doc" xml:lang="en-US">Property and Equipment estimated useful lives [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ReconciliationOfContingentConsiderationTableTextBlock" xlink:to="simu_ReconciliationOfContingentConsiderationTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_ReconciliationOfContingentConsiderationTableTextBlock_doc" xml:lang="en-US">Reconciliation Of Contingent Consideration [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ScheduleOfAmortizationExpensesTableTextBlock" xlink:to="simu_ScheduleOfAmortizationExpensesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_ScheduleOfAmortizationExpensesTableTextBlock_doc" xml:lang="en-US">Schedule of Amortization [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_AmortizationPeriodIntangibleAssets" xlink:to="simu_AmortizationPeriodIntangibleAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_AmortizationPeriodIntangibleAssets_doc" xml:lang="en-US">Amortization period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_PurchasePriceContingentConsiderationAdditions" xlink:to="simu_PurchasePriceContingentConsiderationAdditions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_PurchasePriceContingentConsiderationAdditions_doc" xml:lang="en-US">Purchase price contingent consideration addition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContingentConsiderationPayments" xlink:to="simu_ContingentConsiderationPayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_ContingentConsiderationPayments_doc" xml:lang="en-US">Contingent consideration payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RevenuesOverBillingsOnUncompletedContracts" xlink:to="simu_RevenuesOverBillingsOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_RevenuesOverBillingsOnUncompletedContracts_doc" xml:lang="en-US">Revenues over billings on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RevenuesEarnedToDateOnUncompletedContracts" xlink:to="simu_RevenuesEarnedToDateOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_RevenuesEarnedToDateOnUncompletedContracts_doc" xml:lang="en-US">Revenues earned to date on uncompleted contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_BillingsToDateOnUncompletedContracts" xlink:to="simu_BillingsToDateOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_BillingsToDateOnUncompletedContracts_doc" xml:lang="en-US">Billings to date on uncompleted contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" xlink:to="simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_doc" xml:lang="en-US">Weighted average number of shares outstanding basic and diluted at record date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_OutstandingRemainingContractualLife" xlink:to="simu_OutstandingRemainingContractualLife_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_OutstandingRemainingContractualLife_doc" xml:lang="en-US">Weighted average remaining contractual life outstanding, beginning balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_FairValueOptionsGranted" xlink:to="simu_FairValueOptionsGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_FairValueOptionsGranted_doc" xml:lang="en-US">Estimated fair value of awards granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:to="simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_doc" xml:lang="en-US">Unvested Forfeiture Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_WeightedAverageMarketPrice" xlink:to="simu_WeightedAverageMarketPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_WeightedAverageMarketPrice_doc" xml:lang="en-US">Weighted average market price</link:label>
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EquityPlanTerminationDate" xlink:label="simu_EquityPlanTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_EquityPlanTerminationDate" xlink:to="simu_EquityPlanTerminationDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_EquityPlanTerminationDate_doc" xml:lang="en-US">Equity plan termination date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Customer1Member" xlink:to="simu_Customer1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_Customer1Member_doc" xml:lang="en-US">Customer 1 Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_Customer2Member" xlink:to="simu_Customer2Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_Customer2Member_doc" xml:lang="en-US">Customer 2 Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContractsPayableCurrent" xlink:to="simu_ContractsPayableCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_ContractsPayableCurrent_doc" xml:lang="en-US">Contracts payable, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContractsPayableNoncurrent" xlink:to="simu_ContractsPayableNoncurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_ContractsPayableNoncurrent_doc" xml:lang="en-US">Contracts payable, noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContractsPayable" xlink:to="simu_ContractsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="simu_ContractsPayable_doc" xml:lang="en-US">Contracts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_FormerShareholdersMember" xlink:to="simu_FormerShareholdersMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_FormerShareholdersMember_2_lbl" xml:lang="en-US">Numerator [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" xlink:to="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability_3_lbl" xml:lang="en-US">BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCash" xlink:to="us-gaap_DividendsCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCash_2_lbl" xml:lang="en-US">Dividends, Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:to="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract_2_lbl" xml:lang="en-US">Increase (Decrease) in Cost in Excess of Billing on Uncompleted Contract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings" xlink:to="us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings_2_lbl" xml:lang="en-US">Increase (Decrease) in Billing in Excess of Cost of Earnings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireShortTermInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:to="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates_2_lbl" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries and Affiliates</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToDevelopSoftware" xlink:to="us-gaap_PaymentsToDevelopSoftware_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToDevelopSoftware_2_lbl" xml:lang="en-US">Payments to Develop Software</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividends_2_lbl" xml:lang="en-US">Payments of Dividends</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_PaymentsOnContractsPayable" xlink:to="simu_PaymentsOnContractsPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_PaymentsOnContractsPayable_3_lbl" xml:lang="en-US">PaymentsOnContractsPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_3_lbl" xml:lang="en-US">Business Combination, Contingent Consideration, Asset, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_ContingentConsiderationPayments" xlink:to="simu_ContingentConsiderationPayments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_ContingentConsiderationPayments_3_lbl" xml:lang="en-US">Current portion - Contract payable (note 5)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_RevenuesOverBillingsOnUncompletedContracts" xlink:to="simu_RevenuesOverBillingsOnUncompletedContracts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_RevenuesOverBillingsOnUncompletedContracts_3_lbl" xml:lang="en-US">Revenues over billings on uncompleted contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="simu_BillingsToDateOnUncompletedContracts" xlink:to="simu_BillingsToDateOnUncompletedContracts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="simu_BillingsToDateOnUncompletedContracts_3_lbl" xml:lang="en-US">BillingsToDateOnUncompletedContracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss_2_lbl" xml:lang="en-US">Available-for-sale Securities, Gross Unrealized Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiability_2_lbl" xml:lang="en-US">Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_2_lbl" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_2_lbl" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_2_lbl" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_2_lbl" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2_lbl" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_2_lbl" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:to="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Capitalized Software</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>simu-20200831_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://simulations.com/role/Cover" xlink:href="simu-20200831.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedBalanceSheets" xlink:href="simu-20200831.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="simu-20200831.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedStatementsOfOperations" xlink:href="simu-20200831.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/StatementsOfShareholdersEquity" xlink:href="simu-20200831.xsd#StatementsOfShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="simu-20200831.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/OrganizationAndLinesOfBusiness" xlink:href="simu-20200831.xsd#OrganizationAndLinesOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognition" xlink:href="simu-20200831.xsd#RevenueRecognition" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipment" xlink:href="simu-20200831.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/Investments" xlink:href="simu-20200831.xsd#Investments" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayable" xlink:href="simu-20200831.xsd#ContractsPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingencies" xlink:href="simu-20200831.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquity" xlink:href="simu-20200831.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxes" xlink:href="simu-20200831.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConcentrationsAndUncertainties" xlink:href="simu-20200831.xsd#ConcentrationsAndUncertainties" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReporting" xlink:href="simu-20200831.xsd#SegmentAndGeographicReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RelatedPartyTransactions" xlink:href="simu-20200831.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/EmployeeBenefitPlan" xlink:href="simu-20200831.xsd#EmployeeBenefitPlan" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiaries" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiaries" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnauditedQuarterlyFinancialData" xlink:href="simu-20200831.xsd#UnauditedQuarterlyFinancialData" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SubsequentEvents" xlink:href="simu-20200831.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionTables" xlink:href="simu-20200831.xsd#RevenueRecognitionTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentTables" xlink:href="simu-20200831.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsTables" xlink:href="simu-20200831.xsd#InvestmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayableTables" xlink:href="simu-20200831.xsd#ContractsPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesTables" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityTables" xlink:href="simu-20200831.xsd#ShareholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesTables" xlink:href="simu-20200831.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingTables" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnauditedQuarterlyFinancialDataTables" xlink:href="simu-20200831.xsd#UnauditedQuarterlyFinancialDataTables" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="simu-20200831.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetails-Disaggregation" xlink:href="simu-20200831.xsd#RevenueRecognitionDetails-Disaggregation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess" xlink:href="simu-20200831.xsd#RevenueRecognitionDetails-ContractsInProgess" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RevenueRecognitionDetailsNarrative" xlink:href="simu-20200831.xsd#RevenueRecognitionDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentDetails" xlink:href="simu-20200831.xsd#PropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="simu-20200831.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsDetails" xlink:href="simu-20200831.xsd#InvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/InvestmentsDetailsNarrative" xlink:href="simu-20200831.xsd#InvestmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ContractsPayableDetails" xlink:href="simu-20200831.xsd#ContractsPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesDetails" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="simu-20200831.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-Dividends" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-Dividends" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-OptionActivity" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-OptionActivity" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-IntrinsicValue" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-FairValueOfOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:href="simu-20200831.xsd#ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ShareholdersEquityDetailsNarrative" xlink:href="simu-20200831.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-IncomeTaxProvision" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-Reconciliation" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-Reconciliation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes" xlink:href="simu-20200831.xsd#IncomeTaxesDetails-DeferredTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/IncomeTaxesDetailsNarrative" xlink:href="simu-20200831.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative" xlink:href="simu-20200831.xsd#ConcentrationsAndUncertaintiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingDetails-SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic" xlink:href="simu-20200831.xsd#SegmentAndGeographicReportingDetails-Geographic" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="simu-20200831.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative" xlink:href="simu-20200831.xsd#EmployeeBenefitPlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:href="simu-20200831.xsd#AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails" xlink:href="simu-20200831.xsd#UnaudtedQuarterlyFinancialDataDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaapPrepaidTaxes" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaapCapitalizedComputerSoftwareNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapCapitalizedComputerSoftwareNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableCurrent" xlink:label="loc_simuContractsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_simuContractsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BillingsInExcessOfCost" xlink:label="loc_us-gaapBillingsInExcessOfCost" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapBillingsInExcessOfCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilitiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableNoncurrent" xlink:label="loc_simuContractsPayableNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_simuContractsPayableNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeOperating" xlink:label="loc_us-gaapInterestIncomeOperating" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestIncomeOperating" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" xlink:label="loc_simuBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_simuBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaapComprehensiveIncomeNetOfTax" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComprehensiveIncomeNetOfTaxAbstract" xlink:to="loc_us-gaapComprehensiveIncomeNetOfTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/StatementsOfShareholdersEquity" xlink:title="00000005 - Statement - STATEMENTS OF SHAREHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCash" xlink:label="loc_us-gaapDividendsCash" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606" xlink:label="loc_simuCumulativeEffectOfChangesRelatedToAdoptionOfAsc606" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_simuCumulativeEffectOfChangesRelatedToAdoptionOfAsc606" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:label="loc_us-gaapIncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings" xlink:label="loc_us-gaapIncreaseDecreaseInBillingInExcessOfCostOfEarnings" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInBillingInExcessOfCostOfEarnings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments" xlink:label="loc_us-gaapPaymentsToAcquireShortTermInvestments" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireInterestInSubsidiariesAndAffiliates" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireInterestInSubsidiariesAndAffiliates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToDevelopSoftware" xlink:label="loc_us-gaapPaymentsToDevelopSoftware" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToDevelopSoftware" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaapPaymentsOfDividends" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividends" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_PaymentsOnContractsPayable" xlink:label="loc_simuPaymentsOnContractsPayable" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_simuPaymentsOnContractsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_StockIssuedForAcquisitionOfLixoft" xlink:label="loc_simuStockIssuedForAcquisitionOfLixoft" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_simuStockIssuedForAcquisitionOfLixoft" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaapLiabilitiesAssumed1" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapLiabilitiesAssumed1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RightOfUseAssetsCapitalized" xlink:label="loc_simuRightOfUseAssetsCapitalized" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_simuRightOfUseAssetsCapitalized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/OrganizationAndLinesOfBusiness" xlink:title="00000007 - Disclosure - ORGANIZATION AND LINES OF BUSINESS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognition" xlink:title="00000009 - Disclosure - REVENUE RECOGNITION">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - PROPERTY AND EQUIPMENT">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/Investments" xlink:title="00000011 - Disclosure - INVESTMENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayable" xlink:title="00000012 - Disclosure - CONTRACTS PAYABLE">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquity" xlink:title="00000014 - Disclosure - SHAREHOLDERS&apos; EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConcentrationsAndUncertainties" xlink:title="00000016 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReporting" xlink:title="00000017 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/RelatedPartyTransactions" xlink:title="00000018 - Disclosure - RELATED PARTY TRANSACTIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/EmployeeBenefitPlan" xlink:title="00000019 - Disclosure - EMPLOYEE BENEFIT PLAN">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiaries" xlink:title="00000020 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaapMergersAcquisitionsAndDispositionsDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapMergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/UnauditedQuarterlyFinancialData" xlink:title="00000021 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaapQuarterlyFinancialInformationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapQuarterlyFinancialInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="loc_us-gaapInvestmentPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInvestmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:label="loc_us-gaapResearchDevelopmentAndComputerSoftwarePolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:label="loc_us-gaapBusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:label="loc_simuPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_simuPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock" xlink:label="loc_us-gaapOperatingLeasesOfLesseeDisclosureTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLeasesOfLesseeDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaapScheduleOfGoodwillTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ReconciliationOfContingentConsiderationTableTextBlock" xlink:label="loc_simuReconciliationOfContingentConsiderationTableTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_simuReconciliationOfContingentConsiderationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ScheduleOfAmortizationExpensesTableTextBlock" xlink:label="loc_simuScheduleOfAmortizationExpensesTableTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_simuScheduleOfAmortizationExpensesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionTables" xlink:title="00000025 - Disclosure - REVENUE RECOGNITION (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:label="loc_us-gaapCostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentTables" xlink:title="00000026 - Disclosure - PROPERTY AND EQUIPMENT (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsTables" xlink:title="00000027 - Disclosure - INVESTMENTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTableTextBlock" xlink:label="loc_us-gaapInvestmentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayableTables" xlink:title="00000028 - Disclosure - CONTRACTS PAYABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesTableTextBlock" xlink:label="loc_us-gaapOtherLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapOtherLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesTables" xlink:title="00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityTables" xlink:title="00000030 - Disclosure - SHAREHOLDERS&apos; EQUITY (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDividendsPayableTextBlock" xlink:label="loc_us-gaapScheduleOfDividendsPayableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfDividendsPayableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesTables" xlink:title="00000031 - Disclosure - INCOME TAXES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingTables" xlink:title="00000032 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables" xlink:title="00000033 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/UnauditedQuarterlyFinancialDataTables" xlink:title="00000034 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives" xlink:title="00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentEstimatedUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities" xlink:title="00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost" xlink:title="00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill" xlink:title="00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="loc_simuCognigenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuCognigenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuDILIsymMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets" xlink:title="00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaapTradeNamesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTradeNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="loc_simuCognigenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuCognigenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuDILIsymMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_AmortizationPeriodIntangibleAssets" xlink:label="loc_simuAmortizationPeriodIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_simuAmortizationPeriodIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule" xlink:title="00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements" xlink:title="00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:label="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByFairValueHierarchyLevelAxis" xlink:to="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaapFairValueInputsLevel1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaapFairValueInputsLevel2Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaapFairValueInputsLevel3Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementsFairValueHierarchyDomain" xlink:to="loc_us-gaapFairValueInputsLevel3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaapFairValueByMeasurementFrequencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFairValueByMeasurementFrequencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaapFairValueMeasurementFrequencyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByMeasurementFrequencyAxis" xlink:to="loc_us-gaapFairValueMeasurementFrequencyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaapFairValueMeasurementsRecurringMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueMeasurementFrequencyDomain" xlink:to="loc_us-gaapFairValueMeasurementsRecurringMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="loc_us-gaapCashAndCashEquivalentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapCashAndCashEquivalentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="loc_us-gaapShortTermInvestmentsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapShortTermInvestmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_AquisitionRelatedContingentConsiderationObligationsMember" xlink:label="loc_simuAquisitionRelatedContingentConsiderationObligationsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_simuAquisitionRelatedContingentConsiderationObligationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaapLiabilitiesFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="loc_us-gaapLiabilitiesFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration" xlink:title="00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationAssetCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationAssetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_PurchasePriceContingentConsiderationAdditions" xlink:label="loc_simuPurchasePriceContingentConsiderationAdditions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_simuPurchasePriceContingentConsiderationAdditions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContingentConsiderationPayments" xlink:label="loc_simuContingentConsiderationPayments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_simuContingentConsiderationPayments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationAssetCurrent_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationAssetCurrent_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses" xlink:title="00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_TSRLMember" xlink:label="loc_simuTSRLMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuTSRLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EnslienMember" xlink:label="loc_simuEnslienMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEnslienMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIMember" xlink:label="loc_simuDILIMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuDILIMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EntelosMember" xlink:label="loc_simuEntelosMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEntelosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare" xlink:title="00000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicOtherDisclosuresAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillMember" xlink:label="loc_us-gaapGoodwillMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaapOtherIntangibleAssetsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapOtherIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyAgreementsMember" xlink:label="loc_us-gaapRoyaltyAgreementsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapRoyaltyAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntellectualPropertyMember" xlink:label="loc_us-gaapIntellectualPropertyMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapIntellectualPropertyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_TermAndNonassertionAgrMember" xlink:label="loc_simuTermAndNonassertionAgrMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_simuTermAndNonassertionAgrMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CertainDevelopedTechnologiesMember" xlink:label="loc_simuCertainDevelopedTechnologiesMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_simuCertainDevelopedTechnologiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CertainIntellectualPropertyRightsMember" xlink:label="loc_simuCertainIntellectualPropertyRightsMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_simuCertainIntellectualPropertyRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EnslienMember" xlink:label="loc_simuEnslienMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEnslienMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_TSRLMember" xlink:label="loc_simuTSRLMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuTSRLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuDILIsymMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EntelosHoldingCoMember" xlink:label="loc_simuEntelosHoldingCoMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEntelosHoldingCoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EntelosMember" xlink:label="loc_simuEntelosMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuEntelosMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:label="loc_us-gaapCapitalizedComputerSoftwareAmortization1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareAmortization1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_AmortizationPeriodIntangibleAssets" xlink:label="loc_simuAmortizationPeriodIntangibleAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_simuAmortizationPeriodIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetails-Disaggregation" xlink:title="00000046 - Disclosure - REVENUE RECOGNITION (Details - Disaggregation)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SoftwareLicensesMember" xlink:label="loc_simuSoftwareLicensesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_simuSoftwareLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ConsultingServicesMember" xlink:label="loc_simuConsultingServicesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_simuConsultingServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:label="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceAxis" xlink:to="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember" xlink:label="loc_us-gaapTransferredAtPointInTimeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredAtPointInTimeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember" xlink:label="loc_us-gaapTransferredOverTimeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTimingOfTransferOfGoodOrServiceDomain" xlink:to="loc_us-gaapTransferredOverTimeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess" xlink:title="00000047 - Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BillingsInExcessOfCost" xlink:label="loc_us-gaapBillingsInExcessOfCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapBillingsInExcessOfCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RevenuesOverBillingsOnUncompletedContracts" xlink:label="loc_simuRevenuesOverBillingsOnUncompletedContracts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_simuRevenuesOverBillingsOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RevenuesEarnedToDateOnUncompletedContracts" xlink:label="loc_simuRevenuesEarnedToDateOnUncompletedContracts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_simuRevenuesEarnedToDateOnUncompletedContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_BillingsToDateOnUncompletedContracts" xlink:label="loc_simuBillingsToDateOnUncompletedContracts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_simuBillingsToDateOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/RevenueRecognitionDetailsNarrative" xlink:title="00000048 - Disclosure - REVENUE RECOGNITION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract" xlink:label="loc_us-gaapRevenueFromContractWithCustomerAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueFromContractWithCustomerAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentDetails" xlink:title="00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000050 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsDetails" xlink:title="00000051 - Disclosure - INVESTMENTS (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:label="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:label="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaapInvestmentTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="loc_us-gaapInvestmentTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaapInvestmentTypeCategorizationMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeAxis" xlink:to="loc_us-gaapInvestmentTypeCategorizationMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember" xlink:label="loc_us-gaapCommercialPaperMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentTypeCategorizationMember" xlink:to="loc_us-gaapCommercialPaperMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedGains" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:label="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapAvailableForSaleSecuritiesGrossUnrealizedLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaapInvestmentsFairValueDisclosure" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="loc_us-gaapInvestmentsFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/InvestmentsDetailsNarrative" xlink:title="00000052 - Disclosure - INVESTMENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ContractsPayableDetails" xlink:title="00000053 - Disclosure - CONTRACTS PAYABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="loc_us-gaapOtherLiabilitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherLiabilitiesDisclosureAbstract" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTable" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_HoldbackLiabilityLixoftMember" xlink:label="loc_simuHoldbackLiabilityLixoftMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="loc_simuHoldbackLiabilityLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EarnoutLiabilityLixoftMember" xlink:label="loc_simuEarnoutLiabilityLixoftMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="loc_simuEarnoutLiabilityLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_EarnoutLiabilityDilisymMember" xlink:label="loc_simuEarnoutLiabilityDilisymMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="loc_simuEarnoutLiabilityDilisymMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayable" xlink:label="loc_simuContractsPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_simuContractsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="loc_us-gaapContractWithCustomerLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_us-gaapContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableCurrent" xlink:label="loc_simuContractsPayableCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_simuContractsPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ContractsPayableNoncurrent" xlink:label="loc_simuContractsPayableNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsLineItems" xlink:to="loc_simuContractsPayableNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesDetails" xlink:title="00000054 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfInvestmentHoldingsLineItems" xlink:label="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_WellsFargoMember" xlink:label="loc_simuWellsFargoMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_simuWellsFargoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RoyaltyExpenses" xlink:label="loc_simuRoyaltyExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSummaryOfInvestmentHoldingsLineItems" xlink:to="loc_simuRoyaltyExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-Dividends" xlink:title="00000056 - Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableTable" xlink:label="loc_us-gaapDividendsPayableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapDividendsPayableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableLineItems" xlink:label="loc_us-gaapDividendsPayableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsPayableTable" xlink:to="loc_us-gaapDividendsPayableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsAxis" xlink:label="loc_us-gaapDividendsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsPayableTable" xlink:to="loc_us-gaapDividendsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsDomain" xlink:label="loc_us-gaapDividendsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsAxis" xlink:to="loc_us-gaapDividendsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20181Member" xlink:label="loc_simuRecordDate20181Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20181Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20182Member" xlink:label="loc_simuRecordDate20182Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20182Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20183Member" xlink:label="loc_simuRecordDate20183Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20183Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20184Member" xlink:label="loc_simuRecordDate20184Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20184Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20191Member" xlink:label="loc_simuRecordDate20191Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20191Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20192Member" xlink:label="loc_simuRecordDate20192Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20192Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20193Member" xlink:label="loc_simuRecordDate20193Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20193Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20194Member" xlink:label="loc_simuRecordDate20194Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20194Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20201Member" xlink:label="loc_simuRecordDate20201Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20201Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20202Member" xlink:label="loc_simuRecordDate20202Member" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20202Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20203Member" xlink:label="loc_simuRecordDate20203Member" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20203Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_RecordDate20204Member" xlink:label="loc_simuRecordDate20204Member" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsDomain" xlink:to="loc_simuRecordDate20204Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableDateOfRecordDayMonthAndYear" xlink:label="loc_us-gaapDividendsPayableDateOfRecordDayMonthAndYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapDividendsPayableDateOfRecordDayMonthAndYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableDateDeclaredDayMonthAndYear" xlink:label="loc_us-gaapDividendsPayableDateDeclaredDayMonthAndYear" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapDividendsPayableDateDeclaredDayMonthAndYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" xlink:label="loc_simuWeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_simuWeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared" xlink:label="loc_us-gaapCommonStockDividendsPerShareDeclared" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapCommonStockDividendsPerShareDeclared" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaapDividends" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDividendsPayableLineItems" xlink:to="loc_us-gaapDividends" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-OptionActivity" xlink:title="00000057 - Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_OutstandingRemainingContractualLife" xlink:label="loc_simuOutstandingRemainingContractualLife" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_simuOutstandingRemainingContractualLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue" xlink:title="00000058 - Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions" xlink:title="00000059 - Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_FairValueOptionsGranted" xlink:label="loc_simuFairValueOptionsGranted" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_simuFairValueOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:label="loc_simuShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_simuShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_WeightedAverageMarketPrice" xlink:label="loc_simuWeightedAverageMarketPrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_simuWeightedAverageMarketPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable" xlink:title="00000060 - Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price1Member" xlink:label="loc_simuPrice1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price2Member" xlink:label="loc_simuPrice2Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price3Member" xlink:label="loc_simuPrice3Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price4Member" xlink:label="loc_simuPrice4Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price5Member" xlink:label="loc_simuPrice5Member" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice5Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Price6Member" xlink:label="loc_simuPrice6Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_simuPrice6Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000061 - Disclosure - SHAREHOLDERS&apos; EQUITY (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Equity2017IncentivePlanMember" xlink:label="loc_simuEquity2017IncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_simuEquity2017IncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_simuSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_simuSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision" xlink:title="00000062 - Disclosure - INCOME TAXES (Details - Income tax provision)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentForeignTaxExpenseBenefit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentForeignTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapDeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndTaxCredits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-Reconciliation" xlink:title="00000063 - Disclosure - INCOME TAXES (Details - Reconciliation)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxCreditsResearch" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes" xlink:title="00000064 - Disclosure - INCOME TAXES (Details - Deferred taxes)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:label="loc_us-gaapDeferredTaxAssetsEquityMethodInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes" xlink:label="loc_us-gaapDeferredTaxAssetsStateTaxes" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsStateTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseOther" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxAssetsAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:label="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000065 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative" xlink:title="00000066 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesMember" xlink:label="loc_us-gaapSalesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_InternationalSalesMember" xlink:label="loc_simuInternationalSalesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuInternationalSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer1Member" xlink:label="loc_simuCustomer1Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuCustomer1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer2Member" xlink:label="loc_simuCustomer2Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuCustomer2Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer3Member" xlink:label="loc_simuCustomer3Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuCustomer3Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_Customer4Member" xlink:label="loc_simuCustomer4Member" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuCustomer4Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_ACustomerMember" xlink:label="loc_simuACustomerMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuACustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_BCustomerMember" xlink:label="loc_simuBCustomerMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_simuBCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapCashUninsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting" xlink:title="00000067 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaapSegmentReportingInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapSegmentReportingInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SimulationsMember" xlink:label="loc_simuSimulationsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuSimulationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="loc_simuCognigenMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuCognigenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuDILIsymMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember" xlink:label="loc_us-gaapOperatingSegmentsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_us-gaapOperatingSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis" xlink:label="loc_srtConsolidationItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="loc_srtConsolidationItemsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain" xlink:label="loc_srtConsolidationItemsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidationItemsAxis" xlink:to="loc_srtConsolidationItemsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember" xlink:label="loc_srtConsolidationEliminationsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtConsolidationItemsDomain" xlink:to="loc_srtConsolidationEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaapPaymentsToAcquireProductiveAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapPaymentsToAcquireProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedComputerSoftwareGross" xlink:label="loc_us-gaapCapitalizedComputerSoftwareGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapCapitalizedComputerSoftwareGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingInformationLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic" xlink:title="00000068 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srtStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_srtStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srtSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementGeographicalAxis" xlink:to="loc_srtSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_NorthAndSouthAmericaMember" xlink:label="loc_simuNorthAndSouthAmericaMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_simuNorthAndSouthAmericaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember" xlink:label="loc_srtEuropeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtEuropeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaMember" xlink:label="loc_srtAsiaMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtSegmentGeographicalDomain" xlink:to="loc_srtAsiaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_SimulationsMember" xlink:label="loc_simuSimulationsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuSimulationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_CognigenMember" xlink:label="loc_simuCognigenMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuCognigenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuDILIsymMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_simuLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DILIsymMember" xlink:label="loc_simuDILIsymMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuDILIsymMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srtCounterpartyNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_srtCounterpartyNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srtRepurchaseAgreementCounterpartyNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCounterpartyNameAxis" xlink:to="loc_srtRepurchaseAgreementCounterpartyNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_FormerShareholdersMember" xlink:label="loc_simuFormerShareholdersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuFormerShareholdersMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_DilisymEmployeesMember" xlink:label="loc_simuDilisymEmployeesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_simuDilisymEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRepurchaseAgreementCounterpartyNameDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative" xlink:title="00000070 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:label="loc_us-gaapDefinedBenefitPlanContributionsByEmployer" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDefinedBenefitPlanContributionsByEmployer" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation" xlink:title="00000071 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaapBusinessAcquisitionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="simu-20200831.xsd#simu_LixoftMember" xlink:label="loc_simuLixoftMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_simuLixoftMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation" xlink:title="00000072 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails" xlink:title="00000073 - Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapQuarterlyFinancialInformationDisclosureAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>simulations_i10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:simu="http://simulations.com/20200831"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="simu-20200831.xsd" xlink:type="simple"/>
    <context id="From2019-09-01to2020-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="AsOf2020-11-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <instant>2020-11-16</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="From2018-09-012019-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="AsOf2017-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="AsOf2017-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="AsOf2017-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="AsOf2017-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-02</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2017-08-31_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="AsOf2017-08-31_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="AsOf2017-08-31_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-08-31_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:CognigenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_OtherIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">simu:AquisitionRelatedContingentConsiderationObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2012-02-28_us-gaap_RoyaltyAgreementsMember_custom_EnslienMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-02-28</instant>
        </period>
    </context>
    <context id="From2011-09-012012-02-28_us-gaap_RoyaltyAgreementsMember_custom_EnslienMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:RoyaltyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-09-01</startDate>
            <endDate>2012-02-28</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EnslienMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2014-05-15_custom_TermAndNonassertionAgrMember_custom_TSRLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:TermAndNonassertionAgrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-05-15</instant>
        </period>
    </context>
    <context id="From2013-09-012014-05-15_custom_TermAndNonassertionAgrMember_custom_TSRLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:TermAndNonassertionAgrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-09-01</startDate>
            <endDate>2014-05-15</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:TSRLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2017-06-02_custom_CertainDevelopedTechnologiesMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainDevelopedTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-02</instant>
        </period>
    </context>
    <context id="From2016-09-012017-06-02_custom_CertainDevelopedTechnologiesMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainDevelopedTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-09-01</startDate>
            <endDate>2017-06-02</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIsymMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-09-30_custom_CertainIntellectualPropertyRightsMember_custom_EntelosHoldingCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosHoldingCoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainIntellectualPropertyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="From2018-09-012018-09-30_custom_CertainIntellectualPropertyRightsMember_custom_EntelosHoldingCoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosHoldingCoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainIntellectualPropertyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:EntelosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-04-02_custom_CertainDevelopedTechnologiesMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainDevelopedTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-02</instant>
        </period>
    </context>
    <context id="From2019-09-012020-04-02_custom_CertainDevelopedTechnologiesMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">simu:CertainDevelopedTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-04-02</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:LixoftMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_IntellectualPropertyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DILIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:IntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:SoftwareLicensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:SoftwareLicensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:SoftwareLicensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:SoftwareLicensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_ConsultingServicesMember_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_ConsultingServicesMember_us-gaap_TransferredOverTimeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">simu:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_EquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_CommercialPaperMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_HoldbackLiabilityLixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:HoldbackLiabilityLixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_HoldbackLiabilityLixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:HoldbackLiabilityLixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_EarnoutLiabilityLixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:EarnoutLiabilityLixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_EarnoutLiabilityLixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:EarnoutLiabilityLixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_EarnoutLiabilityDilisymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:EarnoutLiabilityDilisymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_EarnoutLiabilityDilisymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">simu:EarnoutLiabilityDilisymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-03-31_custom_WellsFargoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">simu:WellsFargoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-03-31_custom_WellsFargoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">simu:WellsFargoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_WellsFargoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">simu:WellsFargoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_RecordDate20181Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20181Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_RecordDate20182Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20182Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_RecordDate20183Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20183Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_RecordDate20184Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20184Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_RecordDate20191Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20191Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_RecordDate20192Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20192Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_RecordDate20193Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20193Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_RecordDate20194Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20194Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_RecordDate20201Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20201Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_RecordDate20202Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20202Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_RecordDate20203Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20203Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_RecordDate20204Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">simu:RecordDate20204Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_Equity2017IncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">simu:Equity2017IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2017-08-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price5Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">simu:Price6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_SalesMember_custom_InternationalSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:InternationalSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_SalesMember_custom_InternationalSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:InternationalSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_InternationalSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:InternationalSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer4Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:Customer4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_AccountsReceivableMember_custom_ACustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:ACustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_AccountsReceivableMember_custom_BCustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:BCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_AccountsReceivableMember_custom_ACustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">simu:ACustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_CognigenMember137486375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_DILIsymMember137486390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_LixoftMember137486390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_CognigenMember137486437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_DILIsymMember137486453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_LixoftMember137486453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_srt_ConsolidationEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-08-31_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_CognigenMember137486562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_DILIsymMember137486578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_CognigenMember137486625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_custom_DILIsymMember137486640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_srt_ConsolidationEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="AsOf2019-08-31_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_CognigenMember137486718">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_DILIsymMember137486734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-08-31_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_custom_CognigenMember137486781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_custom_DILIsymMember137486796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_srt_ConsolidationEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="AsOf2018-08-31_us-gaap_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_EuropeMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_AsiaMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_EuropeMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_AsiaMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_EuropeMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_AsiaMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_EuropeMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_AsiaMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_EuropeMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_AsiaMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_EuropeMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_AsiaMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_EuropeMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_AsiaMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_EuropeMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_AsiaMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_LixoftMember137487265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_EuropeMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_AsiaMember_custom_SimulationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:SimulationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_EuropeMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_AsiaMember_custom_CognigenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:CognigenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_EuropeMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_AsiaMember_custom_DILIsymMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_EuropeMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_AsiaMember_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_LixoftMember137487406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">simu:NorthAndSouthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_EuropeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2017-09-012018-08-31_srt_AsiaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:FormerShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:FormerShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="From2018-09-012018-09-30_custom_DILIsymMember_custom_DilisymEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DilisymEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="From2018-09-012018-09-30_custom_DILIsymMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_DILIsymMember_custom_DilisymEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DilisymEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012019-08-31_custom_DILIsymMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_DILIsymMember_custom_DilisymEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:DilisymEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_DILIsymMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:DILIsymMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2019-09-012020-08-31_custom_LixoftMember_custom_FormerShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:FormerShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-08-31_custom_LixoftMember_custom_FormerShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">simu:FormerShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="AsOf2020-04-02_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-02</instant>
        </period>
    </context>
    <context id="From2019-09-012020-04-02_custom_LixoftMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">simu:LixoftMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2020-04-02</endDate>
        </period>
    </context>
    <context id="From2019-09-012019-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="From2019-12-012020-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="From2020-03-012020-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="From2020-06-012020-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="From2018-09-012018-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="From2018-12-012019-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="From2019-03-012019-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="From2019-06-012019-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001023459</identifier>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2019-09-01to2020-08-31">0001023459</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2019-09-01to2020-08-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="From2019-09-01to2020-08-31">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2019-09-01to2020-08-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2019-09-01to2020-08-31">--08-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2020-08-31"
      id="xdx2ixbrl0154"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2019-08-31"
      id="xdx2ixbrl0155"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2017-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0331"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0332"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0343"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0344"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0345"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0349"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606
      contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606
      contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606
      contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0372"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0377"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0379"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0380"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0419"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsCash
      contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0458"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0463"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains
      contextRef="From2019-09-012020-08-31_us-gaap_CommercialPaperMember"
      id="xdx2ixbrl1255"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains
      contextRef="From2019-09-01to2020-08-31"
      id="xdx2ixbrl1263"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1539"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1541"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1579"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1581"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2019-09-01to2020-08-31">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2019-09-01to2020-08-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2019-09-01to2020-08-31">2020-08-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2019-09-01to2020-08-31">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2019-09-01to2020-08-31">001-32046</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2019-09-01to2020-08-31">Simulations Plus, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2019-09-01to2020-08-31">CA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2019-09-01to2020-08-31">95-4595609</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2019-09-01to2020-08-31">42505 Tenth Street West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine1 contextRef="From2019-09-01to2020-08-31">42505 Tenth Street West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2019-09-01to2020-08-31">Lancaster</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2019-09-01to2020-08-31">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2019-09-01to2020-08-31">93534-7059</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2019-09-01to2020-08-31">(661)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2019-09-01to2020-08-31">723-7723</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2019-09-01to2020-08-31">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2019-09-01to2020-08-31">SLP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2019-09-01to2020-08-31">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2019-09-01to2020-08-31">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2019-09-01to2020-08-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2019-09-01to2020-08-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2019-09-01to2020-08-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2019-09-01to2020-08-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2019-09-01to2020-08-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2019-09-01to2020-08-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2019-09-01to2020-08-31">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="AsOf2020-02-29" decimals="0" unitRef="USD">412688004</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2020-11-16" decimals="INF" unitRef="Shares">19931709</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">49207314</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">11435499</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">50000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">7421970</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">5026558</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">3093343</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">3233659</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms>
    <us-gaap:PrepaidTaxes contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">969688</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">765110</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">1595447</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">704316</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ShortTermInvestments contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">66803595</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:ShortTermInvestments>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">129091357</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">21165142</us-gaap:AssetsCurrent>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">13581599</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">12356055</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">6087378</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">4959736</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">437787</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">341145</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">926600</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">5087031</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">3948750</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">11897970</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">5026249</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">1641725</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2019-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">1210000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">7008275</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">3280000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">12921185</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">10387198</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">50965</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">37227</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">168421517</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">45196697</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">349939</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">204075</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">2250692</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">1639038</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <simu:ContractsPayableCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">2000000</simu:ContractsPayableCurrent>
    <simu:ContractsPayableCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">1761028</simu:ContractsPayableCurrent>
    <us-gaap:BillingsInExcessOfCost contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">140991</us-gaap:BillingsInExcessOfCost>
    <us-gaap:BillingsInExcessOfCost contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">798549</us-gaap:BillingsInExcessOfCost>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">463465</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">299482</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">380787</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">5504569</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">4783477</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">2353858</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">2731616</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">463312</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <simu:ContractsPayableNoncurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">4063833</simu:ContractsPayableNoncurrent>
    <simu:ContractsPayableNoncurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</simu:ContractsPayableNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">12385572</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">7515093</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2020-08-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2019-08-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-08-31" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-08-31" decimals="INF" unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-08-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-08-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-08-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-08-31" decimals="INF" unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2020-08-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2019-08-31"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-08-31" decimals="INF" unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-08-31" decimals="INF" unitRef="Shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-08-31" decimals="INF" unitRef="Shares">19923277</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-08-31" decimals="INF" unitRef="Shares">19923277</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-08-31" decimals="INF" unitRef="Shares">17591834</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-08-31" decimals="INF" unitRef="Shares">17591834</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">9926</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">7595</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">128531427</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">15319474</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">58467</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">27436125</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">22354535</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">156035945</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">37681604</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">168421517</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">45196697</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">41589084</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">33970440</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">29666524</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">10649230</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">9025704</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">7994228</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">30939854</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">24944736</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">21672296</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">16360053</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">11796027</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">9583852</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2974623</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">2499980</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">1790656</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">19334676</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">14296007</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">11374508</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">11605178</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">10648729</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">10297788</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOperating
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">29468</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">33522</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">27122</us-gaap:InterestIncomeOperating>
    <simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">202500</simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
    <simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">109078</simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
    <simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">153034</simu:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">-45097</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-16697</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">-32934</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">-218129</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-92253</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">-158846</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">11387049</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">10556476</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">10138942</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2054989</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">1973147</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">1204130</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">9332060</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">8583329</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">8934812</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="USDPShares">0.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="USDPShares">0.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="USDPShares">0.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="USDPShares">0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="USDPShares">0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Shares">17819064</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Shares">17492258</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Shares">17328707</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Shares">18538373</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Shares">18057431</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Shares">17860392</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">58467</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">9390527</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2017-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">17277604</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2017-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">7278</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2017-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">12109141</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2017-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">13688468</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-08-31" decimals="0" unitRef="USD">25804887</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">130006</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">131</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">635452</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">635583</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">562078</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">562078</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8835</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2017-09-012018-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">8</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2017-09-012018-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">146997</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2017-09-012018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">147005</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:DividendsCash
      contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">4161740</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">4161740</us-gaap:DividendsCash>
    <us-gaap:NetIncomeLoss
      contextRef="From2017-09-012018-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">8934812</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">8934812</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2018-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">17416445</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">7417</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">13453668</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2018-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">18461540</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-08-31" decimals="0" unitRef="USD">31922625</us-gaap:StockholdersEquity>
    <simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606
      contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">-493279</simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606>
    <simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-493279</simu:CumulativeEffectOfChangesRelatedToAdoptionOfAsc606>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">166703</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">168</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">787979</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">788147</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">865848</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">865848</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">8686</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2018-09-012019-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">10</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2018-09-012019-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">211979</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2018-09-012019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">211989</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:DividendsCash
      contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">4197055</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">4197055</us-gaap:DividendsCash>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012019-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">8583329</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">8583329</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2019-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">17591834</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">7595</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">15319474</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2019-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">22354535</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">37681604</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">121647</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">121</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">629626</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">629747</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">1286625</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">1286625</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">7205</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">7</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">289893</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">289900</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:DividendsCash
      contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">4250470</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">4250470</us-gaap:DividendsCash>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">111682</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">112</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">3260562</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">3260674</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">2090909</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-09-012020-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">2091</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-09-012020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">107745247</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">107747338</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2019-09-012020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">58467</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">58467</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-012020-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">9332060</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">9332060</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2020-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">19923277</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-31_us-gaap_CommonStockMember"
      decimals="0"
      unitRef="USD">9926</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      unitRef="USD">128531427</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      unitRef="USD">58467</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2020-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      unitRef="USD">27436125</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">156035945</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">9332060</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">8583329</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">8934812</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2961930</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">2750245</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">2721304</us-gaap:DepreciationAndAmortization>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">202500</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">109060</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">152752</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">1576525</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">1077837</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">709083</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">377759</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">299096</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">1731821</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2017792</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-487970</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">1465803</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">-140316</us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract>
    <us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">1248063</us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract>
    <us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">504514</us-gaap:IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">12380</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">452517</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">-149850</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">398213</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">93877</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">153682</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">220584</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-147529</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">110713</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">23030</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">486862</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">168883</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">-657558</us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings>
    <us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">413946</us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings>
    <us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">167645</us-gaap:IncreaseDecreaseInBillingInExcessOfCostOfEarnings>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">-81305</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-29747</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">27966</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">10911938</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">11638420</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">9287188</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">231380</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">137745</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">183291</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">50000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">67248924</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">9471352</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">-0</us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">3799134</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2353188</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">1767996</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">2145429</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">-75505710</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-1955741</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">-2328720</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividends
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">4250470</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">4197055</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">4161740</us-gaap:PaymentsOfDividends>
    <simu:PaymentsOnContractsPayable
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">1761028</simu:PaymentsOnContractsPayable>
    <simu:PaymentsOnContractsPayable
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">4238973</simu:PaymentsOnContractsPayable>
    <simu:PaymentsOnContractsPayable
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">247328</simu:PaymentsOnContractsPayable>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">629747</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">788147</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">635583</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">107747338</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">102365587</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">-7647881</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">-3773485</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">37771815</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">2034798</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">3184983</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">11435499</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-08-31" decimals="0" unitRef="USD">9400701</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-08-31" decimals="0" unitRef="USD">6215718</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">49207314</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">11435499</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-08-31" decimals="0" unitRef="USD">9400701</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2352770</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">2673475</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">2712988</us-gaap:IncomeTaxesPaid>
    <simu:StockIssuedForAcquisitionOfLixoft
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">3260674</simu:StockIssuedForAcquisitionOfLixoft>
    <simu:StockIssuedForAcquisitionOfLixoft
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</simu:StockIssuedForAcquisitionOfLixoft>
    <simu:StockIssuedForAcquisitionOfLixoft
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</simu:StockIssuedForAcquisitionOfLixoft>
    <us-gaap:LiabilitiesAssumed1
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">4528000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:LiabilitiesAssumed1>
    <simu:RightOfUseAssetsCapitalized
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">1498542</simu:RightOfUseAssetsCapitalized>
    <simu:RightOfUseAssetsCapitalized
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</simu:RightOfUseAssetsCapitalized>
    <simu:RightOfUseAssetsCapitalized
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</simu:RightOfUseAssetsCapitalized>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_809_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zTK5N3T9EHLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 1 - &lt;span id="xdx_821_zFrbVCeK9iF9"&gt;ORGANIZATION AND LINES OF BUSINESS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Organization&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Simulations Plus, Inc. (&#x201c;Simulations
Plus&#x201d;, &#x201c;Lancaster&#x201d;) was incorporated on July 17, 1996. In September 2014, Simulations Plus acquired all of the
outstanding equity interests of Cognigen Corporation (&#x201c;Cognigen&#x201d;, &#x201c;Buffalo&#x201d;) and Cognigen became a wholly
owned subsidiary of Simulations Plus, Inc. In June 2017, Simulations Plus acquired DILIsym Services, Inc. (DILIsym) as a wholly
owned subsidiary. In April 2020, Simulations Plus, Inc. acquired Lixoft, a French soci&#xe9;t&#xe9; par actions simplifi&#xe9;e
(&#x201c;Lixoft&#x201d;, &#x201c;Paris&#x201d;) as a wholly-owned subsidiary pursuant to a stock purchase and contribution agreement.
(Collectively, &#x201c;Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Lines of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company designs and develops pharmaceutical
simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education
of pharmacy and medical students, and it provides consulting services to the pharmaceutical and chemical industries. Recently,
the Company has begun to explore developing software applications for defense and for health care outside of the pharmaceutical
industry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zspAg91dKTGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 2 - &lt;span id="xdx_82C_zk26ltINtj87"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zLeqCyNdEKae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of Simulations Plus, Inc. and, as of September 2, 2014, its wholly owned subsidiary, Cognigen Corporation, as of June
1, 2017, the accounts of DILIsym Services, Inc., and as of April 1, 2020, Lixoft accounts. All significant intercompany accounts
and transactions are eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--UseOfEstimates_z01cKeDwoRV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our financial statements and accompanying
notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial
statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue,
and expenses. These estimates and assumptions are affected by management&#x2019;s application of accounting policies. Actual results
could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized
computer software development costs, valuation of stock options, and accounting for income taxes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zyPHw0BDcvE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Reclassifications&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certain numbers in the prior year have
been reclassified to conform to the current year's presentation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_z3lyisFPeqe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In May 2014, the
Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding
Accounting Standards Codification Topic 606 (ASC Topic 606), &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;. The standard provides
principles for recognizing revenue for the transfer of promised goods or services to customers with the consideration to which
the entity expects to be entitled in exchange for those goods or services. The standard also provides guidance on the recognition
of incremental costs related to obtaining customer contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing
the modified retrospective method. This approach was applied to contracts that were in process as of September 1, 2018, and the
corresponding incremental costs of obtaining those contracts, which resulted in a cumulative effect adjustment of $493,279 to the
opening balance of retained earnings at the date of adoption. The adoption of this ASU primarily impacts the timing of our revenue
recognition for certain sales contracts, the capitalization and amortization of incremental costs of obtaining a contract, and
related disclosures. The reported results for fiscal years 2020 and 2019 reflect the application of ASC Topic 606, while the reported
results for fiscal year 2018 are not adjusted and continue to be reported under ASC Topic 605.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company determines revenue recognition
through the following steps:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 5%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;i.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 95%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Identification of the contract, or contracts, with a customer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;ii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;iii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Determination of the transaction price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;iv.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;v.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Recognition of revenue when, or as, the Company satisfies a performance obligation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Deferred Commissions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Sales commissions earned by our sales force
and our commissioned sales representatives are considered incremental and recoverable costs of obtaining a contract with a customer.
Sales commissions for new contracts are deferred and then amortized on a straight-line basis over a period of benefit. We determined
the period of benefit by taking into consideration our customer contracts, our technology and other factors. Sales commissions
for renewal contracts are deferred and then amortized on a straight-line basis over the related contractual renewal period. Amortization
expense is included in sales and marketing expenses on the condensed consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We apply the practical expedient in ASC
Topic 606 to expense costs as incurred for sales commissions when the period of benefit would have been one year or less. Most
of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with
them.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Practical Expedients and Exemptions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has elected the following additional
practical expedients in applying Topic 606:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px; text-align: justify"&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Commission Expense&lt;/i&gt;&lt;/b&gt;: We apply the practical expedient in ASC Topic 606 to expense costs as incurred for sales commissions when the period of benefit is one year or less. Most of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with them&lt;i&gt;.&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; width: 48px; text-align: justify"&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Transaction Price Allocated to Future
        Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 606 requires that the Company disclose
        the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of August
        31, 2020. ASC 606 provides certain practical expedients that limit the requirement to disclose the aggregate amount of transaction
        price allocated to unsatisfied performance obligations.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company applied the practical expedient
        to not disclose the amount of transaction price allocated to unsatisfied performance obligations when the performance obligation
        is part of a contract that has an original expected duration of one year or less.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z42PwMyYxHjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For purposes of the statements of cash
flows, the Company considers all highly liquid investments purchased with original maturities of three months or less to be cash
equivalents.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zBcFHT8No2Ja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We analyze the age of customer balances,
historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability
of the Company&#x2019;s trade accounts receivable balances. If we determine that the financial conditions of any of our customers
have deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts
receivable are written off when all collection attempts have failed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_z91iV48QM9Hj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We may invest excess cash balances in short-term
and long-term marketable debt securities. Investments may consist of certificates of deposit, money market accounts, government-sponsored
enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities
in accordance with FASB ASC 320, Investments &#x2013; Debt and Equity Securities. This statement requires debt securities to be
classified into three categories:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Held-to-maturity&#x2014;Debt securities
that the entity has the positive intent and ability to hold to maturity are reported at amortized cost.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trading Securities&#x2014;Debt securities
that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains
and losses included in earnings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Available-for-Sale&#x2014;Debt securities
not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or
losses excluded from earnings and reported as a separate component of shareholders&#x2019; equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company classifies its investments
in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. During the
years ended August 31, 2020, all of the Company&#x2019;s investments were classified as held-to-maturity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Held-to-maturity investments are measured
and recorded at amortized cost on the Company&#x2019;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt
securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities
are realized until they are sold or a decline in fair value is determined to be other-than-temporary.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zs3HpkzXLr74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Capitalized Computer Software Development
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Software development costs are capitalized
in accordance with ASC 985-20, &lt;i&gt;&#x201c;Costs of Software to Be Sold, Leased, or Marketed&#x201d;&lt;/i&gt;. Capitalization of software
development costs begins upon the establishment of technological feasibility and is discontinued when the product is available
for sale.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The establishment of technological feasibility
and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management
with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues,
estimated economic life, and changes in software and hardware technologies. Capitalized computer software development costs are
comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in the Company's
software products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Amortization of capitalized computer software
development costs is provided on a product-by-product basis on the straight-line method over the estimated economic life of the
products not to exceed five years. Amortization of software development costs amounted to $&lt;span id="xdx_908_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20190901__20200831_pp0p0" title="Amortization of software development"&gt;1,225,544&lt;/span&gt;, $&lt;span id="xdx_901_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20180901__20190831_pp0p0" title="Amortization of software development"&gt;1,331,753&lt;/span&gt;, and $&lt;span id="xdx_90F_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20170901__20180831_pp0p0" title="Amortization of software development"&gt;1,300,434&lt;/span&gt;
for the years ended August 31, 2020, 2019, and 2018, respectively. We expect future amortization expense to vary due to increases
in capitalized computer software development costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We test capitalized computer software development
costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zuOp5O4a3s8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment are recorded at
cost, or fair market value for property and equipment acquired in business combinations, less accumulated depreciation and amortization.
Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z57BwBKBd17j" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zId55k5a3xZf" style="display: none"&gt;Property and Equipment estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20190901__20200831_zRnKl9OntJp7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 47%; text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zSJ94LMI3jW2"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zxYSFSHDCa2i"&gt;3 to 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdwfRk2MRXo4"&gt;5 to 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zZ7hPNG6YRb3"&gt;Shorter of life of asset or lease&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A5_zoCoFxYwtNn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Maintenance and minor replacements are
charged to expense as incurred. Gains and losses on disposals are included in the results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zrcvmE3qmnM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2016, the FASB issued ASU No.
2016-02&#x2014;Leases, to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities
on the balance sheet and disclosing key information about leasing arrangements. A lessee should recognize in the statement of financial
position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying
asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessor
have not significantly changed from previous U.S. GAAP. This ASU was effective for annual periods, including interim periods within
those annual periods, beginning after December 15, 2018. We adopted this ASU on September 1, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We lease various production, administrative
and sales offices under operating leases. We evaluate our contracts to determine if an arrangement is a lease at inception and
classify it as a finance or operating lease. Currently, all our leases are classified as operating leases. Leased assets and corresponding
liabilities are recognized based on the present value of the lease payments over the lease term. Our lease terms may include options
to extend when it is reasonably certain that we will exercise that option. Costs associated with operating leases are recognized
on a straight-line basis within operating expenses over the term of the lease. With the adoption of ASC 842 on September 1, 2019,
we recognized all leases with terms greater than 12 months in duration on our consolidated balance sheets as right-of-use assets
and lease liabilities. We adopted the standard using the prospective approach and did not retrospectively apply to prior periods.
Right-of-use assets are recorded in long-term assets on our consolidated balance sheets. Current and non-current lease liabilities
are recorded as operating lease liabilities within current liabilities and long-term liabilities, respectively, on our consolidated
balance sheets. As part of the adoption of this standard we recorded the following assets and liabilities as of September 1, 2019:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zTtNDqhLnfG7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zSqDmV3ka2a7" style="display: none"&gt;Schedule of Operating assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20190902__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zL2WufTMtCs5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zoaaRhyOZZb9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: left"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;902,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_zcy5QdVlyte6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;537,017&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zbdJMiR7Eh55" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;365,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zNbhSBZ9dUbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We have made certain assumptions and judgments
when applying ASC 842, the most significant of which are:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We elected the package of practical expedients available for transition that allow us to not reassess whether expired or existing contracts contain leases under the new definition of a lease, lease classification for expired or existing leases and whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We did not elect to use hindsight when considering judgments and estimates such as assessments of lessee options&#160;&#160; to extend or terminate a lease or purchase the underlying asset.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The determination of the discount rate used in a lease is our estimated incremental borrowing rate that is based on what we would expect to pay to borrow over a similar term an amount equal to the lease payments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Supplemental balance sheet information
related to operating leases was as follows as of August 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zKoM6hMVYr81" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zf5nJv1vY6T" style="display: none"&gt;Schedule of lease cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20200831_ztCF8vNQALEg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: left"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;926,600&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;463,465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;463,312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating lease costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseCost_pp0p0_c20190901__20200831_zQBxhB4OiEd4" style="text-align: right" title="Operating lease costs"&gt;600,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted Average remaining lease term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200831_zi078OFyofUa" title="Weighted average remaining lease term"&gt;2.27&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted Average Discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pii_dp_c20200831_zvOvrb8miQZ1" title="Weighted average discount rate"&gt;4.25&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_z7z82ziGig1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z8aP6yZfFgAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Intangible Assets and Goodwill &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company performs valuations of assets
acquired and liabilities assumed on each acquisition accounted for as a business combination and recognizes the assets acquired
and liabilities assumed at their acquisition date fair value. Acquired intangible assets include customer relationships, software,
trade name, and non-compete agreements. The Company determines the appropriate useful life by performing an analysis of expected
cash flows based on historical experience of the acquired businesses. Intangible assets are amortized over their estimated useful
lives using the straight-line method, which approximates the pattern in which the majority of the economic benefits are expected
to be consumed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill represents the excess of the cost
of an acquired entity over the fair value of the acquired net assets. Goodwill is not amortized, instead it is tested for impairment
annually or when events or circumstances change that would indicate that goodwill might be impaired. Events or circumstances that
could trigger an impairment review include, but are not limited to, a significant adverse change in legal factors or in the business
climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes
in the manner of the Company's use of the acquired assets or the strategy for the Company's overall business, significant negative
industry or economic trends or significant under-performance relative to expected historical or projected future results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill is tested for impairment at the
reporting unit level, which is one level below or the same as an operating segment. As of August 31, 2020, the Company determined
that it has four reporting units, Simulations Plus, Cognigen Corporation, DILIsym Services, Inc. and Lixoft. When testing
goodwill for impairment, the Company first performs a qualitative assessment to determine whether it is necessary to perform step
one of a two-step annual goodwill impairment test for each reporting unit. The Company is required to perform step one only if
it concludes that it is more likely than not that a reporting unit's fair value is less than its carrying value. Should this be
the case, the first step of the two-step process is to identify whether a potential impairment exists by comparing the estimated
fair values of the Company's reporting units with their respective book values, including goodwill. If the estimated fair value
of the reporting unit exceeds book value, goodwill is considered not to be impaired, and no additional steps are necessary. If,
however, the fair value of the reporting unit is less than book value, then the second step is performed to determine if goodwill
is impaired and to measure the amount of impairment loss, if any. The amount of the impairment loss is the excess of the carrying
amount of the goodwill over its implied fair value. The estimate of implied fair value of goodwill is primarily based on an estimate
of the discounted cash flows expected to result from that reporting unit, but may require valuations of certain internally generated
and unrecognized intangible assets such as the Company's software, technology, patents and trademarks. If the carrying amount of
goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to the excess.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of August 31, 2020, the entire balance
of goodwill was attributed to three of the Company's reporting units, Cognigen Corporation, DILIsym Services and Lixoft. Intangible
assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of
these assets may not be recoverable. The Company has &lt;span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zPQSY2jLPcrl" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zTalRBgg96G3" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z23eeCj7Ky32" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;t recognized any impairment charges during the periods ended August 31,
2020, 2019 and 2018.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Reconciliation of Goodwill for the period
ended August 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfGoodwillTextBlock_z4HAeKRfXG9a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_zuAQoWfd73Qe" style="display: none"&gt;Schedule of reconciliation of goodwill&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;Balance, August 31, 2017&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zoR0fNA1RpMj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zSoxwTUSYCRj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iS_pp0p0_d0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zCFcLsBeuOa4" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20170831_zvEwCAhEXfJi" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zvsgqGbcSyG9" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zhhwZkbMyTLd" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHg46XMJXXJe" style="font-weight: bold; text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831_zHaTc6ijB0Be" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zkbUasYxCbG1" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zuasCTew16Ag" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zzQNnyC5Xr92" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831_zkKJBVSQO7md" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Balance, August 31, 2018&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zMUXOD9rtnRg" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zeXXADTv1cvf" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Goodwill_iS_pp0p0_d0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zR6QbZfcc7Ed" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20180831_zyYx0cSdkeBd" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zLgbuxdmazBk" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zgEZVCjCjow5" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zE5XV05nhK1c" style="font-weight: bold; text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831_zqBiLpeMMal9" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Impairments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zCj29W7ZobBb" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zXdfBHzScdga" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcnZUfhUVYac" style="font-weight: bold; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831_zIhzqb75zgAa" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balance, August 31, 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zSBcD1rOk8mj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zxCJv7IZot2d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_d0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFpsM4tMcXBf" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831_zq5CD50hQSz1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zAA9MZ82Firl" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zUaRbbH9IZ8j" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_pp0p0" style="font-weight: bold; text-align: right" title="Addition"&gt;2,533,987&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831_pp0p0" style="font-weight: bold; text-align: right" title="Addition"&gt;2,533,987&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zpDb6srRyPR6" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zImENgHoNJp8" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zrnP0MMN3oHf" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831_zOVAChUZbsPb" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balance, August 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z8WvpIiRt9X3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;4,789,248&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zQfPUAISziy7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;5,597,950&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zGIfo8AZhXH7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;2,533,987&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_iE_pp0p0_c20200831_zB26qGUiDAe9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;12,921,185&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zHmLQSCUzkp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;









&lt;p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zbMRhXdE1U3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Other Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes other intangible
assets as of August 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zcdMv2SMnMX6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_z8PKBG7mUBPe" style="display: none"&gt;Schedule of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;br/&gt; Period&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Acquisition&lt;br/&gt; Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated&lt;br/&gt; Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net book &lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Customer relationships-Cognigen&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="width: 23%; text-align: left" title="Amortization period"&gt;Straight line 8 years&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Acquisition value"&gt;1,100,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Accumulated amortization"&gt;825,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Net book value"&gt;275,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-Cognigen&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z9H50fVKZ7h4" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Net book value"&gt;500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Covenants not to compete-Cognigen&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="text-align: left" title="Amortization period"&gt;Straight line 5 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zWM81nzb5Q4f" style="text-align: right" title="Net book value"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Covenants not to compete-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period"&gt;Straight line 4 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;80,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;65,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;15,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;860,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zK8OpZ196sib" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;860,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period"&gt;Straight line 10 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;1,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;617,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;1,282,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships-Lixoft&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcuIzsZApaQ7" style="text-align: left" title="Amortization period"&gt;Straight line 14 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxDMpotqsKGh" style="text-align: right" title="Acquisition value"&gt;2,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zwghqLFIKLF2" style="text-align: right" title="Accumulated amortization"&gt;75,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_ztnFFsowEzg1" style="text-align: right" title="Net book value"&gt;2,474,108&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-Lixoft&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHqRhmhyaYL8" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zZXtOxMG2TF1" style="text-align: right" title="Acquisition value"&gt;1,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zTvrtuBVMjP4" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zAqcvFAQ80Y7" style="text-align: right" title="Net book value"&gt;1,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Covenants not to compete-Lixoft&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxkBBuWqUWr1" style="text-align: left; padding-bottom: 1pt" title="Amortization period"&gt;Straight line 3 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z7pFB0M4R3C5" style="border-bottom: Black 1pt solid; text-align: right" title="Acquisition value"&gt;60,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z0gE94uETOqf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"&gt;8,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zexyHyyHGowf" style="border-bottom: Black 1pt solid; text-align: right" title="Net book value"&gt;51,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Acquisition value"&gt;8,650,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accumulated amortization"&gt;1,641,725&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Net book value"&gt;7,008,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AC_zG1JJ03xFfx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Amortization expense for the year ended
August 31, 2020, 2019 and 2018 was $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3ZFxKJwWMbb" title="Amortization of intangible assets"&gt;431,725&lt;/span&gt;, $&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3bmRuno6Ook" title="Amortization of intangible assets"&gt;357,500&lt;/span&gt;, and $&lt;span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVABDRip64Ae" title="Amortization of intangible assets"&gt;357,500&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Future amortization for the next five years is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zxQnkrdiyGO6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span id="xdx_8B9_z234vGfYtfFf" style="display: none"&gt;Schedule of future amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ending&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 35%; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zRWulqymKJsl" style="width: 11%; text-align: right" title="2021"&gt;545,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zCSW1w5HslL6" style="text-align: right" title="2022"&gt;530,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_znfvw1zNOtAf" style="text-align: right" title="2023"&gt;384,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zT0va5RT4hTj" style="text-align: right" title="2024"&gt;372,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyakFlEwBm42" style="text-align: right" title="2025"&gt;372,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zjzYJ5dEGP21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zOecTBEg1Jo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Business Acquisitions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounted for the acquisition
of Cognigen, DILIsym Services, Inc. and Lixoft using the purchase method of accounting where the assets acquired and liabilities
assumed are recognized based on their respective estimated fair values. The excess of the purchase price over the estimated fair
values of the net assets acquired is recorded as goodwill. Determining the fair value of certain acquired assets and liabilities
is subjective in nature and often involves the use of significant estimates and assumptions, including, but not limited to, the
selection of appropriate valuation methodology, projected revenue, expenses and cash flows, weighted average cost of capital, discount
rates, estimates of advertiser and publisher turnover rates and estimates of terminal values. Business acquisitions are included
in the Company's consolidated financial statements as of the date of the acquisition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zSLqoAyvl6U2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Assets and liabilities recorded at fair
value in the Consolidated Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure
their fair value. The categories, as defined by the standard are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level&#160;Input:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 89%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Input Definition:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level I&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level II&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level III&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Unobservable inputs that reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For certain of our financial instruments,
including accounts receivable, accounts payable, accrued payroll and other expenses, and accrued bonuses to officers the carrying
amounts approximate fair value due to their short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes fair value
measurements at August 31, 2020 and August 31, 2019 for assets and liabilities measured at fair value on a recurring basis:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;August 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zYyIrAvXvjG5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_zmHSUlmxpb69" style="display: none"&gt;Summarizes fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zHYQ0Goe3Hb5" style="width: 11%; text-align: right" title="Fair value assets"&gt;49,207,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zZ6wlmbkx7L" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_ziuNLvNKmt38" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z4nxg8L59Dx5" style="width: 11%; text-align: right" title="Fair value assets"&gt;49,207,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAa6u8BjB1X2" style="text-align: right" title="Fair value assets"&gt;66,803,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAWqU7EJeqUj" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zWtPp8qtylG9" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zMPsbjxizirf" style="text-align: right" title="Fair value assets"&gt;66,803,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Acquisition-related contingent consideration obligations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zByirdDWDExh" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zvasR6GY54w7" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zlBoNlObcO7b" style="text-align: right" title="Fair value liabilities"&gt;4,730,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zf1qb4fCDcwg" style="text-align: right" title="Fair value liabilities"&gt;4,730,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;August 31, 2019:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zFigkOPxI4Xe" style="width: 11%; text-align: right" title="Fair value assets"&gt;11,435,499&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z3O9eET3mUIc" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zgzKEnI30r7g" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zNqQAJFxum1h" style="width: 11%; text-align: right" title="Fair value assets"&gt;11,435,499&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zRwKH7oQn7c9" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCgK0YlFXF79" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_z18hJNKcgH31" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCSurT1FLxF7" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Acquisition-related contingent consideration obligations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zGm1wLfpJDr4" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zPbSMnDQbZX4" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zilckSxYLB4c" style="text-align: right" title="Fair value liabilities"&gt;1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zIYMvbu92SJa" style="text-align: right" title="Fair value liabilities"&gt;1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zaLRR8e5v6tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of August 31, 2020 and 2019, the Company
has a liability for contingent consideration related to its acquisition of Lixoft and DILIsym Services, Inc. The fair value measurement
of the contingent consideration obligations is determined using Level 3 inputs. The fair value of contingent consideration obligations
is based on a discounted cash flow model using a probability-weighted income approach. These fair value measurements represent
Level 3 measurements as they are based on significant inputs not observable in the market. Significant judgment is employed in
determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes
in assumptions could have a material impact on the amount of contingent consideration expense the Company records in any given
period. Changes in the value of the contingent consideration obligations are recorded in the Company&#x2019;s Consolidated Statement
of Operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a reconciliation of contingent
consideration value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfContingentConsiderationTableTextBlock_zsdXNYIcBFB" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zPTdvf5hZ8Tc" style="display: none"&gt;Reconciliation of contingent consideration value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;Value at August 31, 2019&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iS_pp0p0_c20190831_znoY4GgeeSva" style="width: 11%; font-weight: bold; text-align: right" title="Contingent consideration, beginning balance"&gt;1,761,028&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Purchase price contingent consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PurchasePriceContingentConsiderationAdditions_c20190901__20200831_pp0p0" style="text-align: right" title="Purchase price contingent consideration"&gt;4,528,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Contingent consideration payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ContingentConsiderationPayments_iN_pp0p0_di_c20190901__20200831_zoY0KuUfKOgj" style="text-align: right" title="Contingent consideration payments"&gt;(1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in value of contingent consideration&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c20190901__20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Change in value of contingent consideration"&gt;202,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Value at August 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iE_pp0p0_c20200831_zxjqMrPZPwba" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Contingent consideration, ending balance"&gt;4,730,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_zfMjwN14OCPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zmjCyVBPBIwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Advertising&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company expenses advertising costs
as incurred. Advertising costs for the years ended August 31, 2020, 2019 and 2018 were approximately $&lt;span id="xdx_901_eus-gaap--AdvertisingExpense_c20190901__20200831_pp0p0" title="Advertising costs"&gt;63,944&lt;/span&gt;, $&lt;span id="xdx_908_eus-gaap--AdvertisingExpense_c20180901__20190831_pp0p0" title="Advertising costs"&gt;83,213&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--AdvertisingExpense_c20170901__20180831_pp0p0" title="Advertising costs"&gt;67,848&lt;/span&gt;,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zWe1iL9IrDuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Research and development costs are charged
to expense as incurred until technological feasibility has been established. These costs include salaries, laboratory experiment,
and purchased software which was developed by other companies and incorporated into, or used in the development of, our final products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zUIPGgh40rS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes in
accordance with ASC 740-10, &lt;i&gt;&#x201c;Income Taxes&#x201d;&lt;/i&gt; which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements or tax returns.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z8GNJWW9O9J9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Intellectual property&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 28, 2012, we bought out the
royalty agreement with Enslein Research. The cost of $&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsGross_c20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Intangible asset acquisition value"&gt;75,000&lt;/span&gt; is being amortized over &lt;span id="xdx_900_ecustom--AmortizationPeriodIntangibleAssets_c20110901__20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember" title="Amortization period"&gt;10 years under the straight-line method&lt;/span&gt;. Amortization
expense for each of the fiscal years ended August 31, 2020 and 2019 was $&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zhbLmTWT8ICe" title="Amortization of intangible assets"&gt;&lt;span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_z7TtErqFcd5f" title="Amortization of intangible assets"&gt;7,500&lt;/span&gt;&lt;/span&gt;. Accumulated amortization as of August 31, 2020
and 2019 was $&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;63,750&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;56,250&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On May 15, 2014, we entered into a termination
and non-assertion agreement with TSRL, Inc., pursuant to which the parties agreed to terminate an exclusive software licensing
agreement entered into between the parties in 1997. As a result, the Company obtained a perpetual right to use certain source code
and data, and TSRL relinquished any rights and claims to any GastroPlus products and to any claims to royalties or other payments
under that 1997 agreement. We agreed to pay TSRL total consideration of $&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsGross_c20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Intangible asset acquisition value"&gt;6,000,000&lt;/span&gt;, which is being amortized over &lt;span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20130901__20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember" title="Amortization period"&gt;10 years under
the straight-line method&lt;/span&gt;. Amortization for the year ended August 31, 2020, and 2019 was $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zwHu0ELID6e4" title="Amortization of intangible assets"&gt;&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zEYLoca8Ywo7" title="Amortization of intangible assets"&gt;600,000&lt;/span&gt;&lt;/span&gt;. Accumulated amortization as of
August 31, 2020 and 2019 was $&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;3,775,000&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;3,175,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 1, 2017, as part of the acquisition
of DILIsym Services, Inc. the Company acquired certain developed technologies associated with the drug induced liver disease (DILI).
These technologies were valued at $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsGross_c20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Intangible asset acquisition value"&gt;2,850,000&lt;/span&gt; and are being amortized over &lt;span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20160901__20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember" title="Amortization period"&gt;9 years under the straight-line method&lt;/span&gt;. Amortization
expense for the fiscal years ended August 31, 2020 and 2019 was $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets"&gt;316,667&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets"&gt;316,667&lt;/span&gt;, respectively, and is included in cost of
revenues. Total accumulated amortization as of August 31, 2020 and 2019 was $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;1,029,167&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;712,500&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In September 2018, we purchased certain
intellectual property rights of Entelos Holding Company, a Delaware Corporation. The cost of $&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember_pp0p0" title="Intangible asset acquisition value"&gt;50,000&lt;/span&gt; is being amortized over &lt;span id="xdx_907_ecustom--AmortizationPeriodIntangibleAssets_c20180901__20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember" title="Amortization period"&gt;10
years under the straight-line method&lt;/span&gt;. Amortization expense for the year ended August 31, 2020 and 2019 was $&lt;span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Amortization of intangible assets"&gt;5,000&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zOs5YJaHO26e" title="Amortization of intangible assets"&gt;5,000&lt;/span&gt;. Accumulated
amortization as of August 31, 2020 and 2019 was $&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zW3aUM43FTwl" title="Accumulated amortization of intellectual property"&gt;10,000&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;5,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 1, 2020, as part of the acquisition
of Lixoft, the Company acquired certain developed technologies associated with the Lixoft scientific software. These technologies
were valued at $&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zpMxPfJZDHJ8" title="Intangible asset acquisition value"&gt;8,010,000&lt;/span&gt; and are being amortized over &lt;span id="xdx_90E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zXXpglxEVPh6" title="Amortization period"&gt;16 years under the straight-line method&lt;/span&gt;. Amortization expense for the fiscal
years ended August 31, 2020 was $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zhQXw7zg7SEg" title="Amortization of intangible assets"&gt;208,594&lt;/span&gt; and is included in cost of revenues. Total accumulated amortization as of August 31, 2020
was $&lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zviBsbOkc0i2" title="Accumulated amortization of intellectual property"&gt;208,594&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Total amortization expense for intellectual
property agreements for the years ended August 31, 2020, 2019 and 2018 was $&lt;span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"&gt;1,138,280&lt;/span&gt;, $&lt;span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"&gt;929,167&lt;/span&gt;, and $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"&gt;924,167&lt;/span&gt;. Accumulated amortization
as of August 31, 2020 and 2019 was $&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zwvNPyR8Newi" title="Accumulated amortization of intellectual property"&gt;5,087,031&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyv8Lja8rOle" title="Accumulated amortization of intellectual property"&gt;3,948,750&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Future amortization for the next five years
is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAmortizationExpensesTableTextBlock_zOT6nlAoXPva" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zQOnpBhAbNVj" style="display: none"&gt;Schedule of future amortization expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zW7YXI5yZCLi" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zX8dAQzarkKd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIMember_zsIOn20qZid7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_z1Tbr52GkpBk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_z4DTQrCGhw8g" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zYZYZ4o7tgSi" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years ending &lt;br/&gt; August 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;TSRL&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Enslein&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILI-Acquired&lt;br/&gt; Developed&lt;br/&gt; Technologies&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft-Acquired&lt;br/&gt; Developed&lt;br/&gt; Technologies&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Entelos&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 16%; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;7,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,429,792&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,426,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_d0_z5Oqy1grb2Yl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,422,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_d0_zBybeV9Z08F8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;425,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_d0_zGkQdQVNENzi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;822,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zHZaIfKMDUP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zebAV6RoGKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Earnings per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company reports earnings per share
in accordance with FASB ACS 260-10. Basic earnings per share is computed by dividing income available to common shareholders by
the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per
share except that the denominator is increased to include the number of additional common shares that would have been outstanding
if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted
earnings per share for the years ended August 31, 2020, 2019 and 2018 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwPNl37oEuQh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BE_zbpYZd26dcYg" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20190901__20200831_z42pDCeajb91" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20180901__20190831_zgQ42h8vLxn6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20170901__20180831_zpLAOwGeQ94d" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;9,332,060&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;8,583,329&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;8,934,812&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pii_zWGOoVnDS8j7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average number of common shares outstanding during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,819,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,492,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,328,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pii_zl1t74brxaL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Dilutive effect of stock options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;719,309&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;565,173&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;531,685&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pii_zuS8ByLCnD6g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Common stock and common stock equivalents used for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18,538,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18,057,431&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;17,860,392&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_8AF_zTKM3q9U7om3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zYvIuhl0p9Rd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for stock options
using the modified prospective method in accordance with FASB ASC 718-10, &lt;i&gt;&#x201c;Compensation-Stock Compensation&#x201d;&lt;/i&gt;.
Under this method, compensation costs include estimated grant date fair value of the awards amortized over the options&#x2019; vesting
period. Stock-based compensation was $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensation_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"&gt;1,286,625&lt;/span&gt;, $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"&gt;865,848&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensation_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"&gt;562,078&lt;/span&gt; for the fiscal years ended August 31, 2020, 2019 and 2018,
respectively, and is included in the statements of operations as Consulting, Salaries, and Research and Development expense.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zt0zasQu6cZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Impairment of Long-lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for the impairment
and disposition of long-lived assets in accordance with ASC 350, &lt;i&gt;&#x201c;Intangibles &#x2013; Goodwill and Other&lt;/i&gt;&#x201d; and
ASC 360, &lt;i&gt;&#x201c;Property and Equipment&#x201d;&lt;/i&gt;. Long-lived assets to be held and used are reviewed for events or changes
in circumstances that indicate that their carrying value may not be recoverable. We measure recoverability by comparing the carrying
amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may
not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an
impairment charge to the extent of the difference between the fair value and the asset's carrying amount. &lt;span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20190901__20200831_z1hibgz7fx1" title="Impairment losses"&gt;&lt;span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20180901__20190831_zdzaE5YyJ5h4" title="Impairment losses"&gt;&lt;span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20170901__20180831_zTk5MITYte01" title="Impairment losses"&gt;No&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; impairment losses
were recorded during the years ended August 31, 2020, 2019 and 2018.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zHjSKuHffNZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding Accounting Standards Codification
Topic 606 (ASC Topic 606), Revenue from Contracts with Customers. The standard provides principles for recognizing revenue for
the transfer of promised goods or services to customers with the consideration to which the entity expects to be entitled in exchange
for those goods or services. The standard also provides guidance on the recognition of incremental costs related to obtaining customer
contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing the modified retrospective method. This approach was
applied to contracts that were in process as of September 1, 2018, and the corresponding incremental costs of obtaining those contracts,
which resulted in a cumulative effect adjustment of $493,279 to the opening balance of retained earnings at the date of adoption.
The adoption of this ASU primarily impacts the timing of our revenue recognition for certain sales contracts, the capitalization
and amortization of incremental costs of obtaining a contract, and related disclosures. The reported results for fiscal year 2019
reflect the application of ASC Topic 606.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2016, the FASB issued ASU 2016-02,
Leases (Topic 842), which supersedes existing guidance on accounting for leases in "Leases (Topic 840)" and generally
requires all leases to be recognized in the consolidated balance sheet. ASU 2016-02 is effective for annual and interim reporting
periods beginning after December 15, 2018. The Company adopted this ASU on September 1, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In April 2016, the FASB issued ASU 2016-10,
Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board's new revenue standard, ASU 2014-09,
Revenue from Contracts with Customers. The standard was adopted concurrently with the adoption of ASU 2014-09 which is effective
for annual and interim periods beginning after December 15, 2017.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zLeqCyNdEKae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of Simulations Plus, Inc. and, as of September 2, 2014, its wholly owned subsidiary, Cognigen Corporation, as of June
1, 2017, the accounts of DILIsym Services, Inc., and as of April 1, 2020, Lixoft accounts. All significant intercompany accounts
and transactions are eliminated in consolidation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84A_eus-gaap--UseOfEstimates_z01cKeDwoRV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our financial statements and accompanying
notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial
statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue,
and expenses. These estimates and assumptions are affected by management&#x2019;s application of accounting policies. Actual results
could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized
computer software development costs, valuation of stock options, and accounting for income taxes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zyPHw0BDcvE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Reclassifications&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Certain numbers in the prior year have
been reclassified to conform to the current year's presentation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_z3lyisFPeqe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In May 2014, the
Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding
Accounting Standards Codification Topic 606 (ASC Topic 606), &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;. The standard provides
principles for recognizing revenue for the transfer of promised goods or services to customers with the consideration to which
the entity expects to be entitled in exchange for those goods or services. The standard also provides guidance on the recognition
of incremental costs related to obtaining customer contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing
the modified retrospective method. This approach was applied to contracts that were in process as of September 1, 2018, and the
corresponding incremental costs of obtaining those contracts, which resulted in a cumulative effect adjustment of $493,279 to the
opening balance of retained earnings at the date of adoption. The adoption of this ASU primarily impacts the timing of our revenue
recognition for certain sales contracts, the capitalization and amortization of incremental costs of obtaining a contract, and
related disclosures. The reported results for fiscal years 2020 and 2019 reflect the application of ASC Topic 606, while the reported
results for fiscal year 2018 are not adjusted and continue to be reported under ASC Topic 605.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company determines revenue recognition
through the following steps:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 5%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;i.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 95%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Identification of the contract, or contracts, with a customer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;ii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;iii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Determination of the transaction price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;iv.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;v.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Recognition of revenue when, or as, the Company satisfies a performance obligation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Deferred Commissions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Sales commissions earned by our sales force
and our commissioned sales representatives are considered incremental and recoverable costs of obtaining a contract with a customer.
Sales commissions for new contracts are deferred and then amortized on a straight-line basis over a period of benefit. We determined
the period of benefit by taking into consideration our customer contracts, our technology and other factors. Sales commissions
for renewal contracts are deferred and then amortized on a straight-line basis over the related contractual renewal period. Amortization
expense is included in sales and marketing expenses on the condensed consolidated statements of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We apply the practical expedient in ASC
Topic 606 to expense costs as incurred for sales commissions when the period of benefit would have been one year or less. Most
of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with
them.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Practical Expedients and Exemptions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has elected the following additional
practical expedients in applying Topic 606:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px; text-align: justify"&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Commission Expense&lt;/i&gt;&lt;/b&gt;: We apply the practical expedient in ASC Topic 606 to expense costs as incurred for sales commissions when the period of benefit is one year or less. Most of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with them&lt;i&gt;.&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: top; width: 48px; text-align: justify"&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Transaction Price Allocated to Future
        Performance Obligations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 606 requires that the Company disclose
        the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of August
        31, 2020. ASC 606 provides certain practical expedients that limit the requirement to disclose the aggregate amount of transaction
        price allocated to unsatisfied performance obligations.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company applied the practical expedient
        to not disclose the amount of transaction price allocated to unsatisfied performance obligations when the performance obligation
        is part of a contract that has an original expected duration of one year or less.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z42PwMyYxHjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For purposes of the statements of cash
flows, the Company considers all highly liquid investments purchased with original maturities of three months or less to be cash
equivalents.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84E_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zBcFHT8No2Ja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We analyze the age of customer balances,
historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability
of the Company&#x2019;s trade accounts receivable balances. If we determine that the financial conditions of any of our customers
have deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts
receivable are written off when all collection attempts have failed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InvestmentPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_z91iV48QM9Hj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Investments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We may invest excess cash balances in short-term
and long-term marketable debt securities. Investments may consist of certificates of deposit, money market accounts, government-sponsored
enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities
in accordance with FASB ASC 320, Investments &#x2013; Debt and Equity Securities. This statement requires debt securities to be
classified into three categories:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Held-to-maturity&#x2014;Debt securities
that the entity has the positive intent and ability to hold to maturity are reported at amortized cost.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Trading Securities&#x2014;Debt securities
that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains
and losses included in earnings.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Available-for-Sale&#x2014;Debt securities
not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or
losses excluded from earnings and reported as a separate component of shareholders&#x2019; equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company classifies its investments
in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. During the
years ended August 31, 2020, all of the Company&#x2019;s investments were classified as held-to-maturity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Held-to-maturity investments are measured
and recorded at amortized cost on the Company&#x2019;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt
securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities
are realized until they are sold or a decline in fair value is determined to be other-than-temporary.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_847_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zs3HpkzXLr74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Capitalized Computer Software Development
Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Software development costs are capitalized
in accordance with ASC 985-20, &lt;i&gt;&#x201c;Costs of Software to Be Sold, Leased, or Marketed&#x201d;&lt;/i&gt;. Capitalization of software
development costs begins upon the establishment of technological feasibility and is discontinued when the product is available
for sale.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The establishment of technological feasibility
and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management
with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues,
estimated economic life, and changes in software and hardware technologies. Capitalized computer software development costs are
comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in the Company's
software products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Amortization of capitalized computer software
development costs is provided on a product-by-product basis on the straight-line method over the estimated economic life of the
products not to exceed five years. Amortization of software development costs amounted to $&lt;span id="xdx_908_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20190901__20200831_pp0p0" title="Amortization of software development"&gt;1,225,544&lt;/span&gt;, $&lt;span id="xdx_901_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20180901__20190831_pp0p0" title="Amortization of software development"&gt;1,331,753&lt;/span&gt;, and $&lt;span id="xdx_90F_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20170901__20180831_pp0p0" title="Amortization of software development"&gt;1,300,434&lt;/span&gt;
for the years ended August 31, 2020, 2019, and 2018, respectively. We expect future amortization expense to vary due to increases
in capitalized computer software development costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We test capitalized computer software development
costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">1225544</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">1331753</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">1300434</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zuOp5O4a3s8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment are recorded at
cost, or fair market value for property and equipment acquired in business combinations, less accumulated depreciation and amortization.
Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z57BwBKBd17j" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zId55k5a3xZf" style="display: none"&gt;Property and Equipment estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20190901__20200831_zRnKl9OntJp7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 47%; text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zSJ94LMI3jW2"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zxYSFSHDCa2i"&gt;3 to 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdwfRk2MRXo4"&gt;5 to 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zZ7hPNG6YRb3"&gt;Shorter of life of asset or lease&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A5_zoCoFxYwtNn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Maintenance and minor replacements are
charged to expense as incurred. Gains and losses on disposals are included in the results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <simu:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z57BwBKBd17j" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B0_zId55k5a3xZf" style="display: none"&gt;Property and Equipment estimated useful lives&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49F_20190901__20200831_zRnKl9OntJp7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 49%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 47%; text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zSJ94LMI3jW2"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zxYSFSHDCa2i"&gt;3 to 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdwfRk2MRXo4"&gt;5 to 7 years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify" title="Estimated useful lives"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zZ7hPNG6YRb3"&gt;Shorter of life of asset or lease&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</simu:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-09-012020-08-31_us-gaap_EquipmentMember">5 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-09-012020-08-31_us-gaap_ComputerEquipmentMember">3 to 7 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-09-012020-08-31_us-gaap_FurnitureAndFixturesMember">5 to 7 years</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="From2019-09-012020-08-31_us-gaap_LeaseholdImprovementsMember">Shorter of life of asset or lease</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zrcvmE3qmnM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2016, the FASB issued ASU No.
2016-02&#x2014;Leases, to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities
on the balance sheet and disclosing key information about leasing arrangements. A lessee should recognize in the statement of financial
position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying
asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessor
have not significantly changed from previous U.S. GAAP. This ASU was effective for annual periods, including interim periods within
those annual periods, beginning after December 15, 2018. We adopted this ASU on September 1, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We lease various production, administrative
and sales offices under operating leases. We evaluate our contracts to determine if an arrangement is a lease at inception and
classify it as a finance or operating lease. Currently, all our leases are classified as operating leases. Leased assets and corresponding
liabilities are recognized based on the present value of the lease payments over the lease term. Our lease terms may include options
to extend when it is reasonably certain that we will exercise that option. Costs associated with operating leases are recognized
on a straight-line basis within operating expenses over the term of the lease. With the adoption of ASC 842 on September 1, 2019,
we recognized all leases with terms greater than 12 months in duration on our consolidated balance sheets as right-of-use assets
and lease liabilities. We adopted the standard using the prospective approach and did not retrospectively apply to prior periods.
Right-of-use assets are recorded in long-term assets on our consolidated balance sheets. Current and non-current lease liabilities
are recorded as operating lease liabilities within current liabilities and long-term liabilities, respectively, on our consolidated
balance sheets. As part of the adoption of this standard we recorded the following assets and liabilities as of September 1, 2019:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zTtNDqhLnfG7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zSqDmV3ka2a7" style="display: none"&gt;Schedule of Operating assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20190902__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zL2WufTMtCs5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zoaaRhyOZZb9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: left"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;902,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_zcy5QdVlyte6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;537,017&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zbdJMiR7Eh55" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;365,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zNbhSBZ9dUbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We have made certain assumptions and judgments
when applying ASC 842, the most significant of which are:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48px"&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We elected the package of practical expedients available for transition that allow us to not reassess whether expired or existing contracts contain leases under the new definition of a lease, lease classification for expired or existing leases and whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;We did not elect to use hindsight when considering judgments and estimates such as assessments of lessee options&#160;&#160; to extend or terminate a lease or purchase the underlying asset.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The determination of the discount rate used in a lease is our estimated incremental borrowing rate that is based on what we would expect to pay to borrow over a similar term an amount equal to the lease payments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Supplemental balance sheet information
related to operating leases was as follows as of August 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zKoM6hMVYr81" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zf5nJv1vY6T" style="display: none"&gt;Schedule of lease cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20200831_ztCF8vNQALEg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: left"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;926,600&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;463,465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;463,312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating lease costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseCost_pp0p0_c20190901__20200831_zQBxhB4OiEd4" style="text-align: right" title="Operating lease costs"&gt;600,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted Average remaining lease term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200831_zi078OFyofUa" title="Weighted average remaining lease term"&gt;2.27&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted Average Discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pii_dp_c20200831_zvOvrb8miQZ1" title="Weighted average discount rate"&gt;4.25&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_z7z82ziGig1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zTtNDqhLnfG7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BE_zSqDmV3ka2a7" style="display: none"&gt;Schedule of Operating assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20190902__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zL2WufTMtCs5" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zoaaRhyOZZb9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: left"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;902,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_zcy5QdVlyte6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;537,017&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zbdJMiR7Eh55" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;365,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">902553</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">537017</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member"
      decimals="0"
      unitRef="USD">365536</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zKoM6hMVYr81" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BC_zf5nJv1vY6T" style="display: none"&gt;Schedule of lease cost&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20200831_ztCF8vNQALEg" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; text-align: left"&gt;Right of use assets&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;926,600&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;463,465&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Lease Liabilities, Long-term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;463,312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Operating lease costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseCost_pp0p0_c20190901__20200831_zQBxhB4OiEd4" style="text-align: right" title="Operating lease costs"&gt;600,717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted Average remaining lease term&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200831_zi078OFyofUa" title="Weighted average remaining lease term"&gt;2.27&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted Average Discount rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pii_dp_c20200831_zvOvrb8miQZ1" title="Weighted average discount rate"&gt;4.25&lt;/span&gt;%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">926600</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">463465</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">463312</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseCost
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">600717</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2020-08-31">P2Y3M7D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2020-08-31" decimals="INF" unitRef="Pure">0.0425</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z8aP6yZfFgAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Intangible Assets and Goodwill &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company performs valuations of assets
acquired and liabilities assumed on each acquisition accounted for as a business combination and recognizes the assets acquired
and liabilities assumed at their acquisition date fair value. Acquired intangible assets include customer relationships, software,
trade name, and non-compete agreements. The Company determines the appropriate useful life by performing an analysis of expected
cash flows based on historical experience of the acquired businesses. Intangible assets are amortized over their estimated useful
lives using the straight-line method, which approximates the pattern in which the majority of the economic benefits are expected
to be consumed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill represents the excess of the cost
of an acquired entity over the fair value of the acquired net assets. Goodwill is not amortized, instead it is tested for impairment
annually or when events or circumstances change that would indicate that goodwill might be impaired. Events or circumstances that
could trigger an impairment review include, but are not limited to, a significant adverse change in legal factors or in the business
climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes
in the manner of the Company's use of the acquired assets or the strategy for the Company's overall business, significant negative
industry or economic trends or significant under-performance relative to expected historical or projected future results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill is tested for impairment at the
reporting unit level, which is one level below or the same as an operating segment. As of August 31, 2020, the Company determined
that it has four reporting units, Simulations Plus, Cognigen Corporation, DILIsym Services, Inc. and Lixoft. When testing
goodwill for impairment, the Company first performs a qualitative assessment to determine whether it is necessary to perform step
one of a two-step annual goodwill impairment test for each reporting unit. The Company is required to perform step one only if
it concludes that it is more likely than not that a reporting unit's fair value is less than its carrying value. Should this be
the case, the first step of the two-step process is to identify whether a potential impairment exists by comparing the estimated
fair values of the Company's reporting units with their respective book values, including goodwill. If the estimated fair value
of the reporting unit exceeds book value, goodwill is considered not to be impaired, and no additional steps are necessary. If,
however, the fair value of the reporting unit is less than book value, then the second step is performed to determine if goodwill
is impaired and to measure the amount of impairment loss, if any. The amount of the impairment loss is the excess of the carrying
amount of the goodwill over its implied fair value. The estimate of implied fair value of goodwill is primarily based on an estimate
of the discounted cash flows expected to result from that reporting unit, but may require valuations of certain internally generated
and unrecognized intangible assets such as the Company's software, technology, patents and trademarks. If the carrying amount of
goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to the excess.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of August 31, 2020, the entire balance
of goodwill was attributed to three of the Company's reporting units, Cognigen Corporation, DILIsym Services and Lixoft. Intangible
assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of
these assets may not be recoverable. The Company has &lt;span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zPQSY2jLPcrl" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zTalRBgg96G3" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z23eeCj7Ky32" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;t recognized any impairment charges during the periods ended August 31,
2020, 2019 and 2018.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Reconciliation of Goodwill for the period
ended August 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfGoodwillTextBlock_z4HAeKRfXG9a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_zuAQoWfd73Qe" style="display: none"&gt;Schedule of reconciliation of goodwill&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;Balance, August 31, 2017&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zoR0fNA1RpMj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zSoxwTUSYCRj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iS_pp0p0_d0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zCFcLsBeuOa4" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20170831_zvEwCAhEXfJi" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zvsgqGbcSyG9" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zhhwZkbMyTLd" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHg46XMJXXJe" style="font-weight: bold; text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831_zHaTc6ijB0Be" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zkbUasYxCbG1" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zuasCTew16Ag" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zzQNnyC5Xr92" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831_zkKJBVSQO7md" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Balance, August 31, 2018&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zMUXOD9rtnRg" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zeXXADTv1cvf" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Goodwill_iS_pp0p0_d0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zR6QbZfcc7Ed" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20180831_zyYx0cSdkeBd" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zLgbuxdmazBk" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zgEZVCjCjow5" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zE5XV05nhK1c" style="font-weight: bold; text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831_zqBiLpeMMal9" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Impairments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zCj29W7ZobBb" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zXdfBHzScdga" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcnZUfhUVYac" style="font-weight: bold; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831_zIhzqb75zgAa" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balance, August 31, 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zSBcD1rOk8mj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zxCJv7IZot2d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_d0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFpsM4tMcXBf" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831_zq5CD50hQSz1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zAA9MZ82Firl" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zUaRbbH9IZ8j" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_pp0p0" style="font-weight: bold; text-align: right" title="Addition"&gt;2,533,987&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831_pp0p0" style="font-weight: bold; text-align: right" title="Addition"&gt;2,533,987&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zpDb6srRyPR6" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zImENgHoNJp8" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zrnP0MMN3oHf" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831_zOVAChUZbsPb" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balance, August 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z8WvpIiRt9X3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;4,789,248&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zQfPUAISziy7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;5,597,950&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zGIfo8AZhXH7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;2,533,987&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_iE_pp0p0_c20200831_zB26qGUiDAe9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;12,921,185&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zHmLQSCUzkp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;









</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2019-09-012020-08-31_us-gaap_GoodwillMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2018-09-012019-08-31_us-gaap_GoodwillMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="From2017-09-012018-08-31_us-gaap_GoodwillMember"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfGoodwillTextBlock_z4HAeKRfXG9a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BF_zuAQoWfd73Qe" style="display: none"&gt;Schedule of reconciliation of goodwill&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; font-weight: bold"&gt;Balance, August 31, 2017&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zoR0fNA1RpMj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zSoxwTUSYCRj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iS_pp0p0_d0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zCFcLsBeuOa4" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20170831_zvEwCAhEXfJi" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zvsgqGbcSyG9" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zhhwZkbMyTLd" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHg46XMJXXJe" style="font-weight: bold; text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831_zHaTc6ijB0Be" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zkbUasYxCbG1" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zuasCTew16Ag" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zzQNnyC5Xr92" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831_zkKJBVSQO7md" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold"&gt;Balance, August 31, 2018&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zMUXOD9rtnRg" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zeXXADTv1cvf" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Goodwill_iS_pp0p0_d0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zR6QbZfcc7Ed" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20180831_zyYx0cSdkeBd" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zLgbuxdmazBk" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zgEZVCjCjow5" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zE5XV05nhK1c" style="font-weight: bold; text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831_zqBiLpeMMal9" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Impairments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zCj29W7ZobBb" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zXdfBHzScdga" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcnZUfhUVYac" style="font-weight: bold; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831_zIhzqb75zgAa" style="text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;Balance, August 31, 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zSBcD1rOk8mj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;4,789,248&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zxCJv7IZot2d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;5,597,950&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_d0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFpsM4tMcXBf" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, beginning balance"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831_zq5CD50hQSz1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance"&gt;10,387,198&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Addition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zAA9MZ82Firl" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zUaRbbH9IZ8j" style="text-align: right" title="Addition"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_pp0p0" style="font-weight: bold; text-align: right" title="Addition"&gt;2,533,987&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831_pp0p0" style="font-weight: bold; text-align: right" title="Addition"&gt;2,533,987&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Impairments&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zpDb6srRyPR6" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zImENgHoNJp8" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zrnP0MMN3oHf" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831_zOVAChUZbsPb" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Balance, August 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z8WvpIiRt9X3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;4,789,248&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zQfPUAISziy7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;5,597,950&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zGIfo8AZhXH7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;2,533,987&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_iE_pp0p0_c20200831_zB26qGUiDAe9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance"&gt;12,921,185&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2017-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">4789248</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2017-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">5597950</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2017-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2017-08-31" decimals="0" unitRef="USD">10387198</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2017-09-012018-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2017-09-012018-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2017-09-012018-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2017-09-012018-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2017-09-012018-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2017-09-012018-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="AsOf2018-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">4789248</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2018-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">5597950</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2018-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2018-08-31" decimals="0" unitRef="USD">10387198</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2018-09-012019-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2018-09-012019-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2018-09-012019-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2018-09-012019-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="AsOf2019-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">4789248</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2019-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">5597950</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2019-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">10387198</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2019-09-012020-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2019-09-012020-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">2533987</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2533987</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2019-09-012020-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2019-09-012020-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="AsOf2020-08-31_custom_CognigenMember"
      decimals="0"
      unitRef="USD">4789248</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2020-08-31_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">5597950</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2020-08-31_custom_LixoftMember"
      decimals="0"
      unitRef="USD">2533987</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">12921185</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zbMRhXdE1U3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Other Intangible Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes other intangible
assets as of August 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zcdMv2SMnMX6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_z8PKBG7mUBPe" style="display: none"&gt;Schedule of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;br/&gt; Period&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Acquisition&lt;br/&gt; Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated&lt;br/&gt; Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net book &lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Customer relationships-Cognigen&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="width: 23%; text-align: left" title="Amortization period"&gt;Straight line 8 years&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Acquisition value"&gt;1,100,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Accumulated amortization"&gt;825,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Net book value"&gt;275,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-Cognigen&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z9H50fVKZ7h4" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Net book value"&gt;500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Covenants not to compete-Cognigen&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="text-align: left" title="Amortization period"&gt;Straight line 5 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zWM81nzb5Q4f" style="text-align: right" title="Net book value"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Covenants not to compete-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period"&gt;Straight line 4 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;80,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;65,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;15,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;860,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zK8OpZ196sib" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;860,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period"&gt;Straight line 10 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;1,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;617,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;1,282,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships-Lixoft&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcuIzsZApaQ7" style="text-align: left" title="Amortization period"&gt;Straight line 14 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxDMpotqsKGh" style="text-align: right" title="Acquisition value"&gt;2,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zwghqLFIKLF2" style="text-align: right" title="Accumulated amortization"&gt;75,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_ztnFFsowEzg1" style="text-align: right" title="Net book value"&gt;2,474,108&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-Lixoft&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHqRhmhyaYL8" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zZXtOxMG2TF1" style="text-align: right" title="Acquisition value"&gt;1,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zTvrtuBVMjP4" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zAqcvFAQ80Y7" style="text-align: right" title="Net book value"&gt;1,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Covenants not to compete-Lixoft&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxkBBuWqUWr1" style="text-align: left; padding-bottom: 1pt" title="Amortization period"&gt;Straight line 3 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z7pFB0M4R3C5" style="border-bottom: Black 1pt solid; text-align: right" title="Acquisition value"&gt;60,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z0gE94uETOqf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"&gt;8,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zexyHyyHGowf" style="border-bottom: Black 1pt solid; text-align: right" title="Net book value"&gt;51,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Acquisition value"&gt;8,650,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accumulated amortization"&gt;1,641,725&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Net book value"&gt;7,008,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AC_zG1JJ03xFfx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Amortization expense for the year ended
August 31, 2020, 2019 and 2018 was $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3ZFxKJwWMbb" title="Amortization of intangible assets"&gt;431,725&lt;/span&gt;, $&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3bmRuno6Ook" title="Amortization of intangible assets"&gt;357,500&lt;/span&gt;, and $&lt;span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVABDRip64Ae" title="Amortization of intangible assets"&gt;357,500&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Future amortization for the next five years is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zxQnkrdiyGO6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span id="xdx_8B9_z234vGfYtfFf" style="display: none"&gt;Schedule of future amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ending&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 35%; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zRWulqymKJsl" style="width: 11%; text-align: right" title="2021"&gt;545,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zCSW1w5HslL6" style="text-align: right" title="2022"&gt;530,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_znfvw1zNOtAf" style="text-align: right" title="2023"&gt;384,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zT0va5RT4hTj" style="text-align: right" title="2024"&gt;372,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyakFlEwBm42" style="text-align: right" title="2025"&gt;372,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zjzYJ5dEGP21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zcdMv2SMnMX6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BB_z8PKBG7mUBPe" style="display: none"&gt;Schedule of other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortization&lt;br/&gt; Period&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Acquisition&lt;br/&gt; Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Accumulated&lt;br/&gt; Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net book &lt;br/&gt; value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Customer relationships-Cognigen&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="width: 23%; text-align: left" title="Amortization period"&gt;Straight line 8 years&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Acquisition value"&gt;1,100,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Accumulated amortization"&gt;825,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Net book value"&gt;275,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-Cognigen&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z9H50fVKZ7h4" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Net book value"&gt;500,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Covenants not to compete-Cognigen&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="text-align: left" title="Amortization period"&gt;Straight line 5 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;50,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zWM81nzb5Q4f" style="text-align: right" title="Net book value"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Covenants not to compete-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period"&gt;Straight line 4 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;80,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;65,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;15,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;860,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zK8OpZ196sib" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;860,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships-DILIsym&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period"&gt;Straight line 10 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value"&gt;1,900,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization"&gt;617,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value"&gt;1,282,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Customer relationships-Lixoft&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcuIzsZApaQ7" style="text-align: left" title="Amortization period"&gt;Straight line 14 years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxDMpotqsKGh" style="text-align: right" title="Acquisition value"&gt;2,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zwghqLFIKLF2" style="text-align: right" title="Accumulated amortization"&gt;75,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_ztnFFsowEzg1" style="text-align: right" title="Net book value"&gt;2,474,108&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Trade Name-Lixoft&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHqRhmhyaYL8" title="Amortization period"&gt;None&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zZXtOxMG2TF1" style="text-align: right" title="Acquisition value"&gt;1,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zTvrtuBVMjP4" style="text-align: right" title="Accumulated amortization"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zAqcvFAQ80Y7" style="text-align: right" title="Net book value"&gt;1,550,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Covenants not to compete-Lixoft&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxkBBuWqUWr1" style="text-align: left; padding-bottom: 1pt" title="Amortization period"&gt;Straight line 3 years&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z7pFB0M4R3C5" style="border-bottom: Black 1pt solid; text-align: right" title="Acquisition value"&gt;60,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z0gE94uETOqf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"&gt;8,333&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zexyHyyHGowf" style="border-bottom: Black 1pt solid; text-align: right" title="Net book value"&gt;51,667&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Acquisition value"&gt;8,650,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accumulated amortization"&gt;1,641,725&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Net book value"&gt;7,008,275&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember">Straight line 8 years</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">1100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">825000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">275000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember">None</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember">Straight line 5 years</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_CognigenMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember">Straight line 4 years</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">80000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">65000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">15000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember">None</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">860000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">860000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember">Straight line 10 years</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">1900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">617500</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">1282500</us-gaap:FiniteLivedIntangibleAssetsNet>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember">Straight line 14 years</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">2550000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">75892</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_CustomerRelationshipsMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">2474108</us-gaap:FiniteLivedIntangibleAssetsNet>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember">None</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">1550000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_TradeNamesMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">1550000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember">Straight line 3 years</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">60000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">8333</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_NoncompeteAgreementsMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">51667</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">8650000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">1641725</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">7008275</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-09-012020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">431725</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2018-09-012019-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">357500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2017-09-012018-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">357500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zxQnkrdiyGO6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span id="xdx_8B9_z234vGfYtfFf" style="display: none"&gt;Schedule of future amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;Year ending&lt;/b&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;August 31,&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 35%; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zRWulqymKJsl" style="width: 11%; text-align: right" title="2021"&gt;545,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zCSW1w5HslL6" style="text-align: right" title="2022"&gt;530,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_znfvw1zNOtAf" style="text-align: right" title="2023"&gt;384,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zT0va5RT4hTj" style="text-align: right" title="2024"&gt;372,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyakFlEwBm42" style="text-align: right" title="2025"&gt;372,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">545000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">530000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">384000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">372000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember"
      decimals="0"
      unitRef="USD">372000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84C_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zOecTBEg1Jo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Business Acquisitions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounted for the acquisition
of Cognigen, DILIsym Services, Inc. and Lixoft using the purchase method of accounting where the assets acquired and liabilities
assumed are recognized based on their respective estimated fair values. The excess of the purchase price over the estimated fair
values of the net assets acquired is recorded as goodwill. Determining the fair value of certain acquired assets and liabilities
is subjective in nature and often involves the use of significant estimates and assumptions, including, but not limited to, the
selection of appropriate valuation methodology, projected revenue, expenses and cash flows, weighted average cost of capital, discount
rates, estimates of advertiser and publisher turnover rates and estimates of terminal values. Business acquisitions are included
in the Company's consolidated financial statements as of the date of the acquisition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zSLqoAyvl6U2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Assets and liabilities recorded at fair
value in the Consolidated Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure
their fair value. The categories, as defined by the standard are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Level&#160;Input:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 89%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Input Definition:&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level I&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level II&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Level III&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Unobservable inputs that reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For certain of our financial instruments,
including accounts receivable, accounts payable, accrued payroll and other expenses, and accrued bonuses to officers the carrying
amounts approximate fair value due to their short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes fair value
measurements at August 31, 2020 and August 31, 2019 for assets and liabilities measured at fair value on a recurring basis:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;August 31, 2020:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zYyIrAvXvjG5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_zmHSUlmxpb69" style="display: none"&gt;Summarizes fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zHYQ0Goe3Hb5" style="width: 11%; text-align: right" title="Fair value assets"&gt;49,207,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zZ6wlmbkx7L" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_ziuNLvNKmt38" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z4nxg8L59Dx5" style="width: 11%; text-align: right" title="Fair value assets"&gt;49,207,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAa6u8BjB1X2" style="text-align: right" title="Fair value assets"&gt;66,803,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAWqU7EJeqUj" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zWtPp8qtylG9" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zMPsbjxizirf" style="text-align: right" title="Fair value assets"&gt;66,803,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Acquisition-related contingent consideration obligations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zByirdDWDExh" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zvasR6GY54w7" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zlBoNlObcO7b" style="text-align: right" title="Fair value liabilities"&gt;4,730,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zf1qb4fCDcwg" style="text-align: right" title="Fair value liabilities"&gt;4,730,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;August 31, 2019:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zFigkOPxI4Xe" style="width: 11%; text-align: right" title="Fair value assets"&gt;11,435,499&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z3O9eET3mUIc" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zgzKEnI30r7g" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zNqQAJFxum1h" style="width: 11%; text-align: right" title="Fair value assets"&gt;11,435,499&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zRwKH7oQn7c9" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCgK0YlFXF79" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_z18hJNKcgH31" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCSurT1FLxF7" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Acquisition-related contingent consideration obligations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zGm1wLfpJDr4" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zPbSMnDQbZX4" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zilckSxYLB4c" style="text-align: right" title="Fair value liabilities"&gt;1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zIYMvbu92SJa" style="text-align: right" title="Fair value liabilities"&gt;1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zaLRR8e5v6tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of August 31, 2020 and 2019, the Company
has a liability for contingent consideration related to its acquisition of Lixoft and DILIsym Services, Inc. The fair value measurement
of the contingent consideration obligations is determined using Level 3 inputs. The fair value of contingent consideration obligations
is based on a discounted cash flow model using a probability-weighted income approach. These fair value measurements represent
Level 3 measurements as they are based on significant inputs not observable in the market. Significant judgment is employed in
determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes
in assumptions could have a material impact on the amount of contingent consideration expense the Company records in any given
period. Changes in the value of the contingent consideration obligations are recorded in the Company&#x2019;s Consolidated Statement
of Operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a reconciliation of contingent
consideration value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfContingentConsiderationTableTextBlock_zsdXNYIcBFB" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zPTdvf5hZ8Tc" style="display: none"&gt;Reconciliation of contingent consideration value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;Value at August 31, 2019&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iS_pp0p0_c20190831_znoY4GgeeSva" style="width: 11%; font-weight: bold; text-align: right" title="Contingent consideration, beginning balance"&gt;1,761,028&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Purchase price contingent consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PurchasePriceContingentConsiderationAdditions_c20190901__20200831_pp0p0" style="text-align: right" title="Purchase price contingent consideration"&gt;4,528,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Contingent consideration payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ContingentConsiderationPayments_iN_pp0p0_di_c20190901__20200831_zoY0KuUfKOgj" style="text-align: right" title="Contingent consideration payments"&gt;(1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in value of contingent consideration&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c20190901__20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Change in value of contingent consideration"&gt;202,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Value at August 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iE_pp0p0_c20200831_zxjqMrPZPwba" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Contingent consideration, ending balance"&gt;4,730,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_zfMjwN14OCPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zYyIrAvXvjG5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B3_zmHSUlmxpb69" style="display: none"&gt;Summarizes fair value measurements&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zHYQ0Goe3Hb5" style="width: 11%; text-align: right" title="Fair value assets"&gt;49,207,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zZ6wlmbkx7L" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_ziuNLvNKmt38" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z4nxg8L59Dx5" style="width: 11%; text-align: right" title="Fair value assets"&gt;49,207,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAa6u8BjB1X2" style="text-align: right" title="Fair value assets"&gt;66,803,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAWqU7EJeqUj" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zWtPp8qtylG9" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zMPsbjxizirf" style="text-align: right" title="Fair value assets"&gt;66,803,595&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Acquisition-related contingent consideration obligations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zByirdDWDExh" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zvasR6GY54w7" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zlBoNlObcO7b" style="text-align: right" title="Fair value liabilities"&gt;4,730,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zf1qb4fCDcwg" style="text-align: right" title="Fair value liabilities"&gt;4,730,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;August 31, 2019:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zFigkOPxI4Xe" style="width: 11%; text-align: right" title="Fair value assets"&gt;11,435,499&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z3O9eET3mUIc" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zgzKEnI30r7g" style="width: 11%; text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zNqQAJFxum1h" style="width: 11%; text-align: right" title="Fair value assets"&gt;11,435,499&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zRwKH7oQn7c9" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCgK0YlFXF79" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_z18hJNKcgH31" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCSurT1FLxF7" style="text-align: right" title="Fair value assets"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Acquisition-related contingent consideration obligations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zGm1wLfpJDr4" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zPbSMnDQbZX4" style="text-align: right" title="Fair value liabilities"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zilckSxYLB4c" style="text-align: right" title="Fair value liabilities"&gt;1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zIYMvbu92SJa" style="text-align: right" title="Fair value liabilities"&gt;1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember"
      decimals="0"
      unitRef="USD">49207314</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember"
      decimals="0"
      unitRef="USD">49207314</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember"
      decimals="0"
      unitRef="USD">66803595</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember"
      decimals="0"
      unitRef="USD">66803595</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember"
      decimals="0"
      unitRef="USD">4730500</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember"
      decimals="0"
      unitRef="USD">4730500</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember"
      decimals="0"
      unitRef="USD">11435499</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember"
      decimals="0"
      unitRef="USD">11435499</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ShortTermInvestmentsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember"
      decimals="0"
      unitRef="USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember"
      decimals="0"
      unitRef="USD">1761028</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2019-08-31_us-gaap_FairValueMeasurementsRecurringMember_custom_AquisitionRelatedContingentConsiderationObligationsMember"
      decimals="0"
      unitRef="USD">1761028</us-gaap:LiabilitiesFairValueDisclosure>
    <simu:ReconciliationOfContingentConsiderationTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfContingentConsiderationTableTextBlock_zsdXNYIcBFB" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zPTdvf5hZ8Tc" style="display: none"&gt;Reconciliation of contingent consideration value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; font-weight: bold"&gt;Value at August 31, 2019&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iS_pp0p0_c20190831_znoY4GgeeSva" style="width: 11%; font-weight: bold; text-align: right" title="Contingent consideration, beginning balance"&gt;1,761,028&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Purchase price contingent consideration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PurchasePriceContingentConsiderationAdditions_c20190901__20200831_pp0p0" style="text-align: right" title="Purchase price contingent consideration"&gt;4,528,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Contingent consideration payments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ContingentConsiderationPayments_iN_pp0p0_di_c20190901__20200831_zoY0KuUfKOgj" style="text-align: right" title="Contingent consideration payments"&gt;(1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Change in value of contingent consideration&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c20190901__20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Change in value of contingent consideration"&gt;202,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Value at August 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iE_pp0p0_c20200831_zxjqMrPZPwba" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Contingent consideration, ending balance"&gt;4,730,500&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</simu:ReconciliationOfContingentConsiderationTableTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationAssetCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">1761028</us-gaap:BusinessCombinationContingentConsiderationAssetCurrent>
    <simu:PurchasePriceContingentConsiderationAdditions
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">4528000</simu:PurchasePriceContingentConsiderationAdditions>
    <simu:ContingentConsiderationPayments
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">1761028</simu:ContingentConsiderationPayments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">202500</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationAssetCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">4730500</us-gaap:BusinessCombinationContingentConsiderationAssetCurrent>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zmjCyVBPBIwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Advertising&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company expenses advertising costs
as incurred. Advertising costs for the years ended August 31, 2020, 2019 and 2018 were approximately $&lt;span id="xdx_901_eus-gaap--AdvertisingExpense_c20190901__20200831_pp0p0" title="Advertising costs"&gt;63,944&lt;/span&gt;, $&lt;span id="xdx_908_eus-gaap--AdvertisingExpense_c20180901__20190831_pp0p0" title="Advertising costs"&gt;83,213&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--AdvertisingExpense_c20170901__20180831_pp0p0" title="Advertising costs"&gt;67,848&lt;/span&gt;,
respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">63944</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">83213</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">67848</us-gaap:AdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zWe1iL9IrDuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Research and Development Costs&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Research and development costs are charged
to expense as incurred until technological feasibility has been established. These costs include salaries, laboratory experiment,
and purchased software which was developed by other companies and incorporated into, or used in the development of, our final products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zUIPGgh40rS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes in
accordance with ASC 740-10, &lt;i&gt;&#x201c;Income Taxes&#x201d;&lt;/i&gt; which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements or tax returns.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z8GNJWW9O9J9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Intellectual property&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 28, 2012, we bought out the
royalty agreement with Enslein Research. The cost of $&lt;span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsGross_c20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Intangible asset acquisition value"&gt;75,000&lt;/span&gt; is being amortized over &lt;span id="xdx_900_ecustom--AmortizationPeriodIntangibleAssets_c20110901__20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember" title="Amortization period"&gt;10 years under the straight-line method&lt;/span&gt;. Amortization
expense for each of the fiscal years ended August 31, 2020 and 2019 was $&lt;span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zhbLmTWT8ICe" title="Amortization of intangible assets"&gt;&lt;span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_z7TtErqFcd5f" title="Amortization of intangible assets"&gt;7,500&lt;/span&gt;&lt;/span&gt;. Accumulated amortization as of August 31, 2020
and 2019 was $&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;63,750&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;56,250&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On May 15, 2014, we entered into a termination
and non-assertion agreement with TSRL, Inc., pursuant to which the parties agreed to terminate an exclusive software licensing
agreement entered into between the parties in 1997. As a result, the Company obtained a perpetual right to use certain source code
and data, and TSRL relinquished any rights and claims to any GastroPlus products and to any claims to royalties or other payments
under that 1997 agreement. We agreed to pay TSRL total consideration of $&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsGross_c20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Intangible asset acquisition value"&gt;6,000,000&lt;/span&gt;, which is being amortized over &lt;span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20130901__20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember" title="Amortization period"&gt;10 years under
the straight-line method&lt;/span&gt;. Amortization for the year ended August 31, 2020, and 2019 was $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zwHu0ELID6e4" title="Amortization of intangible assets"&gt;&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zEYLoca8Ywo7" title="Amortization of intangible assets"&gt;600,000&lt;/span&gt;&lt;/span&gt;. Accumulated amortization as of
August 31, 2020 and 2019 was $&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;3,775,000&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;3,175,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 1, 2017, as part of the acquisition
of DILIsym Services, Inc. the Company acquired certain developed technologies associated with the drug induced liver disease (DILI).
These technologies were valued at $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsGross_c20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Intangible asset acquisition value"&gt;2,850,000&lt;/span&gt; and are being amortized over &lt;span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20160901__20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember" title="Amortization period"&gt;9 years under the straight-line method&lt;/span&gt;. Amortization
expense for the fiscal years ended August 31, 2020 and 2019 was $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets"&gt;316,667&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets"&gt;316,667&lt;/span&gt;, respectively, and is included in cost of
revenues. Total accumulated amortization as of August 31, 2020 and 2019 was $&lt;span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;1,029,167&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;712,500&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In September 2018, we purchased certain
intellectual property rights of Entelos Holding Company, a Delaware Corporation. The cost of $&lt;span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember_pp0p0" title="Intangible asset acquisition value"&gt;50,000&lt;/span&gt; is being amortized over &lt;span id="xdx_907_ecustom--AmortizationPeriodIntangibleAssets_c20180901__20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember" title="Amortization period"&gt;10
years under the straight-line method&lt;/span&gt;. Amortization expense for the year ended August 31, 2020 and 2019 was $&lt;span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Amortization of intangible assets"&gt;5,000&lt;/span&gt; and $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zOs5YJaHO26e" title="Amortization of intangible assets"&gt;5,000&lt;/span&gt;. Accumulated
amortization as of August 31, 2020 and 2019 was $&lt;span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zW3aUM43FTwl" title="Accumulated amortization of intellectual property"&gt;10,000&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Accumulated amortization of intellectual property"&gt;5,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 1, 2020, as part of the acquisition
of Lixoft, the Company acquired certain developed technologies associated with the Lixoft scientific software. These technologies
were valued at $&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zpMxPfJZDHJ8" title="Intangible asset acquisition value"&gt;8,010,000&lt;/span&gt; and are being amortized over &lt;span id="xdx_90E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zXXpglxEVPh6" title="Amortization period"&gt;16 years under the straight-line method&lt;/span&gt;. Amortization expense for the fiscal
years ended August 31, 2020 was $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zhQXw7zg7SEg" title="Amortization of intangible assets"&gt;208,594&lt;/span&gt; and is included in cost of revenues. Total accumulated amortization as of August 31, 2020
was $&lt;span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zviBsbOkc0i2" title="Accumulated amortization of intellectual property"&gt;208,594&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Total amortization expense for intellectual
property agreements for the years ended August 31, 2020, 2019 and 2018 was $&lt;span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"&gt;1,138,280&lt;/span&gt;, $&lt;span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"&gt;929,167&lt;/span&gt;, and $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets"&gt;924,167&lt;/span&gt;. Accumulated amortization
as of August 31, 2020 and 2019 was $&lt;span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zwvNPyR8Newi" title="Accumulated amortization of intellectual property"&gt;5,087,031&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyv8Lja8rOle" title="Accumulated amortization of intellectual property"&gt;3,948,750&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Future amortization for the next five years
is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAmortizationExpensesTableTextBlock_zOT6nlAoXPva" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zQOnpBhAbNVj" style="display: none"&gt;Schedule of future amortization expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zW7YXI5yZCLi" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zX8dAQzarkKd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIMember_zsIOn20qZid7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_z1Tbr52GkpBk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_z4DTQrCGhw8g" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zYZYZ4o7tgSi" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years ending &lt;br/&gt; August 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;TSRL&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Enslein&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILI-Acquired&lt;br/&gt; Developed&lt;br/&gt; Technologies&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft-Acquired&lt;br/&gt; Developed&lt;br/&gt; Technologies&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Entelos&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 16%; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;7,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,429,792&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,426,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_d0_z5Oqy1grb2Yl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,422,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_d0_zBybeV9Z08F8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;425,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_d0_zGkQdQVNENzi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;822,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zHZaIfKMDUP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2012-02-28_us-gaap_RoyaltyAgreementsMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">75000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2011-09-012012-02-28_us-gaap_RoyaltyAgreementsMember_custom_EnslienMember">10 years under the straight-line method</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">7500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">7500</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">63750</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">56250</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2014-05-15_custom_TermAndNonassertionAgrMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">6000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2013-09-012014-05-15_custom_TermAndNonassertionAgrMember_custom_TSRLMember">10 years under
the straight-line method</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">3775000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">3175000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2017-06-02_custom_CertainDevelopedTechnologiesMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">2850000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2016-09-012017-06-02_custom_CertainDevelopedTechnologiesMember_custom_DILIsymMember">9 years under the straight-line method</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">316667</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">316667</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">1029167</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_DILIsymMember"
      decimals="0"
      unitRef="USD">712500</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2018-09-30_custom_CertainIntellectualPropertyRightsMember_custom_EntelosHoldingCoMember"
      decimals="0"
      unitRef="USD">50000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2018-09-012018-09-30_custom_CertainIntellectualPropertyRightsMember_custom_EntelosHoldingCoMember">10
years under the straight-line method</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2020-04-02_custom_CertainDevelopedTechnologiesMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">8010000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <simu:AmortizationPeriodIntangibleAssets contextRef="From2019-09-012020-04-02_custom_CertainDevelopedTechnologiesMember_custom_LixoftMember">16 years under the straight-line method</simu:AmortizationPeriodIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">208594</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">208594</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2019-09-012020-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">1138280</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2018-09-012019-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">929167</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2017-09-012018-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">924167</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">5087031</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2019-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">3948750</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <simu:ScheduleOfAmortizationExpensesTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAmortizationExpensesTableTextBlock_zOT6nlAoXPva" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zQOnpBhAbNVj" style="display: none"&gt;Schedule of future amortization expenses&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zW7YXI5yZCLi" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zX8dAQzarkKd" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIMember_zsIOn20qZid7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_491_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_z1Tbr52GkpBk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_z4DTQrCGhw8g" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zYZYZ4o7tgSi" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years ending &lt;br/&gt; August 31,&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;TSRL&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Enslein&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILI-Acquired&lt;br/&gt; Developed&lt;br/&gt; Technologies&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft-Acquired&lt;br/&gt; Developed&lt;br/&gt; Technologies&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Entelos&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 16%; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;7,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,429,792&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,426,042&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_d0_z5Oqy1grb2Yl" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;600,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,422,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_d0_zBybeV9Z08F8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;425,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,247,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_d0_zGkQdQVNENzi" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2025&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;316,667&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;500,625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;822,292&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</simu:ScheduleOfAmortizationExpensesTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">7500</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember"
      decimals="0"
      unitRef="USD">316667</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">500625</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">1429792</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">3750</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember"
      decimals="0"
      unitRef="USD">316667</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">500625</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">1426042</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember"
      decimals="0"
      unitRef="USD">316667</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">500625</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">1422292</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">425000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember"
      decimals="0"
      unitRef="USD">316667</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">500625</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">1247292</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_TSRLMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EnslienMember"
      decimals="0"
      unitRef="USD">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_DILIMember"
      decimals="0"
      unitRef="USD">316667</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_LixoftMember"
      decimals="0"
      unitRef="USD">500625</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember_custom_EntelosMember"
      decimals="0"
      unitRef="USD">5000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="AsOf2020-08-31_us-gaap_IntellectualPropertyMember"
      decimals="0"
      unitRef="USD">822292</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zebAV6RoGKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Earnings per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company reports earnings per share
in accordance with FASB ACS 260-10. Basic earnings per share is computed by dividing income available to common shareholders by
the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per
share except that the denominator is increased to include the number of additional common shares that would have been outstanding
if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted
earnings per share for the years ended August 31, 2020, 2019 and 2018 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwPNl37oEuQh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BE_zbpYZd26dcYg" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20190901__20200831_z42pDCeajb91" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20180901__20190831_zgQ42h8vLxn6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20170901__20180831_zpLAOwGeQ94d" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;9,332,060&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;8,583,329&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;8,934,812&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pii_zWGOoVnDS8j7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average number of common shares outstanding during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,819,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,492,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,328,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pii_zl1t74brxaL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Dilutive effect of stock options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;719,309&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;565,173&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;531,685&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pii_zuS8ByLCnD6g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Common stock and common stock equivalents used for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18,538,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18,057,431&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;17,860,392&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_8AF_zTKM3q9U7om3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwPNl37oEuQh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BE_zbpYZd26dcYg" style="display: none"&gt;Schedule of earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20190901__20200831_z42pDCeajb91" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20180901__20190831_zgQ42h8vLxn6" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20170901__20180831_zpLAOwGeQ94d" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Numerator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; text-align: left; padding-bottom: 2.5pt"&gt;Net income attributable to common shareholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;9,332,060&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;8,583,329&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right"&gt;8,934,812&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Denominator&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pii_zWGOoVnDS8j7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Weighted-average number of common shares outstanding during the year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,819,064&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,492,258&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;17,328,707&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pii_zl1t74brxaL1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Dilutive effect of stock options&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;719,309&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;565,173&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;531,685&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pii_zuS8ByLCnD6g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Common stock and common stock equivalents used for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18,538,373&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18,057,431&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;17,860,392&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">9332060</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">8583329</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">8934812</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Shares">17819064</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Shares">17492258</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Shares">17328707</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Shares">719309</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Shares">565173</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Shares">531685</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Shares">18538373</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Shares">18057431</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Shares">17860392</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zYvIuhl0p9Rd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for stock options
using the modified prospective method in accordance with FASB ASC 718-10, &lt;i&gt;&#x201c;Compensation-Stock Compensation&#x201d;&lt;/i&gt;.
Under this method, compensation costs include estimated grant date fair value of the awards amortized over the options&#x2019; vesting
period. Stock-based compensation was $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensation_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"&gt;1,286,625&lt;/span&gt;, $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"&gt;865,848&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--ShareBasedCompensation_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation"&gt;562,078&lt;/span&gt; for the fiscal years ended August 31, 2020, 2019 and 2018,
respectively, and is included in the statements of operations as Consulting, Salaries, and Research and Development expense.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensation
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">1286625</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">865848</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">562078</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zt0zasQu6cZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Impairment of Long-lived Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for the impairment
and disposition of long-lived assets in accordance with ASC 350, &lt;i&gt;&#x201c;Intangibles &#x2013; Goodwill and Other&lt;/i&gt;&#x201d; and
ASC 360, &lt;i&gt;&#x201c;Property and Equipment&#x201d;&lt;/i&gt;. Long-lived assets to be held and used are reviewed for events or changes
in circumstances that indicate that their carrying value may not be recoverable. We measure recoverability by comparing the carrying
amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may
not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an
impairment charge to the extent of the difference between the fair value and the asset's carrying amount. &lt;span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20190901__20200831_z1hibgz7fx1" title="Impairment losses"&gt;&lt;span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20180901__20190831_zdzaE5YyJ5h4" title="Impairment losses"&gt;&lt;span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20170901__20180831_zTk5MITYte01" title="Impairment losses"&gt;No&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; impairment losses
were recorded during the years ended August 31, 2020, 2019 and 2018.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zHjSKuHffNZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Recently Issued Accounting Standards&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding Accounting Standards Codification
Topic 606 (ASC Topic 606), Revenue from Contracts with Customers. The standard provides principles for recognizing revenue for
the transfer of promised goods or services to customers with the consideration to which the entity expects to be entitled in exchange
for those goods or services. The standard also provides guidance on the recognition of incremental costs related to obtaining customer
contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing the modified retrospective method. This approach was
applied to contracts that were in process as of September 1, 2018, and the corresponding incremental costs of obtaining those contracts,
which resulted in a cumulative effect adjustment of $493,279 to the opening balance of retained earnings at the date of adoption.
The adoption of this ASU primarily impacts the timing of our revenue recognition for certain sales contracts, the capitalization
and amortization of incremental costs of obtaining a contract, and related disclosures. The reported results for fiscal year 2019
reflect the application of ASC Topic 606.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2016, the FASB issued ASU 2016-02,
Leases (Topic 842), which supersedes existing guidance on accounting for leases in "Leases (Topic 840)" and generally
requires all leases to be recognized in the consolidated balance sheet. ASU 2016-02 is effective for annual and interim reporting
periods beginning after December 15, 2018. The Company adopted this ASU on September 1, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In April 2016, the FASB issued ASU 2016-10,
Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board's new revenue standard, ASU 2014-09,
Revenue from Contracts with Customers. The standard was adopted concurrently with the adoption of ASU 2014-09 which is effective
for annual and interim periods beginning after December 15, 2017.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_807_eus-gaap--RevenueFromContractWithCustomerTextBlock_zKzR0jkn9nw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 3 &#x2013; &lt;span id="xdx_828_zIsxOFXa1L85"&gt;REVENUE RECOGNITION&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company adopted Topic 606 effective
September&#160;1, 2018 using the modified retrospective method applying this guidance to all open contracts at the date of initial
application, which resulted in an adjustment to retained earnings for the cumulative effect of applying this guidance. The most
significant impact of Topic 606 on revenue to the Company relates to the timing of revenue recognition for one of its payment contracts.
Under 606 the revenues under the contract are being recognized as time is expended and costs are being expensed as incurred. Under
ASC 605 revenues were recognized as invoiced and certain costs were capitalized as development.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company determines revenue recognition
through the following steps:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 5%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;i.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 95%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Identification of the contract, or contracts, with a customer&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;ii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;iii.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Determination of the transaction price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;iv.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;v.&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Recognition of revenue when, or as, the Company satisfies a performance obligation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Components of revenue&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following is a description of principal
activities from which the Company generates revenue. As part of the accounting for these arrangements, the Company must develop
assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the
contract. Stand-alone selling prices are determined based on the prices at which the Company separately sells its services or goods.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 49%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Revenue Components&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48%"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Typical payment terms&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Software Revenues:&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Software revenues are generated primarily from sales of software
        licenses at the time the software is unlocked and the term commences. The license period typically is one year or less. Along with
        the license a &lt;i&gt;di minimis&lt;/i&gt; amount of customer support is provided to assist the customer with the software. Should the customer
        need more than a di minimis amount of support they can choose to enter into a separate contract for additional training. Most software
        is installed on our customers&#x2019; servers and the Company has no control of the software once the sale is made.&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For certain software arrangements the Company hosts the licenses
        on servers maintained by the Company, revenue for those arrangements are accounted as &lt;i&gt;Software as a Service&lt;/i&gt; over the life
        of the contract. These arrangements are a small portion of software revenues of the Company.&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Payments are generally due upon invoicing on a net 30 basis unless other payment terms are negotiated with the customer based on customer history. Typical industry standards apply.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Consulting Contracts:&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Consulting services provided to our customers are generally recognized over time as the contracts are performed and the services are rendered. The company measures its consulting revenue based on time expended compared to total estimated hours to complete a project. The Company believes the methods chosen for its contract revenue best depicts the transfer of benefits to the customer under the contracts.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Payment terms vary, depending on the size of the contract, credit history and history with the client and deliverables within the contract.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 49%; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Consortium Member Based Services:&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 48%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;The performance obligation is recognized on a time elapsed basis, by month, for which the services are provided, as the Company transfers control evenly over the contractual period.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;Payment is due at the beginning of the period, generally on a net 30 or 60 basis.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Remaining performance obligations
that do not fall under the expedients require the Company to perform various&#160;consulting and software development
services and consortium memberships of approximately $&lt;span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_c20200831_pp0p0" title="Remaining performance obligations"&gt;3,303,461&lt;/span&gt;.
It is anticipated these revenues will be recognized within the next year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Contract liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended August 31, 2020 the
Company recognized $&lt;span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20190901__20200831_pp0p0" title="Revenues included in contract liabilities"&gt;1,146,000&lt;/span&gt; of revenue that was included in contract liabilities as of August 31, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Disaggregation of Revenues&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zagC0y6wzAVc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Disaggregation)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 10pt"&gt;&lt;span id="xdx_8B3_zQo710fJ5tV3" style="display: none"&gt;Schedule of disaggregation of revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Disaggregation of Revenues:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; August 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; August 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Software licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 70%; text-align: left; text-indent: 10pt"&gt;Point in time&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="width: 11%; text-align: right" title="Revenues"&gt;20,668,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="width: 11%; text-align: right" title="Revenues"&gt;17,425,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; text-indent: 10pt"&gt;Over time&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="text-align: right" title="Revenues"&gt;919,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="text-align: right" title="Revenues"&gt;1,053,562&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Consulting services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Over time&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;20,001,545&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;15,491,525&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;41,589,084&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20180901__20190831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;33,970,440&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AF_zIORA1xti5Ld" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="text-decoration: underline"&gt;Contracts in Progress&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Contracts in progress are included in the accompanying balance
sheets under the following captions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zCdLLMp8FQm3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8BB_zqfCiXdLAFU2" style="display: none"&gt;Schedule of contract in progress&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20200831_zjzGgHGToG3b" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20190831_zJaf8b3ahOO7" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_iI_pp0p0_maROBOUztWJ_zYD86VrOVm5b" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Revenues in excess of billings&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,093,343&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,233,659&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--BillingsInExcessOfCost_iNI_pp0p0_di_msROBOUztWJ_z2FWgTLFLdwc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Billings in excess of revenues&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(140,991&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(798,549&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--RevenuesOverBillingsOnUncompletedContracts_iTI_pp0p0_mtROBOUztWJ_zcQQ5a2vCZgb" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 2.5pt"&gt;Revenues over billings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,952,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,435,110&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cost, estimated earnings, and billings
on uncompleted contracts are summarized as follows as of August 31, 2020 and 2019:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--RevenuesEarnedToDateOnUncompletedContracts_iI_z1MJMCb5jmk6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Revenues earned to date on uncompleted contracts&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;20,235,573&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;19,254,928&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--BillingsToDateOnUncompletedContracts_iNI_di_zfUIObO0Xka1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Billings to date on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(17,283,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(16,819,818&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 2.5pt"&gt;Revenues over billings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,952,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,435,110&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zyxtl2K24A2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Balance increases and decreases in these
accounts are due to the timing of amounts billed, payments received, and revenue recognized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">3303461</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">1146000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zagC0y6wzAVc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Disaggregation)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: 10pt"&gt;&lt;span id="xdx_8B3_zQo710fJ5tV3" style="display: none"&gt;Schedule of disaggregation of revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Disaggregation of Revenues:&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; August 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year Ended &lt;br/&gt; August 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Software licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 70%; text-align: left; text-indent: 10pt"&gt;Point in time&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="width: 11%; text-align: right" title="Revenues"&gt;20,668,195&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="width: 11%; text-align: right" title="Revenues"&gt;17,425,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; text-indent: 10pt"&gt;Over time&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="text-align: right" title="Revenues"&gt;919,344&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="text-align: right" title="Revenues"&gt;1,053,562&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left"&gt;Consulting services&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; text-indent: 10pt"&gt;Over time&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;20,001,545&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;15,491,525&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total Revenue&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;41,589,084&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_c20180901__20190831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;33,970,440&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember"
      decimals="0"
      unitRef="USD">20668195</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember"
      decimals="0"
      unitRef="USD">17425353</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredOverTimeMember"
      decimals="0"
      unitRef="USD">919344</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredOverTimeMember"
      decimals="0"
      unitRef="USD">1053562</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_ConsultingServicesMember_us-gaap_TransferredOverTimeMember"
      decimals="0"
      unitRef="USD">20001545</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_ConsultingServicesMember_us-gaap_TransferredOverTimeMember"
      decimals="0"
      unitRef="USD">15491525</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">41589084</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">33970440</us-gaap:Revenues>
    <us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zCdLLMp8FQm3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span id="xdx_8BB_zqfCiXdLAFU2" style="display: none"&gt;Schedule of contract in progress&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20200831_zjzGgHGToG3b" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20190831_zJaf8b3ahOO7" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_iI_pp0p0_maROBOUztWJ_zYD86VrOVm5b" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Revenues in excess of billings&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,093,343&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,233,659&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--BillingsInExcessOfCost_iNI_pp0p0_di_msROBOUztWJ_z2FWgTLFLdwc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Billings in excess of revenues&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(140,991&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(798,549&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--RevenuesOverBillingsOnUncompletedContracts_iTI_pp0p0_mtROBOUztWJ_zcQQ5a2vCZgb" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 2.5pt"&gt;Revenues over billings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,952,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,435,110&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cost, estimated earnings, and billings
on uncompleted contracts are summarized as follows as of August 31, 2020 and 2019:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--RevenuesEarnedToDateOnUncompletedContracts_iI_z1MJMCb5jmk6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Revenues earned to date on uncompleted contracts&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;20,235,573&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;19,254,928&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--BillingsToDateOnUncompletedContracts_iNI_di_zfUIObO0Xka1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Billings to date on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(17,283,221&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(16,819,818&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 2.5pt"&gt;Revenues over billings on uncompleted contracts&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,952,352&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,435,110&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">3093343</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">3233659</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms>
    <us-gaap:BillingsInExcessOfCost contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">140991</us-gaap:BillingsInExcessOfCost>
    <us-gaap:BillingsInExcessOfCost contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">798549</us-gaap:BillingsInExcessOfCost>
    <simu:RevenuesOverBillingsOnUncompletedContracts contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">2952352</simu:RevenuesOverBillingsOnUncompletedContracts>
    <simu:RevenuesOverBillingsOnUncompletedContracts contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">2435110</simu:RevenuesOverBillingsOnUncompletedContracts>
    <simu:RevenuesEarnedToDateOnUncompletedContracts contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">20235573</simu:RevenuesEarnedToDateOnUncompletedContracts>
    <simu:RevenuesEarnedToDateOnUncompletedContracts contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">19254928</simu:RevenuesEarnedToDateOnUncompletedContracts>
    <simu:BillingsToDateOnUncompletedContracts contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">17283221</simu:BillingsToDateOnUncompletedContracts>
    <simu:BillingsToDateOnUncompletedContracts contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">16819818</simu:BillingsToDateOnUncompletedContracts>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zhY0Pl7JLjBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 &#x2013; &lt;span id="xdx_82B_zzpnZEgZzN14"&gt;PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment at August 31, 2020
and 2019 consisted of the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2XcKW4fbxvg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B7_zb3ozx5Y0Mv8" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: justify"&gt;Equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Property and equipment, gross"&gt;864,560&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Property and equipment, gross"&gt;741,486&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Computer equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;547,738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;411,632&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;160,991&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;160,990&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"&gt;114,005&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"&gt;110,165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"/&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200831_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;1,687,294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20190831_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;1,424,273&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;1,249,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20190831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;1,083,128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_c20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value"&gt;437,787&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_c20190831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value"&gt;341,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Depreciation expense was $&lt;span id="xdx_90D_eus-gaap--Depreciation_c20190901__20200831_pp0p0" title="Depreciation"&gt;166,379&lt;/span&gt;, $&lt;span id="xdx_906_eus-gaap--Depreciation_c20180901__20190831_pp0p0" title="Depreciation"&gt;131,827&lt;/span&gt;,
and $&lt;span id="xdx_908_eus-gaap--Depreciation_c20170901__20180831_pp0p0" title="Depreciation"&gt;139,202&lt;/span&gt; for the years ended August 31, 2020, 2019, and 2018, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2XcKW4fbxvg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B7_zb3ozx5Y0Mv8" style="display: none"&gt;Schedule of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: justify"&gt;Equipment&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Property and equipment, gross"&gt;864,560&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Property and equipment, gross"&gt;741,486&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Computer equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;547,738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;411,632&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Furniture and fixtures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;160,991&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;160,990&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"&gt;114,005&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"&gt;110,165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"/&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200831_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;1,687,294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20190831_pp0p0" style="text-align: right" title="Property and equipment, gross"&gt;1,424,273&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;1,249,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20190831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization"&gt;1,083,128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_c20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value"&gt;437,787&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_c20190831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value"&gt;341,145&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-08-31_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">864560</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-08-31_us-gaap_EquipmentMember"
      decimals="0"
      unitRef="USD">741486</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-08-31_us-gaap_ComputerEquipmentMember"
      decimals="0"
      unitRef="USD">547738</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-08-31_us-gaap_ComputerEquipmentMember"
      decimals="0"
      unitRef="USD">411632</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-08-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">160991</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-08-31_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      unitRef="USD">160990</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2020-08-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">114005</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2019-08-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      unitRef="USD">110165</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">1687294</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">1424273</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">1249507</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">1083128</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">437787</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">341145</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">166379</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">131827</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">139202</us-gaap:Depreciation>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_802_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zgEeqAb9qf26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 &#x2013; &lt;span id="xdx_82B_zMsmAeLKNikj"&gt;INVESTMENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company invests a portion of its
excess cash balances in short-term debt securities. Investments at August 31, 2020 consisted of corporate bonds with
maturities remaining of less than 12 months. The Company may also invest excess cash balances in certificates of deposits,
money market accounts, government-sponsored enterprise securities, corporate bonds and/or commercial paper. The Company
accounts for its investments in accordance with FASB ASC 320, Investments &#x2013; Debt and Equity Securities. At August 31,
2020, all investments were classified as held-to-maturity securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following tables summarize the Company&#x2019;s short-term
investments as of August 31, 2020. The Company had &lt;span id="xdx_90B_eus-gaap--ShortTermInvestments_iI_do_c20190831_z32ektnUzkUg" title="Short-term investments"&gt;no&lt;/span&gt; short-term investments for the year ended August 31, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;FY 2020 &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--InvestmentTableTextBlock_zkCOSS5CwoJj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVESTMENTS (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B6_zWYafKIsrk3d" style="display: none"&gt;Schedule of short term investment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortized Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Gross&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Unrealized&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Gains&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Gross&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Unrealized&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Losses&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-bottom: 1pt"&gt;Commercial notes (due within one year)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShortTermInvestments_iI_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_z5z0YeKmXdRk" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Short term investment, amortized cost"&gt;66,803,595&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Gross unrealized gains"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1255"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_zIqg0YqQOL95" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Gross unrealized loss"&gt;(60,977&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Short term investment, fair value"&gt;66,742,618&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShortTermInvestments_iI_c20200831_zl8P0WCnCdH2" style="border-bottom: Black 2.5pt double; text-align: right" title="Short term investment, amortized cost"&gt;66,803,595&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross unrealized gains"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1263"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831_zbSgKAap4zDc" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross unrealized loss"&gt;(60,977&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_c20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Short term investment, fair value"&gt;66,742,618&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ShortTermInvestments contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:ShortTermInvestments>
    <us-gaap:InvestmentTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--InvestmentTableTextBlock_zkCOSS5CwoJj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVESTMENTS (Details)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B6_zWYafKIsrk3d" style="display: none"&gt;Schedule of short term investment&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Amortized Cost&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Gross&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Unrealized&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Gains&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Gross&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Unrealized&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;Losses&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left; padding-bottom: 1pt"&gt;Commercial notes (due within one year)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShortTermInvestments_iI_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_z5z0YeKmXdRk" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Short term investment, amortized cost"&gt;66,803,595&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Gross unrealized gains"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1255"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_zIqg0YqQOL95" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Gross unrealized loss"&gt;(60,977&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Short term investment, fair value"&gt;66,742,618&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShortTermInvestments_iI_c20200831_zl8P0WCnCdH2" style="border-bottom: Black 2.5pt double; text-align: right" title="Short term investment, amortized cost"&gt;66,803,595&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross unrealized gains"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1263"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831_zbSgKAap4zDc" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross unrealized loss"&gt;(60,977&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_c20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Short term investment, fair value"&gt;66,742,618&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:InvestmentTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="AsOf2020-08-31_us-gaap_CommercialPaperMember"
      decimals="0"
      unitRef="USD">66803595</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="From2019-09-012020-08-31_us-gaap_CommercialPaperMember"
      decimals="0"
      unitRef="USD">60977</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2020-08-31_us-gaap_CommercialPaperMember"
      decimals="0"
      unitRef="USD">66742618</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">66803595</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">60977</us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss>
    <us-gaap:InvestmentsFairValueDisclosure contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">66742618</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_80E_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zR2Xve9UfJva" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 6 - &lt;span id="xdx_827_zUFGZpqzmAEh"&gt;CONTRACTS PAYABLE&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;DILIsym Acquisition Liabilities:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 1, 2017, the Company acquired DILIsym
Services, Inc. The agreement provided for a working capital adjustment, an eighteen-month $1,000,000 holdback provision against
certain representations and warrantees, and an Earn-out agreement of up to an additional $5,000,000 in Earn-out payments based
on earnings over the three years following acquisition. The Earn-out liability has been recorded at an estimated fair value. Payments
under the Earn-out liability will be due starting in FY 2019. In September 2018, $1,556,644 was paid out under the first earn-out
payment, a second earn-out payment was made in August 2019 in the amount of $1,682,329. The final payment of $1,761,028 was paid
in August 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Lixoft Acquisition Liabilities&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"&gt;On April 1, 2020, the Company
acquired Lixoft. The agreement provided for a twenty-four month $2,000,000 holdback provision against certain representations and
warrantees, comprised of $1,333,333 of cash and the release from an escrow shares of stock valued at $666,337 issued at the date
of the Agreement. In addition, based on a revenue growth formula for the two years subsequent to April 1, 2020, the agreement calls
for earn-out payments up to $5,500,000 (two thirds cash and one-third newly issued, unregistered shares of the Company&#x2019;s
common stock). The former shareholders can earn up to $2,000,000 the first year and $3,500,000 in year two.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of August 31, 2020 and 2019 the following
liabilities have been recorded:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--OtherLiabilitiesTableTextBlock_zmP989z4S3jh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTRACTS PAYABLE (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B3_zIUlL5BCIDJ1" style="display: none"&gt;Schedule of Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: justify"&gt;Holdback Liability - Lixoft&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zdDXDKhB3mZh" style="width: 11%; text-align: right" title="Total contract with customer"&gt;1,333,333&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zYCijRiOKDae" style="width: 11%; text-align: right" title="Total contract with customer"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Earn-out Liability - Lixoft&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zcPF0mZJV035" style="text-align: right" title="Total contract with customer"&gt;4,730,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zbVdJZcSIkt" style="text-align: right" title="Total contract with customer"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Earn-out Liability - Dilisym&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zr63wDRbjKu7" style="border-bottom: Black 1pt solid; text-align: right" title="Total contract with customer"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zBzDvLHfQomf" style="border-bottom: Black 1pt solid; text-align: right" title="Total contract with customer"&gt;1,761,028&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Sub Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ContractWithCustomerLiability_c20200831_pp0p0" style="text-align: right" title="Total contract with customer"&gt;6,063,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ContractWithCustomerLiability_c20190831_pp0p0" style="text-align: right" title="Total contract with customer"&gt;1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Current Portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ContractsPayableCurrent_iI_pp0p0_c20200831_zqRAm4D7al37" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Current Portion"&gt;2,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ContractsPayableCurrent_iI_pp0p0_c20190831_zno9uBoiCO5k" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Current Portion"&gt;1,761,028&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Long-Term&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ContractsPayableNoncurrent_iI_pp0p0_c20200831_zPVMD6c1oMi4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term"&gt;4,063,833&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ContractsPayableNoncurrent_iI_pp0p0_d0_c20190831_zuUCoc68wCn4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherLiabilitiesTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--OtherLiabilitiesTableTextBlock_zmP989z4S3jh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTRACTS PAYABLE (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B3_zIUlL5BCIDJ1" style="display: none"&gt;Schedule of Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: justify"&gt;Holdback Liability - Lixoft&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zdDXDKhB3mZh" style="width: 11%; text-align: right" title="Total contract with customer"&gt;1,333,333&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zYCijRiOKDae" style="width: 11%; text-align: right" title="Total contract with customer"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Earn-out Liability - Lixoft&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zcPF0mZJV035" style="text-align: right" title="Total contract with customer"&gt;4,730,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zbVdJZcSIkt" style="text-align: right" title="Total contract with customer"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Earn-out Liability - Dilisym&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zr63wDRbjKu7" style="border-bottom: Black 1pt solid; text-align: right" title="Total contract with customer"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zBzDvLHfQomf" style="border-bottom: Black 1pt solid; text-align: right" title="Total contract with customer"&gt;1,761,028&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Sub Total&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ContractWithCustomerLiability_c20200831_pp0p0" style="text-align: right" title="Total contract with customer"&gt;6,063,833&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ContractWithCustomerLiability_c20190831_pp0p0" style="text-align: right" title="Total contract with customer"&gt;1,761,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Less: Current Portion&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ContractsPayableCurrent_iI_pp0p0_c20200831_zqRAm4D7al37" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Current Portion"&gt;2,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ContractsPayableCurrent_iI_pp0p0_c20190831_zno9uBoiCO5k" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Current Portion"&gt;1,761,028&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Long-Term&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ContractsPayableNoncurrent_iI_pp0p0_c20200831_zPVMD6c1oMi4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term"&gt;4,063,833&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_ecustom--ContractsPayableNoncurrent_iI_pp0p0_d0_c20190831_zuUCoc68wCn4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:OtherLiabilitiesTableTextBlock>
    <simu:ContractsPayable
      contextRef="AsOf2020-08-31_custom_HoldbackLiabilityLixoftMember"
      decimals="0"
      unitRef="USD">1333333</simu:ContractsPayable>
    <simu:ContractsPayable
      contextRef="AsOf2019-08-31_custom_HoldbackLiabilityLixoftMember"
      decimals="0"
      unitRef="USD">0</simu:ContractsPayable>
    <simu:ContractsPayable
      contextRef="AsOf2020-08-31_custom_EarnoutLiabilityLixoftMember"
      decimals="0"
      unitRef="USD">4730500</simu:ContractsPayable>
    <simu:ContractsPayable
      contextRef="AsOf2019-08-31_custom_EarnoutLiabilityLixoftMember"
      decimals="0"
      unitRef="USD">0</simu:ContractsPayable>
    <simu:ContractsPayable
      contextRef="AsOf2020-08-31_custom_EarnoutLiabilityDilisymMember"
      decimals="0"
      unitRef="USD">0</simu:ContractsPayable>
    <simu:ContractsPayable
      contextRef="AsOf2019-08-31_custom_EarnoutLiabilityDilisymMember"
      decimals="0"
      unitRef="USD">1761028</simu:ContractsPayable>
    <us-gaap:ContractWithCustomerLiability contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">6063833</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">1761028</us-gaap:ContractWithCustomerLiability>
    <simu:ContractsPayableCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">2000000</simu:ContractsPayableCurrent>
    <simu:ContractsPayableCurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">1761028</simu:ContractsPayableCurrent>
    <simu:ContractsPayableNoncurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">4063833</simu:ContractsPayableNoncurrent>
    <simu:ContractsPayableNoncurrent contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</simu:ContractsPayableNoncurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_ziW0IEDTohJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 7 - &lt;span id="xdx_820_z05mb5RXPU4"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We lease approximately 13,500 square feet
of space in Lancaster, California. The original lease had a five-year term with two, three-year options to extend. The initial
five-year term expired in February 2011, and we extended the lease to February 2, 2014. In June 2013, the lease was amended to
extend the term to February 2, 2017. The amended lease also provides for an annual base rent increase of 3% per year and two, two-year
options to extend. In May 2016 the Company exercised the two, two-year options extending the term of the lease through February
2, 2021 at a fixed rate of $25,000 per month. The new extension agreement allowed the Company with 90 days&#x2019; notice to opt
out of the remaining lease in the last two years of the term upon payment of a recapture payment equal to the 3% base payment increase
that would have been due under the original agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our Buffalo subsidiary leases approximately
12,623 square feet of space in Buffalo, New York. The initial five-year term expired in October 2018; and was renewed for a three-year
option to extending it to November 2021. The new base rent is $16,147 per month.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;DILIsym leases approximately 2,700 square
feet of space in Research Triangle Park, North Carolina. The initial three-year term was due to expire October 2020. An amendment
to the initial lease became effective April 1, 2020. This amendment added 686 square feet and extended the term of the lease to
September 30, 2023. The new base rent is approximately $7,500 per month with an annual 3% adjustment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In Paris, France Lixoft leases approximately
2,300 square feet of office space, which as of April 1, 2020, had minimum payments equaling $288,000. The lease is for a 9-year
term, with an option to terminate every 3 years, and expires in November of 2024. The rent is $16,555 per quarter and can be adjusted
each December based on a consumer price index.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Rent expense, including common area maintenance
fees for the years ended August 31, 2020, 2019 and 2018 was $&lt;span id="xdx_90A_eus-gaap--OperatingLeaseExpense_c20190901__20200831_pp0p0" title="Rent expense"&gt;644,000&lt;/span&gt;, $&lt;span id="xdx_901_eus-gaap--OperatingLeaseExpense_c20180901__20190831_pp0p0" title="Rent expense"&gt;584,000&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20170901__20180831_pp0p0" title="Rent expense"&gt;567,000&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Future minimum lease payments under non-cancelable
operating leases with remaining terms of one year or more at August 31, 2020 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zwFpebZzQH0i" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zU4P7VpsUZgk" style="display: none"&gt;Future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20200831_zCQu7tjBUsOj" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ending August 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0_maOLFMPzcU7_z9LUrgXv9M8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 33%; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;486,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0_maOLFMPzcU7_zNQr2PI4G4z3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;217,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0_maOLFMPzcU7_zKwWOoiB0PSk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;172,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0_maOLFMPzcU7_z1Q0If2dy0cb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_pp0p0_maOLFMPzcU7_zsICFrla2TX8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0_mtOLFMPzcU7_zq3lZfs7ArKf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: hidden; text-align: center; padding-bottom: 2.5pt"&gt;Future minimum lease payments&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;961,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Line of Credit&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 31, 2020, Simulations Plus,
Inc. entered into a Credit Agreement with Wells Fargo Bank, N.A. The Credit Agreement, has provided Simulations Plus, Inc.
with a credit facility of $&lt;span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20200331__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_pp0p0" title="Line of credit maximum amount"&gt;3,500,000&lt;/span&gt;
through &lt;span id="xdx_90E_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20190901__20200331__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_zce35qmoJiLh" title="Line of credit expiration date"&gt;April
15, 2022&lt;/span&gt;. As of August 31, 2020, there were no amounts drawn against the line of credit. Interest accrues daily at the
bank&#x2019;s base rate. The base rate is the rate equal to the highest of (i) the Prime Rate in effect, (ii) 1.5% above Daily
One Month LIBOR, and (iii) the Federal Funds Rate plus 1.5%. The rate at August 31, 2020 was 3.25%. Under the terms of the
agreement the borrower is to maintain a &lt;span title="Line of credit amount outstanding"&gt;zero &lt;span id="xdx_90A_eus-gaap--LineOfCredit_iI_pp0p0_do_c20200831__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_zzzcvRAi7gX" style="display: none" title="Line of credit amount outstanding"&gt;No&lt;/span&gt;&lt;/span&gt;
balance under this line of credit for a period of thirty consecutive days during each 12-month period commencing March 31,
2020. The Credit Agreement is collateralized by the assets of Simulations Plus Lancaster Division and is subject to certain
financial covenants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Employment Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In the normal course of business the Company
has entered into employment agreements with certain of its key management personnel that may require compensation payments upon
termination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;License Agreement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company had a royalty agreement with
Dassault Syst&#xe8;mes Americas Corp. for access to their Metabolite Database for developing our Metabolite Module within ADMET
Predictor&#x2122;. The module was renamed the Metabolism Module when we released ADMET Predictor version 6 on April 19, 2012. Under
this agreement, we pay a royalty of 25% of revenue derived from the sale of the Metabolism/Metabolite module. This agreement was
recently renegotiated, and the Company does not bear any royalty obligations towards Dassault Syst&#xe8;mes Americas Corp. effective
as of June 30, 2019. In addition, the license agreement terminated on September 5, 2020. Under this agreement for the years ended
August 31, 2020, 2019 and 2018 we incurred royalty expense (benefit) of $&lt;span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20190901__20200831_zgSI0OgHz4a4" title="Royalties expense"&gt;(26,055)&lt;/span&gt;, $&lt;span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20180901__20190831_zIrj4rKBx96j" title="Royalties expense"&gt;195,828&lt;/span&gt; and $&lt;span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20170901__20180831_zFDxrye0Ex84" title="Royalties expense"&gt;175,740&lt;/span&gt;, respectively. The Company
is in the process of replacing the database.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Litigation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We are not a party to any legal proceedings
and are not aware of any pending legal proceedings of any kind.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">644000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">584000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">567000</us-gaap:OperatingLeaseExpense>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zwFpebZzQH0i" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zU4P7VpsUZgk" style="display: none"&gt;Future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20200831_zCQu7tjBUsOj" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Years Ending August 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0_maOLFMPzcU7_z9LUrgXv9M8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 33%; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 13%; text-align: right"&gt;486,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0_maOLFMPzcU7_zNQr2PI4G4z3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;217,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0_maOLFMPzcU7_zKwWOoiB0PSk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;172,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0_maOLFMPzcU7_z1Q0If2dy0cb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_pp0p0_maOLFMPzcU7_zsICFrla2TX8" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;11,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0_mtOLFMPzcU7_zq3lZfs7ArKf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="visibility: hidden; text-align: center; padding-bottom: 2.5pt"&gt;Future minimum lease payments&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;961,000&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">486000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">217000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">172000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">75000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">11000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">961000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2020-03-31_custom_WellsFargoMember"
      decimals="0"
      unitRef="USD">3500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2019-09-012020-03-31_custom_WellsFargoMember">2022-04-15</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCredit
      contextRef="AsOf2020-08-31_custom_WellsFargoMember"
      decimals="0"
      unitRef="USD">0</us-gaap:LineOfCredit>
    <simu:RoyaltyExpenses
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">-26055</simu:RoyaltyExpenses>
    <simu:RoyaltyExpenses
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">195828</simu:RoyaltyExpenses>
    <simu:RoyaltyExpenses
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">175740</simu:RoyaltyExpenses>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zsQqEUnKsSkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 8 - &lt;span id="xdx_821_z7BjDRZPCPwe"&gt;SHAREHOLDERS' EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Dividend &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s Board of Directors
declared cash dividends during fiscal year 2020, 2019 and 2018. The details of dividend paid are in the following tables:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDividendsPayableTextBlock_zYXn5OwzWm9f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B5_zwwsUCr2hev7" style="display: none"&gt;Schedule of dividends declared and paid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="15" style="font-weight: bold; text-align: center"&gt;FY2018&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Record Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Distribution Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of Shares&lt;br/&gt; Outstanding on&lt;br/&gt; Record Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Dividend per&lt;br/&gt; Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 27%; text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" title="Record Date"&gt;11/13/2017&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" style="width: 26%; text-align: center" title="Distribution Date"&gt;11/20/2017&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,284,792&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" style="width: 11%; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount"&gt;1,037,088&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_909_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" title="Record Date"&gt;1/26/2018&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" style="text-align: center" title="Distribution Date"&gt;2/02/2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,317,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,039,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" title="Record Date"&gt;4/25/2018&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" style="text-align: center" title="Distribution Date"&gt;5/02/2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,354,005&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,041,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" title="Record Date"&gt;7/26/2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date"&gt;8/02/2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,405,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount"&gt;1,044,347&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Dividends_c20170901__20180831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount"&gt;4,161,740&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;FY2019&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Record Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Distribution Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of Shares&lt;br/&gt; Outstanding on&lt;br/&gt; Record Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Dividend per&lt;br/&gt; Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 27%; text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" title="Record Date"&gt;11/01/2018&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" style="width: 26%; text-align: center" title="Distribution Date"&gt;11/08/2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,417,875&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" style="width: 11%; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount"&gt;1,045,073&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" title="Record Date"&gt;1/25/2019&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" style="text-align: center" title="Distribution Date"&gt;2/01/2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,481,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,048,887&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" title="Record Date"&gt;4/24/2019&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" style="text-align: center" title="Distribution Date"&gt;5/01/2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,515,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,050,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" title="Record Date"&gt;7/25/2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date"&gt;8/01/2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,536,454&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount"&gt;1,052,181&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Dividends_c20180901__20190831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount"&gt;4,197,055&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;FY2020&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Record Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Distribution Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of Shares&lt;br/&gt; Outstanding on&lt;br/&gt; Record Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Dividend per&lt;br/&gt; Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 27%; text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" title="Record Date"&gt;10/25/2019&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" style="width: 26%; text-align: center" title="Distribution Date"&gt;11/01/2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,606,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" style="width: 11%; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount"&gt;1,056,379&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" title="Record Date"&gt;1/27/2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" style="text-align: center" title="Distribution Date"&gt;2/03/2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,645,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,058,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" title="Record Date"&gt;4/24/2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" style="text-align: center" title="Distribution Date"&gt;5/01/2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,769,134&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,066,148&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" title="Record Date"&gt;7/27/2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date"&gt;8/03/2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,820,057&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount"&gt;1,069,203&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Dividends_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount"&gt;4,250,470&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zolEj0uCF6w8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Although dividend distributions are currently
expected to continue on a quarterly basis, the Company&#x2019;s Board of Directors reserves the right to discontinue the dividend
distribution any time.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Stock Option Plan&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 23, 2007, the Board of Directors
adopted, and the shareholders approved, the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had
been reserved for issuance. On February 25, 2014 the shareholders approved an additional 1,000,000 shares increasing the total
number of shares that may be granted under the Option Plan to 2,000,000. This plan terminated in February 2017 by its term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 23, 2016 the Board of Directors
adopted, and on February 23, 2017 the shareholders approved, the 2017 Equity Incentive Plan under which a total of &lt;span id="xdx_90F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pii_c20200831__us-gaap--PlanNameAxis__custom--Equity2017IncentivePlanMember_zmp3voatPznc" title="Common stock reserved for issuance under the plan"&gt;1,000,000&lt;/span&gt; shares
of common stock has been reserved for issuance. This plan will terminate in &lt;span title="Equity plan termination date"&gt;December 2026&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of August 31, 2020, employees and directors
hold stock options to purchase 1,223,661 shares of common stock at exercise prices ranging from $6.75 to $61.84 per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes information
about stock options:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zSr229JwgMK" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span id="xdx_8B7_zAN0GhH22zpg" style="display: none"&gt;Schedule of stock option activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Transactions in FY18&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of&lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%"&gt;Outstanding, August 31, 2017&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEmJKLz0jDak" style="width: 11%; text-align: right" title="Option outstanding, beginning balance"&gt;1,249,126&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqZvx2UgdR4f" style="width: 11%; text-align: right" title="Outstanding"&gt;8.51&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OutstandingRemainingContractualLife_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zl3sQ6c8ZNv4" style="width: 11%; text-align: right" title="Outstanding, beginning of period"&gt;7.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZeGbhUIA3Ie" style="text-align: right" title="Granted"&gt;52,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;22.36&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfdHMQEFvLOf" style="text-align: right" title="Exercised"&gt;(130,006&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised"&gt;5.97&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Canceled/Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1CCY01E1Ei7" style="text-align: right" title="Canceled/Forfeited"&gt;(30,144&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited"&gt;9.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z74F6X7O9K5h" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;(6,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;5.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, August 31, 2018&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaIyp400GGif" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, ending balance"&gt;1,134,976&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpYo4tgysgU9" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding"&gt;9.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAJq5Md5lLd1" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period"&gt;7.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Vested and Exercisable, August 31, 2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8uNDYErUvQe" style="text-align: right" title="Vested and Exercisable, end of period"&gt;483,696&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPmTRz5nZlv7" style="text-align: right" title="Vested and Exercisable, end of period"&gt;7.79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDGEoaKkCZae" style="text-align: right" title="Vested and Exercisable"&gt;6.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vested and Expected to Vest, August 31, 2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zze8rqGw8XUb" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;1,069,807&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJgbTPCiBn38" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;9.35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z25uFgz35HD1" style="text-align: right" title="Vested and Expected to Vest"&gt;7.26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Transactions in FY19&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of&lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%"&gt;Outstanding, August 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5tiSbVHNHQ1" style="width: 11%; text-align: right" title="Option outstanding, beginning balance"&gt;1,134,976&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuNgDguDPFJe" style="width: 11%; text-align: right" title="Outstanding"&gt;9.44&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--OutstandingRemainingContractualLife_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zD4mZtpPQaA5" style="width: 11%; text-align: right" title="Outstanding, beginning of period"&gt;7.31&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;263,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;22.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0tul9S7E3z1" style="text-align: right" title="Exercised"&gt;(166,703&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised"&gt;7.15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Canceled/Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXwRjy9aqy1i" style="text-align: right" title="Canceled/Forfeited"&gt;(68,514&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited"&gt;12.17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1539"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1541"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, August 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyUPwLwkZob1" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards Outstanding, ending balance"&gt;1,163,259&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWmBv4a6At8j" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding"&gt;12.63&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zK0zy9D79jIl" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period"&gt;7.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Vested and Exercisable, August 31, 2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znG6VYz2SlH5" style="text-align: right" title="Vested and Exercisable, end of period"&gt;515,394&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfXkUtlWsXEe" style="text-align: right" title="Vested and Exercisable, end of period"&gt;8.57&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDfas0zUwvOj" style="text-align: right" title="Vested and Exercisable"&gt;6.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vested and Expected to Vest, August 31, 2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zczJzIX8cWB3" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;1,101,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zoOfywrKUdhd" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;12.39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqPPJ0FIpf0f" style="text-align: right" title="Vested and Expected to Vest"&gt;7.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Transactions in FY20&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of&lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%"&gt;Outstanding, August 31, 2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfwOBZP38bxa" style="width: 11%; text-align: right" title="Option outstanding, beginning balance"&gt;1,163,259&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zmjiDHvEm9nh" style="width: 11%; text-align: right" title="Outstanding"&gt;12.63&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OutstandingRemainingContractualLife_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXj9Bfgi1CYh" style="width: 11%; text-align: right" title="Outstanding, beginning of period"&gt;7.13&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;223,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;39.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zItDmrTb6cn5" style="text-align: right" title="Exercised"&gt;(121,647&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised"&gt;9.29&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Canceled/Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfnRZ3cit0Og" style="text-align: right" title="Canceled/Forfeited"&gt;(40,951&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited"&gt;14.19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1579"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1581"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, August 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrsDghe0G1o2" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards Outstanding, ending balance"&gt;1,223,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuwytd9hDha9" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding"&gt;17.76&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zRiA6Cw8x8ab" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period"&gt;6.79&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Vested and Exercisable, August 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqA24fEGqDMa" style="text-align: right" title="Vested and Exercisable, end of period"&gt;596,311&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0hy42e5eOR2" style="text-align: right" title="Vested and Exercisable, end of period"&gt;10.69&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z97XlNuraP17" style="text-align: right" title="Vested and Exercisable"&gt;5.59&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vested and Expected to Vest, August 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfCoaGynvyS4" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;1,194,239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpvw61my3nP5" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;17.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvoPhIIhYss9" style="text-align: right" title="Vested and Expected to Vest"&gt;6.77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A4_zrmavE32Mks9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Intrinsic Value of options outstanding and options exercisable&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_zZvHpp2Iyuo" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BC_zw3Qq8hTf1wl" style="display: none"&gt;Intrinsic Value of options outstanding and options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Intrinsic Value&lt;br/&gt; of Options&lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Intrinsic&lt;br/&gt; Value of &lt;br/&gt; Options&lt;br/&gt; Exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Intrinsic &lt;br/&gt; Value of&lt;br/&gt; Options&lt;br/&gt; Exercised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%"&gt;FY18&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Outstanding"&gt;13,064,884&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Exercisable"&gt;6,315,086&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Exercised"&gt;1,495,313&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;FY19&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Outstanding"&gt;27,312,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercisable"&gt;14,194,724&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercised"&gt;3,224,454&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;FY20&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Outstanding"&gt;51,272,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercisable"&gt;29,150,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercised"&gt;4,085,753&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zCGlJu08KFZ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The weighted-average remaining contractual
life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified SO, was &lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zBhm4J4yox96" title="Weighted average remaining contractual life"&gt;6.79&lt;/span&gt; years at August 31, 2020.
The total fair value of non-vested stock options as of August 31, 2020 was $&lt;span id="xdx_90C_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pp0p0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNVGLtYjHq27" title="Fair value of non-vested options"&gt;22,122,054&lt;/span&gt; and is amortizable over a weighted average
period of &lt;span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEHuW7CinWU1" title="Fair value amortization period"&gt;3.39&lt;/span&gt; years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;













&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;The
fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model. The Black-Scholes
option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions
and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including
the expected stock price volatility. Because our stock options have characteristics significantly different from those of traded
options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's
opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its stock options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"&gt;The following table summarizes
the fair value of the options, including both ISOs and NQSOs, granted during the current fiscal year 2020 and fiscal year 2019:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_znYDjjsdi7f3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zqwPDquoB8v" style="display: none"&gt;Schedule of fair value of options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20190901__20200831_zvzmEAwEbUs8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20180901__20190831_zsycPpqRHxNh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;FY 2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;FY 2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--FairValueOptionsGranted_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Estimated fair value of awards granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;2,997,120&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,928,820&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_dp_z0I9GPJv0zMd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Unvested Forfeiture Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.20%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_i_pii" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted average grant price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;39.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;22.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--WeightedAverageMarketPrice_i_pii" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average market price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;39.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;22.69&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_zd4EBYOt8dfh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted average volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33.56%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31.61%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_zKQYAbPzJk37" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.39%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.59%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_znRMoWL42Moa" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted average dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.65%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.10%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20190901__20200831_zcTIMfsoCyM5" title="Weighted average expected life"&gt;6.67&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20180901__20190831_zYfunD3yDYn4" title="Weighted average expected life"&gt;6.64&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A8_zjnEgW8tDcdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The exercise prices for the options outstanding
at August 31, 2020 ranged from $6.75 to $61.84, and the information relating to these options is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zwYNb1ixCUm9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zU4aeSWAm19l" style="display: none"&gt;Schedule of options by exercise price range&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Awards Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Awards Exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quantity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted &lt;br/&gt; Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual&lt;br/&gt; Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quantity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual &lt;br/&gt; Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Exercise price low"&gt;6.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Exercise price high"&gt;8.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards outstanding"&gt;177,730&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zYAgfXhLp8Ee" title="Awards outstanding weighted average remaining contractual life"&gt;4.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards outstanding weighted average exercise price"&gt;6.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards exercisable"&gt;177,730&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zLHJiQHfJld" title="Awards exercisable weighted average remaining contractual life"&gt;4.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards exercisable weighted average exercise price"&gt;6.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Exercise price low"&gt;8.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Exercise price high"&gt;16.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards outstanding"&gt;547,901&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zUXqLed3JHo1" title="Awards outstanding weighted average remaining contractual life"&gt;6.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price"&gt;9.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards exercisable"&gt;350,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zKjm2Zf3Jfo3" title="Awards exercisable weighted average remaining contractual life"&gt;6.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price"&gt;9.97&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Exercise price low"&gt;16.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Exercise price high"&gt;24.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards outstanding"&gt;230,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_ztnBAqKE8ai2" title="Awards outstanding weighted average remaining contractual life"&gt;7.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price"&gt;20.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards exercisable"&gt;50,560&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_zTqdaOALFxM7" title="Awards exercisable weighted average remaining contractual life"&gt;7.2&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price"&gt;21.18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Exercise price low"&gt;24.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Exercise price high"&gt;38.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards outstanding"&gt;204,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zlKX79epvqOa" title="Awards outstanding weighted average remaining contractual life"&gt;9.1&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price"&gt;33.45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards exercisable"&gt;17,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zA6ylx0XQ703" title="Awards exercisable weighted average remaining contractual life"&gt;8.9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price"&gt;34.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Exercise price low"&gt;38.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Exercise price high"&gt;52.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Awards outstanding"&gt;19,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zJU0o2pDpEO5" title="Awards outstanding weighted average remaining contractual life"&gt;9.6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price"&gt;38.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zpz92DykdhW" style="text-align: right" title="Awards exercisable"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zniP2siXJeXk" style="text-align: right" title="Awards exercisable weighted average exercise price"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Exercise price low"&gt;52.01&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Exercise price high"&gt;61.84&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Awards outstanding"&gt;43,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zTkUdVyurq8h" title="Awards outstanding weighted average remaining contractual life"&gt;9.9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Awards outstanding weighted average exercise price"&gt;61.84&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zT7mHUedCxAa" style="border-bottom: Black 1pt solid; text-align: right" title="Awards exercisable"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zGi5unlxX5Eg" style="padding-bottom: 1pt; text-align: right" title="Awards exercisable weighted average exercise price"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards outstanding"&gt;1,223,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z56sDULWgo2g" title="Awards outstanding weighted average remaining contractual life"&gt;6.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="padding-bottom: 2.5pt; text-align: right" title="Awards outstanding weighted average exercise price"&gt;17.76&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards exercisable"&gt;596,311&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDOY9JpQkOe8" title="Awards exercisable weighted average remaining contractual life"&gt;5.6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="padding-bottom: 2.5pt; text-align: right" title="Awards exercisable weighted average exercise price"&gt;10.69&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zkS872X5dTVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Follow-on Public Offering&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In August 2020, the company closed an
underwritten public offering of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190901__20200831_zRppK3jiVJt" title="Shares issued under public offering"&gt;2,090,909&lt;/span&gt;
shares of its common stock to the public at $&lt;span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20200831_zFv4QnpxOAS2" title="Shares issued price per share"&gt;55.00&lt;/span&gt;
per share, which included the full exercise of the underwriters&#x2019; option to purchase 272,727 additional shares of common
stock. The aggregate gross proceeds to the company from this offering were approximately $&lt;span title="Proceeds from public offering"&gt;115&lt;/span&gt;
million, before deducting underwriting discounts and commissions; net proceeds were approximately $&lt;span title="Proceeds from public offering"&gt;107.7&lt;/span&gt;
million &lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_dm_c20190901__20200831_zkqECWzRjuUf" style="display: none" title="Proceeds from public offering"&gt;107,747,338&lt;/span&gt;. The offering was made pursuant to the Company&#x2019;s automatic shelf registration statement on Form S-3 filed with
the Securities and Exchange Commission on July 9, 2020.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfDividendsPayableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDividendsPayableTextBlock_zYXn5OwzWm9f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B5_zwwsUCr2hev7" style="display: none"&gt;Schedule of dividends declared and paid&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="15" style="font-weight: bold; text-align: center"&gt;FY2018&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Record Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Distribution Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of Shares&lt;br/&gt; Outstanding on&lt;br/&gt; Record Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Dividend per&lt;br/&gt; Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 27%; text-align: center"&gt;&lt;span id="xdx_908_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" title="Record Date"&gt;11/13/2017&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" style="width: 26%; text-align: center" title="Distribution Date"&gt;11/20/2017&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,284,792&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" style="width: 11%; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount"&gt;1,037,088&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_909_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" title="Record Date"&gt;1/26/2018&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" style="text-align: center" title="Distribution Date"&gt;2/02/2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,317,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,039,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_90A_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" title="Record Date"&gt;4/25/2018&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" style="text-align: center" title="Distribution Date"&gt;5/02/2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,354,005&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,041,240&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" title="Record Date"&gt;7/26/2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date"&gt;8/02/2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,405,775&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount"&gt;1,044,347&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Dividends_c20170901__20180831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount"&gt;4,161,740&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;FY2019&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Record Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Distribution Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of Shares&lt;br/&gt; Outstanding on&lt;br/&gt; Record Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Dividend per&lt;br/&gt; Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 27%; text-align: center"&gt;&lt;span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" title="Record Date"&gt;11/01/2018&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" style="width: 26%; text-align: center" title="Distribution Date"&gt;11/08/2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,417,875&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" style="width: 11%; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount"&gt;1,045,073&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" title="Record Date"&gt;1/25/2019&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" style="text-align: center" title="Distribution Date"&gt;2/01/2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,481,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,048,887&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" title="Record Date"&gt;4/24/2019&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" style="text-align: center" title="Distribution Date"&gt;5/01/2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,515,228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,050,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" title="Record Date"&gt;7/25/2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date"&gt;8/01/2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,536,454&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount"&gt;1,052,181&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Dividends_c20180901__20190831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount"&gt;4,197,055&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;FY2020&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Record Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Distribution Date&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of Shares&lt;br/&gt; Outstanding on&lt;br/&gt; Record Date&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Dividend per&lt;br/&gt; Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 27%; text-align: center"&gt;&lt;span id="xdx_904_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" title="Record Date"&gt;10/25/2019&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" style="width: 26%; text-align: center" title="Distribution Date"&gt;11/01/2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,606,314&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" style="width: 11%; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount"&gt;1,056,379&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" title="Record Date"&gt;1/27/2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" style="text-align: center" title="Distribution Date"&gt;2/03/2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,645,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,058,740&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;&lt;span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" title="Record Date"&gt;4/24/2020&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" style="text-align: center" title="Distribution Date"&gt;5/01/2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,769,134&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" style="text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pp0p0" style="text-align: right" title="Total Amount"&gt;1,066,148&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center; padding-bottom: 1pt"&gt;&lt;span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" title="Record Date"&gt;7/27/2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date"&gt;8/03/2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date"&gt;17,820,057&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share"&gt;0.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount"&gt;1,069,203&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Dividends_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount"&gt;4,250,470&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfDividendsPayableTextBlock>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member">2017-11-13</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member">2017-11-20</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member"
      decimals="INF"
      unitRef="Shares">17284792</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2017-09-012018-08-31_custom_RecordDate20181Member"
      decimals="0"
      unitRef="USD">1037088</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member">2018-01-26</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member">2018-02-02</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member"
      decimals="INF"
      unitRef="Shares">17317752</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2017-09-012018-08-31_custom_RecordDate20182Member"
      decimals="0"
      unitRef="USD">1039065</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member">2018-04-25</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member">2018-05-02</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member"
      decimals="INF"
      unitRef="Shares">17354005</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2017-09-012018-08-31_custom_RecordDate20183Member"
      decimals="0"
      unitRef="USD">1041240</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member">2018-07-26</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member">2018-08-02</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member"
      decimals="INF"
      unitRef="Shares">17405775</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2017-09-012018-08-31_custom_RecordDate20184Member"
      decimals="0"
      unitRef="USD">1044347</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">4161740</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member">2018-11-01</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member">2018-11-08</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member"
      decimals="INF"
      unitRef="Shares">17417875</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2018-09-012019-08-31_custom_RecordDate20191Member"
      decimals="0"
      unitRef="USD">1045073</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member">2019-01-25</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member">2019-02-01</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member"
      decimals="INF"
      unitRef="Shares">17481450</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2018-09-012019-08-31_custom_RecordDate20192Member"
      decimals="0"
      unitRef="USD">1048887</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member">2019-04-24</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member">2019-05-01</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member"
      decimals="INF"
      unitRef="Shares">17515228</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2018-09-012019-08-31_custom_RecordDate20193Member"
      decimals="0"
      unitRef="USD">1050914</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member">2019-07-25</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member">2019-08-01</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member"
      decimals="INF"
      unitRef="Shares">17536454</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2018-09-012019-08-31_custom_RecordDate20194Member"
      decimals="0"
      unitRef="USD">1052181</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">4197055</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member">2019-10-25</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member">2019-11-01</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member"
      decimals="INF"
      unitRef="Shares">17606314</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2019-09-012020-08-31_custom_RecordDate20201Member"
      decimals="0"
      unitRef="USD">1056379</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member">2020-01-27</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member">2020-02-03</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member"
      decimals="INF"
      unitRef="Shares">17645639</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2019-09-012020-08-31_custom_RecordDate20202Member"
      decimals="0"
      unitRef="USD">1058740</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member">2020-04-24</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member">2020-05-01</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member"
      decimals="INF"
      unitRef="Shares">17769134</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2019-09-012020-08-31_custom_RecordDate20203Member"
      decimals="0"
      unitRef="USD">1066148</us-gaap:Dividends>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member">2020-07-27</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member">2020-08-03</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate
      contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member"
      decimals="INF"
      unitRef="Shares">17820057</simu:WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member"
      decimals="INF"
      unitRef="USDPShares">0.06</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends
      contextRef="From2019-09-012020-08-31_custom_RecordDate20204Member"
      decimals="0"
      unitRef="USD">1069203</us-gaap:Dividends>
    <us-gaap:Dividends
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">4250470</us-gaap:Dividends>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2020-08-31_custom_Equity2017IncentivePlanMember"
      decimals="INF"
      unitRef="Shares">1000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zSr229JwgMK" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;&lt;span id="xdx_8B7_zAN0GhH22zpg" style="display: none"&gt;Schedule of stock option activity&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Transactions in FY18&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of&lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%"&gt;Outstanding, August 31, 2017&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEmJKLz0jDak" style="width: 11%; text-align: right" title="Option outstanding, beginning balance"&gt;1,249,126&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqZvx2UgdR4f" style="width: 11%; text-align: right" title="Outstanding"&gt;8.51&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OutstandingRemainingContractualLife_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zl3sQ6c8ZNv4" style="width: 11%; text-align: right" title="Outstanding, beginning of period"&gt;7.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZeGbhUIA3Ie" style="text-align: right" title="Granted"&gt;52,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;22.36&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfdHMQEFvLOf" style="text-align: right" title="Exercised"&gt;(130,006&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised"&gt;5.97&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Canceled/Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1CCY01E1Ei7" style="text-align: right" title="Canceled/Forfeited"&gt;(30,144&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited"&gt;9.10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z74F6X7O9K5h" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;(6,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;5.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, August 31, 2018&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaIyp400GGif" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, ending balance"&gt;1,134,976&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpYo4tgysgU9" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding"&gt;9.44&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAJq5Md5lLd1" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period"&gt;7.31&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Vested and Exercisable, August 31, 2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8uNDYErUvQe" style="text-align: right" title="Vested and Exercisable, end of period"&gt;483,696&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPmTRz5nZlv7" style="text-align: right" title="Vested and Exercisable, end of period"&gt;7.79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDGEoaKkCZae" style="text-align: right" title="Vested and Exercisable"&gt;6.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vested and Expected to Vest, August 31, 2018&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zze8rqGw8XUb" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;1,069,807&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJgbTPCiBn38" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;9.35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z25uFgz35HD1" style="text-align: right" title="Vested and Expected to Vest"&gt;7.26&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Transactions in FY19&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of&lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%"&gt;Outstanding, August 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5tiSbVHNHQ1" style="width: 11%; text-align: right" title="Option outstanding, beginning balance"&gt;1,134,976&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuNgDguDPFJe" style="width: 11%; text-align: right" title="Outstanding"&gt;9.44&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--OutstandingRemainingContractualLife_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zD4mZtpPQaA5" style="width: 11%; text-align: right" title="Outstanding, beginning of period"&gt;7.31&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;263,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;22.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0tul9S7E3z1" style="text-align: right" title="Exercised"&gt;(166,703&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised"&gt;7.15&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Canceled/Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXwRjy9aqy1i" style="text-align: right" title="Canceled/Forfeited"&gt;(68,514&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited"&gt;12.17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1539"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1541"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, August 31, 2019&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyUPwLwkZob1" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards Outstanding, ending balance"&gt;1,163,259&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWmBv4a6At8j" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding"&gt;12.63&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zK0zy9D79jIl" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period"&gt;7.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Vested and Exercisable, August 31, 2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znG6VYz2SlH5" style="text-align: right" title="Vested and Exercisable, end of period"&gt;515,394&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfXkUtlWsXEe" style="text-align: right" title="Vested and Exercisable, end of period"&gt;8.57&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDfas0zUwvOj" style="text-align: right" title="Vested and Exercisable"&gt;6.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vested and Expected to Vest, August 31, 2019&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zczJzIX8cWB3" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;1,101,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zoOfywrKUdhd" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;12.39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqPPJ0FIpf0f" style="text-align: right" title="Vested and Expected to Vest"&gt;7.07&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Transactions in FY20&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Number of&lt;br/&gt; Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Exercise Price &lt;br/&gt; Per Share&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted-Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%"&gt;Outstanding, August 31, 2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfwOBZP38bxa" style="width: 11%; text-align: right" title="Option outstanding, beginning balance"&gt;1,163,259&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zmjiDHvEm9nh" style="width: 11%; text-align: right" title="Outstanding"&gt;12.63&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--OutstandingRemainingContractualLife_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXj9Bfgi1CYh" style="width: 11%; text-align: right" title="Outstanding, beginning of period"&gt;7.13&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;223,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted"&gt;39.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zItDmrTb6cn5" style="text-align: right" title="Exercised"&gt;(121,647&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised"&gt;9.29&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"&gt;Canceled/Forfeited&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfnRZ3cit0Og" style="text-align: right" title="Canceled/Forfeited"&gt;(40,951&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited"&gt;14.19&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Expired&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1579"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1581"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Outstanding, August 31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrsDghe0G1o2" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards Outstanding, ending balance"&gt;1,223,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuwytd9hDha9" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding"&gt;17.76&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zRiA6Cw8x8ab" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period"&gt;6.79&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Vested and Exercisable, August 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqA24fEGqDMa" style="text-align: right" title="Vested and Exercisable, end of period"&gt;596,311&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0hy42e5eOR2" style="text-align: right" title="Vested and Exercisable, end of period"&gt;10.69&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z97XlNuraP17" style="text-align: right" title="Vested and Exercisable"&gt;5.59&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Vested and Expected to Vest, August 31, 2020&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfCoaGynvyS4" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;1,194,239&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpvw61my3nP5" style="text-align: right" title="Vested and Expected to Vest, end of period"&gt;17.75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvoPhIIhYss9" style="text-align: right" title="Vested and Expected to Vest"&gt;6.77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2017-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1249126</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2017-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">8.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <simu:OutstandingRemainingContractualLife contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember">P7Y8M26D</simu:OutstandingRemainingContractualLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">52000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">22.36</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">130006</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">5.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">30144</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">9.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">5.06</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1134976</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">9.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember">P7Y3M21D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">483696</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">7.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember">P6Y5M23D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1069807</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">9.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember">P7Y3M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1134976</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">9.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <simu:OutstandingRemainingContractualLife contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember">P7Y3M21D</simu:OutstandingRemainingContractualLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">263500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">22.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">166703</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">7.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">68514</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1163259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember">P7Y1M17D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">515394</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">8.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember">P6Y1M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1101800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember">P7Y25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1163259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">12.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <simu:OutstandingRemainingContractualLife contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember">P7Y1M17D</simu:OutstandingRemainingContractualLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">223000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">39.23</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">121647</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">9.29</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">40951</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">14.19</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1223661</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">17.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember">P6Y9M14D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">596311</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember">P5Y7M2D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1194239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">17.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember">P6Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_zZvHpp2Iyuo" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span id="xdx_8BC_zw3Qq8hTf1wl" style="display: none"&gt;Intrinsic Value of options outstanding and options exercisable&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Intrinsic Value&lt;br/&gt; of Options&lt;br/&gt; Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Intrinsic&lt;br/&gt; Value of &lt;br/&gt; Options&lt;br/&gt; Exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Intrinsic &lt;br/&gt; Value of&lt;br/&gt; Options&lt;br/&gt; Exercised&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%"&gt;FY18&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Outstanding"&gt;13,064,884&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Exercisable"&gt;6,315,086&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Exercised"&gt;1,495,313&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;FY19&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Outstanding"&gt;27,312,742&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercisable"&gt;14,194,724&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercised"&gt;3,224,454&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;FY20&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Outstanding"&gt;51,272,966&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercisable"&gt;29,150,912&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercised"&gt;4,085,753&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">13064884</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2018-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">6315086</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2017-09-012018-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">1495313</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">27312742</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2019-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">14194724</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2018-09-012019-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">3224454</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">51272966</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">29150912</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">4085753</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <simu:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember">P6Y9M14D</simu:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="0"
      unitRef="USD">22122054</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember">P3Y4M20D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_znYDjjsdi7f3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zqwPDquoB8v" style="display: none"&gt;Schedule of fair value of options&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20190901__20200831_zvzmEAwEbUs8" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20180901__20190831_zsycPpqRHxNh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;FY 2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;FY 2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--FairValueOptionsGranted_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 70%; text-align: left"&gt;Estimated fair value of awards granted&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;2,997,120&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,928,820&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_dp_z0I9GPJv0zMd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Unvested Forfeiture Rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6.20%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_i_pii" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted average grant price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;39.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;22.78&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--WeightedAverageMarketPrice_i_pii" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average market price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;39.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;22.69&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_zd4EBYOt8dfh" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted average volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33.56%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31.61%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_zKQYAbPzJk37" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average risk-free rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.39%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2.59%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_znRMoWL42Moa" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Weighted average dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.65%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.10%&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Weighted average expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20190901__20200831_zcTIMfsoCyM5" title="Weighted average expected life"&gt;6.67&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20180901__20190831_zYfunD3yDYn4" title="Weighted average expected life"&gt;6.64&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <simu:FairValueOptionsGranted
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2997120</simu:FairValueOptionsGranted>
    <simu:FairValueOptionsGranted
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">1928820</simu:FairValueOptionsGranted>
    <simu:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0</simu:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <simu:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.0620</simu:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="USDPShares">39.23</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="USDPShares">22.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <simu:WeightedAverageMarketPrice
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="USDPShares">39.23</simu:WeightedAverageMarketPrice>
    <simu:WeightedAverageMarketPrice
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="USDPShares">22.69</simu:WeightedAverageMarketPrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.3356</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.3161</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.0139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.0259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.0065</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.0110</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2019-09-01to2020-08-31">P6Y8M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-09-012019-08-31">P6Y7M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zwYNb1ixCUm9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zU4aeSWAm19l" style="display: none"&gt;Schedule of options by exercise price range&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Exercise Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Awards Outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Awards Exercisable&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Low&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;High&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quantity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted &lt;br/&gt; Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual&lt;br/&gt; Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quantity&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Remaining&lt;br/&gt; Contractual &lt;br/&gt; Life&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Weighted&lt;br/&gt; Average&lt;br/&gt; Exercise&lt;br/&gt; Price&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Exercise price low"&gt;6.75&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Exercise price high"&gt;8.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards outstanding"&gt;177,730&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zYAgfXhLp8Ee" title="Awards outstanding weighted average remaining contractual life"&gt;4.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards outstanding weighted average exercise price"&gt;6.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards exercisable"&gt;177,730&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zLHJiQHfJld" title="Awards exercisable weighted average remaining contractual life"&gt;4.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards exercisable weighted average exercise price"&gt;6.85&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Exercise price low"&gt;8.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Exercise price high"&gt;16.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards outstanding"&gt;547,901&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zUXqLed3JHo1" title="Awards outstanding weighted average remaining contractual life"&gt;6.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price"&gt;9.98&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards exercisable"&gt;350,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zKjm2Zf3Jfo3" title="Awards exercisable weighted average remaining contractual life"&gt;6.0&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price"&gt;9.97&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Exercise price low"&gt;16.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Exercise price high"&gt;24.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards outstanding"&gt;230,280&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_ztnBAqKE8ai2" title="Awards outstanding weighted average remaining contractual life"&gt;7.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price"&gt;20.70&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards exercisable"&gt;50,560&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_zTqdaOALFxM7" title="Awards exercisable weighted average remaining contractual life"&gt;7.2&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price"&gt;21.18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Exercise price low"&gt;24.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Exercise price high"&gt;38.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards outstanding"&gt;204,950&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zlKX79epvqOa" title="Awards outstanding weighted average remaining contractual life"&gt;9.1&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price"&gt;33.45&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards exercisable"&gt;17,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zA6ylx0XQ703" title="Awards exercisable weighted average remaining contractual life"&gt;8.9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price"&gt;34.23&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Exercise price low"&gt;38.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Exercise price high"&gt;52.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Awards outstanding"&gt;19,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zJU0o2pDpEO5" title="Awards outstanding weighted average remaining contractual life"&gt;9.6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price"&gt;38.64&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zpz92DykdhW" style="text-align: right" title="Awards exercisable"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zniP2siXJeXk" style="text-align: right" title="Awards exercisable weighted average exercise price"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Exercise price low"&gt;52.01&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Exercise price high"&gt;61.84&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Awards outstanding"&gt;43,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zTkUdVyurq8h" title="Awards outstanding weighted average remaining contractual life"&gt;9.9&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Awards outstanding weighted average exercise price"&gt;61.84&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zT7mHUedCxAa" style="border-bottom: Black 1pt solid; text-align: right" title="Awards exercisable"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zGi5unlxX5Eg" style="padding-bottom: 1pt; text-align: right" title="Awards exercisable weighted average exercise price"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards outstanding"&gt;1,223,661&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z56sDULWgo2g" title="Awards outstanding weighted average remaining contractual life"&gt;6.8&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="padding-bottom: 2.5pt; text-align: right" title="Awards outstanding weighted average exercise price"&gt;17.76&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards exercisable"&gt;596,311&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDOY9JpQkOe8" title="Awards exercisable weighted average remaining contractual life"&gt;5.6&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="padding-bottom: 2.5pt; text-align: right" title="Awards exercisable weighted average exercise price"&gt;10.69&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member"
      decimals="INF"
      unitRef="USDPShares">6.75</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member"
      decimals="INF"
      unitRef="USDPShares">8.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member"
      decimals="INF"
      unitRef="Shares">177730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member"
      decimals="INF"
      unitRef="USDPShares">6.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member"
      decimals="INF"
      unitRef="Shares">177730</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price1Member">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price1Member"
      decimals="INF"
      unitRef="USDPShares">6.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member"
      decimals="INF"
      unitRef="USDPShares">8.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member"
      decimals="INF"
      unitRef="USDPShares">16.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member"
      decimals="INF"
      unitRef="Shares">547901</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member"
      decimals="INF"
      unitRef="USDPShares">9.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member"
      decimals="INF"
      unitRef="Shares">350721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price2Member">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price2Member"
      decimals="INF"
      unitRef="USDPShares">9.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member"
      decimals="INF"
      unitRef="USDPShares">16.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member"
      decimals="INF"
      unitRef="USDPShares">24.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member"
      decimals="INF"
      unitRef="Shares">230280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member">P7Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member"
      decimals="INF"
      unitRef="USDPShares">20.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member"
      decimals="INF"
      unitRef="Shares">50560</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price3Member">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price3Member"
      decimals="INF"
      unitRef="USDPShares">21.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member"
      decimals="INF"
      unitRef="USDPShares">24.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member"
      decimals="INF"
      unitRef="USDPShares">38.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member"
      decimals="INF"
      unitRef="Shares">204950</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member">P9Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member"
      decimals="INF"
      unitRef="USDPShares">33.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member"
      decimals="INF"
      unitRef="Shares">17300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price4Member">P8Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price4Member"
      decimals="INF"
      unitRef="USDPShares">34.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price5Member"
      decimals="INF"
      unitRef="USDPShares">38.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price5Member"
      decimals="INF"
      unitRef="USDPShares">52.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member"
      decimals="INF"
      unitRef="Shares">19800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price5Member">P9Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member"
      decimals="INF"
      unitRef="USDPShares">38.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price5Member"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price6Member"
      decimals="INF"
      unitRef="USDPShares">52.01</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price6Member"
      decimals="INF"
      unitRef="USDPShares">61.84</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member"
      decimals="INF"
      unitRef="Shares">43000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember_custom_Price6Member">P9Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member"
      decimals="INF"
      unitRef="USDPShares">61.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member"
      decimals="INF"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember_custom_Price6Member"
      decimals="INF"
      unitRef="USDPShares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">1223661</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember">P6Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">17.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="Shares">596311</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2019-09-012020-08-31_us-gaap_StockOptionMember">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2020-08-31_us-gaap_StockOptionMember"
      decimals="INF"
      unitRef="USDPShares">10.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Shares">2090909</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2020-08-31"
      decimals="INF"
      unitRef="USDPShares">55.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">107747338</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zqXIMdHYeqik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 9 - &lt;span id="xdx_821_zW29q5bloEtc"&gt;INCOME TAXES &lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We utilize FASB ASC 740-10, &lt;i&gt;&#x201c;Income
Taxes&#x201d;&lt;/i&gt; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences
of events that have been included in the financial statements or tax returns.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The components of the income tax provision
for fiscal year 2020, 2019 and 2018 were as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zMFfFcQt1xmg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax provision)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span id="xdx_8B7_zagOldVKEnd2" style="display: none"&gt;Components of the income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20190901__20200831_zsYtLRMf3OBk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20180901__20190831_zeGGgwkwikue" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20170901__20180831_zVeZB6h85yt3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zgXzb3eafgh1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; padding-left: 10pt"&gt;Federal&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;2,097,725&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,794,596&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;2,370,955&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zrEF9BuHWLX7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 10pt"&gt;State&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;477,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;426,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;460,619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zPmxairo0Us4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;39,038&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;51,285&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;104,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01T_pp0p0_mtCITEBzgOr_maITEBzYIH_zYSUWo71p3u6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 1pt"&gt;Total current tax expense (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,614,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,272,245&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,935,951&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zPDAa5MwzY3a" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(427,644&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(140,730&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,698,201&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zhjqJZaXPJ6k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;State&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(131,874&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(158,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33,620&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i01NT_pp0p0_di_mtDITATzwIq_maITEBzYIH_znxE5mdhb7E9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 1pt"&gt;Total deferred federal and state&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(559,518&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(299,098&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,731,821&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_i01T_pp0p0_mtITEBzYIH_zVNPzpxQZ4df" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,054,989&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,973,147&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,204,130&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zQSaklA9ztf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A reconciliation of the expected income
tax (benefit) computed using the federal statutory income tax rate to the Company's effective income tax rate is as follows for
fiscal year 2020, 2019 and 2018:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zwqw6tDO2oE6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Reconciliation)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B1_zeHlw3e1gyG1" style="display: none"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20190901__20200831_zFPXY8wYHiw" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20180901__20190831_zyR2udabmake" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20170901__20180831_zrqvTJHUFK8b" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_ziFhmue5SCxk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; text-align: justify"&gt;Income tax computed at federal statutory tax rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;25.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zDRpPq6iHdq4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;State taxes, net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_dp_zIis2XbHznzg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Meals &amp;amp; entertainment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_dp_zrqJXLlMHj01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Stock based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.2&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_zAcMWigEiG6l" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Other permanent differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pii_dpi_znSDn1apBFKl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Research and development credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pii_dp0_z827QgPMm06a" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Foreign tax related differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_pii_dp0_zF2T52Vq8bWl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Research &amp;amp; credit adjustments to expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_iN_pii_dpi0_z3szFnvHwqD6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Domestic production activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp0_zb9Ev8H2igD5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Change in deferred income taxes due to statutory rate changes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zcBS6RXu5rO7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Change in prior year estimated taxes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1.8&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zpRtCO6unFB3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18.7&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;11.9&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A9_zwONgyhDMZgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Significant components of the Company's
deferred tax assets and liabilities for income taxes for the fiscal years ended August 31, 2020 and 2019 are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zCZXffuI3e0f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Deferred taxes)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;&lt;span id="xdx_8B0_zIMmSciWJ2ml" style="display: none"&gt;Components of the Company deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20200831_zTX8Mol7GUm7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20190831_zVTY58QvbX8f" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_i01I_pp0p0_maDTAGz4SD_zU0Uta00rk6g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 70%; text-align: left; padding-left: 10pt"&gt;Accrued payroll and other expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;402,355&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;236,455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_pp0p0_maDTAGz4SD_zZOAjNd9Pare" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Deferred revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,862&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,038&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsEquityMethodInvestments_i01I_pp0p0_maDTAGz4SD_zvFnqPWEw25l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Capitalized merger costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;742,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;361,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_i01I_pp0p0_maDTAGz4SD_z60sjSZnITR3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Intellectual property&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,301&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsStateTaxes_i01I_pp0p0_maDTAGz4SD_zrJrwnpRb7D8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;State taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,326&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;89,537&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_d0_maDTAGz4SD_zaWJXuWwKFK9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Allowance for doubtful accounts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_i01I_pp0p0_maDTAGz4SD_zLl3hW3ixf18" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;State tax deferred&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;125,417&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;146,815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGz4SD_maDTANzteO_z0LDpi0OTbMk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,398,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;898,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di0_msDTANzteO_zBSFWqsm3dxk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzteO_maDTALNzZow_zEciOfMQmQ2h" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 1pt"&gt;Deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,398,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;898,249&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di_maDITLzYzc_zAUCDGKx7tF5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Property and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(61,991&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesOther_i01NI_pp0p0_di_maDITLzYzc_z5MOCRbkd2a5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;State tax deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,468&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,471&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_pp0p0_di_maDITLzYzc_ztqmljXTTbAc" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Intellectual property&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,876,274&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,217,234&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_i01NI_pp0p0_di_maDITLzYzc_zkggYemUV7H5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Capitalized computer software development costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,774,349&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,334,169&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di_mtDITLzYzc_msDTALNzZow_zwTcyyi37Vye" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,752,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,629,865&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_i01NTI_pp0p0_di_mtDTALNzZow_zs9zP256ZpUe" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(2,353,858&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(2,731,616&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A1_z2yUitcNsUd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We follow guidance issued by the FASB with
regard to our accounting for uncertainty in income taxes recognized in the financial statements. Such guidance prescribes a recognition
threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than
not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume
that the tax position will be examined by taxing authorities. Our policy is to include interest and penalties related to income
tax expense. Interest and penalties totaled $&lt;span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20190901__20200831_pp0p0" title="Interest and penalties"&gt;332&lt;/span&gt;, $&lt;span id="xdx_907_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20180901__20190831_pp0p0" title="Interest and penalties"&gt;2,531&lt;/span&gt;, and $-&lt;span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20170901__20180831_pp0p0" title="Interest and penalties"&gt;0&lt;/span&gt;- for fiscal years 2020, 2019, and 2018, respectively. We file
income tax returns with the IRS and various state jurisdictions and India. Our federal income tax returns for fiscal year 2016
thru 2019 are open for audit, and our state tax returns for fiscal year 2015 through 2019 remain open for audit. In addition, our
California tax return for the fiscal year 2007 and fiscal year 2008 remains open with regard to R&amp;amp;D tax credits as a result
of a previous audit for which we received a letter from the California Franchise Tax Board stating that an audit will not be conducted
for those years at this time; however it may be subject to future audit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Our review of prior year tax positions
using the criteria and provisions presented in guidance issued by FASB did not result in a material impact on our financial position
or results of operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zMFfFcQt1xmg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax provision)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt"&gt;&lt;span id="xdx_8B7_zagOldVKEnd2" style="display: none"&gt;Components of the income tax provision&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20190901__20200831_zsYtLRMf3OBk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20180901__20190831_zeGGgwkwikue" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20170901__20180831_zVeZB6h85yt3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Current&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zgXzb3eafgh1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 55%; padding-left: 10pt"&gt;Federal&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;2,097,725&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,794,596&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;2,370,955&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zrEF9BuHWLX7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 10pt"&gt;State&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;477,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;426,364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;460,619&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zPmxairo0Us4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;39,038&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;51,285&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;104,377&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01T_pp0p0_mtCITEBzgOr_maITEBzYIH_zYSUWo71p3u6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 1pt"&gt;Total current tax expense (benefit)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,614,507&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,272,245&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;2,935,951&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zPDAa5MwzY3a" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-left: 10pt"&gt;Federal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(427,644&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(140,730&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,698,201&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zhjqJZaXPJ6k" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; padding-left: 10pt"&gt;State&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(131,874&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(158,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(33,620&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i01NT_pp0p0_di_mtDITATzwIq_maITEBzYIH_znxE5mdhb7E9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 1pt"&gt;Total deferred federal and state&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(559,518&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(299,098&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,731,821&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_i01T_pp0p0_mtITEBzYIH_zVNPzpxQZ4df" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,054,989&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,973,147&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,204,130&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2097725</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">1794596</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">2370955</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">477744</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">426364</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">460619</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">39038</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">51285</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">104377</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2614507</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">2272245</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">2935951</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">427644</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">140730</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">1698201</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">131874</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">158368</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">33620</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">559518</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">299098</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">1731821</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">2054989</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">1973147</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">1204130</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zwqw6tDO2oE6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Reconciliation)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B1_zeHlw3e1gyG1" style="display: none"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20190901__20200831_zFPXY8wYHiw" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20180901__20190831_zyR2udabmake" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20170901__20180831_zrqvTJHUFK8b" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_ziFhmue5SCxk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; text-align: justify"&gt;Income tax computed at federal statutory tax rate&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;21.0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;25.4&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zDRpPq6iHdq4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;State taxes, net of federal benefit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_dp_zIis2XbHznzg" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Meals &amp;amp; entertainment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.1&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_dp_zrqJXLlMHj01" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Stock based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.2&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.5&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_zAcMWigEiG6l" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Other permanent differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1.2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pii_dpi_znSDn1apBFKl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Research and development credit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.7&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.3&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2.6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pii_dp0_z827QgPMm06a" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Foreign tax related differences&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.4&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_pii_dp0_zF2T52Vq8bWl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Research &amp;amp; credit adjustments to expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.3&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_iN_pii_dpi0_z3szFnvHwqD6" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Domestic production activities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp0_zb9Ev8H2igD5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Change in deferred income taxes due to statutory rate changes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14.8&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zcBS6RXu5rO7" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Change in prior year estimated taxes&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1.8&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.9&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(0.0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zpRtCO6unFB3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18.0&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;18.7&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;11.9&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0.254</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.042</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0.040</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">-0.026</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0.012</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.023</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0.026</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">-0.014</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">-0</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">-0</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">-0.148</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">-0.018</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">-0.009</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">-0.000</us-gaap:EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2019-09-01to2020-08-31"
      decimals="INF"
      unitRef="Pure">0.180</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2018-09-012019-08-31"
      decimals="INF"
      unitRef="Pure">0.187</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2017-09-012018-08-31"
      decimals="INF"
      unitRef="Pure">0.119</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zCZXffuI3e0f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Deferred taxes)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;&lt;span id="xdx_8B0_zIMmSciWJ2ml" style="display: none"&gt;Components of the Company deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49F_20200831_zTX8Mol7GUm7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20190831_zVTY58QvbX8f" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_i01I_pp0p0_maDTAGz4SD_zU0Uta00rk6g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 70%; text-align: left; padding-left: 10pt"&gt;Accrued payroll and other expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;402,355&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;236,455&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_pp0p0_maDTAGz4SD_zZOAjNd9Pare" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Deferred revenue&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,862&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;55,038&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxAssetsEquityMethodInvestments_i01I_pp0p0_maDTAGz4SD_zvFnqPWEw25l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Capitalized merger costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;742,056&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;361,103&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_i01I_pp0p0_maDTAGz4SD_z60sjSZnITR3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Intellectual property&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,677&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,301&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsStateTaxes_i01I_pp0p0_maDTAGz4SD_zrJrwnpRb7D8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;State taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100,326&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;89,537&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_d0_maDTAGz4SD_zaWJXuWwKFK9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Allowance for doubtful accounts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;13,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_i01I_pp0p0_maDTAGz4SD_zLl3hW3ixf18" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;State tax deferred&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;125,417&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;146,815&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGz4SD_maDTANzteO_z0LDpi0OTbMk" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,398,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;898,249&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di0_msDTANzteO_zBSFWqsm3dxk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less: Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzteO_maDTALNzZow_zEciOfMQmQ2h" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="visibility: hidden; padding-bottom: 1pt"&gt;Deferred tax asset&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,398,143&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;898,249&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di_maDITLzYzc_zAUCDGKx7tF5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Property and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(81,910&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(61,991&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesOther_i01NI_pp0p0_di_maDITLzYzc_z5MOCRbkd2a5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;State tax deferred&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(19,468&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,471&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_pp0p0_di_maDITLzYzc_ztqmljXTTbAc" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Intellectual property&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,876,274&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,217,234&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_i01NI_pp0p0_di_maDITLzYzc_zkggYemUV7H5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt"&gt;Capitalized computer software development costs&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,774,349&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,334,169&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di_mtDITLzYzc_msDTALNzZow_zwTcyyi37Vye" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total deferred tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,752,001&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,629,865&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_i01NTI_pp0p0_di_mtDTALNzZow_zs9zP256ZpUe" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(2,353,858&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;(2,731,616&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">402355</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">236455</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">6862</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">55038</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsEquityMethodInvestments contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">742056</us-gaap:DeferredTaxAssetsEquityMethodInvestments>
    <us-gaap:DeferredTaxAssetsEquityMethodInvestments contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">361103</us-gaap:DeferredTaxAssetsEquityMethodInvestments>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">7677</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">9301</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsStateTaxes contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">100326</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsStateTaxes contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">89537</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">13450</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">125417</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">146815</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">1398143</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">898249</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">-0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">-0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">1398143</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">898249</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">81910</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">61991</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">19468</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">16471</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">1876274</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">2217234</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">1774349</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">1334169</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">3752001</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">3629865</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">2353858</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2019-08-31" decimals="0" unitRef="USD">2731616</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">332</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">2531</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_80B_eus-gaap--ConcentrationRiskDisclosureTextBlock_zLyfrtLhpVGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 10 &#x2013; &lt;span id="xdx_82B_z3ByhgWpmBe3"&gt;CONCENTRATIONS AND UNCERTAINTIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially
subject the Company to concentration of credit risk consist principally of cash, cash equivalents and trade accounts receivable.
The Company holds cash and cash equivalents at banks located in California, with balances that often exceed FDIC insured limits.
Historically, the Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit
risk on cash and cash equivalents. However, considering the current banking environment, the Company is investigating alternative
ways to minimize its exposure to such risks. While the Company may be exposed to credit losses due to the nonperformance of its
counterparties, the Company does not expect the settlement of these transactions to have a material effect on its results of operations,
cash flows or financial condition. The Company maintains cash at financial institutions that may, at times, exceed federally insured
limits. At August 31, 2020, the Company had cash and cash equivalents exceeding insured limits by $&lt;span id="xdx_903_eus-gaap--CashUninsuredAmount_c20200831_pp0p0" title="Cash and cash equivalents exceeding insured limits"&gt;10,790,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Revenue concentration shows that international
sales accounted for &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_ztMkU0azh3F1" title="Net sales concentration percentage"&gt;29&lt;/span&gt;%, &lt;span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_zFijk4CsFE8" title="Net sales concentration percentage"&gt;34&lt;/span&gt;% and &lt;span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_zUnsrper1evb" title="Net sales concentration percentage"&gt;39&lt;/span&gt;% of net sales for fiscal years 2020, 2019 and 2018, respectively. Three customers accounted
for &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zjUMSmrDTvca" title="Net sales concentration percentage"&gt;9&lt;/span&gt;%, &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zAbmMpN7R8hf" title="Net sales concentration percentage"&gt;7&lt;/span&gt;% (a dealer account in Japan representing various customers), and &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_zfubQZlpyaFc" title="Net sales concentration percentage"&gt;7&lt;/span&gt;% of net sales for fiscal year 2020. Three customers
accounted for &lt;span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zedJITtibWqf" title="Net sales concentration percentage"&gt;8&lt;/span&gt;%, &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zP6et4e5nok7" title="Net sales concentration percentage"&gt;8&lt;/span&gt;% (a dealer account in Japan representing various customers), and &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_z1yx07xGTmd1" title="Net sales concentration percentage"&gt;7&lt;/span&gt;% of net sales for fiscal year 2019. Four
customers accounted for &lt;span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zBXeKPfsfSJg" title="Net sales concentration percentage"&gt;9&lt;/span&gt;% (a dealer account in Japan representing various customers), &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zSStXQj3gXX9" title="Net sales concentration percentage"&gt;7&lt;/span&gt;%, &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_zY9vq8sXyxJl" title="Net sales concentration percentage"&gt;6&lt;/span&gt;% and &lt;span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer4Member_zzIffaJSpaHf" title="Net sales concentration percentage"&gt;5&lt;/span&gt;% of net sales for fiscal year
2018.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;FY20 accounts receivable concentrations
show that two customers comprised &lt;span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ACustomerMember_zbmzWSy1zkJg" title="Net sales concentration percentage"&gt;13&lt;/span&gt;% and &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--BCustomerMember_zf4UkKL5y218" title="Net sales concentration percentage"&gt;10&lt;/span&gt;% of accounts receivable as of August 31, 2020, respectively. FY19 accounts receivable
concentrations show that one customer comprised &lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ACustomerMember_zuzPRWeNKvNl" title="Net sales concentration percentage"&gt;10&lt;/span&gt;% of accounts receivable as of August 31, 2019.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We operate in the computer software industry,
which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop
new products and find new distribution channels for new and existing products.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The majority of our customers are in the
pharmaceutical industry. During economic downturns, we have seen consolidations in the pharmaceutical industry. Although we have
not seen any significant reduction in total revenues to date, our growth rate could be affected by consolidation and downsizing
in the pharmaceutical industry.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:CashUninsuredAmount contextRef="AsOf2020-08-31" decimals="0" unitRef="USD">10790000</us-gaap:CashUninsuredAmount>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-09-012020-08-31_us-gaap_SalesMember_custom_InternationalSalesMember"
      decimals="INF"
      unitRef="Pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2018-09-012019-08-31_us-gaap_SalesMember_custom_InternationalSalesMember"
      decimals="INF"
      unitRef="Pure">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_InternationalSalesMember"
      decimals="INF"
      unitRef="Pure">0.39</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer1Member"
      decimals="INF"
      unitRef="Pure">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer2Member"
      decimals="INF"
      unitRef="Pure">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-09-012020-08-31_us-gaap_SalesMember_custom_Customer3Member"
      decimals="INF"
      unitRef="Pure">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer1Member"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer2Member"
      decimals="INF"
      unitRef="Pure">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2018-09-012019-08-31_us-gaap_SalesMember_custom_Customer3Member"
      decimals="INF"
      unitRef="Pure">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer1Member"
      decimals="INF"
      unitRef="Pure">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer2Member"
      decimals="INF"
      unitRef="Pure">0.07</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer3Member"
      decimals="INF"
      unitRef="Pure">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2017-09-012018-08-31_us-gaap_SalesMember_custom_Customer4Member"
      decimals="INF"
      unitRef="Pure">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-09-012020-08-31_us-gaap_AccountsReceivableMember_custom_ACustomerMember"
      decimals="INF"
      unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2019-09-012020-08-31_us-gaap_AccountsReceivableMember_custom_BCustomerMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2018-09-012019-08-31_us-gaap_AccountsReceivableMember_custom_ACustomerMember"
      decimals="INF"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_80D_eus-gaap--SegmentReportingDisclosureTextBlock_zGBLN5PDfWCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 11 &#x2013; &lt;span id="xdx_825_zCN6KCYbWm0f"&gt;SEGMENT AND GEOGRAPHIC REPORTING&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-transform: uppercase"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We account for segments and geographic
revenues in accordance with guidance issued by the FASB. Our reportable segments are strategic business units that offer different
products and services.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Results for each segment and consolidated
results are as follows years ended August 31, 2020, 2019 and 2018 (in thousands, because of rounding, numbers may not foot):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_znlQ7VnPMeuh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zNsYceOS2LWd" style="display: none"&gt;Schedule of consolidated results from reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2020&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen Corporation&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 22%; text-align: left"&gt;Net revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zIPywJ9pGXG6" style="width: 10%; text-align: right" title="Net Revenues"&gt;21,961&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zv5nt7qgAwVl" style="width: 10%; text-align: right" title="Net Revenues"&gt;11,105&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zpSrOIEUz3u3" style="width: 10%; text-align: right" title="Net Revenues"&gt;6,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z6YM73V6Tbi4" style="width: 10%; text-align: right" title="Net Revenues"&gt;1,575&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z45ynvxMb8E4" style="width: 10%; text-align: right" title="Net Revenues"&gt;41,589&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income from operations before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zJ2MUtMlxgHb" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;7,374&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zoj7oGP9L2Fg" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcuWRU2Zh0Ld" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zeOykSYmylh1" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zrqzGSMYVjS5" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;11,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Total assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zoGXa3yNB2kk" style="text-align: right" title="Total assets"&gt;162,807&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zin2MELpq9Me" style="text-align: right" title="Total assets"&gt;11,654&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zRkJH5towc67" style="text-align: right" title="Total assets"&gt;14,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z1jzyh0rhdOb" style="text-align: right" title="Total assets"&gt;19,972&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20200831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zT7pazXMHsre" style="text-align: right" title="Total assets"&gt;(40,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zh4OWXVwA3g5" style="text-align: right" title="Total assets"&gt;168,422&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_d0_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3ajge7nSrk2" style="text-align: right" title="Goodwill"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zkwSfZBdeeNd" style="text-align: right" title="Goodwill"&gt;4,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNhiendOEiug" style="text-align: right" title="Goodwill"&gt;5,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zHwKetURkVg9" style="text-align: right" title="Goodwill"&gt;2,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zDvZcR44EVs4" style="text-align: right" title="Goodwill"&gt;12,921&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLu0FkKhDyKk" style="text-align: right" title="Capital expenditures"&gt;111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zDVXBHkGYpee" style="text-align: right" title="Capital expenditures"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxQZg4WltYoi" style="text-align: right" title="Capital expenditures"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zfQWcGWgrRm5" style="text-align: right" title="Capital expenditures"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zwR5az5tFyg1" style="text-align: right" title="Capital expenditures"&gt;231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Capitalized software costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zs0LFsjXIq02" style="text-align: right" title="Capitalized software costs"&gt;2,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdmmXcyK1fG4" style="text-align: right" title="Capitalized software costs"&gt;40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcHgswTtk81b" style="text-align: right" title="Capitalized software costs"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zIAbtTkh5Gvj" style="text-align: right" title="Capitalized software costs"&gt;160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zAYhe7mp9Dld" style="text-align: right" title="Capitalized software costs"&gt;2,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3efLMHOP3q6" style="text-align: right" title="Depreciation and Amortization"&gt;1,713&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zrwFSKywakDf" style="text-align: right" title="Depreciation and Amortization"&gt;349&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0G2yjTh1Bx1" style="text-align: right" title="Depreciation and Amortization"&gt;600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zxs5NEQo86f6" style="text-align: right" title="Depreciation and Amortization"&gt;300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zab7kr5cEef6" style="text-align: right" title="Depreciation and Amortization"&gt;2,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2019&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen Corporation&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 22%; text-align: left"&gt;Net revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zn3r6NCB494a" style="width: 10%; text-align: right" title="Net Revenues"&gt;19,585&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zyOyqLDUPZTl" style="width: 10%; text-align: right" title="Net Revenues"&gt;9,321&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zASPvToUczt7" style="width: 10%; text-align: right" title="Net Revenues"&gt;5,065&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z2ciSn1N3Ey" style="width: 10%; text-align: right" title="Net Revenues"&gt;33,970&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income from operations before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zjpV8RYaPKla" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;7,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zqO7zlgLC8xi" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4AGL3fHx2F7" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_znd8uMPtLDe" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;10,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Total assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zKuiVv1veg41" style="text-align: right" title="Total assets"&gt;38,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zzv2ZI8pODkb" style="text-align: right" title="Total assets"&gt;11,196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXvzQfUGkEq1" style="text-align: right" title="Total assets"&gt;13,168&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zHIsFlb4Ilfa" style="text-align: right" title="Total assets"&gt;(17,702&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zC4oN1WXivla" style="text-align: right" title="Total assets"&gt;45,197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iI_pn3n3_d0_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zP4POxkXCxPg" style="text-align: right" title="Goodwill"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjHihHBK6ith" style="text-align: right" title="Goodwill"&gt;4,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z8G1gG6qqTEk" style="text-align: right" title="Goodwill"&gt;5,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z50Xh3ea9PAj" style="text-align: right" title="Goodwill"&gt;10,387&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zvV317UUkjy1" style="text-align: right" title="Capital expenditures"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zu8XsvhmZmNk" style="text-align: right" title="Capital expenditures"&gt;79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4NfvL1JSBIi" style="text-align: right" title="Capital expenditures"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zYGnIy2MeXI8" style="text-align: right" title="Capital expenditures"&gt;138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Capitalized software costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zxuIiWePb92c" style="text-align: right" title="Capitalized software costs"&gt;1,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zZ4EMeHrhzC3" style="text-align: right" title="Capitalized software costs"&gt;114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zUFbJrqSbbRk" style="text-align: right" title="Capitalized software costs"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z0LbRipTKsja" style="text-align: right" title="Capitalized software costs"&gt;1,768&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zOi20rlPfhTk" style="text-align: right" title="Depreciation and Amortization"&gt;1,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zti5NmFeyJh8" style="text-align: right" title="Depreciation and Amortization"&gt;364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zKwS3AL9OWI3" style="text-align: right" title="Depreciation and Amortization"&gt;580&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zBGgubPSupkd" style="text-align: right" title="Depreciation and Amortization"&gt;2,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2018&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen Corporation&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 22%; text-align: left"&gt;Net revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVLlVPi5RII9" style="width: 10%; text-align: right" title="Net Revenues"&gt;17,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z5RrY4VpIBHl" style="width: 10%; text-align: right" title="Net Revenues"&gt;7,857&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z1h25TrgiGue" style="width: 10%; text-align: right" title="Net Revenues"&gt;4,257&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zEQ7SQCSoWa2" style="width: 10%; text-align: right" title="Net Revenues"&gt;29,667&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income from operations before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zpvlM3Ozyxx" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;7,533&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zFhh4FyUWyCl" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxJuOS4E3Sm4" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z583A7bMubaa" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;10,298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Total assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4ZEwN3Zfo8k" style="text-align: right" title="Total assets"&gt;38,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zUdaU5qVjEOk" style="text-align: right" title="Total assets"&gt;8,733&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zHgkXH2iB4bh" style="text-align: right" title="Total assets"&gt;14,248&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20180831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zCoMpkmy4Az" style="text-align: right" title="Total assets"&gt;(17,702&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zae8v4WmW4U1" style="text-align: right" title="Total assets"&gt;43,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_d0_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_znG7MJKgt4a6" style="text-align: right" title="Goodwill"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMIRR1kmb7hd" style="text-align: right" title="Goodwill"&gt;4,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNMbfUjJs1pk" style="text-align: right" title="Goodwill"&gt;5,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zd2YKBKNnRP9" style="text-align: right" title="Goodwill"&gt;10,387&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPptWlUTBGsl" style="text-align: right" title="Capital expenditures"&gt;65&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zHWWQiN2ku3a" style="text-align: right" title="Capital expenditures"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zkxv0kpkgiSg" style="text-align: right" title="Capital expenditures"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zqrxySbGToQk" style="text-align: right" title="Capital expenditures"&gt;183&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Capitalized software costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zMtcehUmqHy4" style="text-align: right" title="Capitalized software costs"&gt;1,365&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zQdvaXgc19D" style="text-align: right" title="Capitalized software costs"&gt;625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z26ZBHMN1p29" style="text-align: right" title="Capitalized software costs"&gt;155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zfaX3D0GeKf7" style="text-align: right" title="Capitalized software costs"&gt;2,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_ztfkJjILVJH7" style="text-align: right" title="Depreciation and Amortization"&gt;1,748&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z3SemHzU5HNi" style="text-align: right" title="Depreciation and Amortization"&gt;401&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zA2y1TrPxW2a" style="text-align: right" title="Depreciation and Amortization"&gt;572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zP7EnCmLNme6" style="text-align: right" title="Depreciation and Amortization"&gt;2,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zuCGSe30iLF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In addition, the Company allocates revenues
to geographic areas based on the locations of its customers. Geographical revenues for the years ended August 31, 2020, 2019 and
2018 were as follows (in thousands, because of rounding, numbers may not foot):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_pn3n3_zJrhz4QAColl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zuA8uMzIV7U7" style="display: none"&gt;Schedule of geographical revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2020&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;North &amp;amp; South America&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Asia&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRRtk1mciEr5" style="width: 11%; text-align: right" title="Revenues"&gt;11,124&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4yCkIHGEr2k" style="width: 11%; text-align: right" title="Revenues"&gt;5,024&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLGa3wTTIbpl" style="width: 11%; text-align: right" title="Revenues"&gt;5,812&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zipCPTlqCSLi" style="width: 11%; text-align: right" title="Revenues"&gt;21,961&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cognigen Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zS6zaOvq9Tcb" style="text-align: right" title="Revenues"&gt;11,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z4QH0lWQs0El" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zlMUXIoHGoxe" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdhdygJzQwla" style="text-align: right" title="Revenues"&gt;11,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;DILIsym Services, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrOzjHoFpMSe" style="text-align: right" title="Revenues"&gt;6,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zPs7H6lgkPu4" style="text-align: right" title="Revenues"&gt;646&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zvYEwyOsevOl" style="text-align: right" title="Revenues"&gt;246&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z5KLxPhrEwd5" style="text-align: right" title="Revenues"&gt;6,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z07XcB5cktcg" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;1,388&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsqjK87yRc17" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;157&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zZYnEzVzGvY8" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsh10MIbss47" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;1,575&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_z5yqrScQSQwh" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;29,674&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember_zOnois1EIm8f" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,827&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember_zvdDrRbbwXk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;6,088&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;&lt;p id="xdx_98C_eus-gaap--Revenues_pp0p0_c20190901__20200831_z9njnkBHIQ5j" style="font: 13.33px Times New Roman, Times, Serif; color: rgb(0, 0, 0)"&gt;&lt;span style="display: none; font-style: normal; font-weight: normal; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(238, 238, 238)"&gt;41,589,084&lt;/span&gt;&lt;/p&gt;41,589&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2019&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;North &amp;amp; South America&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Asia&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZmTkeGk2Sug" style="width: 11%; text-align: right" title="Revenues"&gt;9,381&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRzm5JMPj6w8" style="width: 11%; text-align: right" title="Revenues"&gt;5,144&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRWStue2Okei" style="width: 11%; text-align: right" title="Revenues"&gt;5,060&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zniiji62O83c" style="width: 11%; text-align: right" title="Revenues"&gt;19,585&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cognigen Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMO6Lxx5Agj3" style="text-align: right" title="Revenues"&gt;9,321&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z6eeplQ50xha" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zwpsWdlPCULf" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zfbqIsA7K6B3" style="text-align: right" title="Revenues"&gt;9,321&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;DILIsym Services, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zTOZ1VBc7xs5" style="text-align: right" title="Revenues"&gt;3,875&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4Y0OFo1EBe8" style="text-align: right" title="Revenues"&gt;685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zzJWHoPnH7xb" style="text-align: right" title="Revenues"&gt;505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z03s9YIMGVMd" style="text-align: right" title="Revenues"&gt;5,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zaluMlhDbgu9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zQWBY2eDLcr" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zoy1dgU5u9f3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBUWGxGn6cUl" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zQXAMrG0aDz1" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;22,577&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember_zGxG2JGrcUf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,829&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember_zVfuqcc6xwlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,565&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;&lt;p id="xdx_98E_eus-gaap--Revenues_pp0p0_c20180901__20190831_zAtGEVnm2Cn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none"&gt;33,970,440&lt;/p&gt;33,971&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2018&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;North &amp;amp; South America&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Asia&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zeII7hrIMrz" style="width: 11%; text-align: right" title="Revenues"&gt;7,856&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZcI0NCLxXm6" style="width: 11%; text-align: right" title="Revenues"&gt;4,964&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVSdlLepy8Cf" style="width: 11%; text-align: right" title="Revenues"&gt;4,733&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPAJQsH37C26" style="width: 11%; text-align: right" title="Revenues"&gt;17,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cognigen Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zpfDKcC42Y2c" style="text-align: right" title="Revenues"&gt;7,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zBnbPWJRwNGe" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjcsa3iwsG1b" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zPEVeQfhi0a4" style="text-align: right" title="Revenues"&gt;7,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;DILIsym Services, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrsSyW0gwLf2" style="text-align: right" title="Revenues"&gt;3,163&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zi7bAEWFFde6" style="text-align: right" title="Revenues"&gt;312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0lqB9ZFUBHk" style="text-align: right" title="Revenues"&gt;782&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXAU3PLhCyF3" style="text-align: right" title="Revenues"&gt;4,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zNN1YKP0Xto7" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zf4xV1WRj6Q9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBfl4xDvSVO2" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zup81ldnN3Ai" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zlyiQa1LsN3a" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;18,876&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember_zISCw3o0FG29" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,276&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember_z6v6aRogU6Kf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,515&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;&lt;p id="xdx_982_eus-gaap--Revenues_pp0p0_c20170901__20180831_zFqi7WVzFyZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none"&gt;29,666,524&lt;/p&gt;29,667&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;*Lixoft was acquired on April 1, 2020.&lt;/p&gt;

&lt;p id="xdx_8A0_zaVCBMc7nXag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&#160;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_znlQ7VnPMeuh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B2_zNsYceOS2LWd" style="display: none"&gt;Schedule of consolidated results from reportable segments&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2020&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen Corporation&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 22%; text-align: left"&gt;Net revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zIPywJ9pGXG6" style="width: 10%; text-align: right" title="Net Revenues"&gt;21,961&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zv5nt7qgAwVl" style="width: 10%; text-align: right" title="Net Revenues"&gt;11,105&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zpSrOIEUz3u3" style="width: 10%; text-align: right" title="Net Revenues"&gt;6,948&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z6YM73V6Tbi4" style="width: 10%; text-align: right" title="Net Revenues"&gt;1,575&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z45ynvxMb8E4" style="width: 10%; text-align: right" title="Net Revenues"&gt;41,589&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income from operations before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zJ2MUtMlxgHb" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;7,374&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zoj7oGP9L2Fg" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,770&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcuWRU2Zh0Ld" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,744&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zeOykSYmylh1" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;717&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zrqzGSMYVjS5" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;11,605&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Total assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zoGXa3yNB2kk" style="text-align: right" title="Total assets"&gt;162,807&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zin2MELpq9Me" style="text-align: right" title="Total assets"&gt;11,654&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zRkJH5towc67" style="text-align: right" title="Total assets"&gt;14,084&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z1jzyh0rhdOb" style="text-align: right" title="Total assets"&gt;19,972&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20200831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zT7pazXMHsre" style="text-align: right" title="Total assets"&gt;(40,095&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zh4OWXVwA3g5" style="text-align: right" title="Total assets"&gt;168,422&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_d0_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3ajge7nSrk2" style="text-align: right" title="Goodwill"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zkwSfZBdeeNd" style="text-align: right" title="Goodwill"&gt;4,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNhiendOEiug" style="text-align: right" title="Goodwill"&gt;5,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zHwKetURkVg9" style="text-align: right" title="Goodwill"&gt;2,534&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zDvZcR44EVs4" style="text-align: right" title="Goodwill"&gt;12,921&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLu0FkKhDyKk" style="text-align: right" title="Capital expenditures"&gt;111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zDVXBHkGYpee" style="text-align: right" title="Capital expenditures"&gt;87&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxQZg4WltYoi" style="text-align: right" title="Capital expenditures"&gt;31&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zfQWcGWgrRm5" style="text-align: right" title="Capital expenditures"&gt;2&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zwR5az5tFyg1" style="text-align: right" title="Capital expenditures"&gt;231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Capitalized software costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zs0LFsjXIq02" style="text-align: right" title="Capitalized software costs"&gt;2,028&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdmmXcyK1fG4" style="text-align: right" title="Capitalized software costs"&gt;40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcHgswTtk81b" style="text-align: right" title="Capitalized software costs"&gt;124&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zIAbtTkh5Gvj" style="text-align: right" title="Capitalized software costs"&gt;160&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zAYhe7mp9Dld" style="text-align: right" title="Capitalized software costs"&gt;2,353&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3efLMHOP3q6" style="text-align: right" title="Depreciation and Amortization"&gt;1,713&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zrwFSKywakDf" style="text-align: right" title="Depreciation and Amortization"&gt;349&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0G2yjTh1Bx1" style="text-align: right" title="Depreciation and Amortization"&gt;600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zxs5NEQo86f6" style="text-align: right" title="Depreciation and Amortization"&gt;300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zab7kr5cEef6" style="text-align: right" title="Depreciation and Amortization"&gt;2,962&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2019&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen Corporation&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 22%; text-align: left"&gt;Net revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zn3r6NCB494a" style="width: 10%; text-align: right" title="Net Revenues"&gt;19,585&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zyOyqLDUPZTl" style="width: 10%; text-align: right" title="Net Revenues"&gt;9,321&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zASPvToUczt7" style="width: 10%; text-align: right" title="Net Revenues"&gt;5,065&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z2ciSn1N3Ey" style="width: 10%; text-align: right" title="Net Revenues"&gt;33,970&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income from operations before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zjpV8RYaPKla" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;7,752&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zqO7zlgLC8xi" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,481&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4AGL3fHx2F7" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,416&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_znd8uMPtLDe" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;10,648&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Total assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zKuiVv1veg41" style="text-align: right" title="Total assets"&gt;38,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zzv2ZI8pODkb" style="text-align: right" title="Total assets"&gt;11,196&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXvzQfUGkEq1" style="text-align: right" title="Total assets"&gt;13,168&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zHIsFlb4Ilfa" style="text-align: right" title="Total assets"&gt;(17,702&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zC4oN1WXivla" style="text-align: right" title="Total assets"&gt;45,197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Goodwill_iI_pn3n3_d0_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zP4POxkXCxPg" style="text-align: right" title="Goodwill"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjHihHBK6ith" style="text-align: right" title="Goodwill"&gt;4,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z8G1gG6qqTEk" style="text-align: right" title="Goodwill"&gt;5,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z50Xh3ea9PAj" style="text-align: right" title="Goodwill"&gt;10,387&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zvV317UUkjy1" style="text-align: right" title="Capital expenditures"&gt;39&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zu8XsvhmZmNk" style="text-align: right" title="Capital expenditures"&gt;79&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4NfvL1JSBIi" style="text-align: right" title="Capital expenditures"&gt;20&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zYGnIy2MeXI8" style="text-align: right" title="Capital expenditures"&gt;138&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Capitalized software costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zxuIiWePb92c" style="text-align: right" title="Capitalized software costs"&gt;1,482&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zZ4EMeHrhzC3" style="text-align: right" title="Capitalized software costs"&gt;114&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zUFbJrqSbbRk" style="text-align: right" title="Capitalized software costs"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z0LbRipTKsja" style="text-align: right" title="Capitalized software costs"&gt;1,768&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zOi20rlPfhTk" style="text-align: right" title="Depreciation and Amortization"&gt;1,806&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zti5NmFeyJh8" style="text-align: right" title="Depreciation and Amortization"&gt;364&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zKwS3AL9OWI3" style="text-align: right" title="Depreciation and Amortization"&gt;580&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zBGgubPSupkd" style="text-align: right" title="Depreciation and Amortization"&gt;2,750&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2018&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Cognigen Corporation&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;DILIsym&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Eliminations&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 22%; text-align: left"&gt;Net revenues&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVLlVPi5RII9" style="width: 10%; text-align: right" title="Net Revenues"&gt;17,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z5RrY4VpIBHl" style="width: 10%; text-align: right" title="Net Revenues"&gt;7,857&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z1h25TrgiGue" style="width: 10%; text-align: right" title="Net Revenues"&gt;4,257&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zEQ7SQCSoWa2" style="width: 10%; text-align: right" title="Net Revenues"&gt;29,667&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Income from operations before income taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zpvlM3Ozyxx" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;7,533&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zFhh4FyUWyCl" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;1,902&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxJuOS4E3Sm4" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;863&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z583A7bMubaa" style="text-align: right" title="Income (loss) from operations before income taxes"&gt;10,298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Total assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4ZEwN3Zfo8k" style="text-align: right" title="Total assets"&gt;38,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zUdaU5qVjEOk" style="text-align: right" title="Total assets"&gt;8,733&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zHgkXH2iB4bh" style="text-align: right" title="Total assets"&gt;14,248&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20180831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zCoMpkmy4Az" style="text-align: right" title="Total assets"&gt;(17,702&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zae8v4WmW4U1" style="text-align: right" title="Total assets"&gt;43,279&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Goodwill&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_d0_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_znG7MJKgt4a6" style="text-align: right" title="Goodwill"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMIRR1kmb7hd" style="text-align: right" title="Goodwill"&gt;4,789&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNMbfUjJs1pk" style="text-align: right" title="Goodwill"&gt;5,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zd2YKBKNnRP9" style="text-align: right" title="Goodwill"&gt;10,387&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Capital expenditures&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPptWlUTBGsl" style="text-align: right" title="Capital expenditures"&gt;65&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zHWWQiN2ku3a" style="text-align: right" title="Capital expenditures"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zkxv0kpkgiSg" style="text-align: right" title="Capital expenditures"&gt;18&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zqrxySbGToQk" style="text-align: right" title="Capital expenditures"&gt;183&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Capitalized software costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zMtcehUmqHy4" style="text-align: right" title="Capitalized software costs"&gt;1,365&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zQdvaXgc19D" style="text-align: right" title="Capitalized software costs"&gt;625&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z26ZBHMN1p29" style="text-align: right" title="Capitalized software costs"&gt;155&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zfaX3D0GeKf7" style="text-align: right" title="Capitalized software costs"&gt;2,145&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation and amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_ztfkJjILVJH7" style="text-align: right" title="Depreciation and Amortization"&gt;1,748&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z3SemHzU5HNi" style="text-align: right" title="Depreciation and Amortization"&gt;401&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zA2y1TrPxW2a" style="text-align: right" title="Depreciation and Amortization"&gt;572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zP7EnCmLNme6" style="text-align: right" title="Depreciation and Amortization"&gt;2,721&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">21961000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375"
      decimals="-3"
      unitRef="USD">11105000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390"
      decimals="-3"
      unitRef="USD">6948000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390"
      decimals="-3"
      unitRef="USD">1575000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">41589000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-09-012020-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">7374000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375"
      decimals="-3"
      unitRef="USD">1770000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390"
      decimals="-3"
      unitRef="USD">1744000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390"
      decimals="-3"
      unitRef="USD">717000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">11605000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Assets
      contextRef="AsOf2020-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">162807000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-08-31_custom_CognigenMember137486437"
      decimals="-3"
      unitRef="USD">11654000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-08-31_custom_DILIsymMember137486453"
      decimals="-3"
      unitRef="USD">14084000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-08-31_custom_LixoftMember137486453"
      decimals="-3"
      unitRef="USD">19972000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-08-31_srt_ConsolidationEliminationsMember"
      decimals="-3"
      unitRef="USD">-40095000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2020-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">168422000</us-gaap:Assets>
    <us-gaap:Goodwill
      contextRef="AsOf2020-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2020-08-31_custom_CognigenMember137486437"
      decimals="-3"
      unitRef="USD">4789000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2020-08-31_custom_DILIsymMember137486453"
      decimals="-3"
      unitRef="USD">5598000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2020-08-31_custom_LixoftMember137486453"
      decimals="-3"
      unitRef="USD">2534000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2020-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">12921000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-09-012020-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">111000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375"
      decimals="-3"
      unitRef="USD">87000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390"
      decimals="-3"
      unitRef="USD">31000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390"
      decimals="-3"
      unitRef="USD">2000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">231000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2020-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">2028000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2020-08-31_custom_CognigenMember137486437"
      decimals="-3"
      unitRef="USD">40000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2020-08-31_custom_DILIsymMember137486453"
      decimals="-3"
      unitRef="USD">124000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2020-08-31_custom_LixoftMember137486453"
      decimals="-3"
      unitRef="USD">160000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2020-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">2353000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-09-012020-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">1713000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375"
      decimals="-3"
      unitRef="USD">349000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390"
      decimals="-3"
      unitRef="USD">600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390"
      decimals="-3"
      unitRef="USD">300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2019-09-012020-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">2962000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">19585000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562"
      decimals="-3"
      unitRef="USD">9321000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578"
      decimals="-3"
      unitRef="USD">5065000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">33970000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2018-09-012019-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">7752000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562"
      decimals="-3"
      unitRef="USD">1481000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578"
      decimals="-3"
      unitRef="USD">1416000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">10648000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Assets
      contextRef="AsOf2019-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">38535000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2019-08-31_custom_CognigenMember137486625"
      decimals="-3"
      unitRef="USD">11196000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2019-08-31_custom_DILIsymMember137486640"
      decimals="-3"
      unitRef="USD">13168000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2019-08-31_srt_ConsolidationEliminationsMember"
      decimals="-3"
      unitRef="USD">-17702000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2019-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">45197000</us-gaap:Assets>
    <us-gaap:Goodwill
      contextRef="AsOf2019-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2019-08-31_custom_CognigenMember137486625"
      decimals="-3"
      unitRef="USD">4789000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2019-08-31_custom_DILIsymMember137486640"
      decimals="-3"
      unitRef="USD">5598000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2019-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">10387000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2018-09-012019-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">39000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562"
      decimals="-3"
      unitRef="USD">79000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578"
      decimals="-3"
      unitRef="USD">20000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">138000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2019-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">1482000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2019-08-31_custom_CognigenMember137486625"
      decimals="-3"
      unitRef="USD">114000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2019-08-31_custom_DILIsymMember137486640"
      decimals="-3"
      unitRef="USD">172000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2019-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">1768000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2018-09-012019-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">1806000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562"
      decimals="-3"
      unitRef="USD">364000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578"
      decimals="-3"
      unitRef="USD">580000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2018-09-012019-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">2750000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">17553000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718"
      decimals="-3"
      unitRef="USD">7857000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734"
      decimals="-3"
      unitRef="USD">4257000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">29667000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2017-09-012018-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">7533000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718"
      decimals="-3"
      unitRef="USD">1902000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734"
      decimals="-3"
      unitRef="USD">863000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">10298000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Assets
      contextRef="AsOf2018-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">38000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2018-08-31_custom_CognigenMember137486781"
      decimals="-3"
      unitRef="USD">8733000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2018-08-31_custom_DILIsymMember137486796"
      decimals="-3"
      unitRef="USD">14248000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2018-08-31_srt_ConsolidationEliminationsMember"
      decimals="-3"
      unitRef="USD">-17702000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2018-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">43279000</us-gaap:Assets>
    <us-gaap:Goodwill
      contextRef="AsOf2018-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2018-08-31_custom_CognigenMember137486781"
      decimals="-3"
      unitRef="USD">4789000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2018-08-31_custom_DILIsymMember137486796"
      decimals="-3"
      unitRef="USD">5598000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2018-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">10387000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2017-09-012018-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">65000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718"
      decimals="-3"
      unitRef="USD">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734"
      decimals="-3"
      unitRef="USD">18000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">183000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2018-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">1365000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2018-08-31_custom_CognigenMember137486781"
      decimals="-3"
      unitRef="USD">625000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2018-08-31_custom_DILIsymMember137486796"
      decimals="-3"
      unitRef="USD">155000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross
      contextRef="AsOf2018-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">2145000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2017-09-012018-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">1748000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718"
      decimals="-3"
      unitRef="USD">401000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734"
      decimals="-3"
      unitRef="USD">572000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2017-09-012018-08-31_us-gaap_OperatingSegmentsMember"
      decimals="-3"
      unitRef="USD">2721000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_pn3n3_zJrhz4QAColl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8B6_zuA8uMzIV7U7" style="display: none"&gt;Schedule of geographical revenues&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2020&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;North &amp;amp; South America&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Asia&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRRtk1mciEr5" style="width: 11%; text-align: right" title="Revenues"&gt;11,124&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4yCkIHGEr2k" style="width: 11%; text-align: right" title="Revenues"&gt;5,024&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLGa3wTTIbpl" style="width: 11%; text-align: right" title="Revenues"&gt;5,812&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zipCPTlqCSLi" style="width: 11%; text-align: right" title="Revenues"&gt;21,961&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cognigen Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zS6zaOvq9Tcb" style="text-align: right" title="Revenues"&gt;11,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z4QH0lWQs0El" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zlMUXIoHGoxe" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdhdygJzQwla" style="text-align: right" title="Revenues"&gt;11,105&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;DILIsym Services, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrOzjHoFpMSe" style="text-align: right" title="Revenues"&gt;6,057&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zPs7H6lgkPu4" style="text-align: right" title="Revenues"&gt;646&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zvYEwyOsevOl" style="text-align: right" title="Revenues"&gt;246&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z5KLxPhrEwd5" style="text-align: right" title="Revenues"&gt;6,948&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z07XcB5cktcg" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;1,388&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsqjK87yRc17" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;157&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zZYnEzVzGvY8" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsh10MIbss47" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;1,575&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_z5yqrScQSQwh" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;29,674&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember_zOnois1EIm8f" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,827&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember_zvdDrRbbwXk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;6,088&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;&lt;p id="xdx_98C_eus-gaap--Revenues_pp0p0_c20190901__20200831_z9njnkBHIQ5j" style="font: 13.33px Times New Roman, Times, Serif; color: rgb(0, 0, 0)"&gt;&lt;span style="display: none; font-style: normal; font-weight: normal; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(238, 238, 238)"&gt;41,589,084&lt;/span&gt;&lt;/p&gt;41,589&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2019&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;North &amp;amp; South America&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Asia&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZmTkeGk2Sug" style="width: 11%; text-align: right" title="Revenues"&gt;9,381&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRzm5JMPj6w8" style="width: 11%; text-align: right" title="Revenues"&gt;5,144&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRWStue2Okei" style="width: 11%; text-align: right" title="Revenues"&gt;5,060&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zniiji62O83c" style="width: 11%; text-align: right" title="Revenues"&gt;19,585&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cognigen Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMO6Lxx5Agj3" style="text-align: right" title="Revenues"&gt;9,321&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z6eeplQ50xha" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zwpsWdlPCULf" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zfbqIsA7K6B3" style="text-align: right" title="Revenues"&gt;9,321&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;DILIsym Services, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zTOZ1VBc7xs5" style="text-align: right" title="Revenues"&gt;3,875&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4Y0OFo1EBe8" style="text-align: right" title="Revenues"&gt;685&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zzJWHoPnH7xb" style="text-align: right" title="Revenues"&gt;505&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z03s9YIMGVMd" style="text-align: right" title="Revenues"&gt;5,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zaluMlhDbgu9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zQWBY2eDLcr" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zoy1dgU5u9f3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBUWGxGn6cUl" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zQXAMrG0aDz1" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;22,577&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember_zGxG2JGrcUf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,829&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember_zVfuqcc6xwlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,565&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;&lt;p id="xdx_98E_eus-gaap--Revenues_pp0p0_c20180901__20190831_zAtGEVnm2Cn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none"&gt;33,970,440&lt;/p&gt;33,971&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Year ended August 31, 2018&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;North &amp;amp; South America&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Europe&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Asia&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Simulations Plus, Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zeII7hrIMrz" style="width: 11%; text-align: right" title="Revenues"&gt;7,856&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZcI0NCLxXm6" style="width: 11%; text-align: right" title="Revenues"&gt;4,964&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVSdlLepy8Cf" style="width: 11%; text-align: right" title="Revenues"&gt;4,733&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPAJQsH37C26" style="width: 11%; text-align: right" title="Revenues"&gt;17,553&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Cognigen Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zpfDKcC42Y2c" style="text-align: right" title="Revenues"&gt;7,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zBnbPWJRwNGe" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjcsa3iwsG1b" style="text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zPEVeQfhi0a4" style="text-align: right" title="Revenues"&gt;7,857&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;DILIsym Services, Inc.&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrsSyW0gwLf2" style="text-align: right" title="Revenues"&gt;3,163&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zi7bAEWFFde6" style="text-align: right" title="Revenues"&gt;312&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0lqB9ZFUBHk" style="text-align: right" title="Revenues"&gt;782&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXAU3PLhCyF3" style="text-align: right" title="Revenues"&gt;4,257&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Lixoft*&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zNN1YKP0Xto7" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zf4xV1WRj6Q9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBfl4xDvSVO2" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zup81ldnN3Ai" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues"&gt;&#x2013;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zlyiQa1LsN3a" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;18,876&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember_zISCw3o0FG29" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,276&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember_z6v6aRogU6Kf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;5,515&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"&gt;&lt;p id="xdx_982_eus-gaap--Revenues_pp0p0_c20170901__20180831_zFqi7WVzFyZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none"&gt;29,666,524&lt;/p&gt;29,667&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;*Lixoft was acquired on April 1, 2020.&lt;/p&gt;

</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">11124000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_EuropeMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">5024000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_AsiaMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">5812000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">21961000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">11105000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_EuropeMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_AsiaMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_CognigenMember137486375"
      decimals="-3"
      unitRef="USD">11105000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">6057000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_EuropeMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">646000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_AsiaMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">246000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember137486390"
      decimals="-3"
      unitRef="USD">6948000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">1388000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_EuropeMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">157000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_AsiaMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">30000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_LixoftMember137486390"
      decimals="-3"
      unitRef="USD">1575000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">29674000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">5827000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-012020-08-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">6088000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">41589084</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">9381000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_EuropeMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">5144000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_AsiaMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">5060000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">19585000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">9321000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_EuropeMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_AsiaMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_CognigenMember137486562"
      decimals="-3"
      unitRef="USD">9321000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">3875000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_EuropeMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">685000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_AsiaMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">505000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember137486578"
      decimals="-3"
      unitRef="USD">5065000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_EuropeMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_AsiaMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_LixoftMember137487265"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_custom_NorthAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">22577000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">5829000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">5565000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">33970440</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">7856000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_EuropeMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">4964000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_AsiaMember_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">4733000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_SimulationsMember"
      decimals="-3"
      unitRef="USD">17553000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">7857000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_EuropeMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_AsiaMember_custom_CognigenMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_CognigenMember137486718"
      decimals="-3"
      unitRef="USD">7857000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">3163000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_EuropeMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">312000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_AsiaMember_custom_DILIsymMember"
      decimals="-3"
      unitRef="USD">782000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_DILIsymMember137486734"
      decimals="-3"
      unitRef="USD">4257000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_EuropeMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_AsiaMember_custom_LixoftMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_LixoftMember137487406"
      decimals="-3"
      unitRef="USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_custom_NorthAndSouthAmericaMember"
      decimals="-3"
      unitRef="USD">18876000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_EuropeMember"
      decimals="-3"
      unitRef="USD">5276000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31_srt_AsiaMember"
      decimals="-3"
      unitRef="USD">5515000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">29666524</us-gaap:Revenues>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zQf2fkS2ccJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 12 &#x2013; &lt;span id="xdx_82A_zfh1wubEino9"&gt;RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On June 1, 2017 the Company acquired
DILIsym Service, Inc. As part of that agreement the Company paid $&lt;span id="xdx_90C_eus-gaap--PaymentsToAcquireBusinessesGross_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_pp0p0" title="Payment for acquisition"&gt;1,704,000&lt;/span&gt;
to former shareholders of DILIsym Services, Inc. who are currently employees of the Consolidated Company. In addition, as
part of the acquisition agreement the Company owes approximately $&lt;span id="xdx_90E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_pp0p0" title="Acquisition liabilities owed"&gt;2,260,000&lt;/span&gt;
of acquisition liabilities at August 31, 2018 to the former shareholders who are still employees of the Consolidated Company.
One of the former shareholders of DILIsym is currently a director of Simulations Plus, under the agreement he received
approximately $29,000 and could receive up to approximately $30,000 in future earn-out payments. In September 2018,
subsequent to year end under terms of the agreement the Company made payments in the amount of approximately $&lt;span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20180930__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_zgZrlgDYJ7e1" title="Earn-out payments made"&gt;587,000&lt;/span&gt;
and $&lt;span id="xdx_90D_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20180930__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zGvNMQVWpKE6" title="Earn-out payments made"&gt;10,000&lt;/span&gt;,
respectively to the employees and the current director. In fiscal year 2019, under terms of the agreement the Company made
payments in the amount of approximately $&lt;span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_zLxMStytowK6" title="Earn-out payments made"&gt;1,599,534&lt;/span&gt;
and $&lt;span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zpwUxQOGPmw6" title="Earn-out payments made"&gt;27,312&lt;/span&gt;,
respectively to the employees and the current director. In August 2020 the Company made final payments under the agreement in
the amount of approximately $&lt;span title="Repayment to related party"&gt;&lt;span id="xdx_905_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_ztoVbqRjFDVi"&gt;664,506&lt;/span&gt;&lt;/span&gt;
and $&lt;span title="Repayment to related party"&gt;&lt;span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zilDiZKOz6R2"&gt;11,346&lt;/span&gt;&lt;/span&gt;,
respectively to the employees and the current director.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 1, 2020 the Company acquired Lixoft
of Paris. As part of that agreement the Company paid $&lt;span id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesGross_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_zVhLCsW09u9d" title="Payment for acquisition"&gt;6,720,615&lt;/span&gt; and issued stock with a value of $&lt;span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_zDSKqEjMsHgl" title="Business acquisition, shares issued"&gt;2,602,081&lt;/span&gt; to former shareholders
of Lixoft who are currently employees of the Consolidated Company. In addition, as part of the acquisition agreement the Company
owes approximately $&lt;span id="xdx_908_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_z8Xy5RvS6Ar7" title="Acquisition liabilities owed"&gt;947,220&lt;/span&gt; of acquisition liabilities at August 31, 2020 to the former shareholders who are still employees of
the Consolidated Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember"
      decimals="0"
      unitRef="USD">1704000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="AsOf2020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember"
      decimals="0"
      unitRef="USD">2260000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2018-09-012018-09-30_custom_DILIsymMember_custom_DilisymEmployeesMember"
      decimals="0"
      unitRef="USD">587000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2018-09-012018-09-30_custom_DILIsymMember_srt_DirectorMember"
      decimals="0"
      unitRef="USD">10000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember_custom_DilisymEmployeesMember"
      decimals="0"
      unitRef="USD">1599534</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2018-09-012019-08-31_custom_DILIsymMember_srt_DirectorMember"
      decimals="0"
      unitRef="USD">27312</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember_custom_DilisymEmployeesMember"
      decimals="0"
      unitRef="USD">664506</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2019-09-012020-08-31_custom_DILIsymMember_srt_DirectorMember"
      decimals="0"
      unitRef="USD">11346</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2019-09-012020-08-31_custom_LixoftMember_custom_FormerShareholdersMember"
      decimals="0"
      unitRef="USD">6720615</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2019-09-012020-08-31_custom_LixoftMember_custom_FormerShareholdersMember"
      decimals="INF"
      unitRef="Shares">2602081</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="AsOf2020-08-31_custom_LixoftMember_custom_FormerShareholdersMember"
      decimals="0"
      unitRef="USD">947220</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_808_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zBpmqGCv9Otf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 13 - &lt;span id="xdx_827_zsWglPwrgAde"&gt;EMPLOYEE BENEFIT PLAN&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We maintain a 401(k) Plan for eligible
employees. We make matching contributions equal to 100% of the employee&#x2019;s elective deferral, not to exceed 4% of the total
employee compensation. We can also elect to make a profit-sharing contribution. We contributed $&lt;span id="xdx_909_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20190901__20200831_pp0p0" title="Contribution by employer in benefit plan"&gt;456,484&lt;/span&gt;, $&lt;span id="xdx_901_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20180901__20190831_pp0p0" title="Contribution by employer in benefit plan"&gt;404,684&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20170901__20180831_pp0p0" title="Contribution by employer in benefit plan"&gt;326,762&lt;/span&gt;
for fiscal years 2020, 2019 and 2018, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">456484</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">404684</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">326762</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_806_eus-gaap--MergersAcquisitionsAndDispositionsDisclosuresTextBlock_zBUOoc3ZhE2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 14 - &lt;span id="xdx_828_zSp288Gg3s91"&gt;ACQUISITION/MERGER WITH SUBSIDIARIES&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On March 31, 2020, the Company entered
into a Stock Purchase and Contribution Agreement (the &#x201c;Agreement&#x201d;) with Lixoft, a French soci&#xe9;t&#xe9; par
actions simplifi&#xe9;e (&#x201c;Lixoft&#x201d;). On April 1, 2020, the Company consummated the acquisition of all outstanding
equity interests of Lixoft pursuant to the terms of the Agreement, with Lixoft becoming a wholly owned subsidiary of the Company.
We believe the combination of Simulations Plus and Lixoft provides substantial future potential based on the complementary strengths
of each of the companies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under the terms of the Agreement, as described
below, the Company will pay the former shareholders of Lixoft total consideration of up to $16,500,000, consisting of two-thirds
cash and one-third newly issued, unregistered shares of the Company&#x2019;s common stock. In addition, the Company will pay $3,456,029
of excess working capital based on the March 31, 2020 financial statements of Lixoft.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On April 1, 2020, the Company paid the
former shareholders of Lixoft a total of $10,789,362, comprised of cash in the amount of $9,460,129 and the issuance of 111,682
shares of the Company&#x2019;s common stock valued at $3,662,337, net of adjustments and a holdback for representations and warranties
(under the terms of the Agreement a price of approximately $32.15 dollars per share was used based upon the volume-weighted average
closing price of the Company&#x2019;s shares of common stock for the 30-consecutive-trading-day period ending two trading days prior
to April 1, 2020). 9,669 shares are held in an escrow for offset for representations and warrantees. Within three business days
following the two-year anniversary of March 31, 2020 (the date of the Agreement) and subject to any offsets for representations
and warrantees, the Company will pay the former shareholders of Lixoft a total of $2,000,000, comprised of $1,333,333 of cash and
the release from an escrow shares of stock valued at $666,337 issued at the date of the Agreement. The Agreement provides for a
two-year market standoff period in which the newly issued shares may not be sold by the recipients thereof.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In addition, the agreement calls for earn-out
payments up to an additional $5,500,000, two-thirds cash and one-third newly issued, unregistered shares of the Company&#x2019;s
common stock based on a revenue growth formula each year for the two years subsequent to April 1, 2020. The former shareholders
can earn up to $2,000,000 the first year and $3,500,000 in year two. The Earn-out liability has been recorded at fair value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under the acquisition method of accounting,
the total purchase price reflects Lixoft&#x2019;s tangible and intangible assets and liabilities based on their estimated fair values
at the date of the completion of the acquisition (April 1, 2020). The following table summarizes the preliminary allocation of
the purchase price for Lixoft:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zcIywZDxNYK8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B3_z2hFyIoMwDi1" style="display: none"&gt;Allocation of purchase price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zJfdS7uAEkF9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 85%; text-align: justify"&gt;Assets acquired, Including cash of $3,799,134 and accounts receivable of $629,481&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,006,892&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Developed Technologies Acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,010,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Estimated value of Intangibles assets acquired (Customer Lists, trade name etc.)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,160,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Estimated Goodwill acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,533,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iNI_pp0p0_di_zTcmmmyhxeZ3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Liabilities Assumed&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,117,519&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total Consideration&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20190901__20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFPT57Vz6TIi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration"&gt;18,593,360&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_zpz8cR8BoPpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill has been provided in the transaction
based on estimates of future earnings of this subsidiary including anticipated synergies associated with the positioning of the
combined company as a leader in model-based drug development.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Consolidated supplemental Pro Forma
information&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following unaudited consolidated supplemental
pro forma information assumes that the acquisition of Lixoft took place on September 1, 2017 for the income statement years periods
ended August 31, 2020. These amounts have been calculated after applying the Company&#x2019;s accounting policies and adjusting
the results of Lixoft to reflect the same expenses in the years ended August 31, 2019 and 2018. The adjustments include costs of
acquisition, and amortization of intangibles and other technologies acquired during the merger, assuming the fair-value adjustments
applied on September 1, 2017, together with consequential tax effects.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zrpcNHjAFaUl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zg37rGxisVDc" style="display: none"&gt;Schedule of statement of income&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20190901__20200831_zShnKeJjCig4" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20180901__20190831_zOEIReq5nt8l" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20170901__20180831_zSWTor0Jq3Ej" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(Pro forma)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(Pro forma)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(Pro forma)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2020*&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(in thousands)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(in thousands)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(in thousands)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaRevenue_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; text-align: justify; padding-bottom: 2.5pt"&gt;Net Sales&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;43,970&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;36,918&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;31,891&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net Income&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,630&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,250&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,132&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;*Balances include five months actual results
for Lixoft.&lt;/p&gt;

&lt;p id="xdx_8AE_zRxGKAQVYcCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zcIywZDxNYK8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span id="xdx_8B3_z2hFyIoMwDi1" style="display: none"&gt;Allocation of purchase price&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zJfdS7uAEkF9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 85%; text-align: justify"&gt;Assets acquired, Including cash of $3,799,134 and accounts receivable of $629,481&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;5,006,892&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Developed Technologies Acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,010,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify"&gt;Estimated value of Intangibles assets acquired (Customer Lists, trade name etc.)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,160,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Estimated Goodwill acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,533,987&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iNI_pp0p0_di_zTcmmmyhxeZ3" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1pt"&gt;Liabilities Assumed&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(1,117,519&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Total Consideration&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20190901__20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFPT57Vz6TIi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration"&gt;18,593,360&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="AsOf2020-04-02_custom_LixoftMember"
      decimals="0"
      unitRef="USD">5006892</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="AsOf2020-04-02_custom_LixoftMember"
      decimals="0"
      unitRef="USD">8010000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="AsOf2020-04-02_custom_LixoftMember"
      decimals="0"
      unitRef="USD">4160000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="AsOf2020-04-02_custom_LixoftMember"
      decimals="0"
      unitRef="USD">2533987</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="AsOf2020-04-02_custom_LixoftMember"
      decimals="0"
      unitRef="USD">1117519</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2019-09-012020-04-02_custom_LixoftMember"
      decimals="0"
      unitRef="USD">18593360</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zrpcNHjAFaUl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BD_zg37rGxisVDc" style="display: none"&gt;Schedule of statement of income&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20190901__20200831_zShnKeJjCig4" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20180901__20190831_zOEIReq5nt8l" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20170901__20180831_zSWTor0Jq3Ej" style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(Pro forma)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(Pro forma)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(Pro forma)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2020*&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2019&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;2018&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(in thousands)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(in thousands)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;(in thousands)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;(unaudited)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaRevenue_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 55%; text-align: justify; padding-bottom: 2.5pt"&gt;Net Sales&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;43,970&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;36,918&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"&gt;31,891&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Net Income&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;10,630&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,250&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;9,132&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;*Balances include five months actual results
for Lixoft.&lt;/p&gt;

</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">43970</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">36918</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">31891</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2019-09-01to2020-08-31"
      decimals="0"
      unitRef="USD">10630</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2018-09-012019-08-31"
      decimals="0"
      unitRef="USD">9250</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="From2017-09-012018-08-31"
      decimals="0"
      unitRef="USD">9132</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_803_eus-gaap--QuarterlyFinancialInformationTextBlock_zZnUM75nCet9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 15 -&#160;&lt;span id="xdx_828_zlyAOAtdiz7k"&gt;UNAUDITED QUARTERLY FINANCIAL
DATA&lt;/span&gt; &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table presents selected unaudited quarterly financial
data for each full quarterly period of the years ended August 31, 2020 and 2019 (in thousands except for per share data), because
of rounding, numbers may not foot:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zM85Pbncz5Lg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zhI0IIPb7xy7" style="display: none"&gt;Quarterly Financial Information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20190901__20191130_zyJOyUoVg2k7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20191201__20200229_zS1UKxhr0GXc" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20200301__20200531_zZ51MpVxUJVk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20200601__20200831_zsZ4o5vBzVP9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;First&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Second&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Third&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Fourth&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Year&#160;ended&#160;August 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--Revenues_pn3n3_zGDaTK6Dgxma" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%"&gt;Revenues&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9,401&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;10,350&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;12,298&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9,540&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--GrossProfit_pn3n3_zEhW7MN3AE0l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gross Profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,683&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_z8Wj5evhf9S" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,150&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,936&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,188&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--EarningsPerShareBasic_pip0_zRUg9Klbn2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Earnings per share, Basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_pip0_zIrzKctB0ENc" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Earnings per share, Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20180901__20181130_zQoWUsEefpAh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20181201__20190228_zX0gUe46UYEj" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20190301__20190531_znowrDpL7UR9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20190601__20190831_zr2jb1KzBpQ1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;First&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Second&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Third&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Fourth&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Year&#160;ended&#160;August 31, 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--Revenues_pn3n3_z3YmL6UNkGY9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%"&gt;Revenues&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;7,536&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;8,472&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9,937&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;8,026&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--GrossProfit_pn3n3_zKPBv6FKcH72" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gross Profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_zAIBuNFd6kv5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,099&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,889&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,059&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_pip0_zswufykBp244" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Earnings per share, Basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--EarningsPerShareDiluted_pip0_zcjpIT9x7tv4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Earnings per share, Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="From2019-09-01to2020-08-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zM85Pbncz5Lg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)"&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span id="xdx_8BF_zhI0IIPb7xy7" style="display: none"&gt;Quarterly Financial Information&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_499_20190901__20191130_zyJOyUoVg2k7" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20191201__20200229_zS1UKxhr0GXc" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20200301__20200531_zZ51MpVxUJVk" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_498_20200601__20200831_zsZ4o5vBzVP9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;First&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Second&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Third&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Fourth&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Year&#160;ended&#160;August 31, 2020&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eus-gaap--Revenues_pn3n3_zGDaTK6Dgxma" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%"&gt;Revenues&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9,401&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;10,350&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;12,298&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9,540&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eus-gaap--GrossProfit_pn3n3_zEhW7MN3AE0l" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gross Profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,758&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,683&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,865&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_z8Wj5evhf9S" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,058&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,150&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,936&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,188&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_eus-gaap--EarningsPerShareBasic_pip0_zRUg9Klbn2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Earnings per share, Basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.17&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_pip0_zIrzKctB0ENc" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Earnings per share, Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20180901__20181130_zQoWUsEefpAh" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20181201__20190228_zX0gUe46UYEj" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_494_20190301__20190531_znowrDpL7UR9" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20190601__20190831_zr2jb1KzBpQ1" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;First&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Second&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Third&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;Fourth&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Year&#160;ended&#160;August 31, 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Quarter&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eus-gaap--Revenues_pn3n3_z3YmL6UNkGY9" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 40%"&gt;Revenues&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;7,536&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;8,472&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;9,937&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;8,026&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_eus-gaap--GrossProfit_pn3n3_zKPBv6FKcH72" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Gross Profit&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;6,264&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7,613&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;5,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_zAIBuNFd6kv5" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,536&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,099&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,889&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,059&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_pip0_zswufykBp244" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Earnings per share, Basic&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eus-gaap--EarningsPerShareDiluted_pip0_zcjpIT9x7tv4" style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;Earnings per share, Diluted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.09&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.12&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2019-09-012019-11-30"
      decimals="-3"
      unitRef="USD">9401000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-12-012020-02-29"
      decimals="-3"
      unitRef="USD">10350000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-03-012020-05-31"
      decimals="-3"
      unitRef="USD">12298000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2020-06-012020-08-31"
      decimals="-3"
      unitRef="USD">9540000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="From2019-09-012019-11-30"
      decimals="-3"
      unitRef="USD">6758000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2019-12-012020-02-29"
      decimals="-3"
      unitRef="USD">7683000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-03-012020-05-31"
      decimals="-3"
      unitRef="USD">9633000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2020-06-012020-08-31"
      decimals="-3"
      unitRef="USD">6865000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-09-012019-11-30"
      decimals="-3"
      unitRef="USD">2058000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-12-012020-02-29"
      decimals="-3"
      unitRef="USD">2150000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-03-012020-05-31"
      decimals="-3"
      unitRef="USD">2936000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2020-06-012020-08-31"
      decimals="-3"
      unitRef="USD">2188000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-09-012019-11-30"
      decimals="INF"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-12-012020-02-29"
      decimals="INF"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-03-012020-05-31"
      decimals="INF"
      unitRef="USDPShares">0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2020-06-012020-08-31"
      decimals="INF"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-09-012019-11-30"
      decimals="INF"
      unitRef="USDPShares">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-12-012020-02-29"
      decimals="INF"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-03-012020-05-31"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2020-06-012020-08-31"
      decimals="INF"
      unitRef="USDPShares">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:Revenues
      contextRef="From2018-09-012018-11-30"
      decimals="-3"
      unitRef="USD">7536000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2018-12-012019-02-28"
      decimals="-3"
      unitRef="USD">8472000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-03-012019-05-31"
      decimals="-3"
      unitRef="USD">9937000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2019-06-012019-08-31"
      decimals="-3"
      unitRef="USD">8026000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="From2018-09-012018-11-30"
      decimals="-3"
      unitRef="USD">5336000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2018-12-012019-02-28"
      decimals="-3"
      unitRef="USD">6264000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2019-03-012019-05-31"
      decimals="-3"
      unitRef="USD">7613000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2019-06-012019-08-31"
      decimals="-3"
      unitRef="USD">5735000</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-09-012018-11-30"
      decimals="-3"
      unitRef="USD">1536000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2018-12-012019-02-28"
      decimals="-3"
      unitRef="USD">2099000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-03-012019-05-31"
      decimals="-3"
      unitRef="USD">2889000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2019-06-012019-08-31"
      decimals="-3"
      unitRef="USD">2059000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2018-09-012018-11-30"
      decimals="INF"
      unitRef="USDPShares">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2018-12-012019-02-28"
      decimals="INF"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-03-012019-05-31"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2019-06-012019-08-31"
      decimals="INF"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2018-09-012018-11-30"
      decimals="INF"
      unitRef="USDPShares">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2018-12-012019-02-28"
      decimals="INF"
      unitRef="USDPShares">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-03-012019-05-31"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2019-06-012019-08-31"
      decimals="INF"
      unitRef="USDPShares">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2019-09-01to2020-08-31">&lt;p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zyuYjK4GCOOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 16 - &lt;span id="xdx_827_zHUcNWpgjPt7"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Dividend Declared&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On October 9, 2020, our Board of Directors
declared a quarterly cash dividend of $0.06 per share to our shareholders. The dividend in the amount of $1,195,461 was distributed
on Monday, November 2, 2020, for shareholders of record as of Monday, October 26, 2020.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130325192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Nov. 16, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--08-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-32046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Simulations Plus, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001023459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4595609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">42505 Tenth Street West<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lancaster<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">93534-7059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(661)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">723-7723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 412,688,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,931,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130388104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 49,207,314<span></span>
</td>
<td class="nump">$ 11,435,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $50,000 and $0</a></td>
<td class="nump">7,421,970<span></span>
</td>
<td class="nump">5,026,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms', window );">Revenues in excess of billings</a></td>
<td class="nump">3,093,343<span></span>
</td>
<td class="nump">3,233,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">969,688<span></span>
</td>
<td class="nump">765,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,595,447<span></span>
</td>
<td class="nump">704,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">66,803,595<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">129,091,357<span></span>
</td>
<td class="nump">21,165,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-term assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized computer software development costs, net of accumulated amortization of $13,581,599 and $12,356,055</a></td>
<td class="nump">6,087,378<span></span>
</td>
<td class="nump">4,959,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net (note 4)</a></td>
<td class="nump">437,787<span></span>
</td>
<td class="nump">341,145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right of use asset</a></td>
<td class="nump">926,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intellectual property, net of accumulated amortization of $5,087,031 and $3,948,750</a></td>
<td class="nump">11,897,970<span></span>
</td>
<td class="nump">5,026,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Other intangible assets net of accumulated amortization of $1,641,725 and $1,210,000</a></td>
<td class="nump">7,008,275<span></span>
</td>
<td class="nump">3,280,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">12,921,185<span></span>
</td>
<td class="nump">10,387,198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">50,965<span></span>
</td>
<td class="nump">37,227<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">168,421,517<span></span>
</td>
<td class="nump">45,196,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">349,939<span></span>
</td>
<td class="nump">204,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and other expenses</a></td>
<td class="nump">2,250,692<span></span>
</td>
<td class="nump">1,639,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ContractsPayableCurrent', window );">Current portion - Contracts payable (note 6)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">1,761,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BillingsInExcessOfCost', window );">Billings in excess of revenues</a></td>
<td class="nump">140,991<span></span>
</td>
<td class="nump">798,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease Liability, current portion</a></td>
<td class="nump">463,465<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">299,482<span></span>
</td>
<td class="nump">380,787<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">5,504,569<span></span>
</td>
<td class="nump">4,783,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">2,353,858<span></span>
</td>
<td class="nump">2,731,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease Liability</a></td>
<td class="nump">463,312<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ContractsPayableNoncurrent', window );">Payments due under Contracts payable (note 6)</a></td>
<td class="nump">4,063,833<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">12,385,572<span></span>
</td>
<td class="nump">7,515,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity (note 8)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value 50,000,000 shares authorized 19,923,277 and 17,591,834 shares issued and outstanding</a></td>
<td class="nump">9,926<span></span>
</td>
<td class="nump">7,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">128,531,427<span></span>
</td>
<td class="nump">15,319,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income</a></td>
<td class="nump">58,467<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">27,436,125<span></span>
</td>
<td class="nump">22,354,535<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">156,035,945<span></span>
</td>
<td class="nump">37,681,604<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 168,421,517<span></span>
</td>
<td class="nump">$ 45,196,697<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ContractsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts payable, current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ContractsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ContractsPayableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts payable, noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ContractsPayableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BillingsInExcessOfCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability attributable to (i) billings in excess of costs under the percentage of completion contract accounting method representing the difference between contractually invoiced amounts (billings) and revenue recognized based, for example, on costs incurred to estimated total costs at period end or (ii) contractually invoiced amounts (billings) in excess of costs incurred and accumulated under the completed contract accounting method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BillingsInExcessOfCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118261985&amp;loc=d3e55302-109406<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130721016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Accumulated amortization of computer software development costs</a></td>
<td class="nump">$ 13,581,599<span></span>
</td>
<td class="nump">$ 12,356,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock shares authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">19,923,277<span></span>
</td>
<td class="nump">17,591,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="nump">19,923,277<span></span>
</td>
<td class="nump">17,591,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on intangible assets</a></td>
<td class="nump">$ 5,087,031<span></span>
</td>
<td class="nump">$ 3,948,750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on intangible assets</a></td>
<td class="nump">$ 1,641,725<span></span>
</td>
<td class="nump">$ 1,210,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574133357800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 41,589,084<span></span>
</td>
<td class="nump">$ 33,970,440<span></span>
</td>
<td class="nump">$ 29,666,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
<td class="nump">10,649,230<span></span>
</td>
<td class="nump">9,025,704<span></span>
</td>
<td class="nump">7,994,228<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">30,939,854<span></span>
</td>
<td class="nump">24,944,736<span></span>
</td>
<td class="nump">21,672,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative</a></td>
<td class="nump">16,360,053<span></span>
</td>
<td class="nump">11,796,027<span></span>
</td>
<td class="nump">9,583,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,974,623<span></span>
</td>
<td class="nump">2,499,980<span></span>
</td>
<td class="nump">1,790,656<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">19,334,676<span></span>
</td>
<td class="nump">14,296,007<span></span>
</td>
<td class="nump">11,374,508<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">11,605,178<span></span>
</td>
<td class="nump">10,648,729<span></span>
</td>
<td class="nump">10,297,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">29,468<span></span>
</td>
<td class="nump">33,522<span></span>
</td>
<td class="nump">27,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability', window );">Change in value of contingent consideration</a></td>
<td class="num">(202,500)<span></span>
</td>
<td class="num">(109,078)<span></span>
</td>
<td class="num">(153,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">(Loss) income on currency exchange</a></td>
<td class="num">(45,097)<span></span>
</td>
<td class="num">(16,697)<span></span>
</td>
<td class="num">(32,934)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(218,129)<span></span>
</td>
<td class="num">(92,253)<span></span>
</td>
<td class="num">(158,846)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before provision for income taxes</a></td>
<td class="nump">11,387,049<span></span>
</td>
<td class="nump">10,556,476<span></span>
</td>
<td class="nump">10,138,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(2,054,989)<span></span>
</td>
<td class="num">(1,973,147)<span></span>
</td>
<td class="num">(1,204,130)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 9,332,060<span></span>
</td>
<td class="nump">$ 8,583,329<span></span>
</td>
<td class="nump">$ 8,934,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">17,819,064<span></span>
</td>
<td class="nump">17,492,258<span></span>
</td>
<td class="nump">17,328,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">18,538,373<span></span>
</td>
<td class="nump">18,057,431<span></span>
</td>
<td class="nump">17,860,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Other Comprehensive Income, net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustments</a></td>
<td class="nump">$ 58,467<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income</a></td>
<td class="nump">$ 9,390,527<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in value of contingent consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048805128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>AOCI Attributable to Parent [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance, value at Aug. 31, 2017</a></td>
<td class="nump">$ 7,278<span></span>
</td>
<td class="nump">$ 12,109,141<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 13,688,468<span></span>
</td>
<td class="nump">$ 25,804,887<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Aug. 31, 2017</a></td>
<td class="nump">17,277,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">635,452<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">635,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="nump">130,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Stock-based Compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">562,078<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">562,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to Directors for services</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">146,997<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">147,005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to Directors for services, shares</a></td>
<td class="nump">8,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Declaration of Dividend</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,161,740)<span></span>
</td>
<td class="num">(4,161,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,934,812<span></span>
</td>
<td class="nump">8,934,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Aug. 31, 2018</a></td>
<td class="nump">$ 7,417<span></span>
</td>
<td class="nump">13,453,668<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,461,540<span></span>
</td>
<td class="nump">31,922,625<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Aug. 31, 2018</a></td>
<td class="nump">17,416,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">787,979<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">788,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="nump">166,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Stock-based Compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">865,848<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">865,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to Directors for services</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">211,979<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">211,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to Directors for services, shares</a></td>
<td class="nump">8,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Declaration of Dividend</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,197,055)<span></span>
</td>
<td class="num">(4,197,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,583,329<span></span>
</td>
<td class="nump">8,583,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606', window );">Cumulative Effect of Changes related to adoption of ASC 606</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(493,279)<span></span>
</td>
<td class="num">(493,279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Aug. 31, 2019</a></td>
<td class="nump">$ 7,595<span></span>
</td>
<td class="nump">15,319,474<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,354,535<span></span>
</td>
<td class="nump">37,681,604<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Aug. 31, 2019</a></td>
<td class="nump">17,591,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">629,626<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">629,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="nump">121,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Stock-based Compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,286,625<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,286,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Shares issued to Directors for services</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">289,893<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">289,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued to Directors for services, shares</a></td>
<td class="nump">7,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Declaration of Dividend</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,250,470)<span></span>
</td>
<td class="num">(4,250,470)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,332,060<span></span>
</td>
<td class="nump">9,332,060<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued - Lixoft</a></td>
<td class="nump">$ 112<span></span>
</td>
<td class="nump">3,260,562<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,260,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued - Lixoft, shares</a></td>
<td class="nump">111,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued for cash, net</a></td>
<td class="nump">$ 2,091<span></span>
</td>
<td class="nump">107,745,247<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 107,747,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued for cash, net, shares</a></td>
<td class="nump">2,090,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,090,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">58,467<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 58,467<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance, value at Aug. 31, 2020</a></td>
<td class="nump">$ 9,926<span></span>
</td>
<td class="nump">$ 128,531,427<span></span>
</td>
<td class="nump">$ 58,467<span></span>
</td>
<td class="nump">$ 27,436,125<span></span>
</td>
<td class="nump">$ 156,035,945<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Aug. 31, 2020</a></td>
<td class="nump">19,923,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative Effect of Changes related to adoption of ASC 606</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130304872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 9,332,060<span></span>
</td>
<td class="nump">$ 8,583,329<span></span>
</td>
<td class="nump">$ 8,934,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,961,930<span></span>
</td>
<td class="nump">2,750,245<span></span>
</td>
<td class="nump">2,721,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="nump">202,500<span></span>
</td>
<td class="nump">109,060<span></span>
</td>
<td class="nump">152,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,576,525<span></span>
</td>
<td class="nump">1,077,837<span></span>
</td>
<td class="nump">709,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(377,759)<span></span>
</td>
<td class="num">(299,096)<span></span>
</td>
<td class="num">(1,731,821)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Increase (decrease) in</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(2,017,792)<span></span>
</td>
<td class="nump">487,970<span></span>
</td>
<td class="num">(1,465,803)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract', window );">Revenues in excess of billings</a></td>
<td class="nump">140,316<span></span>
</td>
<td class="num">(1,248,063)<span></span>
</td>
<td class="num">(504,514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid income taxes</a></td>
<td class="num">(12,380)<span></span>
</td>
<td class="num">(452,517)<span></span>
</td>
<td class="nump">149,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(398,213)<span></span>
</td>
<td class="num">(93,877)<span></span>
</td>
<td class="num">(153,682)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">220,584<span></span>
</td>
<td class="num">(147,529)<span></span>
</td>
<td class="nump">110,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued payroll and other expenses</a></td>
<td class="nump">23,030<span></span>
</td>
<td class="nump">486,862<span></span>
</td>
<td class="nump">168,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings', window );">Billings in excess of revenues</a></td>
<td class="num">(657,558)<span></span>
</td>
<td class="nump">413,946<span></span>
</td>
<td class="nump">167,645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Accrued income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(81,305)<span></span>
</td>
<td class="num">(29,747)<span></span>
</td>
<td class="nump">27,966<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">10,911,938<span></span>
</td>
<td class="nump">11,638,420<span></span>
</td>
<td class="nump">9,287,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows used in investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(231,380)<span></span>
</td>
<td class="num">(137,745)<span></span>
</td>
<td class="num">(183,291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchases of intellectual property</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(67,248,924)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates', window );">Cash used to acquire subsidiaries</a></td>
<td class="num">(9,471,352)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash received in acquisition</a></td>
<td class="nump">3,799,134<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Capitalized computer software development costs</a></td>
<td class="num">(2,353,188)<span></span>
</td>
<td class="num">(1,767,996)<span></span>
</td>
<td class="num">(2,145,429)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(75,505,710)<span></span>
</td>
<td class="num">(1,955,741)<span></span>
</td>
<td class="num">(2,328,720)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows provided by (used in) financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payment of dividends</a></td>
<td class="num">(4,250,470)<span></span>
</td>
<td class="num">(4,197,055)<span></span>
</td>
<td class="num">(4,161,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_PaymentsOnContractsPayable', window );">Payments on contracts payable</a></td>
<td class="num">(1,761,028)<span></span>
</td>
<td class="num">(4,238,973)<span></span>
</td>
<td class="num">(247,328)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">629,747<span></span>
</td>
<td class="nump">788,147<span></span>
</td>
<td class="nump">635,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from follow-on public offering, net</a></td>
<td class="nump">107,747,338<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">102,365,587<span></span>
</td>
<td class="num">(7,647,881)<span></span>
</td>
<td class="num">(3,773,485)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">37,771,815<span></span>
</td>
<td class="nump">2,034,798<span></span>
</td>
<td class="nump">3,184,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of year</a></td>
<td class="nump">11,435,499<span></span>
</td>
<td class="nump">9,400,701<span></span>
</td>
<td class="nump">6,215,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">49,207,314<span></span>
</td>
<td class="nump">11,435,499<span></span>
</td>
<td class="nump">9,400,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">2,352,770<span></span>
</td>
<td class="nump">2,673,475<span></span>
</td>
<td class="nump">2,712,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-Cash Investing and Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_StockIssuedForAcquisitionOfLixoft', window );">Stock issued for acquisition of Lixoft</a></td>
<td class="nump">3,260,674<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Creation of contract liabilities for acquisition of subsidiaries</a></td>
<td class="nump">4,528,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_RightOfUseAssetsCapitalized', window );">Right of use assets capitalized</a></td>
<td class="nump">$ 1,498,542<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_PaymentsOnContractsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment on contracts payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_PaymentsOnContractsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_RightOfUseAssetsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right of use assets capitalized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_RightOfUseAssetsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_StockIssuedForAcquisitionOfLixoft">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued for acquisition of Lixoft</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_StockIssuedForAcquisitionOfLixoft</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the liability reflecting cash payments received before the related costs have been incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the asset reflecting the cost incurred on uncompleted contracts in excess of related billings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048184136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND LINES OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">ORGANIZATION AND LINES OF BUSINESS</a></td>
<td class="text"><p id="xdx_809_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zTK5N3T9EHLk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 - <span id="xdx_821_zFrbVCeK9iF9">ORGANIZATION AND LINES OF BUSINESS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Organization</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulations Plus, Inc. (&#8220;Simulations
Plus&#8221;, &#8220;Lancaster&#8221;) was incorporated on July 17, 1996. In September 2014, Simulations Plus acquired all of the
outstanding equity interests of Cognigen Corporation (&#8220;Cognigen&#8221;, &#8220;Buffalo&#8221;) and Cognigen became a wholly
owned subsidiary of Simulations Plus, Inc. In June 2017, Simulations Plus acquired DILIsym Services, Inc. (DILIsym) as a wholly
owned subsidiary. In April 2020, Simulations Plus, Inc. acquired Lixoft, a French soci&#233;t&#233; par actions simplifi&#233;e
(&#8220;Lixoft&#8221;, &#8220;Paris&#8221;) as a wholly-owned subsidiary pursuant to a stock purchase and contribution agreement.
(Collectively, &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Lines of Business</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company designs and develops pharmaceutical
simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education
of pharmacy and medical students, and it provides consulting services to the pharmaceutical and chemical industries. Recently,
the Company has begun to explore developing software applications for defense and for health care outside of the pharmaceutical
industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046579688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zspAg91dKTGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 - <span id="xdx_82C_zk26ltINtj87">SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zLeqCyNdEKae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Principles of Consolidation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the accounts of Simulations Plus, Inc. and, as of September 2, 2014, its wholly owned subsidiary, Cognigen Corporation, as of June
1, 2017, the accounts of DILIsym Services, Inc., and as of April 1, 2020, Lixoft accounts. All significant intercompany accounts
and transactions are eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_84A_eus-gaap--UseOfEstimates_z01cKeDwoRV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Use of Estimates</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial statements and accompanying
notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial
statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue,
and expenses. These estimates and assumptions are affected by management&#8217;s application of accounting policies. Actual results
could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized
computer software development costs, valuation of stock options, and accounting for income taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zyPHw0BDcvE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Reclassifications</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain numbers in the prior year have
been reclassified to conform to the current year's presentation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_z3lyisFPeqe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Revenue Recognition</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In May 2014, the
Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding
Accounting Standards Codification Topic 606 (ASC Topic 606), <i>Revenue from Contracts with Customers</i>. The standard provides
principles for recognizing revenue for the transfer of promised goods or services to customers with the consideration to which
the entity expects to be entitled in exchange for those goods or services. The standard also provides guidance on the recognition
of incremental costs related to obtaining customer contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing
the modified retrospective method. This approach was applied to contracts that were in process as of September 1, 2018, and the
corresponding incremental costs of obtaining those contracts, which resulted in a cumulative effect adjustment of $493,279 to the
opening balance of retained earnings at the date of adoption. The adoption of this ASU primarily impacts the timing of our revenue
recognition for certain sales contracts, the capitalization and amortization of incremental costs of obtaining a contract, and
related disclosures. The reported results for fiscal years 2020 and 2019 reflect the application of ASC Topic 606, while the reported
results for fiscal year 2018 are not adjusted and continue to be reported under ASC Topic 605.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines revenue recognition
through the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td>
    <td style="width: 95%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the contract, or contracts, with a customer</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Determination of the transaction price</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Recognition of revenue when, or as, the Company satisfies a performance obligation</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Deferred Commissions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales commissions earned by our sales force
and our commissioned sales representatives are considered incremental and recoverable costs of obtaining a contract with a customer.
Sales commissions for new contracts are deferred and then amortized on a straight-line basis over a period of benefit. We determined
the period of benefit by taking into consideration our customer contracts, our technology and other factors. Sales commissions
for renewal contracts are deferred and then amortized on a straight-line basis over the related contractual renewal period. Amortization
expense is included in sales and marketing expenses on the condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We apply the practical expedient in ASC
Topic 606 to expense costs as incurred for sales commissions when the period of benefit would have been one year or less. Most
of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with
them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Practical Expedients and Exemptions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has elected the following additional
practical expedients in applying Topic 606:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Commission Expense</i></b>: We apply the practical expedient in ASC Topic 606 to expense costs as incurred for sales commissions when the period of benefit is one year or less. Most of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with them<i>.</i></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: bottom">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Transaction Price Allocated to Future
        Performance Obligations</i></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 606 requires that the Company disclose
        the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of August
        31, 2020. ASC 606 provides certain practical expedients that limit the requirement to disclose the aggregate amount of transaction
        price allocated to unsatisfied performance obligations.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applied the practical expedient
        to not disclose the amount of transaction price allocated to unsatisfied performance obligations when the performance obligation
        is part of a contract that has an original expected duration of one year or less.</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z42PwMyYxHjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Cash and Cash Equivalents </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of the statements of cash
flows, the Company considers all highly liquid investments purchased with original maturities of three months or less to be cash
equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zBcFHT8No2Ja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Accounts Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We analyze the age of customer balances,
historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability
of the Company&#8217;s trade accounts receivable balances. If we determine that the financial conditions of any of our customers
have deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts
receivable are written off when all collection attempts have failed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_z91iV48QM9Hj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Investments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may invest excess cash balances in short-term
and long-term marketable debt securities. Investments may consist of certificates of deposit, money market accounts, government-sponsored
enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities
in accordance with FASB ASC 320, Investments &#8211; Debt and Equity Securities. This statement requires debt securities to be
classified into three categories:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Held-to-maturity&#8212;Debt securities
that the entity has the positive intent and ability to hold to maturity are reported at amortized cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trading Securities&#8212;Debt securities
that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains
and losses included in earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Available-for-Sale&#8212;Debt securities
not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or
losses excluded from earnings and reported as a separate component of shareholders&#8217; equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company classifies its investments
in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. During the
years ended August 31, 2020, all of the Company&#8217;s investments were classified as held-to-maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Held-to-maturity investments are measured
and recorded at amortized cost on the Company&#8217;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt
securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities
are realized until they are sold or a decline in fair value is determined to be other-than-temporary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_847_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zs3HpkzXLr74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Capitalized Computer Software Development
Costs</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Software development costs are capitalized
in accordance with ASC 985-20, <i>&#8220;Costs of Software to Be Sold, Leased, or Marketed&#8221;</i>. Capitalization of software
development costs begins upon the establishment of technological feasibility and is discontinued when the product is available
for sale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The establishment of technological feasibility
and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management
with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues,
estimated economic life, and changes in software and hardware technologies. Capitalized computer software development costs are
comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in the Company's
software products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization of capitalized computer software
development costs is provided on a product-by-product basis on the straight-line method over the estimated economic life of the
products not to exceed five years. Amortization of software development costs amounted to $<span id="xdx_908_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20190901__20200831_pp0p0" title="Amortization of software development">1,225,544</span>, $<span id="xdx_901_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20180901__20190831_pp0p0" title="Amortization of software development">1,331,753</span>, and $<span id="xdx_90F_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20170901__20180831_pp0p0" title="Amortization of software development">1,300,434</span>
for the years ended August 31, 2020, 2019, and 2018, respectively. We expect future amortization expense to vary due to increases
in capitalized computer software development costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We test capitalized computer software development
costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zuOp5O4a3s8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Property and Equipment</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are recorded at
cost, or fair market value for property and equipment acquired in business combinations, less accumulated depreciation and amortization.
Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z57BwBKBd17j" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zId55k5a3xZf" style="display: none">Property and Equipment estimated useful lives</span></td>
    <td>&#160;</td>
    <td id="xdx_49F_20190901__20200831_zRnKl9OntJp7" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment</span></td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 47%; text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zSJ94LMI3jW2">5 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Computer equipment</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zxYSFSHDCa2i">3 to 7 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdwfRk2MRXo4">5 to 7 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zZ7hPNG6YRb3">Shorter of life of asset or lease</span></span></td></tr>
</table>
<p id="xdx_8A5_zoCoFxYwtNn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maintenance and minor replacements are
charged to expense as incurred. Gains and losses on disposals are included in the results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zrcvmE3qmnM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0"><span style="text-decoration: underline">Leases</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU No.
2016-02&#8212;Leases, to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities
on the balance sheet and disclosing key information about leasing arrangements. A lessee should recognize in the statement of financial
position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying
asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessor
have not significantly changed from previous U.S. GAAP. This ASU was effective for annual periods, including interim periods within
those annual periods, beginning after December 15, 2018. We adopted this ASU on September 1, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We lease various production, administrative
and sales offices under operating leases. We evaluate our contracts to determine if an arrangement is a lease at inception and
classify it as a finance or operating lease. Currently, all our leases are classified as operating leases. Leased assets and corresponding
liabilities are recognized based on the present value of the lease payments over the lease term. Our lease terms may include options
to extend when it is reasonably certain that we will exercise that option. Costs associated with operating leases are recognized
on a straight-line basis within operating expenses over the term of the lease. With the adoption of ASC 842 on September 1, 2019,
we recognized all leases with terms greater than 12 months in duration on our consolidated balance sheets as right-of-use assets
and lease liabilities. We adopted the standard using the prospective approach and did not retrospectively apply to prior periods.
Right-of-use assets are recorded in long-term assets on our consolidated balance sheets. Current and non-current lease liabilities
are recorded as operating lease liabilities within current liabilities and long-term liabilities, respectively, on our consolidated
balance sheets. As part of the adoption of this standard we recorded the following assets and liabilities as of September 1, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zTtNDqhLnfG7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BE_zSqDmV3ka2a7" style="display: none">Schedule of Operating assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20190902__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zL2WufTMtCs5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zoaaRhyOZZb9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Right of use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">902,553</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_zcy5QdVlyte6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease Liabilities, Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">537,017</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zbdJMiR7Eh55" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Lease Liabilities, Long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">365,536</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A3_zNbhSBZ9dUbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have made certain assumptions and judgments
when applying ASC 842, the most significant of which are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We elected the package of practical expedients available for transition that allow us to not reassess whether expired or existing contracts contain leases under the new definition of a lease, lease classification for expired or existing leases and whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We did not elect to use hindsight when considering judgments and estimates such as assessments of lessee options&#160;&#160; to extend or terminate a lease or purchase the underlying asset.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">The determination of the discount rate used in a lease is our estimated incremental borrowing rate that is based on what we would expect to pay to borrow over a similar term an amount equal to the lease payments.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Supplemental balance sheet information
related to operating leases was as follows as of August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zKoM6hMVYr81" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BC_zf5nJv1vY6T" style="display: none">Schedule of lease cost</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20200831_ztCF8vNQALEg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Right of use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">926,600</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease Liabilities, Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">463,465</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Lease Liabilities, Long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">463,312</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseCost_pp0p0_c20190901__20200831_zQBxhB4OiEd4" style="text-align: right" title="Operating lease costs">600,717</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted Average remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200831_zi078OFyofUa" title="Weighted average remaining lease term">2.27</span> years</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Weighted Average Discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pii_dp_c20200831_zvOvrb8miQZ1" title="Weighted average discount rate">4.25</span>%</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A6_z7z82ziGig1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z8aP6yZfFgAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Intangible Assets and Goodwill </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company performs valuations of assets
acquired and liabilities assumed on each acquisition accounted for as a business combination and recognizes the assets acquired
and liabilities assumed at their acquisition date fair value. Acquired intangible assets include customer relationships, software,
trade name, and non-compete agreements. The Company determines the appropriate useful life by performing an analysis of expected
cash flows based on historical experience of the acquired businesses. Intangible assets are amortized over their estimated useful
lives using the straight-line method, which approximates the pattern in which the majority of the economic benefits are expected
to be consumed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of the cost
of an acquired entity over the fair value of the acquired net assets. Goodwill is not amortized, instead it is tested for impairment
annually or when events or circumstances change that would indicate that goodwill might be impaired. Events or circumstances that
could trigger an impairment review include, but are not limited to, a significant adverse change in legal factors or in the business
climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes
in the manner of the Company's use of the acquired assets or the strategy for the Company's overall business, significant negative
industry or economic trends or significant under-performance relative to expected historical or projected future results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is tested for impairment at the
reporting unit level, which is one level below or the same as an operating segment. As of August 31, 2020, the Company determined
that it has four reporting units, Simulations Plus, Cognigen Corporation, DILIsym Services, Inc. and Lixoft. When testing
goodwill for impairment, the Company first performs a qualitative assessment to determine whether it is necessary to perform step
one of a two-step annual goodwill impairment test for each reporting unit. The Company is required to perform step one only if
it concludes that it is more likely than not that a reporting unit's fair value is less than its carrying value. Should this be
the case, the first step of the two-step process is to identify whether a potential impairment exists by comparing the estimated
fair values of the Company's reporting units with their respective book values, including goodwill. If the estimated fair value
of the reporting unit exceeds book value, goodwill is considered not to be impaired, and no additional steps are necessary. If,
however, the fair value of the reporting unit is less than book value, then the second step is performed to determine if goodwill
is impaired and to measure the amount of impairment loss, if any. The amount of the impairment loss is the excess of the carrying
amount of the goodwill over its implied fair value. The estimate of implied fair value of goodwill is primarily based on an estimate
of the discounted cash flows expected to result from that reporting unit, but may require valuations of certain internally generated
and unrecognized intangible assets such as the Company's software, technology, patents and trademarks. If the carrying amount of
goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to the excess.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, the entire balance
of goodwill was attributed to three of the Company's reporting units, Cognigen Corporation, DILIsym Services and Lixoft. Intangible
assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of
these assets may not be recoverable. The Company has <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zPQSY2jLPcrl" title="Impairment of long-lived assets"><span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zTalRBgg96G3" title="Impairment of long-lived assets"><span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z23eeCj7Ky32" title="Impairment of long-lived assets">no</span></span></span>t recognized any impairment charges during the periods ended August 31,
2020, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reconciliation of Goodwill for the period
ended August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfGoodwillTextBlock_z4HAeKRfXG9a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BF_zuAQoWfd73Qe" style="display: none">Schedule of reconciliation of goodwill</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-weight: bold">Balance, August 31, 2017</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zoR0fNA1RpMj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zSoxwTUSYCRj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iS_pp0p0_d0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zCFcLsBeuOa4" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20170831_zvEwCAhEXfJi" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zvsgqGbcSyG9" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zhhwZkbMyTLd" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHg46XMJXXJe" style="font-weight: bold; text-align: right" title="Addition">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831_zHaTc6ijB0Be" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Impairments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zkbUasYxCbG1" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zuasCTew16Ag" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zzQNnyC5Xr92" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831_zkKJBVSQO7md" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance, August 31, 2018</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zMUXOD9rtnRg" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zeXXADTv1cvf" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Goodwill_iS_pp0p0_d0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zR6QbZfcc7Ed" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20180831_zyYx0cSdkeBd" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zLgbuxdmazBk" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zgEZVCjCjow5" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zE5XV05nhK1c" style="font-weight: bold; text-align: right" title="Addition">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831_zqBiLpeMMal9" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Impairments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zCj29W7ZobBb" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zXdfBHzScdga" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcnZUfhUVYac" style="font-weight: bold; text-align: right" title="Impairments">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831_zIhzqb75zgAa" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balance, August 31, 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zSBcD1rOk8mj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zxCJv7IZot2d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_d0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFpsM4tMcXBf" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831_zq5CD50hQSz1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zAA9MZ82Firl" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zUaRbbH9IZ8j" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_pp0p0" style="font-weight: bold; text-align: right" title="Addition">2,533,987</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831_pp0p0" style="font-weight: bold; text-align: right" title="Addition">2,533,987</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Impairments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zpDb6srRyPR6" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zImENgHoNJp8" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zrnP0MMN3oHf" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831_zOVAChUZbsPb" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z8WvpIiRt9X3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">4,789,248</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zQfPUAISziy7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">5,597,950</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zGIfo8AZhXH7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">2,533,987</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iE_pp0p0_c20200831_zB26qGUiDAe9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">12,921,185</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zHmLQSCUzkp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>









<p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zbMRhXdE1U3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Other Intangible Assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes other intangible
assets as of August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zcdMv2SMnMX6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_z8PKBG7mUBPe" style="display: none">Schedule of other intangible assets</span></td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization<br/> Period</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Acquisition<br/> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net book <br/> value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 30%; text-align: left">Customer relationships-Cognigen</td><td style="width: 2%">&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="width: 23%; text-align: left" title="Amortization period">Straight line 8 years</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Acquisition value">1,100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Accumulated amortization">825,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Net book value">275,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Cognigen</td><td>&#160;</td>
    <td id="xdx_98E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z9H50fVKZ7h4" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Net book value">500,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Covenants not to compete-Cognigen</td><td>&#160;</td>
    <td id="xdx_980_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="text-align: left" title="Amortization period">Straight line 5 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Accumulated amortization">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zWM81nzb5Q4f" style="text-align: right" title="Net book value">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Covenants not to compete-DILIsym</td><td>&#160;</td>
    <td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period">Straight line 4 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">15,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Trade Name-DILIsym</td><td>&#160;</td>
    <td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">860,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zK8OpZ196sib" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">860,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships-DILIsym</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period">Straight line 10 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">1,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization">617,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">1,282,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Customer relationships-Lixoft</td><td>&#160;</td>
    <td id="xdx_982_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcuIzsZApaQ7" style="text-align: left" title="Amortization period">Straight line 14 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxDMpotqsKGh" style="text-align: right" title="Acquisition value">2,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zwghqLFIKLF2" style="text-align: right" title="Accumulated amortization">75,892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_ztnFFsowEzg1" style="text-align: right" title="Net book value">2,474,108</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Lixoft</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHqRhmhyaYL8" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zZXtOxMG2TF1" style="text-align: right" title="Acquisition value">1,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zTvrtuBVMjP4" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zAqcvFAQ80Y7" style="text-align: right" title="Net book value">1,550,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Covenants not to compete-Lixoft</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxkBBuWqUWr1" style="text-align: left; padding-bottom: 1pt" title="Amortization period">Straight line 3 years</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z7pFB0M4R3C5" style="border-bottom: Black 1pt solid; text-align: right" title="Acquisition value">60,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z0gE94uETOqf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">8,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zexyHyyHGowf" style="border-bottom: Black 1pt solid; text-align: right" title="Net book value">51,667</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Acquisition value">8,650,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accumulated amortization">1,641,725</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Net book value">7,008,275</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AC_zG1JJ03xFfx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for the year ended
August 31, 2020, 2019 and 2018 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3ZFxKJwWMbb" title="Amortization of intangible assets">431,725</span>, $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3bmRuno6Ook" title="Amortization of intangible assets">357,500</span>, and $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVABDRip64Ae" title="Amortization of intangible assets">357,500</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Future amortization for the next five years is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zxQnkrdiyGO6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span id="xdx_8B9_z234vGfYtfFf" style="display: none">Schedule of future amortization</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ending</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>August 31,</b></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 35%; text-align: center">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zRWulqymKJsl" style="width: 11%; text-align: right" title="2021">545,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zCSW1w5HslL6" style="text-align: right" title="2022">530,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_znfvw1zNOtAf" style="text-align: right" title="2023">384,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zT0va5RT4hTj" style="text-align: right" title="2024">372,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyakFlEwBm42" style="text-align: right" title="2025">372,000</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zjzYJ5dEGP21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p id="xdx_84C_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zOecTBEg1Jo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Business Acquisitions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounted for the acquisition
of Cognigen, DILIsym Services, Inc. and Lixoft using the purchase method of accounting where the assets acquired and liabilities
assumed are recognized based on their respective estimated fair values. The excess of the purchase price over the estimated fair
values of the net assets acquired is recorded as goodwill. Determining the fair value of certain acquired assets and liabilities
is subjective in nature and often involves the use of significant estimates and assumptions, including, but not limited to, the
selection of appropriate valuation methodology, projected revenue, expenses and cash flows, weighted average cost of capital, discount
rates, estimates of advertiser and publisher turnover rates and estimates of terminal values. Business acquisitions are included
in the Company's consolidated financial statements as of the date of the acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zSLqoAyvl6U2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Fair Value of Financial Instruments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities recorded at fair
value in the Consolidated Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure
their fair value. The categories, as defined by the standard are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Level&#160;Input:</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 89%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Input Definition:</b></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level I</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level II</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level III</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unobservable inputs that reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For certain of our financial instruments,
including accounts receivable, accounts payable, accrued payroll and other expenses, and accrued bonuses to officers the carrying
amounts approximate fair value due to their short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes fair value
measurements at August 31, 2020 and August 31, 2019 for assets and liabilities measured at fair value on a recurring basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zYyIrAvXvjG5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B3_zmHSUlmxpb69" style="display: none">Summarizes fair value measurements</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zHYQ0Goe3Hb5" style="width: 11%; text-align: right" title="Fair value assets">49,207,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zZ6wlmbkx7L" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_ziuNLvNKmt38" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z4nxg8L59Dx5" style="width: 11%; text-align: right" title="Fair value assets">49,207,314</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAa6u8BjB1X2" style="text-align: right" title="Fair value assets">66,803,595</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAWqU7EJeqUj" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zWtPp8qtylG9" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zMPsbjxizirf" style="text-align: right" title="Fair value assets">66,803,595</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Acquisition-related contingent consideration obligations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zByirdDWDExh" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zvasR6GY54w7" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zlBoNlObcO7b" style="text-align: right" title="Fair value liabilities">4,730,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zf1qb4fCDcwg" style="text-align: right" title="Fair value liabilities">4,730,500</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zFigkOPxI4Xe" style="width: 11%; text-align: right" title="Fair value assets">11,435,499</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z3O9eET3mUIc" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zgzKEnI30r7g" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zNqQAJFxum1h" style="width: 11%; text-align: right" title="Fair value assets">11,435,499</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zRwKH7oQn7c9" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCgK0YlFXF79" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_z18hJNKcgH31" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCSurT1FLxF7" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Acquisition-related contingent consideration obligations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zGm1wLfpJDr4" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zPbSMnDQbZX4" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zilckSxYLB4c" style="text-align: right" title="Fair value liabilities">1,761,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zIYMvbu92SJa" style="text-align: right" title="Fair value liabilities">1,761,028</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_zaLRR8e5v6tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020 and 2019, the Company
has a liability for contingent consideration related to its acquisition of Lixoft and DILIsym Services, Inc. The fair value measurement
of the contingent consideration obligations is determined using Level 3 inputs. The fair value of contingent consideration obligations
is based on a discounted cash flow model using a probability-weighted income approach. These fair value measurements represent
Level 3 measurements as they are based on significant inputs not observable in the market. Significant judgment is employed in
determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes
in assumptions could have a material impact on the amount of contingent consideration expense the Company records in any given
period. Changes in the value of the contingent consideration obligations are recorded in the Company&#8217;s Consolidated Statement
of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a reconciliation of contingent
consideration value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfContingentConsiderationTableTextBlock_zsdXNYIcBFB" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zPTdvf5hZ8Tc" style="display: none">Reconciliation of contingent consideration value</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; font-weight: bold">Value at August 31, 2019</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iS_pp0p0_c20190831_znoY4GgeeSva" style="width: 11%; font-weight: bold; text-align: right" title="Contingent consideration, beginning balance">1,761,028</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchase price contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--PurchasePriceContingentConsiderationAdditions_c20190901__20200831_pp0p0" style="text-align: right" title="Purchase price contingent consideration">4,528,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Contingent consideration payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ContingentConsiderationPayments_iN_pp0p0_di_c20190901__20200831_zoY0KuUfKOgj" style="text-align: right" title="Contingent consideration payments">(1,761,028</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in value of contingent consideration</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c20190901__20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Change in value of contingent consideration">202,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Value at August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iE_pp0p0_c20200831_zxjqMrPZPwba" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Contingent consideration, ending balance">4,730,500</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A0_zfMjwN14OCPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zmjCyVBPBIwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Advertising</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expenses advertising costs
as incurred. Advertising costs for the years ended August 31, 2020, 2019 and 2018 were approximately $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20190901__20200831_pp0p0" title="Advertising costs">63,944</span>, $<span id="xdx_908_eus-gaap--AdvertisingExpense_c20180901__20190831_pp0p0" title="Advertising costs">83,213</span> and $<span id="xdx_90A_eus-gaap--AdvertisingExpense_c20170901__20180831_pp0p0" title="Advertising costs">67,848</span>,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zWe1iL9IrDuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Research and Development Costs</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs are charged
to expense as incurred until technological feasibility has been established. These costs include salaries, laboratory experiment,
and purchased software which was developed by other companies and incorporated into, or used in the development of, our final products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zUIPGgh40rS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Income Taxes</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes in
accordance with ASC 740-10, <i>&#8220;Income Taxes&#8221;</i> which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements or tax returns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z8GNJWW9O9J9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Intellectual property</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 28, 2012, we bought out the
royalty agreement with Enslein Research. The cost of $<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsGross_c20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Intangible asset acquisition value">75,000</span> is being amortized over <span id="xdx_900_ecustom--AmortizationPeriodIntangibleAssets_c20110901__20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember" title="Amortization period">10 years under the straight-line method</span>. Amortization
expense for each of the fiscal years ended August 31, 2020 and 2019 was $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zhbLmTWT8ICe" title="Amortization of intangible assets"><span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_z7TtErqFcd5f" title="Amortization of intangible assets">7,500</span></span>. Accumulated amortization as of August 31, 2020
and 2019 was $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property">63,750</span> and $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property">56,250</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 15, 2014, we entered into a termination
and non-assertion agreement with TSRL, Inc., pursuant to which the parties agreed to terminate an exclusive software licensing
agreement entered into between the parties in 1997. As a result, the Company obtained a perpetual right to use certain source code
and data, and TSRL relinquished any rights and claims to any GastroPlus products and to any claims to royalties or other payments
under that 1997 agreement. We agreed to pay TSRL total consideration of $<span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsGross_c20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Intangible asset acquisition value">6,000,000</span>, which is being amortized over <span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20130901__20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember" title="Amortization period">10 years under
the straight-line method</span>. Amortization for the year ended August 31, 2020, and 2019 was $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zwHu0ELID6e4" title="Amortization of intangible assets"><span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zEYLoca8Ywo7" title="Amortization of intangible assets">600,000</span></span>. Accumulated amortization as of
August 31, 2020 and 2019 was $<span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property">3,775,000</span> and $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property">3,175,000</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2017, as part of the acquisition
of DILIsym Services, Inc. the Company acquired certain developed technologies associated with the drug induced liver disease (DILI).
These technologies were valued at $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsGross_c20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Intangible asset acquisition value">2,850,000</span> and are being amortized over <span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20160901__20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember" title="Amortization period">9 years under the straight-line method</span>. Amortization
expense for the fiscal years ended August 31, 2020 and 2019 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets">316,667</span> and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets">316,667</span>, respectively, and is included in cost of
revenues. Total accumulated amortization as of August 31, 2020 and 2019 was $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property">1,029,167</span> and $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property">712,500</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2018, we purchased certain
intellectual property rights of Entelos Holding Company, a Delaware Corporation. The cost of $<span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember_pp0p0" title="Intangible asset acquisition value">50,000</span> is being amortized over <span id="xdx_907_ecustom--AmortizationPeriodIntangibleAssets_c20180901__20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember" title="Amortization period">10
years under the straight-line method</span>. Amortization expense for the year ended August 31, 2020 and 2019 was $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Amortization of intangible assets">5,000</span> and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zOs5YJaHO26e" title="Amortization of intangible assets">5,000</span>. Accumulated
amortization as of August 31, 2020 and 2019 was $<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zW3aUM43FTwl" title="Accumulated amortization of intellectual property">10,000</span> and $<span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Accumulated amortization of intellectual property">5,000</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2020, as part of the acquisition
of Lixoft, the Company acquired certain developed technologies associated with the Lixoft scientific software. These technologies
were valued at $<span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zpMxPfJZDHJ8" title="Intangible asset acquisition value">8,010,000</span> and are being amortized over <span id="xdx_90E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zXXpglxEVPh6" title="Amortization period">16 years under the straight-line method</span>. Amortization expense for the fiscal
years ended August 31, 2020 was $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zhQXw7zg7SEg" title="Amortization of intangible assets">208,594</span> and is included in cost of revenues. Total accumulated amortization as of August 31, 2020
was $<span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zviBsbOkc0i2" title="Accumulated amortization of intellectual property">208,594</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total amortization expense for intellectual
property agreements for the years ended August 31, 2020, 2019 and 2018 was $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets">1,138,280</span>, $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets">929,167</span>, and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets">924,167</span>. Accumulated amortization
as of August 31, 2020 and 2019 was $<span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zwvNPyR8Newi" title="Accumulated amortization of intellectual property">5,087,031</span> and $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyv8Lja8rOle" title="Accumulated amortization of intellectual property">3,948,750</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future amortization for the next five years
is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAmortizationExpensesTableTextBlock_zOT6nlAoXPva" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zQOnpBhAbNVj" style="display: none">Schedule of future amortization expenses</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zW7YXI5yZCLi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zX8dAQzarkKd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIMember_zsIOn20qZid7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_z1Tbr52GkpBk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_z4DTQrCGhw8g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zYZYZ4o7tgSi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ending <br/> August 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">TSRL</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Enslein</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILI-Acquired<br/> Developed<br/> Technologies</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft-Acquired<br/> Developed<br/> Technologies</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Entelos</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 16%; text-align: center">2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">600,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">7,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">316,667</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,625</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,429,792</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,426,042</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_d0_z5Oqy1grb2Yl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,422,292</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_d0_zBybeV9Z08F8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">425,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,247,292</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_d0_zGkQdQVNENzi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">822,292</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A6_zHZaIfKMDUP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zebAV6RoGKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Earnings per Share</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reports earnings per share
in accordance with FASB ACS 260-10. Basic earnings per share is computed by dividing income available to common shareholders by
the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per
share except that the denominator is increased to include the number of additional common shares that would have been outstanding
if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted
earnings per share for the years ended August 31, 2020, 2019 and 2018 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwPNl37oEuQh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BE_zbpYZd26dcYg" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20200831_z42pDCeajb91" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20180901__20190831_zgQ42h8vLxn6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20170901__20180831_zpLAOwGeQ94d" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Numerator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left; padding-bottom: 2.5pt">Net income attributable to common shareholders</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">9,332,060</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">8,583,329</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">8,934,812</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pii_zWGOoVnDS8j7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Weighted-average number of common shares outstanding during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,819,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,492,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,328,707</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pii_zl1t74brxaL1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dilutive effect of stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">719,309</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">565,173</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">531,685</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pii_zuS8ByLCnD6g" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Common stock and common stock equivalents used for diluted earnings per share</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18,538,373</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18,057,431</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">17,860,392</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_8AF_zTKM3q9U7om3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zYvIuhl0p9Rd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Stock-Based Compensation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock options
using the modified prospective method in accordance with FASB ASC 718-10, <i>&#8220;Compensation-Stock Compensation&#8221;</i>.
Under this method, compensation costs include estimated grant date fair value of the awards amortized over the options&#8217; vesting
period. Stock-based compensation was $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation">1,286,625</span>, $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation">865,848</span> and $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation">562,078</span> for the fiscal years ended August 31, 2020, 2019 and 2018,
respectively, and is included in the statements of operations as Consulting, Salaries, and Research and Development expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zt0zasQu6cZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Impairment of Long-lived Assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for the impairment
and disposition of long-lived assets in accordance with ASC 350, <i>&#8220;Intangibles &#8211; Goodwill and Other</i>&#8221; and
ASC 360, <i>&#8220;Property and Equipment&#8221;</i>. Long-lived assets to be held and used are reviewed for events or changes
in circumstances that indicate that their carrying value may not be recoverable. We measure recoverability by comparing the carrying
amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may
not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an
impairment charge to the extent of the difference between the fair value and the asset's carrying amount. <span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20190901__20200831_z1hibgz7fx1" title="Impairment losses"><span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20180901__20190831_zdzaE5YyJ5h4" title="Impairment losses"><span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20170901__20180831_zTk5MITYte01" title="Impairment losses">No</span></span></span> impairment losses
were recorded during the years ended August 31, 2020, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zHjSKuHffNZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Recently Issued Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding Accounting Standards Codification
Topic 606 (ASC Topic 606), Revenue from Contracts with Customers. The standard provides principles for recognizing revenue for
the transfer of promised goods or services to customers with the consideration to which the entity expects to be entitled in exchange
for those goods or services. The standard also provides guidance on the recognition of incremental costs related to obtaining customer
contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing the modified retrospective method. This approach was
applied to contracts that were in process as of September 1, 2018, and the corresponding incremental costs of obtaining those contracts,
which resulted in a cumulative effect adjustment of $493,279 to the opening balance of retained earnings at the date of adoption.
The adoption of this ASU primarily impacts the timing of our revenue recognition for certain sales contracts, the capitalization
and amortization of incremental costs of obtaining a contract, and related disclosures. The reported results for fiscal year 2019
reflect the application of ASC Topic 606.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,
Leases (Topic 842), which supersedes existing guidance on accounting for leases in "Leases (Topic 840)" and generally
requires all leases to be recognized in the consolidated balance sheet. ASU 2016-02 is effective for annual and interim reporting
periods beginning after December 15, 2018. The Company adopted this ASU on September 1, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In April 2016, the FASB issued ASU 2016-10,
Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board's new revenue standard, ASU 2014-09,
Revenue from Contracts with Customers. The standard was adopted concurrently with the adoption of ASU 2014-09 which is effective
for annual and interim periods beginning after December 15, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049192248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGNITION</a></td>
<td class="text"><p id="xdx_807_eus-gaap--RevenueFromContractWithCustomerTextBlock_zKzR0jkn9nw9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 &#8211; <span id="xdx_828_zIsxOFXa1L85">REVENUE RECOGNITION</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted Topic 606 effective
September&#160;1, 2018 using the modified retrospective method applying this guidance to all open contracts at the date of initial
application, which resulted in an adjustment to retained earnings for the cumulative effect of applying this guidance. The most
significant impact of Topic 606 on revenue to the Company relates to the timing of revenue recognition for one of its payment contracts.
Under 606 the revenues under the contract are being recognized as time is expended and costs are being expensed as incurred. Under
ASC 605 revenues were recognized as invoiced and certain costs were capitalized as development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines revenue recognition
through the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td>
    <td style="width: 95%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the contract, or contracts, with a customer</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Determination of the transaction price</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Recognition of revenue when, or as, the Company satisfies a performance obligation</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Components of revenue</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a description of principal
activities from which the Company generates revenue. As part of the accounting for these arrangements, the Company must develop
assumptions that require judgment to determine the stand-alone selling price for each performance obligation identified in the
contract. Stand-alone selling prices are determined based on the prices at which the Company separately sells its services or goods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue Components</b></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 48%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Typical payment terms</b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Software Revenues:</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Software revenues are generated primarily from sales of software
        licenses at the time the software is unlocked and the term commences. The license period typically is one year or less. Along with
        the license a <i>di minimis</i> amount of customer support is provided to assist the customer with the software. Should the customer
        need more than a di minimis amount of support they can choose to enter into a separate contract for additional training. Most software
        is installed on our customers&#8217; servers and the Company has no control of the software once the sale is made.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For certain software arrangements the Company hosts the licenses
        on servers maintained by the Company, revenue for those arrangements are accounted as <i>Software as a Service</i> over the life
        of the contract. These arrangements are a small portion of software revenues of the Company.</p></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Payments are generally due upon invoicing on a net 30 basis unless other payment terms are negotiated with the customer based on customer history. Typical industry standards apply.</span></td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: 10pt Times New Roman, Times, Serif"><i>Consulting Contracts:</i></span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Consulting services provided to our customers are generally recognized over time as the contracts are performed and the services are rendered. The company measures its consulting revenue based on time expended compared to total estimated hours to complete a project. The Company believes the methods chosen for its contract revenue best depicts the transfer of benefits to the customer under the contracts.</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Payment terms vary, depending on the size of the contract, credit history and history with the client and deliverables within the contract.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Consortium Member Based Services:</i></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 48%">&#160;</td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">The performance obligation is recognized on a time elapsed basis, by month, for which the services are provided, as the Company transfers control evenly over the contractual period.</span></td>
    <td>&#160;</td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">Payment is due at the beginning of the period, generally on a net 30 or 60 basis.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Remaining performance obligations
that do not fall under the expedients require the Company to perform various&#160;consulting and software development
services and consortium memberships of approximately $<span id="xdx_906_eus-gaap--RevenueRemainingPerformanceObligation_c20200831_pp0p0" title="Remaining performance obligations">3,303,461</span>.
It is anticipated these revenues will be recognized within the next year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Contract liabilities</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended August 31, 2020 the
Company recognized $<span id="xdx_90C_eus-gaap--ContractWithCustomerLiabilityRevenueRecognized_c20190901__20200831_pp0p0" title="Revenues included in contract liabilities">1,146,000</span> of revenue that was included in contract liabilities as of August 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>













<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Disaggregation of Revenues</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zagC0y6wzAVc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Disaggregation)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10pt"><span id="xdx_8B3_zQo710fJ5tV3" style="display: none">Schedule of disaggregation of revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Disaggregation of Revenues:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended <br/> August 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended <br/> August 31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Software licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; text-align: left; text-indent: 10pt">Point in time</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">20,668,195</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">17,425,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: 10pt">Over time</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="text-align: right" title="Revenues">919,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="text-align: right" title="Revenues">1,053,562</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">Consulting services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Over time</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">20,001,545</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">15,491,525</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">41,589,084</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20180901__20190831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">33,970,440</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AF_zIORA1xti5Ld" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Contracts in Progress</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contracts in progress are included in the accompanying balance
sheets under the following captions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zCdLLMp8FQm3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zqfCiXdLAFU2" style="display: none">Schedule of contract in progress</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_49D_20200831_zjzGgHGToG3b" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_49C_20190831_zJaf8b3ahOO7" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_iI_pp0p0_maROBOUztWJ_zYD86VrOVm5b" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Revenues in excess of billings</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,093,343</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,233,659</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--BillingsInExcessOfCost_iNI_pp0p0_di_msROBOUztWJ_z2FWgTLFLdwc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Billings in excess of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(140,991</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(798,549</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--RevenuesOverBillingsOnUncompletedContracts_iTI_pp0p0_mtROBOUztWJ_zcQQ5a2vCZgb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 2.5pt">Revenues over billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,952,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,435,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost, estimated earnings, and billings
on uncompleted contracts are summarized as follows as of August 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_401_ecustom--RevenuesEarnedToDateOnUncompletedContracts_iI_z1MJMCb5jmk6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Revenues earned to date on uncompleted contracts</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20,235,573</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">19,254,928</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--BillingsToDateOnUncompletedContracts_iNI_di_zfUIObO0Xka1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Billings to date on uncompleted contracts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(17,283,221</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(16,819,818</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 2.5pt">Revenues over billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,952,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,435,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A3_zyxtl2K24A2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Balance increases and decreases in these
accounts are due to the timing of amounts billed, payments received, and revenue recognized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046824616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zhY0Pl7JLjBk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 &#8211; <span id="xdx_82B_zzpnZEgZzN14">PROPERTY AND EQUIPMENT</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment at August 31, 2020
and 2019 consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2XcKW4fbxvg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B7_zb3ozx5Y0Mv8" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify">Equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Property and equipment, gross">864,560</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Property and equipment, gross">741,486</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Computer equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">547,738</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">411,632</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and equipment, gross">160,991</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and equipment, gross">160,990</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">114,005</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">110,165</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200831_pp0p0" style="text-align: right" title="Property and equipment, gross">1,687,294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20190831_pp0p0" style="text-align: right" title="Property and equipment, gross">1,424,273</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">1,249,507</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20190831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">1,083,128</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_c20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value">437,787</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_c20190831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value">341,145</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expense was $<span id="xdx_90D_eus-gaap--Depreciation_c20190901__20200831_pp0p0" title="Depreciation">166,379</span>, $<span id="xdx_906_eus-gaap--Depreciation_c20180901__20190831_pp0p0" title="Depreciation">131,827</span>,
and $<span id="xdx_908_eus-gaap--Depreciation_c20170901__20180831_pp0p0" title="Depreciation">139,202</span> for the years ended August 31, 2020, 2019, and 2018, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048190920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS</a></td>
<td class="text"><p id="xdx_802_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zgEeqAb9qf26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 &#8211; <span id="xdx_82B_zMsmAeLKNikj">INVESTMENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company invests a portion of its
excess cash balances in short-term debt securities. Investments at August 31, 2020 consisted of corporate bonds with
maturities remaining of less than 12 months. The Company may also invest excess cash balances in certificates of deposits,
money market accounts, government-sponsored enterprise securities, corporate bonds and/or commercial paper. The Company
accounts for its investments in accordance with FASB ASC 320, Investments &#8211; Debt and Equity Securities. At August 31,
2020, all investments were classified as held-to-maturity securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables summarize the Company&#8217;s short-term
investments as of August 31, 2020. The Company had <span id="xdx_90B_eus-gaap--ShortTermInvestments_iI_do_c20190831_z32ektnUzkUg" title="Short-term investments">no</span> short-term investments for the year ended August 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FY 2020 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--InvestmentTableTextBlock_zkCOSS5CwoJj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVESTMENTS (Details)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8B6_zWYafKIsrk3d" style="display: none">Schedule of short term investment</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Gross</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Unrealized</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Gains</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Gross</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Unrealized</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Losses</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Commercial notes (due within one year)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortTermInvestments_iI_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_z5z0YeKmXdRk" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Short term investment, amortized cost">66,803,595</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Gross unrealized gains"><span style="-sec-ix-hidden: xdx2ixbrl1255">&#8211;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_zIqg0YqQOL95" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Gross unrealized loss">(60,977</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Short term investment, fair value">66,742,618</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortTermInvestments_iI_c20200831_zl8P0WCnCdH2" style="border-bottom: Black 2.5pt double; text-align: right" title="Short term investment, amortized cost">66,803,595</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross unrealized gains"><span style="-sec-ix-hidden: xdx2ixbrl1263">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831_zbSgKAap4zDc" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross unrealized loss">(60,977</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_c20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Short term investment, fair value">66,742,618</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049376632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTRACTS PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">CONTRACTS PAYABLE</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zR2Xve9UfJva" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 6 - <span id="xdx_827_zUFGZpqzmAEh">CONTRACTS PAYABLE</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">DILIsym Acquisition Liabilities:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2017, the Company acquired DILIsym
Services, Inc. The agreement provided for a working capital adjustment, an eighteen-month $1,000,000 holdback provision against
certain representations and warrantees, and an Earn-out agreement of up to an additional $5,000,000 in Earn-out payments based
on earnings over the three years following acquisition. The Earn-out liability has been recorded at an estimated fair value. Payments
under the Earn-out liability will be due starting in FY 2019. In September 2018, $1,556,644 was paid out under the first earn-out
payment, a second earn-out payment was made in August 2019 in the amount of $1,682,329. The final payment of $1,761,028 was paid
in August 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"><span style="text-decoration: underline">Lixoft Acquisition Liabilities</span>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">On April 1, 2020, the Company
acquired Lixoft. The agreement provided for a twenty-four month $2,000,000 holdback provision against certain representations and
warrantees, comprised of $1,333,333 of cash and the release from an escrow shares of stock valued at $666,337 issued at the date
of the Agreement. In addition, based on a revenue growth formula for the two years subsequent to April 1, 2020, the agreement calls
for earn-out payments up to $5,500,000 (two thirds cash and one-third newly issued, unregistered shares of the Company&#8217;s
common stock). The former shareholders can earn up to $2,000,000 the first year and $3,500,000 in year two.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020 and 2019 the following
liabilities have been recorded:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--OtherLiabilitiesTableTextBlock_zmP989z4S3jh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTRACTS PAYABLE (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B3_zIUlL5BCIDJ1" style="display: none">Schedule of Liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify">Holdback Liability - Lixoft</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zdDXDKhB3mZh" style="width: 11%; text-align: right" title="Total contract with customer">1,333,333</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zYCijRiOKDae" style="width: 11%; text-align: right" title="Total contract with customer">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Earn-out Liability - Lixoft</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zcPF0mZJV035" style="text-align: right" title="Total contract with customer">4,730,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zbVdJZcSIkt" style="text-align: right" title="Total contract with customer">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Earn-out Liability - Dilisym</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zr63wDRbjKu7" style="border-bottom: Black 1pt solid; text-align: right" title="Total contract with customer">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zBzDvLHfQomf" style="border-bottom: Black 1pt solid; text-align: right" title="Total contract with customer">1,761,028</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Sub Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ContractWithCustomerLiability_c20200831_pp0p0" style="text-align: right" title="Total contract with customer">6,063,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ContractWithCustomerLiability_c20190831_pp0p0" style="text-align: right" title="Total contract with customer">1,761,028</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Current Portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ContractsPayableCurrent_iI_pp0p0_c20200831_zqRAm4D7al37" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Current Portion">2,000,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ContractsPayableCurrent_iI_pp0p0_c20190831_zno9uBoiCO5k" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Current Portion">1,761,028</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Long-Term</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--ContractsPayableNoncurrent_iI_pp0p0_c20200831_zPVMD6c1oMi4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term">4,063,833</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--ContractsPayableNoncurrent_iI_pp0p0_d0_c20190831_zuUCoc68wCn4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048118472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_ziW0IEDTohJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 - <span id="xdx_820_z05mb5RXPU4">COMMITMENTS AND CONTINGENCIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Leases</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We lease approximately 13,500 square feet
of space in Lancaster, California. The original lease had a five-year term with two, three-year options to extend. The initial
five-year term expired in February 2011, and we extended the lease to February 2, 2014. In June 2013, the lease was amended to
extend the term to February 2, 2017. The amended lease also provides for an annual base rent increase of 3% per year and two, two-year
options to extend. In May 2016 the Company exercised the two, two-year options extending the term of the lease through February
2, 2021 at a fixed rate of $25,000 per month. The new extension agreement allowed the Company with 90 days&#8217; notice to opt
out of the remaining lease in the last two years of the term upon payment of a recapture payment equal to the 3% base payment increase
that would have been due under the original agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Buffalo subsidiary leases approximately
12,623 square feet of space in Buffalo, New York. The initial five-year term expired in October 2018; and was renewed for a three-year
option to extending it to November 2021. The new base rent is $16,147 per month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DILIsym leases approximately 2,700 square
feet of space in Research Triangle Park, North Carolina. The initial three-year term was due to expire October 2020. An amendment
to the initial lease became effective April 1, 2020. This amendment added 686 square feet and extended the term of the lease to
September 30, 2023. The new base rent is approximately $7,500 per month with an annual 3% adjustment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In Paris, France Lixoft leases approximately
2,300 square feet of office space, which as of April 1, 2020, had minimum payments equaling $288,000. The lease is for a 9-year
term, with an option to terminate every 3 years, and expires in November of 2024. The rent is $16,555 per quarter and can be adjusted
each December based on a consumer price index.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Rent expense, including common area maintenance
fees for the years ended August 31, 2020, 2019 and 2018 was $<span id="xdx_90A_eus-gaap--OperatingLeaseExpense_c20190901__20200831_pp0p0" title="Rent expense">644,000</span>, $<span id="xdx_901_eus-gaap--OperatingLeaseExpense_c20180901__20190831_pp0p0" title="Rent expense">584,000</span> and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_c20170901__20180831_pp0p0" title="Rent expense">567,000</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future minimum lease payments under non-cancelable
operating leases with remaining terms of one year or more at August 31, 2020 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zwFpebZzQH0i" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zU4P7VpsUZgk" style="display: none">Future minimum lease payments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20200831_zCQu7tjBUsOj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ending August 31,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0_maOLFMPzcU7_z9LUrgXv9M8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 33%; text-align: center">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">486,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0_maOLFMPzcU7_zNQr2PI4G4z3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0_maOLFMPzcU7_zKwWOoiB0PSk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">172,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0_maOLFMPzcU7_z1Q0If2dy0cb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_pp0p0_maOLFMPzcU7_zsICFrla2TX8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0_mtOLFMPzcU7_zq3lZfs7ArKf" style="vertical-align: bottom; background-color: White">
    <td style="visibility: hidden; text-align: center; padding-bottom: 2.5pt">Future minimum lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">961,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"><span style="text-decoration: underline">Line of Credit</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 31, 2020, Simulations Plus,
Inc. entered into a Credit Agreement with Wells Fargo Bank, N.A. The Credit Agreement, has provided Simulations Plus, Inc.
with a credit facility of $<span id="xdx_90A_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_c20200331__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_pp0p0" title="Line of credit maximum amount">3,500,000</span>
through <span id="xdx_90E_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20190901__20200331__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_zce35qmoJiLh" title="Line of credit expiration date">April
15, 2022</span>. As of August 31, 2020, there were no amounts drawn against the line of credit. Interest accrues daily at the
bank&#8217;s base rate. The base rate is the rate equal to the highest of (i) the Prime Rate in effect, (ii) 1.5% above Daily
One Month LIBOR, and (iii) the Federal Funds Rate plus 1.5%. The rate at August 31, 2020 was 3.25%. Under the terms of the
agreement the borrower is to maintain a <span title="Line of credit amount outstanding">zero <span id="xdx_90A_eus-gaap--LineOfCredit_iI_pp0p0_do_c20200831__us-gaap--LineOfCreditFacilityAxis__custom--WellsFargoMember_zzzcvRAi7gX" style="display: none" title="Line of credit amount outstanding">No</span></span>
balance under this line of credit for a period of thirty consecutive days during each 12-month period commencing March 31,
2020. The Credit Agreement is collateralized by the assets of Simulations Plus Lancaster Division and is subject to certain
financial covenants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Employment Agreements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business the Company
has entered into employment agreements with certain of its key management personnel that may require compensation payments upon
termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">License Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had a royalty agreement with
Dassault Syst&#232;mes Americas Corp. for access to their Metabolite Database for developing our Metabolite Module within ADMET
Predictor&#8482;. The module was renamed the Metabolism Module when we released ADMET Predictor version 6 on April 19, 2012. Under
this agreement, we pay a royalty of 25% of revenue derived from the sale of the Metabolism/Metabolite module. This agreement was
recently renegotiated, and the Company does not bear any royalty obligations towards Dassault Syst&#232;mes Americas Corp. effective
as of June 30, 2019. In addition, the license agreement terminated on September 5, 2020. Under this agreement for the years ended
August 31, 2020, 2019 and 2018 we incurred royalty expense (benefit) of $<span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20190901__20200831_zgSI0OgHz4a4" title="Royalties expense">(26,055)</span>, $<span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20180901__20190831_zIrj4rKBx96j" title="Royalties expense">195,828</span> and $<span id="xdx_90B_ecustom--RoyaltyExpenses_pp0p0_c20170901__20180831_zFDxrye0Ex84" title="Royalties expense">175,740</span>, respectively. The Company
is in the process of replacing the database.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Litigation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not a party to any legal proceedings
and are not aware of any pending legal proceedings of any kind.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049376632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' EQUITY</a></td>
<td class="text"><p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zsQqEUnKsSkd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 - <span id="xdx_821_z7BjDRZPCPwe">SHAREHOLDERS' EQUITY</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Dividend </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&#8217;s Board of Directors
declared cash dividends during fiscal year 2020, 2019 and 2018. The details of dividend paid are in the following tables:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDividendsPayableTextBlock_zYXn5OwzWm9f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zwwsUCr2hev7" style="display: none">Schedule of dividends declared and paid</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="15" style="font-weight: bold; text-align: center">FY2018</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br/> Outstanding on<br/> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br/> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_908_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" title="Record Date">11/13/2017</span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_983_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" style="width: 26%; text-align: center" title="Distribution Date">11/20/2017</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date">17,284,792</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" style="width: 11%; text-align: right" title="Dividend per Share">0.06</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount">1,037,088</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_909_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" title="Record Date">1/26/2018</span></td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" style="text-align: center" title="Distribution Date">2/02/2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,317,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pp0p0" style="text-align: right" title="Total Amount">1,039,065</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" title="Record Date">4/25/2018</span></td><td>&#160;</td>
    <td id="xdx_981_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" style="text-align: center" title="Distribution Date">5/02/2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,354,005</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pp0p0" style="text-align: right" title="Total Amount">1,041,240</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" title="Record Date">7/26/2018</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date">8/02/2018</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date">17,405,775</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share">0.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount">1,044,347</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--Dividends_c20170901__20180831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount">4,161,740</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FY2019</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br/> Outstanding on<br/> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br/> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" title="Record Date">11/01/2018</span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" style="width: 26%; text-align: center" title="Distribution Date">11/08/2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date">17,417,875</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" style="width: 11%; text-align: right" title="Dividend per Share">0.06</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount">1,045,073</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" title="Record Date">1/25/2019</span></td><td>&#160;</td>
    <td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" style="text-align: center" title="Distribution Date">2/01/2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,481,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pp0p0" style="text-align: right" title="Total Amount">1,048,887</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" title="Record Date">4/24/2019</span></td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" style="text-align: center" title="Distribution Date">5/01/2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,515,228</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pp0p0" style="text-align: right" title="Total Amount">1,050,914</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" title="Record Date">7/25/2019</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date">8/01/2019</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date">17,536,454</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share">0.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount">1,052,181</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--Dividends_c20180901__20190831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount">4,197,055</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FY2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br/> Outstanding on<br/> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br/> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_904_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" title="Record Date">10/25/2019</span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_98C_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" style="width: 26%; text-align: center" title="Distribution Date">11/01/2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date">17,606,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" style="width: 11%; text-align: right" title="Dividend per Share">0.06</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount">1,056,379</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" title="Record Date">1/27/2020</span></td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" style="text-align: center" title="Distribution Date">2/03/2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,645,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pp0p0" style="text-align: right" title="Total Amount">1,058,740</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" title="Record Date">4/24/2020</span></td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" style="text-align: center" title="Distribution Date">5/01/2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,769,134</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pp0p0" style="text-align: right" title="Total Amount">1,066,148</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" title="Record Date">7/27/2020</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date">8/03/2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date">17,820,057</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share">0.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount">1,069,203</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--Dividends_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount">4,250,470</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zolEj0uCF6w8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although dividend distributions are currently
expected to continue on a quarterly basis, the Company&#8217;s Board of Directors reserves the right to discontinue the dividend
distribution any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Stock Option Plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 23, 2007, the Board of Directors
adopted, and the shareholders approved, the 2007 Stock Option Plan under which a total of 1,000,000 shares of common stock had
been reserved for issuance. On February 25, 2014 the shareholders approved an additional 1,000,000 shares increasing the total
number of shares that may be granted under the Option Plan to 2,000,000. This plan terminated in February 2017 by its term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 23, 2016 the Board of Directors
adopted, and on February 23, 2017 the shareholders approved, the 2017 Equity Incentive Plan under which a total of <span id="xdx_90F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_pii_c20200831__us-gaap--PlanNameAxis__custom--Equity2017IncentivePlanMember_zmp3voatPznc" title="Common stock reserved for issuance under the plan">1,000,000</span> shares
of common stock has been reserved for issuance. This plan will terminate in <span title="Equity plan termination date">December 2026</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, employees and directors
hold stock options to purchase 1,223,661 shares of common stock at exercise prices ranging from $6.75 to $61.84 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes information
about stock options:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zSr229JwgMK" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"><span id="xdx_8B7_zAN0GhH22zpg" style="display: none">Schedule of stock option activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY18</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Remaining<br/> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2017</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEmJKLz0jDak" style="width: 11%; text-align: right" title="Option outstanding, beginning balance">1,249,126</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqZvx2UgdR4f" style="width: 11%; text-align: right" title="Outstanding">8.51</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--OutstandingRemainingContractualLife_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zl3sQ6c8ZNv4" style="width: 11%; text-align: right" title="Outstanding, beginning of period">7.74</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZeGbhUIA3Ie" style="text-align: right" title="Granted">52,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">22.36</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfdHMQEFvLOf" style="text-align: right" title="Exercised">(130,006</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised">5.97</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1CCY01E1Ei7" style="text-align: right" title="Canceled/Forfeited">(30,144</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited">9.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z74F6X7O9K5h" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">(6,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">5.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2018</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaIyp400GGif" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, ending balance">1,134,976</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpYo4tgysgU9" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding">9.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAJq5Md5lLd1" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period">7.31</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8uNDYErUvQe" style="text-align: right" title="Vested and Exercisable, end of period">483,696</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPmTRz5nZlv7" style="text-align: right" title="Vested and Exercisable, end of period">7.79</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDGEoaKkCZae" style="text-align: right" title="Vested and Exercisable">6.48</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zze8rqGw8XUb" style="text-align: right" title="Vested and Expected to Vest, end of period">1,069,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJgbTPCiBn38" style="text-align: right" title="Vested and Expected to Vest, end of period">9.35</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z25uFgz35HD1" style="text-align: right" title="Vested and Expected to Vest">7.26</td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY19</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Remaining<br/> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5tiSbVHNHQ1" style="width: 11%; text-align: right" title="Option outstanding, beginning balance">1,134,976</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuNgDguDPFJe" style="width: 11%; text-align: right" title="Outstanding">9.44</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--OutstandingRemainingContractualLife_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zD4mZtpPQaA5" style="width: 11%; text-align: right" title="Outstanding, beginning of period">7.31</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">263,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">22.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0tul9S7E3z1" style="text-align: right" title="Exercised">(166,703</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised">7.15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXwRjy9aqy1i" style="text-align: right" title="Canceled/Forfeited">(68,514</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited">12.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl1539">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl1541">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyUPwLwkZob1" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards Outstanding, ending balance">1,163,259</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWmBv4a6At8j" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding">12.63</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zK0zy9D79jIl" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period">7.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znG6VYz2SlH5" style="text-align: right" title="Vested and Exercisable, end of period">515,394</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfXkUtlWsXEe" style="text-align: right" title="Vested and Exercisable, end of period">8.57</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDfas0zUwvOj" style="text-align: right" title="Vested and Exercisable">6.09</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zczJzIX8cWB3" style="text-align: right" title="Vested and Expected to Vest, end of period">1,101,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zoOfywrKUdhd" style="text-align: right" title="Vested and Expected to Vest, end of period">12.39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqPPJ0FIpf0f" style="text-align: right" title="Vested and Expected to Vest">7.07</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY20</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Remaining<br/> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfwOBZP38bxa" style="width: 11%; text-align: right" title="Option outstanding, beginning balance">1,163,259</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zmjiDHvEm9nh" style="width: 11%; text-align: right" title="Outstanding">12.63</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--OutstandingRemainingContractualLife_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXj9Bfgi1CYh" style="width: 11%; text-align: right" title="Outstanding, beginning of period">7.13</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">223,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">39.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zItDmrTb6cn5" style="text-align: right" title="Exercised">(121,647</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised">9.29</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfnRZ3cit0Og" style="text-align: right" title="Canceled/Forfeited">(40,951</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited">14.19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl1579">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl1581">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrsDghe0G1o2" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards Outstanding, ending balance">1,223,661</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuwytd9hDha9" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding">17.76</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zRiA6Cw8x8ab" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period">6.79</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqA24fEGqDMa" style="text-align: right" title="Vested and Exercisable, end of period">596,311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0hy42e5eOR2" style="text-align: right" title="Vested and Exercisable, end of period">10.69</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z97XlNuraP17" style="text-align: right" title="Vested and Exercisable">5.59</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfCoaGynvyS4" style="text-align: right" title="Vested and Expected to Vest, end of period">1,194,239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpvw61my3nP5" style="text-align: right" title="Vested and Expected to Vest, end of period">17.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvoPhIIhYss9" style="text-align: right" title="Vested and Expected to Vest">6.77</td><td style="text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A4_zrmavE32Mks9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Intrinsic Value of options outstanding and options exercisable</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_zZvHpp2Iyuo" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BC_zw3Qq8hTf1wl" style="display: none">Intrinsic Value of options outstanding and options exercisable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value<br/> of Options<br/> Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic<br/> Value of <br/> Options<br/> Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic <br/> Value of<br/> Options<br/> Exercised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">FY18</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Outstanding">13,064,884</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Exercisable">6,315,086</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Exercised">1,495,313</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>FY19</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Outstanding">27,312,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercisable">14,194,724</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercised">3,224,454</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>FY20</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Outstanding">51,272,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercisable">29,150,912</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercised">4,085,753</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A3_zCGlJu08KFZ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The weighted-average remaining contractual
life of options outstanding issued under the Plan, both Qualified ISO and Non-Qualified SO, was <span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zBhm4J4yox96" title="Weighted average remaining contractual life">6.79</span> years at August 31, 2020.
The total fair value of non-vested stock options as of August 31, 2020 was $<span id="xdx_90C_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pp0p0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zNVGLtYjHq27" title="Fair value of non-vested options">22,122,054</span> and is amortizable over a weighted average
period of <span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEHuW7CinWU1" title="Fair value amortization period">3.39</span> years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>













<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify"><span style="background-color: white">The
fair value of these options was estimated at the date of grant using the Black-Scholes option-pricing model. The Black-Scholes
option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions
and are fully transferable. In addition, option valuation models require the input of highly subjective assumptions, including
the expected stock price volatility. Because our stock options have characteristics significantly different from those of traded
options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management's
opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its stock options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">The following table summarizes
the fair value of the options, including both ISOs and NQSOs, granted during the current fiscal year 2020 and fiscal year 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_znYDjjsdi7f3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zqwPDquoB8v" style="display: none">Schedule of fair value of options</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20190901__20200831_zvzmEAwEbUs8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20180901__20190831_zsycPpqRHxNh" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">FY 2020</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">FY 2019</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_403_ecustom--FairValueOptionsGranted_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Estimated fair value of awards granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,997,120</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,928,820</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_dp_z0I9GPJv0zMd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unvested Forfeiture Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.20%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_i_pii" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average grant price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">39.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22.78</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--WeightedAverageMarketPrice_i_pii" style="vertical-align: bottom; background-color: White">
    <td>Weighted average market price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">39.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22.69</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_zd4EBYOt8dfh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33.56%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.61%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_zKQYAbPzJk37" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.39%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.59%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_znRMoWL42Moa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.65%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.10%</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20190901__20200831_zcTIMfsoCyM5" title="Weighted average expected life">6.67</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20180901__20190831_zYfunD3yDYn4" title="Weighted average expected life">6.64</span> years</span></td><td style="text-align: left">&#160;</td></tr>
</table>


<p id="xdx_8A8_zjnEgW8tDcdc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The exercise prices for the options outstanding
at August 31, 2020 ranged from $6.75 to $61.84, and the information relating to these options is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zwYNb1ixCUm9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left"><span id="xdx_8B6_zU4aeSWAm19l" style="display: none">Schedule of options by exercise price range</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quantity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted <br/> Average<br/> Remaining<br/> Contractual<br/> Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quantity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual <br/> Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Exercise price low">6.75</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Exercise price high">8.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards outstanding">177,730</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zYAgfXhLp8Ee" title="Awards outstanding weighted average remaining contractual life">4.0</span> years</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards outstanding weighted average exercise price">6.85</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards exercisable">177,730</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zLHJiQHfJld" title="Awards exercisable weighted average remaining contractual life">4.0</span> years</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards exercisable weighted average exercise price">6.85</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Exercise price low">8.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Exercise price high">16.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards outstanding">547,901</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zUXqLed3JHo1" title="Awards outstanding weighted average remaining contractual life">6.0</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price">9.98</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards exercisable">350,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zKjm2Zf3Jfo3" title="Awards exercisable weighted average remaining contractual life">6.0</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price">9.97</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Exercise price low">16.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Exercise price high">24.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards outstanding">230,280</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_ztnBAqKE8ai2" title="Awards outstanding weighted average remaining contractual life">7.8</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price">20.70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards exercisable">50,560</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_zTqdaOALFxM7" title="Awards exercisable weighted average remaining contractual life">7.2</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price">21.18</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Exercise price low">24.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Exercise price high">38.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards outstanding">204,950</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zlKX79epvqOa" title="Awards outstanding weighted average remaining contractual life">9.1</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price">33.45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards exercisable">17,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zA6ylx0XQ703" title="Awards exercisable weighted average remaining contractual life">8.9</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price">34.23</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Exercise price low">38.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Exercise price high">52.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Awards outstanding">19,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zJU0o2pDpEO5" title="Awards outstanding weighted average remaining contractual life">9.6</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price">38.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zpz92DykdhW" style="text-align: right" title="Awards exercisable">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zniP2siXJeXk" style="text-align: right" title="Awards exercisable weighted average exercise price">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Exercise price low">52.01</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Exercise price high">61.84</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Awards outstanding">43,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zTkUdVyurq8h" title="Awards outstanding weighted average remaining contractual life">9.9</span> years</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Awards outstanding weighted average exercise price">61.84</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zT7mHUedCxAa" style="border-bottom: Black 1pt solid; text-align: right" title="Awards exercisable">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zGi5unlxX5Eg" style="padding-bottom: 1pt; text-align: right" title="Awards exercisable weighted average exercise price">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards outstanding">1,223,661</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z56sDULWgo2g" title="Awards outstanding weighted average remaining contractual life">6.8</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="padding-bottom: 2.5pt; text-align: right" title="Awards outstanding weighted average exercise price">17.76</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards exercisable">596,311</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDOY9JpQkOe8" title="Awards exercisable weighted average remaining contractual life">5.6</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="padding-bottom: 2.5pt; text-align: right" title="Awards exercisable weighted average exercise price">10.69</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_zkS872X5dTVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Follow-on Public Offering</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2020, the company closed an
underwritten public offering of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20190901__20200831_zRppK3jiVJt" title="Shares issued under public offering">2,090,909</span>
shares of its common stock to the public at $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_c20200831_zFv4QnpxOAS2" title="Shares issued price per share">55.00</span>
per share, which included the full exercise of the underwriters&#8217; option to purchase 272,727 additional shares of common
stock. The aggregate gross proceeds to the company from this offering were approximately $<span title="Proceeds from public offering">115</span>
million, before deducting underwriting discounts and commissions; net proceeds were approximately $<span title="Proceeds from public offering">107.7</span>
million <span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_dm_c20190901__20200831_zkqECWzRjuUf" style="display: none" title="Proceeds from public offering">107,747,338</span>. The offering was made pursuant to the Company&#8217;s automatic shelf registration statement on Form S-3 filed with
the Securities and Exchange Commission on July 9, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046583416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zqXIMdHYeqik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 - <span id="xdx_821_zW29q5bloEtc">INCOME TAXES </span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We utilize FASB ASC 740-10, <i>&#8220;Income
Taxes&#8221;</i> which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences
of events that have been included in the financial statements or tax returns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of the income tax provision
for fiscal year 2020, 2019 and 2018 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zMFfFcQt1xmg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax provision)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span id="xdx_8B7_zagOldVKEnd2" style="display: none">Components of the income tax provision</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20190901__20200831_zsYtLRMf3OBk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20180901__20190831_zeGGgwkwikue" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20170901__20180831_zVeZB6h85yt3" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zgXzb3eafgh1" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; padding-left: 10pt">Federal</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,097,725</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,794,596</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,370,955</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zrEF9BuHWLX7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">477,744</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">426,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">460,619</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zPmxairo0Us4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">39,038</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">51,285</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">104,377</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01T_pp0p0_mtCITEBzgOr_maITEBzYIH_zYSUWo71p3u6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Total current tax expense (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,614,507</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,272,245</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,935,951</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zPDAa5MwzY3a" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(427,644</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(140,730</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,698,201</td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zhjqJZaXPJ6k" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(131,874</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(158,368</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,620</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i01NT_pp0p0_di_mtDITATzwIq_maITEBzYIH_znxE5mdhb7E9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Total deferred federal and state</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(559,518</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(299,098</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,731,821</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_i01T_pp0p0_mtITEBzYIH_zVNPzpxQZ4df" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,054,989</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,973,147</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,204,130</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_zQSaklA9ztf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A reconciliation of the expected income
tax (benefit) computed using the federal statutory income tax rate to the Company's effective income tax rate is as follows for
fiscal year 2020, 2019 and 2018:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zwqw6tDO2oE6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Reconciliation)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_zeHlw3e1gyG1" style="display: none">Effective income tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20200831_zFPXY8wYHiw" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20180901__20190831_zyR2udabmake" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20170901__20180831_zrqvTJHUFK8b" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_ziFhmue5SCxk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; text-align: justify">Income tax computed at federal statutory tax rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">25.4</td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zDRpPq6iHdq4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">State taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.0</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_dp_zIis2XbHznzg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Meals &amp; entertainment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_dp_zrqJXLlMHj01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.2</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.6</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.5</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_zAcMWigEiG6l" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Other permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.7</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pii_dpi_znSDn1apBFKl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Research and development credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.7</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.6</td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pii_dp0_z827QgPMm06a" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Foreign tax related differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.4</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_pii_dp0_zF2T52Vq8bWl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Research &amp; credit adjustments to expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_iN_pii_dpi0_z3szFnvHwqD6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Domestic production activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.8</td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp0_zb9Ev8H2igD5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Change in deferred income taxes due to statutory rate changes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.8</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zcBS6RXu5rO7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Change in prior year estimated taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.8</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.0</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zpRtCO6unFB3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18.7</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11.9</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr>
</table>


<p id="xdx_8A9_zwONgyhDMZgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant components of the Company's
deferred tax assets and liabilities for income taxes for the fiscal years ended August 31, 2020 and 2019 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zCZXffuI3e0f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Deferred taxes)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span id="xdx_8B0_zIMmSciWJ2ml" style="display: none">Components of the Company deferred tax assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20200831_zTX8Mol7GUm7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20190831_zVTY58QvbX8f" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_i01I_pp0p0_maDTAGz4SD_zU0Uta00rk6g" style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; text-align: left; padding-left: 10pt">Accrued payroll and other expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">402,355</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">236,455</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_pp0p0_maDTAGz4SD_zZOAjNd9Pare" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,862</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,038</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsEquityMethodInvestments_i01I_pp0p0_maDTAGz4SD_zvFnqPWEw25l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Capitalized merger costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">742,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,103</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_i01I_pp0p0_maDTAGz4SD_z60sjSZnITR3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,677</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,301</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsStateTaxes_i01I_pp0p0_maDTAGz4SD_zrJrwnpRb7D8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,326</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,537</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_d0_maDTAGz4SD_zaWJXuWwKFK9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Allowance for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_i01I_pp0p0_maDTAGz4SD_zLl3hW3ixf18" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">State tax deferred</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">125,417</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">146,815</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGz4SD_maDTANzteO_z0LDpi0OTbMk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,398,143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">898,249</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di0_msDTANzteO_zBSFWqsm3dxk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzteO_maDTALNzZow_zEciOfMQmQ2h" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Deferred tax asset</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,398,143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">898,249</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di_maDITLzYzc_zAUCDGKx7tF5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81,910</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(61,991</td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesOther_i01NI_pp0p0_di_maDITLzYzc_z5MOCRbkd2a5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">State tax deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,468</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,471</td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_pp0p0_di_maDITLzYzc_ztqmljXTTbAc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,876,274</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,217,234</td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_i01NI_pp0p0_di_maDITLzYzc_zkggYemUV7H5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Capitalized computer software development costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,774,349</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,334,169</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di_mtDITLzYzc_msDTALNzZow_zwTcyyi37Vye" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,752,001</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,629,865</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_i01NTI_pp0p0_di_mtDTALNzZow_zs9zP256ZpUe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net deferred tax liabilities</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,353,858</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,731,616</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
</table>

<p id="xdx_8A1_z2yUitcNsUd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We follow guidance issued by the FASB with
regard to our accounting for uncertainty in income taxes recognized in the financial statements. Such guidance prescribes a recognition
threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than
not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume
that the tax position will be examined by taxing authorities. Our policy is to include interest and penalties related to income
tax expense. Interest and penalties totaled $<span id="xdx_90F_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20190901__20200831_pp0p0" title="Interest and penalties">332</span>, $<span id="xdx_907_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20180901__20190831_pp0p0" title="Interest and penalties">2,531</span>, and $-<span id="xdx_901_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_c20170901__20180831_pp0p0" title="Interest and penalties">0</span>- for fiscal years 2020, 2019, and 2018, respectively. We file
income tax returns with the IRS and various state jurisdictions and India. Our federal income tax returns for fiscal year 2016
thru 2019 are open for audit, and our state tax returns for fiscal year 2015 through 2019 remain open for audit. In addition, our
California tax return for the fiscal year 2007 and fiscal year 2008 remains open with regard to R&amp;D tax credits as a result
of a previous audit for which we received a letter from the California Franchise Tax Board stating that an audit will not be conducted
for those years at this time; however it may be subject to future audit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our review of prior year tax positions
using the criteria and provisions presented in guidance issued by FASB did not result in a material impact on our financial position
or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048106184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS AND UNCERTAINTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">CONCENTRATIONS AND UNCERTAINTIES</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--ConcentrationRiskDisclosureTextBlock_zLyfrtLhpVGd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10 &#8211; <span id="xdx_82B_z3ByhgWpmBe3">CONCENTRATIONS AND UNCERTAINTIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially
subject the Company to concentration of credit risk consist principally of cash, cash equivalents and trade accounts receivable.
The Company holds cash and cash equivalents at banks located in California, with balances that often exceed FDIC insured limits.
Historically, the Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit
risk on cash and cash equivalents. However, considering the current banking environment, the Company is investigating alternative
ways to minimize its exposure to such risks. While the Company may be exposed to credit losses due to the nonperformance of its
counterparties, the Company does not expect the settlement of these transactions to have a material effect on its results of operations,
cash flows or financial condition. The Company maintains cash at financial institutions that may, at times, exceed federally insured
limits. At August 31, 2020, the Company had cash and cash equivalents exceeding insured limits by $<span id="xdx_903_eus-gaap--CashUninsuredAmount_c20200831_pp0p0" title="Cash and cash equivalents exceeding insured limits">10,790,000</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue concentration shows that international
sales accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_ztMkU0azh3F1" title="Net sales concentration percentage">29</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_zFijk4CsFE8" title="Net sales concentration percentage">34</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--InternationalSalesMember_zUnsrper1evb" title="Net sales concentration percentage">39</span>% of net sales for fiscal years 2020, 2019 and 2018, respectively. Three customers accounted
for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zjUMSmrDTvca" title="Net sales concentration percentage">9</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zAbmMpN7R8hf" title="Net sales concentration percentage">7</span>% (a dealer account in Japan representing various customers), and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_zfubQZlpyaFc" title="Net sales concentration percentage">7</span>% of net sales for fiscal year 2020. Three customers
accounted for <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zedJITtibWqf" title="Net sales concentration percentage">8</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zP6et4e5nok7" title="Net sales concentration percentage">8</span>% (a dealer account in Japan representing various customers), and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_z1yx07xGTmd1" title="Net sales concentration percentage">7</span>% of net sales for fiscal year 2019. Four
customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer1Member_zBXeKPfsfSJg" title="Net sales concentration percentage">9</span>% (a dealer account in Japan representing various customers), <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer2Member_zSStXQj3gXX9" title="Net sales concentration percentage">7</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer3Member_zY9vq8sXyxJl" title="Net sales concentration percentage">6</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20170901__20180831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesMember__srt--MajorCustomersAxis__custom--Customer4Member_zzIffaJSpaHf" title="Net sales concentration percentage">5</span>% of net sales for fiscal year
2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FY20 accounts receivable concentrations
show that two customers comprised <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ACustomerMember_zbmzWSy1zkJg" title="Net sales concentration percentage">13</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20190901__20200831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--BCustomerMember_zf4UkKL5y218" title="Net sales concentration percentage">10</span>% of accounts receivable as of August 31, 2020, respectively. FY19 accounts receivable
concentrations show that one customer comprised <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_c20180901__20190831__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--ACustomerMember_zuzPRWeNKvNl" title="Net sales concentration percentage">10</span>% of accounts receivable as of August 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate in the computer software industry,
which is highly competitive and changes rapidly. Our operating results could be significantly affected by our ability to develop
new products and find new distribution channels for new and existing products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The majority of our customers are in the
pharmaceutical industry. During economic downturns, we have seen consolidations in the pharmaceutical industry. Although we have
not seen any significant reduction in total revenues to date, our growth rate could be affected by consolidation and downsizing
in the pharmaceutical industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046470008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC REPORTING<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND GEOGRAPHIC REPORTING</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--SegmentReportingDisclosureTextBlock_zGBLN5PDfWCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 11 &#8211; <span id="xdx_825_zCN6KCYbWm0f">SEGMENT AND GEOGRAPHIC REPORTING</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-transform: uppercase">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We account for segments and geographic
revenues in accordance with guidance issued by the FASB. Our reportable segments are strategic business units that offer different
products and services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Results for each segment and consolidated
results are as follows years ended August 31, 2020, 2019 and 2018 (in thousands, because of rounding, numbers may not foot):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_znlQ7VnPMeuh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_zNsYceOS2LWd" style="display: none">Schedule of consolidated results from reportable segments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2020</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zIPywJ9pGXG6" style="width: 10%; text-align: right" title="Net Revenues">21,961</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zv5nt7qgAwVl" style="width: 10%; text-align: right" title="Net Revenues">11,105</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zpSrOIEUz3u3" style="width: 10%; text-align: right" title="Net Revenues">6,948</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z6YM73V6Tbi4" style="width: 10%; text-align: right" title="Net Revenues">1,575</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z45ynvxMb8E4" style="width: 10%; text-align: right" title="Net Revenues">41,589</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zJ2MUtMlxgHb" style="text-align: right" title="Income (loss) from operations before income taxes">7,374</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zoj7oGP9L2Fg" style="text-align: right" title="Income (loss) from operations before income taxes">1,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcuWRU2Zh0Ld" style="text-align: right" title="Income (loss) from operations before income taxes">1,744</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zeOykSYmylh1" style="text-align: right" title="Income (loss) from operations before income taxes">717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zrqzGSMYVjS5" style="text-align: right" title="Income (loss) from operations before income taxes">11,605</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zoGXa3yNB2kk" style="text-align: right" title="Total assets">162,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zin2MELpq9Me" style="text-align: right" title="Total assets">11,654</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zRkJH5towc67" style="text-align: right" title="Total assets">14,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z1jzyh0rhdOb" style="text-align: right" title="Total assets">19,972</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20200831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zT7pazXMHsre" style="text-align: right" title="Total assets">(40,095</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zh4OWXVwA3g5" style="text-align: right" title="Total assets">168,422</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_d0_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3ajge7nSrk2" style="text-align: right" title="Goodwill">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zkwSfZBdeeNd" style="text-align: right" title="Goodwill">4,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNhiendOEiug" style="text-align: right" title="Goodwill">5,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zHwKetURkVg9" style="text-align: right" title="Goodwill">2,534</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zDvZcR44EVs4" style="text-align: right" title="Goodwill">12,921</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLu0FkKhDyKk" style="text-align: right" title="Capital expenditures">111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zDVXBHkGYpee" style="text-align: right" title="Capital expenditures">87</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxQZg4WltYoi" style="text-align: right" title="Capital expenditures">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zfQWcGWgrRm5" style="text-align: right" title="Capital expenditures">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zwR5az5tFyg1" style="text-align: right" title="Capital expenditures">231</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zs0LFsjXIq02" style="text-align: right" title="Capitalized software costs">2,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdmmXcyK1fG4" style="text-align: right" title="Capitalized software costs">40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcHgswTtk81b" style="text-align: right" title="Capitalized software costs">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zIAbtTkh5Gvj" style="text-align: right" title="Capitalized software costs">160</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zAYhe7mp9Dld" style="text-align: right" title="Capitalized software costs">2,353</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3efLMHOP3q6" style="text-align: right" title="Depreciation and Amortization">1,713</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zrwFSKywakDf" style="text-align: right" title="Depreciation and Amortization">349</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0G2yjTh1Bx1" style="text-align: right" title="Depreciation and Amortization">600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zxs5NEQo86f6" style="text-align: right" title="Depreciation and Amortization">300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zab7kr5cEef6" style="text-align: right" title="Depreciation and Amortization">2,962</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2019</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zn3r6NCB494a" style="width: 10%; text-align: right" title="Net Revenues">19,585</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zyOyqLDUPZTl" style="width: 10%; text-align: right" title="Net Revenues">9,321</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zASPvToUczt7" style="width: 10%; text-align: right" title="Net Revenues">5,065</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z2ciSn1N3Ey" style="width: 10%; text-align: right" title="Net Revenues">33,970</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zjpV8RYaPKla" style="text-align: right" title="Income (loss) from operations before income taxes">7,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zqO7zlgLC8xi" style="text-align: right" title="Income (loss) from operations before income taxes">1,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4AGL3fHx2F7" style="text-align: right" title="Income (loss) from operations before income taxes">1,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_znd8uMPtLDe" style="text-align: right" title="Income (loss) from operations before income taxes">10,648</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zKuiVv1veg41" style="text-align: right" title="Total assets">38,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zzv2ZI8pODkb" style="text-align: right" title="Total assets">11,196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXvzQfUGkEq1" style="text-align: right" title="Total assets">13,168</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zHIsFlb4Ilfa" style="text-align: right" title="Total assets">(17,702</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zC4oN1WXivla" style="text-align: right" title="Total assets">45,197</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iI_pn3n3_d0_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zP4POxkXCxPg" style="text-align: right" title="Goodwill">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjHihHBK6ith" style="text-align: right" title="Goodwill">4,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z8G1gG6qqTEk" style="text-align: right" title="Goodwill">5,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z50Xh3ea9PAj" style="text-align: right" title="Goodwill">10,387</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zvV317UUkjy1" style="text-align: right" title="Capital expenditures">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zu8XsvhmZmNk" style="text-align: right" title="Capital expenditures">79</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4NfvL1JSBIi" style="text-align: right" title="Capital expenditures">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zYGnIy2MeXI8" style="text-align: right" title="Capital expenditures">138</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zxuIiWePb92c" style="text-align: right" title="Capitalized software costs">1,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zZ4EMeHrhzC3" style="text-align: right" title="Capitalized software costs">114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zUFbJrqSbbRk" style="text-align: right" title="Capitalized software costs">172</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z0LbRipTKsja" style="text-align: right" title="Capitalized software costs">1,768</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zOi20rlPfhTk" style="text-align: right" title="Depreciation and Amortization">1,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zti5NmFeyJh8" style="text-align: right" title="Depreciation and Amortization">364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zKwS3AL9OWI3" style="text-align: right" title="Depreciation and Amortization">580</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zBGgubPSupkd" style="text-align: right" title="Depreciation and Amortization">2,750</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2018</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVLlVPi5RII9" style="width: 10%; text-align: right" title="Net Revenues">17,553</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z5RrY4VpIBHl" style="width: 10%; text-align: right" title="Net Revenues">7,857</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z1h25TrgiGue" style="width: 10%; text-align: right" title="Net Revenues">4,257</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zEQ7SQCSoWa2" style="width: 10%; text-align: right" title="Net Revenues">29,667</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zpvlM3Ozyxx" style="text-align: right" title="Income (loss) from operations before income taxes">7,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zFhh4FyUWyCl" style="text-align: right" title="Income (loss) from operations before income taxes">1,902</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxJuOS4E3Sm4" style="text-align: right" title="Income (loss) from operations before income taxes">863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z583A7bMubaa" style="text-align: right" title="Income (loss) from operations before income taxes">10,298</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4ZEwN3Zfo8k" style="text-align: right" title="Total assets">38,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zUdaU5qVjEOk" style="text-align: right" title="Total assets">8,733</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zHgkXH2iB4bh" style="text-align: right" title="Total assets">14,248</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20180831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zCoMpkmy4Az" style="text-align: right" title="Total assets">(17,702</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zae8v4WmW4U1" style="text-align: right" title="Total assets">43,279</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_d0_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_znG7MJKgt4a6" style="text-align: right" title="Goodwill">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMIRR1kmb7hd" style="text-align: right" title="Goodwill">4,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNMbfUjJs1pk" style="text-align: right" title="Goodwill">5,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zd2YKBKNnRP9" style="text-align: right" title="Goodwill">10,387</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPptWlUTBGsl" style="text-align: right" title="Capital expenditures">65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zHWWQiN2ku3a" style="text-align: right" title="Capital expenditures">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zkxv0kpkgiSg" style="text-align: right" title="Capital expenditures">18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zqrxySbGToQk" style="text-align: right" title="Capital expenditures">183</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zMtcehUmqHy4" style="text-align: right" title="Capitalized software costs">1,365</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zQdvaXgc19D" style="text-align: right" title="Capitalized software costs">625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z26ZBHMN1p29" style="text-align: right" title="Capitalized software costs">155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zfaX3D0GeKf7" style="text-align: right" title="Capitalized software costs">2,145</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_ztfkJjILVJH7" style="text-align: right" title="Depreciation and Amortization">1,748</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z3SemHzU5HNi" style="text-align: right" title="Depreciation and Amortization">401</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zA2y1TrPxW2a" style="text-align: right" title="Depreciation and Amortization">572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zP7EnCmLNme6" style="text-align: right" title="Depreciation and Amortization">2,721</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zuCGSe30iLF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Company allocates revenues
to geographic areas based on the locations of its customers. Geographical revenues for the years ended August 31, 2020, 2019 and
2018 were as follows (in thousands, because of rounding, numbers may not foot):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_pn3n3_zJrhz4QAColl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zuA8uMzIV7U7" style="display: none">Schedule of geographical revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2020</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRRtk1mciEr5" style="width: 11%; text-align: right" title="Revenues">11,124</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4yCkIHGEr2k" style="width: 11%; text-align: right" title="Revenues">5,024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLGa3wTTIbpl" style="width: 11%; text-align: right" title="Revenues">5,812</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zipCPTlqCSLi" style="width: 11%; text-align: right" title="Revenues">21,961</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zS6zaOvq9Tcb" style="text-align: right" title="Revenues">11,105</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z4QH0lWQs0El" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zlMUXIoHGoxe" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdhdygJzQwla" style="text-align: right" title="Revenues">11,105</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrOzjHoFpMSe" style="text-align: right" title="Revenues">6,057</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zPs7H6lgkPu4" style="text-align: right" title="Revenues">646</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zvYEwyOsevOl" style="text-align: right" title="Revenues">246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z5KLxPhrEwd5" style="text-align: right" title="Revenues">6,948</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z07XcB5cktcg" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,388</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsqjK87yRc17" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">157</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zZYnEzVzGvY8" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">30</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsh10MIbss47" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,575</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_z5yqrScQSQwh" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">29,674</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember_zOnois1EIm8f" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,827</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember_zvdDrRbbwXk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">6,088</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"><p id="xdx_98C_eus-gaap--Revenues_pp0p0_c20190901__20200831_z9njnkBHIQ5j" style="font: 13.33px Times New Roman, Times, Serif; color: rgb(0, 0, 0)"><span style="display: none; font-style: normal; font-weight: normal; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(238, 238, 238)">41,589,084</span></p>41,589</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2019</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZmTkeGk2Sug" style="width: 11%; text-align: right" title="Revenues">9,381</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRzm5JMPj6w8" style="width: 11%; text-align: right" title="Revenues">5,144</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRWStue2Okei" style="width: 11%; text-align: right" title="Revenues">5,060</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zniiji62O83c" style="width: 11%; text-align: right" title="Revenues">19,585</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMO6Lxx5Agj3" style="text-align: right" title="Revenues">9,321</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z6eeplQ50xha" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zwpsWdlPCULf" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zfbqIsA7K6B3" style="text-align: right" title="Revenues">9,321</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zTOZ1VBc7xs5" style="text-align: right" title="Revenues">3,875</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4Y0OFo1EBe8" style="text-align: right" title="Revenues">685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zzJWHoPnH7xb" style="text-align: right" title="Revenues">505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z03s9YIMGVMd" style="text-align: right" title="Revenues">5,065</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zaluMlhDbgu9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zQWBY2eDLcr" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zoy1dgU5u9f3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBUWGxGn6cUl" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zQXAMrG0aDz1" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">22,577</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember_zGxG2JGrcUf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,829</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember_zVfuqcc6xwlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,565</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"><p id="xdx_98E_eus-gaap--Revenues_pp0p0_c20180901__20190831_zAtGEVnm2Cn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none">33,970,440</p>33,971</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2018</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zeII7hrIMrz" style="width: 11%; text-align: right" title="Revenues">7,856</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZcI0NCLxXm6" style="width: 11%; text-align: right" title="Revenues">4,964</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVSdlLepy8Cf" style="width: 11%; text-align: right" title="Revenues">4,733</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPAJQsH37C26" style="width: 11%; text-align: right" title="Revenues">17,553</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zpfDKcC42Y2c" style="text-align: right" title="Revenues">7,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zBnbPWJRwNGe" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjcsa3iwsG1b" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zPEVeQfhi0a4" style="text-align: right" title="Revenues">7,857</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrsSyW0gwLf2" style="text-align: right" title="Revenues">3,163</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zi7bAEWFFde6" style="text-align: right" title="Revenues">312</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0lqB9ZFUBHk" style="text-align: right" title="Revenues">782</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXAU3PLhCyF3" style="text-align: right" title="Revenues">4,257</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zNN1YKP0Xto7" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zf4xV1WRj6Q9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBfl4xDvSVO2" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zup81ldnN3Ai" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zlyiQa1LsN3a" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">18,876</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember_zISCw3o0FG29" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,276</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember_z6v6aRogU6Kf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,515</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"><p id="xdx_982_eus-gaap--Revenues_pp0p0_c20170901__20180831_zFqi7WVzFyZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none">29,666,524</p>29,667</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*Lixoft was acquired on April 1, 2020.</p>

<p id="xdx_8A0_zaVCBMc7nXag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574047856072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zQf2fkS2ccJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 12 &#8211; <span id="xdx_82A_zfh1wubEino9">RELATED PARTY TRANSACTIONS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2017 the Company acquired
DILIsym Service, Inc. As part of that agreement the Company paid $<span id="xdx_90C_eus-gaap--PaymentsToAcquireBusinessesGross_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_pp0p0" title="Payment for acquisition">1,704,000</span>
to former shareholders of DILIsym Services, Inc. who are currently employees of the Consolidated Company. In addition, as
part of the acquisition agreement the Company owes approximately $<span id="xdx_90E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_pp0p0" title="Acquisition liabilities owed">2,260,000</span>
of acquisition liabilities at August 31, 2018 to the former shareholders who are still employees of the Consolidated Company.
One of the former shareholders of DILIsym is currently a director of Simulations Plus, under the agreement he received
approximately $29,000 and could receive up to approximately $30,000 in future earn-out payments. In September 2018,
subsequent to year end under terms of the agreement the Company made payments in the amount of approximately $<span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20180930__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_zgZrlgDYJ7e1" title="Earn-out payments made">587,000</span>
and $<span id="xdx_90D_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20180930__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zGvNMQVWpKE6" title="Earn-out payments made">10,000</span>,
respectively to the employees and the current director. In fiscal year 2019, under terms of the agreement the Company made
payments in the amount of approximately $<span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_zLxMStytowK6" title="Earn-out payments made">1,599,534</span>
and $<span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zpwUxQOGPmw6" title="Earn-out payments made">27,312</span>,
respectively to the employees and the current director. In August 2020 the Company made final payments under the agreement in
the amount of approximately $<span title="Repayment to related party"><span id="xdx_905_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__custom--DilisymEmployeesMember_ztoVbqRjFDVi">664,506</span></span>
and $<span title="Repayment to related party"><span id="xdx_908_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember__srt--CounterpartyNameAxis__srt--DirectorMember_zilDiZKOz6R2">11,346</span></span>,
respectively to the employees and the current director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2020 the Company acquired Lixoft
of Paris. As part of that agreement the Company paid $<span id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesGross_pp0p0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_zVhLCsW09u9d" title="Payment for acquisition">6,720,615</span> and issued stock with a value of $<span id="xdx_903_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_zDSKqEjMsHgl" title="Business acquisition, shares issued">2,602,081</span> to former shareholders
of Lixoft who are currently employees of the Consolidated Company. In addition, as part of the acquisition agreement the Company
owes approximately $<span id="xdx_908_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iI_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember__srt--CounterpartyNameAxis__custom--FormerShareholdersMember_z8Xy5RvS6Ar7" title="Acquisition liabilities owed">947,220</span> of acquisition liabilities at August 31, 2020 to the former shareholders who are still employees of
the Consolidated Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046499576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLAN<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">EMPLOYEE BENEFIT PLAN</a></td>
<td class="text"><p id="xdx_808_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zBpmqGCv9Otf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 13 - <span id="xdx_827_zsWglPwrgAde">EMPLOYEE BENEFIT PLAN</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain a 401(k) Plan for eligible
employees. We make matching contributions equal to 100% of the employee&#8217;s elective deferral, not to exceed 4% of the total
employee compensation. We can also elect to make a profit-sharing contribution. We contributed $<span id="xdx_909_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20190901__20200831_pp0p0" title="Contribution by employer in benefit plan">456,484</span>, $<span id="xdx_901_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20180901__20190831_pp0p0" title="Contribution by employer in benefit plan">404,684</span> and $<span id="xdx_907_eus-gaap--DefinedBenefitPlanContributionsByEmployer_c20170901__20180831_pp0p0" title="Contribution by employer in benefit plan">326,762</span>
for fiscal years 2020, 2019 and 2018, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574129983896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION/MERGER WITH SUBSIDIARIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">ACQUISITION/MERGER WITH SUBSIDIARIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--MergersAcquisitionsAndDispositionsDisclosuresTextBlock_zBUOoc3ZhE2k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 14 - <span id="xdx_828_zSp288Gg3s91">ACQUISITION/MERGER WITH SUBSIDIARIES</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 31, 2020, the Company entered
into a Stock Purchase and Contribution Agreement (the &#8220;Agreement&#8221;) with Lixoft, a French soci&#233;t&#233; par
actions simplifi&#233;e (&#8220;Lixoft&#8221;). On April 1, 2020, the Company consummated the acquisition of all outstanding
equity interests of Lixoft pursuant to the terms of the Agreement, with Lixoft becoming a wholly owned subsidiary of the Company.
We believe the combination of Simulations Plus and Lixoft provides substantial future potential based on the complementary strengths
of each of the companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the Agreement, as described
below, the Company will pay the former shareholders of Lixoft total consideration of up to $16,500,000, consisting of two-thirds
cash and one-third newly issued, unregistered shares of the Company&#8217;s common stock. In addition, the Company will pay $3,456,029
of excess working capital based on the March 31, 2020 financial statements of Lixoft.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2020, the Company paid the
former shareholders of Lixoft a total of $10,789,362, comprised of cash in the amount of $9,460,129 and the issuance of 111,682
shares of the Company&#8217;s common stock valued at $3,662,337, net of adjustments and a holdback for representations and warranties
(under the terms of the Agreement a price of approximately $32.15 dollars per share was used based upon the volume-weighted average
closing price of the Company&#8217;s shares of common stock for the 30-consecutive-trading-day period ending two trading days prior
to April 1, 2020). 9,669 shares are held in an escrow for offset for representations and warrantees. Within three business days
following the two-year anniversary of March 31, 2020 (the date of the Agreement) and subject to any offsets for representations
and warrantees, the Company will pay the former shareholders of Lixoft a total of $2,000,000, comprised of $1,333,333 of cash and
the release from an escrow shares of stock valued at $666,337 issued at the date of the Agreement. The Agreement provides for a
two-year market standoff period in which the newly issued shares may not be sold by the recipients thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the agreement calls for earn-out
payments up to an additional $5,500,000, two-thirds cash and one-third newly issued, unregistered shares of the Company&#8217;s
common stock based on a revenue growth formula each year for the two years subsequent to April 1, 2020. The former shareholders
can earn up to $2,000,000 the first year and $3,500,000 in year two. The Earn-out liability has been recorded at fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the acquisition method of accounting,
the total purchase price reflects Lixoft&#8217;s tangible and intangible assets and liabilities based on their estimated fair values
at the date of the completion of the acquisition (April 1, 2020). The following table summarizes the preliminary allocation of
the purchase price for Lixoft:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zcIywZDxNYK8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B3_z2hFyIoMwDi1" style="display: none">Allocation of purchase price</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zJfdS7uAEkF9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 85%; text-align: justify">Assets acquired, Including cash of $3,799,134 and accounts receivable of $629,481</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,006,892</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Developed Technologies Acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,010,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Estimated value of Intangibles assets acquired (Customer Lists, trade name etc.)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,160,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Estimated Goodwill acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,533,987</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iNI_pp0p0_di_zTcmmmyhxeZ3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Liabilities Assumed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,117,519</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total Consideration</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20190901__20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFPT57Vz6TIi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration">18,593,360</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_zpz8cR8BoPpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill has been provided in the transaction
based on estimates of future earnings of this subsidiary including anticipated synergies associated with the positioning of the
combined company as a leader in model-based drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Consolidated supplemental Pro Forma
information</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following unaudited consolidated supplemental
pro forma information assumes that the acquisition of Lixoft took place on September 1, 2017 for the income statement years periods
ended August 31, 2020. These amounts have been calculated after applying the Company&#8217;s accounting policies and adjusting
the results of Lixoft to reflect the same expenses in the years ended August 31, 2019 and 2018. The adjustments include costs of
acquisition, and amortization of intangibles and other technologies acquired during the merger, assuming the fair-value adjustments
applied on September 1, 2017, together with consequential tax effects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zrpcNHjAFaUl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BD_zg37rGxisVDc" style="display: none">Schedule of statement of income</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20190901__20200831_zShnKeJjCig4" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20180901__20190831_zOEIReq5nt8l" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20170901__20180831_zSWTor0Jq3Ej" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2020*</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2019</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2018</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaRevenue_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; text-align: justify; padding-bottom: 2.5pt">Net Sales</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">43,970</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">36,918</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">31,891</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net Income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,630</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,250</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,132</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*Balances include five months actual results
for Lixoft.</p>

<p id="xdx_8AE_zRxGKAQVYcCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046534824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED QUARTERLY FINANCIAL DATA<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">UNAUDITED QUARTERLY FINANCIAL DATA</a></td>
<td class="text"><p id="xdx_803_eus-gaap--QuarterlyFinancialInformationTextBlock_zZnUM75nCet9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 15 -&#160;<span id="xdx_828_zlyAOAtdiz7k">UNAUDITED QUARTERLY FINANCIAL
DATA</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents selected unaudited quarterly financial
data for each full quarterly period of the years ended August 31, 2020 and 2019 (in thousands except for per share data), because
of rounding, numbers may not foot:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zM85Pbncz5Lg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zhI0IIPb7xy7" style="display: none">Quarterly Financial Information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20191130_zyJOyUoVg2k7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20191201__20200229_zS1UKxhr0GXc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20200301__20200531_zZ51MpVxUJVk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20200601__20200831_zsZ4o5vBzVP9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">First</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Second</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Third</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fourth</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year&#160;ended&#160;August 31, 2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--Revenues_pn3n3_zGDaTK6Dgxma" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">9,401</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">10,350</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">12,298</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">9,540</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--GrossProfit_pn3n3_zEhW7MN3AE0l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,758</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,683</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,865</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_z8Wj5evhf9S" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,058</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,936</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,188</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--EarningsPerShareBasic_pip0_zRUg9Klbn2" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share, Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_pip0_zIrzKctB0ENc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Earnings per share, Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.11</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20180901__20181130_zQoWUsEefpAh" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20181201__20190228_zX0gUe46UYEj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20190301__20190531_znowrDpL7UR9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20190601__20190831_zr2jb1KzBpQ1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">First</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Second</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Third</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fourth</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year&#160;ended&#160;August 31, 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_pn3n3_z3YmL6UNkGY9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">7,536</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">8,472</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">9,937</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">8,026</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--GrossProfit_pn3n3_zKPBv6FKcH72" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,336</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,264</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,735</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_zAIBuNFd6kv5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,536</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,099</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,889</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,059</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_pip0_zswufykBp244" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share, Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--EarningsPerShareDiluted_pip0_zcjpIT9x7tv4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Earnings per share, Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.11</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046462088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zyuYjK4GCOOc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 16 - <span id="xdx_827_zHUcNWpgjPt7">SUBSEQUENT EVENTS</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Dividend Declared</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 9, 2020, our Board of Directors
declared a quarterly cash dividend of $0.06 per share to our shareholders. The dividend in the amount of $1,195,461 was distributed
on Monday, November 2, 2020, for shareholders of record as of Monday, October 26, 2020.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051192520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--ConsolidationPolicyTextBlock_zLeqCyNdEKae" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Principles of Consolidation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include
the accounts of Simulations Plus, Inc. and, as of September 2, 2014, its wholly owned subsidiary, Cognigen Corporation, as of June
1, 2017, the accounts of DILIsym Services, Inc., and as of April 1, 2020, Lixoft accounts. All significant intercompany accounts
and transactions are eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--UseOfEstimates_z01cKeDwoRV6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Use of Estimates</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our financial statements and accompanying
notes are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial
statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue,
and expenses. These estimates and assumptions are affected by management&#8217;s application of accounting policies. Actual results
could differ from those estimates. Significant accounting policies for us include revenue recognition, accounting for capitalized
computer software development costs, valuation of stock options, and accounting for income taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zyPHw0BDcvE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Reclassifications</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain numbers in the prior year have
been reclassified to conform to the current year's presentation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_844_eus-gaap--RevenueRecognitionPolicyTextBlock_z3lyisFPeqe2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Revenue Recognition</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In May 2014, the
Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding
Accounting Standards Codification Topic 606 (ASC Topic 606), <i>Revenue from Contracts with Customers</i>. The standard provides
principles for recognizing revenue for the transfer of promised goods or services to customers with the consideration to which
the entity expects to be entitled in exchange for those goods or services. The standard also provides guidance on the recognition
of incremental costs related to obtaining customer contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing
the modified retrospective method. This approach was applied to contracts that were in process as of September 1, 2018, and the
corresponding incremental costs of obtaining those contracts, which resulted in a cumulative effect adjustment of $493,279 to the
opening balance of retained earnings at the date of adoption. The adoption of this ASU primarily impacts the timing of our revenue
recognition for certain sales contracts, the capitalization and amortization of incremental costs of obtaining a contract, and
related disclosures. The reported results for fiscal years 2020 and 2019 reflect the application of ASC Topic 606, while the reported
results for fiscal year 2018 are not adjusted and continue to be reported under ASC Topic 605.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We generate revenue primarily from the
sale of software licenses and providing consulting services to the pharmaceutical industry for drug development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines revenue recognition
through the following steps:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 5%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">i.</span></td>
    <td style="width: 95%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the contract, or contracts, with a customer</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">ii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Identification of the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iii.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Determination of the transaction price</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">iv.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Allocation of the transaction price to the performance obligations in the contract</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">v.</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Recognition of revenue when, or as, the Company satisfies a performance obligation</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Deferred Commissions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales commissions earned by our sales force
and our commissioned sales representatives are considered incremental and recoverable costs of obtaining a contract with a customer.
Sales commissions for new contracts are deferred and then amortized on a straight-line basis over a period of benefit. We determined
the period of benefit by taking into consideration our customer contracts, our technology and other factors. Sales commissions
for renewal contracts are deferred and then amortized on a straight-line basis over the related contractual renewal period. Amortization
expense is included in sales and marketing expenses on the condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We apply the practical expedient in ASC
Topic 606 to expense costs as incurred for sales commissions when the period of benefit would have been one year or less. Most
of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with
them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Practical Expedients and Exemptions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has elected the following additional
practical expedients in applying Topic 606:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px; text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b><i>Commission Expense</i></b>: We apply the practical expedient in ASC Topic 606 to expense costs as incurred for sales commissions when the period of benefit is one year or less. Most of our contracts are of a duration of one year or less, few, if any of the longer-term contracts have commissions associated with them<i>.</i></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 48px; text-align: justify"><span style="font: 10pt Symbol">&#183;</span></td>
    <td style="vertical-align: bottom">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Transaction Price Allocated to Future
        Performance Obligations</i></b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC 606 requires that the Company disclose
        the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of August
        31, 2020. ASC 606 provides certain practical expedients that limit the requirement to disclose the aggregate amount of transaction
        price allocated to unsatisfied performance obligations.</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applied the practical expedient
        to not disclose the amount of transaction price allocated to unsatisfied performance obligations when the performance obligation
        is part of a contract that has an original expected duration of one year or less.</p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z42PwMyYxHjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Cash and Cash Equivalents </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For purposes of the statements of cash
flows, the Company considers all highly liquid investments purchased with original maturities of three months or less to be cash
equivalents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zBcFHT8No2Ja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Accounts Receivable</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We analyze the age of customer balances,
historical bad debt experience, customer creditworthiness, and changes in customer payment terms when making estimates of the collectability
of the Company&#8217;s trade accounts receivable balances. If we determine that the financial conditions of any of our customers
have deteriorated, whether due to customer-specific or general economic issues, an increase in the allowance may be made. Accounts
receivable are written off when all collection attempts have failed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><p id="xdx_840_eus-gaap--InvestmentPolicyTextBlock_z91iV48QM9Hj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Investments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may invest excess cash balances in short-term
and long-term marketable debt securities. Investments may consist of certificates of deposit, money market accounts, government-sponsored
enterprise securities, corporate bonds and/or commercial paper. The Company accounts for its investment in marketable securities
in accordance with FASB ASC 320, Investments &#8211; Debt and Equity Securities. This statement requires debt securities to be
classified into three categories:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Held-to-maturity&#8212;Debt securities
that the entity has the positive intent and ability to hold to maturity are reported at amortized cost.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trading Securities&#8212;Debt securities
that are bought and held primarily for the purpose of selling in the near term are reported at fair value, with unrealized gains
and losses included in earnings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Available-for-Sale&#8212;Debt securities
not classified as either securities held-to-maturity or trading securities are reported at fair value with unrealized gains or
losses excluded from earnings and reported as a separate component of shareholders&#8217; equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company classifies its investments
in marketable debt securities based on the facts and circumstances present at the time of purchase of the securities. During the
years ended August 31, 2020, all of the Company&#8217;s investments were classified as held-to-maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Held-to-maturity investments are measured
and recorded at amortized cost on the Company&#8217;s Consolidated Balance Sheet. Discounts and premiums to par value of the debt
securities are amortized to interest income/expense over the term of the security. No gains or losses on investment securities
are realized until they are sold or a decline in fair value is determined to be other-than-temporary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Capitalized Computer Software Development Costs</a></td>
<td class="text"><p id="xdx_847_eus-gaap--ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_zs3HpkzXLr74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Capitalized Computer Software Development
Costs</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Software development costs are capitalized
in accordance with ASC 985-20, <i>&#8220;Costs of Software to Be Sold, Leased, or Marketed&#8221;</i>. Capitalization of software
development costs begins upon the establishment of technological feasibility and is discontinued when the product is available
for sale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The establishment of technological feasibility
and the ongoing assessment for recoverability of capitalized software development costs require considerable judgment by management
with respect to certain external factors including, but not limited to, technological feasibility, anticipated future gross revenues,
estimated economic life, and changes in software and hardware technologies. Capitalized computer software development costs are
comprised primarily of salaries and direct payroll-related costs and the purchase of existing software to be used in the Company's
software products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization of capitalized computer software
development costs is provided on a product-by-product basis on the straight-line method over the estimated economic life of the
products not to exceed five years. Amortization of software development costs amounted to $<span id="xdx_908_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20190901__20200831_pp0p0" title="Amortization of software development">1,225,544</span>, $<span id="xdx_901_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20180901__20190831_pp0p0" title="Amortization of software development">1,331,753</span>, and $<span id="xdx_90F_eus-gaap--CapitalizedComputerSoftwareAmortization1_c20170901__20180831_pp0p0" title="Amortization of software development">1,300,434</span>
for the years ended August 31, 2020, 2019, and 2018, respectively. We expect future amortization expense to vary due to increases
in capitalized computer software development costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We test capitalized computer software development
costs for recoverability whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zuOp5O4a3s8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Property and Equipment</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are recorded at
cost, or fair market value for property and equipment acquired in business combinations, less accumulated depreciation and amortization.
Depreciation and amortization are provided using the straight-line method over the estimated useful lives as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z57BwBKBd17j" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zId55k5a3xZf" style="display: none">Property and Equipment estimated useful lives</span></td>
    <td>&#160;</td>
    <td id="xdx_49F_20190901__20200831_zRnKl9OntJp7" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment</span></td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 47%; text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zSJ94LMI3jW2">5 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Computer equipment</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zxYSFSHDCa2i">3 to 7 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdwfRk2MRXo4">5 to 7 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zZ7hPNG6YRb3">Shorter of life of asset or lease</span></span></td></tr>
</table>
<p id="xdx_8A5_zoCoFxYwtNn9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maintenance and minor replacements are
charged to expense as incurred. Gains and losses on disposals are included in the results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zrcvmE3qmnM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.2pt 0pt 0"><span style="text-decoration: underline">Leases</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU No.
2016-02&#8212;Leases, to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities
on the balance sheet and disclosing key information about leasing arrangements. A lessee should recognize in the statement of financial
position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying
asset for the lease term. The recognition, measurement and presentation of expenses and cash flows arising from a lease by a lessor
have not significantly changed from previous U.S. GAAP. This ASU was effective for annual periods, including interim periods within
those annual periods, beginning after December 15, 2018. We adopted this ASU on September 1, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We lease various production, administrative
and sales offices under operating leases. We evaluate our contracts to determine if an arrangement is a lease at inception and
classify it as a finance or operating lease. Currently, all our leases are classified as operating leases. Leased assets and corresponding
liabilities are recognized based on the present value of the lease payments over the lease term. Our lease terms may include options
to extend when it is reasonably certain that we will exercise that option. Costs associated with operating leases are recognized
on a straight-line basis within operating expenses over the term of the lease. With the adoption of ASC 842 on September 1, 2019,
we recognized all leases with terms greater than 12 months in duration on our consolidated balance sheets as right-of-use assets
and lease liabilities. We adopted the standard using the prospective approach and did not retrospectively apply to prior periods.
Right-of-use assets are recorded in long-term assets on our consolidated balance sheets. Current and non-current lease liabilities
are recorded as operating lease liabilities within current liabilities and long-term liabilities, respectively, on our consolidated
balance sheets. As part of the adoption of this standard we recorded the following assets and liabilities as of September 1, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zTtNDqhLnfG7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BE_zSqDmV3ka2a7" style="display: none">Schedule of Operating assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20190902__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zL2WufTMtCs5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zoaaRhyOZZb9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Right of use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">902,553</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_zcy5QdVlyte6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease Liabilities, Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">537,017</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zbdJMiR7Eh55" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Lease Liabilities, Long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">365,536</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A3_zNbhSBZ9dUbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have made certain assumptions and judgments
when applying ASC 842, the most significant of which are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 48px">&#160;</td>
    <td style="width: 48px"><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We elected the package of practical expedients available for transition that allow us to not reassess whether expired or existing contracts contain leases under the new definition of a lease, lease classification for expired or existing leases and whether previously capitalized initial direct costs would qualify for capitalization under ASC 842.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">We did not elect to use hindsight when considering judgments and estimates such as assessments of lessee options&#160;&#160; to extend or terminate a lease or purchase the underlying asset.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases.</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font: 10pt Symbol">&#183;</span></td>
    <td><span style="font: 10pt Times New Roman, Times, Serif">The determination of the discount rate used in a lease is our estimated incremental borrowing rate that is based on what we would expect to pay to borrow over a similar term an amount equal to the lease payments.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Supplemental balance sheet information
related to operating leases was as follows as of August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zKoM6hMVYr81" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BC_zf5nJv1vY6T" style="display: none">Schedule of lease cost</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20200831_ztCF8vNQALEg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Right of use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">926,600</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease Liabilities, Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">463,465</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Lease Liabilities, Long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">463,312</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseCost_pp0p0_c20190901__20200831_zQBxhB4OiEd4" style="text-align: right" title="Operating lease costs">600,717</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted Average remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200831_zi078OFyofUa" title="Weighted average remaining lease term">2.27</span> years</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Weighted Average Discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pii_dp_c20200831_zvOvrb8miQZ1" title="Weighted average discount rate">4.25</span>%</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A6_z7z82ziGig1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><p id="xdx_841_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_z8aP6yZfFgAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Intangible Assets and Goodwill </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company performs valuations of assets
acquired and liabilities assumed on each acquisition accounted for as a business combination and recognizes the assets acquired
and liabilities assumed at their acquisition date fair value. Acquired intangible assets include customer relationships, software,
trade name, and non-compete agreements. The Company determines the appropriate useful life by performing an analysis of expected
cash flows based on historical experience of the acquired businesses. Intangible assets are amortized over their estimated useful
lives using the straight-line method, which approximates the pattern in which the majority of the economic benefits are expected
to be consumed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill represents the excess of the cost
of an acquired entity over the fair value of the acquired net assets. Goodwill is not amortized, instead it is tested for impairment
annually or when events or circumstances change that would indicate that goodwill might be impaired. Events or circumstances that
could trigger an impairment review include, but are not limited to, a significant adverse change in legal factors or in the business
climate, an adverse action or assessment by a regulator, unanticipated competition, a loss of key personnel, significant changes
in the manner of the Company's use of the acquired assets or the strategy for the Company's overall business, significant negative
industry or economic trends or significant under-performance relative to expected historical or projected future results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Goodwill is tested for impairment at the
reporting unit level, which is one level below or the same as an operating segment. As of August 31, 2020, the Company determined
that it has four reporting units, Simulations Plus, Cognigen Corporation, DILIsym Services, Inc. and Lixoft. When testing
goodwill for impairment, the Company first performs a qualitative assessment to determine whether it is necessary to perform step
one of a two-step annual goodwill impairment test for each reporting unit. The Company is required to perform step one only if
it concludes that it is more likely than not that a reporting unit's fair value is less than its carrying value. Should this be
the case, the first step of the two-step process is to identify whether a potential impairment exists by comparing the estimated
fair values of the Company's reporting units with their respective book values, including goodwill. If the estimated fair value
of the reporting unit exceeds book value, goodwill is considered not to be impaired, and no additional steps are necessary. If,
however, the fair value of the reporting unit is less than book value, then the second step is performed to determine if goodwill
is impaired and to measure the amount of impairment loss, if any. The amount of the impairment loss is the excess of the carrying
amount of the goodwill over its implied fair value. The estimate of implied fair value of goodwill is primarily based on an estimate
of the discounted cash flows expected to result from that reporting unit, but may require valuations of certain internally generated
and unrecognized intangible assets such as the Company's software, technology, patents and trademarks. If the carrying amount of
goodwill exceeds the implied fair value of that goodwill, an impairment loss is recognized in an amount equal to the excess.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020, the entire balance
of goodwill was attributed to three of the Company's reporting units, Cognigen Corporation, DILIsym Services and Lixoft. Intangible
assets subject to amortization are reviewed for impairment whenever events or circumstances indicate that the carrying amount of
these assets may not be recoverable. The Company has <span id="xdx_900_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zPQSY2jLPcrl" title="Impairment of long-lived assets"><span id="xdx_90E_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_zTalRBgg96G3" title="Impairment of long-lived assets"><span id="xdx_90D_eus-gaap--ImpairmentOfLongLivedAssetsHeldForUse_do_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z23eeCj7Ky32" title="Impairment of long-lived assets">no</span></span></span>t recognized any impairment charges during the periods ended August 31,
2020, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reconciliation of Goodwill for the period
ended August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfGoodwillTextBlock_z4HAeKRfXG9a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BF_zuAQoWfd73Qe" style="display: none">Schedule of reconciliation of goodwill</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-weight: bold">Balance, August 31, 2017</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zoR0fNA1RpMj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zSoxwTUSYCRj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iS_pp0p0_d0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zCFcLsBeuOa4" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20170831_zvEwCAhEXfJi" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zvsgqGbcSyG9" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zhhwZkbMyTLd" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHg46XMJXXJe" style="font-weight: bold; text-align: right" title="Addition">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831_zHaTc6ijB0Be" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Impairments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zkbUasYxCbG1" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zuasCTew16Ag" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zzQNnyC5Xr92" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831_zkKJBVSQO7md" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance, August 31, 2018</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zMUXOD9rtnRg" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zeXXADTv1cvf" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Goodwill_iS_pp0p0_d0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zR6QbZfcc7Ed" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20180831_zyYx0cSdkeBd" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zLgbuxdmazBk" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zgEZVCjCjow5" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zE5XV05nhK1c" style="font-weight: bold; text-align: right" title="Addition">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831_zqBiLpeMMal9" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Impairments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zCj29W7ZobBb" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zXdfBHzScdga" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcnZUfhUVYac" style="font-weight: bold; text-align: right" title="Impairments">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831_zIhzqb75zgAa" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balance, August 31, 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zSBcD1rOk8mj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zxCJv7IZot2d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_d0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFpsM4tMcXBf" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831_zq5CD50hQSz1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zAA9MZ82Firl" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zUaRbbH9IZ8j" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_pp0p0" style="font-weight: bold; text-align: right" title="Addition">2,533,987</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831_pp0p0" style="font-weight: bold; text-align: right" title="Addition">2,533,987</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Impairments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zpDb6srRyPR6" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zImENgHoNJp8" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zrnP0MMN3oHf" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831_zOVAChUZbsPb" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z8WvpIiRt9X3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">4,789,248</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zQfPUAISziy7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">5,597,950</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zGIfo8AZhXH7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">2,533,987</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iE_pp0p0_c20200831_zB26qGUiDAe9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">12,921,185</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A5_zHmLQSCUzkp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>









<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Other Intangible Assets</a></td>
<td class="text"><p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zbMRhXdE1U3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Other Intangible Assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes other intangible
assets as of August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zcdMv2SMnMX6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_z8PKBG7mUBPe" style="display: none">Schedule of other intangible assets</span></td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization<br/> Period</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Acquisition<br/> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net book <br/> value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 30%; text-align: left">Customer relationships-Cognigen</td><td style="width: 2%">&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="width: 23%; text-align: left" title="Amortization period">Straight line 8 years</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Acquisition value">1,100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Accumulated amortization">825,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Net book value">275,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Cognigen</td><td>&#160;</td>
    <td id="xdx_98E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z9H50fVKZ7h4" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Net book value">500,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Covenants not to compete-Cognigen</td><td>&#160;</td>
    <td id="xdx_980_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="text-align: left" title="Amortization period">Straight line 5 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Accumulated amortization">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zWM81nzb5Q4f" style="text-align: right" title="Net book value">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Covenants not to compete-DILIsym</td><td>&#160;</td>
    <td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period">Straight line 4 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">15,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Trade Name-DILIsym</td><td>&#160;</td>
    <td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">860,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zK8OpZ196sib" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">860,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships-DILIsym</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period">Straight line 10 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">1,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization">617,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">1,282,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Customer relationships-Lixoft</td><td>&#160;</td>
    <td id="xdx_982_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcuIzsZApaQ7" style="text-align: left" title="Amortization period">Straight line 14 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxDMpotqsKGh" style="text-align: right" title="Acquisition value">2,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zwghqLFIKLF2" style="text-align: right" title="Accumulated amortization">75,892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_ztnFFsowEzg1" style="text-align: right" title="Net book value">2,474,108</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Lixoft</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHqRhmhyaYL8" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zZXtOxMG2TF1" style="text-align: right" title="Acquisition value">1,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zTvrtuBVMjP4" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zAqcvFAQ80Y7" style="text-align: right" title="Net book value">1,550,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Covenants not to compete-Lixoft</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxkBBuWqUWr1" style="text-align: left; padding-bottom: 1pt" title="Amortization period">Straight line 3 years</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z7pFB0M4R3C5" style="border-bottom: Black 1pt solid; text-align: right" title="Acquisition value">60,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z0gE94uETOqf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">8,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zexyHyyHGowf" style="border-bottom: Black 1pt solid; text-align: right" title="Net book value">51,667</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Acquisition value">8,650,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accumulated amortization">1,641,725</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Net book value">7,008,275</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AC_zG1JJ03xFfx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense for the year ended
August 31, 2020, 2019 and 2018 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3ZFxKJwWMbb" title="Amortization of intangible assets">431,725</span>, $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_z3bmRuno6Ook" title="Amortization of intangible assets">357,500</span>, and $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zVABDRip64Ae" title="Amortization of intangible assets">357,500</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Future amortization for the next five years is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zxQnkrdiyGO6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span id="xdx_8B9_z234vGfYtfFf" style="display: none">Schedule of future amortization</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ending</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>August 31,</b></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 35%; text-align: center">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zRWulqymKJsl" style="width: 11%; text-align: right" title="2021">545,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zCSW1w5HslL6" style="text-align: right" title="2022">530,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_znfvw1zNOtAf" style="text-align: right" title="2023">384,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zT0va5RT4hTj" style="text-align: right" title="2024">372,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyakFlEwBm42" style="text-align: right" title="2025">372,000</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8AA_zjzYJ5dEGP21" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock', window );">Business Acquisitions</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock_zOecTBEg1Jo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Business Acquisitions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounted for the acquisition
of Cognigen, DILIsym Services, Inc. and Lixoft using the purchase method of accounting where the assets acquired and liabilities
assumed are recognized based on their respective estimated fair values. The excess of the purchase price over the estimated fair
values of the net assets acquired is recorded as goodwill. Determining the fair value of certain acquired assets and liabilities
is subjective in nature and often involves the use of significant estimates and assumptions, including, but not limited to, the
selection of appropriate valuation methodology, projected revenue, expenses and cash flows, weighted average cost of capital, discount
rates, estimates of advertiser and publisher turnover rates and estimates of terminal values. Business acquisitions are included
in the Company's consolidated financial statements as of the date of the acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zSLqoAyvl6U2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Fair Value of Financial Instruments</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assets and liabilities recorded at fair
value in the Consolidated Balance Sheets are categorized based upon the level of judgment associated with the inputs used to measure
their fair value. The categories, as defined by the standard are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Level&#160;Input:</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: justify">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 89%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Input Definition:</b></span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level I</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level II</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr>
<tr style="vertical-align: top">
    <td><span style="font: 10pt Times New Roman, Times, Serif">Level III</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unobservable inputs that reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For certain of our financial instruments,
including accounts receivable, accounts payable, accrued payroll and other expenses, and accrued bonuses to officers the carrying
amounts approximate fair value due to their short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes fair value
measurements at August 31, 2020 and August 31, 2019 for assets and liabilities measured at fair value on a recurring basis:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 31, 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zYyIrAvXvjG5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B3_zmHSUlmxpb69" style="display: none">Summarizes fair value measurements</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zHYQ0Goe3Hb5" style="width: 11%; text-align: right" title="Fair value assets">49,207,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zZ6wlmbkx7L" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_ziuNLvNKmt38" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z4nxg8L59Dx5" style="width: 11%; text-align: right" title="Fair value assets">49,207,314</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAa6u8BjB1X2" style="text-align: right" title="Fair value assets">66,803,595</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAWqU7EJeqUj" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zWtPp8qtylG9" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zMPsbjxizirf" style="text-align: right" title="Fair value assets">66,803,595</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Acquisition-related contingent consideration obligations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zByirdDWDExh" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zvasR6GY54w7" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zlBoNlObcO7b" style="text-align: right" title="Fair value liabilities">4,730,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zf1qb4fCDcwg" style="text-align: right" title="Fair value liabilities">4,730,500</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zFigkOPxI4Xe" style="width: 11%; text-align: right" title="Fair value assets">11,435,499</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z3O9eET3mUIc" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zgzKEnI30r7g" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zNqQAJFxum1h" style="width: 11%; text-align: right" title="Fair value assets">11,435,499</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zRwKH7oQn7c9" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCgK0YlFXF79" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_z18hJNKcgH31" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCSurT1FLxF7" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Acquisition-related contingent consideration obligations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zGm1wLfpJDr4" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zPbSMnDQbZX4" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zilckSxYLB4c" style="text-align: right" title="Fair value liabilities">1,761,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zIYMvbu92SJa" style="text-align: right" title="Fair value liabilities">1,761,028</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A8_zaLRR8e5v6tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of August 31, 2020 and 2019, the Company
has a liability for contingent consideration related to its acquisition of Lixoft and DILIsym Services, Inc. The fair value measurement
of the contingent consideration obligations is determined using Level 3 inputs. The fair value of contingent consideration obligations
is based on a discounted cash flow model using a probability-weighted income approach. These fair value measurements represent
Level 3 measurements as they are based on significant inputs not observable in the market. Significant judgment is employed in
determining the appropriateness of these assumptions as of the acquisition date and for each subsequent period. Accordingly, changes
in assumptions could have a material impact on the amount of contingent consideration expense the Company records in any given
period. Changes in the value of the contingent consideration obligations are recorded in the Company&#8217;s Consolidated Statement
of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a reconciliation of contingent
consideration value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfContingentConsiderationTableTextBlock_zsdXNYIcBFB" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zPTdvf5hZ8Tc" style="display: none">Reconciliation of contingent consideration value</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; font-weight: bold">Value at August 31, 2019</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iS_pp0p0_c20190831_znoY4GgeeSva" style="width: 11%; font-weight: bold; text-align: right" title="Contingent consideration, beginning balance">1,761,028</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchase price contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--PurchasePriceContingentConsiderationAdditions_c20190901__20200831_pp0p0" style="text-align: right" title="Purchase price contingent consideration">4,528,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Contingent consideration payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ContingentConsiderationPayments_iN_pp0p0_di_c20190901__20200831_zoY0KuUfKOgj" style="text-align: right" title="Contingent consideration payments">(1,761,028</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in value of contingent consideration</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c20190901__20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Change in value of contingent consideration">202,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Value at August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iE_pp0p0_c20200831_zxjqMrPZPwba" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Contingent consideration, ending balance">4,730,500</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A0_zfMjwN14OCPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zmjCyVBPBIwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Advertising</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company expenses advertising costs
as incurred. Advertising costs for the years ended August 31, 2020, 2019 and 2018 were approximately $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20190901__20200831_pp0p0" title="Advertising costs">63,944</span>, $<span id="xdx_908_eus-gaap--AdvertisingExpense_c20180901__20190831_pp0p0" title="Advertising costs">83,213</span> and $<span id="xdx_90A_eus-gaap--AdvertisingExpense_c20170901__20180831_pp0p0" title="Advertising costs">67,848</span>,
respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_zWe1iL9IrDuk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Research and Development Costs</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and development costs are charged
to expense as incurred until technological feasibility has been established. These costs include salaries, laboratory experiment,
and purchased software which was developed by other companies and incorporated into, or used in the development of, our final products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_849_eus-gaap--IncomeTaxPolicyTextBlock_zUIPGgh40rS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Income Taxes</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes in
accordance with ASC 740-10, <i>&#8220;Income Taxes&#8221;</i> which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements or tax returns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under this method, deferred income taxes
are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their
financial reporting amounts at each year-end based on enacted tax laws and statutory tax rates applicable to the periods in which
the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred
tax assets to the amount expected to be realized. The provision for income taxes represents the tax payable for the period and
the change during the period in deferred tax assets and liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intellectual property</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z8GNJWW9O9J9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Intellectual property</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 28, 2012, we bought out the
royalty agreement with Enslein Research. The cost of $<span id="xdx_908_eus-gaap--FiniteLivedIntangibleAssetsGross_c20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Intangible asset acquisition value">75,000</span> is being amortized over <span id="xdx_900_ecustom--AmortizationPeriodIntangibleAssets_c20110901__20120228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--RoyaltyAgreementsMember__srt--CounterpartyNameAxis__custom--EnslienMember" title="Amortization period">10 years under the straight-line method</span>. Amortization
expense for each of the fiscal years ended August 31, 2020 and 2019 was $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zhbLmTWT8ICe" title="Amortization of intangible assets"><span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_z7TtErqFcd5f" title="Amortization of intangible assets">7,500</span></span>. Accumulated amortization as of August 31, 2020
and 2019 was $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property">63,750</span> and $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_pp0p0" title="Accumulated amortization of intellectual property">56,250</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 15, 2014, we entered into a termination
and non-assertion agreement with TSRL, Inc., pursuant to which the parties agreed to terminate an exclusive software licensing
agreement entered into between the parties in 1997. As a result, the Company obtained a perpetual right to use certain source code
and data, and TSRL relinquished any rights and claims to any GastroPlus products and to any claims to royalties or other payments
under that 1997 agreement. We agreed to pay TSRL total consideration of $<span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetsGross_c20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Intangible asset acquisition value">6,000,000</span>, which is being amortized over <span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20130901__20140515__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--TermAndNonassertionAgrMember__srt--CounterpartyNameAxis__custom--TSRLMember" title="Amortization period">10 years under
the straight-line method</span>. Amortization for the year ended August 31, 2020, and 2019 was $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zwHu0ELID6e4" title="Amortization of intangible assets"><span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zEYLoca8Ywo7" title="Amortization of intangible assets">600,000</span></span>. Accumulated amortization as of
August 31, 2020 and 2019 was $<span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property">3,775,000</span> and $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_pp0p0" title="Accumulated amortization of intellectual property">3,175,000</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2017, as part of the acquisition
of DILIsym Services, Inc. the Company acquired certain developed technologies associated with the drug induced liver disease (DILI).
These technologies were valued at $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsGross_c20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Intangible asset acquisition value">2,850,000</span> and are being amortized over <span id="xdx_905_ecustom--AmortizationPeriodIntangibleAssets_c20160901__20170602__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--DILIsymMember" title="Amortization period">9 years under the straight-line method</span>. Amortization
expense for the fiscal years ended August 31, 2020 and 2019 was $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets">316,667</span> and $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Amortization of intangible assets">316,667</span>, respectively, and is included in cost of
revenues. Total accumulated amortization as of August 31, 2020 and 2019 was $<span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property">1,029,167</span> and $<span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIsymMember_pp0p0" title="Accumulated amortization of intellectual property">712,500</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2018, we purchased certain
intellectual property rights of Entelos Holding Company, a Delaware Corporation. The cost of $<span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember_pp0p0" title="Intangible asset acquisition value">50,000</span> is being amortized over <span id="xdx_907_ecustom--AmortizationPeriodIntangibleAssets_c20180901__20180930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainIntellectualPropertyRightsMember__srt--CounterpartyNameAxis__custom--EntelosHoldingCoMember" title="Amortization period">10
years under the straight-line method</span>. Amortization expense for the year ended August 31, 2020 and 2019 was $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Amortization of intangible assets">5,000</span> and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zOs5YJaHO26e" title="Amortization of intangible assets">5,000</span>. Accumulated
amortization as of August 31, 2020 and 2019 was $<span id="xdx_90B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_zW3aUM43FTwl" title="Accumulated amortization of intellectual property">10,000</span> and $<span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_pp0p0" title="Accumulated amortization of intellectual property">5,000</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 1, 2020, as part of the acquisition
of Lixoft, the Company acquired certain developed technologies associated with the Lixoft scientific software. These technologies
were valued at $<span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zpMxPfJZDHJ8" title="Intangible asset acquisition value">8,010,000</span> and are being amortized over <span id="xdx_90E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200402__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CertainDevelopedTechnologiesMember__srt--CounterpartyNameAxis__custom--LixoftMember_zXXpglxEVPh6" title="Amortization period">16 years under the straight-line method</span>. Amortization expense for the fiscal
years ended August 31, 2020 was $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zhQXw7zg7SEg" title="Amortization of intangible assets">208,594</span> and is included in cost of revenues. Total accumulated amortization as of August 31, 2020
was $<span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_zviBsbOkc0i2" title="Accumulated amortization of intellectual property">208,594</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total amortization expense for intellectual
property agreements for the years ended August 31, 2020, 2019 and 2018 was $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets">1,138,280</span>, $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20180901__20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets">929,167</span>, and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20170901__20180831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_pp0p0" title="Amortization of intangible assets">924,167</span>. Accumulated amortization
as of August 31, 2020 and 2019 was $<span id="xdx_901_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zwvNPyR8Newi" title="Accumulated amortization of intellectual property">5,087,031</span> and $<span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20190831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zyv8Lja8rOle" title="Accumulated amortization of intellectual property">3,948,750</span>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future amortization for the next five years
is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAmortizationExpensesTableTextBlock_zOT6nlAoXPva" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zQOnpBhAbNVj" style="display: none">Schedule of future amortization expenses</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zW7YXI5yZCLi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zX8dAQzarkKd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIMember_zsIOn20qZid7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_z1Tbr52GkpBk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_z4DTQrCGhw8g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zYZYZ4o7tgSi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ending <br/> August 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">TSRL</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Enslein</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILI-Acquired<br/> Developed<br/> Technologies</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft-Acquired<br/> Developed<br/> Technologies</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Entelos</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 16%; text-align: center">2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">600,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">7,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">316,667</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,625</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,429,792</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,426,042</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_d0_z5Oqy1grb2Yl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,422,292</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_d0_zBybeV9Z08F8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">425,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,247,292</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_d0_zGkQdQVNENzi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">822,292</td><td style="text-align: left">&#160;</td></tr>
</table>

<p id="xdx_8A6_zHZaIfKMDUP8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Share</a></td>
<td class="text"><p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zebAV6RoGKLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Earnings per Share</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reports earnings per share
in accordance with FASB ACS 260-10. Basic earnings per share is computed by dividing income available to common shareholders by
the weighted-average number of common shares available. Diluted earnings per share is computed similarly to basic earnings per
share except that the denominator is increased to include the number of additional common shares that would have been outstanding
if the potential common shares had been issued and if the additional common shares were dilutive. The components of basic and diluted
earnings per share for the years ended August 31, 2020, 2019 and 2018 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwPNl37oEuQh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BE_zbpYZd26dcYg" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20200831_z42pDCeajb91" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20180901__20190831_zgQ42h8vLxn6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20170901__20180831_zpLAOwGeQ94d" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Numerator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left; padding-bottom: 2.5pt">Net income attributable to common shareholders</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">9,332,060</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">8,583,329</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">8,934,812</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pii_zWGOoVnDS8j7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Weighted-average number of common shares outstanding during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,819,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,492,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,328,707</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pii_zl1t74brxaL1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dilutive effect of stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">719,309</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">565,173</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">531,685</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pii_zuS8ByLCnD6g" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Common stock and common stock equivalents used for diluted earnings per share</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18,538,373</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18,057,431</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">17,860,392</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_8AF_zTKM3q9U7om3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zYvIuhl0p9Rd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Stock-Based Compensation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for stock options
using the modified prospective method in accordance with FASB ASC 718-10, <i>&#8220;Compensation-Stock Compensation&#8221;</i>.
Under this method, compensation costs include estimated grant date fair value of the awards amortized over the options&#8217; vesting
period. Stock-based compensation was $<span id="xdx_909_eus-gaap--ShareBasedCompensation_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation">1,286,625</span>, $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation">865,848</span> and $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" title="Stock-based compensation">562,078</span> for the fiscal years ended August 31, 2020, 2019 and 2018,
respectively, and is included in the statements of operations as Consulting, Salaries, and Research and Development expense.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-lived Assets</a></td>
<td class="text"><p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zt0zasQu6cZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Impairment of Long-lived Assets</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for the impairment
and disposition of long-lived assets in accordance with ASC 350, <i>&#8220;Intangibles &#8211; Goodwill and Other</i>&#8221; and
ASC 360, <i>&#8220;Property and Equipment&#8221;</i>. Long-lived assets to be held and used are reviewed for events or changes
in circumstances that indicate that their carrying value may not be recoverable. We measure recoverability by comparing the carrying
amount of an asset to the expected future undiscounted net cash flows generated by the asset. If we determine that the asset may
not be recoverable, or if the carrying amount of an asset exceeds its estimated future undiscounted cash flows, we recognize an
impairment charge to the extent of the difference between the fair value and the asset's carrying amount. <span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20190901__20200831_z1hibgz7fx1" title="Impairment losses"><span id="xdx_90D_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20180901__20190831_zdzaE5YyJ5h4" title="Impairment losses"><span id="xdx_906_eus-gaap--ImpairmentOfIntangibleAssetsExcludingGoodwill_do_c20170901__20180831_zTk5MITYte01" title="Impairment losses">No</span></span></span> impairment losses
were recorded during the years ended August 31, 2020, 2019 and 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards</a></td>
<td class="text"><p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zHjSKuHffNZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Recently Issued Accounting Standards</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May 2014, the Financial Accounting Standards
Board (FASB) issued Accounting Standards Update (ASU) 2014-09 and its related amendments regarding Accounting Standards Codification
Topic 606 (ASC Topic 606), Revenue from Contracts with Customers. The standard provides principles for recognizing revenue for
the transfer of promised goods or services to customers with the consideration to which the entity expects to be entitled in exchange
for those goods or services. The standard also provides guidance on the recognition of incremental costs related to obtaining customer
contracts. We adopted ASC Topic 606, effective September 1, 2018, utilizing the modified retrospective method. This approach was
applied to contracts that were in process as of September 1, 2018, and the corresponding incremental costs of obtaining those contracts,
which resulted in a cumulative effect adjustment of $493,279 to the opening balance of retained earnings at the date of adoption.
The adoption of this ASU primarily impacts the timing of our revenue recognition for certain sales contracts, the capitalization
and amortization of incremental costs of obtaining a contract, and related disclosures. The reported results for fiscal year 2019
reflect the application of ASC Topic 606.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,
Leases (Topic 842), which supersedes existing guidance on accounting for leases in "Leases (Topic 840)" and generally
requires all leases to be recognized in the consolidated balance sheet. ASU 2016-02 is effective for annual and interim reporting
periods beginning after December 15, 2018. The Company adopted this ASU on September 1, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In April 2016, the FASB issued ASU 2016-10,
Revenue from Contracts with Customers (Topic 606), which amends certain aspects of the Board's new revenue standard, ASU 2014-09,
Revenue from Contracts with Customers. The standard was adopted concurrently with the adoption of ASU 2014-09 which is effective
for annual and interim periods beginning after December 15, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116873391&amp;loc=d3e408-128459<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=13988685&amp;loc=d3e8784-128493<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574050887256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock', window );">Property and Equipment estimated useful lives</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z57BwBKBd17j" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B0_zId55k5a3xZf" style="display: none">Property and Equipment estimated useful lives</span></td>
    <td>&#160;</td>
    <td id="xdx_49F_20190901__20200831_zRnKl9OntJp7" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 49%; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Equipment</span></td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 47%; text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_zSJ94LMI3jW2">5 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Computer equipment</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zxYSFSHDCa2i">3 to 7 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Furniture and fixtures</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zdwfRk2MRXo4">5 to 7 years</span></span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Leasehold improvements</span></td>
    <td>&#160;</td>
    <td style="text-align: justify" title="Estimated useful lives"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20190901__20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zZ7hPNG6YRb3">Shorter of life of asset or lease</span></span></td></tr>
</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock', window );">Schedule of Operating assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OperatingLeasesOfLesseeDisclosureTextBlock_zTtNDqhLnfG7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BE_zSqDmV3ka2a7" style="display: none">Schedule of Operating assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20190902__us-gaap--AdjustmentsForNewAccountingPronouncementsAxis__us-gaap--AccountingStandardsUpdate201602Member_zL2WufTMtCs5" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_zoaaRhyOZZb9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Right of use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">902,553</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_zcy5QdVlyte6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease Liabilities, Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">537,017</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zbdJMiR7Eh55" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Lease Liabilities, Long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">365,536</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of lease cost</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--LeaseCostTableTextBlock_zKoM6hMVYr81" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BC_zf5nJv1vY6T" style="display: none">Schedule of lease cost</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20200831_ztCF8vNQALEg" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; text-align: left">Right of use assets</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">926,600</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Lease Liabilities, Current</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">463,465</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Lease Liabilities, Long-term</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">463,312</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Operating lease costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseCost_pp0p0_c20190901__20200831_zQBxhB4OiEd4" style="text-align: right" title="Operating lease costs">600,717</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted Average remaining lease term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200831_zi078OFyofUa" title="Weighted average remaining lease term">2.27</span> years</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Weighted Average Discount rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pii_dp_c20200831_zvOvrb8miQZ1" title="Weighted average discount rate">4.25</span>%</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of reconciliation of goodwill</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfGoodwillTextBlock_z4HAeKRfXG9a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BF_zuAQoWfd73Qe" style="display: none">Schedule of reconciliation of goodwill</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; font-weight: bold">Balance, August 31, 2017</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98B_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zoR0fNA1RpMj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zSoxwTUSYCRj" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iS_pp0p0_d0_c20170831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zCFcLsBeuOa4" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20170831_zvEwCAhEXfJi" style="width: 11%; font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zvsgqGbcSyG9" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zhhwZkbMyTLd" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHg46XMJXXJe" style="font-weight: bold; text-align: right" title="Addition">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20170901__20180831_zHaTc6ijB0Be" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Impairments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zkbUasYxCbG1" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zuasCTew16Ag" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zzQNnyC5Xr92" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20170901__20180831_zkKJBVSQO7md" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">Balance, August 31, 2018</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zMUXOD9rtnRg" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Goodwill_iS_pp0p0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zeXXADTv1cvf" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Goodwill_iS_pp0p0_d0_c20180831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zR6QbZfcc7Ed" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_c20180831_zyYx0cSdkeBd" style="font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zLgbuxdmazBk" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zgEZVCjCjow5" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zE5XV05nhK1c" style="font-weight: bold; text-align: right" title="Addition">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20180901__20190831_zqBiLpeMMal9" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Impairments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zCj29W7ZobBb" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zXdfBHzScdga" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcnZUfhUVYac" style="font-weight: bold; text-align: right" title="Impairments">&#8211;</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20180901__20190831_zIhzqb75zgAa" style="text-align: right" title="Impairments">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 1pt">Balance, August 31, 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zSBcD1rOk8mj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">4,789,248</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zxCJv7IZot2d" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">5,597,950</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Goodwill_iS_pp0p0_d0_c20190831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFpsM4tMcXBf" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill, beginning balance">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Goodwill_iS_pp0p0_c20190831_zq5CD50hQSz1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Goodwill, beginning balance">10,387,198</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Addition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zAA9MZ82Firl" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--GoodwillAcquiredDuringPeriod_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zUaRbbH9IZ8j" style="text-align: right" title="Addition">&#8211;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_pp0p0" style="font-weight: bold; text-align: right" title="Addition">2,533,987</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillAcquiredDuringPeriod_c20190901__20200831_pp0p0" style="font-weight: bold; text-align: right" title="Addition">2,533,987</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 1pt">Impairments</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zpDb6srRyPR6" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zImENgHoNJp8" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zrnP0MMN3oHf" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--GoodwillImpairmentLoss_pp0p0_d0_c20190901__20200831_zOVAChUZbsPb" style="border-bottom: Black 1pt solid; text-align: right" title="Impairments">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z8WvpIiRt9X3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">4,789,248</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zQfPUAISziy7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">5,597,950</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iE_pp0p0_c20200831__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zGIfo8AZhXH7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">2,533,987</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iE_pp0p0_c20200831_zB26qGUiDAe9" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Goodwill, ending balance">12,921,185</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of other intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zcdMv2SMnMX6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BB_z8PKBG7mUBPe" style="display: none">Schedule of other intangible assets</span></td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortization<br/> Period</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Acquisition<br/> Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Accumulated<br/> Amortization</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net book <br/> value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 30%; text-align: left">Customer relationships-Cognigen</td><td style="width: 2%">&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="width: 23%; text-align: left" title="Amortization period">Straight line 8 years</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Acquisition value">1,100,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Accumulated amortization">825,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="width: 11%; text-align: right" title="Net book value">275,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Cognigen</td><td>&#160;</td>
    <td id="xdx_98E_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value">500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_z9H50fVKZ7h4" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Net book value">500,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Covenants not to compete-Cognigen</td><td>&#160;</td>
    <td id="xdx_980_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember" style="text-align: left" title="Amortization period">Straight line 5 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Acquisition value">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_pp0p0" style="text-align: right" title="Accumulated amortization">50,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--CognigenMember_zWM81nzb5Q4f" style="text-align: right" title="Net book value">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Covenants not to compete-DILIsym</td><td>&#160;</td>
    <td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period">Straight line 4 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">80,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization">65,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">15,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Trade Name-DILIsym</td><td>&#160;</td>
    <td id="xdx_989_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">860,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_zK8OpZ196sib" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">860,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Customer relationships-DILIsym</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember" style="text-align: left" title="Amortization period">Straight line 10 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Acquisition value">1,900,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Accumulated amortization">617,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--DILIsymMember_pp0p0" style="text-align: right" title="Net book value">1,282,500</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Customer relationships-Lixoft</td><td>&#160;</td>
    <td id="xdx_982_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zcuIzsZApaQ7" style="text-align: left" title="Amortization period">Straight line 14 years</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxDMpotqsKGh" style="text-align: right" title="Acquisition value">2,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zwghqLFIKLF2" style="text-align: right" title="Accumulated amortization">75,892</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_ztnFFsowEzg1" style="text-align: right" title="Net book value">2,474,108</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade Name-Lixoft</td><td>&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zHqRhmhyaYL8" title="Amortization period">None</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zZXtOxMG2TF1" style="text-align: right" title="Acquisition value">1,550,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zTvrtuBVMjP4" style="text-align: right" title="Accumulated amortization">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zAqcvFAQ80Y7" style="text-align: right" title="Net book value">1,550,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Covenants not to compete-Lixoft</td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_ecustom--AmortizationPeriodIntangibleAssets_c20190901__20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zxkBBuWqUWr1" style="text-align: left; padding-bottom: 1pt" title="Amortization period">Straight line 3 years</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z7pFB0M4R3C5" style="border-bottom: Black 1pt solid; text-align: right" title="Acquisition value">60,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_z0gE94uETOqf" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization">8,333</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zexyHyyHGowf" style="border-bottom: Black 1pt solid; text-align: right" title="Net book value">51,667</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Acquisition value">8,650,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accumulated amortization">1,641,725</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Net book value">7,008,275</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Schedule of future amortization</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zxQnkrdiyGO6" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span id="xdx_8B9_z234vGfYtfFf" style="display: none">Schedule of future amortization</span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Year ending</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>August 31,</b></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 35%; text-align: center">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zRWulqymKJsl" style="width: 11%; text-align: right" title="2021">545,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zCSW1w5HslL6" style="text-align: right" title="2022">530,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_znfvw1zNOtAf" style="text-align: right" title="2023">384,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zT0va5RT4hTj" style="text-align: right" title="2024">372,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_c20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zyakFlEwBm42" style="text-align: right" title="2025">372,000</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Summarizes fair value measurements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zYyIrAvXvjG5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B3_zmHSUlmxpb69" style="display: none">Summarizes fair value measurements</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zHYQ0Goe3Hb5" style="width: 11%; text-align: right" title="Fair value assets">49,207,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zZ6wlmbkx7L" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_ziuNLvNKmt38" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z4nxg8L59Dx5" style="width: 11%; text-align: right" title="Fair value assets">49,207,314</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAa6u8BjB1X2" style="text-align: right" title="Fair value assets">66,803,595</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zAWqU7EJeqUj" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zWtPp8qtylG9" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zMPsbjxizirf" style="text-align: right" title="Fair value assets">66,803,595</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Acquisition-related contingent consideration obligations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zByirdDWDExh" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zvasR6GY54w7" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zlBoNlObcO7b" style="text-align: right" title="Fair value liabilities">4,730,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20200831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zf1qb4fCDcwg" style="text-align: right" title="Fair value liabilities">4,730,500</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 1</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Level 3</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zFigkOPxI4Xe" style="width: 11%; text-align: right" title="Fair value assets">11,435,499</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_z3O9eET3mUIc" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zgzKEnI30r7g" style="width: 11%; text-align: right" title="Fair value assets">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--CashAndCashEquivalentsMember_zNqQAJFxum1h" style="width: 11%; text-align: right" title="Fair value assets">11,435,499</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zRwKH7oQn7c9" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCgK0YlFXF79" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_z18hJNKcgH31" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__us-gaap--ShortTermInvestmentsMember_zCSurT1FLxF7" style="text-align: right" title="Fair value assets">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Acquisition-related contingent consideration obligations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zGm1wLfpJDr4" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_d0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zPbSMnDQbZX4" style="text-align: right" title="Fair value liabilities">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zilckSxYLB4c" style="text-align: right" title="Fair value liabilities">1,761,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_c20190831__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FinancialInstrumentAxis__custom--AquisitionRelatedContingentConsiderationObligationsMember_zIYMvbu92SJa" style="text-align: right" title="Fair value liabilities">1,761,028</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ReconciliationOfContingentConsiderationTableTextBlock', window );">Reconciliation of contingent consideration value</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfContingentConsiderationTableTextBlock_zsdXNYIcBFB" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zPTdvf5hZ8Tc" style="display: none">Reconciliation of contingent consideration value</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; font-weight: bold">Value at August 31, 2019</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iS_pp0p0_c20190831_znoY4GgeeSva" style="width: 11%; font-weight: bold; text-align: right" title="Contingent consideration, beginning balance">1,761,028</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Purchase price contingent consideration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--PurchasePriceContingentConsiderationAdditions_c20190901__20200831_pp0p0" style="text-align: right" title="Purchase price contingent consideration">4,528,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Contingent consideration payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_ecustom--ContingentConsiderationPayments_iN_pp0p0_di_c20190901__20200831_zoY0KuUfKOgj" style="text-align: right" title="Contingent consideration payments">(1,761,028</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Change in value of contingent consideration</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c20190901__20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Change in value of contingent consideration">202,500</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Value at August 31, 2020</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98D_eus-gaap--BusinessCombinationContingentConsiderationAssetCurrent_iE_pp0p0_c20200831_zxjqMrPZPwba" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Contingent consideration, ending balance">4,730,500</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ScheduleOfAmortizationExpensesTableTextBlock', window );">Schedule of future amortization expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfAmortizationExpensesTableTextBlock_zOT6nlAoXPva" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zQOnpBhAbNVj" style="display: none">Schedule of future amortization expenses</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--TSRLMember_zW7YXI5yZCLi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EnslienMember_zX8dAQzarkKd" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--DILIMember_zsIOn20qZid7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_491_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--LixoftMember_z1Tbr52GkpBk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember__srt--CounterpartyNameAxis__custom--EntelosMember_z4DTQrCGhw8g" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20200831__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zYZYZ4o7tgSi" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years ending <br/> August 31,</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">TSRL</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Enslein</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILI-Acquired<br/> Developed<br/> Technologies</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft-Acquired<br/> Developed<br/> Technologies</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Entelos</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 16%; text-align: center">2021</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">600,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">7,500</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">316,667</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">500,625</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,429,792</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,426,042</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_d0_z5Oqy1grb2Yl" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">600,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,422,292</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_d0_zBybeV9Z08F8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">425,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,247,292</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_d0_zGkQdQVNENzi" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">316,667</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">500,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">822,292</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earnings per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zwPNl37oEuQh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BE_zbpYZd26dcYg" style="display: none">Schedule of earnings per share</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20200831_z42pDCeajb91" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20180901__20190831_zgQ42h8vLxn6" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20170901__20180831_zpLAOwGeQ94d" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Numerator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--NetIncomeLoss_i01_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; text-align: left; padding-bottom: 2.5pt">Net income attributable to common shareholders</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">9,332,060</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">8,583,329</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 2%; font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; font-weight: bold; text-align: right">8,934,812</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--EarningsPerShareBasicOtherDisclosuresAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Denominator</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pii_zWGOoVnDS8j7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Weighted-average number of common shares outstanding during the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,819,064</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,492,258</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17,328,707</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--IncrementalCommonSharesAttributableToCallOptionsAndWarrants_i01_pii_zl1t74brxaL1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Dilutive effect of stock options</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">719,309</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">565,173</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">531,685</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pii_zuS8ByLCnD6g" style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Common stock and common stock equivalents used for diluted earnings per share</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18,538,373</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18,057,431</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">17,860,392</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property and Equipment estimated useful lives [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ReconciliationOfContingentConsiderationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation Of Contingent Consideration [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ReconciliationOfContingentConsiderationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ScheduleOfAmortizationExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Amortization [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ScheduleOfAmortizationExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 1,3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121549808&amp;loc=d3e36991-112694<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048511416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of revenues</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_zagC0y6wzAVc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Disaggregation)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: 10pt"><span id="xdx_8B3_zQo710fJ5tV3" style="display: none">Schedule of disaggregation of revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Disaggregation of Revenues:</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended <br/> August 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended <br/> August 31, 2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Software licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; text-align: left; text-indent: 10pt">Point in time</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">20,668,195</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredAtPointInTimeMember_pp0p0" style="width: 11%; text-align: right" title="Revenues">17,425,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: 10pt">Over time</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="text-align: right" title="Revenues">919,344</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--SoftwareLicensesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="text-align: right" title="Revenues">1,053,562</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">Consulting services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: 10pt">Over time</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_c20190901__20200831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">20,001,545</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_c20180901__20190831__srt--ProductOrServiceAxis__custom--ConsultingServicesMember__us-gaap--TimingOfTransferOfGoodOrServiceAxis__us-gaap--TransferredOverTimeMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">15,491,525</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Revenue</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">41,589,084</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20180901__20190831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">33,970,440</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock', window );">Schedule of contract in progress</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock_zCdLLMp8FQm3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_zqfCiXdLAFU2" style="display: none">Schedule of contract in progress</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_49D_20200831_zjzGgHGToG3b" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_49C_20190831_zJaf8b3ahOO7" style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_iI_pp0p0_maROBOUztWJ_zYD86VrOVm5b" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Revenues in excess of billings</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,093,343</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,233,659</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--BillingsInExcessOfCost_iNI_pp0p0_di_msROBOUztWJ_z2FWgTLFLdwc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Billings in excess of revenues</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(140,991</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(798,549</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--RevenuesOverBillingsOnUncompletedContracts_iTI_pp0p0_mtROBOUztWJ_zcQQ5a2vCZgb" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 2.5pt">Revenues over billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,952,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,435,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost, estimated earnings, and billings
on uncompleted contracts are summarized as follows as of August 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_401_ecustom--RevenuesEarnedToDateOnUncompletedContracts_iI_z1MJMCb5jmk6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Revenues earned to date on uncompleted contracts</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20,235,573</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">19,254,928</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_ecustom--BillingsToDateOnUncompletedContracts_iNI_di_zfUIObO0Xka1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Billings to date on uncompleted contracts</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(17,283,221</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(16,819,818</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 2.5pt">Revenues over billings on uncompleted contracts</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,952,352</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,435,110</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-term contract or program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046471976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_882_eus-gaap--PropertyPlantAndEquipmentTextBlock_z2XcKW4fbxvg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B7_zb3ozx5Y0Mv8" style="display: none">Schedule of property and equipment</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify">Equipment</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Property and equipment, gross">864,560</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 11%; text-align: right" title="Property and equipment, gross">741,486</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Computer equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">547,738</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">411,632</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Furniture and fixtures</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and equipment, gross">160,991</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Property and equipment, gross">160,990</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1pt">Leasehold improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20200831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">114,005</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20190831__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">110,165</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify"/><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200831_pp0p0" style="text-align: right" title="Property and equipment, gross">1,687,294</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_c20190831_pp0p0" style="text-align: right" title="Property and equipment, gross">1,424,273</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20200831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">1,249,507</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c20190831_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less accumulated depreciation and amortization">1,083,128</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentNet_c20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value">437,787</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentNet_c20190831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net Book Value">341,145</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574129983896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Schedule of short term investment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--InvestmentTableTextBlock_zkCOSS5CwoJj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVESTMENTS (Details)">
<tr style="vertical-align: bottom">
    <td><span id="xdx_8B6_zWYafKIsrk3d" style="display: none">Schedule of short term investment</span></td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amortized Cost</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Gross</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Unrealized</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Gains</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Gross</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Unrealized</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Losses</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left; padding-bottom: 1pt">Commercial notes (due within one year)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShortTermInvestments_iI_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_z5z0YeKmXdRk" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Short term investment, amortized cost">66,803,595</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Gross unrealized gains"><span style="-sec-ix-hidden: xdx2ixbrl1255">&#8211;</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_zIqg0YqQOL95" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Gross unrealized loss">(60,977</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--InvestmentsFairValueDisclosure_c20200831__us-gaap--InvestmentTypeAxis__us-gaap--CommercialPaperMember_pp0p0" style="border-bottom: Black 1pt solid; width: 11%; text-align: right" title="Short term investment, fair value">66,742,618</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShortTermInvestments_iI_c20200831_zl8P0WCnCdH2" style="border-bottom: Black 2.5pt double; text-align: right" title="Short term investment, amortized cost">66,803,595</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedGains_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross unrealized gains"><span style="-sec-ix-hidden: xdx2ixbrl1263">&#8211;</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--AvailableForSaleSecuritiesGrossUnrealizedLoss_iN_pp0p0_di_c20190901__20200831_zbSgKAap4zDc" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross unrealized loss">(60,977</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--InvestmentsFairValueDisclosure_c20200831_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Short term investment, fair value">66,742,618</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI http://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI http://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048024440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTRACTS PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesTableTextBlock', window );">Schedule of Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--OtherLiabilitiesTableTextBlock_zmP989z4S3jh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - CONTRACTS PAYABLE (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B3_zIUlL5BCIDJ1" style="display: none">Schedule of Liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: justify">Holdback Liability - Lixoft</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zdDXDKhB3mZh" style="width: 11%; text-align: right" title="Total contract with customer">1,333,333</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--HoldbackLiabilityLixoftMember_zYCijRiOKDae" style="width: 11%; text-align: right" title="Total contract with customer">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Earn-out Liability - Lixoft</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zcPF0mZJV035" style="text-align: right" title="Total contract with customer">4,730,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--ContractsPayable_iI_pp0p0_d0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityLixoftMember_zbVdJZcSIkt" style="text-align: right" title="Total contract with customer">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Earn-out Liability - Dilisym</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_d0_c20200831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zr63wDRbjKu7" style="border-bottom: Black 1pt solid; text-align: right" title="Total contract with customer">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ContractsPayable_iI_pp0p0_c20190831__us-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAxis__custom--EarnoutLiabilityDilisymMember_zBzDvLHfQomf" style="border-bottom: Black 1pt solid; text-align: right" title="Total contract with customer">1,761,028</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Sub Total</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ContractWithCustomerLiability_c20200831_pp0p0" style="text-align: right" title="Total contract with customer">6,063,833</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ContractWithCustomerLiability_c20190831_pp0p0" style="text-align: right" title="Total contract with customer">1,761,028</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Less: Current Portion</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ContractsPayableCurrent_iI_pp0p0_c20200831_zqRAm4D7al37" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Current Portion">2,000,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_ecustom--ContractsPayableCurrent_iI_pp0p0_c20190831_zno9uBoiCO5k" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Current Portion">1,761,028</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Long-Term</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--ContractsPayableNoncurrent_iI_pp0p0_c20200831_zPVMD6c1oMi4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term">4,063,833</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--ContractsPayableNoncurrent_iI_pp0p0_d0_c20190831_zuUCoc68wCn4" style="border-bottom: Black 2.5pt double; text-align: right" title="Long-Term">&#8211;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046470008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Future minimum lease payments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zwFpebZzQH0i" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BD_zU4P7VpsUZgk" style="display: none">Future minimum lease payments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20200831_zCQu7tjBUsOj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Years Ending August 31,</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueCurrent_iI_pp0p0_maOLFMPzcU7_z9LUrgXv9M8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 33%; text-align: center">2021</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">486,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInTwoYears_iI_pp0p0_maOLFMPzcU7_zNQr2PI4G4z3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInThreeYears_iI_pp0p0_maOLFMPzcU7_zKwWOoiB0PSk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">172,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFourYears_iI_pp0p0_maOLFMPzcU7_z1Q0If2dy0cb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--OperatingLeasesFutureMinimumPaymentsDueInFiveYears_iI_pp0p0_maOLFMPzcU7_zsICFrla2TX8" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center; padding-bottom: 1pt">2025</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">11,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--OperatingLeasesFutureMinimumPaymentsDue_iI_pp0p0_mtOLFMPzcU7_zq3lZfs7ArKf" style="vertical-align: bottom; background-color: White">
    <td style="visibility: hidden; text-align: center; padding-bottom: 2.5pt">Future minimum lease payments</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">961,000</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048633976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDividendsPayableTextBlock', window );">Schedule of dividends declared and paid</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_890_eus-gaap--ScheduleOfDividendsPayableTextBlock_zYXn5OwzWm9f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B5_zwwsUCr2hev7" style="display: none">Schedule of dividends declared and paid</span></td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="15" style="font-weight: bold; text-align: center">FY2018</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br/> Outstanding on<br/> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br/> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_908_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" title="Record Date">11/13/2017</span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_983_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member" style="width: 26%; text-align: center" title="Distribution Date">11/20/2017</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date">17,284,792</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pii" style="width: 11%; text-align: right" title="Dividend per Share">0.06</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20181Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount">1,037,088</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_909_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" title="Record Date">1/26/2018</span></td><td>&#160;</td>
    <td id="xdx_982_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member" style="text-align: center" title="Distribution Date">2/02/2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,317,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20182Member_pp0p0" style="text-align: right" title="Total Amount">1,039,065</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_90A_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" title="Record Date">4/25/2018</span></td><td>&#160;</td>
    <td id="xdx_981_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member" style="text-align: center" title="Distribution Date">5/02/2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,354,005</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20183Member_pp0p0" style="text-align: right" title="Total Amount">1,041,240</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" title="Record Date">7/26/2018</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date">8/02/2018</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date">17,405,775</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share">0.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Dividends_c20170901__20180831__us-gaap--DividendsAxis__custom--RecordDate20184Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount">1,044,347</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_98F_eus-gaap--Dividends_c20170901__20180831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount">4,161,740</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FY2019</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br/> Outstanding on<br/> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br/> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_90B_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" title="Record Date">11/01/2018</span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_980_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member" style="width: 26%; text-align: center" title="Distribution Date">11/08/2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date">17,417,875</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pii" style="width: 11%; text-align: right" title="Dividend per Share">0.06</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20191Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount">1,045,073</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" title="Record Date">1/25/2019</span></td><td>&#160;</td>
    <td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member" style="text-align: center" title="Distribution Date">2/01/2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,481,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20192Member_pp0p0" style="text-align: right" title="Total Amount">1,048,887</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" title="Record Date">4/24/2019</span></td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member" style="text-align: center" title="Distribution Date">5/01/2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,515,228</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20193Member_pp0p0" style="text-align: right" title="Total Amount">1,050,914</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" title="Record Date">7/25/2019</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date">8/01/2019</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date">17,536,454</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--CommonStockDividendsPerShareDeclared_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share">0.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Dividends_c20180901__20190831__us-gaap--DividendsAxis__custom--RecordDate20194Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount">1,052,181</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_989_eus-gaap--Dividends_c20180901__20190831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount">4,197,055</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FY2020</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Record Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Distribution Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares<br/> Outstanding on<br/> Record Date</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Dividend per<br/> Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 27%; text-align: center"><span id="xdx_904_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" title="Record Date">10/25/2019</span></td><td style="width: 2%">&#160;</td>
    <td id="xdx_98C_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member" style="width: 26%; text-align: center" title="Distribution Date">11/01/2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" style="width: 11%; text-align: right" title="Number of Shares Outstanding on Record Date">17,606,314</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pii" style="width: 11%; text-align: right" title="Dividend per Share">0.06</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20201Member_pp0p0" style="width: 11%; text-align: right" title="Total Amount">1,056,379</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center"><span id="xdx_905_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" title="Record Date">1/27/2020</span></td><td>&#160;</td>
    <td id="xdx_98D_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member" style="text-align: center" title="Distribution Date">2/03/2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,645,639</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20202Member_pp0p0" style="text-align: right" title="Total Amount">1,058,740</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center"><span id="xdx_906_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" title="Record Date">4/24/2020</span></td><td>&#160;</td>
    <td id="xdx_98E_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member" style="text-align: center" title="Distribution Date">5/01/2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" style="text-align: right" title="Number of Shares Outstanding on Record Date">17,769,134</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pii" style="text-align: right" title="Dividend per Share">0.06</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20203Member_pp0p0" style="text-align: right" title="Total Amount">1,066,148</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_907_eus-gaap--DividendsPayableDateOfRecordDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" title="Record Date">7/27/2020</span></td><td style="padding-bottom: 1pt">&#160;</td>
    <td id="xdx_98F_eus-gaap--DividendsPayableDateDeclaredDayMonthAndYear_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member" style="text-align: center; padding-bottom: 1pt" title="Distribution Date">8/03/2020</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_ecustom--WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" style="padding-bottom: 1pt; text-align: right" title="Number of Shares Outstanding on Record Date">17,820,057</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_988_eus-gaap--CommonStockDividendsPerShareDeclared_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pii" style="padding-bottom: 1pt; text-align: right" title="Dividend per Share">0.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Dividends_c20190901__20200831__us-gaap--DividendsAxis__custom--RecordDate20204Member_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total Amount">1,069,203</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="text-align: justify; padding-bottom: 2.5pt">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_987_eus-gaap--Dividends_c20190901__20200831_pp0p0" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total Amount">4,250,470</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zSr229JwgMK" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt"><span id="xdx_8B7_zAN0GhH22zpg" style="display: none">Schedule of stock option activity</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY18</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Remaining<br/> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2017</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEmJKLz0jDak" style="width: 11%; text-align: right" title="Option outstanding, beginning balance">1,249,126</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqZvx2UgdR4f" style="width: 11%; text-align: right" title="Outstanding">8.51</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--OutstandingRemainingContractualLife_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zl3sQ6c8ZNv4" style="width: 11%; text-align: right" title="Outstanding, beginning of period">7.74</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZeGbhUIA3Ie" style="text-align: right" title="Granted">52,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">22.36</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfdHMQEFvLOf" style="text-align: right" title="Exercised">(130,006</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised">5.97</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1CCY01E1Ei7" style="text-align: right" title="Canceled/Forfeited">(30,144</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited">9.10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pii_di_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z74F6X7O9K5h" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">(6,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired">5.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2018</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zaIyp400GGif" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, ending balance">1,134,976</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpYo4tgysgU9" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding">9.44</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAJq5Md5lLd1" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period">7.31</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z8uNDYErUvQe" style="text-align: right" title="Vested and Exercisable, end of period">483,696</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zPmTRz5nZlv7" style="text-align: right" title="Vested and Exercisable, end of period">7.79</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDGEoaKkCZae" style="text-align: right" title="Vested and Exercisable">6.48</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zze8rqGw8XUb" style="text-align: right" title="Vested and Expected to Vest, end of period">1,069,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJgbTPCiBn38" style="text-align: right" title="Vested and Expected to Vest, end of period">9.35</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z25uFgz35HD1" style="text-align: right" title="Vested and Expected to Vest">7.26</td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY19</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Remaining<br/> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5tiSbVHNHQ1" style="width: 11%; text-align: right" title="Option outstanding, beginning balance">1,134,976</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuNgDguDPFJe" style="width: 11%; text-align: right" title="Outstanding">9.44</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--OutstandingRemainingContractualLife_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zD4mZtpPQaA5" style="width: 11%; text-align: right" title="Outstanding, beginning of period">7.31</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">263,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">22.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0tul9S7E3z1" style="text-align: right" title="Exercised">(166,703</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised">7.15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXwRjy9aqy1i" style="text-align: right" title="Canceled/Forfeited">(68,514</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited">12.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl1539">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl1541">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2019</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyUPwLwkZob1" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards Outstanding, ending balance">1,163,259</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWmBv4a6At8j" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding">12.63</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zK0zy9D79jIl" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period">7.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znG6VYz2SlH5" style="text-align: right" title="Vested and Exercisable, end of period">515,394</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfXkUtlWsXEe" style="text-align: right" title="Vested and Exercisable, end of period">8.57</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDfas0zUwvOj" style="text-align: right" title="Vested and Exercisable">6.09</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zczJzIX8cWB3" style="text-align: right" title="Vested and Expected to Vest, end of period">1,101,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zoOfywrKUdhd" style="text-align: right" title="Vested and Expected to Vest, end of period">12.39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqPPJ0FIpf0f" style="text-align: right" title="Vested and Expected to Vest">7.07</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Transactions in FY20</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of<br/> Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Exercise Price <br/> Per Share</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted-Average<br/> Remaining<br/> Contractual Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">Outstanding, August 31, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfwOBZP38bxa" style="width: 11%; text-align: right" title="Option outstanding, beginning balance">1,163,259</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zmjiDHvEm9nh" style="width: 11%; text-align: right" title="Outstanding">12.63</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--OutstandingRemainingContractualLife_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zXj9Bfgi1CYh" style="width: 11%; text-align: right" title="Outstanding, beginning of period">7.13</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">223,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Granted">39.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zItDmrTb6cn5" style="text-align: right" title="Exercised">(121,647</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Exercised">9.29</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: -10pt; padding-left: 20pt">Canceled/Forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pii_di_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfnRZ3cit0Og" style="text-align: right" title="Canceled/Forfeited">(40,951</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="text-align: right" title="Canceled/Forfeited">14.19</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Expired</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl1579">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"><span style="-sec-ix-hidden: xdx2ixbrl1581">&#8211;</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Outstanding, August 31, 2020</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zrsDghe0G1o2" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards Outstanding, ending balance">1,223,661</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zuwytd9hDha9" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding">17.76</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zRiA6Cw8x8ab" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding, end of period">6.79</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Vested and Exercisable, August 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqA24fEGqDMa" style="text-align: right" title="Vested and Exercisable, end of period">596,311</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z0hy42e5eOR2" style="text-align: right" title="Vested and Exercisable, end of period">10.69</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z97XlNuraP17" style="text-align: right" title="Vested and Exercisable">5.59</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Vested and Expected to Vest, August 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zfCoaGynvyS4" style="text-align: right" title="Vested and Expected to Vest, end of period">1,194,239</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pii_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zpvw61my3nP5" style="text-align: right" title="Vested and Expected to Vest, end of period">17.75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zvoPhIIhYss9" style="text-align: right" title="Vested and Expected to Vest">6.77</td><td style="text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock', window );">Intrinsic Value of options outstanding and options exercisable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock_zZvHpp2Iyuo" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)">
<tr style="vertical-align: bottom; background-color: White">
    <td><span id="xdx_8BC_zw3Qq8hTf1wl" style="display: none">Intrinsic Value of options outstanding and options exercisable</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic Value<br/> of Options<br/> Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic<br/> Value of <br/> Options<br/> Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Intrinsic <br/> Value of<br/> Options<br/> Exercised</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%">FY18</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Outstanding">13,064,884</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Exercisable">6,315,086</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20170901__20180831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="width: 11%; text-align: right" title="Intrinsic Value of Options Exercised">1,495,313</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>FY19</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Outstanding">27,312,742</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercisable">14,194,724</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20180901__20190831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercised">3,224,454</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>FY20</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Outstanding">51,272,966</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercisable">29,150,912</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pp0p0" style="text-align: right" title="Intrinsic Value of Options Exercised">4,085,753</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of fair value of options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_znYDjjsdi7f3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zqwPDquoB8v" style="display: none">Schedule of fair value of options</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49B_20190901__20200831_zvzmEAwEbUs8" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_495_20180901__20190831_zsycPpqRHxNh" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">FY 2020</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">FY 2019</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_403_ecustom--FairValueOptionsGranted_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 70%; text-align: left">Estimated fair value of awards granted</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,997,120</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,928,820</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_408_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate_dp_z0I9GPJv0zMd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Unvested Forfeiture Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.20%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_i_pii" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average grant price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">39.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22.78</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_ecustom--WeightedAverageMarketPrice_i_pii" style="vertical-align: bottom; background-color: White">
    <td>Weighted average market price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">39.23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22.69</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_zd4EBYOt8dfh" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33.56%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.61%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_zKQYAbPzJk37" style="vertical-align: bottom; background-color: White">
    <td>Weighted average risk-free rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.39%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.59%</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_znRMoWL42Moa" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Weighted average dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.65%</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.10%</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Weighted average expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20190901__20200831_zcTIMfsoCyM5" title="Weighted average expected life">6.67</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20180901__20190831_zYfunD3yDYn4" title="Weighted average expected life">6.64</span> years</span></td><td style="text-align: left">&#160;</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Schedule of options by exercise price range</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zwYNb1ixCUm9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: left"><span id="xdx_8B6_zU4aeSWAm19l" style="display: none">Schedule of options by exercise price range</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Awards Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quantity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted <br/> Average<br/> Remaining<br/> Contractual<br/> Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quantity</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Remaining<br/> Contractual <br/> Life</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Exercise price low">6.75</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Exercise price high">8.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards outstanding">177,730</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zYAgfXhLp8Ee" title="Awards outstanding weighted average remaining contractual life">4.0</span> years</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards outstanding weighted average exercise price">6.85</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards exercisable">177,730</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_zLHJiQHfJld" title="Awards exercisable weighted average remaining contractual life">4.0</span> years</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price1Member_pii" style="width: 11%; text-align: right" title="Awards exercisable weighted average exercise price">6.85</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Exercise price low">8.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Exercise price high">16.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards outstanding">547,901</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zUXqLed3JHo1" title="Awards outstanding weighted average remaining contractual life">6.0</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price">9.98</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards exercisable">350,721</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_zKjm2Zf3Jfo3" title="Awards exercisable weighted average remaining contractual life">6.0</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price2Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price">9.97</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Exercise price low">16.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Exercise price high">24.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards outstanding">230,280</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_ztnBAqKE8ai2" title="Awards outstanding weighted average remaining contractual life">7.8</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price">20.70</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards exercisable">50,560</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_zTqdaOALFxM7" title="Awards exercisable weighted average remaining contractual life">7.2</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price3Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price">21.18</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Exercise price low">24.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Exercise price high">38.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards outstanding">204,950</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zlKX79epvqOa" title="Awards outstanding weighted average remaining contractual life">9.1</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price">33.45</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards exercisable">17,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_zA6ylx0XQ703" title="Awards exercisable weighted average remaining contractual life">8.9</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price4Member_pii" style="text-align: right" title="Awards exercisable weighted average exercise price">34.23</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Exercise price low">38.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Exercise price high">52.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Awards outstanding">19,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zJU0o2pDpEO5" title="Awards outstanding weighted average remaining contractual life">9.6</span> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_pii" style="text-align: right" title="Awards outstanding weighted average exercise price">38.64</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zpz92DykdhW" style="text-align: right" title="Awards exercisable">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price5Member_zniP2siXJeXk" style="text-align: right" title="Awards exercisable weighted average exercise price">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Exercise price low">52.01</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Exercise price high">61.84</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="border-bottom: Black 1pt solid; text-align: right" title="Awards outstanding">43,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zTkUdVyurq8h" title="Awards outstanding weighted average remaining contractual life">9.9</span> years</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_pii" style="padding-bottom: 1pt; text-align: right" title="Awards outstanding weighted average exercise price">61.84</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zT7mHUedCxAa" style="border-bottom: Black 1pt solid; text-align: right" title="Awards exercisable">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_pii_d0_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Price6Member_zGi5unlxX5Eg" style="padding-bottom: 1pt; text-align: right" title="Awards exercisable weighted average exercise price">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards outstanding">1,223,661</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z56sDULWgo2g" title="Awards outstanding weighted average remaining contractual life">6.8</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="padding-bottom: 2.5pt; text-align: right" title="Awards outstanding weighted average exercise price">17.76</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="border-bottom: Black 2.5pt double; text-align: right" title="Awards exercisable">596,311</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20190901__20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDOY9JpQkOe8" title="Awards exercisable weighted average remaining contractual life">5.6</span> years</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20200831__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_pii" style="padding-bottom: 2.5pt; text-align: right" title="Awards exercisable weighted average exercise price">10.69</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDividendsPayableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all or some of the information related to dividends declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDividendsPayableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046629992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of the income tax provision</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zMFfFcQt1xmg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Income tax provision)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt"><span id="xdx_8B7_zagOldVKEnd2" style="display: none">Components of the income tax provision</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20190901__20200831_zsYtLRMf3OBk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20180901__20190831_zeGGgwkwikue" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20170901__20180831_zVeZB6h85yt3" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Current</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CurrentFederalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zgXzb3eafgh1" style="vertical-align: bottom; background-color: White">
    <td style="width: 55%; padding-left: 10pt">Federal</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,097,725</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,794,596</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,370,955</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zrEF9BuHWLX7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">State</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">477,744</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">426,364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">460,619</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_i01_pp0p0_maCITEBzgOr_zPmxairo0Us4" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">Foreign</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">39,038</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">51,285</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">104,377</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--CurrentIncomeTaxExpenseBenefit_i01T_pp0p0_mtCITEBzgOr_maITEBzYIH_zYSUWo71p3u6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Total current tax expense (benefit)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,614,507</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,272,245</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">2,935,951</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td>Deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zPDAa5MwzY3a" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 10pt">Federal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(427,644</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(140,730</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,698,201</td><td style="text-align: left">)</td></tr>
<tr id="xdx_400_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_i01N_pp0p0_di_maDITATzwIq_zhjqJZaXPJ6k" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; padding-left: 10pt">State</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(131,874</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(158,368</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(33,620</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--DeferredIncomeTaxesAndTaxCredits_i01NT_pp0p0_di_mtDITATzwIq_maITEBzYIH_znxE5mdhb7E9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Total deferred federal and state</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(559,518</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(299,098</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,731,821</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--IncomeTaxExpenseBenefit_i01T_pp0p0_mtITEBzYIH_zVNPzpxQZ4df" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,054,989</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,973,147</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,204,130</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Effective income tax rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zwqw6tDO2oE6" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Reconciliation)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B1_zeHlw3e1gyG1" style="display: none">Effective income tax rate</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20200831_zFPXY8wYHiw" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49C_20180901__20190831_zyR2udabmake" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20170901__20180831_zrqvTJHUFK8b" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2018</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_ziFhmue5SCxk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; text-align: justify">Income tax computed at federal statutory tax rate</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">21.0</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">25.4</td><td style="width: 1%; text-align: left">%</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dp_zDRpPq6iHdq4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">State taxes, net of federal benefit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.0</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_dp_zIis2XbHznzg" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Meals &amp; entertainment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.0</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_dp_zrqJXLlMHj01" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.2</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.6</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.5</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp_zAcMWigEiG6l" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Other permanent differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.7</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.2</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment_iN_pii_dpi_znSDn1apBFKl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Research and development credit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.7</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.3</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.6</td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_pii_dp0_z827QgPMm06a" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Foreign tax related differences</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.4</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_pii_dp0_zF2T52Vq8bWl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Research &amp; credit adjustments to expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities_iN_pii_dpi0_z3szFnvHwqD6" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Domestic production activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.8</td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_dp0_zb9Ev8H2igD5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Change in deferred income taxes due to statutory rate changes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.8</td><td style="text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_dp_zcBS6RXu5rO7" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Change in prior year estimated taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.8</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.9</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.0</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_zpRtCO6unFB3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18.0</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">18.7</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">11.9</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</td></tr>
</table>


<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of the Company deferred tax assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zCZXffuI3e0f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details - Deferred taxes)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt"><span id="xdx_8B0_zIMmSciWJ2ml" style="display: none">Components of the Company deferred tax assets and liabilities</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49F_20200831_zTX8Mol7GUm7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20190831_zVTY58QvbX8f" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--ComponentsOfDeferredTaxAssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_i01I_pp0p0_maDTAGz4SD_zU0Uta00rk6g" style="vertical-align: bottom; background-color: White">
    <td style="width: 70%; text-align: left; padding-left: 10pt">Accrued payroll and other expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">402,355</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">236,455</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_pp0p0_maDTAGz4SD_zZOAjNd9Pare" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,862</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">55,038</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxAssetsEquityMethodInvestments_i01I_pp0p0_maDTAGz4SD_zvFnqPWEw25l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Capitalized merger costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">742,056</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">361,103</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--DeferredTaxAssetsGoodwillAndIntangibleAssets_i01I_pp0p0_maDTAGz4SD_z60sjSZnITR3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,677</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,301</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsStateTaxes_i01I_pp0p0_maDTAGz4SD_zrJrwnpRb7D8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">State taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,326</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">89,537</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_i01I_pp0p0_d0_maDTAGz4SD_zaWJXuWwKFK9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Allowance for doubtful accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,450</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseOther_i01I_pp0p0_maDTAGz4SD_zLl3hW3ixf18" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">State tax deferred</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">125,417</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">146,815</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_mtDTAGz4SD_maDTANzteO_z0LDpi0OTbMk" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,398,143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">898,249</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di0_msDTANzteO_zBSFWqsm3dxk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Less: Valuation allowance</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_mtDTANzteO_maDTALNzZow_zEciOfMQmQ2h" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="visibility: hidden; padding-bottom: 1pt">Deferred tax asset</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,398,143</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">898,249</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--ComponentsOfDeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di_maDITLzYzc_zAUCDGKx7tF5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(81,910</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(61,991</td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesOther_i01NI_pp0p0_di_maDITLzYzc_z5MOCRbkd2a5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">State tax deferred</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(19,468</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,471</td><td style="text-align: left">)</td></tr>
<tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_i01NI_pp0p0_di_maDITLzYzc_ztqmljXTTbAc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Intellectual property</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,876,274</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,217,234</td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_i01NI_pp0p0_di_maDITLzYzc_zkggYemUV7H5" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Capitalized computer software development costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,774,349</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,334,169</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_40F_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di_mtDITLzYzc_msDTALNzZow_zwTcyyi37Vye" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-bottom: 1pt">Total deferred tax liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,752,001</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,629,865</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--DeferredTaxAssetsLiabilitiesNet_i01NTI_pp0p0_di_mtDTALNzZow_zs9zP256ZpUe" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net deferred tax liabilities</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,353,858</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,731,616</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td></tr>
</table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046532664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC REPORTING (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of consolidated results from reportable segments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_896_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_znlQ7VnPMeuh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B2_zNsYceOS2LWd" style="display: none">Schedule of consolidated results from reportable segments</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2020</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zIPywJ9pGXG6" style="width: 10%; text-align: right" title="Net Revenues">21,961</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zv5nt7qgAwVl" style="width: 10%; text-align: right" title="Net Revenues">11,105</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zpSrOIEUz3u3" style="width: 10%; text-align: right" title="Net Revenues">6,948</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z6YM73V6Tbi4" style="width: 10%; text-align: right" title="Net Revenues">1,575</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z45ynvxMb8E4" style="width: 10%; text-align: right" title="Net Revenues">41,589</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zJ2MUtMlxgHb" style="text-align: right" title="Income (loss) from operations before income taxes">7,374</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zoj7oGP9L2Fg" style="text-align: right" title="Income (loss) from operations before income taxes">1,770</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcuWRU2Zh0Ld" style="text-align: right" title="Income (loss) from operations before income taxes">1,744</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zeOykSYmylh1" style="text-align: right" title="Income (loss) from operations before income taxes">717</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zrqzGSMYVjS5" style="text-align: right" title="Income (loss) from operations before income taxes">11,605</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zoGXa3yNB2kk" style="text-align: right" title="Total assets">162,807</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zin2MELpq9Me" style="text-align: right" title="Total assets">11,654</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zRkJH5towc67" style="text-align: right" title="Total assets">14,084</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z1jzyh0rhdOb" style="text-align: right" title="Total assets">19,972</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Assets_iI_pn3n3_c20200831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zT7pazXMHsre" style="text-align: right" title="Total assets">(40,095</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--Assets_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zh4OWXVwA3g5" style="text-align: right" title="Total assets">168,422</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_d0_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3ajge7nSrk2" style="text-align: right" title="Goodwill">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zkwSfZBdeeNd" style="text-align: right" title="Goodwill">4,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNhiendOEiug" style="text-align: right" title="Goodwill">5,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zHwKetURkVg9" style="text-align: right" title="Goodwill">2,534</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--Goodwill_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zDvZcR44EVs4" style="text-align: right" title="Goodwill">12,921</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLu0FkKhDyKk" style="text-align: right" title="Capital expenditures">111</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zDVXBHkGYpee" style="text-align: right" title="Capital expenditures">87</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxQZg4WltYoi" style="text-align: right" title="Capital expenditures">31</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zfQWcGWgrRm5" style="text-align: right" title="Capital expenditures">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zwR5az5tFyg1" style="text-align: right" title="Capital expenditures">231</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zs0LFsjXIq02" style="text-align: right" title="Capitalized software costs">2,028</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdmmXcyK1fG4" style="text-align: right" title="Capitalized software costs">40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zcHgswTtk81b" style="text-align: right" title="Capitalized software costs">124</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zIAbtTkh5Gvj" style="text-align: right" title="Capitalized software costs">160</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zAYhe7mp9Dld" style="text-align: right" title="Capitalized software costs">2,353</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z3efLMHOP3q6" style="text-align: right" title="Depreciation and Amortization">1,713</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zrwFSKywakDf" style="text-align: right" title="Depreciation and Amortization">349</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0G2yjTh1Bx1" style="text-align: right" title="Depreciation and Amortization">600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zxs5NEQo86f6" style="text-align: right" title="Depreciation and Amortization">300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zab7kr5cEef6" style="text-align: right" title="Depreciation and Amortization">2,962</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2019</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zn3r6NCB494a" style="width: 10%; text-align: right" title="Net Revenues">19,585</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zyOyqLDUPZTl" style="width: 10%; text-align: right" title="Net Revenues">9,321</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zASPvToUczt7" style="width: 10%; text-align: right" title="Net Revenues">5,065</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z2ciSn1N3Ey" style="width: 10%; text-align: right" title="Net Revenues">33,970</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zjpV8RYaPKla" style="text-align: right" title="Income (loss) from operations before income taxes">7,752</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zqO7zlgLC8xi" style="text-align: right" title="Income (loss) from operations before income taxes">1,481</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4AGL3fHx2F7" style="text-align: right" title="Income (loss) from operations before income taxes">1,416</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingIncomeLoss_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_znd8uMPtLDe" style="text-align: right" title="Income (loss) from operations before income taxes">10,648</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zKuiVv1veg41" style="text-align: right" title="Total assets">38,535</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zzv2ZI8pODkb" style="text-align: right" title="Total assets">11,196</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXvzQfUGkEq1" style="text-align: right" title="Total assets">13,168</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--Assets_iI_pn3n3_c20190831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zHIsFlb4Ilfa" style="text-align: right" title="Total assets">(17,702</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Assets_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zC4oN1WXivla" style="text-align: right" title="Total assets">45,197</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--Goodwill_iI_pn3n3_d0_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zP4POxkXCxPg" style="text-align: right" title="Goodwill">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjHihHBK6ith" style="text-align: right" title="Goodwill">4,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z8G1gG6qqTEk" style="text-align: right" title="Goodwill">5,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Goodwill_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z50Xh3ea9PAj" style="text-align: right" title="Goodwill">10,387</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zvV317UUkjy1" style="text-align: right" title="Capital expenditures">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zu8XsvhmZmNk" style="text-align: right" title="Capital expenditures">79</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4NfvL1JSBIi" style="text-align: right" title="Capital expenditures">20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zYGnIy2MeXI8" style="text-align: right" title="Capital expenditures">138</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zxuIiWePb92c" style="text-align: right" title="Capitalized software costs">1,482</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zZ4EMeHrhzC3" style="text-align: right" title="Capitalized software costs">114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zUFbJrqSbbRk" style="text-align: right" title="Capitalized software costs">172</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z0LbRipTKsja" style="text-align: right" title="Capitalized software costs">1,768</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zOi20rlPfhTk" style="text-align: right" title="Depreciation and Amortization">1,806</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zti5NmFeyJh8" style="text-align: right" title="Depreciation and Amortization">364</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zKwS3AL9OWI3" style="text-align: right" title="Depreciation and Amortization">580</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zBGgubPSupkd" style="text-align: right" title="Depreciation and Amortization">2,750</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="24" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2018</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Simulations Plus, Inc.</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Cognigen Corporation</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">DILIsym</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Lixoft*</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Eliminations</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 22%; text-align: left">Net revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVLlVPi5RII9" style="width: 10%; text-align: right" title="Net Revenues">17,553</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z5RrY4VpIBHl" style="width: 10%; text-align: right" title="Net Revenues">7,857</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z1h25TrgiGue" style="width: 10%; text-align: right" title="Net Revenues">4,257</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zEQ7SQCSoWa2" style="width: 10%; text-align: right" title="Net Revenues">29,667</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income from operations before income taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zpvlM3Ozyxx" style="text-align: right" title="Income (loss) from operations before income taxes">7,533</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zFhh4FyUWyCl" style="text-align: right" title="Income (loss) from operations before income taxes">1,902</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zxJuOS4E3Sm4" style="text-align: right" title="Income (loss) from operations before income taxes">863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingIncomeLoss_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_z583A7bMubaa" style="text-align: right" title="Income (loss) from operations before income taxes">10,298</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Total assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4ZEwN3Zfo8k" style="text-align: right" title="Total assets">38,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zUdaU5qVjEOk" style="text-align: right" title="Total assets">8,733</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zHgkXH2iB4bh" style="text-align: right" title="Total assets">14,248</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--Assets_iI_pn3n3_c20180831__srt--ConsolidationItemsAxis__srt--ConsolidationEliminationsMember_zCoMpkmy4Az" style="text-align: right" title="Total assets">(17,702</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--Assets_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zae8v4WmW4U1" style="text-align: right" title="Total assets">43,279</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Goodwill</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_d0_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_znG7MJKgt4a6" style="text-align: right" title="Goodwill">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMIRR1kmb7hd" style="text-align: right" title="Goodwill">4,789</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zNMbfUjJs1pk" style="text-align: right" title="Goodwill">5,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--Goodwill_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zd2YKBKNnRP9" style="text-align: right" title="Goodwill">10,387</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Capital expenditures</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPptWlUTBGsl" style="text-align: right" title="Capital expenditures">65</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zHWWQiN2ku3a" style="text-align: right" title="Capital expenditures">100</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zkxv0kpkgiSg" style="text-align: right" title="Capital expenditures">18</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--PaymentsToAcquireProductiveAssets_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zqrxySbGToQk" style="text-align: right" title="Capital expenditures">183</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Capitalized software costs</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zMtcehUmqHy4" style="text-align: right" title="Capitalized software costs">1,365</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zQdvaXgc19D" style="text-align: right" title="Capitalized software costs">625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z26ZBHMN1p29" style="text-align: right" title="Capitalized software costs">155</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--CapitalizedComputerSoftwareGross_iI_pn3n3_c20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zfaX3D0GeKf7" style="text-align: right" title="Capitalized software costs">2,145</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_ztfkJjILVJH7" style="text-align: right" title="Depreciation and Amortization">1,748</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z3SemHzU5HNi" style="text-align: right" title="Depreciation and Amortization">401</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zA2y1TrPxW2a" style="text-align: right" title="Depreciation and Amortization">572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--OperatingSegmentsMember_zP7EnCmLNme6" style="text-align: right" title="Depreciation and Amortization">2,721</td><td style="text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of geographical revenues</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_pn3n3_zJrhz4QAColl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8B6_zuA8uMzIV7U7" style="display: none">Schedule of geographical revenues</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2020</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRRtk1mciEr5" style="width: 11%; text-align: right" title="Revenues">11,124</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_z4yCkIHGEr2k" style="width: 11%; text-align: right" title="Revenues">5,024</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zLGa3wTTIbpl" style="width: 11%; text-align: right" title="Revenues">5,812</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zipCPTlqCSLi" style="width: 11%; text-align: right" title="Revenues">21,961</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zS6zaOvq9Tcb" style="text-align: right" title="Revenues">11,105</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z4QH0lWQs0El" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_d0_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zlMUXIoHGoxe" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zdhdygJzQwla" style="text-align: right" title="Revenues">11,105</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrOzjHoFpMSe" style="text-align: right" title="Revenues">6,057</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zPs7H6lgkPu4" style="text-align: right" title="Revenues">646</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zvYEwyOsevOl" style="text-align: right" title="Revenues">246</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z5KLxPhrEwd5" style="text-align: right" title="Revenues">6,948</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_z07XcB5cktcg" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,388</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsqjK87yRc17" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">157</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zZYnEzVzGvY8" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">30</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20190901__20200831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zsh10MIbss47" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">1,575</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_z5yqrScQSQwh" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">29,674</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--EuropeMember_zOnois1EIm8f" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,827</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20190901__20200831__srt--StatementGeographicalAxis__srt--AsiaMember_zvdDrRbbwXk8" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">6,088</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"><p id="xdx_98C_eus-gaap--Revenues_pp0p0_c20190901__20200831_z9njnkBHIQ5j" style="font: 13.33px Times New Roman, Times, Serif; color: rgb(0, 0, 0)"><span style="display: none; font-style: normal; font-weight: normal; text-transform: none; letter-spacing: normal; word-spacing: 0px; background-color: rgb(238, 238, 238)">41,589,084</span></p>41,589</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>











<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2019</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZmTkeGk2Sug" style="width: 11%; text-align: right" title="Revenues">9,381</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRzm5JMPj6w8" style="width: 11%; text-align: right" title="Revenues">5,144</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zRWStue2Okei" style="width: 11%; text-align: right" title="Revenues">5,060</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zniiji62O83c" style="width: 11%; text-align: right" title="Revenues">19,585</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zMO6Lxx5Agj3" style="text-align: right" title="Revenues">9,321</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_z6eeplQ50xha" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zwpsWdlPCULf" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zfbqIsA7K6B3" style="text-align: right" title="Revenues">9,321</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zTOZ1VBc7xs5" style="text-align: right" title="Revenues">3,875</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z4Y0OFo1EBe8" style="text-align: right" title="Revenues">685</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zzJWHoPnH7xb" style="text-align: right" title="Revenues">505</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z03s9YIMGVMd" style="text-align: right" title="Revenues">5,065</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zaluMlhDbgu9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zQWBY2eDLcr" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zoy1dgU5u9f3" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--Revenues_pn3n3_d0_c20180901__20190831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBUWGxGn6cUl" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zQXAMrG0aDz1" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">22,577</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--EuropeMember_zGxG2JGrcUf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,829</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20180901__20190831__srt--StatementGeographicalAxis__srt--AsiaMember_zVfuqcc6xwlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,565</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"><p id="xdx_98E_eus-gaap--Revenues_pp0p0_c20180901__20190831_zAtGEVnm2Cn1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none">33,970,440</p>33,971</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="16" style="border-bottom: Black 1pt solid; text-align: center"><b>Year ended August 31, 2018</b></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">North &amp; South America</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Europe</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Asia</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%; text-align: left">Simulations Plus, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zeII7hrIMrz" style="width: 11%; text-align: right" title="Revenues">7,856</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zZcI0NCLxXm6" style="width: 11%; text-align: right" title="Revenues">4,964</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zVSdlLepy8Cf" style="width: 11%; text-align: right" title="Revenues">4,733</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--SimulationsMember_zPAJQsH37C26" style="width: 11%; text-align: right" title="Revenues">17,553</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cognigen Corporation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zpfDKcC42Y2c" style="text-align: right" title="Revenues">7,857</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zBnbPWJRwNGe" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zjcsa3iwsG1b" style="text-align: right" title="Revenues">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--CognigenMember_zPEVeQfhi0a4" style="text-align: right" title="Revenues">7,857</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">DILIsym Services, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zrsSyW0gwLf2" style="text-align: right" title="Revenues">3,163</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zi7bAEWFFde6" style="text-align: right" title="Revenues">312</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_z0lqB9ZFUBHk" style="text-align: right" title="Revenues">782</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--DILIsymMember_zXAU3PLhCyF3" style="text-align: right" title="Revenues">4,257</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Lixoft*</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zNN1YKP0Xto7" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zf4xV1WRj6Q9" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zBfl4xDvSVO2" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--Revenues_pn3n3_d0_c20170901__20180831__us-gaap--StatementBusinessSegmentsAxis__custom--LixoftMember_zup81ldnN3Ai" style="border-bottom: Black 1pt solid; text-align: right" title="Revenues">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__custom--NorthAndSouthAmericaMember_zlyiQa1LsN3a" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">18,876</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--EuropeMember_zISCw3o0FG29" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,276</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_pn3n3_c20170901__20180831__srt--StatementGeographicalAxis__srt--AsiaMember_z6v6aRogU6Kf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues">5,515</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right" title="Revenues"><p id="xdx_982_eus-gaap--Revenues_pp0p0_c20170901__20180831_zFqi7WVzFyZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none">29,666,524</p>29,667</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*Lixoft was acquired on April 1, 2020.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046627976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Allocation of purchase price</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zcIywZDxNYK8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span id="xdx_8B3_z2hFyIoMwDi1" style="display: none">Allocation of purchase price</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zJfdS7uAEkF9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 85%; text-align: justify">Assets acquired, Including cash of $3,799,134 and accounts receivable of $629,481</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">5,006,892</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Developed Technologies Acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,010,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify">Estimated value of Intangibles assets acquired (Customer Lists, trade name etc.)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,160,000</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_402_eus-gaap--Goodwill_iI_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Estimated Goodwill acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,533,987</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_iNI_pp0p0_di_zTcmmmyhxeZ3" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: justify; padding-bottom: 1pt">Liabilities Assumed</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1,117,519</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Total Consideration</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20190901__20200402__us-gaap--BusinessAcquisitionAxis__custom--LixoftMember_zFPT57Vz6TIi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total Consideration">18,593,360</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of statement of income</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zrpcNHjAFaUl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span id="xdx_8BD_zg37rGxisVDc" style="display: none">Schedule of statement of income</span></td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_49D_20190901__20200831_zShnKeJjCig4" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_492_20180901__20190831_zOEIReq5nt8l" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" id="xdx_496_20170901__20180831_zSWTor0Jq3Ej" style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(Pro forma)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2020*</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2019</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">2018</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(in thousands)</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(unaudited)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaRevenue_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 55%; text-align: justify; padding-bottom: 2.5pt">Net Sales</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">43,970</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">36,918</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 11%; text-align: right">31,891</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_i_pp0p0" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 2.5pt">Net Income</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">10,630</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,250</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9,132</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*Balances include five months actual results
for Lixoft.</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046470008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED QUARTERLY FINANCIAL DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Quarterly Financial Information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_pn3n3_zM85Pbncz5Lg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)">
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span id="xdx_8BF_zhI0IIPb7xy7" style="display: none">Quarterly Financial Information</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_499_20190901__20191130_zyJOyUoVg2k7" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_493_20191201__20200229_zS1UKxhr0GXc" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49A_20200301__20200531_zZ51MpVxUJVk" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_498_20200601__20200831_zsZ4o5vBzVP9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">First</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Second</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Third</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fourth</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year&#160;ended&#160;August 31, 2020</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40F_eus-gaap--Revenues_pn3n3_zGDaTK6Dgxma" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">9,401</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">10,350</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">12,298</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">9,540</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_406_eus-gaap--GrossProfit_pn3n3_zEhW7MN3AE0l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,758</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,683</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,865</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_z8Wj5evhf9S" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,058</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,150</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,936</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,188</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_404_eus-gaap--EarningsPerShareBasic_pip0_zRUg9Klbn2" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share, Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_407_eus-gaap--EarningsPerShareDiluted_pip0_zIrzKctB0ENc" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Earnings per share, Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.11</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_496_20180901__20181130_zQoWUsEefpAh" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_492_20181201__20190228_zX0gUe46UYEj" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_494_20190301__20190531_znowrDpL7UR9" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20190601__20190831_zr2jb1KzBpQ1" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">First</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Second</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Third</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Fourth</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Year&#160;ended&#160;August 31, 2019</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quarter</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--Revenues_pn3n3_z3YmL6UNkGY9" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 40%">Revenues</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">7,536</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">8,472</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">9,937</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">8,026</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr id="xdx_405_eus-gaap--GrossProfit_pn3n3_zKPBv6FKcH72" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,336</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">6,264</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,735</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40C_eus-gaap--NetIncomeLoss_pn3n3_zAIBuNFd6kv5" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,536</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,099</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,889</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,059</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_pip0_zswufykBp244" style="vertical-align: bottom; background-color: White">
    <td>Earnings per share, Basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_409_eus-gaap--EarningsPerShareDiluted_pip0_zcjpIT9x7tv4" style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>Earnings per share, Diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.09</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.12</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.16</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.11</td><td style="text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121640914&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130514136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">3 to 7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">5 to 7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property, Plant and Equipment, Estimated Useful Lives</a></td>
<td class="text">Shorter of life of asset or lease<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68071081&amp;loc=d3e1205-110223<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130112360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Sep. 02, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">$ 926,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease Liabilities, Current</a></td>
<td class="nump">463,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease Liabilities, Long-term</a></td>
<td class="nump">$ 463,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 902,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease Liabilities, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">537,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease Liabilities, Long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 365,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574046477560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">$ 926,600<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease Liabilities, Current</a></td>
<td class="nump">463,465<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease Liabilities, Long-term</a></td>
<td class="nump">463,312<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 600,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">2 years 3 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130537240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 10,387,198<span></span>
</td>
<td class="nump">$ 10,387,198<span></span>
</td>
<td class="nump">$ 10,387,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Addition</a></td>
<td class="nump">2,533,987<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">12,921,185<span></span>
</td>
<td class="nump">10,387,198<span></span>
</td>
<td class="nump">10,387,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_CognigenMember', window );">Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">4,789,248<span></span>
</td>
<td class="nump">4,789,248<span></span>
</td>
<td class="nump">4,789,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Addition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">4,789,248<span></span>
</td>
<td class="nump">4,789,248<span></span>
</td>
<td class="nump">4,789,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember', window );">D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">5,597,950<span></span>
</td>
<td class="nump">5,597,950<span></span>
</td>
<td class="nump">5,597,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Addition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">5,597,950<span></span>
</td>
<td class="nump">5,597,950<span></span>
</td>
<td class="nump">5,597,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_LixoftMember', window );">Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Addition</a></td>
<td class="nump">2,533,987<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 2,533,987<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_CognigenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_CognigenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_LixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_LixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574055642840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 7,008,275<span></span>
</td>
<td class="nump">$ 3,280,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">Straight line 8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">825,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">Straight line 10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">617,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 1,282,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member] | Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">Straight line 14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 2,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">75,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 2,474,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names [Member] | Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 1,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 1,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member] | Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">Straight line 5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member] | D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">Straight line 4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member] | Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">Straight line 3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">8,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">51,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Acquisition value</a></td>
<td class="nump">8,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">1,641,725<span></span>
</td>
<td class="nump">$ 1,210,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net book value</a></td>
<td class="nump">$ 7,008,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_AmortizationPeriodIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_AmortizationPeriodIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_CognigenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_CognigenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_LixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_LixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048645048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule) - Other Intangible Assets [Member]<br></strong></div></th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 545,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">530,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">384,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">372,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">$ 372,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574133218504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements) - Fair Value, Recurring [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Cash and Cash Equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="nump">$ 49,207,314<span></span>
</td>
<td class="nump">$ 11,435,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Short-term Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="nump">66,803,595<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Aquisition Related Contingent Consideration Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value liabilities</a></td>
<td class="nump">4,730,500<span></span>
</td>
<td class="nump">1,761,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Cash and Cash Equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="nump">49,207,314<span></span>
</td>
<td class="nump">11,435,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Short-term Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="nump">66,803,595<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Aquisition Related Contingent Consideration Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Cash and Cash Equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Short-term Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Aquisition Related Contingent Consideration Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Cash and Cash Equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Short-term Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Aquisition Related Contingent Consideration Obligations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value liabilities</a></td>
<td class="nump">$ 4,730,500<span></span>
</td>
<td class="nump">$ 1,761,028<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=simu_AquisitionRelatedContingentConsiderationObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=simu_AquisitionRelatedContingentConsiderationObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051008920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent', window );">Contingent consideration, beginning balance</a></td>
<td class="nump">$ 1,761,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_PurchasePriceContingentConsiderationAdditions', window );">Purchase price contingent consideration</a></td>
<td class="nump">4,528,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ContingentConsiderationPayments', window );">Contingent consideration payments</a></td>
<td class="num">(1,761,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="nump">202,500<span></span>
</td>
<td class="nump">$ 109,060<span></span>
</td>
<td class="nump">$ 152,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent', window );">Contingent consideration, ending balance</a></td>
<td class="nump">$ 4,730,500<span></span>
</td>
<td class="nump">$ 1,761,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ContingentConsiderationPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent consideration payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ContingentConsiderationPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_PurchasePriceContingentConsiderationAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price contingent consideration addition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_PurchasePriceContingentConsiderationAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574055627592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses) - Intellectual Property [Member]<br></strong></div></th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 1,429,792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">1,426,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">1,422,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">1,247,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">822,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">T S R L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">425,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Enslien [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">7,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">3,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">D I L I [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">316,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">316,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">316,667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">316,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">316,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">500,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">500,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">500,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">500,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">500,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Entelos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_TSRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_TSRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_EnslienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_EnslienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_DILIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_DILIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_LixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_LixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_EntelosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_EntelosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049857496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to common shareholders</a></td>
<td class="nump">$ 2,188,000<span></span>
</td>
<td class="nump">$ 2,936,000<span></span>
</td>
<td class="nump">$ 2,150,000<span></span>
</td>
<td class="nump">$ 2,058,000<span></span>
</td>
<td class="nump">$ 2,059,000<span></span>
</td>
<td class="nump">$ 2,889,000<span></span>
</td>
<td class="nump">$ 2,099,000<span></span>
</td>
<td class="nump">$ 1,536,000<span></span>
</td>
<td class="nump">$ 9,332,060<span></span>
</td>
<td class="nump">$ 8,583,329<span></span>
</td>
<td class="nump">$ 8,934,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares outstanding during the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,819,064<span></span>
</td>
<td class="nump">17,492,258<span></span>
</td>
<td class="nump">17,328,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Dilutive effect of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">719,309<span></span>
</td>
<td class="nump">565,173<span></span>
</td>
<td class="nump">531,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Common stock and common stock equivalents used for diluted earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,538,373<span></span>
</td>
<td class="nump">18,057,431<span></span>
</td>
<td class="nump">17,860,392<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048971144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Feb. 28, 2012</div></th>
<th class="th"><div>Apr. 02, 2020</div></th>
<th class="th"><div>May 15, 2014</div></th>
<th class="th"><div>Jun. 02, 2017</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of software development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,225,544<span></span>
</td>
<td class="nump">$ 1,331,753<span></span>
</td>
<td class="nump">$ 1,300,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,944<span></span>
</td>
<td class="nump">83,213<span></span>
</td>
<td class="nump">67,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,576,525<span></span>
</td>
<td class="nump">1,077,837<span></span>
</td>
<td class="nump">709,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,286,625<span></span>
</td>
<td class="nump">865,848<span></span>
</td>
<td class="nump">562,078<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember', window );">Goodwill [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">431,725<span></span>
</td>
<td class="nump">357,500<span></span>
</td>
<td class="nump">357,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible asset acquisition value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,641,725<span></span>
</td>
<td class="nump">1,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember', window );">Royalty Agreements [Member] | Enslien [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible asset acquisition value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years under the straight-line method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,138,280<span></span>
</td>
<td class="nump">929,167<span></span>
</td>
<td class="nump">$ 924,167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,087,031<span></span>
</td>
<td class="nump">3,948,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member] | Enslien [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,750<span></span>
</td>
<td class="nump">56,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member] | T S R L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,775,000<span></span>
</td>
<td class="nump">3,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member] | D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,667<span></span>
</td>
<td class="nump">316,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,029,167<span></span>
</td>
<td class="nump">712,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member] | Entelos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember', window );">Intellectual Property [Member] | Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization of intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 208,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_TermAndNonassertionAgrMember', window );">Term And Nonassertion Agr [Member] | T S R L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible asset acquisition value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years under
the straight-line method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_CertainDevelopedTechnologiesMember', window );">Certain Developed Technologies [Member] | D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible asset acquisition value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years under the straight-line method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_CertainDevelopedTechnologiesMember', window );">Certain Developed Technologies [Member] | Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible asset acquisition value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,010,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years under the straight-line method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_CertainIntellectualPropertyRightsMember', window );">Certain Intellectual Property Rights [Member] | FY 2016 3rd Qtr [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible asset acquisition value</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_AmortizationPeriodIntangibleAssets', window );">Amortization period</a></td>
<td class="text">10
years under the straight-line method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_AmortizationPeriodIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_AmortizationPeriodIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_RoyaltyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_EnslienMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_EnslienMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_IntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_TSRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_TSRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_DILIsymMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_DILIsymMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_EntelosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_EntelosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_LixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_LixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_TermAndNonassertionAgrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_TermAndNonassertionAgrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_CertainDevelopedTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_CertainDevelopedTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_CertainIntellectualPropertyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=simu_CertainIntellectualPropertyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_EntelosHoldingCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_EntelosHoldingCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049464184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details - Disaggregation) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 9,540,000<span></span>
</td>
<td class="nump">$ 12,298,000<span></span>
</td>
<td class="nump">$ 10,350,000<span></span>
</td>
<td class="nump">$ 9,401,000<span></span>
</td>
<td class="nump">$ 8,026,000<span></span>
</td>
<td class="nump">$ 9,937,000<span></span>
</td>
<td class="nump">$ 8,472,000<span></span>
</td>
<td class="nump">$ 7,536,000<span></span>
</td>
<td class="nump">$ 41,589,084<span></span>
</td>
<td class="nump">$ 33,970,440<span></span>
</td>
<td class="nump">$ 29,666,524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=simu_SoftwareLicensesMember', window );">Software Licenses [Member] | Transferred at Point in Time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,668,195<span></span>
</td>
<td class="nump">17,425,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=simu_SoftwareLicensesMember', window );">Software Licenses [Member] | Transferred over Time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">919,344<span></span>
</td>
<td class="nump">1,053,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=simu_ConsultingServicesMember', window );">Consulting Services [Member] | Transferred over Time [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,001,545<span></span>
</td>
<td class="nump">$ 15,491,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=simu_SoftwareLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=simu_SoftwareLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=simu_ConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=simu_ConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130383624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details - Contracts in Progess) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms', window );">Revenues in excess of billings</a></td>
<td class="nump">$ 3,093,343<span></span>
</td>
<td class="nump">$ 3,233,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BillingsInExcessOfCost', window );">Billings in excess of revenues</a></td>
<td class="num">(140,991)<span></span>
</td>
<td class="num">(798,549)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_RevenuesOverBillingsOnUncompletedContracts', window );">Revenues over billings on uncompleted contracts</a></td>
<td class="nump">2,952,352<span></span>
</td>
<td class="nump">2,435,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_RevenuesEarnedToDateOnUncompletedContracts', window );">Revenues earned to date on uncompleted contracts</a></td>
<td class="nump">20,235,573<span></span>
</td>
<td class="nump">19,254,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_BillingsToDateOnUncompletedContracts', window );">Billings to date on uncompleted contracts</a></td>
<td class="num">$ (17,283,221)<span></span>
</td>
<td class="num">$ (16,819,818)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_BillingsToDateOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Billings to date on uncompleted contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_BillingsToDateOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_RevenuesEarnedToDateOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues earned to date on uncompleted contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_RevenuesEarnedToDateOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_RevenuesOverBillingsOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenues over billings on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_RevenuesOverBillingsOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BillingsInExcessOfCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability attributable to (i) billings in excess of costs under the percentage of completion contract accounting method representing the difference between contractually invoiced amounts (billings) and revenue recognized based, for example, on costs incurred to estimated total costs at period end or (ii) contractually invoiced amounts (billings) in excess of costs incurred and accumulated under the completed contract accounting method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BillingsInExcessOfCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118261985&amp;loc=d3e55302-109406<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049192248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 3,303,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenues included in contract liabilities</a></td>
<td class="nump">$ 1,146,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130176872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 1,687,294<span></span>
</td>
<td class="nump">$ 1,424,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="nump">1,249,507<span></span>
</td>
<td class="nump">1,083,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Book Value</a></td>
<td class="nump">437,787<span></span>
</td>
<td class="nump">341,145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">864,560<span></span>
</td>
<td class="nump">741,486<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">547,738<span></span>
</td>
<td class="nump">411,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">160,991<span></span>
</td>
<td class="nump">160,990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 114,005<span></span>
</td>
<td class="nump">$ 110,165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051020824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 166,379<span></span>
</td>
<td class="nump">$ 131,827<span></span>
</td>
<td class="nump">$ 139,202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051756728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Net Investment Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term investment, amortized cost</a></td>
<td class="nump">$ 66,803,595<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains', window );">Gross unrealized gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Gross unrealized loss</a></td>
<td class="num">(60,977)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short term investment, fair value</a></td>
<td class="nump">66,742,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Net Investment Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term investment, amortized cost</a></td>
<td class="nump">66,803,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains', window );">Gross unrealized gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss', window );">Gross unrealized loss</a></td>
<td class="num">(60,977)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Short term investment, fair value</a></td>
<td class="nump">$ 66,742,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048093512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">$ 66,803,595<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051305176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONTRACTS PAYABLE (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Total contract with customer</a></td>
<td class="nump">$ 6,063,833<span></span>
</td>
<td class="nump">$ 1,761,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ContractsPayableCurrent', window );">Less: Current Portion</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">1,761,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ContractsPayableNoncurrent', window );">Long-Term</a></td>
<td class="nump">4,063,833<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_HoldbackLiabilityLixoftMember', window );">Holdback Liability Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ContractsPayable', window );">Total contract with customer</a></td>
<td class="nump">1,333,333<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_EarnoutLiabilityLixoftMember', window );">Earnout Liability Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ContractsPayable', window );">Total contract with customer</a></td>
<td class="nump">4,730,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_EarnoutLiabilityDilisymMember', window );">Earnout Liability Dilisym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems', window );"><strong>Business Combination, Separately Recognized Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ContractsPayable', window );">Total contract with customer</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,761,028<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ContractsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ContractsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ContractsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts payable, current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ContractsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ContractsPayableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts payable, noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ContractsPayableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_HoldbackLiabilityLixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_HoldbackLiabilityLixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_EarnoutLiabilityLixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_EarnoutLiabilityLixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_EarnoutLiabilityDilisymMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=simu_EarnoutLiabilityDilisymMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051196392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2021</a></td>
<td class="nump">$ 486,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2022</a></td>
<td class="nump">217,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2023</a></td>
<td class="nump">172,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2024</a></td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2025</a></td>
<td class="nump">11,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Future minimum lease payments</a></td>
<td class="nump">$ 961,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051562712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 644,000<span></span>
</td>
<td class="nump">$ 584,000<span></span>
</td>
<td class="nump">$ 567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_RoyaltyExpenses', window );">Royalties expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,055)<span></span>
</td>
<td class="nump">$ 195,828<span></span>
</td>
<td class="nump">$ 175,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=simu_WellsFargoMember', window );">Wells Fargo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfInvestmentHoldingsLineItems', window );"><strong>Summary of Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit maximum amount</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit expiration date</a></td>
<td class="text">Apr. 15,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_RoyaltyExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_RoyaltyExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfInvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfInvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=simu_WellsFargoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=simu_WellsFargoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049141512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS EQUITY (Details - Dividends) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="nump">$ 4,250,470<span></span>
</td>
<td class="nump">$ 4,197,055<span></span>
</td>
<td class="nump">$ 4,161,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20181Member', window );">Record Date 20181 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 13,  2017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov. 20,  2017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,284,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,037,088<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20182Member', window );">Record Date 20182 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 26,  2018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb.  02,  2018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,317,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,039,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20183Member', window );">Record Date 20183 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 25,  2018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  02,  2018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,354,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,041,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20184Member', window );">Record Date 20184 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 26,  2018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  02,  2018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,405,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,044,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20191Member', window );">Record Date 20191 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  01,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nov.  08,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,417,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,045,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20192Member', window );">Record Date 20192 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 25,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb.  01,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,481,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,048,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20193Member', window );">Record Date 20193 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 24,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  01,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,515,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,050,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20194Member', window );">Record Date 20194 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 25,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  01,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,536,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,052,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20201Member', window );">Record Date 20201 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">Oct. 25,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">Nov.  01,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="nump">17,606,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="nump">$ 1,056,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20202Member', window );">Record Date 20202 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">Jan. 27,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">Feb.  03,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="nump">17,645,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="nump">$ 1,058,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20203Member', window );">Record Date 20203 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">Apr. 24,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">May  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="nump">17,769,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="nump">$ 1,066,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsAxis=simu_RecordDate20204Member', window );">Record Date 20204 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear', window );">Record Date</a></td>
<td class="text">Jul. 27,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear', window );">Distribution Date</a></td>
<td class="text">Aug.  03,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate', window );">Number of Shares Outstanding on Record Date</a></td>
<td class="nump">17,820,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividend per Share</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="nump">$ 1,069,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of shares outstanding basic and diluted at record date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateDeclaredDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the dividend to be paid was declared, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateDeclaredDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableDateOfRecordDayMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the holder must own the stock to be entitled to the dividend, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableDateOfRecordDayMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20181Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20181Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20182Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20182Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20183Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20183Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20184Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20184Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20191Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20191Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20192Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20192Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20193Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20193Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20194Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20194Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20201Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20201Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20202Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20202Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20203Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20203Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsAxis=simu_RecordDate20204Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsAxis=simu_RecordDate20204Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574045378040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS EQUITY (Details - Option activity) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">$ 39.23<span></span>
</td>
<td class="nump">$ 22.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Option outstanding, beginning balance</a></td>
<td class="nump">1,163,259<span></span>
</td>
<td class="nump">1,134,976<span></span>
</td>
<td class="nump">1,249,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding</a></td>
<td class="nump">$ 12.63<span></span>
</td>
<td class="nump">$ 9.44<span></span>
</td>
<td class="nump">$ 8.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_OutstandingRemainingContractualLife', window );">Outstanding, beginning of period</a></td>
<td class="text">7 years 1 month 17 days<span></span>
</td>
<td class="text">7 years 3 months 21 days<span></span>
</td>
<td class="text">7 years 8 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">223,000<span></span>
</td>
<td class="nump">263,500<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">$ 39.23<span></span>
</td>
<td class="nump">$ 22.78<span></span>
</td>
<td class="nump">$ 22.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(121,647)<span></span>
</td>
<td class="num">(166,703)<span></span>
</td>
<td class="num">(130,006)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">$ 9.29<span></span>
</td>
<td class="nump">$ 7.15<span></span>
</td>
<td class="nump">$ 5.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled/Forfeited</a></td>
<td class="num">(40,951)<span></span>
</td>
<td class="num">(68,514)<span></span>
</td>
<td class="num">(30,144)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled/Forfeited</a></td>
<td class="nump">$ 14.19<span></span>
</td>
<td class="nump">$ 12.17<span></span>
</td>
<td class="nump">$ 9.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards Outstanding, ending balance</a></td>
<td class="nump">1,223,661<span></span>
</td>
<td class="nump">1,163,259<span></span>
</td>
<td class="nump">1,134,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding</a></td>
<td class="nump">$ 17.76<span></span>
</td>
<td class="nump">$ 12.63<span></span>
</td>
<td class="nump">$ 9.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Outstanding, end of period</a></td>
<td class="text">6 years 9 months 14 days<span></span>
</td>
<td class="text">7 years 1 month 17 days<span></span>
</td>
<td class="text">7 years 3 months 21 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Vested and Exercisable, end of period</a></td>
<td class="nump">596,311<span></span>
</td>
<td class="nump">515,394<span></span>
</td>
<td class="nump">483,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Vested and Exercisable, end of period</a></td>
<td class="nump">$ 10.69<span></span>
</td>
<td class="nump">$ 8.57<span></span>
</td>
<td class="nump">$ 7.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Vested and Exercisable</a></td>
<td class="text">5 years 7 months 2 days<span></span>
</td>
<td class="text">6 years 1 month 2 days<span></span>
</td>
<td class="text">6 years 5 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and Expected to Vest, end of period</a></td>
<td class="nump">1,194,239<span></span>
</td>
<td class="nump">1,101,800<span></span>
</td>
<td class="nump">1,069,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and Expected to Vest, end of period</a></td>
<td class="nump">$ 17.75<span></span>
</td>
<td class="nump">$ 12.39<span></span>
</td>
<td class="nump">$ 9.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and Expected to Vest</a></td>
<td class="text">6 years 9 months 7 days<span></span>
</td>
<td class="text">7 years 25 days<span></span>
</td>
<td class="text">7 years 3 months 3 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_OutstandingRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life outstanding, beginning balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_OutstandingRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574129822536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS EQUITY (Details - Intrinsic Value) - Equity Option [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic Value of Options Outstanding</a></td>
<td class="nump">$ 51,272,966<span></span>
</td>
<td class="nump">$ 27,312,742<span></span>
</td>
<td class="nump">$ 13,064,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic Value of Options Exercisable</a></td>
<td class="nump">29,150,912<span></span>
</td>
<td class="nump">14,194,724<span></span>
</td>
<td class="nump">6,315,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic Value of Options Exercised</a></td>
<td class="nump">$ 4,085,753<span></span>
</td>
<td class="nump">$ 3,224,454<span></span>
</td>
<td class="nump">$ 1,495,313<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574047914040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS EQUITY (Details - Fair value of options) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_FairValueOptionsGranted', window );">Estimated fair value of awards granted</a></td>
<td class="nump">$ 2,997,120<span></span>
</td>
<td class="nump">$ 1,928,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate', window );">Unvested Forfeiture Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average grant price</a></td>
<td class="nump">$ 39.23<span></span>
</td>
<td class="nump">$ 22.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_WeightedAverageMarketPrice', window );">Weighted average market price</a></td>
<td class="nump">$ 39.23<span></span>
</td>
<td class="nump">$ 22.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Weighted average volatility</a></td>
<td class="nump">33.56%<span></span>
</td>
<td class="nump">31.61%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free rate</a></td>
<td class="nump">1.39%<span></span>
</td>
<td class="nump">2.59%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Weighted average dividend yield</a></td>
<td class="nump">0.65%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted average expected life</a></td>
<td class="text">6 years 8 months 1 day<span></span>
</td>
<td class="text">6 years 7 months 20 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_FairValueOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated fair value of awards granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_FairValueOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unvested Forfeiture Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_WeightedAverageMarketPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average market price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_WeightedAverageMarketPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049961032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable) - Equity Option [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">1,223,661<span></span>
</td>
<td class="nump">1,163,259<span></span>
</td>
<td class="nump">1,134,976<span></span>
</td>
<td class="nump">1,249,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Awards outstanding weighted average remaining contractual life</a></td>
<td class="text">6 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Awards outstanding weighted average exercise price</a></td>
<td class="nump">$ 17.76<span></span>
</td>
<td class="nump">$ 12.63<span></span>
</td>
<td class="nump">$ 9.44<span></span>
</td>
<td class="nump">$ 8.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Awards exercisable</a></td>
<td class="nump">596,311<span></span>
</td>
<td class="nump">515,394<span></span>
</td>
<td class="nump">483,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Awards exercisable weighted average remaining contractual life</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Awards exercisable weighted average exercise price</a></td>
<td class="nump">$ 10.69<span></span>
</td>
<td class="nump">$ 8.57<span></span>
</td>
<td class="nump">$ 7.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">$1.00 to $1.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price low</a></td>
<td class="nump">6.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price high</a></td>
<td class="nump">$ 8.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">177,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Awards outstanding weighted average remaining contractual life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Awards outstanding weighted average exercise price</a></td>
<td class="nump">$ 6.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Awards exercisable</a></td>
<td class="nump">177,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Awards exercisable weighted average remaining contractual life</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Awards exercisable weighted average exercise price</a></td>
<td class="nump">$ 6.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">$7.51 to $9.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price low</a></td>
<td class="nump">8.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price high</a></td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">547,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Awards outstanding weighted average remaining contractual life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Awards outstanding weighted average exercise price</a></td>
<td class="nump">$ 9.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Awards exercisable</a></td>
<td class="nump">350,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Awards exercisable weighted average remaining contractual life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Awards exercisable weighted average exercise price</a></td>
<td class="nump">$ 9.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">$3.01 to $4.50 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price low</a></td>
<td class="nump">16.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price high</a></td>
<td class="nump">$ 24.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">230,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Awards outstanding weighted average remaining contractual life</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Awards outstanding weighted average exercise price</a></td>
<td class="nump">$ 20.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Awards exercisable</a></td>
<td class="nump">50,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Awards exercisable weighted average remaining contractual life</a></td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Awards exercisable weighted average exercise price</a></td>
<td class="nump">$ 21.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">$4.51 to $6.00 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price low</a></td>
<td class="nump">24.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price high</a></td>
<td class="nump">$ 38.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">204,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Awards outstanding weighted average remaining contractual life</a></td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Awards outstanding weighted average exercise price</a></td>
<td class="nump">$ 33.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Awards exercisable</a></td>
<td class="nump">17,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Awards exercisable weighted average remaining contractual life</a></td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Awards exercisable weighted average exercise price</a></td>
<td class="nump">$ 34.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Price 5 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price low</a></td>
<td class="nump">38.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price high</a></td>
<td class="nump">$ 52.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">19,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Awards outstanding weighted average remaining contractual life</a></td>
<td class="text">9 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Awards outstanding weighted average exercise price</a></td>
<td class="nump">$ 38.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Awards exercisable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Awards exercisable weighted average exercise price</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Price 6 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price low</a></td>
<td class="nump">52.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price high</a></td>
<td class="nump">$ 61.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Awards outstanding</a></td>
<td class="nump">43,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Awards outstanding weighted average remaining contractual life</a></td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Awards outstanding weighted average exercise price</a></td>
<td class="nump">$ 61.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Awards exercisable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Awards exercisable weighted average exercise price</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=simu_Price6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051038968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHAREHOLDERS' EQUITY (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued under public offering</a></td>
<td class="nump">2,090,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="nump">$ 55.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from public offering</a></td>
<td class="nump">$ 107,747,338<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted average remaining contractual life</a></td>
<td class="text">6 years 9 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Fair value of non-vested options</a></td>
<td class="nump">$ 22,122,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Fair value amortization period</a></td>
<td class="text">3 years 4 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=simu_Equity2017IncentivePlanMember', window );">Numerator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance under the plan</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>simu_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=simu_Equity2017IncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=simu_Equity2017IncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574129829688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Income tax provision) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 2,097,725<span></span>
</td>
<td class="nump">$ 1,794,596<span></span>
</td>
<td class="nump">$ 2,370,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">477,744<span></span>
</td>
<td class="nump">426,364<span></span>
</td>
<td class="nump">460,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">39,038<span></span>
</td>
<td class="nump">51,285<span></span>
</td>
<td class="nump">104,377<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current tax expense (benefit)</a></td>
<td class="nump">2,614,507<span></span>
</td>
<td class="nump">2,272,245<span></span>
</td>
<td class="nump">2,935,951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(427,644)<span></span>
</td>
<td class="num">(140,730)<span></span>
</td>
<td class="num">(1,698,201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(131,874)<span></span>
</td>
<td class="num">(158,368)<span></span>
</td>
<td class="num">(33,620)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Total deferred federal and state</a></td>
<td class="num">(559,518)<span></span>
</td>
<td class="num">(299,098)<span></span>
</td>
<td class="num">(1,731,821)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 2,054,989<span></span>
</td>
<td class="nump">$ 1,973,147<span></span>
</td>
<td class="nump">$ 1,204,130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049377176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Reconciliation)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax computed at federal statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">25.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Meals &amp; entertainment</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock based compensation</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(2.60%)<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Other permanent differences</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment', window );">Research and development credit</a></td>
<td class="num">(2.70%)<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
<td class="num">(2.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax related differences</a></td>
<td class="num">(1.40%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research &amp; credit adjustments to expense</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities', window );">Domestic production activities</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Change in deferred income taxes due to statutory rate changes</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(14.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes', window );">Change in prior year estimated taxes</a></td>
<td class="num">(1.80%)<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
<td class="nump">(0.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">18.70%<span></span>
</td>
<td class="nump">11.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for qualified production activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051546264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES (Details - Deferred taxes) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Accrued payroll and other expenses</a></td>
<td class="nump">$ 402,355<span></span>
</td>
<td class="nump">$ 236,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">6,862<span></span>
</td>
<td class="nump">55,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsEquityMethodInvestments', window );">Capitalized merger costs</a></td>
<td class="nump">742,056<span></span>
</td>
<td class="nump">361,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intellectual property</a></td>
<td class="nump">7,677<span></span>
</td>
<td class="nump">9,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsStateTaxes', window );">State taxes</a></td>
<td class="nump">100,326<span></span>
</td>
<td class="nump">89,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">13,450<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">State tax deferred</a></td>
<td class="nump">125,417<span></span>
</td>
<td class="nump">146,815<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">1,398,143<span></span>
</td>
<td class="nump">898,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Valuation allowance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">1,398,143<span></span>
</td>
<td class="nump">898,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(81,910)<span></span>
</td>
<td class="num">(61,991)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">State tax deferred</a></td>
<td class="num">(19,468)<span></span>
</td>
<td class="num">(16,471)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intellectual property</a></td>
<td class="num">(1,876,274)<span></span>
</td>
<td class="num">(2,217,234)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware', window );">Capitalized computer software development costs</a></td>
<td class="num">(1,774,349)<span></span>
</td>
<td class="num">(1,334,169)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(3,752,001)<span></span>
</td>
<td class="num">(3,629,865)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (2,353,858)<span></span>
</td>
<td class="num">$ (2,731,616)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from capitalized software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574129780472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Interest and penalties</a></td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">$ 2,531<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130134168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONCENTRATIONS AND UNCERTAINTIES (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash and cash equivalents exceeding insured limits</a></td>
<td class="nump">$ 10,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales [Member] | International Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net sales concentration percentage</a></td>
<td class="nump">29.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales [Member] | Customer 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net sales concentration percentage</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales [Member] | Customer 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net sales concentration percentage</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales [Member] | Customer 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net sales concentration percentage</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember', window );">Sales [Member] | Denominator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net sales concentration percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | A Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net sales concentration percentage</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member] | B Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Net sales concentration percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=simu_InternationalSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=simu_InternationalSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=simu_Customer1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=simu_Customer1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=simu_Customer2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=simu_Customer2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=simu_Customer3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=simu_Customer3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=simu_Customer4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=simu_Customer4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=simu_ACustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=simu_ACustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=simu_BCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=simu_BCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574041829528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Revenues</a></td>
<td class="nump">$ 9,540,000<span></span>
</td>
<td class="nump">$ 12,298,000<span></span>
</td>
<td class="nump">$ 10,350,000<span></span>
</td>
<td class="nump">$ 9,401,000<span></span>
</td>
<td class="nump">$ 8,026,000<span></span>
</td>
<td class="nump">$ 9,937,000<span></span>
</td>
<td class="nump">$ 8,472,000<span></span>
</td>
<td class="nump">$ 7,536,000<span></span>
</td>
<td class="nump">$ 41,589,084<span></span>
</td>
<td class="nump">$ 33,970,440<span></span>
</td>
<td class="nump">$ 29,666,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,605,178<span></span>
</td>
<td class="nump">10,648,729<span></span>
</td>
<td class="nump">10,297,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">168,421,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,196,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,421,517<span></span>
</td>
<td class="nump">45,196,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">12,921,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,387,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,921,185<span></span>
</td>
<td class="nump">10,387,198<span></span>
</td>
<td class="nump">10,387,198<span></span>
</td>
<td class="nump">$ 10,387,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember', window );">Consolidation, Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="num">(40,095,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,702,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40,095,000)<span></span>
</td>
<td class="num">(17,702,000)<span></span>
</td>
<td class="num">(17,702,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=simu_SimulationsMember', window );">Simulations Plus, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,961,000<span></span>
</td>
<td class="nump">19,585,000<span></span>
</td>
<td class="nump">17,553,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,374,000<span></span>
</td>
<td class="nump">7,752,000<span></span>
</td>
<td class="nump">7,533,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">162,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,535,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,807,000<span></span>
</td>
<td class="nump">38,535,000<span></span>
</td>
<td class="nump">38,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,000<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software costs</a></td>
<td class="nump">2,028,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,028,000<span></span>
</td>
<td class="nump">1,482,000<span></span>
</td>
<td class="nump">1,365,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,713,000<span></span>
</td>
<td class="nump">1,806,000<span></span>
</td>
<td class="nump">1,748,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=simu_CognigenMember', window );">Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,105,000<span></span>
</td>
<td class="nump">9,321,000<span></span>
</td>
<td class="nump">7,857,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,770,000<span></span>
</td>
<td class="nump">1,481,000<span></span>
</td>
<td class="nump">1,902,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,654,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,654,000<span></span>
</td>
<td class="nump">11,196,000<span></span>
</td>
<td class="nump">8,733,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,789,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,789,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,789,000<span></span>
</td>
<td class="nump">4,789,000<span></span>
</td>
<td class="nump">4,789,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,000<span></span>
</td>
<td class="nump">79,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software costs</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">114,000<span></span>
</td>
<td class="nump">625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
<td class="nump">364,000<span></span>
</td>
<td class="nump">401,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=simu_DILIsymMember', window );">D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,948,000<span></span>
</td>
<td class="nump">5,065,000<span></span>
</td>
<td class="nump">4,257,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,744,000<span></span>
</td>
<td class="nump">1,416,000<span></span>
</td>
<td class="nump">863,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">14,084,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,084,000<span></span>
</td>
<td class="nump">13,168,000<span></span>
</td>
<td class="nump">14,248,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,598,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,598,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,598,000<span></span>
</td>
<td class="nump">5,598,000<span></span>
</td>
<td class="nump">5,598,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software costs</a></td>
<td class="nump">124,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,000<span></span>
</td>
<td class="nump">172,000<span></span>
</td>
<td class="nump">155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">580,000<span></span>
</td>
<td class="nump">572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=simu_LixoftMember', window );">Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,575,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">19,972,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,972,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software costs</a></td>
<td class="nump">160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,589,000<span></span>
</td>
<td class="nump">33,970,000<span></span>
</td>
<td class="nump">29,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,605,000<span></span>
</td>
<td class="nump">10,648,000<span></span>
</td>
<td class="nump">10,298,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">168,422,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,197,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,422,000<span></span>
</td>
<td class="nump">45,197,000<span></span>
</td>
<td class="nump">43,279,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">12,921,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,921,000<span></span>
</td>
<td class="nump">10,387,000<span></span>
</td>
<td class="nump">10,387,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231,000<span></span>
</td>
<td class="nump">138,000<span></span>
</td>
<td class="nump">183,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software costs</a></td>
<td class="nump">$ 2,353,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,768,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,353,000<span></span>
</td>
<td class="nump">1,768,000<span></span>
</td>
<td class="nump">2,145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,962,000<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="nump">$ 2,721,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=simu_SimulationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=simu_SimulationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=simu_CognigenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=simu_CognigenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=simu_DILIsymMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=simu_DILIsymMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=simu_LixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=simu_LixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574045218184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 9,540,000<span></span>
</td>
<td class="nump">$ 12,298,000<span></span>
</td>
<td class="nump">$ 10,350,000<span></span>
</td>
<td class="nump">$ 9,401,000<span></span>
</td>
<td class="nump">$ 8,026,000<span></span>
</td>
<td class="nump">$ 9,937,000<span></span>
</td>
<td class="nump">$ 8,472,000<span></span>
</td>
<td class="nump">$ 7,536,000<span></span>
</td>
<td class="nump">$ 41,589,084<span></span>
</td>
<td class="nump">$ 33,970,440<span></span>
</td>
<td class="nump">$ 29,666,524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=simu_SimulationsMember', window );">Simulations Plus, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,961,000<span></span>
</td>
<td class="nump">19,585,000<span></span>
</td>
<td class="nump">17,553,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=simu_CognigenMember', window );">Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,105,000<span></span>
</td>
<td class="nump">9,321,000<span></span>
</td>
<td class="nump">7,857,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=simu_DILIsymMember', window );">D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,948,000<span></span>
</td>
<td class="nump">5,065,000<span></span>
</td>
<td class="nump">4,257,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=simu_LixoftMember', window );">Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,575,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=simu_NorthAndSouthAmericaMember', window );">North And South America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,674,000<span></span>
</td>
<td class="nump">22,577,000<span></span>
</td>
<td class="nump">18,876,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=simu_NorthAndSouthAmericaMember', window );">North And South America [Member] | Simulations Plus, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,124,000<span></span>
</td>
<td class="nump">9,381,000<span></span>
</td>
<td class="nump">7,856,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=simu_NorthAndSouthAmericaMember', window );">North And South America [Member] | Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,105,000<span></span>
</td>
<td class="nump">9,321,000<span></span>
</td>
<td class="nump">7,857,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=simu_NorthAndSouthAmericaMember', window );">North And South America [Member] | D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,057,000<span></span>
</td>
<td class="nump">3,875,000<span></span>
</td>
<td class="nump">3,163,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=simu_NorthAndSouthAmericaMember', window );">North And South America [Member] | Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,388,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,827,000<span></span>
</td>
<td class="nump">5,829,000<span></span>
</td>
<td class="nump">5,276,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member] | Simulations Plus, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,024,000<span></span>
</td>
<td class="nump">5,144,000<span></span>
</td>
<td class="nump">4,964,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member] | Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member] | D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">646,000<span></span>
</td>
<td class="nump">685,000<span></span>
</td>
<td class="nump">312,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe [Member] | Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,088,000<span></span>
</td>
<td class="nump">5,565,000<span></span>
</td>
<td class="nump">5,515,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member] | Simulations Plus, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,812,000<span></span>
</td>
<td class="nump">5,060,000<span></span>
</td>
<td class="nump">4,733,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member] | Cognigen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member] | D I L Isym [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,000<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">782,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaMember', window );">Asia [Member] | Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=simu_SimulationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=simu_SimulationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=simu_CognigenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=simu_CognigenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=simu_DILIsymMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=simu_DILIsymMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=simu_LixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=simu_LixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=simu_NorthAndSouthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=simu_NorthAndSouthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574130396696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Apr. 02, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember', window );">D I L Isym [Member] | Numerator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payment for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,704,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Acquisition liabilities owed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember', window );">D I L Isym [Member] | Dilisym Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Earn-out payments made</a></td>
<td class="nump">$ 587,000<span></span>
</td>
<td class="nump">664,506<span></span>
</td>
<td class="nump">$ 1,599,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember', window );">D I L Isym [Member] | Director [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Earn-out payments made</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">11,346<span></span>
</td>
<td class="nump">$ 27,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_LixoftMember', window );">Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Acquisition liabilities owed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,117,519<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_LixoftMember', window );">Lixoft [Member] | Numerator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payment for acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,720,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Acquisition liabilities owed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 947,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,602,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_DILIsymMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_FormerShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_FormerShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=simu_DilisymEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=simu_DilisymEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_LixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_LixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574049371384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLAN (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Contribution by employer in benefit plan</a></td>
<td class="nump">$ 456,484<span></span>
</td>
<td class="nump">$ 404,684<span></span>
</td>
<td class="nump">$ 326,762<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574051101512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 02, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Estimated Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,921,185<span></span>
</td>
<td class="nump">$ 10,387,198<span></span>
</td>
<td class="nump">$ 10,387,198<span></span>
</td>
<td class="nump">$ 10,387,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=simu_LixoftMember', window );">Lixoft [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Assets acquired, Including cash of $3,799,134 and accounts receivable of $629,481</a></td>
<td class="nump">$ 5,006,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Developed Technologies Acquired</a></td>
<td class="nump">8,010,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Estimated value of Intangibles assets acquired (Customer Lists, trade name etc.)</a></td>
<td class="nump">4,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Estimated Goodwill acquired</a></td>
<td class="nump">2,533,987<span></span>
</td>
<td class="nump">$ 2,533,987<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities Assumed</a></td>
<td class="num">(1,117,519)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total Consideration</a></td>
<td class="nump">$ 18,593,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=simu_LixoftMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=simu_LixoftMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574048057528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Net Sales</a></td>
<td class="nump">$ 43,970<span></span>
</td>
<td class="nump">$ 36,918<span></span>
</td>
<td class="nump">$ 31,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 10,630<span></span>
</td>
<td class="nump">$ 9,250<span></span>
</td>
<td class="nump">$ 9,132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140574050867224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDTED QUARTERLY FINANCIAL DATA (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 9,540,000<span></span>
</td>
<td class="nump">$ 12,298,000<span></span>
</td>
<td class="nump">$ 10,350,000<span></span>
</td>
<td class="nump">$ 9,401,000<span></span>
</td>
<td class="nump">$ 8,026,000<span></span>
</td>
<td class="nump">$ 9,937,000<span></span>
</td>
<td class="nump">$ 8,472,000<span></span>
</td>
<td class="nump">$ 7,536,000<span></span>
</td>
<td class="nump">$ 41,589,084<span></span>
</td>
<td class="nump">$ 33,970,440<span></span>
</td>
<td class="nump">$ 29,666,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">6,865,000<span></span>
</td>
<td class="nump">9,633,000<span></span>
</td>
<td class="nump">7,683,000<span></span>
</td>
<td class="nump">6,758,000<span></span>
</td>
<td class="nump">5,735,000<span></span>
</td>
<td class="nump">7,613,000<span></span>
</td>
<td class="nump">6,264,000<span></span>
</td>
<td class="nump">5,336,000<span></span>
</td>
<td class="nump">30,939,854<span></span>
</td>
<td class="nump">24,944,736<span></span>
</td>
<td class="nump">21,672,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 2,188,000<span></span>
</td>
<td class="nump">$ 2,936,000<span></span>
</td>
<td class="nump">$ 2,150,000<span></span>
</td>
<td class="nump">$ 2,058,000<span></span>
</td>
<td class="nump">$ 2,059,000<span></span>
</td>
<td class="nump">$ 2,889,000<span></span>
</td>
<td class="nump">$ 2,099,000<span></span>
</td>
<td class="nump">$ 1,536,000<span></span>
</td>
<td class="nump">$ 9,332,060<span></span>
</td>
<td class="nump">$ 8,583,329<span></span>
</td>
<td class="nump">$ 8,934,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, Basic</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.17<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, Diluted</a></td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>88
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M X"0AV/?PXT6V^P@="FT%G%VN>$LX-)\ .]70NCCC?F!XO!]_!]02P,$%
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M//^F>X=$,U]BLJK]BYY[6[Q 25U9D_>#04&>%MW_^*4/Q-$ PB<&T'X /7<
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M >#_STJ9W4LUP/Y6_/(_4$L#!!0    ( )&*<%%,O27*H0<  %8M   8
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M.R9K.)Z'EPODSN/1HI2H79"G5F^1&<$T@2" 8/IB2+Y8#8U@"+%G>"&++<S
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MALU?FR30<2!E\_8>M,4.;4'Q,& M(-1(:+@[#^D#4S,(.MG>/>M1[\8Y,[!
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M,H#["C8-EICH7U'_9Q3G^8TXQ&3T'.@*Y"U &[!,WNSVPHPN?D!FV0:>SL5
MDC  X'M;D2^'V&_H.0XB2!R&)3B9JQXSIR/)5@_Y& >R\!]=MJ5[HK"Z(AP
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MXRE/,)TS7NU_/A<7:SX[1VF^MD%!'.7N@\JFD LWQ\.H_Q00*<WD8;PB_:<
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M9@./CLX7\V<<F+)?VNI +Y1<52V@BS[N3 JZ$&^ WS<5>#CR!2=P;QC]^7\
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MLID/>IQ7X\:J;I@13\K2Q!G,BD8\:N= ]SNE[&GC$DQ_&JM_ 5!+ P04
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MZ4D/=/74JR96%>YYM5:6'FMNF-#K&#4;T/>-4K:9<(#VO;WX&U!+ P04
M" "1BG!1-9.;WG8(   I$P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6RM6-MNVT@2?>=7%#2>P0R@Z$)=D]@&?,NN%_$%L;/!8+$/+;(E]89D:[J;
MEK5?/Z>Z28I*',\^+!#$)-5=777JU*DBC[?:?+5K*1T]YUEA3SIKYS;O^GV;
MK&4N;$]O9(%?EMKDPN'6K/IV8Z1(_:8\Z\>#P;2?"U5T3H_]LWMS>JQ+EZE"
MWANR99X+LSN7F=Z>=(:=^L$GM5H[?M _/=Z(E7R0[O/FWN"NWUA)52X+JW1!
M1BY/.F?#=^=C7N\7_%/)K6U=$T>RT/HKWURG)YT!.R0SF3BV(/#G25[(+&-#
M<../RF:G.9(WMJ]KZQ]\[(AE(:R\T-D7E;KU26?>H50N19FY3WK[=UG%,V%[
MB<ZL_Y^V8>TD[E!26J?S:C,\R%41_HKG"H?6AOG@!QOB:D/L_0X'>2\OA1.G
MQT9OR?!J6.,+'ZK?#>=4P4EY< :_*NQSIQ=W-S?7CS=7MX\/='9[21=WMX_7
MMW^[NKVXOGHX[CL<P0O[267N/)B+?V!N&-.-+MS:TE61RO300!^^-0[&M8/G
M\:L6S\I5CT;#+L6#>/"*O5$3\,C;&_TH8)WGRH%6SI(H4KJ NZI8R2)1TM*E
MLDFF;6DD_>ML89T!:_[]RJGCYM2Q/W7\_X+Y57-<J>_L1B3RI(-2M-(\R<[I
M[=WC%<WH#;UZ&'V4(+&E+Y(ROB*QV1C]K$!PF>UH..I.!@,41RF P1*TBO22
M_%FD"OHHBD18)TV7+D2F( J%$CUZ7$O21JU4(;+*[%JD)&B)DGNSD\(0]N3@
MMEN3V^HNN;61U2]ZP_5IR6F2STX6:;"G"N64R*)O3,CGC3(R96<^R(6!FSM0
M8PB"<#:WLK*!%6Y=APC+^[7,I.&X1]<%_:,L)-^-NJW%6P%BY)4)'05S_G=_
M_O>V9L'?>D^%:F8U =@GE0)LX 3W\*\H 1"K" 2M< @B,7XY,![]3!MIR$?*
MH028MMK''KT $@*X$3[XJ7</S-Z(8H??I4F4K1 X,--@'6R ]_O X$(+L;71
MY6K=A!KY4.,A">>S^@SK!HSA74?QI#L 9]C[G(L_X%% D?TQ7K_%"OGFJ@,R
M: 25<[7+GA=O!Y2*G?WEIWD\G+VG0CN5^-S!Z0C]I/;02&XV['OP%4SPCH.7
M'*A'T-:+?6CE!AYLQ,Z?CQ\$;"1BX[C,Z\?R#TX-3N-=R(5/4OUCG:?(K0'
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M*F^@/#)907U$JESVYO":E;?]9JDTB;I:@[W=^6&+Y8]-!R/.-DU?=X[O+_P
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M182C(_M&;+SIFJWY@H.*W34;<[E6Z(*:"/!\U33=>$,;3)_T3O\'4$L#!!0
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M9X&?IZEWC202+,FP*TE8$LW]>([K//#G8>ZA*P#S&Q;G?A O6!KZT2)E89"
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M#(81KB^?W+;#YV&\4^IGNLRAX@:8'.WV+HM"M7B$5J<@SU)+F\Q=3F@@5!(
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M2CZKHQBXCF(EMIN1%^HPYD_IMZN3N "O+]!K7B^A9X2?:0LT 4M!')VV"L(
M373)NR#KB5F?+5WM@HS>C8S8&_.=Q.#)J.Z:B_55KD>_/%C'_$W7[W5G)3B
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M4F6I2_TPIVL1M4N@];52M@W<!MU%._T#4$L#!!0    ( )&*<%&>K;QUN2<
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MXDVJ6:3C'O,-2CHDALBBHGV^E^H<8*3(#'PS2Q4!:PW9+1E9@#94Q$6%.B9
M5RU LQO]J0L40>AV)0 % ,4(3/(88=H L^T2(/#?M:/K6,EA-A]"E%71%]P
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MP@21,0I0 GN.+RT%6Y=P!7NZ7++S#U#OJ-<:E<:\+D,LIW#IH=B("4*U,:.
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M+: -Q76P.[2\FB !IL^OX79?H^V^(DMBG2_#@I=.=;J:+'EEV:V)FB:DNZ2
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MGA]1ZVU,Y3GF/27SV)_&MDS$,_1B^JZQ$Y^Q<6]L*,YTR^JK/,-LIR2@(DE
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M(<DKB@KH+F!A)BWO/6*-@@[8[: D:)L>:(X<5#])\W2;2CY/Y,9TLZDF].$
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M'48!#V^LUU(L$STF^/5)T;JN"AUS7%BZO6<E-&DZWI1@RTKI2]*F<RM@2QH
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MKN"<8,@-A19?Z GP?<6Y:@=:0/?7RME?4$L#!!0    ( )&*<%'PM0YAE0,
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M/K^\\)!LO=\NM*B=WU*AC7M=6)IQ"=(FF/-""'U86(%N ,_^ E!+ P04
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M[1Z]T"!?CNEYS"P;>\E!')4*7N+T&WJ)#BH-#@LZ::HA.^2>EQ1L&8=> D-
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MGZRZA[9:A\]$5U7;5JNPO/%IYFLD@/?+JFJW#WC \-WP]!]02P,$%     @
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MF?U))Z>=4N"9O!>%4+PB;XA/O2RAB1]ASVB2A33*8O<^2#R:1='DRG C2)B
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MN'N[[1H?.T)9 OR_DM(\'*R \?/IZ&]02P,$%     @ D8IP42]'?5.+!0
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MD&-UU(?8M,I\5OW_/G_O3R4-4G[7$' .*MRPWKLIZV4E?419=%4M+487S?@
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MF287EU0SW;T(W<*JK9_"*V6)U%ZLZ1%%[13H?*V4?5TX!X=G>?8_4$L#!!0
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M%'P-PD1K-]/(DYFK]?(I,_L^5D*/4JU3[?%D,.C<_X2[&QCW;H>]FU[4&3Y
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M\B.E_$:P37;(LF!"L#B[7&,_P$D*D-^O&!/[FW2"\F!O_!M02P,$%     @
MD8IP49MOU+')!0  P2(  !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL
MO9IM;]I($,>_R@K=BU:ZUMXGXU0$B9*FAY20*&GN=#KUA0,;L&I[J;TDZ>D^
M_*V-XS$UWG4*(B^"GW9F=CW_'S/8@R>9?LN60BCT'$=)=MI;*K7ZX#C9;"GB
M('LO5R+19QYD&@=*[Z8+)UNE(I@7@^+((:[K.7$0)KWAH#AVG0X'<JVB,!'7
M*<K6<1RD/SZ*2#Z=]G#OY<!-N%BJ_( S'*R"A;@5ZFYUG>H]I[(R#V.19*%,
M4"H>3GLC_&'LT7Q <<6?H7C*:MLHG\J]E-_RG<G\M.?F$8E(S%1N(M ?CV(L
MHBBWI./X7AKM53[S@?7M%^OGQ>3U9.Z#3(QE]%<X5\O3GM]#<_$0K"-U(Y_^
M$.6$>&YO)J.L^(^>RFO='IJM,R7C<K".( Z3S6?P7"Y$;0"A+0-(.8#\- "S
ME@&T'%"LG+.)K)C66:""X2"53RC-K];6\HUB;8K1>C9ADM_&6Y7JLZ$>IX:W
M=Y>7HYN_T=4YNIU\GD[.)^/1] L:C<=7=],OD^EG='UU,1E//MVB-V="!6&4
MH7?H2BU%BB:)"I)%>!\)-,HRH;*W^M3=[1EZ\]O;@:-T=+D/9U9&\G$3"6F)
M!!-T*1.US-"G9"[FVP8</:UJ;N1E;A^)T>)HO7B/*/X=$9>X.P(:=QZ.3PSA
MT&JI:6&/MMF;?5^'J9BC\S )E7AWH?-WWEQ$],^%'H@F2L395X-;5KEEA5O6
MXG:J69#+"#T&T5KLNB^;\;P8G\O^<=AW79_T^<!YK"]7\SI*?%?_5==M!<BK
M +DQP'&1Y3J?;D04Y-K.EN%*+\.EB.]%^A7]A\9RD80+D53'#,OB55Z]8]Z-
M?N6V;YSL*):I"O\MYHE6(@WE?-<M,1O1VT&.)Y2?0#[Z(8(T,P3G5\'YYN#R
M-<G"(K;6;/$;68"QVYX%)Y7O$XOOV3I>ZP30=R&H+=*N$#:6O%H(/N&M$6 7
M6.CN*9720'WV6B?MKFL8QGN*X Q-T 6:9#_B+C+ !#R38PH! PXQ/804+%:V
MM8!=JQ@P@!.;R=E)#KA)17QBT ,&+&(S%U^CB-)471(>SA.S)0B@)/;VE837
M7 !2Z+'%-Z 2FS%GU\1%^"P?5"<]  .Q?U0]  "QA8 =]6"V\I,>F%4/!/!(
MS'CLI >R@Y"<M^N! "*)&9&OT4-IJJZ'/O=/2$L, $M"]I1#:6!K_JS/L.NW
M^ 9>$C/IOJ3!7*!I$(M?+HX(L(^P8ZJ  /6(A7K=5&"Q,I6),(4#_"-F_G7+
M^28"N>$K@  !B:5:?$W*]QLIW^8?6$C,!6&'=&^6@\:I PV)F6,MV?ZZ*H@"
MVZA[S'RG0#5JH5JW?+=8L>0[!<!1,^ ZY3MM,L[WVF\ZK77(EI+P%?E>FNJ0
M[Q2H1_?ME6FSW#-.';A'S<1JR??N%0X%IM&CMKX4<$8/TOQ:K-AR'>A&#]#N
MTAW]KJF>H4 X>KB.ES9;WA;_#)#']NUV6;.6,\Z= ?68E5<S&:^$TLFV2(6(
M1:)^N:IA0#=VU%Z7 =C807I=BY7MVIY;2WM6^XWP *TN:[+/E R /G:X1I<U
M&UU3#,!$MF^?RYI%7IM7 "*SHLPL@]>5.PS0QX[:Y#* 'CM(DVNQLBT$>X_+
M 8K\ #TN;W+1]#LX4)$?KL/ES0[7:_\AD@,B^;X=+F]6?]C@&1C)S72SBJ%[
M+<0!?/RH?2ZO/?0X2)]KL;(M!&H7 @"1'Z#QY4TF&HIA#ESDA^M[>;/O]2FE
M+2$ (?F^K6]I8.NK"'M>O\4S()*;X=;R<+73PR_@G'?4?M<#QGDVQG7(*Z\)
M-]\S?,][@#?/UM]VSZS25#T*[#'<)S\_&/5V$)%@0[C 1,_"1&L6E@9,3V\W
MOIW:2P*Q2!?%NQ,9FLEUHC;O"U1'J_<S1L5;"0Y<OGFYXS)(%V&2H4@\Z*'N
M^[[VGF[>E]CL*+DJ7CFXETK)N-A<"MW?IOD%^OR#E.IE)W=0O;4R_!]02P,$
M%     @ D8IP46:1-K]C @  T 4  !D   !X;"]W;W)K<VAE971S+W-H965T
M-# N>&ULA91=;YLP%(;_BH5VT4IK(1"2JB)(-%TZI.9#3;-IFGKAA)-@U<:I
M;9IVOWZVH2A38;D!']OO^YQC\(D.7#S+'$"A-T8+.7)RI?;7KBLW.3 L+_D>
M"KVRY8)AI4.Q<^5> ,ZLB%'7][R!RS IG#BR<PL11[Q4E!2P$$B6C&'Q?@.4
M'T9.S_F8>""[7)D)-X[V> =+4*O]0NC(;5PRPJ"0A!=(P';D)+WKFZ'9;S?\
M('"01V-D*EES_FR"-!LYGDD(*&R4<<#Z]0ICH-08Z31>:D^G01KA\?C#?6)K
MU[6LL80QIS])IO*1<^6@#+:XI.J!'[Y#74]H_#:<2OM$AWJOYZ!-*15GM5AG
MP$A1O?%;?0Y' K_7(?!K@6_SKD VRUNL<!P)?D#"[-9N9F!+M6J='"G,1UDJ
MH5>)UJEXN9I.DX=?:#Y!R_1NED[2<3)[1,EX/%_-'M/9'5K,[]-Q^FV)SFY!
M84(END )XT*1/]@>K/E1LI+"N5Z8JQP$2@N%BQU94T")E* D^CT%M@;Q%+E*
M)VW0[J9.\*9*T.](,"EWERCH?46^YWNKY2TZ^W+^KXNK2V[J]INZ?6L;=-EN
M7DHB($,34A %%_?ZW\C:$K_70I0J8/+I/]B@P086V^_ ZB)Z;6=0J4*K,O?H
M-0[[H>=YD?O:0NLWM/XIFM]&JU2#8UK@==+"AA:>H@5MM/ 3+;CJ=](&#6UP
MBM9OHPT^TX9^)VW8T(:G:&$;;?CIN[72W*,+:GK=%(L=*22BL-5"[W*H'435
M/ZI \;V]LVNN= >PPURW7!!F@U[?<JX^ M,&FB8>_P502P,$%     @ D8IP
M4;2*W.E+!   .!@  !D   !X;"]W;W)K<VAE971S+W-H965T-#$N>&ULQ9EO
M;]HZ%,:_BA7=%YO4-;$= DR Q.BZBU3:"MI-T]5]8<" M?RAM@.;=#_\M4,:
MARTD44N5-\5)SCE^?![EAW%[^XC_$!M*)?@9^*'H6QLIMQ]M6RPV-"#B,MK2
M4#U913P@4EWRM2VVG))EDA3X-G(<SPX("ZU!+[EWSP>]*)8^"^D]!R(. L)_
M?:)^M.];T'J^,67KC=0W[$%O2]9T1N7C]IZK*SNKLF0!#06+0L#IJF\-X<<1
M;NN$).(KHWN1&P.]E'D4_= 7XV7?<K0BZM.%U"6(^MC1$?5]74GI>$J+6MF<
M.C$_?JY^G2Q>+69.!!U%_C>VE)N^U;' DJY([,MIM/^;I@MJZ7J+R!?)7[!/
M8QT++&(AHR!-5@H"%AX^R<^T$;D$Z)Y(0&D"JIN TP2<+/2@+%G6%9%DT./1
M'G =K:KI0=*;)%NMAH7:QIGDZBE3>7(P>YQ,AM/OX.X:S,9?;L?7X]'P]@$,
M1Z.[Q]N'\>T7<']W,QZ-/\_ NRLJ"?,%^ "N">-@1_R8@H 2$7.JG)7B_?.C
MK_K1!9C21<PY"]?@GPD-YI3_JP(>9U?@W5_O>[94\K4(>Y%*_720BDY('<;K
M2X#A!4 .<@K21[738?<XW59-RSJ'LLZAI)Y[HMZ(B T@X1(D@\]/,5,-T5W(
M%ELR"<XFP<DD^,0DIIM@8AH-QN$V5A/IV?5#DKP1#W2Q"=E33)6"&U4'C"4-
M1)D*-U/AEBXU9S<1@DI19-ZA1"LIH>&Q&[A=Y+0Q='OV+F_3GX$0NKCE=KM9
MX)'*5J:R5:IRMHFX_" I#U1_=E3(H*X;7C:#UZ ;[4Q%^_5N'$IXN29[7L?!
MK6[K-S?^#'2*;>AD\CJE\H;J31 LZ<&4^D12]89$H504T+U20\&6E!^:=#?W
MV3H9UO*IFTGH-N@3= Q;G;I.^8S,F:_:0@OM2@OE;7#;V&DYSF]V%03"M@<=
MU"EV#>:^"&"UV!3<ATY=@!NZHSZ !M__@5=A#QJX0M2DA8:_$+_^94MK>-7L
M*X@LAQ\TC(8U(%WMW\LI"0V(8:M)\PRNH7<&\[RZJ"R(/,%*:%@.:\"\VK4W
MA"HT8(>=)FTU=(?=<V&U6^)8:FI9R/'&T' ?U>!^H:GH;"A%!NP(-F@;RNV7
MRS?,M=[&M$:98Z4AQ]H,YE$-S%<[]G)X(L-QY#9IEX$X*M].U[.K56U76<BQ
M-@-V5 /LU7:](361(3QJ-^FGH3<JWY?7IV9:J-34LI!C@0;KJ ;6"TW%9Z,F
M-@S'3H.V84-O7&-;7O4:IC7*'"L-.=9FB(YK$+W:L9=3$^?.29H\*,&&WO@,
M1R5IC5*[RD*.M1FBXQI$K[;K#:F)#>%QDT<MV- ;USYLJ:!F6NCH *SP)WQ!
M8/%/>#MWK*O/U">$KYEJM$]7*M.Y;*L2_'!,?;B0T38YZ9U'4D9!,MQ0HLS2
M >KY*HKD\X4^/,[^63#X'U!+ P04    " "1BG!1K#0D.O,"  !A"   &0
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M (0QT/LKSM5^8AR4?Q7=/U!+ P04    " "1BG!16[/?CCD$  "[%   &0
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M8W&)#1NP<A+0M@:'J$X9I;;1RPB&J-_MHX'_8L&%-2YTX9 -=XB*WN.B(&S
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ME0^[E1\O(L>!9+N\&5PR"<UE_KJ%NQOE"@#_KQF3IX%:H+P-]G\#4$L#!!0
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M &H+P 4 MP78!<!N"R %@&P <*\&X!0 9P, G1J 6P#<38!= _ *@-<6T"L
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M(3NU-^>1S/Z#7:YU7 /,-U+QN(!U!'&8Y+_T1_$@C@!MIQ[ !8!/ 7(&( 5
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M(;,?#]?IS>SVGAPE#"@7AMQ2K:EMS3'Y2AX6"3GZ<CSR 3U;O)^U7J:-E_"
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MSFRG9?OULYTT+:/-8(*7Q!_WG'M\[7OMP9KQ1Y$ 2/1$22:&5B)E?F;;(DJ
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MM*.^::F#(]33>CL@X?",!'[@?P"??1D^O/H?3HW(7FG0*PT<7WA,:;D#C68
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MJZ0IQ<L=IS=>LO*C% 3\4:A:ABW\)N4FSO(DBS?%+L6'.,OBL#A<<V_)DUQ
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M>[&[P=*@CN$+1:SL+^R*M;V! V&NM$A*,"E(>%K\LU^E(TX 0><50% "@F<
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M*J=D??S;BT;#F(YX_/RB_MF'MV$>12MO5/5W69CM/,HB4,BUV%?FBSK\(?M
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MK"O=%7%=PZB=+VL>E;%%DG_<VL)7:@>P[]=*F9>&&V HI1?_ U!+ P04
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MJ^ES5R]2K^)YLQJ24?*!I'$:.SJT>#.>G#KP[.WXU!/-J#-^9/5&?<;S7%1
M[N@CR9C*2Z$:">3O\WNE)4Z&?SQ-C+LFQK:)L;\)C4W@0=UH* C59 D%2%H2
MI:ENM)!/]@E)-;A&V=]$F@SC^"?78+R3RP+<\7#\DCOPYKCSYM@K=(O!6VM
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M<R:3E8%YOA="OPZJDTQW<EW]"U!+ P04    " "1BG!1:N_.+4P"  "3!0
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MC$"DE%EZ_;'V&5K[C "DSPWJ!"MU@LWJQ$2\6.=[RGV=2D:VP(DM,+0%1A;
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MJ* PO<0\AG!0*1+ 44QJ-Q?;^@+!;/6Z;,T3#J:,F'594&'*FEG[@@H#"RJ
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M*ON+=OE:+[#0,E5:1 48,HAXG/_2YZ(1!P#@J0>0 D!. ?X%0*L M$X![@6
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MZY[*#8\5"MD:*)WK +HD\\M,_J!%DGVM+X2&;_]LN(4+()-F ;Q?"Z'W#R9
M>:7L_P]02P,$%     @ D8IP42:S30ME @  M@4  !D   !X;"]W;W)K<VAE
M971S+W-H965T-S N>&ULC51M3]LP$/XKIV@?0-IPFJ2%H312W]"0@%4P-DW3
M/KC-M;%P[,QV*/Q[;"?-.M8BOL0^^Y[GN3OG+MU(]: +1 -/)1=Z&!3&5.>$
MZ&6!)=4GLD)A;U92E=184ZV)KA32W(-*3J(P')"2,A%DJ3^;JRR5M>%,X%R!
MKLN2JN<Q<KD9!KU@>W#+UH5Q!R1+*[K&.S3WU5Q9BW0L.2M1:"8%*%P-@U'O
M?)HX?^_PG>%&[^S!9;*0\L$9E_DP"%U R'%I' .URR-.D'-'9,/XTW(&G:0#
M[NZW[!<^=YO+@FJ<2/Z#Y:88!F<!Y+BB-3>W<O,%VWSZCF\IN?9?V#2^_2B
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M5;KK9JJ*9^"E@9K?,":?.V6 IAP?_0=02P,$%     @ D8IP4<WS?<F) @
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MWUX6N%=0T*[WNV(0<(@].LQ.ZIJM/S-:"@YN\4<73&.RR4.55/3)5+-7)3,
M*(Q6H#3-QLAO1>H%='ISG;KBL.;I?ZCY[^YS"0(486/1YNZ?\BZ_6;'O!/]"
M<_];V5?\HLC9Q]/7Z+O?J8N<G[[(V?5):@Q\UQFUMIW&-J#(/B 2_,,^5MBV
M*%JVE&DJO%?1/ ?QK+\9>DV6YCFXPV_FYU"0ENG%$$SPUOX..6WY]3#KWFZ$
MG[6UO]GE1?.^X/;-F?X!4$L#!!0    ( )&*<%&7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ D8IP4<""DUR"!0
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M+'R/.=Z4+83'6\;K520\ #E&(,?$S;U:+IUPW;:UF'GB1KB.%S/'=?V5%PL
M>8Y GM-"AOR6>RO.0N[ZBK$)* "[0, N:,&"L!FX\;IM7C4Z1-#T0SAGC[!)
M>T1+)[Q;'L7MR(!(J$?H11*'CJN&:N"LG>L%AV"8/S1R@2R7XABKMC$;4.'-
MN.<*WHD>Y@^-6"#O9F,1KR$;I@V-V!O"4R'D+';^[,8+LX1&KPF7-QVNF3&.
M[;I2=\+8$:IU.WT/\X1&+(J(SYJ.U_+-N#\+G6 N7#7;!7X8=T2A8:;0B%41
M\D7KV\!I9CP552]2([F)+"3$-*$1>X(O@X6_YIQ=<X_?B)@%*A&$<)@J-&)7
M.*X:KU$KK\V2AS,>LC]$/&?1ZCH24VA:'9.&3BR-E>>LIJ)IYZ\KU= \7*S9
MC?!40BV<!9M"3$PD.K%(FJBI"; 9-DURT*U#T$*$6"1H0K71(2:F$IU:)2BF
M 3$QJ^C$5NG)_-B9JM4S6?T*&3'+Z,26Z4\">S$QR^C$E@'98"\;IA:=6"WO
MTL)>0DPM.K%:T/R0G4%,3#(ZL63Z,L2^6!J88@SRNN0M5>R%P\1B4(L%2\8Z
M\[>!:<8@U@R:370QT14O8LV@V407$].,0;WHA=K0A)B8:0QBT^"8%L3$3&-0
MUS,HI@TQ,>D8IUSZVHPA)F8>@]@\..8YQ,3,8U";!\6\@(O;F'M,8O=@F)MV
MM>X5$[.025[>8)@:Q,0L9)ZPV-EH<'HW,0N9)RQV-AHL=DQTY^6$%MIHT$(F
M9B&3V$*]-=E4UDF:5>PW!C$Q"YG$%D(Q.ZF'B5G()%]50S ]N'-I8A8RB2WT
M49'[DQ1B8A8R3[(A\Q.ST^@69B'K\W9F7D,(*R +<X]%[)X^.-43RS)I#DIT
M,#'W6/1;_O]=,^B+).8=BWS#'UDTZ/9&S#L6L7=P3*A'"]WSIZY^P-K&Z])&
MKW<LS#L6=?6#878;'?..15W]H)B=1L>\8U%7/R@FS(DLS#O6)ZZ[O<>$E;F-
M><>FKGYZEP=?YWB(B1G()C<07"!\&^(BWQ8'"4>ZC1G()C;01YBAW!;Y-H68
MF(5L8@M]A#F5>UF6$F)B%K(_\0!!3]X!,3$+V:<\4]"9WFWT[-DISQ1TIG<;
MLY!-;2$4$T[O-F8AF_P VD='']J>"C$Q"]G$%NH]__ VEN")0\Q"8V(+X7L7
ML&^.,0N-B2V$8\*^.<8L-":V4+O%\N%Y#0=B8A8:MQ8:ME^NOESMY#[-Y<Y3
M_Z)2][=)M@U*UGP<C^J95G.89O^89:ZZY^>+(MF]G))_.>'_Y5]02P,$%
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " "1BG!1F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M )&*<%$CDDP_F04  (@7   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " "1BG!1L%$^SK@'  !!'@  &
M            @('<#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ D8IP490.&XK, P  #PX  !@              ("!RA4  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( )&*<%'P%>P("P8  "$7
M   8              " @<P9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " "1BG!13+TERJ$'  !6+0  &               @($-(
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ D8IP4?-*BHOC
M"   UB0  !@              ("!Y"<  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( )&*<%&"!B2D6P0  +P)   8              "
M@?TP  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "1BG!1
M:JVBT_XE  !M=   &               @(&.-0  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ D8IP43/BWG$B"0  E!8  !@
M     ("!PEL  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M )&*<%$WY/<%$0,  $ &   9              " @1IE  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ D8IP40CHIVG% P  /0@  !D
M             ("!8F@  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " "1BG!1%\!- QX%  !["P  &0              @(%>;   >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( )&*<%$UDYO>=@@
M "D3   9              " @;-Q  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ D8IP44\=7![["@  WAL  !D              ("!
M8'H  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "1BG!1
ML\$B.LD(   H%   &0              @(&2A0  >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( )&*<%% LVB'8@4  - +   9
M      " @9*.  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ D8IP48P%BC!\!@  .A(  !D              ("!*Y0  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " "1BG!1/=*^N;,"  #&!0
M&0              @('>F@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( )&*<%%GZVTAJ@(  * %   9              " @<B=  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ D8IP44XTF79:
M"0  1!8  !D              ("!J:   'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " "1BG!1?GJJ99$#  !0"   &0
M@($ZJ@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( )&*
M<%$)E-S9B (  '0%   9              " @0*N  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ D8IP49ZMO'6Y)P  DH$  !D
M         ("!P;   'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    " "1BG!1'!N_&M8'  !F&0  &0              @(&QV   >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( )&*<%'PM0YAE0,  '@(
M   9              " @;[@  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ D8IP4:\BVD_+ @  K04  !D              ("!BN0
M 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "1BG!1JEYX
M38P"  !V!0  &0              @(&,YP  >&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;%!+ 0(4 Q0    ( )&*<%$]'&"QDP(  (P%   9
M  " @4_J  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
MD8IP4;CS?.1H @  + 4  !D              ("!&>T  'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " "1BG!1)Z11"2T'  !#%   &0
M            @(&X[P  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( )&*<%'M)^'BMP4  $H-   9              " @1SW  !X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ D8IP42]'?5.+!0
M6Q   !D              ("!"OT  'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " "1BG!1J!WR:94#  "B!P  &0              @(',
M @$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( )&*<%&U
MNSJ!$P,  $ '   9              " @9@& 0!X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ D8IP4>KK"-_6 @  K0D  !D
M     ("!X@D! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )&*<%%FD3:_8P(  - %   9              "
M@:$= 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ D8IP
M4;2*W.E+!   .!@  !D              ("!.R ! 'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    " "1BG!1K#0D.O,"  !A"   &0
M        @(&]) $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   ( )&*<%%;L]^..00  +L4   9              " @><G 0!X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ D8IP47CO6U<-!   &0X
M !D              ("!5RP! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    " "1BG!11;F3,XT'  !6*P  &0              @(&;, $
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( )&*<%'P$S4^
MW ,  &8/   9              " @5\X 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ D8IP4>6_BBN[ @  A0<  !D
M ("!<CP! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " "1
MBG!1O=/_J5("   )!0  &0              @(%D/P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( )&*<%$F75&/20,  ,X+   9
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M970U,RYX;6Q02P$"% ,4    " "1BG!1SE.-(EH"   ,!@  &0
M    @(&F4 $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (
M )&*<%'G//!0(@,  *$)   9              " @3=3 0!X;"]W;W)K<VAE
M971S+W-H965T-34N>&UL4$L! A0#%     @ D8IP4:D2V19)!P  7B\  !D
M             ("!D%8! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"
M% ,4    " "1BG!1G=):F(@%   .&@  &0              @($07@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( )&*<%&]-H?9[0(
M ,L'   9              " @<]C 0!X;"]W;W)K<VAE971S+W-H965T-3@N
M>&UL4$L! A0#%     @ D8IP49W[!M]2 P  J H  !D              ("!
M\V8! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " "1BG!1
M9$43;7\&  !6*P  &0              @(%\:@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8P+GAM;%!+ 0(4 Q0    ( )&*<%&J>79[G@,  $0+   9
M      " @3)Q 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%
M  @ D8IP4:-RK"5M P  5@L  !D              ("!!W4! 'AL+W=O<FMS
M:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " "1BG!13!G:>C($  !Z$0
M&0              @(&K> $ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+
M 0(4 Q0    ( )&*<%%#U-?:& 0  ,4.   9              " @11] 0!X
M;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ D8IP46KOSBU,
M @  DP4  !D              ("!8X$! 'AL+W=O<FMS:&5E=',O<VAE970V
M-2YX;6Q02P$"% ,4    " "1BG!1G7&&R[@#  "#$0  &0
M@('F@P$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( )&*
M<%$]!:</K0@  .@S   9              " @=6' 0!X;"]W;W)K<VAE971S
M+W-H965T-C<N>&UL4$L! A0#%     @ D8IP4=8D>T2R!@  -"L  !D
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M=#<R+GAM;%!+ 0(4 Q0    ( )&*<%'9U2<+=00  ,@2   9
M  " @0:E 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @
MD8IP438-Z. Y @  @ H   T              ( !LJD! 'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " "1BG!1EXJ[',     3 @  "P              @ $6
MK $ 7W)E;',O+G)E;'-02P$"% ,4    " "1BG!1P(*37((%  !E,   #P
M            @ '_K $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ D8IP
M4;?' S!" @  0BL  !H              ( !KK(! 'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ D8IP4?C# AT& @  3RH  !,
M         ( !*+4! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %$ 40 N
)%@  7[<!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>316</ContextCount>
  <ElementCount>411</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>86</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - STATEMENTS OF SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/StatementsOfShareholdersEquity</Role>
      <ShortName>STATEMENTS OF SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - ORGANIZATION AND LINES OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/OrganizationAndLinesOfBusiness</Role>
      <ShortName>ORGANIZATION AND LINES OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - REVENUE RECOGNITION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/RevenueRecognition</Role>
      <ShortName>REVENUE RECOGNITION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/PropertyAndEquipment</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/Investments</Role>
      <ShortName>INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - CONTRACTS PAYABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ContractsPayable</Role>
      <ShortName>CONTRACTS PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ShareholdersEquity</Role>
      <ShortName>SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ConcentrationsAndUncertainties</Role>
      <ShortName>CONCENTRATIONS AND UNCERTAINTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SegmentAndGeographicReporting</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC REPORTING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - RELATED PARTY TRANSACTIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/RelatedPartyTransactions</Role>
      <ShortName>RELATED PARTY TRANSACTIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - EMPLOYEE BENEFIT PLAN</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/EmployeeBenefitPlan</Role>
      <ShortName>EMPLOYEE BENEFIT PLAN</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/AcquisitionmergerWithSubsidiaries</Role>
      <ShortName>ACQUISITION/MERGER WITH SUBSIDIARIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/UnauditedQuarterlyFinancialData</Role>
      <ShortName>UNAUDITED QUARTERLY FINANCIAL DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - REVENUE RECOGNITION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/RevenueRecognitionTables</Role>
      <ShortName>REVENUE RECOGNITION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/RevenueRecognition</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/PropertyAndEquipment</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/InvestmentsTables</Role>
      <ShortName>INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/Investments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - CONTRACTS PAYABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ContractsPayableTables</Role>
      <ShortName>CONTRACTS PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/ContractsPayable</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SHAREHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ShareholdersEquityTables</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/ShareholdersEquity</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/IncomeTaxesTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/IncomeTaxes</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SegmentAndGeographicReportingTables</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC REPORTING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/SegmentAndGeographicReporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables</Role>
      <ShortName>ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/AcquisitionmergerWithSubsidiaries</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/UnauditedQuarterlyFinancialDataTables</Role>
      <ShortName>UNAUDITED QUARTERLY FINANCIAL DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://simulations.com/role/UnauditedQuarterlyFinancialData</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - REVENUE RECOGNITION (Details - Disaggregation)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/RevenueRecognitionDetails-Disaggregation</Role>
      <ShortName>REVENUE RECOGNITION (Details - Disaggregation)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/RevenueRecognitionTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess</Role>
      <ShortName>REVENUE RECOGNITION (Details - Contracts in Progess)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/RevenueRecognitionTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - REVENUE RECOGNITION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/RevenueRecognitionDetailsNarrative</Role>
      <ShortName>REVENUE RECOGNITION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/RevenueRecognitionTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/PropertyAndEquipmentDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - INVESTMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/InvestmentsDetails</Role>
      <ShortName>INVESTMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/InvestmentsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - INVESTMENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/InvestmentsDetailsNarrative</Role>
      <ShortName>INVESTMENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/InvestmentsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - CONTRACTS PAYABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ContractsPayableDetails</Role>
      <ShortName>CONTRACTS PAYABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/ContractsPayableTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ShareholdersEquityDetails-Dividends</Role>
      <ShortName>SHAREHOLDERS EQUITY (Details - Dividends)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ShareholdersEquityDetails-OptionActivity</Role>
      <ShortName>SHAREHOLDERS EQUITY (Details - Option activity)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue</Role>
      <ShortName>SHAREHOLDERS EQUITY (Details - Intrinsic Value)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions</Role>
      <ShortName>SHAREHOLDERS EQUITY (Details - Fair value of options)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable</Role>
      <ShortName>SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - SHAREHOLDERS' EQUITY (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ShareholdersEquityDetailsNarrative</Role>
      <ShortName>SHAREHOLDERS' EQUITY (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/ShareholdersEquityTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - INCOME TAXES (Details - Income tax provision)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision</Role>
      <ShortName>INCOME TAXES (Details - Income tax provision)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/IncomeTaxesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - INCOME TAXES (Details - Reconciliation)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/IncomeTaxesDetails-Reconciliation</Role>
      <ShortName>INCOME TAXES (Details - Reconciliation)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/IncomeTaxesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - INCOME TAXES (Details - Deferred taxes)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes</Role>
      <ShortName>INCOME TAXES (Details - Deferred taxes)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/IncomeTaxesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative</Role>
      <ShortName>CONCENTRATIONS AND UNCERTAINTIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/ConcentrationsAndUncertainties</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SegmentAndGeographicReportingTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic</Role>
      <ShortName>SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/SegmentAndGeographicReportingTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>RELATED PARTY TRANSACTIONS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/RelatedPartyTransactions</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative</Role>
      <ShortName>EMPLOYEE BENEFIT PLAN (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/EmployeeBenefitPlan</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation</Role>
      <ShortName>ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation</Role>
      <ShortName>ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="simulations_i10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails</Role>
      <ShortName>UNAUDTED QUARTERLY FINANCIAL DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="simulations_i10k.htm">simulations_i10k.htm</File>
    <File>simu-20200831.xsd</File>
    <File>simu-20200831_cal.xml</File>
    <File>simu-20200831_def.xml</File>
    <File>simu-20200831_lab.xml</File>
    <File>simu-20200831_pre.xml</File>
    <File>simulations_ex2101.htm</File>
    <File>simulations_ex2301.htm</File>
    <File>simulations_ex3101.htm</File>
    <File>simulations_ex3102.htm</File>
    <File>simulations_ex3201.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>94
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "simulations_i10k.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "contextCount": 316,
   "dts": {
    "calculationLink": {
     "local": [
      "simu-20200831_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "simu-20200831_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "simulations_i10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "simu-20200831_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "simu-20200831_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "simu-20200831.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 578,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 49,
    "http://simulations.com/20200831": 3,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 57
   },
   "keyCustom": 24,
   "keyStandard": 387,
   "memberCustom": 48,
   "memberStandard": 33,
   "nsprefix": "simu",
   "nsuri": "http://simulations.com/20200831",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://simulations.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - PROPERTY AND EQUIPMENT",
     "role": "http://simulations.com/role/PropertyAndEquipment",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - INVESTMENTS",
     "role": "http://simulations.com/role/Investments",
     "shortName": "INVESTMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - CONTRACTS PAYABLE",
     "role": "http://simulations.com/role/ContractsPayable",
     "shortName": "CONTRACTS PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://simulations.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - SHAREHOLDERS' EQUITY",
     "role": "http://simulations.com/role/ShareholdersEquity",
     "shortName": "SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - INCOME TAXES",
     "role": "http://simulations.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES",
     "role": "http://simulations.com/role/ConcentrationsAndUncertainties",
     "shortName": "CONCENTRATIONS AND UNCERTAINTIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING",
     "role": "http://simulations.com/role/SegmentAndGeographicReporting",
     "shortName": "SEGMENT AND GEOGRAPHIC REPORTING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - RELATED PARTY TRANSACTIONS",
     "role": "http://simulations.com/role/RelatedPartyTransactions",
     "shortName": "RELATED PARTY TRANSACTIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - EMPLOYEE BENEFIT PLAN",
     "role": "http://simulations.com/role/EmployeeBenefitPlan",
     "shortName": "EMPLOYEE BENEFIT PLAN",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://simulations.com/role/ConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES",
     "role": "http://simulations.com/role/AcquisitionmergerWithSubsidiaries",
     "shortName": "ACQUISITION/MERGER WITH SUBSIDIARIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA",
     "role": "http://simulations.com/role/UnauditedQuarterlyFinancialData",
     "shortName": "UNAUDITED QUARTERLY FINANCIAL DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://simulations.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "simu:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "simu:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - REVENUE RECOGNITION (Tables)",
     "role": "http://simulations.com/role/RevenueRecognitionTables",
     "shortName": "REVENUE RECOGNITION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://simulations.com/role/PropertyAndEquipmentTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - INVESTMENTS (Tables)",
     "role": "http://simulations.com/role/InvestmentsTables",
     "shortName": "INVESTMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - CONTRACTS PAYABLE (Tables)",
     "role": "http://simulations.com/role/ContractsPayableTables",
     "shortName": "CONTRACTS PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://simulations.com/role/CommitmentsAndContingenciesTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDividendsPayableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - SHAREHOLDERS' EQUITY (Tables)",
     "role": "http://simulations.com/role/ShareholdersEquityTables",
     "shortName": "SHAREHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDividendsPayableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://simulations.com/role/IncomeTaxesTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Tables)",
     "role": "http://simulations.com/role/SegmentAndGeographicReportingTables",
     "shortName": "SEGMENT AND GEOGRAPHIC REPORTING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)",
     "role": "http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables",
     "shortName": "ACQUISITION/MERGER WITH SUBSIDIARIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - UNAUDITED QUARTERLY FINANCIAL DATA (Tables)",
     "role": "http://simulations.com/role/UnauditedQuarterlyFinancialDataTables",
     "shortName": "UNAUDITED QUARTERLY FINANCIAL DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "simu:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_us-gaap_EquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Useful lives)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "simu:PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_us-gaap_EquipmentMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease assets and liabilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OperatingLeasesOfLesseeDisclosureTextBlock",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2019-09-02_us-gaap_AccountingStandardsUpdate201602Member",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Lease cost)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2019-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Goodwill)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Other Intangible Assets)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_us-gaap_CustomerRelationshipsMember_custom_CognigenMember",
      "decimals": null,
      "lang": "en-US",
      "name": "simu:AmortizationPeriodIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://simulations.com/role/ConsolidatedStatementsOfOperations",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization schedule)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_OtherIntangibleAssetsMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair value measurements)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_CashAndCashEquivalentsMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "simu:ReconciliationOfContingentConsiderationTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2019-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessCombinationContingentConsiderationAssetCurrent",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Reconciliation of contingent consideration)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "simu:ReconciliationOfContingentConsiderationTableTextBlock",
       "us-gaap:FairValueOfFinancialInstrumentsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "lang": null,
      "name": "simu:PurchasePriceContingentConsiderationAdditions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "simu:ScheduleOfAmortizationExpensesTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_IntellectualPropertyMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Amortization expenses)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "simu:ScheduleOfAmortizationExpensesTableTextBlock",
       "us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_IntellectualPropertyMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2020-06-012020-08-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings per share)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CapitalizedComputerSoftwareAmortization1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CapitalizedComputerSoftwareAmortization1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2020-06-012020-08-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - REVENUE RECOGNITION (Details - Disaggregation)",
     "role": "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation",
     "shortName": "REVENUE RECOGNITION (Details - Disaggregation)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_custom_SoftwareLicensesMember_us-gaap_TransferredAtPointInTimeMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - REVENUE RECOGNITION (Details - Contracts in Progess)",
     "role": "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess",
     "shortName": "REVENUE RECOGNITION (Details - Contracts in Progess)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "lang": null,
      "name": "simu:RevenuesOverBillingsOnUncompletedContracts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - REVENUE RECOGNITION (Details Narrative)",
     "role": "http://simulations.com/role/RevenueRecognitionDetailsNarrative",
     "shortName": "REVENUE RECOGNITION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - PROPERTY AND EQUIPMENT (Details)",
     "role": "http://simulations.com/role/PropertyAndEquipmentDetails",
     "shortName": "PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2017-08-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - STATEMENTS OF SHAREHOLDERS' EQUITY",
     "role": "http://simulations.com/role/StatementsOfShareholdersEquity",
     "shortName": "STATEMENTS OF SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2017-08-31_us-gaap_CommonStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)",
     "role": "http://simulations.com/role/PropertyAndEquipmentDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - INVESTMENTS (Details)",
     "role": "http://simulations.com/role/InvestmentsDetails",
     "shortName": "INVESTMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentTableTextBlock",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - INVESTMENTS (Details Narrative)",
     "role": "http://simulations.com/role/InvestmentsDetailsNarrative",
     "shortName": "INVESTMENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - CONTRACTS PAYABLE (Details)",
     "role": "http://simulations.com/role/ContractsPayableDetails",
     "shortName": "CONTRACTS PAYABLE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:OtherLiabilitiesTableTextBlock",
       "us-gaap:OtherLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://simulations.com/role/CommitmentsAndContingenciesDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDividendsPayableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Dividends",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - SHAREHOLDERS EQUITY (Details - Dividends)",
     "role": "http://simulations.com/role/ShareholdersEquityDetails-Dividends",
     "shortName": "SHAREHOLDERS EQUITY (Details - Dividends)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDividendsPayableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Dividends",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - SHAREHOLDERS EQUITY (Details - Option activity)",
     "role": "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
     "shortName": "SHAREHOLDERS EQUITY (Details - Option activity)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_us-gaap_StockOptionMember",
      "decimals": null,
      "lang": "en-US",
      "name": "simu:OutstandingRemainingContractualLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_StockOptionMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - SHAREHOLDERS EQUITY (Details - Intrinsic Value)",
     "role": "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue",
     "shortName": "SHAREHOLDERS EQUITY (Details - Intrinsic Value)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_StockOptionMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "simu:FairValueOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - SHAREHOLDERS EQUITY (Details - Fair value of options)",
     "role": "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions",
     "shortName": "SHAREHOLDERS EQUITY (Details - Fair value of options)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "simu:FairValueOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://simulations.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31_us-gaap_StockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)",
     "role": "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable",
     "shortName": "SHAREHOLDERS EQUITY (Details - Options outstanding and exercisable)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_us-gaap_StockOptionMember",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - SHAREHOLDERS' EQUITY (Details Narrative)",
     "role": "http://simulations.com/role/ShareholdersEquityDetailsNarrative",
     "shortName": "SHAREHOLDERS' EQUITY (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - INCOME TAXES (Details - Income tax provision)",
     "role": "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision",
     "shortName": "INCOME TAXES (Details - Income tax provision)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - INCOME TAXES (Details - Reconciliation)",
     "role": "http://simulations.com/role/IncomeTaxesDetails-Reconciliation",
     "shortName": "INCOME TAXES (Details - Reconciliation)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - INCOME TAXES (Details - Deferred taxes)",
     "role": "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes",
     "shortName": "INCOME TAXES (Details - Deferred taxes)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - INCOME TAXES (Details Narrative)",
     "role": "http://simulations.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashUninsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - CONCENTRATIONS AND UNCERTAINTIES (Details Narrative)",
     "role": "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative",
     "shortName": "CONCENTRATIONS AND UNCERTAINTIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashUninsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2020-06-012020-08-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)",
     "role": "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting",
     "shortName": "SEGMENT AND GEOGRAPHIC REPORTING (Details - Segment reporting)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2018-08-31_srt_ConsolidationEliminationsMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2020-06-012020-08-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)",
     "role": "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic",
     "shortName": "SEGMENT AND GEOGRAPHIC REPORTING (Details - geographic)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_custom_NorthAndSouthAmericaMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
     "role": "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
     "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-012020-08-31_custom_DILIsymMember_custom_FormerShareholdersMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - ORGANIZATION AND LINES OF BUSINESS",
     "role": "http://simulations.com/role/OrganizationAndLinesOfBusiness",
     "shortName": "ORGANIZATION AND LINES OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - EMPLOYEE BENEFIT PLAN (Details Narrative)",
     "role": "http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative",
     "shortName": "EMPLOYEE BENEFIT PLAN (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)",
     "role": "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation",
     "shortName": "ACQUISITION/MERGER WITH SUBSIDIARIES (Details - purchase price allocation)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "AsOf2020-04-02_custom_LixoftMember",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)",
     "role": "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation",
     "shortName": "ACQUISITION/MERGER WITH SUBSIDIARIES (Details - Proforma Information)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2020-06-012020-08-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - UNAUDTED QUARTERLY FINANCIAL DATA (Details)",
     "role": "http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails",
     "shortName": "UNAUDTED QUARTERLY FINANCIAL DATA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:QuarterlyFinancialInformationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2020-06-012020-08-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://simulations.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - REVENUE RECOGNITION",
     "role": "http://simulations.com/role/RevenueRecognition",
     "shortName": "REVENUE RECOGNITION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "simulations_i10k.htm",
      "contextRef": "From2019-09-01to2020-08-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 86,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r597",
      "r599",
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "simu_ACustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "A Customer [Member]"
       }
      }
     },
     "localname": "ACustomerMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_AmortizationPeriodIntangibleAssets": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortization period",
        "label": "Amortization period"
       }
      }
     },
     "localname": "AmortizationPeriodIntangibleAssets",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "simu_AquisitionRelatedContingentConsiderationObligationsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Aquisition Related Contingent Consideration Obligations [Member]"
       }
      }
     },
     "localname": "AquisitionRelatedContingentConsiderationObligationsMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_BCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "B Customer [Member]"
       }
      }
     },
     "localname": "BCustomerMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_BillingsToDateOnUncompletedContracts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Billings to date on uncompleted contracts",
        "label": "BillingsToDateOnUncompletedContracts",
        "negatedLabel": "Billings to date on uncompleted contracts"
       }
      }
     },
     "localname": "BillingsToDateOnUncompletedContracts",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Change in value of contingent consideration",
        "label": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability",
        "negatedLabel": "Change in value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_CertainDevelopedTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Certain Developed Technologies [Member]"
       }
      }
     },
     "localname": "CertainDevelopedTechnologiesMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_CertainIntellectualPropertyRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Certain Intellectual Property Rights [Member]"
       }
      }
     },
     "localname": "CertainIntellectualPropertyRightsMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_CognigenMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cognigen [Member]"
       }
      }
     },
     "localname": "CognigenMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_ConsultingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consulting Services [Member]"
       }
      }
     },
     "localname": "ConsultingServicesMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_ContingentConsiderationPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contingent consideration payments.",
        "label": "Current portion - Contract payable (note 5)",
        "negatedLabel": "Contingent consideration payments"
       }
      }
     },
     "localname": "ContingentConsiderationPayments",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_ContractsPayable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts payable",
        "label": "Total contract with customer"
       }
      }
     },
     "localname": "ContractsPayable",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_ContractsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts payable, current",
        "label": "Current portion - Contracts payable (note 6)",
        "verboseLabel": "Less: Current Portion"
       }
      }
     },
     "localname": "ContractsPayableCurrent",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_ContractsPayableNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts payable, noncurrent",
        "label": "Payments due under Contracts payable (note 6)",
        "verboseLabel": "Long-Term"
       }
      }
     },
     "localname": "ContractsPayableNoncurrent",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_CumulativeEffectOfChangesRelatedToAdoptionOfAsc606": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cumulative Effect of Changes related to adoption of ASC 606",
        "label": "Cumulative Effect of Changes related to adoption of ASC 606"
       }
      }
     },
     "localname": "CumulativeEffectOfChangesRelatedToAdoptionOfAsc606",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_Customer1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer 1 Member",
        "label": "Customer 1 [Member]"
       }
      }
     },
     "localname": "Customer1Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Customer2Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer 2 Member",
        "label": "Customer 2 [Member]"
       }
      }
     },
     "localname": "Customer2Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Customer3Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer 3 [Member]"
       }
      }
     },
     "localname": "Customer3Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Customer4Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Denominator"
       }
      }
     },
     "localname": "Customer4Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_DILIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "D I L I [Member]"
       }
      }
     },
     "localname": "DILIMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_DILIsymMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "D I L Isym [Member]"
       }
      }
     },
     "localname": "DILIsymMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_DilisymEmployeesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Dilisym Employees [Member]"
       }
      }
     },
     "localname": "DilisymEmployeesMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_EarnoutLiabilityDilisymMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnout Liability Dilisym [Member]"
       }
      }
     },
     "localname": "EarnoutLiabilityDilisymMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_EarnoutLiabilityLixoftMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnout Liability Lixoft [Member]"
       }
      }
     },
     "localname": "EarnoutLiabilityLixoftMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_EnslienMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Enslien [Member]"
       }
      }
     },
     "localname": "EnslienMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_EntelosHoldingCoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "FY 2016 3rd Qtr [Member]"
       }
      }
     },
     "localname": "EntelosHoldingCoMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_EntelosMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Entelos [Member]"
       }
      }
     },
     "localname": "EntelosMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Equity2017IncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Numerator"
       }
      }
     },
     "localname": "Equity2017IncentivePlanMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_FairValueOptionsGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Estimated fair value of awards granted",
        "label": "Estimated fair value of awards granted"
       }
      }
     },
     "localname": "FairValueOptionsGranted",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_FormerShareholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Numerator [Default Label]",
        "verboseLabel": "Numerator"
       }
      }
     },
     "localname": "FormerShareholdersMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_HoldbackLiabilityLixoftMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Holdback Liability Lixoft [Member]"
       }
      }
     },
     "localname": "HoldbackLiabilityLixoftMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_InternationalSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "International Sales [Member]"
       }
      }
     },
     "localname": "InternationalSalesMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_LixoftMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Lixoft [Member]"
       }
      }
     },
     "localname": "LixoftMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation",
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_NorthAndSouthAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "North And South America [Member]"
       }
      }
     },
     "localname": "NorthAndSouthAmericaMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_OutstandingRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual life outstanding, beginning balance",
        "label": "Outstanding, beginning of period"
       }
      }
     },
     "localname": "OutstandingRemainingContractualLife",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "durationItemType"
    },
    "simu_PaymentsOnContractsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Payment on contracts payable",
        "label": "PaymentsOnContractsPayable",
        "negatedLabel": "Payments on contracts payable"
       }
      }
     },
     "localname": "PaymentsOnContractsPayable",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_Price1Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "$1.00 to $1.50 [Member]"
       }
      }
     },
     "localname": "Price1Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Price2Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "$7.51 to $9.00 [Member]"
       }
      }
     },
     "localname": "Price2Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Price3Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "$3.01 to $4.50 [Member]"
       }
      }
     },
     "localname": "Price3Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Price4Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "$4.51 to $6.00 [Member]"
       }
      }
     },
     "localname": "Price4Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Price5Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Price 5 [Member]"
       }
      }
     },
     "localname": "Price5Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_Price6Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Price 6 [Member]"
       }
      }
     },
     "localname": "Price6Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Property and Equipment estimated useful lives [Table Text Block]",
        "label": "Property and Equipment estimated useful lives"
       }
      }
     },
     "localname": "PropertyAndEquipmentEstimatedUsefulLivesTableTextBlock",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "simu_PurchasePriceContingentConsiderationAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchase price contingent consideration addition",
        "label": "Purchase price contingent consideration"
       }
      }
     },
     "localname": "PurchasePriceContingentConsiderationAdditions",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_ReconciliationOfContingentConsiderationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reconciliation Of Contingent Consideration [Table Text Block]",
        "label": "Reconciliation of contingent consideration value"
       }
      }
     },
     "localname": "ReconciliationOfContingentConsiderationTableTextBlock",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "simu_RecordDate20181Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20181 [Member]"
       }
      }
     },
     "localname": "RecordDate20181Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20182Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20182 [Member]"
       }
      }
     },
     "localname": "RecordDate20182Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20183Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20183 [Member]"
       }
      }
     },
     "localname": "RecordDate20183Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20184Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20184 [Member]"
       }
      }
     },
     "localname": "RecordDate20184Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20191Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20191 [Member]"
       }
      }
     },
     "localname": "RecordDate20191Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20192Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20192 [Member]"
       }
      }
     },
     "localname": "RecordDate20192Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20193Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20193 [Member]"
       }
      }
     },
     "localname": "RecordDate20193Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20194Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20194 [Member]"
       }
      }
     },
     "localname": "RecordDate20194Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20201Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20201 [Member]"
       }
      }
     },
     "localname": "RecordDate20201Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20202Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20202 [Member]"
       }
      }
     },
     "localname": "RecordDate20202Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20203Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20203 [Member]"
       }
      }
     },
     "localname": "RecordDate20203Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RecordDate20204Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Record Date 20204 [Member]"
       }
      }
     },
     "localname": "RecordDate20204Member",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_RevenuesEarnedToDateOnUncompletedContracts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenues earned to date on uncompleted contracts",
        "label": "Revenues earned to date on uncompleted contracts"
       }
      }
     },
     "localname": "RevenuesEarnedToDateOnUncompletedContracts",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_RevenuesOverBillingsOnUncompletedContracts": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Revenues over billings on uncompleted contracts.",
        "label": "Revenues over billings on uncompleted contracts",
        "totalLabel": "Revenues over billings on uncompleted contracts"
       }
      }
     },
     "localname": "RevenuesOverBillingsOnUncompletedContracts",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_RightOfUseAssetsCapitalized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Right of use assets capitalized",
        "label": "Right of use assets capitalized"
       }
      }
     },
     "localname": "RightOfUseAssetsCapitalized",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_RoyaltyExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "label": "Royalties expense"
       }
      }
     },
     "localname": "RoyaltyExpenses",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_ScheduleOfAmortizationExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Amortization [Table Text Block]",
        "label": "Schedule of future amortization expenses"
       }
      }
     },
     "localname": "ScheduleOfAmortizationExpensesTableTextBlock",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "simu_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unvested Forfeiture Rate",
        "label": "Unvested Forfeiture Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions"
     ],
     "xbrltype": "percentItemType"
    },
    "simu_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "simu_SimulationsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Simulations Plus, Inc. [Member]"
       }
      }
     },
     "localname": "SimulationsMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_SoftwareLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Software Licenses [Member]"
       }
      }
     },
     "localname": "SoftwareLicensesMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_StockIssuedForAcquisitionOfLixoft": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock issued for acquisition of Lixoft",
        "label": "Stock issued for acquisition of Lixoft"
       }
      }
     },
     "localname": "StockIssuedForAcquisitionOfLixoft",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "simu_TSRLMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "T S R L [Member]"
       }
      }
     },
     "localname": "TSRLMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_TermAndNonassertionAgrMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Term And Nonassertion Agr [Member]"
       }
      }
     },
     "localname": "TermAndNonassertionAgrMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "simu_WeightedAverageMarketPrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average market price",
        "label": "Weighted average market price"
       }
      }
     },
     "localname": "WeightedAverageMarketPrice",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions"
     ],
     "xbrltype": "perShareItemType"
    },
    "simu_WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average number of shares outstanding basic and diluted at record date",
        "label": "Number of Shares Outstanding on Record Date"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAndDilutedAtRecordDate",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "sharesItemType"
    },
    "simu_WellsFargoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Wells Fargo [Member]"
       }
      }
     },
     "localname": "WellsFargoMember",
     "nsuri": "http://simulations.com/20200831",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Asia [Member]"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation, Eliminations [Member]"
       }
      }
     },
     "localname": "ConsolidationEliminationsMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r151",
      "r164",
      "r165",
      "r166",
      "r167",
      "r169",
      "r171",
      "r175"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r151",
      "r164",
      "r165",
      "r166",
      "r167",
      "r169",
      "r171",
      "r175"
     ],
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r49",
      "r98"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Director [Member]"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r181",
      "r281",
      "r287",
      "r540"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r181",
      "r281",
      "r287",
      "r540"
     ],
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r177",
      "r281",
      "r285",
      "r501",
      "r537",
      "r538"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r177",
      "r281",
      "r285",
      "r501",
      "r537",
      "r538"
     ],
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r178",
      "r179",
      "r281",
      "r286",
      "r539",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582"
     ],
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r178",
      "r179",
      "r281",
      "r286",
      "r539",
      "r570",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r23",
      "r184",
      "r185"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts receivable, net of allowance for doubtful accounts of $50,000 and $0"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r36",
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r51",
      "r52",
      "r53",
      "r526",
      "r548",
      "r552"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r50",
      "r53",
      "r54",
      "r103",
      "r104",
      "r105",
      "r417",
      "r543",
      "r544"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r24",
      "r346"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r343",
      "r344",
      "r345"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r109",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r373",
      "r374",
      "r375",
      "r376",
      "r503",
      "r504",
      "r505",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.",
        "label": "Stock-based Compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r30",
      "r190",
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r83",
      "r231",
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r96",
      "r159",
      "r166",
      "r173",
      "r201",
      "r413",
      "r418",
      "r433",
      "r509",
      "r525"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r48",
      "r96",
      "r201",
      "r413",
      "r418",
      "r433"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Fair value assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Long-term assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGains": {
     "auth_ref": [
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain before deducting unrealized loss on investments in debt and equity securities classified as available-for-sale securities.",
        "label": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossUnrealizedGains",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossUnrealizedLoss": {
     "auth_ref": [
      "r195"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized loss before deducting unrealized gain on investments in available-for-sale securities.",
        "label": "Available-for-sale Securities, Gross Unrealized Loss",
        "negatedLabel": "Gross unrealized loss"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossUnrealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r314",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable",
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BillingsInExcessOfCost": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess": {
       "order": 2.0,
       "parentTag": "simu_RevenuesOverBillingsOnUncompletedContracts",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Liability attributable to (i) billings in excess of costs under the percentage of completion contract accounting method representing the difference between contractually invoiced amounts (billings) and revenue recognized based, for example, on costs incurred to estimated total costs at period end or (ii) contractually invoiced amounts (billings) in excess of costs incurred and accumulated under the completed contract accounting method.",
        "label": "Billings in excess of revenues",
        "negatedLabel": "Billings in excess of revenues"
       }
      }
     },
     "localname": "BillingsInExcessOfCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation",
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r310",
      "r311",
      "r391",
      "r392"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation",
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business acquisition, shares issued"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r389",
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Schedule of statement of income"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r389",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Net Income"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r389",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Net Sales"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-ProformaInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r402",
      "r403",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Total Consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r82",
      "r408"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Change in value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAssetCurrent": {
     "auth_ref": [
      "r401",
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Asset, Current",
        "periodEndLabel": "Contingent consideration, ending balance",
        "periodStartLabel": "Contingent consideration, beginning balance"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAssetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-ReconciliationOfContingentConsideration"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Assets acquired, Including cash of $3,799,134 and accounts receivable of $629,481"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Acquisition liabilities owed",
        "negatedLabel": "Liabilities Assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation",
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Estimated value of Intangibles assets acquired (Customer Lists, trade name etc.)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r393",
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Developed Technologies Acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction."
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Combination, Separately Recognized Transactions [Line Items]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTable": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule detailing the disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Table]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock": {
     "auth_ref": [
      "r91",
      "r387",
      "r409"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for business combinations and other business acquisition transactions not accounted for using the purchase method, such as an exchange of shares between entities under common control.",
        "label": "Business Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsAndOtherPurchaseOfBusinessTransactionsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.",
        "label": "Accumulated amortization of computer software development costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r585",
      "r587"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Amortization of software development"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "auth_ref": [
      "r586"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.",
        "label": "Capitalized software costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.",
        "label": "Capitalized computer software development costs, net of accumulated amortization of $13,581,599 and $12,356,055"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash received in acquisition"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r5",
      "r33",
      "r85"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of year"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.",
        "label": "Cash and Cash Equivalents, Period Increase (Decrease)",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r86",
      "r92"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Non-Cash Investing and Financing Activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash and cash equivalents exceeding insured limits"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r45",
      "r263",
      "r515",
      "r530"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies (note 7)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common stock reserved for issuance under the plan"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Dividend per Share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common stock par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common stock shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common stock shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r19",
      "r267"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common stock shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common stock, $0.001 par value 50,000,000 shares authorized 19,923,277 and 17,591,834 shares issued and outstanding"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r293",
      "r294",
      "r312",
      "r348"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "EMPLOYEE BENEFIT PLAN"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/EmployeeBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred tax assets"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred tax liabilities"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r56",
      "r58",
      "r59",
      "r63",
      "r517",
      "r532"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r140",
      "r141",
      "r181",
      "r430",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r140",
      "r141",
      "r181",
      "r430",
      "r431",
      "r553"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "CONCENTRATIONS AND UNCERTAINTIES"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertainties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r140",
      "r141",
      "r181",
      "r430",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Net sales concentration percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r142",
      "r430",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r415"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r270",
      "r271",
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "verboseLabel": "Total contract with customer"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ContractsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r270",
      "r271",
      "r282"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Revenues included in contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r68",
      "r96",
      "r201",
      "r433"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of long-term contract or program.",
        "label": "Schedule of contract in progress"
       }
      }
     },
     "localname": "CostsInExcessOfBillingsAndBillingsInExcessOfCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r497"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess": {
       "order": 1.0,
       "parentTag": "simu_RevenuesOverBillingsOnUncompletedContracts",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings.",
        "label": "Revenues in excess of billings"
       }
      }
     },
     "localname": "CostsInExcessOfBillingsOnUncompletedContractsOrPrograms",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/RevenueRecognitionDetails-ContractsInProgess"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r370",
      "r379"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r101",
      "r370"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r370",
      "r379",
      "r380"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current tax expense (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r370",
      "r379"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r371",
      "r379"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "negatedLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r16",
      "r17",
      "r362",
      "r510",
      "r522"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r354",
      "r355"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "negatedTotalLabel": "Total deferred federal and state"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r371",
      "r379"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "negatedLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsEquityMethodInvestments": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from equity method investments.",
        "label": "Capitalized merger costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "verboseLabel": "Intellectual property"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "negatedTotalLabel": "Net deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsStateTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.",
        "label": "State taxes"
       }
      }
     },
     "localname": "DeferredTaxAssetsStateTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "verboseLabel": "Accrued payroll and other expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.",
        "label": "State tax deferred"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r364"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized software.",
        "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Software",
        "negatedLabel": "Capitalized computer software development costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedLabel": "Intellectual property"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "State tax deferred"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r368",
      "r369"
     ],
     "calculation": {
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-DeferredTaxes"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r295",
      "r296",
      "r297",
      "r307",
      "r308",
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Contribution by employer in benefit plan"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/EmployeeBenefitPlanDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r83",
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r83",
      "r247"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r83",
      "r154"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r281",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Schedule of disaggregation of revenues"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r268",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Total Amount"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information about distribution of earnings to shareholders including, but not limited to, cash, property or capital stock.",
        "label": "Dividends [Axis]"
       }
      }
     },
     "localname": "DividendsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r268",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedLabel": "Declaration of Dividend"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Distributions of earnings to shareholders including but not limited to cash, property or capital stock."
       }
      }
     },
     "localname": "DividendsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date the dividend to be paid was declared, in CCYY-MM-DD format.",
        "label": "Distribution Date"
       }
      }
     },
     "localname": "DividendsPayableDateDeclaredDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableDateOfRecordDayMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date the holder must own the stock to be entitled to the dividend, in CCYY-MM-DD format.",
        "label": "Record Date"
       }
      }
     },
     "localname": "DividendsPayableDateOfRecordDayMonthAndYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-Dividends"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r64",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r118",
      "r120",
      "r125",
      "r126",
      "r127",
      "r130",
      "r131",
      "r518",
      "r533"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic",
        "verboseLabel": "Earnings per share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "verboseLabel": "Denominator"
       }
      }
     },
     "localname": "EarningsPerShareBasicOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r64",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r120",
      "r125",
      "r126",
      "r127",
      "r130",
      "r131",
      "r518",
      "r533"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted",
        "verboseLabel": "Earnings per share, Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r128",
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Income tax computed at federal statutory tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for qualified production activity.",
        "label": "Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent",
        "negatedLabel": "Domestic production activities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Foreign tax related differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.",
        "label": "Meals &amp; entertainment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Other permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent",
        "negatedLabel": "Research and development credit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Stock based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Change in deferred income taxes due to statutory rate changes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.",
        "label": "Change in prior year estimated taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "State taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r357",
      "r381"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Research &amp; credit adjustments to expense"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetails-Reconciliation"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued payroll and other expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Fair value amortization period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Fair value of non-vested options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r107",
      "r115",
      "r117",
      "r134",
      "r207",
      "r267",
      "r268",
      "r343",
      "r344",
      "r345",
      "r375",
      "r376",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r543",
      "r544",
      "r545"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r308",
      "r423",
      "r470",
      "r471",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r425",
      "r427"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r296",
      "r297",
      "r302",
      "r308",
      "r423",
      "r470"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r296",
      "r297",
      "r302",
      "r308",
      "r423",
      "r471"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r308",
      "r423",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r422",
      "r423"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of liabilities measured at fair value measured on a recurring or nonrecurring basis. Includes, but is not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2.",
        "label": "Summarizes fair value measurements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement frequency."
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r308",
      "r470",
      "r471",
      "r472"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r92",
      "r428",
      "r429"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r196",
      "r197",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r237"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Accumulated amortization on intangible assets",
        "terseLabel": "Accumulated amortization of intellectual property",
        "verboseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Schedule of future amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r232",
      "r233",
      "r237",
      "r240",
      "r502",
      "r506"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r237",
      "r506"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Acquisition value",
        "verboseLabel": "Intangible asset acquisition value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r232",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r237",
      "r502"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Other intangible assets net of accumulated amortization of $1,641,725 and $1,210,000",
        "verboseLabel": "Net book value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r434",
      "r435",
      "r436",
      "r437"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "(Loss) income on currency exchange"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r222",
      "r224",
      "r508"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "verboseLabel": "Estimated Goodwill acquired"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation",
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r225"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Addition"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r92",
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Intellectual property"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r227",
      "r234"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r83",
      "r223",
      "r226",
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Impairments"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill [Member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r67",
      "r96",
      "r159",
      "r165",
      "r169",
      "r172",
      "r175",
      "r201",
      "r433"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r83",
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment losses"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r83",
      "r246",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r244",
      "r253"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment of Long-lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r100",
      "r159",
      "r165",
      "r169",
      "r172",
      "r175"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r358",
      "r360",
      "r367",
      "r377",
      "r382",
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r359"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.",
        "label": "Interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r97",
      "r116",
      "r117",
      "r157",
      "r356",
      "r378",
      "r383",
      "r535"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/IncomeTaxesDetails-IncomeTaxProvision"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r92",
      "r352",
      "r353",
      "r360",
      "r361",
      "r366",
      "r372",
      "r571"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r80",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Accrued income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInBillingInExcessOfCostOfEarnings": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the liability reflecting cash payments received before the related costs have been incurred.",
        "label": "Increase (Decrease) in Billing in Excess of Cost of Earnings",
        "verboseLabel": "Billings in excess of revenues"
       }
      }
     },
     "localname": "IncreaseDecreaseInBillingInExcessOfCostOfEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the asset reflecting the cost incurred on uncompleted contracts in excess of related billings.",
        "label": "Increase (Decrease) in Cost in Excess of Billing on Uncompleted Contract",
        "negatedLabel": "Revenues in excess of billings"
       }
      }
     },
     "localname": "IncreaseDecreaseInCostInExcessOfBillingOnUncompletedContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "verboseLabel": "Accrued payroll and other expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (decrease) in"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r121",
      "r122",
      "r123",
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Dilutive effect of stock options"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r92",
      "r236",
      "r498",
      "r499",
      "r500",
      "r502"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Other Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r230",
      "r235"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intellectual property, net of accumulated amortization of $5,087,031 and $3,948,750"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntellectualPropertyMember": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.",
        "label": "Intellectual Property [Member]"
       }
      }
     },
     "localname": "IntellectualPropertyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeOperating": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.",
        "label": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r200",
      "r534"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTableTextBlock": {
     "auth_ref": [
      "r198",
      "r199",
      "r202",
      "r203"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment.",
        "label": "Schedule of short term investment"
       }
      }
     },
     "localname": "InvestmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Short term investment, fair value"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r198",
      "r507",
      "r520",
      "r569"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "INVESTMENTS"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Schedule of lease cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r41",
      "r96",
      "r167",
      "r201",
      "r414",
      "r418",
      "r419",
      "r433"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r96",
      "r201",
      "r433",
      "r512",
      "r528"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r88",
      "r89",
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Creation of contract liabilities for acquisition of subsidiaries"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r96",
      "r201",
      "r414",
      "r418",
      "r419",
      "r433"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Fair value liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r15",
      "r511",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of credit amount outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r40",
      "r99"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date the credit facility terminates, in CCYY-MM-DD format.",
        "label": "Line of credit expiration date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of credit maximum amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r40",
      "r99"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r3",
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "ACQUISITION/MERGER WITH SUBSIDIARIES"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiaries"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash flows provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash flows used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r79",
      "r81",
      "r84"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r55",
      "r57",
      "r62",
      "r84",
      "r96",
      "r106",
      "r110",
      "r111",
      "r112",
      "r113",
      "r116",
      "r117",
      "r124",
      "r159",
      "r165",
      "r169",
      "r172",
      "r175",
      "r201",
      "r433",
      "r516",
      "r531"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net income",
        "terseLabel": "Net Income",
        "totalLabel": "Net Income",
        "verboseLabel": "Net income attributable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows",
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/StatementsOfShareholdersEquity",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare",
      "http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "verboseLabel": "Numerator"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recently Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r159",
      "r165",
      "r169",
      "r172",
      "r175"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Income (loss) from operations before income taxes",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r455",
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r452"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease Liability, current portion",
        "verboseLabel": "Lease Liabilities, Current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r452"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease Liability",
        "verboseLabel": "Lease Liabilities, Long-term"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating lease right of use asset",
        "verboseLabel": "Right of use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r457",
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r456",
      "r459"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseCost"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r446",
      "r448"
     ],
     "calculation": {
      "http://simulations.com/role/CommitmentsAndContingenciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "verboseLabel": "Future minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r446",
      "r448"
     ],
     "calculation": {
      "http://simulations.com/role/CommitmentsAndContingenciesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "verboseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r446",
      "r448"
     ],
     "calculation": {
      "http://simulations.com/role/CommitmentsAndContingenciesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r446",
      "r448"
     ],
     "calculation": {
      "http://simulations.com/role/CommitmentsAndContingenciesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r446",
      "r448"
     ],
     "calculation": {
      "http://simulations.com/role/CommitmentsAndContingenciesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r446",
      "r448"
     ],
     "calculation": {
      "http://simulations.com/role/CommitmentsAndContingenciesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock": {
     "auth_ref": [
      "r265",
      "r444",
      "r445",
      "r447",
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for lessee's operating leases. Includes, but is not limited to, description of lessee's operating lease, existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.",
        "label": "Schedule of Operating assets and liabilities"
       }
      }
     },
     "localname": "OperatingLeasesOfLesseeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r167",
      "r169",
      "r175"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r4",
      "r420"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "ORGANIZATION AND LINES OF BUSINESS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/OrganizationAndLinesOfBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r411",
      "r412",
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Foreign currency translation adjustments",
        "verboseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other income (expense)"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "CONTRACTS PAYABLE"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ContractsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of other liabilities.",
        "label": "Schedule of Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ContractsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Payment of dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Earn-out payments made"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesAndInterestInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r74",
      "r406"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payment for acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Purchases of intellectual property"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).",
        "label": "Payments to Acquire Interest in Subsidiaries and Affiliates",
        "negatedLabel": "Cash used to acquire subsidiaries"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiariesAndAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Develop Software",
        "negatedLabel": "Capitalized computer software development costs"
       }
      }
     },
     "localname": "PaymentsToDevelopSoftware",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r314",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred stock par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock, $0.001 par value 10,000,000 shares authorized no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r8",
      "r31",
      "r32"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r7",
      "r9",
      "r220",
      "r221"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from follow-on public offering, net",
        "verboseLabel": "Proceeds from public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows",
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r77",
      "r338"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from the exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r36",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r254",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r92",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r35",
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r250",
      "r529"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment, net (note 4)",
        "verboseLabel": "Net Book Value"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/PropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r92",
      "r250",
      "r572",
      "r573"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r12",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r12",
      "r248"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Quarterly Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "UNAUDITED QUARTERLY FINANCIAL DATA"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/UnauditedQuarterlyFinancialData"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r460",
      "r461",
      "r462",
      "r463",
      "r464"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "RELATED PARTY TRANSACTIONS"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r351",
      "r586"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r92",
      "r351"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r37",
      "r92",
      "r242",
      "r243",
      "r586"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Capitalized Computer Software Development Costs"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r268",
      "r346",
      "r527",
      "r547",
      "r552"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r107",
      "r115",
      "r117",
      "r207",
      "r343",
      "r344",
      "r345",
      "r375",
      "r376",
      "r543",
      "r545"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r279",
      "r280",
      "r284",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r93",
      "r94"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r61",
      "r96",
      "r150",
      "r151",
      "r164",
      "r170",
      "r171",
      "r177",
      "r178",
      "r181",
      "r201",
      "r433",
      "r519"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "verboseLabel": "Net Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting",
      "http://simulations.com/role/UnaudtedQuarterlyFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyAgreementsMember": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual arrangement, generally for a defined period of time, entitling the entity to use the rights and property of another party. Examples include, but not limited to, licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Agreements [Member]"
       }
      }
     },
     "localname": "RoyaltyAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConcentrationsAndUncertaintiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r391",
      "r392"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesDetails-PurchasePriceAllocation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Components of the income tax provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Components of the Company deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r303",
      "r304",
      "r305",
      "r306",
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDividendsPayableTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of all or some of the information related to dividends declared, but not paid, as of the financial reporting date.",
        "label": "Schedule of dividends declared and paid"
       }
      }
     },
     "localname": "ScheduleOfDividendsPayableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of earnings per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective income tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r232",
      "r236",
      "r502"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationExpenses",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-AmortizationSchedule",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r232",
      "r236"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of other intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Future minimum lease payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r227",
      "r229"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of reconciliation of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r70",
      "r72",
      "r536"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/InvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r36",
      "r250"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/PropertyAndEquipmentDetails",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-UsefulLives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/UnauditedQuarterlyFinancialDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Allocation of purchase price"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/AcquisitionmergerWithSubsidiariesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r256",
      "r257",
      "r258"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-Goodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r66",
      "r180"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of geographical revenues"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r61",
      "r180"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r159",
      "r162",
      "r168",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r159",
      "r162",
      "r168",
      "r227"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of consolidated results from reportable segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.",
        "label": "Intrinsic Value of options outstanding and options exercisable"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r314",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable",
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Schedule of options by exercise price range"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r317",
      "r324",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Schedule of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r147",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r164",
      "r165",
      "r166",
      "r167",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r537"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r159",
      "r163",
      "r169",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "SEGMENT AND GEOGRAPHIC REPORTING"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general, and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Weighted average dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Weighted average volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Weighted average risk-free rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable",
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Awards exercisable",
        "periodEndLabel": "Vested and Exercisable, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Awards exercisable weighted average exercise price",
        "periodEndLabel": "Vested and Exercisable, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Intrinsic Value of Options Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired",
        "verboseLabel": "Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled/Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Schedule of fair value of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Intrinsic Value of Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r319",
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Awards outstanding",
        "periodEndLabel": "Awards Outstanding, ending balance",
        "periodStartLabel": "Option outstanding, beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Awards outstanding weighted average exercise price",
        "periodEndLabel": "Outstanding",
        "periodStartLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "periodEndLabel": "Vested and Expected to Vest, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Vested and Expected to Vest, end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r313",
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable",
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Canceled/Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Weighted average grant price",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r92",
      "r314",
      "r316"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Exercise price low"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Exercise price high"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r331",
      "r347"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Weighted average expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-FairValueOfOptions"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Intrinsic Value of Options Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Awards exercisable weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Awards outstanding weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Vested and Expected to Vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Vested and Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Outstanding, end of period"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares issued price per share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r14",
      "r513",
      "r514",
      "r524"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term investments",
        "verboseLabel": "Short term investment, amortized cost"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/InvestmentsDetails",
      "http://simulations.com/role/InvestmentsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r147",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r164",
      "r165",
      "r166",
      "r167",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r181",
      "r227",
      "r252",
      "r255",
      "r259",
      "r537"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-Geographic",
      "http://simulations.com/role/SegmentAndGeographicReportingDetails-SegmentReporting"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r47",
      "r103",
      "r104",
      "r105",
      "r107",
      "r115",
      "r117",
      "r134",
      "r207",
      "r267",
      "r268",
      "r343",
      "r344",
      "r345",
      "r375",
      "r376",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r543",
      "r544",
      "r545"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r134",
      "r501"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r18",
      "r19",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Shares issued - Lixoft, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Shares issued to Directors for services, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r18",
      "r19",
      "r267",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Common stock issued for cash, net, shares",
        "verboseLabel": "Shares issued under public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative",
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r19",
      "r267",
      "r268",
      "r321"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Exercise of stock options, shares",
        "negatedLabel": "Exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r47",
      "r267",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Shares issued - Lixoft"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Shares issued to Directors for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r18",
      "r19",
      "r267",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Common stock issued for cash, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r47",
      "r267",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquityDetails-IntrinsicValue",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionActivity",
      "http://simulations.com/role/ShareholdersEquityDetails-OptionsOutstandingAndExercisable",
      "http://simulations.com/role/ShareholdersEquityDetailsNarrative",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r27",
      "r28",
      "r96",
      "r192",
      "r201",
      "r433"
     ],
     "calculation": {
      "http://simulations.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets",
      "http://simulations.com/role/StatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Shareholders' equity (note 8)"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r95",
      "r268",
      "r269"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfInvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary of Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "SummaryOfInvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r281",
      "r290"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r281",
      "r290"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time."
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r193"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-OtherIntangibleAssets"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred at Point in Time [Member]"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/RevenueRecognitionDetails-Disaggregation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r196",
      "r197",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-FairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r109",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r373",
      "r374",
      "r375",
      "r376",
      "r503",
      "r504",
      "r505",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-LeaseAssetsAndLiabilities"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r138",
      "r143",
      "r144",
      "r145"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r119",
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Common stock and common stock equivalents used for diluted earnings per share",
        "verboseLabel": "Diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted-average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r118",
      "r127"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted-average number of common shares outstanding during the year",
        "verboseLabel": "Basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://simulations.com/role/ConsolidatedStatementsOfOperations",
      "http://simulations.com/role/SummaryOfSignificantAccountingPoliciesDetails-EarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1828-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=d3e1280-108306"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "http://asc.fasb.org/topic&trid=75115024"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(c)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "http://asc.fasb.org/topic&trid=2197064"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(c)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(c)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12069-110248"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116873391&loc=d3e408-128459"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "44",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5558-128473"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=13988685&loc=d3e8784-128493"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121549808&loc=d3e36991-112694"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 1,3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=118261985&loc=d3e55302-109406"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r588": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r589": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r590": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r591": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r592": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r593": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r594": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r595": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r596": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r597": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r598": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r599": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r600": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r601": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r602": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r603": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r604": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r605": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r606": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>95
<FILENAME>0001683168-20-003974-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-20-003974-xbrl.zip
M4$L#!!0    ( )&*<%&P^EUA#Q8  .<6   -    :6UA9V5?,# Q+FIP9ZV7
M=504WIO_9ZAA0$&D:^A0">D&)8:2EJ&DI!GI&$ 1!$% .J51&AQ"NI$8RI$:
M<@!AZ$ZE8?U\?[_=_6?_V-VS[WON7\_[WG->]WF?\YQ[.WV["+BG 56' H!
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M+E"GI&I^PLF0I'XGN/I^K4:'9I@(SZ\4S_<BR_4AD:L5/^0K@!Y12/JRXJ<
MR(I:?I _A8[^?1CY;HT/.@D%L6M_S >)!%P7=&4.&S.Z1VO5N<X01!\#P>'V
M=4+?*+-C$I__WG$/(MD6#Q%Z]Z^#(0VC8BYFJA.5/FJFOXQ2V*(F3##)-+<
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M/66@1D46K#\"5*'2_;_>H-N9?P-02P,$%     @ D8IP4?_&V9ZZAP  S)T
M  T   !I;6%G95\P,#(N:G!G[+P'4%3=ER_:2&@DH\0&!&V09".IR4%$LHCD
MT$3).0=!E* DH8$6&FURSDAJ,DB0)J<FYPQ-% 0$0>#R??^9-W/OW'DS<^N]
MJE?U9G?5JK/.3N>LO=9OK[7/JKZ>NEX"4*DJJB@"\/#P .8W/\#U+$ >0$1
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MVASC=$XF:ZWRY-DS@F?_3!@NQA>B>EP1-9LON[FS-S:]TUHE>K/;1BEBU+3
MDFMNGV*JEO??7O'4CD9CC86KE)PT7CL_FOGJ!V3D>UOV=HDRUUD1=Y(#8W(5
M.=?7@J*2A1@P5!II#6EI'\8_]7=OH>9]E5?#PGZM.V[#/Q][</>!G9U&A)?Z
MN\L7-SPRWMF!)H=QB83DW *=FF*.K6L&F$W]@11_VEE%+_]9UY%>50;<DE<
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MJJV7>NVQV>EX)FR4KR'QK&5B;B"0D%8&'*)(KB2&7P1@]VAE7T6[WL';?DX
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M$XROYWUUH\$MEE@AU4&OQNPC+$X1/NM<C1WDYG DCOG0%4JATF7?.^='FD)
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MLQK[I"3\^/?CF+8!F5?T@_X"D!#(XZ8V+ V%MTX558\-!<2B9Q-NN!S:1QJ
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MXA"I:J^?S;%(XK2S*SE//,B1+>+4KGW]K^PH[T>@];9L@X,AH]T("8'@G#A
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MWT9AL>5[\1!@)^ W?A_W/'Z02ZP(;@3)WKV!I.XJJ>G'KN ,:[+?F*=UW%/
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MJ446% <:RA\'@C'JQ"]6_*&_$<O9=]E?O%PWM(M8./L<6RRZ9;(1$:O/.ZY
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M"K?F&+OXWO?))M8_TF;>?XUE@F?-K2\Z-94U+HLO_9?QU1DQ2B*0R@!"IJY
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M-.$-ZBT._>HOEV\9B[+]U&T>>+#;#E.K60O+G(,.CBD("^37[H3#NQ#YH)5
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MSMI[@[,\'<:];A=3DF:V+!'&M%^#)^IPKZA^HE=?:]I^'@,Q)$*L/ F6D$W
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M2U^WM;$'VR^G9PM$6#/V_Y3P\Z/,WFFZ?E&7%LHZ73NSD!II@-CMG!+'?O4
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MH,["TXZRKA%4LT"DRJ5?$GTW-H;_ J!GB5+W'Z)"G\:_G0PVHW,I\)VBBHQ
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MZK=0*[JL$RS5 (?H:+3TQ]NRH5P8XC+,ATNBC5:^,I!2)^<KH1[)&OWH.]4
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M6B6-E#%XIH$'P\6,(\_]]%,_%\C^_R8 4$L#!!0    ( )&*<%$@,-1#2A$
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M@<:K/O,Z8-O1YY/ERBYX@9N^*VB\DJ5QZ"U3KT H!T)<1>\(6S<>G)UQNRQ
M58GE( GKZ2JAOL8#M2.<EX6I&JD<)&'EO#O^UWB(J@4N^MA'Q/(Z<P\O FM
MUOO%/8J*RZ$4UMS[!$&BYI@!\ 85B[780EP)HP%&'E8]#_.)]("@1V(1?\\H
MY>[*Y/ +B_[#X.?-*XBWKR#'!$-(.&C-H3J"/=?S#X:?%Y;#+;ZY?P7<!K37
M@EL)GWO7-9^)91V";5)6#NTKMIEGH8U;:X&M!,[(?\)4!^F=)8'I3>B!#T&Y
MN"(YY$(HY3#(>=-*VK82-MY:0"7@5)LM0</O=M@G_F80[T=^@WJD^'\4PS@'
MX9]M6?&BIEOT*Z%VAPCEQTD\P) ((-C9=_ROKTB.OQ!9.@Q_UK2R9FTK=J;Q
MU@(J <=><L+J&2:\K)K1(HF(^^P32V)&GQL?8A-5JY9;2<'FD4.L9)L9Q5W
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MJY.]U=EU?%1O"XZ@\]&*D:H&V*[D$)P2:CE,XE88.4QAY0J*:F_!$M2OPU2
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M^MH:(.BLOE@]S[X>NFOO)VL,=O"+=0]=B$'@X9^L7X$3TF^\ 7(@MKK>;N_
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MV >B-X%X&U$0Q0?.L2P0[T#70JX54_YGI>MK!0&ZR:MXDR>(X_1V/_>RHKS
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MSI>-C^^0RW:@:3&BVF0[',E/UO$U"_GR\8$;<OE2!^_>VO(BTIJMTY^$@1\
M=T63B=U5?)^$,#?PDS2N56BOON4=FV'A6O#8D"X-R ?23WRTA3B"M_UMPT,P
M[[%#QE^Q7'%?=.SY*6=3+AW@F^Z-E* 5@!=KGY#4N3L4K^U+OQ%;5$_G46'$
MV@#20!*GO$SBBKIW>]3 .CWQ4U.'<:Y[S#=['):&P)*6*H!95%WW[LTYD*JI
MQE1@!QXF[+@5^J>PHNX-F+/Z9X$ZC(,QYWD\8HODLTN^1+([@(MK&B!6/%Z6
MGAA5Z^N>2U3AXQ[9+:,>8XTV,W16QEB-BNXIYDRDRZC*.+Q+0VML?ZTTJ=0"
M5]OV6DY29>LV:T<R9ZV9C8S/7V=R$12B=6:66/L+YP06\14XG[A8"I$L"2VZ
M:H9:8RE24D5Y0/?8\Q4\G=/R!LR !Y;(#R>O'J:?M29]*>Y_9<0L05/WN"J'
M5##85%>><3,D)U)V0"T!^FE%W?/(><CFJ\%\^*+-V <8;.EUF HOLJA3T+V\
M/@_0 L68CVR2D4M&%?77E,I1T1VW<![""@HR'V6VW,IX30J@IBOI#CDX#T->
M?/,AXYV &?0A?HJ>]J&O3@+'[SB.]TSO'1]XN.>%C\$Z=))'B,_RK$JWI?O-
MEKH]KHK*OD2[8K<1G&4M,04U&_A\,3:048SYR(ZAPNYBMK1QZZ24#(43<P9<
MX]&A42J18I-AI 18>96-6PF5P$ZL#/.>N^'V G/N35(XCLK4,D"<+$L5GL\M
M3<B4P48&I-APRRC+Y-$H)8?ZQ,]7,F7T.1O,BYGD4SQ+UJ25%O%529NR=W.V
M$510Z(68RNE&,MBC #CH+[@J?J*S.D53MGS.-@QU]9EL#Y'EIL0JMU0XK6C*
M1%X@69$3FBYJY)GU>7)*;=^PRSOXL]Z"B&_I2R=:+BR0O'ZB)E+IUU T) 3)
M;GM.#NGC0O*74SZ5?CDE?78?-V'AI T3Y#[^*5]B/L6FA,2; _'&;S-S<I^0
M4;/AG ?(1$_*M&^].<_,*$GUF4NDR7UVIGV!"N\J3TQS&F)["WPXQ<B&=,O%
M%D<#?>:2:=0N,3_:ZCYNS=K3YBQP:,\8=6!O[>$=&+KL0ZP*+@&GK"J2EJQ4
M4VW<\RZ\YEUV#\UG+@Z,W?,NO^8]>[-.[#C0_QZ)!9!O_@]02P,$%     @
MD8IP4?_UOW-=,@  N& # !4   !S:6UU+3(P,C P.#,Q7V1E9BYX;6SM?5MS
MXSB2[ON)V/^@4QNQL?-07;[6I6?Z;-"R[&*$+*DEN7IJ7Q0T"<F<I@@U2-K6
M_/H#D*)$D<2%%$F LOJA2Y9PR<PO 202B<0__N=MZ71> /)LZ/[VX?R7LP\=
MX)K0LMW%;Q\>)Q^U25?7/W0\WW MPX$N^.V#"S_\S__[C__3P?_]X_]^_-BY
MLX%C_=JYA>9'W9W#OW<&QA+\VKD'+D"&#]'?.S\,)R#?P#O; :C3A<N5 WR
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M%!FNA\>AB%7#JU<9@3W< EP#<(,W<G/;'V'+CT<;HTIE9&DF'FY>N+XL 5H
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MG7NVN]C<<&'@ERG;:LPHW*BYE6,P>H^@5RY2/:S99@S%>*.:1!5GR4], B.
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M0_NTHEK.U;2.J$0/ $,G6+7:AS.?&X'3J8:=[0S?+=L5?7U6T(G;E#=:=U^
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M_DKZNKD\T1!6Q.>78.,6F(Z!P&'X4AII-;Y,GAKR:OT![,4S2:/S I"Q (.
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M9&=I=<S*.><6)."DI0?(C:J["CASJUI8$O)0TZ(H3^!QZKXB<J6.C78[AG\
MCTC M4C*61-_G$+R58.&AB@%QZG=30F.JKZ*.Y8/EH$<:^4PNDZJ7KTXJ0-
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M]/P!]'\"?PQ,N'!)B&1B%F=LJAKI_GC4MW&IJ;G[JXW_*($?7F8V7Y%RC)B
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MW&I3;<OJAJ<-X.1_3X8'\#?_'U!+ P04    " "1BG!15#Y#ON)Q  "!H08
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M<(DP"]6[$-.0@\&864<A7&HX4)<%&,AFT=_+O.":763D"C_3U6]6I@5=9M!
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MJJF9P&#05E-5W;\.(PS8*=YSM O=['@!/,QI$<S9,(*!X1AME2_[\7]TV&$
MDE5&P=0V7AN@+@:;TV&#J9KW":YL5#2+):]+0(XRIPM(*T8P@!RCK:*T=(XV
M]#"@N"GN8^</-?1^"CQ9^#TE,1AHF334%#.# :,;G&/:=H]G- 9(LJKR);MO
MOUJ7!2:WV;)X#@BVC?8FR7(; 6YA;C\JG" (#&RWT5Z<LML'BE C 34B4.<+
M]-<<"NR5Y3/MD&[/#J(0J@6>;7G!0'BDPJKZO?W"O3# >8GS'.-+]@2]Y6)'
MR^'TY3^SZKT7 -7D8(!FUG&(K8H6!I8^95GT'"<)'2'SM*!:QC2"K2H[VD%K
MC "72!MO6!=X]MQ@<#A:93'V;+A0Q<9]7R,6!ER'EEW$:5S@R_@)1]K%M06?
MVU6.I1G]U8Z!"0P4;3655^L4< @#>M(TX'K3X)JVWF/ SI\:JNX%(#M'ND/Y
MWE.^MVD68W[X%.%@AL:N+5)FGG=S>V$,H(L@)K\$28D[#P;.T[P@Y6JS :QH
M-DM>E\ ?94X7U%:,8  [1MLA&!DOXLS]9U4[_#"@.8N>Z&*/#I?T@6]"V'EL
M(Y?35Q[M3.@]]:AG 0-!.SV%G?D-%PR0-9MJ[*;%9M?K_(5=9M,?#5EQ^M@F
MM3!%MBFJ80,#.GM=Q>/RBI,OGX#N;[:%VFP/AU3D7DKF61T-R6G!X,N@H+HB
MXP'L',GW'\;O6ZCD -E'TIMIN9TD%P(&IE,UEVPNX23!85'2^&]=;Z[# /)Y
M0%(:).37F-P^6A]F&KF<%N&V,Z%7E5O/ @: =GH*%_QK+K1FAXV,#P;6N"HG
M=(T?=:L8+-9U+8,YKRH8/V%>Q4#K-B=)<GK)9;JIO>LOX\6 P>YTW84K,ZQ4
M^#$7A;JR8*!ZOEK3E3Z+<1>DND0>)(OE998^\#W?,<=)TT0YC4*W,+87H4Z0
M P;96R@O1 :M*+9)Q$0<)TP&J,W_*_Q<9_K16>6:9"G]9X@[.V!VZ!XOQB6R
MIQK91?58&6 0/5%QR04-RI*\HGF>EPS$K4QT2\/E*"#1UI#.XU7)@?KFIQJF
M["]MQDLWV:6YYQ1]R?&R3-C@S.]8DJH*J5M)<@'6'9C*\+J%&.^0W5YWNVPG
MA!MYJ.0"$7/,0#SR@BH<L'%59=/0R8?GX8QX,W&$ *=/)XXVK/>"HC6W=QA/
M5ED(CL-'')4)/V1JA:%@D\.2;%YIA %>;BG;#M;Z8B.UV\P]K<K]K#TI*1C
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M-0[-,H"BU%KQ(88;1A14G(@TK#6HH7K @<7LO1\6Q;*,R6M,PLZD-J;AI&+
M8%ICI#6F)3(. ]-JQ8V8CFI6D#FP-S@O2!D695W._ 8G;$=C4]K.XJS<*,%7
M_H.E::K<!@,[&.".UUEWFMN3P;>\:BF(BX%UG-"D8\S3""_5+UZ8=K7&BW$)
MZ:E&=G$]5@88<$]47,BZJ<6@C9SZJ=Z-I/K57@B[3\TC7+*N;'YSO )>\^O
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MR-6/MG;!149N@P3?LKJ3?&>&+["_I 17-V ^!;%0TFFJ$*=KRDD&]E:.HR2
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ME9ZJR@'SBGNQ38$I##+1?C>W$#Q?KO[J;U$#N2[]KWPO>G<7H$5_\"\0!1U
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M3@&GGJ)-@\@C!JS,U]Q*)+0!8S)^[$A1R3NH(6(P0AHW,N#C_ BEN& 9D<W
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MC"SN PB:R>;!ALA3R];5-QA<V([)I2*Q6$+FN+UUT-=IIW@:Y]N$$OT1L<9
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MU/W3)?T7_7/S)_I_6 H3_<O_#U!+ P04    " "1BG!1%QJ _5Y4  #$R@4
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M@#S8.HCL,[&[> X'\\W;)O'7<G^)[W7^$N.)^.>AVY^,6X.[UF#8';4G/5$
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M+!VS'PI^-NW.KX^]<>+L]NU#=_2Y.VK]WIO\TAH_WHQ[M[WV"/=D6)*P&;"
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M9I/MC_L_)F6A?!_=,+8=\CA5J E7&K-VF1E=-V\78HN79VND,'6_O;2-QSS
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M^>%F PB-L\QA6(F1?(XWF#]N]K%J[@S5D,\JM6T5M(EI%&!E>!5BIV[K]RF
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M4*5"@ 8_TNM.IG:*6'O!&2Q6AJX.MN=+/9R94:'!7NGAU$2?MA)T>OQ$FT
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MO>7*<;E4X<'\/O 7B>BIP+\P;W87\,=0XU(&K([]X*0&>JV HL%M5NT&\[S
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M2WMY&^C9?NHB6@<1C:B4)?=UVSO/0T4\N*[['GI=MVU+/M5@X?6ZKKZ@'JO
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M)S5#=PZ/F@E7[U4W?Y'_]^2$3/SF_P%02P,$%     @ D8IP41:;7.,] 0
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M/7J][@J_Q)B_U<@O/_X+4$L#!!0    ( )&*<%% V@<F,@<  ($H   6
M<VEM=6QA=&EO;G-?97@S,3 R+FAT;>U:;4\C-Q#^CL1_L)!:@93C[8ZJ@C12
M"*&77@HHA _]Z.S.)N[MVCE[-R']]7W&WKP X2ZTA+MKX4.2W1V/QYYY9IXQ
M6WW?_;U=V]RHOF_6S_ M^*_:;77;S5IU+WSCZ5[YN'IZ>?:'N.[^T6[^LI48
MG1^+@_UA+KHJ(R<N:"PZ)I.Z$FY4Q#59E6QA((9>/77<B<BD[2M]+%AT_T3D
M=)N_D:GJXY95_4&^5:N>UIJW ]53N7A[L'M8W3N%V5?KF# BG9/U,_ZH>VYX
M\C)S=6[:37'P5KXY>+<M=T2CV>FVSEN->K=U>?$"%DR7NM9)KEN_W[3]BJ[%
M5?OFNB):%XW=ZFD'DTK1@'1BK%921,8.C96Y,OI[7O>?A<M5,MFJW?&FN#P7
MC?>MYKDX;UW4+QJM>ANW\+39V=S8OK)*1VHH4W&NM,1/_+I,$A61W5FWF2^S
M&:V*^,T,M.CLB@^:E*.T G=8?BCR@<R/_PO++&\J'1,KW=\]4GJK=K ;YE[E
ML[6Y,9 C$I9&BL848V^4$W6M"T1$AX"/7!@MSHW-8/.;#\(DXEIE1>IAX\15
M6L#@EHYV*^(Q<'V53?AZVW_XA.T_E8[BS0WL<#81'[49IQ3WJ1*\8,/VQP96
M:I-C2W4NE1923T2A<UN0<+G,*</L[!<)DY%N&,N)C'#+"I.AE.4FR#T0T!21
M<]).-C<@D\F/A(D7E#K<BV$-YDRY0/(D+! I&Q49Q#3&PY28K!@/5#00KN"/
M^?@Q62J5\ HRY5*2L=)],5;Y "MT0XK80E@ Q4,89V(L=(1QL>A-%C?B?Q9&
M;Y\EC$@DLP0_]PNPJF-A\-@N/%<:V,T\9/$[2HL8/H#O%WQ00> HFT[$$*[C
ML.-P3--97&UNE"YU]^9&[,:*-5?8Z44* 023@</+1,(&1=(-1)*:L9M&FJ6^
M<KF5F$GRS6 XS QK"_'BIM;P'MRU]W\6,^^>$#/= ;&WIOO[HW6?"G/BRJ@H
M2R4CU01>X'>^):0E#UOX3/528E\(0F3U4N4&+,YB&=(4IRJ^CI6+4N,*C.,$
M9DT:G#VT)J(8MQWX")P;$Z(E!%SS-AI(W2=11V[H%"FVRG/6HVW:\6,/CN)P
M%2X5LRP=HHPG$)P_%H(OQ (;\\A$FQL/9DKNS)1@)E[I_9B$!)?/-9.)E<*L
M6S\%MV\TV^WKJWJC=?'K+UO[6_[ZJGYV-KU^LG5C%><#%MW_X43TC$6N?Q.9
M-)5#1R"XY2]NRJK=SE3]B*,GDNET';D9;I7M8+5[-I4J5;_[>7@[7TWW[ N"
MU?/+B^[3FT:T.]4]'EI;/L=2#O</YSHC!ST(,5\.OPR "I?J2!9N]2%<U'N$
M6"YG"D78%!8*D!5'ROE<"RG27@]SWGGY7TSUEIC, 1P0OAO?E;(,\$.%C U;
MG$E5#"UL:,^I6$FK> $J< 5??#1K*AR7;Y],G"_V/C$;1S H1R7@04/)80(N
MR14%R_)&S&D 1@16L<B&\*M'+(B<C_$4GRRZ%1\=?\+@T5![!D"^XNR)..M]
M+9RM7 4>P&WU^K$RZH#4D8H93-(9+;E22@<@,F5FA$D;3Z,=^%.RIU*53YCV
M+)N6L>^!X6,^P/:.Z +E]@7YMES0L$ 7YK"'S-,B]&2Q-\"3[SYIL*\4T,,3
M&C*F602=18"7/R% 17P%V+<%L.CE -8<R;3PV9ZCCY($S%Z-$#=N"4.?,<@5
MJE>X+$G[O1[#XPD#47E<: UZIL@?MV"5^BIGTL2-3R*^V&V*'O=4?/;A4P2%
MG>#3#%;^"HEO"A+Q"]:<$&T/HY9/9<JVQ3]9"HTG5!KF:R:*"LNQN4".EFC-
MC,MQGT^;H<O!.>)3 6X%U=N/#$D ,M2 >]*EX>C#R1\H\5F3/PD,=NT$JP;2
MS9@D5P\/2HI]6?7[49:\B4C51\*7/URZ)U_YUUOT-8#X@NW=T?I[>7_R&T\#
MNC)/>9R!%X-JGOTX+)9Z:'-C*=-ZT%/,;)/H*W)CW8S<^!O0F64JSXD^4V!Z
M!O2)G\<*!GHEVP86(*$[+ACXYO9FBACZ5"@LP*.CT)$_;]IY;=F__;3^@BU[
M/06)AB8%?/#)#A\218H0SR5;F;7.8Y(?F7X$4NT)B&\'_''[]#SS49@LS?6A
MRPTG:TMRIXPQT-$L=3Z*J+*)P!#  GZO! [DL$Q79 A:]1?YQ90E:^G1[RN_
M^?: \((]=1TT)K'(Q16$)?GZ@<#V_[PI$5 )+$#ID4E'Q%1 RW[Y3RA;EAS*
MAJF9$)Z.!R;4&7D'7\##L_"DW==(72U2CUCSLQ)A[@N/Q04\D_7@G(.?*N)P
M_W#_LY$Z-V9JJ1=8T[_@3R?'BRQ)5&]J>V[O_GL!J].LY_VL[MV4[]NL=Q\>
M4)'#!2ZR^B?OVMS4^?9]1TMH#!0E<UL?O/KR'2UE_@;/9];C7^594V9\[/VY
M-;S-]HA>KWN/7R$,[Q3RJX=_ U!+ P04    " "1BG!1ZC?(; D$   '$0
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M*H+[R&S%B3<#[H($%<TZ<&T8W%L#=T&"+68=N#8\Z*T4."LJ+)VH,+/JVHN
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MZ +"UCI&GN<GO-$7E:#<Y3"5RO&WDVOG4CPSC.385E>^<?<(KG*.R>++(SU
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MZHIAVZ%W*[^;,-*R>AQ&W7SL@3+Q%?H]&'(WD76+#%ADDV=9L6YMT )6('+
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MGPX<(#+(VH+:!"]RI5V8B*Z7)L*!T5C\=@UM'P329.!T(:1@0Z>00LA LIQ
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MAH12NC;:1',=TGF4[1$$)/9;C96;C>&)%J4-Z>OS-OEFP7$CAML\%CM:^^,
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MA]]$(_.$+<8HPZZ/G4@X$8C7XX[IT4X?U8]0Y_ :"BA0U:,^[QUVHV])Z\!
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MG),;_7VY5LZ77_7P-YW*T*3N_MXVLND@YM/V"Z P<"S>$(FNO9207J O (I
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M*'29F*=ZI\$L!NBM"^QC/)O!I,HE\2@9>)JCGH=:*.% %HB[]=#;ZYQ7O\@
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M+V<)EE*DI[=\7=1(K@E38C)9()F8YD(J#]'.B&ZP=9 T7*$<Y8-9"9<T ->
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MJC4-HRS2G(N[RHGRO\^DR75<E0M\*THU[TTRE! 1Y1/O*:VYJG[#B[:ZK)$
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MBO$S&=/?FS.T2/0-)8/?=5U&2**<X%8'SEARS *KU,R]^B(DR_0:[W\W_#"
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ML1)R-Y9NQ3GB!+R2[?.6-]S^SH#6D^8.$N&R#KKJMS$F$+GFG#/<(YIHV.*
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MH9)H1"55E016</^Z=.:;LL4IER"<09T:3*.SDI-^<57FW\&D+6"=A=\81X*
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M+5N"CY#<G+2UFZ[V-@4 #-9LZAXD5^J?.Y(QW<"$LHS7 ZWF;>X#RW? J.A
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M\K_PTU_?HQ&'($JHDJ.+.1.Y.='2)AHBP# @HV@ME(/5-!>B=T_KK7;(N_0
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M)%5YDYA6CAI0+/\RXY%X!2''K7@4P0"S@1,#Z:6 G]<G!^<EQR[7ZG:^]GH
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MYTW][K,R0-Q"'9=8,BP!E_K&C3SX# N7G(IO80"'PT_K;N E%/V%@PA=YO:
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M2@+Q 'K#L.5&;30W7M!Q(XK =VJ%IN^1L5UQHW8%Q(^=Y,F-!+&(@H!I5;U
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MH6YK^('4HD%>0O927]\5FW%/"IO@42D$^AS@0I ;FPBW[?E#-6**$=IA7]^
MN?@T^BZ2&\!W'UT? XS.\5&<WB)38* NB_48DC#T8Z,$8W2P7M &L4=#VYPB
M/J$_B+N828G$ Q<=#2&:@4V$MYHH<BW>XR/ICNN7T[SUP&RN'L&6JI]]<L\%
M]@R16T!E".Q,N7B[A3?P$"[%B:R,\"B#_QCZCT+[KB X6/860[+)VUQ<+UH.
MK)[ >*"%LJ85[+J/^!UY1>R:4X2UP1?0$@S:0_I3Y&+$2C4;$VLU\ L10E[
M]RF+I,K"<#5P>%3G$2=JM$]AY%/>T\7(KDF=,S3"08^,+(?7<<_U?<ENH69-
M7_^>N\O9UL4@"ON"!?E7%SZQ(VT+(_U03U/*$X^/1NL3R>%\\GP?V_$(?"0@
M[6I[B6HX<T%#,)41)NBU(VB0X;':>C/3!IZF4D:EA,W-4*",<G$IQ%+:/N[;
M88A.*QA0S229&SAJ<(UAOE1'A14'>F](&R4WN#(6.[+.L W;(99G\&[$BB>0
M 7@\D>A#W-5%0<"2/41N+SX^8MZ)A PBEK1@20<864$<XQ^M;OB$6\ZFE?L4
MNA'=CY][L,?!2N%=%.WDF(1-M4[JT;)R%>\LL)0&_G?I\OU+4XMX^8E4>-DM
MG2JD;]?ZOFA_2_S_ *MR=OWMIG%[<6[]?GG_F_7Y#R/7OY;\]DHZ[1 ?#8]I
M,"FQ\ 5U+'M8-'A\Q)>)F"I*>^C0D4FO%T_H\ D',1BG^+TV4? !],G!"Y 1
M/VTN>BKX2>")P:;"NW=.02FWS+BBPN;I-CH,*=8[&_X37"A^4>9/X)F=X(*]
MMTX^B98K_0S""*'&5SY1><NC=>F$89)[OZ+UG+BSE\43,!D;95D$ L]F029'
M<0LB%R@M&GS:C"5(^T8'OEIV@0D2?5E0BQ+S8B0[$0-6KV!YX;P$KTNZP?:L
M?2@Z'Y BH/EK)J/VPMJ_.-?#4KQN*?#@7>12K 03O)3_9<HQ<&64F4U)*BT%
M"]D9_;@"YG3L\C@!ZYJ G)]]\K09P%&5@]-J0Z8PK_R+1;L^3E*\3_)?,M3;
M\^?E6<A9O6E;<N&V>5:AS_,< QJZ-!O=RZRCV*;I%\JYV0A#=G'R=3L_CI>W
M-[,O5!:R]"M';YUBE+X8U=';O"S%B<C">Z.5U5)N#*AQ;R9?*$W"-MV;Z5>+
M"UG[U?A&6*;C^Y0;>Q !W4MQ75S/0VR B/J'U6SFQ#6=+-%)WDO%+E:6#4,^
M\VB*]=RR<:5GEXQC5^O+!D6?73*E\;-V.X[5VRGW==ML9PH0/>ZQE<V- ='O
MS=P+=GF<G6!O9E_=HN-UBCEB]'EY@69 HF[SLCAUNUC<7WM4JN3V=_).R2Z,
MNRE[,_U2(3?&M[$-.0BLIYK4+KP"K[:27S;%P\RC*51S8YG3M?G[$_.X:_/W
MG?&C=H-/U6LJ]94]U"?R3'V_S8;EI# CM?GX&+9[WOE7'Z;;/>_Z:X.:[9YV
M?CSC,M^\UW!T&G@-W+>!E!^OIF";Y^PL+IV1:)ZS<]F\4?.<G>7RYN3*G/$$
MQ0:?G2<WV(>/L&OO5;,&:G9&I;?2M!3L?'D_SY+2N%N[%_-V['KUC<?)ELZ\
MG'NCM[@!Z?I"KHPB3D_7EV8DOS#WFM#WK'8X:/IBIFJN.9^BJS.*Q1>=.GK*
MZW,CRQ+!')KYHAP(,F]+Y; @5:C9Y=J+AFE#1;!052@O2A66P&XYK8_(TR_V
MEM^6-4?'$AK*6UW!:+0I+7>(,^!G'A\UAXR4B=UXB*2I@>@(.-/)E3-XC=1[
M)?$RB[EZ-?LWA!:\'D365S=HN7&"[7QG,"CP50//)>#;F#^KWZY'A.AN, P3
M7=(IY!P)I <CS$\9!KRS,CZ*=TZNFF+J8:>YF[Z7OFF\FXLJ$L:8H_[#0:?C
M^@CET8R]MN=&0^OD+'P(//CD>SOSJ+!CP?N<7W+6%"K/$_G[]U.G[>1J-7/>
MQ6JN\ M-P8 %3&M@:39C0_Z,0%+=S(@9DQ'&^]3UX$_PM>,CS9U"9(^6;-7*
ML4"S+>[R!TW@. %\]5TQYV16K)*K_8*O\X6)IJ.^>7R41?,KI<R=A":*<N1F
MZ8A1)6DM5["15VHU=O=EF=<\!Y]2.\"GK ,^I7R 3]F);3:KVZ&:)];M>K1&
MFCA&W \XZ"J94Z26RS.ZZRB0L7'LUT<= CSUOR*&989Q..4KSAX]QBOMXZ.>
MZP4,3&#"7NHO3#C*<M9H9PIEY-J$5Z A1\:&8HR@4"U)Q.!.)Q8)20)\))'Z
M%2,,RP6GJOB5HW#H^LDP9>EUD:C7]_%_X7,%^ARV>T<P,738U3CT%U;-PYQN
MU66^JV'%\ L$\W.#Q"+B(G:=1C7P^ A7:QK"CX8XE: ^,3'SN$C"Y?;PH?]V
M]8/=OI? ,!#R17_?Q!HAZ&SE@GG2#6T+Q+T@=)N.]U/I!^S@+I&/(]&0]>A&
M'I]D]+<4:CM5P7MDP<V,2,T37.GB^,[)*&!&NXZ/8*\526T(NV?%+MAJM&-L
MQV)48. ?&']##QV- LB@XWI(X$'8(W%"\#&)A;U,OVBYCH@,NUU^44;)'MG4
M#MHVZELG0B'\UXZ(=YZ3B3MHOLD.FO6<2L]P'*00]\^3'!CGT2BQ@0Q#"REW
M(J, >>GIA^9 LRY.B)/A8&*S$2,X#D)*6;5*KOI+9N1H!80.6,]5B#UM<O5R
MG0\1.&;KOS B%G^*X$+*Q5PQ#64)>^N*X$;.W @$%[@2I(V0G-[5ZU5YTO#S
M4=<K57B"?*1M@8K' ]QEU0(.7(]'G==,X&D\4WZ"J0:*F76H%3',WHV]<DWH
M8GYVF;JN&5N#OF&#TB\8-$\T,]C"HLW,6$[B8&:$T3;SQ6B;:63:9HZ/+G1=
M[\KLT&@[CSVAG\<ZN?ORGVZO_['Q_OC(\-OT5B[ERJD/2WDC))Y@O[F2*TU+
MESFYV@3/N6$<A>89"=.2HP!C! J(?3>_D*N+S[0S"EDLX?O5(W=#V]"X]MQ_
M&LB(Y#LKH2B'&H0C(*H]<"K,R*DP&P@"?NRUZ"3S@44_@QDMQU*O3$,,>2WG
MR2!2S)%DIPVPTS1H'0D!';OD5%00R*0\;DQX^>C0T&&.CS&I>^"#?,KFS$ ,
MU!K3X((M"C+_M"U?/*C&PE8K'""0(EBH]@#B&<_'S'=+8E5^D[J?!K<J/,Y9
MJX/]7ID"+'+1D0?1B\E#TR:=:+8'?;SDD*1/8UZB$?VE!P #LB&G=XQ$"6D&
MH!W"*S%8I4\<5N1%-@%,U5C$?V*>KTZ9\RA$\,F1N>@AHGLTE!_&S6#DAGA#
M&FN%(3QR?J1(\'"^)QX=[X=U>7Y4ZH %'78)SQ>%_40HA:.9O)(.O#Z.;QV$
M!NXU(7)1UC#]=E>X;3)TS*A!_E&& $%2NO#[L\G!47#_@^%[?E27L$LBXF"6
M=L_<:04.2C_"8A;Y>$-7$Y;'3[HZ=4GXSP38C+N,%FO24N*:R:TF_;7#RCP[
MJAMW"*&]CU6DD]:F5*VI0PG6KM/!]#;H?]=[0(L(!M$/AP*3E$KXM&%T:OJP
M+U[P B7 ,052(# V4]J H8$KUN5% 7-9$R:\8>(843Q%(>^[7EO>0R!N,I]1
M$YY]V!?/CZJ4=WY,VA#2*V@S 9'ACBGD\!WF>4FC8972/D3#AVAX$;OM/G+;
M@A+=#$P=N8_"M\SKTUCKG/3[2F7:B/+N5NY'/WQ"_HDD$4&;W U\FH\D&_*1
M\E'\:<44<C"%SX[JEEG6B!P#4P;9A:B1R[86J[?3U52;6;I5/Y1NK:-TJW(H
MW=J);3;KS54&"^O<Q,):V275[V)J'KIL%PLUF8?&4HDI/#OJK*5$-]X7Y:QK
M>0?N]C!@M"'VMXOEHH[YS7(:?-H[PL_2?Y;^99LHH-3@CH]&1E>R"Y6:+I6:
M<7!4NCXZ.,>NRB=-&5P9XC+X,]^-I:-#/]F\C84'Y2MY31!?*.5JO]@4NA'&
MT-0QTA/;'K(/R90'W?5268XD4&/W1_)_F"5K.#L9'.IR?-8F6:>NR@RVCHZ(
M_W^N[ 7R?1[54OW9.J5?SK?1=$LMY7DEU,H]=]2N;*NAOO0S S%;>VF=WQ5R
M^7):#Z%N8#,7L.\<LR.#/Z):,CAU@_?*F.BA#%GJQL4^'@ZP=^ A7'V9N31V
M:KMWL3OF"I]V7)#<\,\O1BI=B&]3:;(D/:0PDUO4#<"E\/HR<,'<,V<'D@'1
M[>$7XO'RSD(992SCDEN*I\\M6!_8_?!N/'AA_+QV'!0='S%'SPG^3GZ0]K?Z
M;%N('M6])DALAXZ55*JVP.I&W/GO4Q8_2O_I]![S>&7R1BH6X[?"2XZ/)GR*
M+)@7_VN Y4Q#-*WP4S^4&?4<;#"+Z?3BQ *]I9=Q)0'H>-A2QXT?AT8!'6;Q
M4V)%(_M%M3$\BG[$/3<F(9_*3J)I%E'+BQ4O7^A3/3!2R,$2\@.8F3&V'B)8
M0-Y/,-(>VPK\IQ=E+G+DMX^/^KY+U',P(GD-I#Z$,DV%S>Q*%*"*MI%.-?=D
M3AJ=U>R!3;;+V#(GK?$*#;&!%Y*]9:J6=-T<&D/[^ CM;3U7G%)F4YO0E+9E
MRSG-<,Y+U@8.RQA96^U UK9)9&TI(]LX65N-_E0[D+4=R-H.9&UO%O-B)+O?
M#&&'I7C]4M0.9&T3WW$@"]L%LK9"W:Y4QG#W]DG^![*V!>%T'0B[]G;R5;M>
MWV-BJ,JK(0E7YQG,;I-VA:OMP->UQUO2L2O5_672@;5?,W/#UG&U;3DCV?+&
M4K?+M8T!PRX6YB6QVY13=3>IV@Z$7?LY=[26BSAAMG/VE=PBM/Y U7:@ZUKD
M]!=$U[6=DT?^D#VF#2W67DTULU9G:6U4;5M.2+94R13J8WP+:PR$YB0%.E"U
M':B[%C#M-U-W;>F\G?)^LNN\F9EOCZC:MIR0;*F2<8J;XU64#E1MFV!:#L1=
M^S9OQR[D7YL;W.Z9EUZ=@CA0M;U<RW7@YWJ+'!;'S[7%JE OONCG;J@(%JD*
MQ7S..5"U+:CQ?G.IVJSF\/C(*>7*3-56,GK/")M^$AT;9R(+]5QE]$^U^9C:
M#.8,9FK+%S.4+4ZN(C'R)_&Q*>SIZMB?:L1S5JI,!\G'YF?Z>CJ"M_*UU6"P
M\_"U61FZMEJ^RCW_C*&?XQG.SYWFY&HC(LP_PYTVRAZ3*V? \4'J^3'NM-J.
MM!SNTEMF =DIY0\@.^L V:D>0':V>&/M)#':R#%;R-69X6$"_9GN/!_]2^UY
M8C1YAF9!8N2)>GRD46)&89?K>::+"N@HRQM4%)&(^XQKX ^MUU"K$:\5GOL9
M:K1WQ1J_4M,I><&X!">PL*50ZX2-2EW1") .[W03Y080I%#L/CW'P79\I- _
M9^%66UG'_VKVUX%;37&K.;EB<6SS/<NM5G24UNP0$,0BZ=1,QK0)=&IU]<?:
M*)U:'NEH]I[G:)/IU(JY0C4;JI136N]2KEZ:<HX5G(E!:S9L6@"C&C*>O851
MK5@H*V28JB14,VG,RD4B\YZ14<W).:8\4EHUDS_-H%4KUW'C9&C5=B7HFTJ1
M-F)*CH^RMF2$%FV,,\TQ;4DV,:"-R2D:D],]-28[39I6R!4*&=*T FD$):XF
M,:-IMN%R;=P6S4R:5L)=JO#X1DC3"JATN[5U#Z1IRX")+]7Z/V>"(RB4\(,[
MA4#^+&^64R@PM*J,-9]ARTJZ43AXZ,)'^@BZ"GXJ<3$I%JT##ORSHVIH7C@V
MO8.VEV@2.1,LK\CK,<I-QZ"T%#(:CB,]AJ$KF68+S:/O(7K_6&Q]6* 7MLE4
M,K/J%-H2Q13#ZSC":';@,EO(LLS,958O2B*LU]&8'?C*%K9DS_.5.37%5U8M
M+9RO[+ TSX_J!<(RQZD\0UAV8"=;! <6<\*IPR3IFG]\E@?K(-M)I#IH [I>
ME'*(9FQ-:0+-433"R(.0W2T/$:D[7@M#TC@, N%;2HR'E7AF5'?J;L'W6AQ:
MC*U"K3IA$3BD> S]04]H5TD^ Y=EJ2;]I5^.U7+M2DKAP#QW2"DL8M<3X]PI
M7@2</D<S)R]\7V"9HV\>*-"V^F6S4J"5G$-UUCJJLVJ'ZJR=V&:[08%FDHS-
M3H'V)I:Q.2C0BG9=,JG/0X%6F\C/IHA6)PZ.H)-FHD K%@N: *V6*[V>_ZPF
MJYOK!O\9_9$*;?2LM0^OJ]Q&"[ZIWGO+;MSVD_L,><U&N<]&+U+A0X7\*/E9
M;2KY61K<,>=92G F.<\<H^IHV[1DJJC-K#(S:F5VD.5:,:A*  ;E7P,WPF)0
M8H!Q8XBWXIZ\YFZ+CJ ]Q2ND:>F)AQ[&IV2,7#,NT=YH#BW4+NML(*][_AHV
M8ZO!^3EX3]4ZP8_\YW_4"H7\1_S%\1%^'CY!OW,^OL_!T1B Q^V!U3!NH^X2
M>)P;M6/K4PC_8YW(9WQNW'U27YW\^;.P326-E%:_#_M>RZJ6\K;<#/1^F(=Z
M7N/N#/^L'QF!$^)%BHL'!T\:&0RIJ.<A #MII"'YZJOK!ISX)SGY[E.,%C&5
MF>1L[*AY(LV:)@E2C#Y]6/00.<QD\2/1 *E'T\6H%'W.:O1"F'$HRQ]A]LA5
M]M(@6E@FR;G3!/GN^#B@>BL22-\=DI^JQD-&%LM":5Q$V?8$+BO^+_Y9?IU8
MC+P>KL"(&EF^!UZ?[R7J=B3S1U2_),X='WTR52U52L[UGDG1]\'P4S55&(A3
M>!UO^J8(1,=+E'C3"<$1ILY7^3?> HHU26T$/.9Q,_#+4CHZK"3&^E5,Q0WP
MI$K'GID4ZP='CJF@TYT!.P=VH=HQ:EEVQO*8;'?/<B9B/=<<I(FE::2)4Y@-
M7R8G/#X:82><P$&87LTMBW^0".9F(2"T%L$_*+D'MTK5=HMN,)MU*I8=551:
M!#]$T@U.(!7431_UT9+T&OO@9K.$?!6Z5-@IF>"N<WVT.J0(_.ZD*[+65UI.
M*ET%)ZNLWP.;IS6(2:F;X:-0YC,(0?7@S].]2U6R'Z%N:C]BMWRM.6D2[RX:
M=]=7C:^7]W^LF!H1_6.^R1 _NU[3PWQ5#P]!-PX#./\Z/MB/ 8TXQOII+.0A
M!R4<8!GSR"EY\M<!G+K,(/A>56J"AG7=1[1-Z@B,%46ANDH9]'KP[4>7/3$V
MWDH]7+11ZA0%-80!@]XE,,HH1E?,J7ZTP(;KKHU!0"5%\$TY*G@_O\T+0!5[
M[.QA*7%3B  LM^ @0OH5L8L05&[LQ=I]"0(X,LQO'Q_)^C&L3?)C\=1%GXLV
M 'RMP9^_%5Q] 7H-WX,%._T;SLM6&P6\S4!6<\#:N0^"?9E(='SR%K'ZV6WC
M0K'S=R(+G4&0M!D#' U&S^A]$>QMD&#IQWOP)> LBO&B&[>>2Y725EKQIBKG
M148@>D8YZRI#(8E.E5I?O":##7Y\I%[A47-7FUSH1XKTLU^4/A$[AA\MK+M_
MQ&[SIB*3'$SO%0)1RNLT6AST25FRM#HVIEW :W+]F(8UB >D:JBAGK&4:NC4
M)>)VU#]SULG5!.[*=& IR^7*^"RWX4*)4YOFG9)FNRLXT^CNFL_![;R=VP[U
M]8[4+L.;2OX>SBJ*WX_QWKV>0/+YN;UE'I__&!WF\Q>^ANC7)/G/7@2V_.^\
MQ>8;_(;.Z(ZCOUV:$IR*T6[-Z#,['[LT)<*PGVDF2X854U?^R%G\RND4\H7\
MLQ?YFL]PINH#Y_4C>3?3,*9<%+[RG76[E'<6//T9/_;N=?,<N:#D^\S\V&UF
M_O7ZK:31EX.;_?^6/S@G;Q?+>6.(V[%HKYQL@1'1MT@[7[L+RZ5%&Z'=LU4E
MQR[7ZJ\0TUL.H5%XW=<?,\[DH2^T:/7Y95G<4E3M<K'R1C=FVA9;W"AK=@FI
M"#=\E'6[7JQN_"AK=K[PYA7?<*TF2O3)WM *?-HW6);)9^16KD'5SE?F,93K
MV0U5\,*V8<^6R\6-'V7%KM3F4>!MU.I"W:Y47E:8#7%4YM'L#1=\V2[-91W7
MLP7*=C6_^>Y4Q:Z6-E^6%;M0*>^Z.2G93O'EI=@\1V4>)=_P-2C9M>+F.RIE
MVZF4-GZ4%3OOO.QWKWN4$!V4=]U1<2 :G2%FWA!'91X[O^&"+]GYVN:[ "6[
M7-U\<U*VZZ7-S_L4[:KSYE%NN%8[-;OHO*PPF^>HS*/D&[X&!;M2VH;#-5_;
MAE%6MT"6CEV?<FVV0Y;%L4N5Y>9J%^BHS).%VW#!XYWLY+O*3=H"1=O9@KP/
M&+WZFW,5*S GY<K.FY.\G=_*JY]Y/,@-7P.P+%N07RS8U2E%"!LVRBVX^G;
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MA8"10#)M/9*)[\E7<YIHC$$3U$B] !$^:0+8$LPP+<;C-->8F@AS'Q(;D7B
M=>J)Z $[C(DNH_6O@2>Q1JP3Q(HG*A)3,MB3'H2J$YOG(9N_L9T:Q"MQ@&!
M9,QQA"'U61,"D'P=45.;KWL/NA%&/UC!>0M)Z")ZG&V0;\B6?0-%!/0!-@IN
M8=8L?(H7/$H&32^ D701!+6=;9#G*6O()>9YE*]* :J?9RD@BB7XO=QD1<<V
M-MJ9%EK;>E>JYPHF  ;N8ZD,N*-QLH^N3[(CW+I*)9<A=(J[,(13D&A/SHT$
MLR-8%+^CL?31_#$&#-I(\9.1!+1"N(CZ9>#P@.D(E(JG!A4\&S H30&KUNEX
M!#F.RM@3@A]K/H D'_!& 84<U4!>'/ZW"?3'>X@A)G C"$::(AP!VI[@"W2(
ML=[K\#M2/OC1T1+>67:H,?PI[C#G[<3-@!C2! G0CMRG]%")Q&/H$X@%'IFD
MK00T9&E$C*8;_"!X0_E].G?PC82$E1I1?%DRM C+NID@W-0@8G@+^%783%PO
M(/(R$!!*D=_2 ?>3H:043I&%)U+"&U^BA>%^C$GDM!OE"8""HRT#M@^!O9H(
MX8#P69+A@G0B^QC$^>!U=A]=SZ<5(".(\R/!Z]_;_'T2!'\%7LSP6I+4!\8!
M^RI&:R#Z2?HLF$C'&CN_]>(='R$40T^,K: \P86YT I^3>*0X6DM">*\#LTV
M%7\J*Z(8)GF+-@DH,( X0%\'?IN@/9,((5 BD3$[.$MXPI".3-33""%P8,XC
M:!;-00S/A^,03F=?$-I>PLS!!I450U9,<$-VR 1)Z!#+)6P/Q/("*281';"T
M%WJ(V6 3_I<Z]FQ6<OK  '0U0M'15B&EPP=%#%33A*/<]W[@B4[\"(3416MD
M(B#Y'NR]-NV^#MLKAI:C4Y_&0G[?\9%V_-!G(W<O!8R1X%]ZG=J"',EQ!S2S
MD*R-3TPH0[AZJ+/T2E.GI>TC(SAJ_'9#%:X#9*H%:S/Y.">_ALP7>C;6'7F_
M-](GY2.=:*Z\YH \UH;RBC+HD?JW&JN1S/17[V?821"E[3-('H$3PY;WG_]1
M*!8_)OP_B/M&B$-H56(/F<@Z\A/P=@4$R<])42EA3@V(6'QKXI2(4:O78RHM
M=)13UXSV 9C-<) @'A<Y5_)\\$@0DC&-7PC>_B"*!R[;00*W(\LJ_7H]:=N<
M+2+:A 2Z"/:J&R)$3OA$\'J#9@R; 6&"Y /D@'/6=PU+..4%O$/4!,GR]]VA
M.K5[*B:!U[71_]4SD(B_A&34EM8;_SKH,X9K18$QVE:*=D2O?PI/$\2QB W?
MCA >"=R"T1/!Z1^@*1\$$(@@)2PJ4AJS&$.684\VR**359T4(Z"2R!S_KFB7
MRA4[7Z@3&J3XV2*[/N+79/!0LYJ>HGI:!JBG%@ZYNPIWD(0_+BP>E@X%, #V
M?7:PP$H%H$>X$/Q@%JH;F*??NW(JX1&96J\3Z?'1<S)-Q>$J?E1%08:*,O!=
M&#>(B-"9E.,' Y-&%W64<DVD\9D]QD:;M>WX**-NZ.6@-)1:,?(T NHQM"IB
MUC <5$"K:@" TJ_A_3DP:<*Z0BP[IZ1@M!!T1.!1%;<BKV\ :1T?Z:VQ2U9Z
MR+)VJGANQ? !PE7E=36,&&Q&;83)\(PB;1.>;@YEI4'=[R//#1[@;#OSHA9Z
MD5E6;%NYCH@GIT?QC"$E1#2TI!2.&]94;4N)LMF9-CC3LHX>.ZGATTS>EG1.
ME4T])9L*>I@QJG<>:C@?)C<^NKPO6E;3[/S9.G'>L^V1]EX/WE3WSYC#^L;!
M[/'1.2->V8A17W;*=KU6T'B]RDWVPUC957RY<1[!^/])[@GX).QN93#HB*H*
M7HLWIO&8O<I8*CHBP$&CG(MZEK91"AQ2 QZ[J02,,23=,!;FI\UT"1OELM[<
M\"1M^U(WKBA-B:!P:B25D)HG'!FB(YLJ(K-.)B#YCFQO\,?IT-9^)\6I F%H
M,1DS""C4'$UGF3DEBMY"C(0CJX=2H@@RD^3"Z+O-I&1XA+@FZJB%KY$&E$/Q
MN&O),(H1^9I"Q>4,ADNTL *A;Q,#1_!)R"P=I2%D<&5F)[(/9OP_5![3":,0
M#E2L;8038B1"1N#)!+7;#"!1A &!!AJ8BY-#5)(7CI8E,J1S.2&Z5N\QZQ-2
M:$#AIY( 25@FNTU1P"<#?"@&0C@8VM0P/QUCBS0HR0B"!*<T@/:L,2T%19Q]
M$SK?Z2#-;"#'T)0:"5T)WHE^ _F<1O)8)SIV9!/MTEMFNGLM'NY>UW#W6LH?
M[EZW=V/]76,0PU31^+=3)Z7GMH5"\N:(]O,?X),P%R6Q&*@D+FAW^$0(RKA@
MJ[:?*\&C':O!>\(:O.4 U:X-+96NC_\ 7W,1F)5KF<,M5A"TK7-P"><$JUW+
M<,]A'^E<X5^:D?4!1O2*P:]==_Z#XDE*O*AI7!MA;ABHW[YZ@39TXN?:;(I(
MS9'DL!.S(]A7K9@-NC=[+5;UVP!?G2DNRRR@AZ/^QAOE,A78;VS("X5N+"]V
M%H[S(>]\F HE]LI!5A<_R-K"!_D&55KT_*IV"?ZK52?WA"U7H;8+"S2?FP*8
M=!"261"?1S[,:G%1!GJTTV12??LL^V?6S\_O7RYR-WXHE#_,!]NZA%$4I%U>
MT"A6)3NP9#7'+KV] V?#^S&FVJ'=F2):D9I=JU57Z.;MI$$I?2B4UF]0RMMJ
M4/!^L%#8]4;T_3 HY;Q=SV+L'-R26:&'-\(MJ6VM%2E6P"UY,X;9AF^Q/;$B
M!=O)@D9M@5NR:)JB]<9(^8VP1CI[M77FJ)*OS(20M]U[=4_,$2QEM7YP:EZ7
M:P&_9BX3MYQ<2W&!HUBA%2F5[<K;T:@W?(OMB16IV=4LV,H6.#4;9U!DKF7-
M!D7F6K;/H%0K==LI'MR2K9\B&)1*Q7:RN'H'MV3V7,L&N"6U;75+:H4\G&>[
M#LFU)U:D;A?R$R^2%P<RMM;:5VS0^Q2Z41MKU]I>)%I)*#NIO: -QI%*7!&V
MA7HX="^&.[3>H0I8_QHKGHV-WH^ID 9QBG.A7W^N7S_2^ )C5 \_/FH;Y8(Q
M/)#_+%K4?80-+52R2]V,Z=B:;@Q_T9U$"H0@;?9$1GG9$X-%OFE#3=]W P9T
MN(:Q-;%EB=N'IPP=1N*[$77AZ6IB<\CX:9:<A@7B-DG]:<0\H+XI+["NPD?1
M@Y=R.^6.]#',!WSUMZOKWZ^L^]N+J_,[Z_K6^GYU=G%[W[B\NK]<.>Q50T$"
M/4G,*NPLBA%Q@ !^X,->!_8,-OU&C(/$V#6RK9;Z==J@6+9^ 'TYQMXU[/+!
M\D57?8G I+)(%; E82@1[+4!@3*!Q(*P!UK:#I^"9! %C). 7?B9Q\7I:!&+
MQ[4"1('"IB;1Z6 ?'^HEZ#-W,\>N+R0D%,*&R'<:NSKN4N?3R"MPW^ X8N_?
MA$\BIZ#';#:RA2W8@K;L'90 $BUZJ-N&5\0($N'U^FXK4<@N+#]\AVX#? A1
M!ITP>H)=N".;HQ$35-8@CM/6@LB+?V!K5MK-[($]=O*G?^-6U*<P L%I\ N7
MEA2^WF994[?J]3\NST^=.A@6V%F@,:@G"MPJ$A+6*I$/R'0!JF4(I%ZHM;"/
MCQ XBMMYU6/I07V$[&@KXQ\)[/F+#7"0(5EM'EA6_S02"\P<G'$&[2'@)UIY
M/PP>" %J1Q9[%/6)T<L0)"F,4.Y1B'!X\#]D2AZ]9*AW5:2ZM&G7(99.V*?N
M;I<_B0 L?)QC(W:(.T1]##=- ,/N"3C?4=SC?:8I.(N!I.*VN>N0^KACW39-
M(^B%;4&MC4D8^K%L-(WE_GX2<@YPTJ&\Y(3,8<=3#)Y6B%@\]%(K09@_V1&*
M]A0KX5'C\Y!:=AC?"#[:9'0I6*0?(IG'80G2\<<2@BD=BG$ J.738'!Z<!(&
M L>6LS[#3]C *1*&.>3>5N[];(>T)=$<(% A@Y!P*ZXQ"G"()J[^CFP1!)I4
MFMD&AT[$"4,]F%W,8SKA9I:BU76#!Y%9A%$->;Y+&E5'M=GNRD&#+F<_))<>
M$;=@\A+S \1'UH&WQO'1B<@]Y&RK*Q /L06B>(].MK;FA-\Y9D#$S[X?,AP7
M@EJ:'>L6GQHDY<1#?(:8,)<\ ]PP$?*P"2/4;S3YB.A&.Q!66<*-<O]UDUNO
M\23A?G)P'09H#H0?BR?<SCNR8G/ZS9=7G[\V[B^OKU;L(_]NN,99?P1102+0
M-HS'Z"3KR!-$>K-D_^$383M6 )L$2@![-0CUMY7+ $K(.%VIHQ000LTN(7'M
MTEMFZE\O'?K7U]&_[ASZU[=X8\UW,%Q__GSZJ?&U<75V8=W]=G%Q;S5N;QM7
M7RZ^75S=KSRC,AD]&-U?KRT3%H\$*CB$DU\"-76]/B-RHANBDQ!XY >)AFE-
M<WN(?P1>!7W-UK%)^MD.(DA&HB.BB((E_*M&%&W+!PF";([AP*%',N*R?HA"
M]F:71(.?6^"N@OI[<5<&=0P0SM^%>4O(6%="Z'5.FZY/<#;P!8'@F1%ZK@I>
M&D9 /A(Z6@A*,Z"C-(!/(1AZ9/E>ST,I*#AH G_"Z=H*@ ;E:9S"<'X2 KH$
MJ-;P,G:*PFE+1]"F]TND6TI(D#,F<S810I=['<YJX3(\P.9J,W1TJYM=N!TY
MF7_7 1JM=E8W<:5AZ6*)4HF!(B@K8VIS!*B4CZ0(6],CC0E$1Z.4PE)[$.F%
MP:D'>Q?!ES' ,]\CMP"#$E.6S*==@/J^.Q'@G-;M[/KJ_K9Q=O^]\=6Z_O3U
M\@OYP$LS:QQ(C8!_**BJV #<-Y#7+?Q5U*8D:3C([&<K!&OQX.J[#6T;6=8:
M$^V$/-YP$",@[_O%K?0SN"(SN$RSOW0VYVI>^) I'A-Y:$\"'13\DM]&"%F:
MC/8EG'XRY8I8PP\XM6GX V/>Z(073O+4;A3(#"9JFT,9^XR.?L)0)[QAW/.:
M$WGEM5.#'3=9??^\G&68B@+QVE4@>(=%"'WC9^H0S.)>3+5 2+?.QR+#=C"^
MY%[,O"1G7MZ[F7^#Z)%?B9B+<OKEQ0E@222X61F_? @]\X5E5+BI>'\4>84S
M%]<:1M\G '_#_D])'!1>AT_"KWLWY:'UR<F(.E*E3_S"Y,<_FW!9Y<!+M<IV
M#KR(),';./!M%;BT]J\>_.J*[/'=4PX*Y4'&U@VC8,]@KI\7\4M'RJPK.L]S
MY(I4['RE---Y,^L@MFGVA.._M[,O[?7:3[%%A_G//?]%TJ+/XE].,=?39//"
MO<_L#SR,YC":^4>S7)]E=+L6<F6T.3.EB>1GY[9/]#VK'0[ ]YG)*9SS*5+8
M53M?*,\TA]<;Z T70<&>$%OMEPA*=JE<W&\1[+L*S.BIS"2$T7ZHI=X$JA=O
M'#W[[<79Q=7]US^LR[N[[Q?GV*AR=?$[_-PXO[ZYOS@_/FJ<G5U_O[J_O/IB
MW=TWKLX;M^>K+K:X9,:P0MXI<>? 9UTCT4AYH.\0L-R-VO'Q$?<WG7QNW'UZ
M+WGF)G[2^M[' @SKI''W_3T]_S1?9Y*9)-;WTFY/!&V^\=(WH),?=Q:VJ7B7
MR\WOP[[7LBKY"C[_S-(_OK>M6\E71S?F:1J!+L;/8-IA3T22.S263T\O9R6!
M/=:98FU&!"O[$%#SBN;!ZX22HHJN\SLBPAM9>$#/P[J)AS!D9M18$I41'X]Z
M;4H[G.52A,]PL0CU/V AP%!6,M+WF_*7/A=0B)]<OJPXE[%R9.R](S-T_3A,
MI_DP\-I45!*JU@&:I^HFH?IY7!7J@HN-]<(^'<T;I*9%G44L9BK]I:X 5 MS
M96Q9I(E5#7=8<4\];,P15[.M0>+Y+&<<3X\6F^KWDRC$"AOZ7D_ 9-LX,R]F
M0G@D(7QRD4&^W_<]H5E9><V9DDD0&1CSO\?J"GW"$% W>6FB2,3],)"DZ:.R
MP()[+0.6OGXE\E#30G+A.:^7"Y+BUHBTNRJE9Z/NOU*]:!>J==4"$_8%/5W5
M_L!'0!)$>9S6J,ON$-IE2*,G>S%RL#NZ0O^HNH-@-;ZC>H-1\'0G%7=*)EY/
M\LH9C549G4 ]4V1P7(6=SIAEQGQ]WK]=@T>^AV1A_)O)6I61I*N?R4NA5$XV
M.R#)..MT)+!TG)0#9<P[M<,D'40$B?!76/K?\9FR5UBD'2T]DHQB[DA-#!CR
MSZ(9#9#+# 10D=8<S+2VTJ  ^)?3? '4]"M>SL36"<NA5BJ\5P5K\0"KD@3:
M"<TW;QH,-S7/*'F?'P2:\9__42Q]''UN_CW]FI:4*_E]?XBK0Q1I,;6PR$>P
MI5,V-ZWASM3S9<KA<N:DJ/Q;VQCJ" F"@>2L)UY>KR>5A^IL5%UY4X!P606)
M9^Y<M*1E*+-I8+53I++*NNE-!2(9M2;U%2G5RE2+.5Q?T"LG;R.1R0S'KU(/
M/K%9[<@5B%/^RIB//TE226['_XFI#T59*'6XV6H(Z&+,.H21\Q$[K-7*@K[)
M;G!_F)[8ID$UWB=';^H>G\L3E&]6C:ONB$W:I;?,U*I0/K0JK*-5H7!H5=CB
MC35?5'UW^>7J\O/E6>/JWC+BYYOKKY=GJT=_6)&(9A7.!7P!B_EC+8;EM^*F
M315PF"8B99Q&/Y%<)O*V@C 1W#;;!Q^,X% \]B4C]BSIH/W2:-SDK!OZ!#F8
MDQZN?4<8M<N]$,PC_$-@=P5+@(< 'DJO+PON*1KDSD,9],HXPB7^+G(U$*8
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M7BJO4,/Y:' 5*5M.8FAHDS33,BW+0J@#'<J12L+95$"YXZ/OJ#ST3K9@$KN
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M8L2DO)2B3)];)T:!,-C9.QTTPIBD$]EH)=2_X=2+)>L$3;]\B_D)^;SWUNT
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M=0_+VGYRAZ:)/BGDG:+548]_;TY$9Z[2:2C[B?%:Q@T3OEPV,M"<R0&=Q$9
M]DPX#PA#TP=A(!LB?XCA1-51QZD^LZQVV*)"6'JKK9/,E-\!;6KI>V=<'5QB
ML,EZR47PZ$5A@-_?$:N[2V^9Y=JYG#]<.Z_CVKEZN';>WHWU*>U6]TQ+;IM.
M2M>%&&$D[IGKW*0RI33$F1BT&<?E9%^#.^YG<#;>[&A84_P,#)34 V=T.>A>
MX]$33Z(MAZKOOL8;9TR'0+?J-B <2=*3G")G%/ZG$'MN*<4!X5L21CM3RXA]
MG!A#@12^8K^_<E,"Z\)T#B0&!'L!NQH@&"@([-%=7'/T^?D:T0="$:O[<JX
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MKN,R:AYO(B]H>7W7'V<UW> %*&SN A1>O0!CU+$;NP"%S=T!A=$=4,]7GE^
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MN^X2UQA(N3]4[($:[T+!K#/=)*+;6H.^Q/03\;QV([M"KY74%'OPVEHO BC
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MY/*LD"MDK+9:?<MVV\@>U,U'Y+BDIC)Z_[0IP_+B2P&IE=N[07_'&FQ!+H=
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MP'/DVZ&1+;."@'5$\13I295861CP>8CUL!R7R8+Z/Y=462B#'"M@RTOD,L[
M'%;9ZDL.4!T6-''V0"'.'@B'O,Q8!)XA,%#J5[5R<S*H-CJ3VYK^[?+ZNMYJ
M&H>6D*/G8'KXQOJ6@67^"19!2, =V@30"B^RN6(FTNM/)E<65@$4R4ALD9=/
MQ$J76%G8!1PVX8IL43K9!2]$$Q\6-*MJP,D4.,KV)5-+)W.;CMY_\X&.(]2I
MHO_+<_I/J_^.#)I5Z8PZM(\@QZ5,&(CBJ41&HUZ=E)_ZG<ES;UR1OSR.N._Y
MG60RHDD+'U"/(_>;^EJ M1UF$F0V7UBMM XS<;@.]C*PT 2!%?ECW2"^#NZR
MJ'$JLKFM<;<@>JZ.'"PYSLXN1HYN(L<I6X.N;A+/,E@C[>*?'%WS',Z2;2OX
MMV022[D//];-T@#+'+?96_ 5?XP/F0[8\,<!ZYV!$TBYL7KG_A@9C>_]C :0
M)A-X]$!8W'D[7JP>H3$]$YE,$QPJ:Y;\*YXG'7TP>K<;:NU0LG(\*\;N2UG%
MXIG;1@=*ADR<:)GE$H0[3D3(TCD6!9:+W<>1D BKHJ(UR\8^B%D>V38RU7$;
MH\2A[_BHZ";$ 2[(I!YO>/N\/8ITOO!I8O;%XF$4UOP%,/_M^TR8-U3O: QZ
M5@F5CSF*LX#S?<MD#6IF*<T=#,-_WYS%#-#C-AB>MR#*\_>)C@OIF(HZ6$#%
MW&8C$$]47)N*J>B3!504>%9.H%?6H^*JDIR&95K3@>9(S6:8B/-URU0B[EM^
M\J@.M,*SL\FVT9U4YRP-UKU _EY(SCWH%CXG8:\XM7S/B6R[4"4RS_().AE.
M-%N39EDJCIPHL5(^M<JX.<UQ2M/]F="LLAW"Q#0P.?7/1YC!FD'E"S6FZ.>P
M286<:]VT;.RL^_':DJE-/X5.#;]&;M_"?WG$'R'!@&EK)+1!P.N]FHS'O<Z$
MZUGF@]PTN]V,ID0E2@]Z%4!TEBXSM*U'W0'9@?_IVR$N(&+?X?*=46ZG]4""
M5&2Y_&J3XU"3&/NE2C9E/Z)88/,)ZK9/--E==4\.2SDYGT7"JC2G'S!./,/H
M IFH1]?;S:28/!'^C!I7Y9Z1N[W;=>#RS8>;E:+Z!=JP"RBTR]8_3LRSLG3R
M$E.F5A:RG)6+ IO+GP*-*=,JDS8_GLMC,9]:<^:2<&(N&DY$[J):?E_*#Y1R
MO=%L3RYR6F>B?AK\_-GX\LG0]F>T+]S;A \SLVEXR5/_P-U/4\3>G<Z 5D"L
M-PKK\_9IZ=>N")^!^I'() MA@X#RB>R[(GL&FDR"I!@KY58[*REO>#L%/O]8
M:%95A_NKI&^0W8)=H1>*HZLPUD$W1B[2=M^H\.:##Q(S1#9=8'J(B#U!LQ[3
M7:QB.EH IF]2D9ML3S>MX"+O6JD4EVN_S51;&GHK%G,IVZOU1FU:<]V05SEO
M/G#G"89OI6F;'#\9-K4>EQ$A05;@1(0T;+E=WX0XN<DMD9N>DMY"<B;0T'%"
MU'OQBV$=[SR[%*2K7?X_\0XO(T0FHG1U!\*)##L0IAG<AI/O^Z=#LZHW_QOA
M)NSD8LZ ]=6C01?9S1YER^;(=5S%!-5W&-WZ/K1G"@47W\W! -]DXB$[C!7"
M>XBT.$&S>7%:4CY]D6YTXBCVVDIO+;1F:AKZBC!79*6<S'*%U:T3!V:5'#*5
MTK$;(S3*D\KRH[,<#YE&Z1B5$1H)O,06$\SM3,5'%U8+:\^BGD/)B_;==\YQ
MB["\&^DML2(FA5!<W7/RITN&M>B4LOR66$[$,ES(G:B4)I52E^!2@6,%.=,H
MZRDP\&="LZK:NVP-AC;J(]/1'[UR^ 9RF[VV\GP8L0 ZN6\*3*^\CV5,1#8C
MN\KS(:+^!,UZ;)F?G249PYN+)P&43(W\RZ C:;1?(]J@X7/SC663/[BNK7='
MKM(U4-NZP2+8="/S6#1NNM+U6;YKE,P;:\P?R%06#P'A,!8W/#2C!*>>:W](
MNFU\F[KM%,O@DC\UV53>7;+3[FIJ18G-%S8L[-_"#MM!P?_:7'*$++'"V)\@
MV](4IY^0%_[W_TE\+O?^Z.=T_PF47^% ' [E5Y54+K$>IY7JY&-.M=O&\(+[
MGM'4F6U:1N*L2V8##?H'5),OH?A.>TEDCA43+!M-OZD@&YJG0^#,J7D8*LLC
MXHEB"2AV&*HF$<4\9?,/T9_X)_SS,"I\J0O$M/4!<I@&>F)NK8%BLO07+--"
MMMY[SPP4^U['SX>/<MXK=5-#\'V^<"Y$23],]2W>P50$$P3>?&CW$:.HF$!#
MQ1S#JD'3<O$CL57 *":CXP_=VXJ!=8CMOGX%48P^<A 9A0QVC>(BC>GIIF*J
M.OZ4X^)?$,?N/#6P4\?#,3PP>-3_G)TQ-1T9VCOF1KG'5[&%?H^PW8?>,:+,
MG)WY0D'3'_V7TD>=N=;P'5, ?O9^X7-Y 7CK7\*^F L,P[L%Y![!OYVAHOK_
M3FC<>G_'9I"A#!T,F__3>^9)U]P^X(![ZRDT1Y\@/TZP).:+X8^[BI'KZSU:
M$-XNDJG^)_)OXYF_=A9%L(_:]TQ[/,0@EFREJZOOF086;13]#0M0GH]^Z1__
M6_"71>\7WL;*T%FQX@N5?__!Y(RA[!"#<-:UD?)P1F< O6,4XTD9.P&-5Q!]
M.,TCA-VBW#OUXN@AX?"4VP[QOL0KJ.Z'5OWZ[JK4KC<;+>;FZJ[%,O5&&4NF
M[H?,7_TOOD4F<4>4#L?EX4;#;SZ4,2S-JWJEU*Y67K]JM?%_KZN-=HMIUIC6
M9>FV>MF\JE1O6__'5+_<U=L_=@(L=BE!KC-CI-@.@[ :TIC2Z!Z[CXR08QFP
MB>%_<S+97@Y*.@I6^'\9 >@??RV1E1R"9,+KS?(,U0)IE3#20(PM3Y9.O7,W
MAL<"?*=]S]<@HN_'"URAD\OE.Q-4%!Z:Q4GNB0?'?#3 +QJ3CV"Q[1L=S!FS
M^$+]KS*TL)RDMVJ&2Z0=,<GZ(?@-/,!#RI]L"TT0SKF0.D$T)Z W'74%KH9E
M@LU9>M:=3C3H,[#,EFNI#]<(TN>=":\_?+^XNK3NBO*;@SUI8>V3EO ] O]&
M,6X47:N;966HNXKAG_IQ_/6Z9M1OJ]^%PSUU>?U3J^IH,#+  UD4*O4QX/XV
MZY.[7N_GUU^'BX'JVABX1:ZBFTCS>T7\XU9R3P7G4[DA_S)2/NYZ91;AV?C.
MQ"E^J7^Y+6J_##TA4/$O2U@KLFY)");#8)_]]PT?"YWO,"Q^U.$^.10/FST]
M7FH$3P^O(4/N8<;8B"7KEK_<@*F2 []^4BK 42&Q QX'!E6 #-& ZP*S'=PA
M;5<F<WQ@07.=U<W=PBFL#^>4EMD/JGRQO_';_X";PV]U<VC-X[[NS"80TSU6
MQP2Q9Z3NZ\)O G+\N+Z=8\XW]U*Y_[NJF@C2#99/]+3ER92KG.<X/]H,?WW'
MF)!-,I+9[A$Z;6F6[?/K0IJ'S5AW!)Z"('942 =R,I?K="#2R$E"= 8HL6;Z
MEH$9SZ'>44=O=28_;70]X;4?72.;L@TOQL-+;V.S\K%7YT(Q%%-%['0H-5=<
MD"3(K?'H;6[E\M<E=EAE28J29;Z+JA5+R:1.[M(XSJ="5_W&CR=Z%_N2KN["
ML2_0O6Z"7,0$]O!.^[ 3RUH/,?)JQ"1*@:]HTB@YS1Y-?$.ZVS]N9^ZTVS9M
M\,4B6^!6MZ]&V"+M0LP#9_"U2_G29I0YD98II\Q52P"/K&Z=/?''D?''TJCP
MIKR2XUG8$YS+K^[5.S%,A@Q#LLO>T\\<I)[ISV=]7=,0_@S6SKS^W+4-3LB)
MD6(HDG\^4>G(KW5\T'_C^RRP!0G:,W:O !;9V+E5U3R[8J@D1(YP!7!4B@3?
ME**\R$I<GI6D!57'2=$>5U-?G77$ZHXS0EIE9&/$WR!;M[2OBC%"Y&_-(=E@
M5'U&MJH[2"/U]97*\^=!M?];0%**C6IQ(XN]UT+CI0/@,!:%)]VTG2R55^.$
M6N/Q2,G,1U+;O<M+LWK!H7S@(RU$RIROM)DT6^OHR>J LW*,!([EN&/=&[;V
MW=L1KF/4RVH[\<]$<2;6>4$0V7R",;A_*,J3%HPDZCW8K./@S\1\$IMU=VC>
M>E;(/G&ZC6@0I05SD!*'YZ=V!H0-ID[;6B#/B+[M*OAX<-OP55.\1E7_V,U>
M%!F=R=7%A>.Z.5<1Y;TU8+[Y0& Z(W S4<"SOJ;T@P&7'XCL2!ALX.55P8;#
ME'X9\/$A& -B@6>Y!('=0V<K+/,.E:V2GH#?Z@2[T5=[NP69\'=RC59(&-.@
MOZY9=@O9C[J*'!+/N/W"H6Y5KORJ;**NMJKZIZXLHQ.X&-=B*KJ-5->R';)D
MV/' 3#O>D4\:[YA'6&:QCDK^RV.SYC9U8!DOUI$0/1E'/N:0L->HA\1*@GBX
M"F%C>WI?6)[?)WA"[FZ,FUR^P,KRZL$:?R"Z3U&./6#]%.%(!9^;BX,BRW$+
M5%MR6S"ZV:NB/^K8D-><,B991V_X0Z+TSJ0UX!O#ZW:NW=[9!LX*4@W%IN,3
MK1[C Y=]/.(H(Q%YX=A=QGS^Z$^PLO1D7R?X:[E8F[KX&:B!32:)Y=E<(<<6
M\ZN7<LWCY>]454+ZR,L<.^'1_TXF^J=6D7=T*OEWZ]XO*&?!D#'ZEETH&S1O
M++M@&\R]7*!5#GWD9VKG3RQ"5P;43RB;09G(G5"V+LI6QM?_')0MU6U3:F''
MAL%,F(F5A3PKY597>JQ/NKUV"69%AXP0G;RMK4:"WU(0_)83M;71B<1<]X=@
M5/N?-QGMG_%$X@4M;M(LTQS64.*%N8U"DHZV62*FDL&HZOW)QX??XG/K?MN.
MMO2'*2?K9,NX8+/(YG,%-I]?G;](?YCR8;'OOF9J)ZQ?SRRY ARPCU':)^IO
M0?ULLC\"FQ<%MI"@:^7$#H?%#@>0G3JQQ$&Q1,H-;=#,EF/%!*'2E/A@E<-T
M*,SAT3"=)K4M_2KL)\@\SQ;XK5-V0@>IV/.P!MBLII(%"Y)JKX=4M]DK]Q7S
M'CFWB @<*&NC_4[-7LE1"URA,ZG\^JBJ5J%<_9KF>G:"=G^:_YDXOR0M.:.%
MAV+HJ2#]YYV+L>G!H+I)\8X&?RZURDP!FIM.R<&8>%?AZ).#A:-/#A:.+3GH
MZ(/1N_4%3++M-.FE#_%),-[G\F.RP/)%^5!SAYGB-EOD)4HM%K?JFIZH@W;S
M1ZG1KSSG]]@1L[-^ZKFHZ/K]U-E$Z!Y+:N&VZ=@J.J)^ZL6R)N7P7*' %KD%
M[64'(-9WT:N7/J[GO9L$$8\_$\69Q)F*4I&5-U*<AV5N%8^^A:IX#"U4&?'X
MYMPKL;G\JC$P*SWL4M8MOX/FQ\_*SWYW4MEY"]7>VGR/TG,N%@]6C!Q$:^..
MM9-4$%DI?\ &05*V.MR^\80GD%96G1V =MK;+<B$OY/KKP0.Y9(&7^F[_K&I
MUI_:E_OTOO?4ZWNQ7:]O)GYXOBLCWB[<5P3^*'M]=^612VQ!>HGSS?:%Y7E?
M?)-FC)>.W4P,':Q7#]L-WQ^Z#Z"<XL_#^JG9-Q5\;B4.I)49F77B&DN:?=6;
MYO=OQG=M9!9V'9XX-?VNXX3)1Q_DE+<+<A[""0ZVMF+KOM4,L_:+VUKE(LN)
MFTSL.;"FWVW2\IMA)U%F/K>PZ7?2J#2>'N3'FFQL,J@\J[:;4Q/PR^DU3"I2
M5P;=3RB;19ET0MFZ*#NUFJ?5?)J=H3#;FRI* BOPJ^,B?V83<'IYB.6(3MX$
MS).HN.Q'Q7DN<1.P\XV_R[6OQ2+:9+]EJG-(EG?^RK.<<BC=#^M4'2[J_)VE
M7"KYC O3M=7OOWX+YJ]C[?S-N+2PR(IRCI6$U3LL3YU=>^WLRBS5 AQPZOL^
M,NIGT_DKLD).9O/%DS X-G8X@%35B24.BB72]8=XGA7$/"LFF'!^ZOS=FH@;
M=_X6V8*46[R1?+-AO1NT597OQ*^3ZOWC[\N=#?'=60]5@HZS53U4F?@ZW[^(
MOS^UGX?EAG9$/52R'TC@N6P='1[?BT7U^@>00MM%\T/ZN(Y98?YG[Z1<C.)L
M=E+R,EO@#[@2,5F$/)\[V-1VXA/DCZ!*/54>=ZV0R[?AW^+V751RYEU4C[U:
MX[DP^%063VU4AWT/#[??Y2 :2':LH'(L+Q46CR(Z!+(D9"S^V"O@\OPQM/GN
M^!ZDH<16\'AR-29NW$PU<=K?[]JR]+$N]?Z\3BIINTZJ3+SQ+E_MMHKZ[Z:L
M'F4GU:[\\B+++UHM=0BB->.R_1UXY"\QY+$M<K-II))D5I(/>$I/4C/A< <1
M)#W!RA+% S!T4N/O-$P8X%V96[GB:94!4TS6]5.US/NRHM^YI5R6WO2IQV>]
M:R,<?1!.V"X(=P@G.+;9G<G;5!:KX^QZ?'B18_/%%[#8;RM9OR%^$G7Y)/59
M2RIVH1S=BZ<^_;BYU1I-XZZZ23QULP3QM/=UQESISU;/3=L7S2?U1:<0DID;
M*M<N[X;Z0^'&R2UP0WU$9.QU1H^[WT1P+L<6I-7+O8[/*]H#BN=C80G6IOU1
MF,W$U118OL"Q8N& <9W0WLD??50]?PQ1]328.PT_DS)N85&!<7)/LY;0[&B@
M)_(7;',@WBKH7^Z_?+Q$N\[A4O'J56!Y>A<BOBHV]UC&1/NS0D+\9&:"?!D^
M7-=&[=Q/)^S!68F0C*V1X-A[-45X%N.;Q4@_7#&^L539-8;G0UH8N2^Q%FU3
MQ&:3WN>*;#$OLOPA5U8F5>2'6SF2\ 2K]W,?N"F2B+=32=D3OBVR@K#U!-3H
M6MM%O3<UR\86@ED>V38RU7';5DR'OJUD:N1?!BUA"(H?&LAM]MK*\XUEDS^X
MKJUW1Z[2-5#;NL'JPW0[$^%)&WT4W0>YKF4312'$36?5EH<"QL<!$SDV$RGZ
M.,7FXZ_VP<:%$Y^@<+ G6"JO=GJGU]7IF[7])9>3(BQ\/'[5+AY#0OA@&"T-
M!;N,<=;:/[EHA%CID_+C0:JH/]J;C!!+=6C':6[8RQE/E%"@%%:&+4\HFT79
MRCCI"66S*%M9D/'GH&S+>579%1],ZST9NY0\RQ767Y#]9\P-2]'$6('JY)/#
M:AM,#JMV)H-?Y1_JH"A*S5\[*[E?:UX8S\URR*',3%@G>S$_+ZR:7:[BOM;^
M7.A_>^X^B6$//7GM40P+R[IT0F9E'A;VKO8(3\-@]CD,)KNL"G# ZG;S$_4/
MBOK9I'YXB16QHLGS)VEP;/QP(&'#$UL<%%ND/#&LR.:% IM+T/I]FABV-1$W
M'_E88#E!9.7\)MW+_Y"8,OZ)_M^_PRBJL0/*8:2T]0%RF 9Z8FZM@6*R]!<L
MTT*VWGO/#!3[7L=(@8]RTWA2L<V.^2]X\?!#AB]I]Q&CJ%CT#15S#/:^:;GX
MD=CP9123T?&'[FW%P QCNZ]?63T&RTT' 4&(KPRBE.GI)O80=/PIQ_= G/.,
MP4X9-\?PP.!1_W-VQM1T9&COF!OE'M^[%OH]0MA'>\<4..;LS.==37_T7TH?
M=>9:0_P9D#'>+_S;7(#;_R_A:HQBP_#D [DX\&]GJ*C^OQ,&4;R_8[??4(8.
MALW_Z3WSI&MN'W# O?6$AJ-/$$4*@&$O"BM@^.-D841*>8\6A+>+5*7_B?S;
M>,ZJG441[*/V/=,>#S&()5OIZNI[IH%E%D5_PP*4B]$O_>-_"_ZRZ/W"VUCI
M."MM?%GS[S^8G#&4'6(0SKHV4A[.N@C+0@R58CPI8R>@\0JB#Z=YA+!;E'NG
M7AP])!R><MLAWI=X\Z'[H56_OKLJM>O-1HNYN;IKL4R]4<;2JOLA\U?3\#>$
M>Y0.QXEPHTEPNXQA:5[5*Z5VM<*TVO@_U]5&N\4T:TRYU+ID:E?-;ZV=0%BS
M;!#PS!@IML,@4\/2?2:T1@?R8]V@P0]2%*SP_S("T#_^6G(J.03))-8;+XZZ
MGHA*&(,FYI0G0*?>N=P(R1C?J5_N9 3T Z,")W0FW:%4LPI-O3^$E=FC 7[!
MF/P9RVC?ZF#.F$1W:5^\D3POGVH=21#QE\5.3 !Y<N7^?NJC?'N@_EI6=KZZ
M.B7]$I@0]$HG9O?WY*GVQ;6Y2>/7U?WA@EX%@(L!Z!(%O??[YZ#YT;F0NT;:
MH(?)GJ6,N)C?UO <%R?;,&N#>OOO&SZQS;C"@?1-M+@43VQ:,:8;]L@..K_[
MYJ4>5$KCH*LZM1O(A5;S&]N"QG/M8GSG(*UN-H<(IF68]R75U1]U5T=.J>NX
M$!#HZ!>=R5BM7 X??E?NRKM+><9T4V'(F9YA/3E,S[8&C.5#S2@!V-F7$>]>
MDKYD:.(85EI8_:=C%3)0RI.J==V9Y+KMC_<.?W_12',VJV?-B.+;.!9<7.WG
M?8]_NT!V3'\L%_OTN;BQ_^G9CQ]=4492#"P-61P5;G>U*._/PVPQP*RT+69E
M(<]*"287),;LJI;EJ2FGMPB?3M4--'7FMK6)AKZH#BZ^WT\*$W>3T5IKMP2!
MRSC;$T1_-X^?R)EA]J7MGQK:?3UA"K^'?T$;,#/TCLYTQR<5_P*@657@7T%#
MS!.Z/\NW-(#NA0GYY[3"_ZZ( ZDZE/H/_105?C(FC@))@G]*!,RLL;YBB-1B
M_&4^/I"5"SDL13<9M'4(/5[KHBXUI<ZS19%C^47)UQ>'N-1T-D8<GV.%18NN
M4O,[+D:.;B+'*5N#KFZ2@Y7QL;"@P'H,_^1@#44'3)9L6\&_)?JMW(<?ZR;&
MQ\ATF[T%7[G2E:YNZ.XX-RW@[B3'D"Z;U=\_Y&R4>#)91T^!53/S",W9,$%3
M#0Y"4M_!2?;+A3LB4N92E.-9<=$0UH,7!?LD0FKR.,?)B9S7$PDRD^PY$93B
MMI/-XN1Z:;:MX&)VA<2T&/[RY7ME],7]P?]*<V!4,MD;W?JC[G#K3X(FA#FL
M9;]?0RP66/&0=\BDA;7T!!G+%8NL)!QP[WY:.$M-\A1!^$O;#O"/DSR5B.2I
MFZJ-\,$JB/ZW;E90#]DV1'<@!M)6GA&)<#=@5OK \831@_KCB_3\>%E\VJ=)
MZ(,:Q&L V*PY9<7PY$0(S7RP(;YM17&306Y_'RWZTO."97SQY$VV6!XO\M*S
ME]BBD&.EC?:N+IGK75LJLDC;2!B+=ASD.MC_]VU$'28LNE.!:7U8K%5^W9JC
MUB8+JA894_-'^LL']F] &OD)"ZM#C(>>H%E/B9:7<F1)5<%]<6Z1BO1'J*N;
MUZ&U_D-]P#W)SJ"X3R7J@PHI$ _6@Q-C\^C,/H:,A2);E#?Q_#)7 QFA;PL-
MZF#P_OOF;&ZE@U1DY8T67NQ&&&3%B"FJTWQ!9"5N$S=@B3HM+!5>9<MQZV;U
M646.T^Q=Z(:!I4C3O ,;8F@@%[P@T].ELT)-_/KK4J_]NKVX?]AYE.(6/2)S
M!+LD3 81Z"%(W*7P9^X7K,M*R;&<P0J6^.N:RW.LD#O<_>UK7]<M<9QB_(//
M2RQ7V.(:OQRLIB8<12[/BKE-<FY+1*.T5#3>V&BHZ%KU&8) ,3;=Y_%W_DFN
M?E)^9S0#-YDD], \[+C(-"XS#]ORK"!MOGKKR!"7FN3*BSR^8YO$;0_."DZ
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MU8=T5T,9%["%HP]&[Q8C,/MEFT7,'!Q_D$-]4D19BJ('U)M</*:)T)L@++W
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MI \;Y^P G<%)SIEZCWF*1%U#"RWL7(((HDYUG!4X4-% JX/Q 985>8I.9TQ
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ML51$SPNY%Z*HOH$I@1&=^/1@-SBN$V>O@>V+0.. D>,2]SA:I#(5L=%-C21
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MU^G1JJ]AN/& --"1B1X893I!'>F04+QW8.(I!'G02Q&,4XILTC7&7M[8:ZW
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M!$?D+A9>!2+9F[T[!Y4 YQV]3FN,.Q-+46[[X^;/G]TP4IU%98DT&V:A1R*
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MS!&QJ4>&6CP0;F5 W';C))2C"<D?0C0.^,7)_7,_7Y;6'OC1A:=9X[5Q G?
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M=^'R=I+3<@]/F8@VMGQ+_W-TQ%1%8<#_8!I<#QCA3G@;XR#U'TPNQQP=F6*
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MN3S^]7;_2TFNY>SSP4>T514A.@#3P9KHQ670["X4S2C(+C^JEA-7F=MT)1M
MY0Q]MM^6ZC?"%=@!LVKV=E1DP*RO+?HIHZ#\1.^DF!F?-.MOW> :[S89(-KR
MD7!9HL"FT^G/RQ$K5*/L"?4+'].SZ?3L5)XL+3S>)LV'5[P2+GUGDVPNM_KP
MMMW,@5T^W6VE'V^V?ORGSYWL)BF0#/B8_?V*N7U;&FT7BI:VX+QAW#^Y@#;T
M[SA?<4/?Y6YH?AU-;*NDOXE^%BDSP%V52;+YU/9&1.X3,^PD_3$XX:^BA&V5
MW(.J9I&2=AYD?(%-Y6,[_;32TD^3Y^>)]$>U^U'8SO33B.:\N;R/PL=(D%0<
M4Z<P@&#BK,.!NP)_># S@ [_?[+(<!*/_R@P$TYE_G"/_BHFG'DFSA?5NUOQ
MX"[B1SW]7/VX.)_\NFJWO5VQ<G=^!-DRSEI\R&^K>69#X3$W9V72?E<&&:W&
MSJ,PNQH*"R8* 9G1H[ ]O!U+<JXNO^X4A043A8C,J%&8SOH5&A@H1):<0V-R
M-33F+306HD?C0ZE\?"N.<IF2L%,TYBTT%G:.QN^AR?W0+Y)O/ZMC#8=>.C5V
MZ\J0 *A,%\B#1GH8D0PPI7-/U?"FELZ>*J(AI8L, \?I3^B]N?&TTD) $V[9
MJUOZQXWTJO#B]+0>Q=A2%W>JQN3.=8:6&H.?42'[P7!C30XRQS2+\]N,)Q6J
MX^&C@4:;>CC25O<@STXX+;;T5#KS?MI]TKK5;I )I]UY#IJ9;KJ"J;7-"8 +
M9WQ&./%O0[R9@PM#UJ*M9=L_GPQ5&<[_WS]M,DR:B>YMMC)NOBSF=.,8?#J6
M@B2(Q&149/9/[W/ !9*</454,ZF"5I3,WPK7L'YS(@S>A2L 9C^2?(6%JMWM
MK_'@;3J\.%<'EFJ'H(M^4MIR8.S>SY'-[-<D*@?QI]9,=MS 5^>!4A2ZS8F\
M=;*NW/U*3K)GZN RYR3K5#0YL[[GC@$%I_<KI]%!P>D0*7A]"4TPV5<$8>LT
M+'7?)TG]NJZ5NDX:3F^5AO'DNZ?B="$3_PY*#M+-Q(9TJ_)8V3KE-A/O7/:V
MF>DW7YR4F]DFY>+!8T"X^=2^BM]LB#0<,''+#Y7PVZW3\)1[K0Y.)N5A)N6D
MX>Q6:1A^^\EH.&@ K]327_2G\RQ_<MIP6".AFNDS;M?9[83OK#23 RORL"U*
MM,RX)/$$>XVQTNESJE#OFK]J*IRD4EBK#;#A.U.GY](!K(PSBA?:.UIZ7>@T
MRR>]Y+F<B2B"2OUT3OH!BI05LNL?0(:\H&!5PK>?YGX91Q*6:CGDH@W -OL"
M ]"$5TT9KM-!]XC 6^YTSM[0X8'<9<Q)+"QCM!;"5[V+'7QI3>I\)]$?FA7)
MX*%Z9)61@1EF*&A]F4</I/$J_,4$<"?0MQ'.IB]5,"<'%AN(7%L<P X$]?
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M+DAC@34#_70#'4[M,UV,S[ ,];?AZ0$!7$\ P:1J!#S<2-2X <OPHDHHY_!
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MVC]GE)"@.R=!^TN\FBG0:GC__J"Q>SOM8VZ_GDSN$PV<0TN E/M5 5 H;@0
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M@DF^J9TH;]4.G^VN!)/%+KV%4%GD'?:8D++@O)O)6+=D#?U$<P[=;9\H[Y,
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M@@W8037*K $%9:K#*<H4%4.J50VY*2/)&KY5 5I JY*4HOY"!9$C=776Y^)
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MO;$IV1%50+7$#*?2Z\]PC!*UXW]51H*#F!+*O-Q8<PNH8@3=PLS]B+%^$[-
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MO;L#1BX,+7#4'-#8@.)#[PD3@K1<<,806"*981.)3]R\:#6S8D/Y^PG)<4Y
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MDPI&M0\_/ +I-P2UJ@T2W$+O=\9!#A[E6NXBK8ZLC+ OO0#"7^)5D/-:__
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MZ@BHNN72RU2W/49;= J:WK[K792X448_[FRB8RW%X[94JW SF .J3X%):^F
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MLF/^2+*)1 +_QV#+#[1*Z((J*:8E*I5V>-"A:9V,@G4;*JQ%($OG'TPX1>&
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M:C3E/3QH@QPP&],:^1VP72H4K#\QOD_2T4B2@#-[K \W)BX.+_Q+_)M\U%!
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MKF:P-9\!18<ZVS6N]!W20\BWY#,X/&6+F,\@:B7TQVE:.*=V:;<^=2FEB<^
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MYFF-0E,\T&8*YQDJ#5M1*)/V&[!!#!JW71E!.O! #"I',O;N)T^EXG@9(HE
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MYNL7>)GL=1PY2ZB!?53A2%/!<U3%G)QC.;DI0B%H0WUAF66_61-@+8"B@;J
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M]B* LHNW?KF+"!TX%05"?0A@=+FIM?OV&@!"?TD&($J'"PSQ Q,-0W8QM*H
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MQTUF=E#W;4B1EOI83TJ!2BDB*@0!*A$M4=I))2)3B:A26^0.0&<'E5AF3=O
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M+7>B0WJ,$ 96F,K]1_<E_U&)BV)U2Q!XS*3'J"#@VZ72N<Q=<XK926@2HP.
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MCPWSW\;TP8U?4U+,Z</\Y'7$$G4=L<2F>2)P6R1PRYP(W$X$;B<"MQ.!VXG
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M7-2TAW3182:RRYG9=QOC>.C;LCMST* #@+=F4^X\]=XO)TSZR&?B:+C Z73
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M]*>J8#O13O5]F JY@JU1E=2<;"S8^)'8R*T1=9L*-C+"$,1GPM.)0-DK/(4
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M)=3JT86FM"_J?AVR8-$7-]Z?6G2YH@U5[DJ"G1;I?QX?D:0BJ]+?P-'LR[_
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M0TLBY[LV_Q]02P$"% ,4    " "1BG!1L/I=80\6  #G%@  #0
M    @ $     :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    ( )&*<%'_QMF>NH<
M ,R=   -              "  3H6  !I;6%G95\P,#(N:G!G4$L! A0#%
M  @ D8IP42 PU$-*$0  &+X  !$              ( !'YX  '-I;74M,C R
M,# X,S$N>'-D4$L! A0#%     @ D8IP4?#P9T&N%P  C# ! !4
M     ( !F*\  '-I;74M,C R,# X,S%?8V%L+GAM;%!+ 0(4 Q0    ( )&*
M<%'_];]S73(  +A@ P 5              "  7G'  !S:6UU+3(P,C P.#,Q
M7V1E9BYX;6Q02P$"% ,4    " "1BG!15#Y#ON)Q  "!H08 %0
M    @ $)^@  <VEM=2TR,#(P,#@S,5]L86(N>&UL4$L! A0#%     @ D8IP
M41<:@/U>5   Q,H% !4              ( !'FP! '-I;74M,C R,# X,S%?
M<')E+GAM;%!+ 0(4 Q0    ( )&*<%$6FUSC/0$  $L&   6
M  "  :_  0!S:6UU;&%T:6]N<U]E>#(Q,#$N:'1M4$L! A0#%     @ D8IP
M42(BDTQ6 @  A@D  !8              ( !(,(! '-I;75L871I;VYS7V5X
M,C,P,2YH=&U02P$"% ,4    " "1BG!1N90 K#8'   #*0  %@
M    @ &JQ $ <VEM=6QA=&EO;G-?97@S,3 Q+FAT;5!+ 0(4 Q0    ( )&*
M<%% V@<F,@<  ($H   6              "  13, 0!S:6UU;&%T:6]N<U]E
M>#,Q,#(N:'1M4$L! A0#%     @ D8IP4>HWR&P)!   !Q$  !8
M     ( !>M,! '-I;75L871I;VYS7V5X,S(P,2YH=&U02P$"% ,4    " "1
MBG!1FW,%/7&S @#LBAH %               @ &WUP$ <VEM=6QA=&EO;G-?
>:3$P:RYH=&U02P4&      T #0!7 P  6HL$

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
